data_2lx9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lx9 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 . . . . . 0 N--CA 1.465 0.286 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.9 158.87 74.41 Favored Pre-proline 0 N--CA 1.468 0.441 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 39' ' ' VAL . 44.1 Cg_endo -66.97 -19.41 52.05 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.549 2.166 . . . . 0.0 112.369 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -136.98 92.63 2.75 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.83 131.81 26.14 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.63 102.22 14.39 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 22.4 m0 -101.44 132.04 47.24 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.191 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -86.84 136.63 32.9 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.8 mt -92.4 117.93 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 12.5 p -104.21 -32.24 9.22 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.73 0.3 . . . . 0.0 110.25 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.72 174.48 21.79 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -90.15 153.49 20.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.801 0.334 . . . . 0.0 110.334 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.433 ' O ' ' CG2' ' A' ' 18' ' ' ILE . 1.5 t -80.73 168.32 18.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.659 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -68.36 -40.57 81.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.877 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -63.63 -17.4 62.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.419 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.433 ' CG2' ' O ' ' A' ' 15' ' ' SER . 10.8 tp -41.89 147.42 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.587 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.98 155.15 84.78 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.343 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.98 -31.03 66.86 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.562 2.175 . . . . 0.0 112.213 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.24 -56.82 12.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.142 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -61.44 -44.2 97.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.65 0.738 . . . . 0.0 110.543 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -58.0 -47.62 82.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.589 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 45.4 tp60 -57.98 -37.27 73.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.532 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -57.91 -40.82 81.33 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.388 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.38 -42.86 99.39 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.81 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.92 -39.95 96.11 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.199 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.5 m -60.47 -44.11 96.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.795 0.331 . . . . 0.0 111.205 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 pp -93.5 132.65 37.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.555 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.94 -2.02 69.86 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 71.8 mtm -86.95 75.0 9.62 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -82.6 168.62 22.08 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.127 -179.199 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.451 ' O ' ' O ' ' A' ' 32' ' ' LEU . 77.5 Cg_exo -43.47 177.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.603 2.202 . . . . 0.0 112.412 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.95 11.96 7.34 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.487 ' OG ' ' N ' ' A' ' 36' ' ' SER . 34.9 t -144.2 -172.0 3.69 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.848 0.356 . . . . 0.0 110.344 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.487 ' N ' ' OG ' ' A' ' 35' ' ' SER . 67.7 m -128.28 155.7 44.18 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.517 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -135.53 159.14 42.55 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.349 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -111.97 150.64 30.28 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.572 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' PRO . 13.1 t -86.1 126.82 40.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.526 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 p -67.86 -41.46 84.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.825 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -173.78 161.51 3.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.994 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.86 121.99 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.33 110.57 49.37 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.507 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -76.65 -11.74 18.5 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.042 1.828 . . . . 0.0 112.327 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.0 mt -59.67 -31.04 69.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.996 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 132.12 24.83 0.77 Allowed Glycine 0 N--CA 1.468 0.772 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.71 160.36 28.8 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.93 175.42 0.46 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.86 2.374 . . . . 0.0 112.02 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.472 ' N ' ' O ' ' A' ' 60' ' ' LEU . 7.6 mm -92.05 114.81 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.885 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -92.74 122.16 34.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.872 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.5 pt -127.5 150.69 33.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.801 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -128.83 137.64 51.61 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.128 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.561 ' HG1' ' H ' ' A' ' 56' ' ' VAL . 0.7 OUTLIER -129.49 138.27 51.29 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.753 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -43.78 -21.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.59 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 53' ' ' THR . 85.0 mtt85 -82.81 -48.81 10.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.533 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.561 ' H ' ' HG1' ' A' ' 53' ' ' THR . 14.9 p -169.66 168.55 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.665 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.444 ' N ' ' CG2' ' A' ' 56' ' ' VAL . 5.3 p -99.6 146.15 26.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.551 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.7 tp -155.96 147.86 23.18 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.335 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.3 p -126.68 131.43 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.615 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 49' ' ' ILE . 2.6 mp -132.95 155.05 49.82 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.056 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -72.91 162.09 29.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.941 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -54.55 -45.9 73.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.869 0.366 . . . . 0.0 110.807 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -59.98 -40.67 89.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.526 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -61.12 -40.76 95.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.495 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -63.06 -42.12 99.63 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.24 93.52 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.214 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.27 -42.13 84.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.221 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.5 mt -66.81 135.74 54.39 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.626 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.453 ' O ' ' OG1' ' A' ' 12' ' ' THR . 94.6 mt-10 -79.97 113.25 17.99 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.142 0.496 . . . . 0.0 110.175 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.9 m -132.16 155.94 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.747 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -142.54 137.9 30.48 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.754 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.9 148.03 51.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.145 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 38.7 t . . . . . 0 N--CA 1.466 0.372 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.347 -179.555 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 . . . . . 0 N--CA 1.456 -0.147 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.476 ' HG1' ' H ' ' A' ' 6' ' ' ASP . 0.1 OUTLIER -137.91 155.99 74.46 Favored Pre-proline 0 N--CA 1.467 0.38 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 -179.184 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 39' ' ' VAL . 43.3 Cg_endo -66.79 -22.19 49.95 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.51 2.14 . . . . 0.0 112.288 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.476 ' H ' ' HG1' ' A' ' 4' ' ' THR . 39.1 p-10 -137.42 93.61 2.83 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.735 0.302 . . . . 0.0 110.304 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.424 ' OG1' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -139.51 129.81 25.4 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.6 102.44 15.18 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 18.1 m0 -101.57 137.52 39.78 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.933 0.397 . . . . 0.0 110.322 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -95.24 129.57 42.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.038 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.2 mt -82.42 122.62 37.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.123 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 8.9 p -110.75 -19.33 12.89 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.559 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.72 -179.95 22.41 Favored Glycine 0 N--CA 1.464 0.559 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -100.12 157.42 16.58 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.848 0.356 . . . . 0.0 110.321 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 67' ' ' LEU . 15.5 m -74.8 165.76 24.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.765 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -70.54 -38.99 74.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.56 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -74.15 -6.34 47.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.383 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.6 tp -41.41 146.58 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.449 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.42 155.2 93.04 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.248 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.82 -31.27 68.23 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.415 2.077 . . . . 0.0 112.13 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.46 -53.47 42.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.224 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -63.06 -46.4 87.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.745 0.783 . . . . 0.0 110.652 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 67.0 ttp85 -57.99 -44.18 86.99 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.729 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -61.09 -36.12 78.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.08 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -59.22 -43.0 92.32 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.437 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 29' ' ' LEU . 4.6 mm? -62.43 -43.66 98.28 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.032 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 49.1 mt -70.35 -32.56 70.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.81 0.338 . . . . 0.0 111.091 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.5 m -58.91 -44.03 91.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.334 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -118.73 173.21 7.0 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.295 -179.691 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -88.92 -3.14 77.11 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 33.2 ttm -64.6 74.18 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.2 mp -99.8 169.96 7.38 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.289 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 32' ' ' LEU . 62.9 Cg_exo -49.67 -164.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.331 2.021 . . . . 0.0 112.564 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.77 5.1 56.74 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.9 m -138.63 -156.28 0.67 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.813 0.34 . . . . 0.0 110.2 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.5 p -146.38 164.23 33.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.505 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -139.21 151.54 46.64 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.232 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -108.84 146.98 32.81 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.431 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' PRO . 10.0 t -87.03 127.15 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.597 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 p -69.93 -39.05 77.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.885 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -173.44 166.93 4.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.284 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 36.0 m -139.29 117.02 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.62 110.91 50.04 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.492 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.19 -11.68 19.34 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.135 1.89 . . . . 0.0 112.312 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.2 mt -58.58 -30.54 67.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.744 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.48 25.37 0.78 Allowed Glycine 0 N--CA 1.467 0.712 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.68 160.25 29.08 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -60.2 172.06 2.73 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.754 2.302 . . . . 0.0 111.88 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.2 mm -96.87 119.06 44.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.163 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -101.97 131.02 48.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.117 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.7 pt -127.26 149.84 32.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.5 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -138.91 144.42 39.09 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.034 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 56' ' ' VAL . 1.0 OUTLIER -132.5 173.15 11.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.515 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 53' ' ' THR . 99.8 mtt180 -33.6 -52.25 0.4 Allowed 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.35 0.406 . . . . 0.0 111.788 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -142.93 32.44 1.39 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.008 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 53' ' ' THR . 2.3 t -141.54 139.13 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.82 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.0 m -137.53 143.22 41.53 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.45 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.6 tp -161.57 152.49 18.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.203 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 p -122.32 128.87 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.7 mt -136.66 161.52 35.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.366 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -85.47 162.55 18.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.801 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -58.09 -37.55 74.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.605 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -61.8 -41.1 97.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.535 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -59.84 -45.86 91.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.347 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.2 mp -62.02 -41.08 97.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.264 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.03 -47.27 83.57 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.276 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.476 ' O ' ' OG ' ' A' ' 15' ' ' SER . 11.1 mp -75.98 -52.52 10.07 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.336 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.6 tp -43.03 128.66 4.42 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.479 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.45 ' O ' ' OG1' ' A' ' 12' ' ' THR . 78.8 mm-40 -70.28 109.52 4.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.237 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.0 m -137.88 159.36 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.544 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -141.31 124.66 16.58 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.518 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.9 132.4 49.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.873 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.418 179.881 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 . . . . . 0 CA--C 1.519 -0.236 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.426 ' OG1' ' CG2' ' A' ' 7' ' ' THR . 13.0 p -138.46 148.94 61.11 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.773 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 39' ' ' VAL . 42.8 Cg_endo -66.56 -52.46 0.76 Allowed 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.438 2.092 . . . . 0.0 112.34 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -117.14 94.47 4.58 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.873 0.368 . . . . 0.0 110.917 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.426 ' CG2' ' OG1' ' A' ' 4' ' ' THR . 1.5 t -141.39 150.3 42.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.13 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -99.6 102.21 13.66 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 18.4 m0 -97.8 137.62 36.39 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.285 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -93.55 140.91 29.06 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.4 mt -93.79 119.46 41.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 123.357 0.411 . . . . 0.0 110.248 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.5 m -102.21 -46.99 4.66 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.494 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.57 177.07 32.33 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.2 p90 -95.84 146.48 24.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.809 0.338 . . . . 0.0 110.322 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.43 ' O ' ' CG2' ' A' ' 18' ' ' ILE . 40.0 t -77.55 172.2 13.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.485 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -69.68 -39.61 76.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.882 0.372 . . . . 0.0 110.806 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -67.44 -14.36 62.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.386 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.43 ' CG2' ' O ' ' A' ' 15' ' ' SER . 10.4 tp -41.5 147.41 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.751 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.41 154.72 87.9 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.354 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.91 -31.3 67.33 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.67 2.247 . . . . 0.0 111.989 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.99 -54.78 25.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.984 0.421 . . . . 0.0 111.116 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -62.58 -44.98 94.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.594 0.711 . . . . 0.0 110.308 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -57.82 -39.93 78.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.821 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 28' ' ' SER . 15.9 mm-40 -63.77 -36.25 83.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.948 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -60.31 -44.81 95.09 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.55 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.2 -41.56 97.02 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.175 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 tt -75.16 -28.1 59.96 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.107 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.527 ' N ' ' O ' ' A' ' 24' ' ' GLN . 14.5 t -61.2 -44.67 96.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.171 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.45 169.21 9.34 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.257 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.53 5.86 84.23 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.2 tpt -76.89 73.82 3.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.898 0.38 . . . . 0.0 110.05 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.8 mp -95.8 166.73 13.93 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.424 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 32' ' ' LEU . 77.9 Cg_exo -45.11 178.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.265 1.977 . . . . 0.0 112.162 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.43 3.4 14.61 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 m -141.31 -157.05 0.73 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.818 0.342 . . . . 0.0 110.26 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 89.3 p -143.78 163.29 33.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.397 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -140.93 159.79 41.46 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.332 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -113.26 144.76 42.17 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.567 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 5' ' ' PRO . 99.2 t -85.98 129.13 38.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.287 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 p -67.29 -41.84 87.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.187 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -174.9 161.13 2.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.94 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.2 t -131.88 122.47 49.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.1 110.82 50.38 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.406 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.61 -11.22 20.41 Favored 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 122.287 1.992 . . . . 0.0 112.226 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.48 ' CD2' ' N ' ' A' ' 45' ' ' LEU . 4.1 mm? -60.65 -31.8 71.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.986 -178.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 132.72 24.69 0.73 Allowed Glycine 0 N--CA 1.465 0.611 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.23 160.17 29.56 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.57 170.09 2.04 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.682 2.254 . . . . 0.0 111.78 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.464 ' N ' ' O ' ' A' ' 60' ' ' LEU . 7.5 mm -95.46 114.42 32.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.872 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -97.13 125.85 41.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.709 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.8 pt -125.99 150.05 31.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.699 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -134.98 111.97 10.23 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.987 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 54' ' ' ARG . 1.3 p -83.5 173.89 11.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.511 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 53' ' ' THR . 91.2 mtm180 -33.68 -53.14 0.43 Allowed 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.409 0.443 . . . . 0.0 111.779 -178.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -142.53 31.67 1.49 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.323 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 t -140.57 136.95 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.499 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.1 p -112.0 138.81 48.12 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.181 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.8 tp -155.22 149.88 26.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.079 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.1 p -124.24 128.44 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.79 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 49' ' ' ILE . 82.6 mt -133.62 161.16 35.38 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.417 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -94.74 160.47 14.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.418 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -53.32 -37.31 62.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.916 0.389 . . . . 0.0 110.642 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.43 -42.18 99.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.39 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -60.83 -42.1 97.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.342 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.2 -41.81 98.71 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.074 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.72 -51.7 68.83 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.35 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.424 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 4.1 mm? -69.17 -40.18 78.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.019 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.7 tp -60.16 136.08 57.92 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -86.86 109.9 19.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.038 0.447 . . . . 0.0 110.37 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 m -132.6 157.11 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.628 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -142.4 143.93 32.89 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.854 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.17 147.09 53.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.041 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.465 0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.198 -179.7 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 . . . . . 0 CA--C 1.523 -0.072 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.32 151.66 56.84 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.321 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 39' ' ' VAL . 42.5 Cg_endo -66.11 -27.49 49.4 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.513 2.142 . . . . 0.0 111.876 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -135.69 94.52 3.09 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.907 0.384 . . . . 0.0 110.703 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -140.44 152.24 45.53 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.137 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.74 102.79 14.64 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 12.9 m0 -99.69 134.32 42.74 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.217 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -97.79 130.44 44.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.816 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.9 mt -84.03 118.33 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.265 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.5 m -99.12 -35.63 9.95 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.032 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 144.75 176.89 19.15 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -89.03 146.29 24.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.818 0.342 . . . . 0.0 110.33 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 67' ' ' LEU . 11.5 m -74.99 171.19 14.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.429 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.1 ttm-85 -69.31 -41.32 76.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.549 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -72.44 -4.72 31.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.664 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.1 tp -41.84 147.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.665 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 m -68.12 152.11 96.71 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.058 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.97 -31.22 56.4 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.427 2.085 . . . . 0.0 112.075 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.74 -53.93 23.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.492 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.404 ' CE1' ' CD2' ' A' ' 26' ' ' LEU . 33.4 t80 -61.65 -44.25 97.32 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.295 0.569 . . . . 0.0 110.335 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -59.7 -42.78 93.76 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.825 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 19.6 tm0? -61.8 -37.21 83.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.641 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -59.9 -45.67 91.79 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.746 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.404 ' CD2' ' CE1' ' A' ' 22' ' ' TYR . 4.6 mm? -62.86 -41.33 99.33 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.497 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.2 mt -62.18 -38.75 90.26 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.392 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 p -80.13 -10.24 59.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.835 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.1 tp -100.16 126.87 46.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.482 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.28 1.9 73.71 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 77.3 mtm -108.81 74.82 0.93 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.259 0.552 . . . . 0.0 109.701 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.3 mp -78.87 165.94 45.79 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.831 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 32' ' ' LEU . 68.1 Cg_exo -42.65 179.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.788 2.325 . . . . 0.0 113.043 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.0 11.86 7.36 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.2 p -143.07 -160.38 1.1 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.72 0.295 . . . . 0.0 110.396 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 97.6 p -139.98 165.15 28.1 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.542 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -143.63 169.12 18.33 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.438 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 16.4 p-10 -124.88 151.64 45.06 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.306 0.574 . . . . 0.0 110.279 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' PRO . 16.6 t -87.06 124.94 40.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.425 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 p -71.63 -39.81 70.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.913 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -172.99 166.76 5.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.672 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.409 ' O ' ' CG2' ' A' ' 42' ' ' VAL . 33.3 m -149.31 104.65 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.894 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.83 111.29 53.84 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.405 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -75.87 -9.96 19.69 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.455 2.103 . . . . 0.0 112.348 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 45' ' ' LEU . 10.6 mp -52.12 -30.15 25.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.768 -178.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 147.36 16.15 0.13 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -97.96 153.05 38.33 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.26 -175.03 0.47 Allowed 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.216 1.944 . . . . 0.0 111.778 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.8 mm -91.49 114.55 28.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.716 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -95.71 120.49 36.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.233 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.4 pt -125.18 144.42 35.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.229 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.435 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 13.1 tm-20 -123.62 124.66 43.28 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.187 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 56' ' ' VAL . 0.9 OUTLIER -118.49 141.25 48.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.336 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 -50.11 -38.94 41.19 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.978 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -67.77 -41.06 83.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.756 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.572 ' CG2' ' H ' ' A' ' 57' ' ' SER . 13.1 p -170.7 177.18 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.578 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.572 ' H ' ' CG2' ' A' ' 56' ' ' VAL . 47.8 t -111.48 145.11 39.6 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.273 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.3 tp -147.76 149.21 31.95 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.552 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.7 p -137.19 122.98 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.7 mt -140.98 175.95 9.2 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.442 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -86.64 162.69 17.82 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.07 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -58.37 -32.91 69.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.611 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.06 -41.6 98.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.209 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -60.08 -44.62 94.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.496 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.01 -40.91 97.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.976 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.85 -48.86 78.57 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.455 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.441 ' O ' ' OG ' ' A' ' 15' ' ' SER . 4.1 mm? -67.14 -40.24 86.68 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.888 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 77.1 mt -66.62 140.64 57.94 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.511 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -84.29 108.66 17.27 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.443 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.1 m -132.38 158.91 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.296 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -143.09 129.57 20.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.48 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.61 129.21 36.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.683 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.7 m . . . . . 0 N--CA 1.464 0.246 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.19 179.776 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 . . . . . 0 CA--C 1.517 -0.293 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.06 153.15 76.63 Favored Pre-proline 0 N--CA 1.465 0.297 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.396 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 39' ' ' VAL . 40.1 Cg_endo -66.52 -33.96 35.04 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.518 2.145 . . . . 0.0 112.22 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -136.7 95.2 3.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.702 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -140.03 148.17 41.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.277 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -103.2 102.0 11.97 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 27.4 m0 -96.37 147.33 23.92 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.396 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -105.1 125.7 51.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.743 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.2 mt -82.86 120.33 34.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.194 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.2 p -104.55 -10.48 17.58 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.495 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 142.09 167.46 11.33 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.15 161.86 25.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.399 . . . . 0.0 110.074 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.6 p -72.64 163.29 28.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.555 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 85.4 mtm-85 -69.89 -39.78 76.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.588 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -79.78 -3.38 47.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.183 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.1 tp -41.25 144.81 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.683 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 57.3 m -80.17 148.72 68.08 Favored Pre-proline 0 C--N 1.327 -0.383 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.934 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -50.09 -40.18 50.69 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.299 1.999 . . . . 0.0 112.35 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.38 -56.53 17.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.002 0.43 . . . . 0.0 111.201 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -63.36 -51.22 66.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.405 0.622 . . . . 0.0 110.517 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 68.6 ttt-85 -55.51 -44.12 76.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.482 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 28' ' ' SER . 68.9 tp60 -62.82 -32.6 73.83 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.818 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -59.4 -47.03 87.02 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.456 -0.497 . . . . 0.0 109.837 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.43 ' CD2' ' N ' ' A' ' 26' ' ' LEU . 4.4 mm? -65.54 -37.85 87.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.151 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.5 tp -74.62 -28.44 60.88 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.871 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 24' ' ' GLN . 68.7 m -57.61 -44.41 85.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.05 -178.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.453 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -114.54 153.13 30.61 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.114 -179.743 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -61.79 -24.59 64.67 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 67.6 mtt -61.13 73.67 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 120.976 0.417 . . . . 0.0 109.994 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 30' ' ' GLY . 0.5 OUTLIER -86.66 168.57 17.9 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.826 -179.167 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.435 ' O ' ' O ' ' A' ' 32' ' ' LEU . 67.6 Cg_exo -46.52 -178.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.29 1.993 . . . . 0.0 111.97 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.77 -11.78 45.87 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.2 m -100.73 -171.82 2.08 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.984 0.421 . . . . 0.0 110.238 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.3 m -130.19 157.59 42.04 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.427 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -138.65 158.38 44.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.215 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -112.38 145.03 40.83 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.562 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 5' ' ' PRO . 51.7 t -89.81 124.56 42.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.135 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 p -68.61 -41.22 82.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.069 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -173.68 164.22 4.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.119 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -135.99 124.15 36.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.045 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.98 110.76 51.65 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.736 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.32 -12.02 19.06 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.781 2.321 . . . . 0.0 112.184 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.405 ' N ' ' CD1' ' A' ' 45' ' ' LEU . 10.9 mp -60.6 -32.34 71.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.626 -178.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 135.33 22.03 0.65 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.97 160.03 30.08 Favored Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.46 169.08 3.35 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.77 2.313 . . . . 0.0 111.808 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.511 ' N ' ' O ' ' A' ' 60' ' ' LEU . 8.3 mm -93.48 114.41 30.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.976 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -91.3 122.88 34.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.856 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' A' ' 58' ' ' LEU . 44.9 pt -125.65 147.43 30.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.266 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -127.65 129.66 47.6 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.27 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.623 ' HG1' ' H ' ' A' ' 56' ' ' VAL . 0.7 OUTLIER -121.76 137.56 54.72 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.795 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.618 ' NE ' ' NH1' ' A' ' 55' ' ' ARG . 35.1 ptt180 -44.99 -31.46 1.3 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.245 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.618 ' NH1' ' NE ' ' A' ' 54' ' ' ARG . 86.5 mmt-85 -71.88 -46.37 58.07 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.599 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.623 ' H ' ' HG1' ' A' ' 53' ' ' THR . 13.9 p -170.97 168.46 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.794 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.439 ' N ' ' CG2' ' A' ' 56' ' ' VAL . 97.5 p -89.18 153.52 20.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.609 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 51' ' ' ILE . 61.1 tp -162.62 149.16 12.9 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.332 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 p -130.29 131.39 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 49' ' ' ILE . 89.7 mt -134.91 161.39 35.36 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.47 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -88.14 161.85 17.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.749 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.405 ' CG ' ' N ' ' A' ' 63' ' ' LYS . 20.4 ptmt -55.32 -41.0 71.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.965 0.412 . . . . 0.0 110.777 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.405 ' N ' ' CG ' ' A' ' 62' ' ' LYS . 21.0 ptmt -60.36 -40.21 89.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.67 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.92 -44.4 97.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.549 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.42 -41.86 97.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.703 0.287 . . . . 0.0 110.232 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.65 -50.51 73.57 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.395 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.27 -40.45 81.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.752 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.7 tp -61.76 129.71 42.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.338 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -74.53 107.58 6.75 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.64 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.2 m -132.68 161.89 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.607 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -143.0 140.74 31.14 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.37 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.03 112.59 20.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.301 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 63.0 t . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.518 -179.627 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 . . . . . 0 N--CA 1.455 -0.22 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.42 ' OG1' ' OG1' ' A' ' 7' ' ' THR . 0.1 OUTLIER -140.83 156.63 68.68 Favored Pre-proline 0 N--CA 1.467 0.411 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.06 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 39' ' ' VAL . 45.3 Cg_endo -67.09 -21.72 48.56 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.45 2.1 . . . . 0.0 112.289 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -137.01 93.06 2.79 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.42 ' OG1' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -140.3 131.83 27.04 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.85 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.55 103.05 15.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.408 ' HE1' HG22 ' A' ' 7' ' ' THR . 10.4 m0 -101.63 136.32 41.67 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.287 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -101.13 130.98 47.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.828 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.3 mt -83.97 124.29 39.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.723 -178.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.1 m -109.91 -41.34 4.52 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.812 0.339 . . . . 0.0 110.489 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 160.53 -174.31 37.21 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -103.74 147.1 27.66 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.815 0.34 . . . . 0.0 110.982 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 67' ' ' LEU . 3.5 m -78.84 173.16 12.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.604 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.415 ' N ' ' CD ' ' A' ' 16' ' ' ARG . 3.0 mpt_? -69.79 -40.37 76.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.61 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -68.66 -11.98 60.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.724 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.0 tp -41.16 148.35 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.625 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.9 p -76.35 141.16 69.67 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.57 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -49.49 -40.0 45.17 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 121.605 1.537 . . . . 0.0 112.952 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.62 -54.99 37.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 111.689 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -63.55 -45.79 88.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.451 0.643 . . . . 0.0 110.382 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -58.3 -44.55 88.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.945 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.482 ' O ' ' N ' ' A' ' 28' ' ' SER . 62.3 tp60 -61.57 -33.96 74.78 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -59.64 -47.29 86.18 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.904 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -62.68 -42.19 99.5 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.102 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.5 tt -72.99 -30.7 63.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.88 0.372 . . . . 0.0 110.871 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 24' ' ' GLN . 74.6 m -60.18 -43.28 95.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.395 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.66 171.96 7.83 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.398 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.77 6.79 73.88 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 97.1 mtp -77.94 74.9 4.48 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.9 OUTLIER -92.96 169.89 9.72 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.131 -179.173 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 32' ' ' LEU . 51.4 Cg_exo -49.38 -169.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.123 1.882 . . . . 0.0 112.595 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.91 0.87 19.54 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.1 m -139.8 -173.25 3.58 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.728 0.299 . . . . 0.0 110.266 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 73.0 m -128.82 155.93 44.42 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.817 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -130.14 157.12 43.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.42 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -113.58 152.41 30.34 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.297 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 5' ' ' PRO . 20.8 t -87.95 123.0 40.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.479 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.6 p -66.67 -42.01 89.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.689 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.548 ' NH2' ' CE1' ' A' ' 50' ' ' HIS . 50.7 ptt85 -172.94 162.94 4.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.489 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.8 t -128.06 127.95 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.39 110.77 48.78 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.366 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.05 -12.62 19.48 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.813 1.675 . . . . 0.0 112.516 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.2 tp -57.85 -30.52 65.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.959 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.81 30.51 1.24 Allowed Glycine 0 N--CA 1.467 0.753 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -98.74 -179.16 0.8 Allowed Pre-proline 0 N--CA 1.467 0.378 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.425 ' CD ' ' CB ' ' A' ' 47' ' ' ASP . 15.5 Cg_exo -65.53 -173.12 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.762 1.641 . . . . 0.0 111.594 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.8 mm -105.62 114.26 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.801 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.548 ' CE1' ' NH2' ' A' ' 41' ' ' ARG . 15.2 m170 -89.63 116.95 28.15 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.404 ' O ' ' O ' ' A' ' 58' ' ' LEU . 44.8 pt -124.41 148.25 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.147 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -125.81 123.96 39.88 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.865 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 p -107.44 137.03 46.23 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.765 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -38.46 -35.7 0.2 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.869 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.432 ' O ' ' CG1' ' A' ' 56' ' ' VAL . 3.6 mpt_? -72.51 -49.35 33.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.079 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.432 ' CG1' ' O ' ' A' ' 55' ' ' ARG . 15.7 m -162.55 -176.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 120.977 0.417 . . . . 0.0 110.991 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.2 m -99.78 145.84 27.25 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.792 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.404 ' O ' ' O ' ' A' ' 51' ' ' ILE . 60.3 tp -153.78 144.8 22.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.374 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.0 p -130.72 128.72 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.6 mt -136.95 166.19 24.22 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.85 0.357 . . . . 0.0 110.514 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -82.33 160.71 22.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.867 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -57.34 -34.59 68.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.746 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.7 -40.61 97.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.109 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -61.05 -45.9 92.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.812 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 mp -62.0 -42.3 99.0 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.141 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.01 -49.68 76.72 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.083 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.463 ' O ' ' OG ' ' A' ' 15' ' ' SER . 96.8 mt -68.81 -41.41 78.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.487 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.2 tp -60.48 132.11 52.86 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.715 -0.394 . . . . 0.0 109.94 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -74.73 110.87 9.38 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.446 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.3 m -137.23 162.25 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.813 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -138.84 127.42 23.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.329 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.78 125.21 28.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.856 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.464 0.259 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.082 -179.949 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.985 0.421 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.73 156.45 36.53 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.982 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 39' ' ' VAL . 37.1 Cg_endo -65.13 -31.52 54.32 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.697 2.264 . . . . 0.0 111.925 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -136.78 94.66 3.01 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.696 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.493 ' HG1' ' N ' ' A' ' 8' ' ' ALA . 3.5 t -140.53 151.15 44.53 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.922 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.493 ' N ' ' HG1' ' A' ' 7' ' ' THR . . . -104.92 102.49 12.01 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.417 ' O ' ' OG ' ' A' ' 36' ' ' SER . 26.1 m0 -96.63 132.61 42.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.213 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.5 tttt -87.43 127.22 35.22 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.76 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.6 mt -81.53 122.51 36.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.213 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.9 m -104.25 -49.09 3.67 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.515 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.3 169.87 30.47 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -88.41 152.82 21.65 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.713 0.292 . . . . 0.0 110.241 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.456 ' O ' ' CG2' ' A' ' 18' ' ' ILE . 38.3 t -82.81 168.77 16.82 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.094 0.474 . . . . 0.0 110.782 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -66.62 -40.03 88.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.362 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' A' ' 17' ' ' GLU . 52.5 mp0 -65.13 -15.47 62.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.657 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.456 ' CG2' ' O ' ' A' ' 15' ' ' SER . 10.6 tp -42.34 146.75 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.598 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.7 p -79.85 141.41 55.25 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.551 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -47.15 -41.42 27.11 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.927 1.751 . . . . 0.0 112.616 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.33 -57.47 9.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.821 0.343 . . . . 0.0 111.296 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -61.95 -46.25 90.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.47 0.652 . . . . 0.0 110.444 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -57.37 -43.63 83.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.114 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.53 ' NE2' ' OG ' ' A' ' 28' ' ' SER . 3.1 tm0? -60.29 -37.94 82.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.111 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -60.7 -41.96 96.25 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.178 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.59 -42.25 99.45 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.201 -0.6 . . . . 0.0 110.276 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mp -73.9 -29.77 62.24 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.474 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.53 ' OG ' ' NE2' ' A' ' 24' ' ' GLN . 49.9 m -58.7 -44.83 90.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.388 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.417 ' H ' HD11 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -115.9 170.97 8.07 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.28 -179.688 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -87.11 -3.22 82.78 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 22.3 mmt -67.26 73.45 0.13 Allowed 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 120.868 0.366 . . . . 0.0 110.118 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.2 mp -99.07 169.85 7.65 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.425 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 32' ' ' LEU . 72.2 Cg_exo -48.63 -168.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.332 2.022 . . . . 0.0 112.462 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.95 7.06 56.73 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.6 m -139.54 -156.65 0.7 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.826 0.346 . . . . 0.0 110.387 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 9' ' ' TRP . 33.4 t -148.8 153.56 38.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.441 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -128.94 155.54 45.15 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.291 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -106.42 143.81 34.01 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.523 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 5' ' ' PRO . 14.5 t -88.12 122.82 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.281 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 p -68.31 -39.99 81.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.878 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.542 ' NH2' ' ND1' ' A' ' 50' ' ' HIS . 38.1 ptt-85 -174.69 159.87 2.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.136 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 36.0 m -133.89 123.84 45.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.68 110.4 49.05 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.686 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -76.42 -11.67 18.93 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.481 2.121 . . . . 0.0 112.176 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.59 -33.15 72.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.645 -177.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.13 20.9 0.49 Allowed Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.03 160.22 29.59 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.33 168.03 5.45 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.878 2.386 . . . . 0.0 111.819 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.405 ' N ' ' O ' ' A' ' 60' ' ' LEU . 5.5 mm -89.63 119.77 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.884 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.542 ' ND1' ' NH2' ' A' ' 41' ' ' ARG . 12.4 m170 -95.47 122.64 38.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.887 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.7 pt -125.87 148.91 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.278 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -130.71 132.36 45.32 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.422 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 55' ' ' ARG . 1.4 p -122.63 137.1 55.0 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.0 ptt-85 -41.17 -21.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.871 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 53' ' ' THR . 33.7 mmt180 -85.3 -50.57 7.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.924 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.434 ' CG1' ' O ' ' A' ' 55' ' ' ARG . 14.8 m -161.01 -176.0 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.515 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.7 p -113.29 145.27 41.32 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.396 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.9 tp -149.75 148.28 29.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.309 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.8 p -136.54 126.69 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.743 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 49' ' ' ILE . 23.3 mt -132.23 165.57 23.84 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.378 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -81.06 148.49 29.65 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.215 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -41.78 -40.81 2.16 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.961 0.41 . . . . 0.0 111.122 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -58.03 -40.58 81.23 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.563 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -62.08 -41.39 98.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.842 0.353 . . . . 0.0 110.53 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.503 ' CD2' ' N ' ' A' ' 65' ' ' LEU . 4.0 mm? -62.14 -42.08 98.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.913 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.18 -41.54 97.07 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.371 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.8 mt -68.33 -43.29 77.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.987 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.5 mt -65.33 133.42 51.36 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.284 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.3 112.2 16.3 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.009 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.53 160.39 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.591 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -144.72 128.31 17.09 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.507 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.74 132.61 47.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.951 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.8 t . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.225 -179.618 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 . . . . . 0 CA--C 1.518 -0.261 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.455 ' OG1' ' OG1' ' A' ' 7' ' ' THR . 0.8 OUTLIER -135.24 156.58 77.97 Favored Pre-proline 0 N--CA 1.466 0.351 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.302 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 39' ' ' VAL . 52.4 Cg_exo -51.06 -35.35 50.63 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.907 1.738 . . . . 0.0 112.885 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -135.74 95.93 3.33 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.455 ' OG1' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -131.5 130.82 42.87 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 -179.782 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.89 102.39 15.09 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 22.1 m0 -103.2 144.32 31.48 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.057 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -96.89 140.73 31.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.505 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.9 mt -96.94 122.03 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 O-C-N 123.263 0.352 . . . . 0.0 110.295 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 29.2 p -109.78 -44.7 3.78 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.761 0.315 . . . . 0.0 110.441 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 167.62 -179.33 41.11 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -97.66 152.18 19.35 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.779 0.323 . . . . 0.0 110.649 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 67' ' ' LEU . 2.6 m -80.05 169.87 17.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.718 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -68.8 -39.61 80.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.574 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -65.64 -14.66 61.63 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.694 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.418 ' CG2' ' O ' ' A' ' 15' ' ' SER . 10.5 tp -42.29 147.08 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.465 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.9 m -82.0 150.17 64.57 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.904 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -51.25 -39.31 62.39 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.074 1.849 . . . . 0.0 112.652 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.56 -56.77 15.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 0.0 111.374 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -64.11 -47.02 81.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.513 0.673 . . . . 0.0 110.477 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -56.88 -43.79 81.63 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.029 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -63.51 -33.58 75.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.023 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -59.61 -47.37 85.83 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 29' ' ' LEU . 4.5 mm? -63.06 -42.19 99.64 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.121 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.3 tp -68.8 -34.33 75.35 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.9 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.2 t -59.69 -44.61 93.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.62 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -116.26 168.42 10.14 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.834 0.35 . . . . 0.0 110.219 -179.447 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.02 -1.08 80.11 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.6 mtt -67.78 73.6 0.17 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 120.863 0.363 . . . . 0.0 110.021 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.3 mp -95.78 167.75 12.04 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.261 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 32' ' ' LEU . 75.8 Cg_exo -46.03 -179.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.236 1.957 . . . . 0.0 112.322 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.46 7.16 11.2 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' A' ' 36' ' ' SER . 28.9 t -145.77 -175.59 4.8 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.817 0.341 . . . . 0.0 110.446 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.492 ' N ' ' OG ' ' A' ' 35' ' ' SER . 46.9 m -127.18 156.03 42.46 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.509 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -132.53 150.93 52.08 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.286 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -106.74 146.33 30.96 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.36 0.6 . . . . 0.0 110.401 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' PRO . 6.7 t -83.49 127.3 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.363 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 p -71.13 -38.39 70.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.112 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -172.83 154.13 2.84 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.994 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 73.5 t -126.32 118.91 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.71 111.27 51.91 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.221 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -76.27 -11.2 19.27 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.148 1.899 . . . . 0.0 112.262 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.403 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 10.7 mp -59.89 -31.71 70.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.646 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.7 27.93 0.71 Allowed Glycine 0 N--CA 1.466 0.697 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.84 160.21 29.06 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.23 172.06 1.01 Allowed 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.835 2.356 . . . . 0.0 111.859 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.412 ' N ' ' O ' ' A' ' 60' ' ' LEU . 7.3 mm -90.42 116.93 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.995 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -96.72 121.89 39.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.706 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.5 pt -129.2 147.25 33.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.632 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.429 ' OE1' ' OG ' ' A' ' 57' ' ' SER . 57.0 mm-40 -122.49 114.51 20.79 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.099 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.02 137.5 44.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.685 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -42.89 -40.28 2.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.439 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -66.23 -47.03 75.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.562 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.492 ' CG2' ' H ' ' A' ' 57' ' ' SER . 11.2 p -170.52 173.39 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 120.981 0.42 . . . . 0.0 110.59 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.492 ' H ' ' CG2' ' A' ' 56' ' ' VAL . 4.4 m -95.19 152.8 18.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.38 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.3 tp -155.66 145.33 21.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.019 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.8 p -137.99 126.08 30.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 49' ' ' ILE . 19.0 mt -132.37 -178.63 5.0 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.499 ' N ' ' CD ' ' A' ' 61' ' ' ARG . 9.8 mpt_? -94.85 150.97 19.62 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.348 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -42.07 -43.34 3.21 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.828 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.47 -40.02 85.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.466 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -59.42 -43.08 93.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.51 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.483 ' CD2' ' N ' ' A' ' 65' ' ' LEU . 3.8 mm? -62.81 -41.87 99.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.812 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.3 -46.03 89.68 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.229 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.466 ' O ' ' OG ' ' A' ' 15' ' ' SER . 9.9 mp -67.3 -40.25 86.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.675 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.5 mt -63.47 128.02 33.93 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.204 -0.599 . . . . 0.0 110.173 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.414 ' O ' ' OG1' ' A' ' 12' ' ' THR . 95.2 mt-10 -77.5 104.87 8.28 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.649 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.0 m -125.05 160.3 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.424 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -142.86 134.67 26.81 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.36 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.16 132.78 47.8 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.601 -0.44 . . . . 0.0 109.857 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.553 -179.701 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 . . . . . 0 CA--C 1.518 -0.288 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 p -130.77 150.52 76.7 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 121.044 -0.263 . . . . 0.0 110.454 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 39' ' ' VAL . 42.6 Cg_exo -50.75 -49.39 16.96 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.794 1.662 . . . . 0.0 113.147 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -134.18 103.35 5.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.065 0.459 . . . . 0.0 111.165 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.403 ' OG1' ' CD1' ' A' ' 9' ' ' TRP . 0.3 OUTLIER -137.72 144.42 41.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.529 179.106 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.46 101.89 14.63 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.574 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.403 ' CD1' ' OG1' ' A' ' 7' ' ' THR . 23.8 m0 -100.36 141.23 33.48 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.015 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -95.25 130.37 42.03 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.3 mt -83.52 121.26 36.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.243 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.6 m -103.06 -49.64 3.71 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.812 0.339 . . . . 0.0 110.648 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.16 169.89 27.25 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -85.34 158.33 20.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.901 0.381 . . . . 0.0 110.396 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.2 t -79.87 169.44 17.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.72 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -69.67 -39.61 76.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.841 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -74.6 -7.62 53.74 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.458 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.4 tp -42.46 148.6 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.648 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.1 m -75.16 154.14 86.37 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.355 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.98 -25.79 51.68 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.516 2.144 . . . . 0.0 112.137 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.0 -55.93 9.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.18 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -63.45 -45.65 89.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.189 0.518 . . . . 0.0 110.596 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -58.11 -45.54 87.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.136 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 17.1 tm0? -62.24 -33.73 75.16 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -59.21 -46.79 87.5 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.695 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -62.03 -39.54 92.67 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.229 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.9 tp -59.95 -42.38 93.91 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.227 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.0 t -82.92 -9.43 59.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.296 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.7 tp -94.91 124.67 39.09 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.937 0.398 . . . . 0.0 110.367 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.6 -19.45 74.76 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 45.1 ttp -89.51 73.13 7.84 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.632 0.73 . . . . 0.0 109.306 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' A' ' 33' ' ' PRO . 9.5 mt -80.51 156.91 73.08 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.983 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 32' ' ' LEU . 75.6 Cg_exo -37.91 162.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.476 2.117 . . . . 0.0 112.444 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.16 3.75 17.02 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 96.4 p -129.3 -156.66 0.77 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.767 0.318 . . . . 0.0 110.346 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.5 t -145.3 151.99 39.21 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.702 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -132.62 159.43 39.57 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.356 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -111.38 146.37 37.26 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.733 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 5' ' ' PRO . 51.2 t -90.45 125.66 43.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.146 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -66.83 -42.22 88.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 50.1 ptt85 -174.28 156.75 2.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.076 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.9 m -128.92 117.23 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.09 110.31 47.32 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 120.951 -0.299 . . . . 0.0 110.413 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.67 -11.58 18.49 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.181 1.921 . . . . 0.0 112.187 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tp -57.15 -31.08 65.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.973 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.62 22.98 0.66 Allowed Glycine 0 N--CA 1.465 0.604 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.35 159.82 30.3 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -59.84 173.46 1.69 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.763 2.309 . . . . 0.0 111.761 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.472 ' N ' ' O ' ' A' ' 60' ' ' LEU . 8.2 mm -92.96 114.63 30.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.093 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -96.0 121.93 38.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.093 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.7 pt -126.26 149.37 31.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.286 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -129.32 135.15 48.37 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.553 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.535 ' HG1' ' H ' ' A' ' 56' ' ' VAL . 1.1 p -126.69 145.59 50.52 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.797 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -50.09 -38.6 39.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.169 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.0 tpm_? -67.74 -43.7 79.31 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.772 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.554 ' CG2' ' H ' ' A' ' 57' ' ' SER . 11.8 p -170.74 176.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.584 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.554 ' H ' ' CG2' ' A' ' 56' ' ' VAL . 47.4 t -105.87 149.2 26.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.43 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.4 tp -152.77 149.4 28.3 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.205 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.2 p -128.93 128.22 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.64 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 49' ' ' ILE . 58.7 mt -132.34 162.59 30.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.269 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -85.58 171.9 11.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.717 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -61.9 -40.07 94.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.625 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.48 -39.26 87.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.467 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -57.17 -47.13 81.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.345 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.62 -40.88 98.35 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.661 -0.416 . . . . 0.0 109.924 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.07 -54.11 48.94 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.499 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.1 mp -69.53 -41.57 75.8 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.153 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 38.7 tp -59.0 130.32 46.44 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -83.84 114.03 21.36 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 110.23 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.26 158.43 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.912 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -144.11 141.81 30.23 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.759 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.1 145.4 51.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.098 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.149 -179.741 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 . . . . . 0 CA--C 1.52 -0.197 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.453 ' OG1' ' OG1' ' A' ' 7' ' ' THR . 0.1 OUTLIER -136.15 155.29 77.58 Favored Pre-proline 0 N--CA 1.466 0.357 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.19 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 39' ' ' VAL . 50.1 Cg_endo -67.68 -23.12 42.84 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.638 2.225 . . . . 0.0 112.307 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -137.86 94.4 2.89 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.689 0.281 . . . . 0.0 110.582 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.453 ' OG1' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -139.12 130.7 27.26 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.846 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.9 101.94 14.03 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -101.76 145.86 28.56 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.23 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -102.8 128.51 49.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.88 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.0 mt -81.03 123.74 37.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.337 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 7.8 p -111.47 -15.17 13.59 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.55 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.34 178.28 16.84 Favored Glycine 0 N--CA 1.465 0.598 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.421 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.5 p90 -98.58 152.17 19.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.85 0.357 . . . . 0.0 110.119 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.433 ' O ' ' CG2' ' A' ' 18' ' ' ILE . 5.1 t -80.21 168.71 18.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.463 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.1 mtp-105 -68.56 -39.52 81.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.943 0.401 . . . . 0.0 110.662 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -64.24 -17.08 63.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.616 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.433 ' CG2' ' O ' ' A' ' 15' ' ' SER . 10.7 tp -41.92 147.89 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.476 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.5 t -80.96 146.33 59.03 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.699 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -49.67 -41.05 46.61 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.874 1.716 . . . . 0.0 112.755 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.52 -56.27 20.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.244 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -61.94 -46.75 87.97 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.48 0.657 . . . . 0.0 110.396 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -57.34 -44.08 83.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.848 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 28' ' ' SER . 5.9 tm0? -60.12 -38.39 82.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.361 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -57.87 -43.92 86.29 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -63.51 -40.84 98.1 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.269 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.4 mt -80.74 -18.14 48.74 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.885 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 24' ' ' GLN . 38.8 t -61.04 -43.97 98.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.077 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.406 HD13 ' H ' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -115.82 154.53 29.5 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.398 -179.527 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.65 5.97 42.51 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.512 ' N ' ' SD ' ' A' ' 31' ' ' MET . 0.0 OUTLIER -89.27 74.73 7.86 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -82.42 171.24 12.33 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.355 -178.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 32' ' ' LEU . 63.3 Cg_exo -48.47 -171.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.321 2.014 . . . . 0.0 112.206 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.01 11.25 8.46 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 81.8 p -139.24 -156.83 0.71 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.921 0.391 . . . . 0.0 110.413 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.8 p -141.15 163.0 34.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.468 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -139.51 160.93 38.72 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.194 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.413 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 24.2 p30 -119.22 151.19 38.8 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.24 0.543 . . . . 0.0 110.429 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' PRO . 61.0 t -88.15 127.53 41.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.279 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -69.06 -41.3 81.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.069 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -173.56 162.07 4.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.964 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 68.0 t -130.14 124.2 57.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.39 110.56 49.39 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.28 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.72 -11.31 20.22 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.29 1.994 . . . . 0.0 112.331 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.48 ' CD2' ' N ' ' A' ' 45' ' ' LEU . 4.1 mm? -60.65 -31.43 70.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.708 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.5 24.76 0.82 Allowed Glycine 0 N--CA 1.465 0.606 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.1 160.05 29.92 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.05 173.15 0.62 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.805 2.336 . . . . 0.0 111.665 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.437 ' N ' ' O ' ' A' ' 60' ' ' LEU . 8.5 mm -93.48 114.26 29.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -92.17 122.33 34.55 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.891 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 58' ' ' LEU . 44.4 pt -126.84 151.91 34.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.574 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.413 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 95.1 mt-10 -130.95 134.46 46.76 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.248 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.22 141.85 51.63 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.996 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -40.89 -36.53 0.66 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.36 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -65.54 -50.39 65.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.87 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.478 ' CG2' ' H ' ' A' ' 57' ' ' SER . 8.5 p -172.39 174.56 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-O 120.905 0.383 . . . . 0.0 110.808 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.478 ' H ' ' CG2' ' A' ' 56' ' ' VAL . 89.8 p -89.07 150.09 22.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.233 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 51' ' ' ILE . 63.9 tp -159.96 145.42 15.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.783 0.325 . . . . 0.0 110.342 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.8 p -126.5 129.96 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 49' ' ' ILE . 67.2 mt -132.93 161.41 34.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.55 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -85.25 165.29 17.46 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.706 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -59.11 -35.85 74.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.485 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.82 -40.41 95.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.595 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -60.64 -46.4 90.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.723 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.6 mp -62.71 -40.26 96.6 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.67 -38.62 91.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.517 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.1 mt -82.32 -54.97 4.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.031 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 66.2 mt -45.81 137.61 5.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.657 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.43 ' O ' ' OG1' ' A' ' 12' ' ' THR . 97.2 mt-10 -80.02 111.56 16.49 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.295 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.7 m -135.97 159.04 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.395 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -141.54 131.58 24.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.718 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.22 142.36 54.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.115 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t . . . . . 0 C--N 1.332 -0.187 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.258 -179.964 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 . . . . . 0 CA--C 1.52 -0.185 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.46 ' OG1' ' OG1' ' A' ' 7' ' ' THR . 0.1 OUTLIER -138.22 156.51 73.71 Favored Pre-proline 0 N--CA 1.466 0.33 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.174 -179.353 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 39' ' ' VAL . 41.4 Cg_endo -66.69 -27.75 44.7 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.683 2.255 . . . . 0.0 112.322 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -136.39 94.91 3.08 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.582 0.229 . . . . 0.0 110.408 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.46 ' OG1' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -139.21 128.77 24.46 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.13 101.52 14.18 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 25.2 m0 -99.57 140.59 33.54 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.213 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -98.26 120.44 38.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.882 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.7 mt -74.65 128.52 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.327 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.2 m -110.13 -47.41 3.32 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.567 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 170.62 166.3 29.31 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -87.42 157.25 19.27 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.84 0.352 . . . . 0.0 110.106 179.673 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 67' ' ' LEU . 13.0 m -73.77 163.85 27.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.519 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -69.82 -40.76 75.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.376 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -68.95 -12.19 61.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.355 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.428 ' CG2' ' O ' ' A' ' 15' ' ' SER . 10.3 tp -41.37 146.95 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.614 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.26 156.97 83.46 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.352 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.61 -30.57 70.49 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.777 2.318 . . . . 0.0 111.756 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.78 -56.8 12.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.881 0.372 . . . . 0.0 111.24 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -61.93 -45.46 93.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.364 0.602 . . . . 0.0 110.442 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -57.26 -43.16 82.75 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.946 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.513 ' O ' ' N ' ' A' ' 28' ' ' SER . 63.5 tp60 -61.51 -38.22 86.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.145 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.435 ' O ' ' OG ' ' A' ' 28' ' ' SER . 97.8 mttt -59.75 -41.47 91.08 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.456 -0.498 . . . . 0.0 109.819 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.04 -39.03 93.18 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.425 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.8 tt -82.34 -24.47 34.54 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.071 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 24' ' ' GLN . 96.5 p -60.84 -45.78 93.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.772 0.32 . . . . 0.0 111.484 -178.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.488 ' H ' HD13 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -103.43 161.69 13.64 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.978 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.98 31.28 3.42 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 65.6 mtt -111.65 73.08 0.8 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.473 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.2 mm? -82.84 153.06 67.09 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.648 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 32' ' ' LEU . 77.8 Cg_exo -39.62 167.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.459 2.106 . . . . 0.0 111.918 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.39 -16.19 12.84 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.811 -0.915 . . . . 0.0 110.811 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.8 m -100.18 -170.76 1.92 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.731 0.301 . . . . 0.0 110.302 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 73.4 m -132.39 156.34 46.84 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.481 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -139.17 157.06 46.61 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.241 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -112.2 146.45 38.08 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.468 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 5' ' ' PRO . 17.5 t -86.3 129.7 37.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.434 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -70.31 -40.24 77.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.146 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -173.77 161.45 3.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.114 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 69.5 t -134.47 110.61 13.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.69 111.55 53.08 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.47 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.551 ' C ' ' H ' ' A' ' 46' ' ' GLY . 60.4 Cg_endo -75.82 -12.13 19.97 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.353 2.035 . . . . 0.0 112.135 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.442 ' N ' ' CD1' ' A' ' 45' ' ' LEU . 10.2 mp -55.09 -3.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.812 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.551 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 103.37 26.62 6.83 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.27 159.58 30.92 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-O 121.028 0.442 . . . . 0.0 109.997 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.415 ' HG2' ' HE2' ' A' ' 50' ' ' HIS . 20.7 Cg_endo -59.95 177.54 0.5 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.758 2.305 . . . . 0.0 111.521 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.41 ' N ' ' O ' ' A' ' 60' ' ' LEU . 10.2 mm -95.92 115.42 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.269 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.415 ' HE2' ' HG2' ' A' ' 48' ' ' PRO . 11.9 m170 -98.71 122.39 41.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.838 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.412 HG21 HD11 ' A' ' 51' ' ' ILE . 35.7 pt -126.77 148.0 31.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.748 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -134.36 111.96 10.61 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.875 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.453 ' HG1' ' H ' ' A' ' 56' ' ' VAL . 1.3 p -83.65 175.26 9.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.683 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 53' ' ' THR . 99.8 mtt180 -33.53 -53.3 0.41 Allowed 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.548 0.53 . . . . 0.0 111.548 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -143.04 31.41 1.4 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.351 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.453 ' H ' ' HG1' ' A' ' 53' ' ' THR . 2.3 t -138.48 134.01 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 120.369 -0.533 . . . . 0.0 110.454 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.7 m -111.12 136.94 49.42 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.195 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.2 tp -156.42 147.27 21.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.245 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.9 p -127.5 126.03 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.846 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 49' ' ' ILE . 50.0 mt -132.18 167.72 19.28 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.289 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -85.72 166.32 16.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.517 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -60.53 -35.79 76.84 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.999 0.428 . . . . 0.0 110.549 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.27 -41.13 98.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.274 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -57.5 -47.13 82.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.535 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.0 mp -61.79 -41.09 97.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.095 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.09 -52.01 67.01 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.598 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.465 ' O ' ' OG ' ' A' ' 15' ' ' SER . 10.8 mp -68.8 -42.34 77.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.038 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 tp -56.43 132.22 50.61 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.286 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -78.91 110.03 13.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.224 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.71 159.05 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.418 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -142.86 133.09 24.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.608 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.23 145.45 54.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.173 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.9 t . . . . . 0 C--N 1.332 -0.17 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.191 -179.959 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.52 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.5 OUTLIER . . . . . 0 CA--C 1.519 -0.226 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.441 ' OG1' ' OG1' ' A' ' 7' ' ' THR . 0.1 OUTLIER -138.68 164.55 39.02 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.912 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 39' ' ' VAL . 31.3 Cg_exo -55.64 -36.14 94.22 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.878 1.719 . . . . 0.0 112.687 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 6' ' ' ASP . 47.0 p-10 -136.74 94.38 2.98 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.796 0.331 . . . . 0.0 110.533 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.441 ' OG1' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -136.29 130.52 33.1 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.716 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.95 102.6 15.37 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -105.96 141.33 37.54 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.912 0.387 . . . . 0.0 110.464 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -94.52 147.86 22.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.838 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.3 mt -101.63 115.83 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.0 m -97.73 -43.58 7.11 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.852 0.358 . . . . 0.0 110.42 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.65 179.52 34.52 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.9 OUTLIER -95.84 149.0 22.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.938 0.399 . . . . 0.0 110.506 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 67' ' ' LEU . 4.3 m -78.28 172.16 13.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.545 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -69.49 -40.54 76.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.618 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -66.8 -13.79 61.91 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.968 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.4 tp -41.53 148.49 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.715 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.05 155.21 86.52 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.302 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.99 -31.02 66.8 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.645 2.23 . . . . 0.0 112.216 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.44 -55.34 18.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.902 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -62.82 -43.51 98.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.435 0.636 . . . . 0.0 110.513 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -58.51 -43.32 89.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.6 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.535 ' O ' ' N ' ' A' ' 28' ' ' SER . 18.8 mm-40 -63.36 -35.18 79.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.043 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -59.74 -41.95 92.08 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.368 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -70.06 -39.0 75.94 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.748 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp -81.91 -15.48 53.76 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.432 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 24' ' ' GLN . 2.8 m -57.14 -29.73 63.83 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.596 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.602 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -134.69 -176.92 4.39 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.696 0.284 . . . . 0.0 110.723 179.513 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.39 -9.2 56.97 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 79.2 mtp -76.08 75.13 2.94 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.5 OUTLIER -83.04 171.82 10.83 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.034 -179.275 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' A' ' 32' ' ' LEU . 77.7 Cg_exo -48.74 -168.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.523 2.149 . . . . 0.0 112.589 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.03 11.99 7.27 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.6 p -136.12 -158.11 0.84 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.761 0.315 . . . . 0.0 110.214 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 82.5 p -138.68 161.56 36.84 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.761 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -141.21 159.4 42.29 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.183 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 47.6 p-10 -117.38 151.16 37.59 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.196 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 5' ' ' PRO . 61.1 t -87.88 126.34 41.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.283 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 p -68.72 -43.31 83.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.941 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -173.23 147.26 1.53 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.391 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.9 m -115.99 125.64 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.36 110.39 48.35 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.805 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.1 -12.19 17.6 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.854 1.703 . . . . 0.0 112.315 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.8 mt -60.6 -31.02 70.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.011 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.34 26.34 0.89 Allowed Glycine 0 N--CA 1.469 0.869 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.02 160.27 28.8 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -54.81 175.24 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.603 2.202 . . . . 0.0 111.645 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.4 mm -94.64 113.68 29.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.018 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 16.2 m170 -93.95 119.65 33.14 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.1 pt -127.17 150.43 33.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.368 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.429 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 8.6 tm-20 -126.25 132.31 51.74 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.214 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.08 138.4 54.46 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.924 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -40.59 -38.58 0.89 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.332 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -67.13 -48.66 67.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.744 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.46 ' CG2' ' H ' ' A' ' 57' ' ' SER . 8.5 p -171.5 172.07 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.933 0.397 . . . . 0.0 110.87 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.46 ' H ' ' CG2' ' A' ' 56' ' ' VAL . 10.7 p -86.26 151.26 23.76 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.461 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.1 tp -155.66 146.45 22.2 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.884 0.373 . . . . 0.0 110.299 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.6 p -125.65 130.9 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.64 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.4 mt -134.71 163.2 30.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.576 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 83.6 mtt85 -92.08 174.8 7.13 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.972 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -62.05 -44.67 96.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.092 0.472 . . . . 0.0 110.623 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -61.63 -38.02 86.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.627 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -59.47 -48.36 81.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.259 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.433 ' CD2' ' CE1' ' A' ' 3' ' ' TYR . 10.5 mp -62.92 -41.77 99.57 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.113 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.36 -50.94 71.85 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.269 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.468 ' O ' ' OG ' ' A' ' 15' ' ' SER . 92.0 mt -68.83 -41.92 77.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.239 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.2 tp -62.19 136.21 57.83 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -84.9 116.37 23.3 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.871 0.367 . . . . 0.0 110.427 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.0 m -133.28 161.45 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.527 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -145.59 145.98 31.2 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.463 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.96 135.92 45.07 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.8 t . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.787 0.327 . . . . 0.0 110.289 -179.742 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 . . . . . 0 CA--C 1.52 -0.196 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.07 152.34 38.55 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.314 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -49.9 -44.05 38.58 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.852 1.701 . . . . 0.0 112.816 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -135.47 100.64 4.56 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.935 0.398 . . . . 0.0 110.835 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.629 ' HG1' ' HE1' ' A' ' 9' ' ' TRP . 0.3 OUTLIER -137.35 143.45 42.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.389 179.381 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -96.48 102.45 14.24 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.576 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.629 ' HE1' ' HG1' ' A' ' 7' ' ' THR . 26.5 m0 -98.51 145.77 26.45 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.377 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -100.34 132.58 45.64 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.788 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 36.1 mt -82.37 124.56 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.21 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.5 m -108.03 -49.55 3.19 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.81 0.338 . . . . 0.0 110.804 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.11 -178.88 40.54 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 2.3 p90 -102.52 144.29 31.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.909 0.385 . . . . 0.0 110.464 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 67' ' ' LEU . 19.7 m -75.31 171.36 14.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.453 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -68.78 -38.48 80.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.785 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -71.7 -10.27 59.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.482 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.0 tp -41.56 147.51 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.518 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.2 t -78.64 140.72 59.54 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.356 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -48.25 -40.24 35.09 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.902 1.735 . . . . 0.0 112.89 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.53 -58.14 8.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.897 0.379 . . . . 0.0 111.364 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -62.07 -47.2 85.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.55 0.691 . . . . 0.0 110.471 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -56.51 -43.16 79.5 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.878 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -59.73 -37.53 79.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.182 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -59.47 -43.03 93.32 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.633 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 29' ' ' LEU . 4.5 mm? -62.4 -42.62 99.57 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.967 178.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 48.7 mt -70.85 -32.55 69.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.917 0.389 . . . . 0.0 110.928 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 64.7 m -58.0 -44.12 87.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.399 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -117.94 166.24 12.74 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.161 -179.777 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.4 8.49 79.73 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 16.1 mmt -78.4 73.37 4.96 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.5 mp -91.4 167.84 14.79 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.089 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 32' ' ' LEU . 71.6 Cg_exo -44.33 176.69 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 122.292 1.994 . . . . 0.0 112.363 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.34 1.58 15.91 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.439 ' HG ' ' NH2' ' A' ' 54' ' ' ARG . 32.7 t -134.48 -155.85 0.69 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.903 0.382 . . . . 0.0 110.321 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.401 ' N ' ' OG ' ' A' ' 35' ' ' SER . 27.3 p -150.71 161.94 41.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.554 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -138.38 156.49 47.55 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.293 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -108.95 145.72 35.0 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.496 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.7 t -89.85 126.72 42.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.434 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -67.52 -42.31 86.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.114 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -173.87 156.93 2.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.059 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.8 m -126.05 122.11 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.75 110.27 48.43 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.511 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -76.86 -11.88 18.08 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.199 1.933 . . . . 0.0 112.283 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.1 mt -59.69 -31.47 69.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.026 -178.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.83 25.01 0.78 Allowed Glycine 0 N--CA 1.466 0.673 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.52 160.13 29.47 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.4 169.58 2.19 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.898 2.399 . . . . 0.0 111.638 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.454 ' N ' ' O ' ' A' ' 60' ' ' LEU . 6.1 mm -92.77 113.65 28.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.99 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -95.6 121.25 37.09 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.909 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 48.0 pt -127.93 149.87 33.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.428 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.431 ' OE2' ' OG ' ' A' ' 57' ' ' SER . 67.0 mm-40 -118.97 125.51 49.6 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.173 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 56' ' ' VAL . 6.0 p -111.77 136.94 50.36 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.439 ' NH2' ' HG ' ' A' ' 35' ' ' SER . 85.7 mtm180 -39.29 -40.23 0.74 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.804 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.446 ' O ' ' CG1' ' A' ' 56' ' ' VAL . 56.6 ttt85 -67.88 -49.71 60.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.21 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.446 ' CG1' ' O ' ' A' ' 55' ' ' ARG . 4.4 m -164.77 -176.68 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.556 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.431 ' OG ' ' OE2' ' A' ' 52' ' ' GLU . 40.0 t -96.23 136.96 36.0 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.488 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.5 tp -138.04 145.27 41.61 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.987 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.9 p -126.42 130.46 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.694 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 49' ' ' ILE . 80.8 mt -134.3 162.26 32.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.475 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -91.89 165.03 13.44 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.623 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.6 ' HZ3' ' H ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -57.0 -40.93 77.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.072 0.463 . . . . 0.0 110.635 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -62.22 -36.92 83.44 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.793 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.29 -42.85 99.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.278 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.7 mp -63.06 -41.96 99.59 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.884 -0.414 . . . . 0.0 109.884 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.31 -50.77 72.43 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.146 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.433 ' O ' ' OG ' ' A' ' 15' ' ' SER . 97.5 mt -69.2 -40.48 78.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.004 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.3 tp -62.58 134.02 55.76 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -85.13 112.47 20.72 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.003 0.43 . . . . 0.0 110.118 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.0 m -132.5 158.99 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.63 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -142.92 141.68 31.53 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.823 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.61 150.55 42.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.164 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.6 t . . . . . 0 N--CA 1.466 0.375 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.197 -179.933 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 . . . . . 0 CA--C 1.518 -0.26 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.456 ' OG1' ' CG2' ' A' ' 7' ' ' THR . 15.4 p -132.39 148.07 68.2 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.484 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 39' ' ' VAL . 44.9 Cg_endo -66.22 -31.29 44.78 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.392 2.062 . . . . 0.0 112.473 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -136.23 93.99 2.97 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.725 0.298 . . . . 0.0 111.318 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.52 ' HG1' ' N ' ' A' ' 8' ' ' ALA . 0.9 OUTLIER -141.77 149.16 40.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.368 178.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.52 ' N ' ' HG1' ' A' ' 7' ' ' THR . . . -102.78 102.05 12.16 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 25.3 m0 -97.46 142.74 28.94 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.894 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -100.68 123.66 45.19 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.5 mt -79.6 120.43 30.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.904 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.6 p -104.08 -15.66 15.5 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.348 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.47 164.66 10.41 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.88 169.51 17.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.9 t -84.03 166.42 17.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.447 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.9 ptt-85 -70.58 -37.03 73.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.556 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -81.09 -5.42 57.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.028 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.6 tp -41.15 141.75 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.386 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.8 m -80.02 150.88 72.52 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.806 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.06 -38.84 60.47 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.9 1.733 . . . . 0.0 112.544 179.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.63 -58.12 8.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.437 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -63.32 -48.65 77.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.346 0.594 . . . . 0.0 110.555 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -57.93 -40.76 81.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.04 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 28' ' ' SER . 12.1 tm0? -61.8 -39.44 91.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.207 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.51 -43.73 96.77 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.253 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.47 -39.21 93.86 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.283 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.5 tt -81.13 -23.18 38.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.958 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.469 ' N ' ' O ' ' A' ' 24' ' ' GLN . 40.3 t -61.22 -45.24 95.38 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.167 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.486 ' H ' HD13 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -107.71 160.47 15.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.173 -179.554 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.04 33.92 2.4 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.404 ' H ' ' C ' ' A' ' 29' ' ' LEU . 36.5 tpp -112.8 74.01 0.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.464 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.2 mm? -81.86 153.58 70.06 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.075 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 32' ' ' LEU . 66.4 Cg_exo -40.12 169.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 122.78 2.32 . . . . 0.0 112.439 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.15 12.11 7.13 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 90.2 p -126.63 -171.36 2.39 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 73.5 m -131.45 157.47 43.39 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.72 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -137.88 159.96 40.58 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.296 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -117.35 145.85 43.77 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.893 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 5' ' ' PRO . 57.5 t -86.06 127.66 40.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.213 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 p -70.65 -41.37 77.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.209 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -176.41 171.31 2.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.818 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.56 130.65 37.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.36 109.61 43.82 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.716 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.545 ' C ' ' H ' ' A' ' 46' ' ' GLY . 33.9 Cg_exo -60.57 -21.86 70.26 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 121.793 1.662 . . . . 0.0 112.334 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.5 mt -52.99 -5.72 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.634 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 90.8 33.95 8.06 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.7 169.75 8.11 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -54.51 -171.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 121.807 1.672 . . . . 0.0 111.939 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.487 ' N ' ' O ' ' A' ' 60' ' ' LEU . 9.5 mm -111.89 109.67 29.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.744 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -85.71 125.73 33.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.161 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.6 pt -127.66 151.22 34.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.524 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.4 ' OE1' ' C ' ' A' ' 52' ' ' GLU . 1.9 pp20? -130.7 136.86 49.19 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.212 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 56' ' ' VAL . 2.9 p -128.87 143.68 50.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.09 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -49.28 -37.45 23.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.659 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -72.74 -37.82 67.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.91 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 53' ' ' THR . 3.5 p -169.53 -176.1 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.824 0.345 . . . . 0.0 110.207 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.454 ' H ' HG21 ' A' ' 56' ' ' VAL . 36.5 p -130.65 150.49 51.81 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.8 tt -163.81 164.95 23.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.354 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 p -126.47 137.79 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.828 0.347 . . . . 0.0 110.419 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 49' ' ' ILE . 11.9 mt -134.11 152.07 51.67 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.704 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -77.83 162.05 27.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.508 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -58.4 -39.49 79.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.862 0.363 . . . . 0.0 110.34 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.89 -39.68 92.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.4 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -59.87 -45.94 90.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.516 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 mp -62.02 -41.8 98.47 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.341 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.12 -51.76 68.0 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.18 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.23 -39.95 82.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.944 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.9 tp -60.02 128.92 39.24 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -75.59 110.28 9.85 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.423 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.6 m -133.24 161.4 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.64 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -143.28 138.35 29.51 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.395 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.81 134.13 44.78 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 80.9 t . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.383 -179.868 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 . . . . . 0 CA--C 1.518 -0.274 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 p -130.09 152.49 80.15 Favored Pre-proline 0 N--CA 1.466 0.343 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 39' ' ' VAL . 52.6 Cg_exo -50.45 -41.45 51.96 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.972 1.781 . . . . 0.0 112.586 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -134.37 100.59 4.72 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.003 0.43 . . . . 0.0 111.026 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 t -137.35 144.52 42.56 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.296 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.36 102.43 14.41 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.745 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 14.5 m0 -100.62 142.59 31.89 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.345 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -97.49 139.61 33.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.632 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.4 mt -98.84 114.88 37.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 m -97.26 -40.42 8.77 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.44 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.65 164.77 21.79 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.65 162.32 27.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.78 0.324 . . . . 0.0 110.172 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.428 ' O ' ' CG2' ' A' ' 18' ' ' ILE . 5.8 t -78.69 163.45 25.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.518 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 49.6 ptt85 -68.67 -37.62 79.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -70.08 -14.65 62.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.603 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.428 ' CG2' ' O ' ' A' ' 15' ' ' SER . 10.8 tp -41.94 145.53 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.404 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 t -84.98 149.84 54.13 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.515 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -48.94 -37.12 36.24 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.952 1.768 . . . . 0.0 112.394 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.38 -58.48 7.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.485 -178.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -63.45 -46.61 85.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.427 0.632 . . . . 0.0 110.668 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -57.49 -43.32 84.07 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.936 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -63.42 -37.79 88.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.216 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -59.06 -45.45 90.75 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.884 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.34 -43.52 98.63 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.184 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.3 tp -63.64 -42.42 98.15 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.536 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.6 m -72.32 -39.73 67.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.453 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.54 ' C ' ' H ' ' A' ' 31' ' ' MET . 1.7 tt -82.5 132.1 35.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.774 -178.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -73.26 32.21 0.8 Allowed Glycine 0 N--CA 1.462 0.427 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.54 ' H ' ' C ' ' A' ' 29' ' ' LEU . 11.3 tpt -124.67 72.7 1.22 Allowed 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.0 mm? -81.62 152.01 69.08 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.106 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 32' ' ' LEU . 72.5 Cg_exo -40.77 169.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 122.676 2.251 . . . . 0.0 112.491 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.72 -17.92 15.35 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.5 m -103.36 -169.44 1.65 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.827 0.346 . . . . 0.0 110.269 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.6 m -132.17 155.58 47.94 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.579 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -132.07 155.25 48.41 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.027 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -112.81 145.14 41.14 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.364 0.602 . . . . 0.0 110.858 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 5' ' ' PRO . 58.6 t -83.54 127.43 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.14 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 p -70.42 -39.3 76.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.132 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -173.67 160.56 3.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.564 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 70.5 t -136.17 112.11 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.64 109.81 45.59 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 119.494 -0.289 . . . . 0.0 110.928 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.579 ' C ' ' H ' ' A' ' 46' ' ' GLY . 31.7 Cg_exo -57.81 -12.52 12.09 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 121.838 1.692 . . . . 0.0 112.156 178.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 82.0 mt -51.58 -5.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.819 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.579 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 89.11 31.69 11.64 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.34 162.39 22.8 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -52.96 -170.74 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.885 1.723 . . . . 0.0 111.876 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.426 ' N ' ' O ' ' A' ' 60' ' ' LEU . 6.6 mm -109.64 113.57 44.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.428 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -96.62 127.75 42.91 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.433 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.1 pt -127.33 149.61 32.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.654 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -135.69 131.55 35.82 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.503 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.527 ' HG1' ' H ' ' A' ' 56' ' ' VAL . 2.7 p -125.52 137.48 53.94 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.074 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -39.05 -24.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.755 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.511 ' N ' ' O ' ' A' ' 53' ' ' THR . 84.8 mtt85 -84.96 -49.86 7.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.208 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.527 ' H ' ' HG1' ' A' ' 53' ' ' THR . 16.0 m -161.2 -174.87 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.474 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.8 p -131.05 151.76 51.07 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.637 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.2 tp -154.21 151.91 29.73 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.274 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.0 t -118.91 129.5 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' A' ' 49' ' ' ILE . 94.1 mt -137.79 152.26 48.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.467 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.408 ' HG3' ' H ' ' A' ' 62' ' ' LYS . 7.8 tpp85 -81.22 162.79 23.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.462 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.408 ' H ' ' HG3' ' A' ' 61' ' ' ARG . 21.1 ptmt -57.7 -37.59 73.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.021 0.438 . . . . 0.0 110.502 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -61.57 -41.24 97.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.175 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.13 -46.02 91.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.371 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.6 mp -60.92 -40.96 95.16 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.182 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.56 -51.37 69.74 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.454 -0.499 . . . . 0.0 110.445 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.99 -42.61 80.5 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.382 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.3 mt -60.92 134.55 57.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.304 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -78.01 108.06 11.01 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.758 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.2 m -131.03 160.71 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.806 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -147.72 145.75 28.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.514 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.37 135.77 53.74 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 C--N 1.331 -0.226 0 CA-C-O 120.854 0.359 . . . . 0.0 110.438 -179.499 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.67 154.59 59.62 Favored Pre-proline 0 N--CA 1.467 0.395 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.45 -32.9 59.38 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.477 2.118 . . . . 0.0 112.085 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 6' ' ' ASP . 47.8 p-10 -136.72 93.77 2.9 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.928 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.5 t -140.69 151.04 44.23 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.093 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -100.71 102.45 13.56 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 22.9 m0 -98.93 129.4 45.26 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.247 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -85.66 136.31 33.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.877 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.1 mt -91.2 119.07 37.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.1 m -102.16 -43.01 5.86 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.827 0.346 . . . . 0.0 110.33 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.06 -174.1 33.98 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.7 OUTLIER -95.0 157.1 16.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.901 0.381 . . . . 0.0 110.325 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.463 ' HG ' ' N ' ' A' ' 16' ' ' ARG . 6.8 t -85.23 171.89 11.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.599 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.463 ' N ' ' HG ' ' A' ' 15' ' ' SER . 89.6 mtm180 -68.48 -38.28 80.87 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.869 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.458 ' H ' ' HG ' ' A' ' 15' ' ' SER . 24.1 tp10 -75.81 -6.01 48.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.434 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.3 tp -41.9 147.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.601 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.45 155.66 87.49 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.436 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.32 -30.1 63.44 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.535 2.156 . . . . 0.0 112.028 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.89 -53.46 31.99 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.004 0.43 . . . . 0.0 111.161 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -63.68 -46.33 86.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.342 0.591 . . . . 0.0 110.268 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -56.46 -44.51 80.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.96 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 28' ' ' SER . 39.5 mm-40 -64.07 -31.57 72.8 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -59.09 -48.91 79.87 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.469 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 29' ' ' LEU . 4.5 mm? -64.7 -40.7 95.81 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.104 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.2 tp -69.37 -34.33 74.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.219 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 24' ' ' GLN . 11.9 t -59.44 -44.67 92.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.4 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -116.36 167.9 10.62 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.269 -179.631 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.81 7.91 80.55 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 94.2 mtp -77.6 73.96 4.16 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.4 mp -93.77 169.21 10.41 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.576 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 32' ' ' LEU . 54.0 Cg_exo -48.6 -170.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.317 2.011 . . . . 0.0 112.333 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.83 5.34 20.44 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.0 t -145.43 -172.31 3.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.759 0.314 . . . . 0.0 110.366 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.5 t -130.11 155.75 45.67 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.496 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -131.84 164.57 25.76 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.27 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 38' ' ' ASN . 12.8 p-10 -116.64 149.68 39.35 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.518 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.5 t -88.31 125.21 41.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.501 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.2 p -67.51 -42.54 87.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.348 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.48 ' NH2' ' ND1' ' A' ' 50' ' ' HIS . 37.0 ptt-85 -170.1 160.19 7.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.409 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 86.4 t -129.24 127.58 65.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.39 110.93 49.8 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.507 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -76.28 -11.39 19.21 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.073 1.848 . . . . 0.0 112.415 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.416 ' N ' ' CD1' ' A' ' 45' ' ' LEU . 10.5 mp -59.29 -30.63 68.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.579 -178.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.39 28.23 1.36 Allowed Glycine 0 N--CA 1.468 0.78 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -97.9 178.72 1.25 Allowed Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 47' ' ' ASP . 19.2 Cg_exo -64.13 -179.14 0.73 Allowed 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.974 1.783 . . . . 0.0 111.888 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.0 mm -103.6 117.95 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.528 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.48 ' ND1' ' NH2' ' A' ' 41' ' ' ARG . 10.8 m170 -96.37 117.47 30.91 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.2 pt -118.66 147.38 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.431 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.413 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 84.2 tt0 -134.26 112.04 10.73 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.217 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 54' ' ' ARG . 1.2 p -86.46 172.56 10.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.766 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 53' ' ' THR . 95.5 mtt180 -34.02 -51.84 0.43 Allowed 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.479 0.487 . . . . 0.0 111.929 -178.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.6 tpt85 -142.03 31.68 1.58 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.619 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -141.96 138.08 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.541 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.3 t -116.9 131.91 56.83 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.35 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.1 tp -145.87 146.38 31.09 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.932 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.9 p -136.93 127.2 39.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.8 mt -138.17 165.38 26.8 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.587 0.232 . . . . 0.0 110.428 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -74.0 148.14 42.31 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 120.94 0.4 . . . . 0.0 111.275 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -43.94 -41.77 5.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.184 0.516 . . . . 0.0 110.807 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -57.98 -40.63 81.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.387 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -60.05 -42.66 94.97 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.477 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.477 ' CD2' ' N ' ' A' ' 65' ' ' LEU . 4.0 mm? -62.05 -42.07 98.79 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.59 -48.48 81.51 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.669 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.37 -39.26 85.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.873 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 38.5 mt -62.78 138.99 58.66 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.341 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -83.14 102.15 11.66 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.488 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.1 m -127.07 152.35 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.306 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -144.04 123.46 13.12 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.708 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.11 145.73 53.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.111 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.466 0.349 0 CA-C-O 120.762 0.315 . . . . 0.0 110.671 -179.905 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 . . . . . 0 CA--C 1.519 -0.217 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.48 157.26 78.76 Favored Pre-proline 0 N--CA 1.466 0.342 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 39' ' ' VAL . 52.2 Cg_exo -50.19 -35.22 42.22 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.03 1.82 . . . . 0.0 112.768 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -136.56 96.54 3.36 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.708 0.29 . . . . 0.0 110.328 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.86 130.99 42.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.982 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.3 102.32 15.04 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 20.1 m0 -105.5 143.67 33.33 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.185 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -95.57 147.75 23.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.817 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 46.9 mt -100.12 123.0 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.8 m -103.86 -47.88 4.08 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.795 0.331 . . . . 0.0 110.405 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 160.6 169.9 24.49 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.9 OUTLIER -83.4 151.22 25.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.916 0.389 . . . . 0.0 110.546 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.2 t -82.46 174.36 11.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.538 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -70.74 -40.09 72.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.0 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -70.77 -10.4 59.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.305 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.3 tp -41.38 149.51 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.776 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.66 154.25 87.38 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.368 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.52 -30.96 51.78 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.528 2.152 . . . . 0.0 112.179 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.43 -54.36 25.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.921 0.391 . . . . 0.0 111.286 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -63.76 -45.72 88.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.351 0.596 . . . . 0.0 110.194 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 68.2 ttp85 -57.89 -44.72 86.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.293 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 69.5 tp60 -61.78 -34.2 75.45 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -59.68 -48.41 81.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.067 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -61.88 -41.38 97.81 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.597 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.0 mt -61.8 -39.81 93.02 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.448 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.1 m -82.66 -12.98 57.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.849 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.4 tp -95.85 124.54 39.91 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.799 0.333 . . . . 0.0 110.15 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.87 13.1 32.44 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.451 ' CE ' HH21 ' A' ' 55' ' ' ARG . 68.6 mtp -118.49 75.66 1.03 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.26 0.552 . . . . 0.0 109.531 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.496 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.7 mp -78.7 166.69 40.8 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.839 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.496 ' O ' ' O ' ' A' ' 32' ' ' LEU . 80.1 Cg_exo -40.56 175.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.666 2.244 . . . . 0.0 112.747 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.71 12.49 6.59 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.6 t -140.8 -156.37 0.67 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.836 0.351 . . . . 0.0 110.266 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.0 t -147.7 153.79 39.75 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.839 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -129.76 149.97 51.27 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.492 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -108.06 144.13 35.82 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.316 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 5' ' ' PRO . 12.5 t -81.05 121.02 33.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.488 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 p -68.34 -37.67 78.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.509 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -171.82 155.66 3.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.366 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.4 t -123.68 114.06 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.3 111.99 54.41 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.403 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.591 ' C ' ' H ' ' A' ' 46' ' ' GLY . 61.4 Cg_endo -75.0 -11.64 21.48 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.916 1.744 . . . . 0.0 112.269 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.438 ' N ' ' CD1' ' A' ' 45' ' ' LEU . 9.9 mp -60.14 5.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.954 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.591 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 88.63 29.51 18.56 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.41 160.01 29.81 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.43 172.44 2.63 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.969 2.446 . . . . 0.0 112.002 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.3 mm -91.48 113.26 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.893 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -94.53 125.09 38.96 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.162 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.3 pt -124.57 146.71 29.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.099 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -136.79 129.06 29.84 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.234 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -130.57 144.45 51.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.519 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -49.19 -33.19 11.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.937 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.451 HH21 ' CE ' ' A' ' 31' ' ' MET . 73.8 mtp85 -69.96 -43.92 70.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.714 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.591 ' CG2' ' H ' ' A' ' 57' ' ' SER . 9.8 p -170.05 -179.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.433 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.591 ' H ' ' CG2' ' A' ' 56' ' ' VAL . 20.7 t -128.49 150.94 49.94 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.247 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 52.7 tp -163.21 157.22 20.14 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.036 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.5 p -130.98 131.79 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.3 mp -126.33 150.6 48.42 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.645 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' A' ' 64' ' ' ASP . 88.6 mtm180 -79.03 143.65 35.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.286 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -40.47 -40.92 1.31 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.125 0.488 . . . . 0.0 111.124 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -61.19 -42.32 98.36 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.368 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 61' ' ' ARG . 98.1 m-20 -61.4 -38.51 87.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.229 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.444 ' N ' ' CD2' ' A' ' 65' ' ' LEU . 4.1 mm? -62.58 -42.72 99.73 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.14 -51.25 70.83 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.154 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' A' ' 67' ' ' LEU . 4.1 mm? -68.56 -39.76 80.91 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.178 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.16 134.11 56.12 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -83.14 114.55 21.41 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.077 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 m -132.09 161.85 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.022 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -146.13 144.77 30.19 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.506 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.66 147.45 52.68 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.1 t . . . . . 0 N--CA 1.464 0.253 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.512 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 . . . . . 0 C--O 1.232 0.16 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -143.3 153.3 59.29 Favored Pre-proline 0 N--CA 1.464 0.264 0 C-N-CA 121.136 -0.226 . . . . 0.0 110.404 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 39' ' ' VAL . 34.9 Cg_exo -50.96 -43.02 49.91 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.626 1.551 . . . . 0.0 112.407 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 6' ' ' ASP . 48.0 p-10 -135.29 98.45 3.97 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.946 0.403 . . . . 0.0 111.526 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 t -131.9 143.92 50.48 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.241 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -87.54 102.68 14.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -103.17 136.09 43.61 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 -178.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.0 tttt -91.88 143.97 25.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.773 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 48.9 mt -101.43 119.13 49.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 6.6 p -108.63 -19.14 13.53 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.773 0.321 . . . . 0.0 110.588 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.04 -177.59 23.39 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.101 -0.799 . . . . 0.0 111.101 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -104.76 150.43 24.77 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.808 0.337 . . . . 0.0 110.41 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.542 ' HG ' ' H ' ' A' ' 16' ' ' ARG . 8.3 t -77.86 170.24 16.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.854 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.542 ' H ' ' HG ' ' A' ' 15' ' ' SER . 40.8 ptt180 -70.7 -39.48 73.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.106 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -66.83 -14.81 63.1 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.002 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.44 ' CG2' ' HE ' ' A' ' 23' ' ' ARG . 10.0 tp -41.23 149.34 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.759 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.35 154.5 88.04 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.981 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.25 -30.09 64.12 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.534 2.156 . . . . 0.0 112.362 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.3 -52.06 45.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.468 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -63.13 -46.7 86.04 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.59 0.71 . . . . 0.0 110.527 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.44 ' HE ' ' CG2' ' A' ' 18' ' ' ILE . 33.9 ttm180 -58.42 -48.51 80.46 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.407 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -59.84 -30.84 69.23 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -57.5 -44.23 84.84 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 29' ' ' LEU . 4.6 mm? -61.8 -42.62 99.24 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 120.071 -0.651 . . . . 0.0 109.647 178.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.428 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 3.9 mm? -67.94 -33.59 74.96 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.788 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.7 t -60.1 -44.26 94.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.73 -178.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -118.19 170.3 8.98 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.033 0.444 . . . . 0.0 110.599 -179.602 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.64 4.18 81.93 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 58.6 mmm -73.34 73.76 1.34 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.1 mp -95.36 170.38 7.91 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.104 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 32' ' ' LEU . 52.9 Cg_exo -50.0 -165.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.402 2.068 . . . . 0.0 113.028 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.33 5.34 55.94 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 76.9 p -143.15 -172.93 3.78 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.733 0.301 . . . . 0.0 110.289 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.8 m -130.04 156.13 45.0 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.745 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -128.5 153.56 47.03 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.989 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 39' ' ' VAL . 59.9 t-20 -108.74 147.07 32.55 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.662 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.525 ' N ' ' OD1' ' A' ' 38' ' ' ASN . 21.4 t -89.58 126.51 42.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.647 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 p -72.24 -41.76 66.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.716 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -173.32 154.98 2.78 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.419 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.9 m -139.56 122.45 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.294 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -95.47 110.07 48.89 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.754 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.602 ' C ' ' H ' ' A' ' 46' ' ' GLY . 38.1 Cg_exo -61.56 -14.63 36.55 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 121.811 1.674 . . . . 0.0 111.869 178.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 78.3 mt -53.73 2.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.863 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.602 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 90.04 26.08 25.07 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.01 162.26 23.48 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.99 170.46 2.12 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.181 1.92 . . . . 0.0 111.39 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 60' ' ' LEU . 6.7 mm -96.85 115.97 37.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.606 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -93.77 120.47 34.07 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.401 ' O ' ' O ' ' A' ' 58' ' ' LEU . 47.0 pt -118.95 148.54 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.461 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.784 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -133.97 128.84 35.24 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.066 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.41 ' O ' ' O ' ' A' ' 56' ' ' VAL . 1.2 p -118.47 137.46 53.16 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -41.34 -35.86 0.72 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.256 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.416 ' O ' ' CG1' ' A' ' 56' ' ' VAL . 78.7 mmt-85 -70.02 -47.43 62.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.955 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.416 ' CG1' ' O ' ' A' ' 55' ' ' ARG . 16.3 m -160.6 -175.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.004 0.43 . . . . 0.0 111.049 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 t -116.6 142.39 46.95 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.551 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.401 ' O ' ' O ' ' A' ' 51' ' ' ILE . 63.6 tp -150.6 150.06 30.69 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.507 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.7 p -125.69 130.54 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 49' ' ' ILE . 94.3 mt -132.41 155.79 47.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.619 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -84.84 168.33 15.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.842 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -59.21 -43.42 92.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.532 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -59.22 -39.3 82.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.725 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -60.11 -45.7 92.07 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.453 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.54 -40.96 98.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.863 0.363 . . . . 0.0 110.15 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.99 -39.08 90.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.483 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.4 mt -82.08 -55.29 4.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.815 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 70.6 mt -46.74 132.88 11.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.398 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.407 ' O ' ' OG1' ' A' ' 12' ' ' THR . 96.8 mt-10 -76.27 108.87 9.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.5 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.36 161.58 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.634 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 31.0 tp10 -145.42 143.05 29.85 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.412 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.31 131.41 41.88 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 36.0 t . . . . . 0 C--N 1.327 -0.371 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.409 -179.506 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 . . . . . 0 CA--C 1.521 -0.135 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.9 151.5 78.32 Favored Pre-proline 0 N--CA 1.468 0.46 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 39' ' ' VAL . 43.3 Cg_endo -66.96 -33.68 31.83 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.659 2.24 . . . . 0.0 112.228 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -136.63 94.65 3.02 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.818 0.342 . . . . 0.0 110.995 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 t -140.4 148.19 40.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.246 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -96.02 102.07 13.82 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 19.2 m0 -99.34 137.46 37.82 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.25 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -93.41 130.29 39.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.863 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.6 mt -83.05 115.84 26.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.0 m -98.73 -43.72 6.68 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.849 0.357 . . . . 0.0 110.422 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.06 -179.79 31.7 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.8 p90 -95.89 147.67 23.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.855 0.359 . . . . 0.0 110.475 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 67' ' ' LEU . 5.7 m -78.47 172.93 12.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.517 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 85.6 mmt-85 -70.06 -40.35 75.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.607 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -65.72 -15.18 62.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.628 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.429 ' CG2' ' O ' ' A' ' 15' ' ' SER . 10.5 tp -41.58 148.43 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.636 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 92.6 p -83.05 144.83 48.08 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.713 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -50.17 -37.18 48.18 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.051 1.834 . . . . 0.0 112.692 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.24 -58.51 7.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.891 0.377 . . . . 0.0 111.414 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -64.33 -47.18 80.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.261 0.553 . . . . 0.0 110.681 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -57.56 -47.55 81.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.371 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 68.3 tp60 -60.18 -32.27 70.91 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -60.8 -44.36 96.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.895 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -62.25 -42.94 99.77 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.368 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.16 -39.9 96.0 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.743 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.1 t -60.71 -45.2 95.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.039 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 pp -92.74 133.94 35.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.502 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.7 -1.67 72.81 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 67.2 mtt -86.66 74.46 9.85 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -82.23 168.54 23.03 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.336 -179.096 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 32' ' ' LEU . 72.7 Cg_exo -43.4 177.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 122.451 2.101 . . . . 0.0 112.312 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.42 11.88 7.09 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 99.0 p -146.43 -161.94 1.42 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.845 0.355 . . . . 0.0 110.306 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.5 m -135.3 158.34 44.62 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.632 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -136.6 156.05 49.09 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.147 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -110.56 146.33 36.25 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.485 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.428 ' O ' ' O ' ' A' ' 5' ' ' PRO . 21.5 t -86.7 126.33 40.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.494 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 p -68.02 -41.21 84.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.95 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -174.74 160.56 2.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.083 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.4 t -133.31 118.23 30.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.2 110.39 48.02 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.474 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -76.4 -11.55 18.99 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.292 1.995 . . . . 0.0 112.271 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.0 mt -56.98 -30.45 64.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.686 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.98 21.98 0.68 Allowed Glycine 0 N--CA 1.465 0.609 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.16 159.81 30.46 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -60.55 173.9 1.86 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.761 2.307 . . . . 0.0 111.819 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 60' ' ' LEU . 8.0 mm -93.07 114.1 29.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.325 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -93.63 125.47 38.27 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.296 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.4 pt -127.1 150.25 32.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.571 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -127.07 137.97 53.13 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.356 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 56' ' ' VAL . 0.8 OUTLIER -131.53 137.95 48.71 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.9 ptt-85 -42.73 -44.65 4.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.793 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 76.2 mmt-85 -65.12 -42.08 94.27 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.675 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.604 ' CG2' ' H ' ' A' ' 57' ' ' SER . 11.1 p -169.46 179.43 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.239 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.604 ' H ' ' CG2' ' A' ' 56' ' ' VAL . 8.1 p -123.16 150.6 43.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.165 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.1 tt -159.68 162.82 35.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.395 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.1 p -122.14 132.49 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.096 0.474 . . . . 0.0 110.661 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 49' ' ' ILE . 51.5 mt -124.79 157.58 35.44 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.36 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -91.01 170.95 9.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.011 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -61.08 -44.37 97.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.201 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -62.42 -37.35 85.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.564 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -59.96 -46.0 90.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.447 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.31 -42.16 98.99 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.083 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.47 -49.44 77.34 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.2 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' OG ' ' A' ' 15' ' ' SER . 96.2 mt -69.71 -41.8 74.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.314 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.1 tp -63.12 134.19 55.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.27 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -83.24 115.01 21.77 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.227 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.1 m -134.04 155.34 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.554 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -141.15 142.45 34.06 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.675 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.74 145.73 46.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.255 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.465 0.298 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.231 -179.77 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 5.0 m-85 . . . . . 0 CA--C 1.519 -0.249 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.447 ' OG1' ' OG1' ' A' ' 7' ' ' THR . 0.1 OUTLIER -117.68 158.46 45.35 Favored Pre-proline 0 N--CA 1.469 0.503 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -51.14 -38.73 61.05 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.996 1.798 . . . . 0.0 112.735 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -136.79 94.62 3.0 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.447 ' OG1' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -129.76 129.22 43.85 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.852 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.16 102.13 14.85 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 24.4 m0 -100.86 141.39 33.81 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.292 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -97.16 129.11 44.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.781 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.2 mt -80.62 122.56 36.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.061 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 6.2 p -109.12 -15.33 14.35 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.342 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.81 178.41 15.64 Favored Glycine 0 N--CA 1.466 0.686 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.5 p90 -99.36 153.36 19.04 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.583 ' HG ' ' N ' ' A' ' 16' ' ' ARG . 1.9 t -82.29 171.97 13.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.647 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.583 ' N ' ' HG ' ' A' ' 15' ' ' SER . 99.6 mtt180 -69.89 -40.67 75.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.835 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -66.19 -14.94 62.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.297 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.436 ' CG2' ' O ' ' A' ' 15' ' ' SER . 10.5 tp -41.06 147.33 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.729 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.76 155.23 87.09 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.521 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.12 -31.57 64.79 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.577 2.185 . . . . 0.0 112.016 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.66 -54.39 32.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.892 0.377 . . . . 0.0 111.129 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -62.62 -45.5 92.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.466 0.65 . . . . 0.0 110.34 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -57.64 -42.7 83.95 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.811 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 28' ' ' SER . 58.3 tp60 -61.77 -37.3 83.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.063 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.434 ' HZ2' ' CD1' ' A' ' 58' ' ' LEU . 54.8 mtpt -60.54 -43.25 97.39 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 120.081 -0.647 . . . . 0.0 110.025 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.43 -40.12 96.33 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.401 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.4 tt -80.3 -26.45 38.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.437 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.46 ' N ' ' O ' ' A' ' 24' ' ' GLN . 15.0 t -60.59 -45.53 93.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.336 -178.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.467 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -107.16 163.55 12.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.247 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.63 34.24 4.11 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.409 ' H ' HD11 ' A' ' 29' ' ' LEU . 94.7 mtp -108.71 73.92 0.89 Allowed 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 33' ' ' PRO . 3.3 mm? -81.59 154.55 71.18 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.142 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.471 ' O ' ' O ' ' A' ' 32' ' ' LEU . 77.3 Cg_exo -42.48 176.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 122.742 2.295 . . . . 0.0 112.537 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.24 12.05 7.11 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 95.7 p -136.94 -156.93 0.74 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.863 0.363 . . . . 0.0 110.268 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 97.3 p -146.61 161.36 40.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.459 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -138.05 155.09 49.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.29 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 27.4 p30 -109.85 152.35 25.87 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.534 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.6 t -92.96 125.26 45.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.503 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.7 p -67.14 -41.69 87.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.026 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.607 ' NH2' ' ND1' ' A' ' 50' ' ' HIS . 37.7 ptt-85 -172.12 157.2 4.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.252 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.6 t -126.33 120.21 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.22 110.56 49.08 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.355 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -76.53 -12.24 18.62 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.008 1.805 . . . . 0.0 112.213 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.1 tp -57.63 -31.29 66.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.873 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.87 25.97 0.8 Allowed Glycine 0 N--CA 1.464 0.532 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.2 159.69 30.7 Favored Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -56.56 175.7 0.26 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.838 2.359 . . . . 0.0 111.764 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.473 ' N ' ' O ' ' A' ' 60' ' ' LEU . 7.2 mm -92.5 114.21 29.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.936 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.607 ' ND1' ' NH2' ' A' ' 41' ' ' ARG . 15.8 m170 -94.32 119.91 33.78 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.872 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 58' ' ' LEU . 48.2 pt -126.11 149.87 31.26 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.221 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 12.5 tm-20 -132.68 130.11 39.67 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.188 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.4 p -116.06 137.14 52.38 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.701 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -39.08 -36.76 0.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.818 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.422 ' O ' ' CG1' ' A' ' 56' ' ' VAL . 32.9 mmt180 -71.11 -49.05 48.45 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.147 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.422 ' CG1' ' O ' ' A' ' 55' ' ' ARG . 15.2 m -160.81 -176.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.95 0.405 . . . . 0.0 110.501 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 m -109.06 148.18 31.2 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.741 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.434 ' CD1' ' HZ2' ' A' ' 25' ' ' LYS . 63.0 tp -152.61 149.16 28.17 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.4 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 p -128.84 129.76 68.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.624 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.473 ' O ' ' N ' ' A' ' 49' ' ' ILE . 76.3 mt -133.59 163.8 28.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.325 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -93.66 164.23 13.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.492 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -55.91 -39.09 71.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.035 0.445 . . . . 0.0 110.288 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -62.0 -40.94 97.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.729 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -60.43 -43.86 96.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.151 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.64 -42.22 99.48 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.31 -50.32 74.04 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.243 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.3 mt -68.79 -41.1 79.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.2 tp -65.1 131.22 45.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.107 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.444 ' O ' ' OG1' ' A' ' 12' ' ' THR . 94.3 mt-10 -78.19 115.29 17.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.181 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.4 160.2 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.419 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -141.0 132.34 26.69 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.156 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.31 135.33 54.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.884 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 85.0 t . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.176 -179.906 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 . . . . . 0 CA--C 1.516 -0.336 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.459 ' OG1' ' OG1' ' A' ' 7' ' ' THR . 1.0 OUTLIER -123.22 154.92 65.41 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.47 -179.312 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' A' ' 39' ' ' VAL . 51.8 Cg_exo -51.18 -36.51 56.11 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.075 1.85 . . . . 0.0 112.793 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -131.98 98.64 4.5 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.748 0.308 . . . . 0.0 110.371 -179.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.459 ' OG1' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -136.55 129.71 31.31 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.992 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -88.47 102.1 14.57 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 22.4 m0 -105.13 144.39 31.99 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.118 -179.092 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -100.46 132.05 46.05 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.185 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 34.2 mt -82.03 120.54 33.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.5 m -102.39 -40.49 6.7 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.374 179.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 161.14 175.34 32.06 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -96.47 143.55 27.39 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.48 ' OG ' ' O ' ' A' ' 67' ' ' LEU . 3.6 m -72.0 167.01 21.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.677 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -66.49 -39.02 88.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.333 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.98 -17.61 64.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.812 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.455 ' CG2' ' O ' ' A' ' 15' ' ' SER . 10.6 tp -41.88 146.36 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.398 -179.399 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.0 p -81.9 147.98 59.71 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.561 -179.324 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -49.85 -41.97 45.64 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.848 1.699 . . . . 0.0 112.644 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.95 -57.87 7.46 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.158 -178.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -63.23 -44.41 95.32 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.469 0.652 . . . . 0.0 110.734 -179.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -57.8 -46.09 85.14 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.989 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 28' ' ' SER . 78.0 mt-30 -64.59 -31.98 73.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.752 179.205 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.6 mmtt -59.77 -42.64 93.76 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 119.891 -0.723 . . . . 0.0 109.241 179.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.51 -41.29 96.51 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.794 178.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 45.0 mt -79.68 -16.12 56.3 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.895 0.379 . . . . 0.0 110.945 -179.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 24' ' ' GLN . 37.2 t -59.45 -41.56 89.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.035 -179.045 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.553 ' CD2' ' H ' ' A' ' 29' ' ' LEU . 0.6 OUTLIER -124.16 -171.16 2.27 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.948 -179.498 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.13 43.2 2.04 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -179.334 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 64.1 mtt -120.12 71.98 0.92 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.485 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.1 mm? -82.98 152.05 64.88 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.333 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 32' ' ' LEU . 77.2 Cg_exo -41.88 171.6 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.586 2.191 . . . . 0.0 112.366 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.51 -12.94 18.47 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 179.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.2 m -96.11 -156.68 0.54 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.893 0.378 . . . . 0.0 110.347 179.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.7 p -150.37 160.57 43.64 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.447 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -146.21 165.96 27.63 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.507 -179.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -126.13 143.88 50.96 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.267 0.556 . . . . 0.0 110.57 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.443 ' O ' ' O ' ' A' ' 5' ' ' PRO . 61.5 t -78.54 128.97 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.219 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.9 p -76.1 -40.44 37.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.09 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -173.16 160.95 4.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.097 -179.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 55.2 t -126.25 131.19 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -92.82 111.29 50.54 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-O 119.451 -0.309 . . . . 0.0 110.321 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.29 -13.11 18.94 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.923 1.748 . . . . 0.0 112.056 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.1 tp -61.98 -32.08 72.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.646 -179.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 127.79 30.01 0.78 Allowed Glycine 0 N--CA 1.464 0.542 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.89 173.29 4.08 Favored Pre-proline 0 CA--C 1.534 0.327 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -179.35 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -61.46 -170.94 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.141 1.894 . . . . 0.0 111.503 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 60' ' ' LEU . 10.4 mm -108.17 114.48 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -88.45 124.5 34.03 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.285 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.2 pt -129.21 144.25 38.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.397 179.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -124.17 114.34 19.51 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.125 179.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.527 ' HG1' ' H ' ' A' ' 56' ' ' VAL . 0.7 OUTLIER -105.83 137.82 43.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.895 -179.585 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -41.43 -42.42 2.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.474 -179.503 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -67.12 -44.6 79.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.718 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.527 ' H ' ' HG1' ' A' ' 53' ' ' THR . 14.8 p -170.28 172.85 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.499 -179.71 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.512 ' H ' ' CG2' ' A' ' 56' ' ' VAL . 94.2 p -111.52 153.8 25.68 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.561 179.409 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.2 tt -161.35 159.66 28.66 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.585 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.9 p -114.96 130.45 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.824 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' A' ' 49' ' ' ILE . 1.3 tp -133.53 152.34 51.89 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.035 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -82.63 161.64 22.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.626 -179.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.1 -45.94 91.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.644 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.69 -40.4 87.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.853 -179.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.46 -40.32 96.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.262 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.3 mp -61.64 -44.47 96.92 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.62 -42.45 98.9 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.28 -179.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.48 ' O ' ' OG ' ' A' ' 15' ' ' SER . 94.2 mt -68.02 -41.13 82.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.669 179.698 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.1 tp -64.95 131.03 45.54 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.066 -179.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -74.76 114.47 13.24 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.154 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.9 m -132.57 158.19 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.647 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -143.55 135.69 26.81 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.694 -179.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.37 129.29 37.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.345 179.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.3 t . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.854 -179.739 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 . . . . . 0 N--CA 1.456 -0.142 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.417 ' OG1' ' OG1' ' A' ' 7' ' ' THR . 0.1 OUTLIER -139.18 155.71 72.4 Favored Pre-proline 0 N--CA 1.466 0.325 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.154 -179.44 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 39' ' ' VAL . 40.9 Cg_endo -66.43 -22.1 52.63 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.653 2.235 . . . . 0.0 112.192 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.43 ' C ' ' HG1' ' A' ' 7' ' ' THR . 37.0 t70 -137.11 93.4 2.82 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.709 0.29 . . . . 0.0 110.325 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.43 ' HG1' ' C ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -139.92 130.71 25.94 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.995 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.12 102.46 15.0 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 18.3 m0 -102.22 140.63 36.24 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.884 0.373 . . . . 0.0 110.17 -179.211 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -98.15 128.51 44.68 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.536 179.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.7 mt -81.85 124.49 39.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.232 -179.302 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -109.35 -44.06 3.99 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.49 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.32 -176.68 39.47 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -100.63 150.15 23.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.854 0.359 . . . . 0.0 110.479 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.3 t -78.24 169.86 17.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.564 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -69.74 -39.24 76.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.925 0.393 . . . . 0.0 110.784 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -66.83 -14.94 63.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.451 -179.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.5 tp -40.63 146.86 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.545 -179.473 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.9 m -79.5 143.84 60.25 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.507 -179.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -47.99 -41.06 33.41 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.917 1.745 . . . . 0.0 112.663 179.209 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.13 -55.99 19.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.86 0.362 . . . . 0.0 111.492 -178.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -63.24 -47.26 83.2 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.476 0.655 . . . . 0.0 110.623 -179.592 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -56.78 -44.87 82.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.999 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -60.43 -35.81 76.69 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.024 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -56.73 -46.71 81.16 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 29' ' ' LEU . 4.5 mm? -63.05 -43.44 98.63 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.506 179.488 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.58 -31.3 68.26 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.721 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.0 t -58.94 -45.03 91.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.228 -179.163 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -119.22 174.84 6.1 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.39 -179.697 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -90.67 0.16 76.57 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 46.3 tpp -66.85 73.7 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.5 mp -99.59 169.47 8.05 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.369 -179.041 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 32' ' ' LEU . 61.7 Cg_exo -49.96 -166.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.242 1.961 . . . . 0.0 112.256 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.94 4.98 51.04 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.1 m -140.65 -169.92 2.9 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.925 0.393 . . . . 0.0 110.259 179.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.2 p -134.04 158.74 42.8 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.194 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -137.72 163.87 30.25 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.218 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.491 ' OD1' ' N ' ' A' ' 38' ' ' ASN . 12.1 p-10 -121.66 150.28 41.98 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.314 0.578 . . . . 0.0 110.387 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.438 ' O ' ' O ' ' A' ' 5' ' ' PRO . 14.8 t -85.41 128.73 38.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.504 -179.651 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 p -68.95 -40.93 81.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.248 179.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -174.85 167.27 3.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.994 -179.198 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.6 m -133.51 125.1 49.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.084 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.76 111.21 51.76 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.582 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -76.24 -11.91 19.21 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.051 1.834 . . . . 0.0 112.311 179.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.419 ' N ' ' CD1' ' A' ' 45' ' ' LEU . 10.6 mp -61.52 -32.23 72.27 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.809 -178.882 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.2 26.48 0.82 Allowed Glycine 0 N--CA 1.466 0.669 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.27 160.32 29.18 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -55.71 173.72 0.35 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.698 2.265 . . . . 0.0 111.855 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.4 mm -92.84 118.0 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.771 -179.376 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -97.02 123.7 40.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.03 179.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.412 HD13 HG23 ' A' ' 51' ' ' ILE . 33.8 pt -127.33 148.88 32.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.719 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 97.0 mt-10 -134.95 112.16 10.4 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.094 179.593 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.425 ' O ' ' C ' ' A' ' 54' ' ' ARG . 1.2 p -85.52 173.93 9.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.889 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 53' ' ' THR . 99.9 mtt180 -33.55 -52.95 0.41 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.708 -178.186 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 57.4 ttp85 -142.93 32.29 1.4 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.016 179.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -140.62 136.98 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.489 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.6 t -113.7 130.47 56.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.237 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.9 tp -145.62 148.09 32.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.111 -179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.8 p -136.4 123.6 32.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.32 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.4 mt -140.68 173.16 11.76 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.443 -179.513 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.9 mtm-85 -84.05 163.31 19.96 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.922 0.391 . . . . 0.0 110.91 -179.519 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -58.73 -34.37 71.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.517 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -60.6 -40.25 91.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.546 179.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -61.56 -43.84 98.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.512 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 mp -61.58 -42.12 98.4 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.79 -44.24 97.26 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.326 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.6 mt -68.75 -41.19 79.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.042 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 63.7 mt -64.06 137.64 58.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.875 0.369 . . . . 0.0 110.611 -179.477 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -79.39 108.58 13.02 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.215 -179.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.4 m -134.95 156.54 39.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.479 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -138.92 128.06 23.97 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.595 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.1 134.58 48.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.095 179.675 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.8 m . . . . . 0 N--CA 1.466 0.333 0 CA-C-O 121.029 0.443 . . . . 0.0 110.348 179.975 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 . . . . . 0 CA--C 1.516 -0.351 0 CA-C-O 120.917 0.389 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.07 154.44 40.63 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.424 -179.101 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 39' ' ' VAL . 41.2 Cg_endo -67.33 -37.42 17.89 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.672 2.248 . . . . 0.0 112.243 179.733 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -136.56 95.95 3.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.626 -179.596 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -140.07 147.76 40.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.383 179.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -97.25 101.8 13.43 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.632 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 28.7 m0 -98.02 142.95 29.1 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.341 -179.34 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -99.78 131.37 45.8 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.881 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.0 mt -80.98 125.58 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.467 -179.386 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.4 m -104.93 -51.95 2.95 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.475 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 168.14 167.78 29.29 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.0 OUTLIER -87.7 148.26 24.85 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 179.616 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.468 ' O ' ' CG2' ' A' ' 18' ' ' ILE . 43.7 t -80.68 171.05 15.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.659 179.874 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -67.16 -38.85 86.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.343 179.673 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -65.4 -18.31 65.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.689 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.468 ' CG2' ' O ' ' A' ' 15' ' ' SER . 10.8 tp -41.91 147.27 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.822 -179.698 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.58 158.19 81.37 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.28 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.88 -32.39 45.62 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.663 2.242 . . . . 0.0 111.958 179.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.15 -57.42 11.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.018 0.437 . . . . 0.0 110.979 -179.465 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -61.27 -45.29 95.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.603 0.716 . . . . 0.0 110.322 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -56.51 -42.86 79.08 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.192 -179.65 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 28' ' ' SER . 62.8 mt-30 -62.15 -37.2 84.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.414 179.41 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -58.81 -43.34 90.58 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.811 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.68 -41.71 95.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.262 0.553 . . . . 0.0 110.575 179.638 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.4 tt -78.73 -26.21 44.67 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.19 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 24' ' ' GLN . 14.4 t -61.19 -45.18 95.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.273 -178.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.504 HD13 ' H ' ' A' ' 31' ' ' MET . 0.3 OUTLIER -112.03 169.27 8.97 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.237 -179.742 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.05 40.76 2.95 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.571 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.549 ' SD ' ' CZ ' ' A' ' 55' ' ' ARG . 38.0 ttp -108.82 72.11 0.81 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.188 0.518 . . . . 0.0 109.793 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.506 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.2 mm? -82.74 151.88 65.31 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.566 -179.276 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 32' ' ' LEU . 73.9 Cg_exo -41.96 175.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 122.49 2.126 . . . . 0.0 112.009 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.5 -21.22 9.27 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.783 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.8 m -97.63 -174.43 2.9 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.8 m -133.6 151.68 51.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.332 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -133.17 155.04 50.02 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.109 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -109.05 145.0 36.33 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.318 0.58 . . . . 0.0 110.713 -179.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.446 ' O ' ' O ' ' A' ' 5' ' ' PRO . 48.8 t -89.45 125.05 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.18 -179.908 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 p -69.11 -40.44 80.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.965 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.2 ptt-85 -176.82 166.84 2.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.006 -178.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.9 m -132.67 122.31 46.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.031 179.299 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.89 111.98 56.47 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.577 ' C ' ' H ' ' A' ' 46' ' ' GLY . 59.2 Cg_endo -75.75 -11.98 20.12 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.642 2.228 . . . . 0.0 112.013 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.9 mt -61.83 4.91 0.1 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.955 -179.191 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.577 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 91.07 24.98 25.66 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.42 160.07 30.46 Favored Pre-proline 0 C--N 1.332 -0.176 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.62 168.01 4.55 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.809 2.339 . . . . 0.0 111.749 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 60' ' ' LEU . 5.9 mm -90.12 118.23 34.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.097 0.475 . . . . 0.0 110.074 -179.362 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -96.72 121.52 38.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.064 179.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.1 pt -123.84 147.73 28.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.141 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -129.85 135.27 48.19 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.471 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.753 ' HG1' ' H ' ' A' ' 56' ' ' VAL . 1.7 p -123.94 143.57 50.3 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.911 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -54.27 -18.32 3.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.771 -178.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.549 ' CZ ' ' SD ' ' A' ' 31' ' ' MET . 16.8 ptm180 -97.97 -31.31 12.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.891 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.753 ' H ' ' HG1' ' A' ' 53' ' ' THR . 4.2 p -170.22 179.37 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.969 0.414 . . . . 0.0 110.393 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.445 ' H ' HG21 ' A' ' 56' ' ' VAL . 54.3 m -124.25 155.91 37.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.478 178.711 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.4 tp -158.66 151.71 22.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.292 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 p -135.82 126.68 43.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.025 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 49' ' ' ILE . 35.8 mt -131.56 161.8 31.78 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.505 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -78.23 150.86 33.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.569 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -44.71 -47.22 10.66 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.279 0.561 . . . . 0.0 110.857 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -52.96 -34.63 56.58 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.263 -179.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -63.6 -40.78 97.8 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.348 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.513 ' CD2' ' N ' ' A' ' 65' ' ' LEU . 4.0 mm? -63.33 -43.21 98.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.076 -179.285 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.84 -47.25 85.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.207 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.8 mt -68.31 -41.81 80.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.567 179.77 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 49.7 tp -64.63 131.47 47.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.26 -179.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -81.55 114.32 20.18 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.441 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.4 m -130.98 156.42 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.335 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -137.39 125.55 23.04 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.444 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.03 138.98 52.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.281 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.463 0.21 0 CA-C-O 120.886 0.374 . . . . 0.0 110.285 -179.875 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 . . . . . 0 CA--C 1.519 -0.232 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 p -128.45 152.17 77.84 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.491 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.57 -40.82 54.66 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.944 1.763 . . . . 0.0 112.765 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -135.24 101.22 4.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.021 0.439 . . . . 0.0 111.036 -179.297 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.407 ' OG1' ' CD1' ' A' ' 9' ' ' TRP . 0.9 OUTLIER -137.86 142.8 40.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.393 179.143 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.66 102.21 14.38 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.565 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.407 ' CD1' ' OG1' ' A' ' 7' ' ' THR . 18.9 m0 -100.65 137.04 39.58 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.394 -179.254 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -91.57 143.89 26.11 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.768 179.515 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.5 mt -97.2 117.01 41.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.316 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.9 m -101.7 -47.04 4.75 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.597 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 162.16 176.63 34.44 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.4 p90 -92.11 148.4 22.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.219 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.442 ' OG ' ' N ' ' A' ' 16' ' ' ARG . 1.9 t -75.89 172.18 13.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.528 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.442 ' N ' ' OG ' ' A' ' 15' ' ' SER . 35.8 ptt-85 -71.54 -37.13 71.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.665 179.712 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -69.67 -13.84 62.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.327 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.6 tp -41.35 149.44 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.516 -179.566 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.4 p -79.21 140.65 57.05 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.522 -179.541 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -47.44 -40.95 29.46 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 121.941 1.761 . . . . 0.0 112.703 179.061 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.98 -56.71 16.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.903 0.383 . . . . 0.0 111.19 -178.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -61.7 -44.35 97.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.285 0.564 . . . . 0.0 110.484 -179.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -58.62 -43.19 89.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.935 -179.386 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -62.81 -37.07 85.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.977 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -58.4 -47.35 84.17 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -63.21 -38.98 93.31 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.098 179.627 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.6 tp -60.34 -44.26 95.67 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.108 -179.39 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.5 m -75.97 -33.15 59.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.805 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.4 tp -71.34 129.47 38.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.259 -179.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.63 2.49 87.26 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 24.0 tpp -109.39 75.78 0.97 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.068 0.461 . . . . 0.0 109.854 179.484 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.2 mp -79.42 165.82 45.68 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.858 -179.213 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.479 ' O ' ' O ' ' A' ' 32' ' ' LEU . 71.4 Cg_exo -40.34 172.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.578 2.185 . . . . 0.0 112.393 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.42 8.64 9.09 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 t -137.2 -157.52 0.78 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.903 0.382 . . . . 0.0 110.207 179.563 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.9 m -145.33 157.96 43.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.445 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -139.35 153.75 47.74 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.378 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -107.06 147.95 29.35 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.342 0.591 . . . . 0.0 110.682 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.6 t -88.12 126.49 41.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.241 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 p -64.66 -39.9 87.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.891 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -174.08 161.13 3.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.096 -179.474 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 55.8 t -126.39 125.23 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.02 111.69 54.13 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.43 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.67 -11.99 20.26 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.202 1.934 . . . . 0.0 112.0 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.8 tp -58.68 -31.55 68.32 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.832 -178.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.71 32.98 1.13 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -100.24 179.45 1.02 Allowed Pre-proline 0 N--CA 1.466 0.343 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.463 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 47' ' ' ASP . 24.0 Cg_exo -62.7 -178.19 0.37 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.36 2.04 . . . . 0.0 111.71 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.3 mm -107.87 119.9 58.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.449 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -102.31 123.09 45.49 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.816 179.644 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.8 pt -127.81 152.13 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.054 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -123.52 135.61 54.12 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.08 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 56' ' ' VAL . 1.4 p -131.45 140.88 49.7 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -38.85 -37.3 0.33 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.565 -179.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.3 ttp85 -75.34 -49.4 19.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.777 179.608 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.607 ' CG2' ' H ' ' A' ' 57' ' ' SER . 10.2 p -171.73 -179.59 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.621 -179.564 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.607 ' H ' ' CG2' ' A' ' 56' ' ' VAL . 1.7 t -107.72 164.08 12.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.13 178.724 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.8 tp -149.15 146.31 27.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.205 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.4 t -127.9 124.41 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.79 178.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.6 mt -144.55 167.32 22.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.71 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -81.94 147.91 29.0 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.036 0.446 . . . . 0.0 111.424 -179.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -42.2 -40.99 2.56 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.701 -179.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -55.44 -38.81 69.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.547 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -61.75 -41.01 97.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.431 179.869 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.527 ' CD2' ' N ' ' A' ' 65' ' ' LEU . 3.3 mm? -62.84 -42.14 99.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.972 -179.301 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.65 98.13 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.048 179.608 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.36 -41.96 79.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.035 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.0 mt -68.36 135.71 52.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.861 0.362 . . . . 0.0 110.222 -179.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -81.31 111.35 17.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.283 -179.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.4 m -130.97 156.36 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.632 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -144.07 146.82 33.08 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.907 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.65 143.0 56.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.105 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.9 t . . . . . 0 N--CA 1.463 0.218 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.343 -179.775 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 . . . . . 0 N--CA 1.456 -0.139 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.01 156.91 70.23 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.092 -179.371 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -67.73 -50.25 0.93 Allowed 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.708 2.272 . . . . 0.0 112.196 -179.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -129.06 97.58 4.66 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.81 -179.599 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.479 ' HG1' ' N ' ' A' ' 8' ' ' ALA . 1.9 t -139.49 151.87 46.52 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.273 179.485 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.479 ' N ' ' HG1' ' A' ' 7' ' ' THR . . . -101.61 102.73 13.48 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.126 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -99.53 133.8 43.33 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.889 0.376 . . . . 0.0 110.152 -179.104 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -92.18 133.49 35.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.98 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.3 mt -85.34 123.31 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.303 -179.242 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.8 m -106.33 -47.74 3.73 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.874 0.369 . . . . 0.0 110.563 179.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 164.79 170.73 30.14 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.8 p90 -89.91 146.04 24.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.874 0.369 . . . . 0.0 110.412 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 67' ' ' LEU . 3.8 m -74.63 170.1 16.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.537 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -69.13 -37.74 78.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.481 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -72.06 -10.01 59.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.543 -179.581 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.8 tp -41.5 146.99 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.517 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.04 153.92 95.01 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.325 -179.586 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.14 -33.16 62.17 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.382 2.055 . . . . 0.0 112.117 -179.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.29 -55.29 22.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.827 0.346 . . . . 0.0 111.278 -179.42 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.406 ' CE1' ' CD2' ' A' ' 26' ' ' LEU . 31.5 t80 -61.64 -42.3 98.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.569 0.7 . . . . 0.0 110.338 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 68.5 ttp85 -58.07 -44.11 87.35 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.838 179.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 28' ' ' SER . 73.2 mt-30 -62.41 -36.3 81.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.252 179.115 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.414 ' O ' ' CD1' ' A' ' 29' ' ' LEU . 26.7 mmtp -59.27 -45.65 90.67 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.954 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 29' ' ' LEU . 4.6 mm? -63.62 -43.5 96.68 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.519 179.027 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 tt -70.71 -33.77 71.22 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.28 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 24' ' ' GLN . 74.8 m -58.86 -43.61 90.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.293 -178.729 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.416 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -119.72 176.92 5.16 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.475 -179.559 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -90.51 -2.96 72.33 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.552 ' CE ' ' HE ' ' A' ' 55' ' ' ARG . 35.4 tpp -61.89 73.85 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.783 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 30' ' ' GLY . 1.6 mp -101.12 169.9 7.21 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.34 -179.058 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.479 ' O ' ' O ' ' A' ' 32' ' ' LEU . 57.3 Cg_exo -50.19 -160.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.381 2.054 . . . . 0.0 112.584 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.22 10.66 59.35 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.1 t -142.41 -156.53 0.69 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.755 0.312 . . . . 0.0 110.376 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.3 p -151.86 164.02 37.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.591 -179.782 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -143.62 162.09 36.83 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.552 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 38' ' ' ASN . 7.9 p-10 -114.18 147.95 38.08 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.258 0.551 . . . . 0.0 110.84 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.8 t -88.7 123.11 40.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.234 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 p -66.47 -41.61 88.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.209 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -174.17 166.78 4.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.913 -179.453 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.6 m -128.72 130.12 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.0 110.95 49.21 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.545 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -76.65 -13.21 18.16 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.922 1.748 . . . . 0.0 112.392 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.3 mt -62.45 -30.99 71.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.768 -178.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.52 28.69 0.96 Allowed Glycine 0 N--CA 1.466 0.698 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.94 163.93 18.42 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.87 -173.8 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.913 1.742 . . . . 0.0 111.902 179.431 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.2 mm -103.07 115.08 44.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.775 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -92.02 119.1 31.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.174 -0.467 . . . . 0.0 109.779 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.6 pt -125.06 146.88 29.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.274 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.415 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 93.6 mt-10 -127.38 128.41 45.8 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.464 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 56' ' ' VAL . 0.8 OUTLIER -119.69 138.26 53.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.562 179.991 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.6 mmm-85 -45.25 -38.29 5.38 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.382 -179.342 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.552 ' HE ' ' CE ' ' A' ' 31' ' ' MET . 74.6 mtp85 -69.95 -43.38 71.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.849 179.679 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.483 ' CG2' ' H ' ' A' ' 57' ' ' SER . 14.7 p -170.38 171.11 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-O 120.93 0.395 . . . . 0.0 110.648 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.483 ' H ' ' CG2' ' A' ' 56' ' ' VAL . 28.4 t -98.62 161.08 13.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.7 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 64.8 tp -163.56 149.25 11.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.11 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.3 p -134.48 127.81 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.4 mp -133.33 155.82 48.74 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.399 -179.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.445 ' O ' ' N ' ' A' ' 64' ' ' ASP . 95.3 mtm-85 -78.4 143.92 36.36 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.123 179.91 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -39.5 -43.4 1.26 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.479 -179.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -58.54 -41.83 86.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.353 179.821 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 61' ' ' ARG . 97.3 m-20 -62.75 -40.17 96.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.354 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.429 ' N ' ' CD2' ' A' ' 65' ' ' LEU . 4.2 mm? -61.28 -42.38 98.55 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.3 -40.17 96.6 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.15 179.585 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.454 ' O ' ' OG ' ' A' ' 15' ' ' SER . 96.8 mt -67.32 -41.36 85.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.196 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.5 mt -71.05 141.38 50.91 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.618 -179.733 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -84.19 103.42 13.38 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.093 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.8 m -122.85 154.8 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.279 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.531 ' N ' ' OE1' ' A' ' 71' ' ' GLU . 56.6 mp0 -142.57 125.6 16.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.575 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.03 132.35 48.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.911 179.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.464 0.248 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.362 179.928 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 . . . . . 0 CA--C 1.516 -0.335 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.448 ' OG1' ' OG1' ' A' ' 7' ' ' THR . 0.6 OUTLIER -106.31 156.99 35.97 Favored Pre-proline 0 N--CA 1.464 0.262 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.559 -179.448 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 39' ' ' VAL . 51.3 Cg_exo -50.95 -38.64 58.96 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.164 1.909 . . . . 0.0 112.616 179.358 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -136.8 95.82 3.2 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -179.546 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.448 ' OG1' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -126.75 129.21 47.93 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.84 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.21 101.55 13.13 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.235 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -102.29 148.06 25.91 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.333 -179.101 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -100.39 128.9 46.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.761 179.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.456 ' CD1' ' NH2' ' A' ' 55' ' ' ARG . 32.3 mt -83.85 122.53 37.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.24 -179.47 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.3 m -108.31 -46.17 3.77 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.87 0.367 . . . . 0.0 110.502 179.796 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.6 -179.44 39.95 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.87 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -90.57 160.09 16.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 0.0 110.435 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.8 t -82.25 169.21 16.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.614 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -69.74 -38.5 76.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.531 179.377 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -74.0 -6.59 48.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.881 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.0 tp -42.55 147.04 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.524 -179.532 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.9 p -82.73 149.19 59.67 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.754 -179.563 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.11 -38.81 50.99 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 122.303 2.002 . . . . 0.0 112.554 178.913 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.43 -57.11 13.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.859 0.361 . . . . 0.0 111.153 -179.081 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -63.58 -49.08 74.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.287 0.565 . . . . 0.0 110.578 -179.841 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -57.0 -43.86 82.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.237 -179.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -63.2 -33.11 74.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.755 179.293 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -59.76 -49.01 79.38 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.543 -0.463 . . . . 0.0 109.941 179.668 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.87 -38.94 92.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.278 179.593 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.4 tp -60.55 -41.13 93.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.335 -179.353 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.3 m -83.65 -11.78 56.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.897 -179.398 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.5 tp -97.27 123.25 41.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.888 0.375 . . . . 0.0 110.261 -179.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.27 3.81 61.12 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 66.7 mtt -108.48 75.83 1.0 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.21 0.529 . . . . 0.0 109.803 179.575 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.503 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.9 OUTLIER -78.51 167.9 31.58 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.093 -178.942 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.503 ' O ' ' O ' ' A' ' 32' ' ' LEU . 72.9 Cg_exo -42.2 177.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.509 2.139 . . . . 0.0 112.416 -179.551 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.74 11.06 7.33 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 179.784 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.9 m -143.5 -169.54 3.09 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.736 0.303 . . . . 0.0 110.37 179.587 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.45 ' O ' ' NH1' ' A' ' 54' ' ' ARG . 69.0 m -131.41 157.42 43.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.449 -179.74 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -133.52 157.72 44.95 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.212 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -112.93 147.16 37.66 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.447 -179.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 5' ' ' PRO . 14.5 t -85.27 127.03 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.171 179.867 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 p -68.26 -40.11 82.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.839 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -173.98 157.35 2.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.14 -179.072 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 73.8 t -131.82 105.93 10.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.72 111.4 52.47 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.525 -179.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.89 -9.2 19.47 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.952 2.435 . . . . 0.0 112.275 -179.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 51.8 mt -50.73 -29.62 11.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.733 -178.149 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 132.29 20.55 1.01 Allowed Glycine 0 N--CA 1.467 0.723 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.362 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -97.4 160.89 27.75 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.647 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -60.17 175.31 1.08 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.749 2.3 . . . . 0.0 111.671 179.708 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.7 mm -94.55 115.73 34.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.185 -179.593 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -96.13 122.65 39.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.077 179.59 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.6 pt -128.37 147.26 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.361 179.71 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -122.87 121.03 35.23 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.019 179.635 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 55' ' ' ARG . 1.4 p -108.74 135.85 49.29 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.45 ' NH1' ' O ' ' A' ' 36' ' ' SER . 8.1 ptp85 -43.13 -18.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.62 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.516 ' N ' ' O ' ' A' ' 53' ' ' THR . 88.5 mtm180 -87.36 -51.38 5.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.967 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.446 ' CG1' ' O ' ' A' ' 55' ' ' ARG . 13.2 m -162.25 177.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.652 -179.547 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.3 p -97.63 143.14 28.61 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.337 179.539 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.1 tp -147.49 144.33 28.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.253 179.549 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.8 p -136.9 124.14 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.864 179.2 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.7 mt -138.8 178.81 6.88 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.561 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -88.35 161.89 16.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.806 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -58.71 -32.52 69.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.503 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.87 -42.19 99.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.501 179.926 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -60.9 -44.57 96.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.504 -179.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.8 mp -62.81 -41.65 99.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.218 179.652 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.94 -51.36 69.45 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.304 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.98 -43.45 78.92 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.864 179.759 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.8 tp -53.0 132.67 38.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.36 -179.004 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -75.43 108.2 8.06 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.442 -179.557 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.8 m -134.22 160.36 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.733 179.812 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -145.19 136.93 25.47 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.598 179.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -76.31 129.5 36.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.145 179.467 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.1 t . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.254 -179.785 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.422 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 41.5 m-85 . . . . . 0 C--O 1.231 0.128 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.44 156.33 41.56 Favored Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.99 -179.512 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 39' ' ' VAL . 40.5 Cg_endo -66.09 -20.1 56.97 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.522 2.148 . . . . 0.0 112.211 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -136.62 93.53 2.88 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.393 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.96 131.52 27.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.203 -179.544 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.02 102.41 14.48 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.056 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 24.4 m0 -101.37 135.71 42.4 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.362 -179.213 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -90.25 131.79 35.87 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.5 mt -84.73 117.78 30.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.765 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 11.0 p -102.43 -19.34 14.97 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.745 0.307 . . . . 0.0 110.187 179.735 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 137.63 179.04 16.52 Favored Glycine 0 N--CA 1.463 0.474 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 179.425 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -96.06 147.77 23.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.625 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.406 ' O ' ' CG2' ' A' ' 18' ' ' ILE . 10.1 t -76.92 170.46 16.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.578 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -69.01 -38.85 79.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.543 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -69.62 -13.23 62.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.634 -179.431 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.406 ' CG2' ' O ' ' A' ' 15' ' ' SER . 10.2 tp -41.45 147.1 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.725 -179.911 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.02 154.48 90.76 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.114 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.11 -29.72 56.13 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.456 2.104 . . . . 0.0 112.276 -179.607 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.33 -55.6 17.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.629 -179.206 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -62.25 -44.12 97.27 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.449 0.642 . . . . 0.0 110.346 -179.569 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -59.1 -45.7 90.21 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.999 179.758 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -59.28 -37.98 79.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.959 179.584 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -60.36 -41.66 94.15 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.839 179.367 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.73 -43.91 97.93 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.269 179.39 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.27 -38.89 92.67 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.375 179.418 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.0 m -61.12 -42.39 98.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.367 -179.191 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.47 ' CD1' ' O ' ' A' ' 31' ' ' MET . 2.5 pp -96.81 131.15 43.84 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.957 0.408 . . . . 0.0 110.675 -179.351 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.01 -22.95 72.68 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.47 ' O ' ' CD1' ' A' ' 29' ' ' LEU . 63.6 ttp -69.89 73.99 0.44 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.306 0.574 . . . . 0.0 109.789 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -82.03 169.45 18.46 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.815 -179.178 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 32' ' ' LEU . 61.0 Cg_exo -44.11 176.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.551 2.167 . . . . 0.0 112.946 -178.961 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.83 11.34 9.31 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.769 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 m -138.35 -156.16 0.66 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.754 0.311 . . . . 0.0 110.483 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.4 p -144.68 162.28 37.09 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.414 -179.75 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -139.37 163.47 32.42 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.284 -179.708 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -122.22 144.38 49.01 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.309 0.575 . . . . 0.0 110.731 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' PRO . 19.4 t -82.32 125.67 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.535 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 p -68.77 -39.75 80.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.728 179.386 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.3 ptt-85 -173.24 160.9 4.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.732 -179.44 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 62.4 t -129.55 118.71 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.007 179.087 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.61 111.15 51.27 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.463 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.91 -11.25 19.88 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.065 1.843 . . . . 0.0 112.357 179.843 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.472 ' CD2' ' N ' ' A' ' 45' ' ' LEU . 4.0 mm? -59.43 -31.59 69.42 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.842 -178.624 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.55 26.32 0.8 Allowed Glycine 0 N--CA 1.469 0.838 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.747 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -97.59 159.9 29.98 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.78 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.45 175.39 0.55 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.308 2.005 . . . . 0.0 111.628 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.503 ' N ' ' O ' ' A' ' 60' ' ' LEU . 8.3 mm -94.27 115.33 32.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.794 -179.579 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -94.6 125.44 39.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.156 -179.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.1 pt -127.15 148.58 31.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.474 179.737 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -130.91 130.33 43.36 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.488 179.784 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.38 138.06 54.4 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.511 -179.697 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -42.95 -34.62 1.01 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.437 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -69.73 -46.49 65.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.647 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.467 ' CG2' ' N ' ' A' ' 57' ' ' SER . 14.8 p -170.86 167.57 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 120.922 0.391 . . . . 0.0 111.177 -179.918 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.467 ' N ' ' CG2' ' A' ' 56' ' ' VAL . 9.9 p -93.25 154.79 17.82 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.599 178.994 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 64.2 tp -163.3 148.43 11.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.331 179.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.9 p -128.58 131.4 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 49' ' ' ILE . 91.7 mt -135.05 161.15 36.13 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.519 -179.428 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -86.33 164.82 16.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.571 179.734 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -59.0 -39.16 80.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.988 0.423 . . . . 0.0 110.542 -179.604 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -61.78 -40.15 94.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.59 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -59.66 -44.88 93.4 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.804 -0.359 . . . . 0.0 110.375 -179.581 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.2 mp -62.62 -41.42 98.99 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.275 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.22 -52.32 65.78 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.403 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.14 -40.69 78.09 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.301 179.609 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.9 tp -59.87 135.63 57.76 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.331 -179.309 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.445 ' O ' ' OG1' ' A' ' 12' ' ' THR . 70.7 mm-40 -81.51 113.69 19.73 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.547 -179.545 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.0 m -133.93 160.43 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.692 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -143.75 139.53 29.48 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.442 179.761 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.5 136.22 51.16 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.002 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 51.7 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.154 -179.657 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.421 ' OG1' ' OG1' ' A' ' 7' ' ' THR . 0.1 OUTLIER -142.77 155.93 62.9 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.136 -179.2 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 39' ' ' VAL . 39.1 Cg_endo -65.63 -23.45 56.73 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.596 2.197 . . . . 0.0 112.348 179.91 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -137.36 93.86 2.86 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.421 ' OG1' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -139.66 131.46 27.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.36 -0.382 . . . . 0.0 109.995 -179.969 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.11 101.74 14.27 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.252 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 22.2 m0 -102.85 142.06 34.61 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.083 -179.001 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -94.25 143.41 26.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.899 179.605 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.6 mt -96.66 115.59 36.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 O-C-N 123.23 0.332 . . . . 0.0 110.112 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.5 m -98.81 -44.12 6.5 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.558 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.67 177.34 27.05 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.865 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.497 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.7 OUTLIER -86.38 154.09 21.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.875 0.369 . . . . 0.0 110.466 -179.933 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.441 ' O ' ' CG2' ' A' ' 18' ' ' ILE . 8.1 t -85.11 172.44 11.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.467 179.543 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.401 ' N ' ' OG ' ' A' ' 15' ' ' SER . 99.7 mtt180 -68.11 -39.09 82.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.777 179.712 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 17' ' ' GLU . 3.0 tm-20 -69.27 -15.7 63.41 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.561 -179.844 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.441 ' CG2' ' O ' ' A' ' 15' ' ' SER . 10.6 tp -40.81 146.72 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.427 -179.567 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.4 m -80.61 143.7 55.34 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.741 -179.375 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -49.31 -39.14 43.5 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.801 1.667 . . . . 0.0 112.609 179.056 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.43 -57.83 9.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.866 0.365 . . . . 0.0 111.043 -178.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -63.69 -43.71 95.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.447 0.642 . . . . 0.0 110.551 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -57.85 -44.97 86.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.956 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -62.7 -35.72 80.62 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.541 179.178 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.2 mmtt -59.46 -44.15 93.05 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.714 179.667 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -63.32 -42.16 98.97 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.163 178.725 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.84 -39.49 94.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.745 179.901 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.7 m -61.43 -44.64 96.77 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.317 -179.461 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 pp -92.85 138.07 31.81 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.521 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.85 -2.19 90.04 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.216 -0.753 . . . . 0.0 111.216 -179.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 48.3 ttp -86.82 75.29 9.63 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.681 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -82.56 169.96 16.33 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.034 -179.262 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' A' ' 32' ' ' LEU . 73.7 Cg_exo -44.76 -179.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.531 2.154 . . . . 0.0 112.454 -179.652 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.96 11.67 7.5 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 179.609 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 86.7 p -144.33 -157.76 0.82 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.673 0.273 . . . . 0.0 110.306 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 82.8 p -140.83 164.62 29.75 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.628 -179.822 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -143.14 162.12 36.41 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.373 -179.696 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.445 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 22.2 p-10 -119.38 148.19 43.49 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.429 0.633 . . . . 0.0 110.638 179.692 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 5' ' ' PRO . 5.9 t -84.43 127.09 40.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.448 -179.716 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 p -68.67 -39.21 80.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.813 179.464 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -172.82 160.65 4.47 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.132 -179.377 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 67.4 t -125.67 126.36 70.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.129 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.8 111.56 53.3 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.582 -179.787 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -75.74 -11.77 20.15 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.181 1.921 . . . . 0.0 112.314 -179.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.9 mt -58.46 -29.91 66.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.805 -178.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.96 27.42 2.08 Favored Glycine 0 N--CA 1.467 0.72 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -97.51 178.31 1.39 Allowed Pre-proline 0 CA--C 1.531 0.237 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.817 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 47' ' ' ASP . 19.5 Cg_exo -64.28 -177.88 0.56 Allowed 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.047 1.832 . . . . 0.0 112.265 -179.888 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.8 mm -106.57 117.84 53.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.885 -179.186 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -96.62 125.05 40.82 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.261 179.788 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.7 pt -123.63 147.85 27.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.134 179.49 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.445 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 13.3 tm-20 -132.59 130.09 39.81 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.182 -179.603 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.522 ' O ' ' N ' ' A' ' 55' ' ' ARG . 1.0 OUTLIER -122.44 136.78 54.97 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.883 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.8 ptt85 -40.4 -22.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.865 -179.632 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 53' ' ' THR . 94.1 mtm-85 -86.07 -49.88 7.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.101 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.41 ' CG1' ' O ' ' A' ' 55' ' ' ARG . 16.6 m -160.43 -175.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.456 -179.224 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.3 p -128.5 150.88 49.97 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.707 179.601 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.0 tp -154.28 150.5 28.07 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.16 -179.831 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.0 t -117.45 130.4 72.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 98.1 mt -135.92 139.74 43.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.979 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.564 ' O ' ' N ' ' A' ' 64' ' ' ASP . 81.8 mtp180 -78.34 142.18 37.88 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.576 179.635 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 61' ' ' ARG . 16.8 ptpt -35.22 -35.18 0.04 OUTLIER 'General case' 0 C--O 1.235 0.301 0 O-C-N 123.313 0.383 . . . . 0.0 111.385 179.799 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 61' ' ' ARG . 54.9 mtpt -62.82 -44.78 95.24 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.159 179.149 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.564 ' N ' ' O ' ' A' ' 61' ' ' ARG . 10.6 m-20 -64.13 -36.27 83.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.233 179.024 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.479 ' CD2' ' N ' ' A' ' 65' ' ' LEU . 4.0 mm? -62.22 -42.86 99.69 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.725 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.16 -44.1 93.11 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.994 0.426 . . . . 0.0 110.088 179.433 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.9 mt -68.23 -38.97 82.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.658 179.559 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.5 tp -69.78 125.09 25.7 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.849 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -76.03 115.48 15.79 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.091 -179.674 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.9 m -131.87 158.73 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.731 -179.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -143.32 144.58 32.15 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.429 179.645 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.27 140.77 54.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.924 179.274 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.4 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.385 -179.927 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 C--O 1.231 0.112 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.81 159.34 47.38 Favored Pre-proline 0 N--CA 1.465 0.314 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.203 -179.525 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 39' ' ' VAL . 43.8 Cg_endo -66.82 -32.63 36.19 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.688 2.259 . . . . 0.0 112.119 -179.826 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -136.62 95.5 3.16 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.906 -179.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 t -140.11 148.79 42.22 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.382 179.313 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -101.04 102.09 13.0 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.156 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.41 ' O ' ' OG ' ' A' ' 36' ' ' SER . 19.8 m0 -98.48 136.41 38.64 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.178 -179.008 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -95.45 129.5 42.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.969 179.805 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.6 mt -81.86 123.67 38.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.21 -179.296 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 11.7 p -108.14 -17.94 13.9 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.498 179.845 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 136.2 -179.04 18.28 Favored Glycine 0 N--CA 1.464 0.539 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -98.68 150.87 21.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.879 0.371 . . . . 0.0 110.472 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.402 ' OG ' ' N ' ' A' ' 16' ' ' ARG . 5.6 t -77.13 171.64 14.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.491 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.402 ' N ' ' OG ' ' A' ' 15' ' ' SER . 9.1 mpt_? -71.78 -40.64 69.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.503 -179.802 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -66.37 -13.1 60.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.248 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.4 ' CG2' ' O ' ' A' ' 15' ' ' SER . 10.1 tp -40.61 148.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.618 -179.828 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 72.0 p -81.16 142.78 51.61 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.687 -179.46 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -49.04 -38.15 39.12 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.916 1.744 . . . . 0.0 112.638 178.938 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.97 -57.4 12.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.877 0.37 . . . . 0.0 111.451 -178.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -63.02 -48.48 78.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.271 0.558 . . . . 0.0 110.579 -179.623 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.5 ttp85 -58.43 -46.37 86.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.168 0.509 . . . . 0.0 110.243 -179.677 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -60.46 -31.04 70.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.576 179.382 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.407 ' HZ3' ' CD2' ' A' ' 58' ' ' LEU . 29.6 ttpt -61.18 -44.95 96.48 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.867 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' A' ' 29' ' ' LEU . 4.6 mm? -61.77 -43.1 99.52 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.308 179.621 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.75 -38.71 92.13 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.692 179.554 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.0 t -60.46 -43.92 96.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.023 -179.212 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.475 ' CD1' ' O ' ' A' ' 31' ' ' MET . 2.3 pp -97.5 131.53 44.03 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.475 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.5 -21.53 74.51 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.475 ' O ' ' CD1' ' A' ' 29' ' ' LEU . 26.0 mmt -69.48 76.29 0.4 Allowed 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -82.2 169.69 17.48 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.324 -178.984 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 32' ' ' LEU . 71.3 Cg_exo -46.5 -178.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.435 2.09 . . . . 0.0 112.275 -179.475 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.89 8.91 9.34 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 179.665 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 m -138.03 -158.25 0.84 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.784 0.326 . . . . 0.0 110.256 179.657 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 9' ' ' TRP . 31.7 t -141.6 153.06 44.55 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.46 -179.838 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -128.37 157.41 41.09 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.339 -179.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 39' ' ' VAL . 50.0 t-20 -110.05 146.94 34.51 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.543 -179.803 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.529 ' N ' ' OD1' ' A' ' 38' ' ' ASN . 54.3 t -88.22 126.52 41.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.041 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 p -70.27 -40.64 78.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.075 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -173.73 159.25 3.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.152 -179.279 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.4 t -131.31 120.93 47.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.772 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.49 110.75 50.69 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.444 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -76.7 -11.69 18.42 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.2 1.933 . . . . 0.0 112.299 179.805 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.8 mt -59.39 -30.91 68.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.956 -178.551 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.24 22.77 0.7 Allowed Glycine 0 N--CA 1.465 0.568 0 N-CA-C 111.006 -0.837 . . . . 0.0 111.006 179.755 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.6 159.8 30.19 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.11 171.7 2.12 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.795 2.33 . . . . 0.0 111.939 -179.814 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.407 ' N ' ' O ' ' A' ' 60' ' ' LEU . 8.4 mm -92.56 114.27 29.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.799 -179.255 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -92.0 122.21 34.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.893 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.422 ' O ' ' O ' ' A' ' 58' ' ' LEU . 45.6 pt -127.54 149.17 32.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.326 -179.966 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -126.85 129.87 49.1 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.375 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.95 138.87 54.56 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.847 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -41.16 -37.03 0.83 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.346 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -65.47 -49.02 70.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.555 179.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.461 ' CG2' ' H ' ' A' ' 57' ' ' SER . 7.1 p -171.13 173.1 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.803 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.461 ' H ' ' CG2' ' A' ' 56' ' ' VAL . 40.0 t -92.11 136.71 32.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.151 178.812 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 51' ' ' ILE . 64.1 tp -143.03 148.72 37.21 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.791 0.329 . . . . 0.0 110.154 -179.877 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 p -130.13 130.54 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.099 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 49' ' ' ILE . 80.4 mt -134.59 155.69 50.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.323 -179.506 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -77.63 170.15 17.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.683 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.15 -47.07 87.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.132 0.492 . . . . 0.0 110.578 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -58.41 -38.23 76.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.733 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -58.07 -46.56 85.24 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.37 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.0 mp -62.75 -41.49 99.24 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.175 179.172 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.68 -53.11 59.14 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.365 -179.711 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.421 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 4.2 mm? -68.57 -41.11 80.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.146 179.482 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.2 tp -58.15 133.13 55.33 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.185 -179.038 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.429 ' O ' ' OG1' ' A' ' 12' ' ' THR . 47.6 mm-40 -77.85 110.42 12.72 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.312 -179.46 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.36 156.9 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.472 179.608 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -141.79 137.05 31.27 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.493 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.45 117.48 27.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.203 179.768 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.343 -179.671 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 . . . . . 0 CA--C 1.522 -0.13 0 CA-C-O 120.907 0.384 . . . . 0.0 109.977 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.66 159.13 32.4 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.12 -179.257 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 39' ' ' VAL . 42.6 Cg_endo -67.5 -20.19 47.97 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.697 2.264 . . . . 0.0 112.078 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.408 ' C ' ' HG1' ' A' ' 7' ' ' THR . 99.3 m-20 -136.47 93.81 2.93 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.823 0.344 . . . . 0.0 110.121 179.976 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.408 ' HG1' ' C ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -139.51 131.64 28.05 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.838 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.88 102.12 14.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.228 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 21.1 m0 -100.04 140.37 34.35 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.118 -179.353 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -101.39 125.23 48.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.733 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.2 mt -81.14 123.6 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.393 -179.169 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.9 p -105.29 -16.16 14.84 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.436 179.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.39 163.08 9.64 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.516 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.84 159.54 33.59 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.56 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 p -77.35 167.41 21.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.643 -179.733 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.25 -40.44 74.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.863 0.363 . . . . 0.0 110.7 179.508 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -80.47 -2.39 45.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.145 -179.725 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.6 tp -40.42 146.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.561 -179.406 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.2 p -76.23 137.95 68.3 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.461 -179.258 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -46.92 -41.97 25.42 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.883 1.722 . . . . 0.0 112.666 179.195 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.83 -54.28 44.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.912 0.387 . . . . 0.0 111.228 -179.181 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -63.07 -49.24 75.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.355 0.598 . . . . 0.0 110.557 -179.859 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.1 ttt-85 -57.2 -42.67 81.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.088 -179.247 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.524 ' NE2' ' OG ' ' A' ' 28' ' ' SER . 12.4 tm0? -62.52 -34.99 78.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.02 179.332 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -59.22 -46.47 88.36 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.942 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -65.19 -37.79 88.46 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.821 179.557 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 tt -75.66 -23.83 56.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.082 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.524 ' OG ' ' NE2' ' A' ' 24' ' ' GLN . 49.1 m -58.11 -44.09 87.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.903 0.382 . . . . 0.0 111.317 -179.2 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.438 ' H ' HD13 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -116.9 156.65 27.0 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.162 -179.675 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -63.16 -26.24 69.04 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.769 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 86.9 mtp -61.55 73.96 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.006 0.432 . . . . 0.0 110.109 -179.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -85.38 169.2 16.72 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.585 -178.357 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 32' ' ' LEU . 55.7 Cg_exo -47.69 -177.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.075 1.85 . . . . 0.0 112.009 -179.764 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.63 -4.63 39.95 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.537 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.8 m -101.18 -169.6 1.72 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.713 0.292 . . . . 0.0 110.25 179.544 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.1 t -133.05 151.26 52.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.383 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -138.11 163.53 31.42 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.228 -179.654 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -122.57 146.67 47.21 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.446 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 5' ' ' PRO . 62.1 t -85.48 126.75 40.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.295 -179.83 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 p -70.04 -41.1 79.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.16 179.736 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.3 ptt-85 -174.25 169.42 3.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.966 -179.209 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.6 m -136.12 116.62 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.123 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.31 111.3 51.39 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.311 -179.745 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.532 ' C ' ' H ' ' A' ' 46' ' ' GLY . 60.3 Cg_endo -75.45 -11.76 20.68 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.287 1.991 . . . . 0.0 112.054 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.465 ' CD2' ' N ' ' A' ' 45' ' ' LEU . 4.2 mm? -53.0 -6.69 0.06 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.58 -178.978 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.532 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 104.37 23.69 7.88 Favored Glycine 0 N--CA 1.462 0.418 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.613 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.73 165.01 16.31 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 -179.491 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -58.06 -170.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.025 1.817 . . . . 0.0 111.704 179.257 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.8 mm -106.36 112.9 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -88.19 120.49 29.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.958 -179.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 58' ' ' LEU . 48.6 pt -126.33 147.99 31.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.144 179.901 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -127.97 129.43 46.76 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.306 179.649 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.567 ' HG1' ' H ' ' A' ' 56' ' ' VAL . 1.5 p -114.19 136.7 52.67 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.807 -179.945 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -39.04 -35.39 0.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.808 -179.433 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.417 ' O ' ' CG1' ' A' ' 56' ' ' VAL . 18.9 mmm180 -73.3 -49.29 28.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.109 -179.537 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.567 ' H ' ' HG1' ' A' ' 53' ' ' THR . 15.6 m -160.94 -176.84 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.517 -179.472 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 p -106.58 148.21 28.55 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.699 179.721 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' A' ' 51' ' ' ILE . 61.0 tp -154.6 150.31 27.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.473 179.896 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.1 p -127.57 131.33 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.82 179.194 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.6 mt -136.69 159.71 41.02 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.308 -179.445 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -85.06 166.63 16.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.339 -179.583 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -58.49 -44.43 89.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.856 0.36 . . . . 0.0 110.588 179.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -57.38 -39.92 77.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.723 -179.719 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -60.27 -45.15 94.3 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.394 179.992 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.5 -41.04 98.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.786 0.326 . . . . 0.0 110.127 179.47 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.06 -40.79 98.73 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.565 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.9 mt -75.8 -48.82 20.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.355 -179.641 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.2 mt -55.74 133.09 50.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.351 -179.151 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -74.27 109.38 7.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.192 -179.401 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.48 159.74 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.436 179.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -139.82 126.34 20.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.513 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.92 124.13 22.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.91 179.771 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.464 0.233 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.42 179.846 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.453 ' SD ' ' N ' ' A' ' 1' ' ' MET . 2.6 mpt? . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -62.82 -44.22 96.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.547 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -105.75 137.11 44.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.922 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.9 158.87 74.41 Favored Pre-proline 0 N--CA 1.468 0.441 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 39' ' ' VAL . 44.1 Cg_endo -66.97 -19.41 52.05 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.549 2.166 . . . . 0.0 112.369 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -136.98 92.63 2.75 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.83 131.81 26.14 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.63 102.22 14.39 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 22.4 m0 -101.44 132.04 47.24 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.191 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -86.84 136.63 32.9 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.8 mt -92.4 117.93 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 12.5 p -104.21 -32.24 9.22 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.73 0.3 . . . . 0.0 110.25 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.72 174.48 21.79 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -90.15 153.49 20.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.801 0.334 . . . . 0.0 110.334 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.433 ' O ' ' CG2' ' A' ' 18' ' ' ILE . 1.5 t -80.73 168.32 18.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.659 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -68.36 -40.57 81.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.877 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -63.63 -17.4 62.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.419 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.433 ' CG2' ' O ' ' A' ' 15' ' ' SER . 10.8 tp -41.89 147.42 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.587 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.98 155.15 84.78 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.343 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.98 -31.03 66.86 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.562 2.175 . . . . 0.0 112.213 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.24 -56.82 12.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.142 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -61.44 -44.2 97.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.65 0.738 . . . . 0.0 110.543 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -58.0 -47.62 82.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.589 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 45.4 tp60 -57.98 -37.27 73.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.532 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -57.91 -40.82 81.33 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.388 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.38 -42.86 99.39 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.81 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.92 -39.95 96.11 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.199 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.5 m -60.47 -44.11 96.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.795 0.331 . . . . 0.0 111.205 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 pp -93.5 132.65 37.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.555 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.94 -2.02 69.86 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 71.8 mtm -86.95 75.0 9.62 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -82.6 168.62 22.08 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.127 -179.199 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.451 ' O ' ' O ' ' A' ' 32' ' ' LEU . 77.5 Cg_exo -43.47 177.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.603 2.202 . . . . 0.0 112.412 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.95 11.96 7.34 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.487 ' OG ' ' N ' ' A' ' 36' ' ' SER . 34.9 t -144.2 -172.0 3.69 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.848 0.356 . . . . 0.0 110.344 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.487 ' N ' ' OG ' ' A' ' 35' ' ' SER . 67.7 m -128.28 155.7 44.18 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.517 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -135.53 159.14 42.55 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.349 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -111.97 150.64 30.28 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.572 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' PRO . 13.1 t -86.1 126.82 40.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.526 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 p -67.86 -41.46 84.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.825 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -173.78 161.51 3.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.994 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.86 121.99 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.33 110.57 49.37 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.507 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -76.65 -11.74 18.5 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.042 1.828 . . . . 0.0 112.327 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.0 mt -59.67 -31.04 69.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.996 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 132.12 24.83 0.77 Allowed Glycine 0 N--CA 1.468 0.772 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.71 160.36 28.8 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.93 175.42 0.46 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.86 2.374 . . . . 0.0 112.02 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.472 ' N ' ' O ' ' A' ' 60' ' ' LEU . 7.6 mm -92.05 114.81 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.885 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -92.74 122.16 34.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.872 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.5 pt -127.5 150.69 33.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.801 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -128.83 137.64 51.61 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.128 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.561 ' HG1' ' H ' ' A' ' 56' ' ' VAL . 0.7 OUTLIER -129.49 138.27 51.29 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.753 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -43.78 -21.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.59 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 53' ' ' THR . 85.0 mtt85 -82.81 -48.81 10.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.533 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.561 ' H ' ' HG1' ' A' ' 53' ' ' THR . 14.9 p -169.66 168.55 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.665 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.444 ' N ' ' CG2' ' A' ' 56' ' ' VAL . 5.3 p -99.6 146.15 26.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.551 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.7 tp -155.96 147.86 23.18 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.335 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.3 p -126.68 131.43 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.615 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 49' ' ' ILE . 2.6 mp -132.95 155.05 49.82 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.056 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -72.91 162.09 29.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.941 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -54.55 -45.9 73.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.869 0.366 . . . . 0.0 110.807 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -59.98 -40.67 89.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.526 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -61.12 -40.76 95.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.495 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -63.06 -42.12 99.63 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.24 93.52 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.214 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.27 -42.13 84.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.221 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.5 mt -66.81 135.74 54.39 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.626 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.453 ' O ' ' OG1' ' A' ' 12' ' ' THR . 94.6 mt-10 -79.97 113.25 17.99 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.142 0.496 . . . . 0.0 110.175 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.9 m -132.16 155.94 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.747 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -142.54 137.9 30.48 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.754 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.9 148.03 51.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.145 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 38.7 t -113.28 132.43 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.347 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 65.4 p -150.21 11.88 0.73 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.549 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.3 t -61.86 -42.48 99.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.427 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.0 mt 49.18 87.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.226 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -136.64 140.49 42.81 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.109 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -140.05 144.57 36.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.185 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -114.85 143.33 45.28 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.289 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -91.83 125.04 36.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.454 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -59.86 -45.69 91.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.651 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -150.23 152.82 35.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.511 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 78.9 m80 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.624 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.6 mtp . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -66.51 -24.49 66.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -71.73 138.2 48.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.566 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.476 ' HG1' ' H ' ' A' ' 6' ' ' ASP . 0.1 OUTLIER -137.91 155.99 74.46 Favored Pre-proline 0 N--CA 1.467 0.38 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 -179.184 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 39' ' ' VAL . 43.3 Cg_endo -66.79 -22.19 49.95 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.51 2.14 . . . . 0.0 112.288 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.476 ' H ' ' HG1' ' A' ' 4' ' ' THR . 39.1 p-10 -137.42 93.61 2.83 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.735 0.302 . . . . 0.0 110.304 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.424 ' OG1' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -139.51 129.81 25.4 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.6 102.44 15.18 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 18.1 m0 -101.57 137.52 39.78 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.933 0.397 . . . . 0.0 110.322 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -95.24 129.57 42.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.038 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.2 mt -82.42 122.62 37.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.123 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 8.9 p -110.75 -19.33 12.89 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.559 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.72 -179.95 22.41 Favored Glycine 0 N--CA 1.464 0.559 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -100.12 157.42 16.58 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.848 0.356 . . . . 0.0 110.321 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 67' ' ' LEU . 15.5 m -74.8 165.76 24.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.765 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -70.54 -38.99 74.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.56 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -74.15 -6.34 47.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.383 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.6 tp -41.41 146.58 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.449 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.42 155.2 93.04 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.248 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.82 -31.27 68.23 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.415 2.077 . . . . 0.0 112.13 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.46 -53.47 42.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.224 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -63.06 -46.4 87.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.745 0.783 . . . . 0.0 110.652 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 67.0 ttp85 -57.99 -44.18 86.99 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.729 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -61.09 -36.12 78.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.08 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -59.22 -43.0 92.32 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.437 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 29' ' ' LEU . 4.6 mm? -62.43 -43.66 98.28 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.032 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 49.1 mt -70.35 -32.56 70.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.81 0.338 . . . . 0.0 111.091 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.5 m -58.91 -44.03 91.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.334 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -118.73 173.21 7.0 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.295 -179.691 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -88.92 -3.14 77.11 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 33.2 ttm -64.6 74.18 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.2 mp -99.8 169.96 7.38 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.289 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 32' ' ' LEU . 62.9 Cg_exo -49.67 -164.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.331 2.021 . . . . 0.0 112.564 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.77 5.1 56.74 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.9 m -138.63 -156.28 0.67 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.813 0.34 . . . . 0.0 110.2 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.5 p -146.38 164.23 33.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.505 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -139.21 151.54 46.64 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.232 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -108.84 146.98 32.81 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.431 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' PRO . 10.0 t -87.03 127.15 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.597 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 p -69.93 -39.05 77.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.885 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -173.44 166.93 4.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.284 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 36.0 m -139.29 117.02 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.62 110.91 50.04 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.492 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.19 -11.68 19.34 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.135 1.89 . . . . 0.0 112.312 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.2 mt -58.58 -30.54 67.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.744 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.48 25.37 0.78 Allowed Glycine 0 N--CA 1.467 0.712 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.68 160.25 29.08 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -60.2 172.06 2.73 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.754 2.302 . . . . 0.0 111.88 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.2 mm -96.87 119.06 44.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.163 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -101.97 131.02 48.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.117 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.7 pt -127.26 149.84 32.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.5 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -138.91 144.42 39.09 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.034 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 56' ' ' VAL . 1.0 OUTLIER -132.5 173.15 11.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.515 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 53' ' ' THR . 99.8 mtt180 -33.6 -52.25 0.4 Allowed 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.35 0.406 . . . . 0.0 111.788 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -142.93 32.44 1.39 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.008 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 53' ' ' THR . 2.3 t -141.54 139.13 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.82 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.0 m -137.53 143.22 41.53 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.45 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.6 tp -161.57 152.49 18.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.203 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 p -122.32 128.87 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.7 mt -136.66 161.52 35.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.366 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -85.47 162.55 18.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.801 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -58.09 -37.55 74.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.605 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -61.8 -41.1 97.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.535 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -59.84 -45.86 91.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.347 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.2 mp -62.02 -41.08 97.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.264 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.03 -47.27 83.57 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.276 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.476 ' O ' ' OG ' ' A' ' 15' ' ' SER . 11.1 mp -75.98 -52.52 10.07 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.336 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.6 tp -43.03 128.66 4.42 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.479 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.45 ' O ' ' OG1' ' A' ' 12' ' ' THR . 78.8 mm-40 -70.28 109.52 4.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.237 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.0 m -137.88 159.36 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.544 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -141.31 124.66 16.58 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.518 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.9 132.4 49.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.873 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.9 m -134.89 160.26 41.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.418 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.0 m -139.38 36.91 2.07 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.575 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 63.2 m -130.96 120.53 23.66 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.968 0.414 . . . . 0.0 110.375 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 77.8 mt -93.95 -2.73 52.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.511 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -133.04 149.75 52.16 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.306 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -143.8 65.15 1.31 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.343 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 61.1 m170 44.97 79.02 0.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.672 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.468 ' CD2' ' N ' ' A' ' 81' ' ' HIS . 35.0 p-80 -60.37 -44.15 95.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.611 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.468 ' N ' ' CD2' ' A' ' 80' ' ' HIS . 85.9 t60 44.59 96.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.728 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -70.71 135.92 48.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.532 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.625 179.952 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.6 mtp . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -64.54 -46.13 84.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.961 0.41 . . . . 0.0 110.966 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -78.21 140.41 38.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.637 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.426 ' OG1' ' CG2' ' A' ' 7' ' ' THR . 13.0 p -138.46 148.94 61.11 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.773 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 39' ' ' VAL . 42.8 Cg_endo -66.56 -52.46 0.76 Allowed 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.438 2.092 . . . . 0.0 112.34 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -117.14 94.47 4.58 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.873 0.368 . . . . 0.0 110.917 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.426 ' CG2' ' OG1' ' A' ' 4' ' ' THR . 1.5 t -141.39 150.3 42.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.13 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -99.6 102.21 13.66 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 18.4 m0 -97.8 137.62 36.39 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.285 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -93.55 140.91 29.06 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.4 mt -93.79 119.46 41.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 123.357 0.411 . . . . 0.0 110.248 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.5 m -102.21 -46.99 4.66 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.494 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.57 177.07 32.33 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.2 p90 -95.84 146.48 24.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.809 0.338 . . . . 0.0 110.322 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.43 ' O ' ' CG2' ' A' ' 18' ' ' ILE . 40.0 t -77.55 172.2 13.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.485 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -69.68 -39.61 76.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.882 0.372 . . . . 0.0 110.806 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -67.44 -14.36 62.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.386 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.43 ' CG2' ' O ' ' A' ' 15' ' ' SER . 10.4 tp -41.5 147.41 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.751 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.41 154.72 87.9 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.354 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.91 -31.3 67.33 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.67 2.247 . . . . 0.0 111.989 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.99 -54.78 25.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.984 0.421 . . . . 0.0 111.116 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -62.58 -44.98 94.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.594 0.711 . . . . 0.0 110.308 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -57.82 -39.93 78.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.821 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 28' ' ' SER . 15.9 mm-40 -63.77 -36.25 83.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.948 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -60.31 -44.81 95.09 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.55 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.2 -41.56 97.02 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.175 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 tt -75.16 -28.1 59.96 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.107 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.527 ' N ' ' O ' ' A' ' 24' ' ' GLN . 14.5 t -61.2 -44.67 96.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.171 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.45 169.21 9.34 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.257 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.53 5.86 84.23 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.2 tpt -76.89 73.82 3.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.898 0.38 . . . . 0.0 110.05 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.8 mp -95.8 166.73 13.93 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.424 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 32' ' ' LEU . 77.9 Cg_exo -45.11 178.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.265 1.977 . . . . 0.0 112.162 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.43 3.4 14.61 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 m -141.31 -157.05 0.73 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.818 0.342 . . . . 0.0 110.26 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 89.3 p -143.78 163.29 33.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.397 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -140.93 159.79 41.46 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.332 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -113.26 144.76 42.17 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.567 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 5' ' ' PRO . 99.2 t -85.98 129.13 38.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.287 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 p -67.29 -41.84 87.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.187 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -174.9 161.13 2.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.94 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.2 t -131.88 122.47 49.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.1 110.82 50.38 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.406 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.61 -11.22 20.41 Favored 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 122.287 1.992 . . . . 0.0 112.226 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.48 ' CD2' ' N ' ' A' ' 45' ' ' LEU . 4.1 mm? -60.65 -31.8 71.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.986 -178.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 132.72 24.69 0.73 Allowed Glycine 0 N--CA 1.465 0.611 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.23 160.17 29.56 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.57 170.09 2.04 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.682 2.254 . . . . 0.0 111.78 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.464 ' N ' ' O ' ' A' ' 60' ' ' LEU . 7.5 mm -95.46 114.42 32.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.872 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -97.13 125.85 41.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.709 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.8 pt -125.99 150.05 31.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.699 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -134.98 111.97 10.23 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.987 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 54' ' ' ARG . 1.3 p -83.5 173.89 11.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.511 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 53' ' ' THR . 91.2 mtm180 -33.68 -53.14 0.43 Allowed 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.409 0.443 . . . . 0.0 111.779 -178.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -142.53 31.67 1.49 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.323 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 t -140.57 136.95 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.499 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.1 p -112.0 138.81 48.12 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.181 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.8 tp -155.22 149.88 26.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.079 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.1 p -124.24 128.44 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.79 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 49' ' ' ILE . 82.6 mt -133.62 161.16 35.38 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.417 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -94.74 160.47 14.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.418 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -53.32 -37.31 62.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.916 0.389 . . . . 0.0 110.642 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.43 -42.18 99.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.39 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -60.83 -42.1 97.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.342 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.2 -41.81 98.71 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.074 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.72 -51.7 68.83 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.35 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.424 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 4.1 mm? -69.17 -40.18 78.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.019 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.7 tp -60.16 136.08 57.92 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -86.86 109.9 19.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.038 0.447 . . . . 0.0 110.37 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 m -132.6 157.11 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.628 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -142.4 143.93 32.89 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.854 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.17 147.09 53.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.041 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.8 t -108.44 130.42 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.198 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.1 p -155.51 156.96 36.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.264 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.9 m 38.6 80.79 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.812 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 56.5 tp -62.67 -43.09 99.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.273 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.525 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 96.5 mt-10 42.63 76.05 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.57 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.525 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 38.7 p-80 41.27 -164.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.547 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -101.97 122.73 44.62 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.869 0.366 . . . . 0.0 110.27 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -85.07 136.71 33.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.282 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.493 ' O ' ' CG ' ' A' ' 81' ' ' HIS . 42.5 p-80 -87.61 86.64 7.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.498 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -65.68 -43.64 88.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.448 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.512 ' ND1' ' OXT' ' A' ' 83' ' ' HIS . 60.1 t-80 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.536 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.414 ' H3 ' ' H ' ' A' ' 2' ' ' GLN . 67.3 mtt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.414 ' H ' ' H3 ' ' A' ' 1' ' ' MET . 12.0 pt20 -150.35 -7.94 0.29 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.858 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -85.66 90.89 8.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.806 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.32 151.66 56.84 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.321 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 39' ' ' VAL . 42.5 Cg_endo -66.11 -27.49 49.4 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.513 2.142 . . . . 0.0 111.876 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -135.69 94.52 3.09 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.907 0.384 . . . . 0.0 110.703 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -140.44 152.24 45.53 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.137 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.74 102.79 14.64 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 12.9 m0 -99.69 134.32 42.74 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.217 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -97.79 130.44 44.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.816 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.9 mt -84.03 118.33 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.265 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.5 m -99.12 -35.63 9.95 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.032 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 144.75 176.89 19.15 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -89.03 146.29 24.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.818 0.342 . . . . 0.0 110.33 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 67' ' ' LEU . 11.5 m -74.99 171.19 14.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.429 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.1 ttm-85 -69.31 -41.32 76.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.549 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -72.44 -4.72 31.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.664 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.1 tp -41.84 147.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.665 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 m -68.12 152.11 96.71 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.058 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.97 -31.22 56.4 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.427 2.085 . . . . 0.0 112.075 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.74 -53.93 23.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.492 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.404 ' CE1' ' CD2' ' A' ' 26' ' ' LEU . 33.4 t80 -61.65 -44.25 97.32 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.295 0.569 . . . . 0.0 110.335 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -59.7 -42.78 93.76 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.825 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 19.6 tm0? -61.8 -37.21 83.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.641 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -59.9 -45.67 91.79 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.746 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.404 ' CD2' ' CE1' ' A' ' 22' ' ' TYR . 4.6 mm? -62.86 -41.33 99.33 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.497 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.2 mt -62.18 -38.75 90.26 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.392 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 p -80.13 -10.24 59.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.835 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.1 tp -100.16 126.87 46.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.482 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.28 1.9 73.71 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 77.3 mtm -108.81 74.82 0.93 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.259 0.552 . . . . 0.0 109.701 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.3 mp -78.87 165.94 45.79 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.831 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 32' ' ' LEU . 68.1 Cg_exo -42.65 179.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.788 2.325 . . . . 0.0 113.043 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.0 11.86 7.36 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.2 p -143.07 -160.38 1.1 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.72 0.295 . . . . 0.0 110.396 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 97.6 p -139.98 165.15 28.1 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.542 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -143.63 169.12 18.33 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.438 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 16.4 p-10 -124.88 151.64 45.06 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.306 0.574 . . . . 0.0 110.279 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' PRO . 16.6 t -87.06 124.94 40.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.425 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 p -71.63 -39.81 70.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.913 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -172.99 166.76 5.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.672 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.409 ' O ' ' CG2' ' A' ' 42' ' ' VAL . 33.3 m -149.31 104.65 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.894 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.83 111.29 53.84 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.405 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -75.87 -9.96 19.69 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.455 2.103 . . . . 0.0 112.348 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 45' ' ' LEU . 10.6 mp -52.12 -30.15 25.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.768 -178.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 147.36 16.15 0.13 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -97.96 153.05 38.33 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.26 -175.03 0.47 Allowed 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.216 1.944 . . . . 0.0 111.778 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.8 mm -91.49 114.55 28.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.716 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -95.71 120.49 36.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.233 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.4 pt -125.18 144.42 35.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.229 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.435 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 13.1 tm-20 -123.62 124.66 43.28 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.187 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 56' ' ' VAL . 0.9 OUTLIER -118.49 141.25 48.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.336 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 -50.11 -38.94 41.19 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.978 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -67.77 -41.06 83.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.756 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.572 ' CG2' ' H ' ' A' ' 57' ' ' SER . 13.1 p -170.7 177.18 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.578 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.572 ' H ' ' CG2' ' A' ' 56' ' ' VAL . 47.8 t -111.48 145.11 39.6 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.273 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.3 tp -147.76 149.21 31.95 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.552 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.7 p -137.19 122.98 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.7 mt -140.98 175.95 9.2 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.442 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -86.64 162.69 17.82 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.07 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -58.37 -32.91 69.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.611 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.06 -41.6 98.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.209 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -60.08 -44.62 94.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.496 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.01 -40.91 97.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.976 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.85 -48.86 78.57 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.455 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.441 ' O ' ' OG ' ' A' ' 15' ' ' SER . 4.1 mm? -67.14 -40.24 86.68 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.888 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 77.1 mt -66.62 140.64 57.94 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.511 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -84.29 108.66 17.27 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.443 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.1 m -132.38 158.91 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.296 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -143.09 129.57 20.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.48 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.61 129.21 36.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.683 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.7 m -128.45 155.87 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.19 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.1 t -106.31 -32.91 7.96 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.666 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.4 p -72.92 143.42 47.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.555 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 77' ' ' GLU . 45.9 tp -64.25 -51.36 63.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.14 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 76' ' ' LEU . 96.7 mt-10 35.59 52.87 0.78 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.408 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.494 ' O ' ' N ' ' A' ' 80' ' ' HIS . 18.5 t-80 -63.96 -44.12 93.73 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.841 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 74.1 m80 43.12 -92.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.756 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 78' ' ' HIS . 86.6 t60 47.51 71.66 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.596 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -84.75 -11.07 56.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.477 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.551 ' CG ' ' N ' ' A' ' 83' ' ' HIS . 85.9 t60 48.39 -108.45 0.26 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.592 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.551 ' N ' ' CG ' ' A' ' 82' ' ' HIS . 54.4 t-80 . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.561 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mtp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -64.76 -40.16 94.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.475 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -75.81 137.8 40.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.929 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.06 153.15 76.63 Favored Pre-proline 0 N--CA 1.465 0.297 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.396 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 39' ' ' VAL . 40.1 Cg_endo -66.52 -33.96 35.04 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.518 2.145 . . . . 0.0 112.22 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -136.7 95.2 3.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.702 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -140.03 148.17 41.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.277 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -103.2 102.0 11.97 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 27.4 m0 -96.37 147.33 23.92 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.396 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -105.1 125.7 51.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.743 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.2 mt -82.86 120.33 34.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.194 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.2 p -104.55 -10.48 17.58 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.495 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 142.09 167.46 11.33 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.15 161.86 25.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.399 . . . . 0.0 110.074 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.6 p -72.64 163.29 28.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.555 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 85.4 mtm-85 -69.89 -39.78 76.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.588 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -79.78 -3.38 47.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.183 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.1 tp -41.25 144.81 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.683 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 57.3 m -80.17 148.72 68.08 Favored Pre-proline 0 C--N 1.327 -0.383 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.934 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -50.09 -40.18 50.69 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.299 1.999 . . . . 0.0 112.35 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.38 -56.53 17.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.002 0.43 . . . . 0.0 111.201 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -63.36 -51.22 66.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.405 0.622 . . . . 0.0 110.517 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 68.6 ttt-85 -55.51 -44.12 76.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.482 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 28' ' ' SER . 68.9 tp60 -62.82 -32.6 73.83 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.818 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -59.4 -47.03 87.02 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.456 -0.497 . . . . 0.0 109.837 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.43 ' CD2' ' N ' ' A' ' 26' ' ' LEU . 4.4 mm? -65.54 -37.85 87.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.151 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.5 tp -74.62 -28.44 60.88 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.871 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 24' ' ' GLN . 68.7 m -57.61 -44.41 85.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.05 -178.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.453 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -114.54 153.13 30.61 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.114 -179.743 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -61.79 -24.59 64.67 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 67.6 mtt -61.13 73.67 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 120.976 0.417 . . . . 0.0 109.994 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 30' ' ' GLY . 0.5 OUTLIER -86.66 168.57 17.9 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.826 -179.167 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.435 ' O ' ' O ' ' A' ' 32' ' ' LEU . 67.6 Cg_exo -46.52 -178.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.29 1.993 . . . . 0.0 111.97 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.77 -11.78 45.87 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.2 m -100.73 -171.82 2.08 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.984 0.421 . . . . 0.0 110.238 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.3 m -130.19 157.59 42.04 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.427 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -138.65 158.38 44.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.215 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -112.38 145.03 40.83 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.562 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 5' ' ' PRO . 51.7 t -89.81 124.56 42.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.135 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 p -68.61 -41.22 82.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.069 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -173.68 164.22 4.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.119 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -135.99 124.15 36.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.045 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.98 110.76 51.65 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.736 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.32 -12.02 19.06 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.781 2.321 . . . . 0.0 112.184 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.405 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 10.9 mp -60.6 -32.34 71.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.626 -178.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 135.33 22.03 0.65 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.97 160.03 30.08 Favored Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.46 169.08 3.35 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.77 2.313 . . . . 0.0 111.808 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.511 ' N ' ' O ' ' A' ' 60' ' ' LEU . 8.3 mm -93.48 114.41 30.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.976 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -91.3 122.88 34.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.856 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' A' ' 58' ' ' LEU . 44.9 pt -125.65 147.43 30.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.266 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -127.65 129.66 47.6 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.27 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.623 ' HG1' ' H ' ' A' ' 56' ' ' VAL . 0.7 OUTLIER -121.76 137.56 54.72 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.795 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.618 ' NE ' ' NH1' ' A' ' 55' ' ' ARG . 35.1 ptt180 -44.99 -31.46 1.3 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.245 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.618 ' NH1' ' NE ' ' A' ' 54' ' ' ARG . 86.5 mmt-85 -71.88 -46.37 58.07 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.599 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.623 ' H ' ' HG1' ' A' ' 53' ' ' THR . 13.9 p -170.97 168.46 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.794 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.439 ' N ' ' CG2' ' A' ' 56' ' ' VAL . 97.5 p -89.18 153.52 20.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.609 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 51' ' ' ILE . 61.1 tp -162.62 149.16 12.9 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.332 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 p -130.29 131.39 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 49' ' ' ILE . 89.7 mt -134.91 161.39 35.36 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.47 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -88.14 161.85 17.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.749 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.405 ' CG ' ' N ' ' A' ' 63' ' ' LYS . 20.4 ptmt -55.32 -41.0 71.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.965 0.412 . . . . 0.0 110.777 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.405 ' N ' ' CG ' ' A' ' 62' ' ' LYS . 21.0 ptmt -60.36 -40.21 89.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.67 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.92 -44.4 97.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.549 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.42 -41.86 97.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.703 0.287 . . . . 0.0 110.232 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.65 -50.51 73.57 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.395 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.27 -40.45 81.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.752 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.7 tp -61.76 129.71 42.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.338 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -74.53 107.58 6.75 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.64 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.2 m -132.68 161.89 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.607 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -143.0 140.74 31.14 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.37 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.03 112.59 20.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.301 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 63.0 t -63.48 -46.0 96.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.518 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.2 m 46.69 28.64 0.82 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.7 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.8 p -149.52 127.9 12.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.4 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 56.9 tp -63.02 -48.33 79.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.744 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -174.32 153.52 1.98 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.442 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -151.49 64.01 0.88 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.622 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.507 ' CG ' ' O ' ' A' ' 79' ' ' HIS . 21.6 t-160 -101.25 53.19 0.83 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.457 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.517 ' O ' ' ND1' ' A' ' 82' ' ' HIS . 64.6 t-80 -157.51 81.26 0.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.542 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.583 ' CG ' ' H ' ' A' ' 82' ' ' HIS . 52.5 t-80 44.22 -114.21 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.586 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.583 ' H ' ' CG ' ' A' ' 81' ' ' HIS . 71.8 m80 43.31 -168.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.648 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 79.4 m80 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.56 -179.97 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -65.05 -39.09 92.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.648 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -69.54 136.91 51.98 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.42 ' OG1' ' OG1' ' A' ' 7' ' ' THR . 0.1 OUTLIER -140.83 156.63 68.68 Favored Pre-proline 0 N--CA 1.467 0.411 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.06 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 39' ' ' VAL . 45.3 Cg_endo -67.09 -21.72 48.56 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.45 2.1 . . . . 0.0 112.289 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -137.01 93.06 2.79 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.42 ' OG1' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -140.3 131.83 27.04 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.85 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.55 103.05 15.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.408 ' HE1' HG22 ' A' ' 7' ' ' THR . 10.4 m0 -101.63 136.32 41.67 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.287 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -101.13 130.98 47.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.828 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.3 mt -83.97 124.29 39.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.723 -178.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.1 m -109.91 -41.34 4.52 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.812 0.339 . . . . 0.0 110.489 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 160.53 -174.31 37.21 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -103.74 147.1 27.66 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.815 0.34 . . . . 0.0 110.982 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 67' ' ' LEU . 3.5 m -78.84 173.16 12.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.604 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.415 ' N ' ' CD ' ' A' ' 16' ' ' ARG . 3.0 mpt_? -69.79 -40.37 76.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.61 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -68.66 -11.98 60.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.724 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.0 tp -41.16 148.35 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.625 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.9 p -76.35 141.16 69.67 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.57 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -49.49 -40.0 45.17 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 121.605 1.537 . . . . 0.0 112.952 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.62 -54.99 37.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 111.689 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -63.55 -45.79 88.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.451 0.643 . . . . 0.0 110.382 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -58.3 -44.55 88.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.945 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.482 ' O ' ' N ' ' A' ' 28' ' ' SER . 62.3 tp60 -61.57 -33.96 74.78 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -59.64 -47.29 86.18 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.904 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -62.68 -42.19 99.5 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.102 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.5 tt -72.99 -30.7 63.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.88 0.372 . . . . 0.0 110.871 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 24' ' ' GLN . 74.6 m -60.18 -43.28 95.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.395 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.66 171.96 7.83 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.398 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.77 6.79 73.88 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 97.1 mtp -77.94 74.9 4.48 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.9 OUTLIER -92.96 169.89 9.72 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.131 -179.173 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 32' ' ' LEU . 51.4 Cg_exo -49.38 -169.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.123 1.882 . . . . 0.0 112.595 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.91 0.87 19.54 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.1 m -139.8 -173.25 3.58 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.728 0.299 . . . . 0.0 110.266 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 73.0 m -128.82 155.93 44.42 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.817 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -130.14 157.12 43.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.42 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -113.58 152.41 30.34 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.297 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 5' ' ' PRO . 20.8 t -87.95 123.0 40.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.479 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.6 p -66.67 -42.01 89.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.689 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.548 ' NH2' ' CE1' ' A' ' 50' ' ' HIS . 50.7 ptt85 -172.94 162.94 4.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.489 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.8 t -128.06 127.95 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.39 110.77 48.78 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.366 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.05 -12.62 19.48 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.813 1.675 . . . . 0.0 112.516 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.2 tp -57.85 -30.52 65.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.959 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.81 30.51 1.24 Allowed Glycine 0 N--CA 1.467 0.753 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -98.74 -179.16 0.8 Allowed Pre-proline 0 N--CA 1.467 0.378 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.425 ' CD ' ' CB ' ' A' ' 47' ' ' ASP . 15.5 Cg_exo -65.53 -173.12 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.762 1.641 . . . . 0.0 111.594 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.8 mm -105.62 114.26 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.801 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.548 ' CE1' ' NH2' ' A' ' 41' ' ' ARG . 15.2 m170 -89.63 116.95 28.15 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.404 ' O ' ' O ' ' A' ' 58' ' ' LEU . 44.8 pt -124.41 148.25 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.147 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -125.81 123.96 39.88 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.865 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 p -107.44 137.03 46.23 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.765 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -38.46 -35.7 0.2 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.869 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.432 ' O ' ' CG1' ' A' ' 56' ' ' VAL . 3.6 mpt_? -72.51 -49.35 33.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.079 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.432 ' CG1' ' O ' ' A' ' 55' ' ' ARG . 15.7 m -162.55 -176.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 120.977 0.417 . . . . 0.0 110.991 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.2 m -99.78 145.84 27.25 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.792 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.404 ' O ' ' O ' ' A' ' 51' ' ' ILE . 60.3 tp -153.78 144.8 22.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.374 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.0 p -130.72 128.72 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.6 mt -136.95 166.19 24.22 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.85 0.357 . . . . 0.0 110.514 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -82.33 160.71 22.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.867 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -57.34 -34.59 68.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.746 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.7 -40.61 97.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.109 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -61.05 -45.9 92.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.812 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 mp -62.0 -42.3 99.0 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.141 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.01 -49.68 76.72 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.083 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.463 ' O ' ' OG ' ' A' ' 15' ' ' SER . 96.8 mt -68.81 -41.41 78.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.487 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.2 tp -60.48 132.11 52.86 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.715 -0.394 . . . . 0.0 109.94 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -74.73 110.87 9.38 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.446 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.3 m -137.23 162.25 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.813 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -138.84 127.42 23.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.329 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.78 125.21 28.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.856 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.3 m -123.24 131.22 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.082 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.5 m -88.13 -8.55 55.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.517 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.0 p -74.38 156.63 36.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.48 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.1 tp -164.02 55.32 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.277 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -151.64 136.98 17.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.594 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.464 ' O ' ' N ' ' A' ' 80' ' ' HIS . 44.9 p-80 -156.42 154.48 30.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.328 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 78.7 m80 39.85 25.91 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.832 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.464 ' N ' ' O ' ' A' ' 78' ' ' HIS . 85.8 t60 -59.2 -44.73 92.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.459 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -88.5 135.72 33.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.472 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -65.78 -39.64 91.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.548 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.475 179.986 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.43 ' O ' ' N ' ' A' ' 3' ' ' TYR . 66.5 mtm . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 48.93 -92.86 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.732 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.43 ' N ' ' O ' ' A' ' 1' ' ' MET . 76.1 m-85 -72.13 89.8 1.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.985 0.421 . . . . 0.0 110.17 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.73 156.45 36.53 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.982 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 39' ' ' VAL . 37.1 Cg_endo -65.13 -31.52 54.32 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.697 2.264 . . . . 0.0 111.925 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -136.78 94.66 3.01 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.696 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.493 ' HG1' ' N ' ' A' ' 8' ' ' ALA . 3.5 t -140.53 151.15 44.53 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.922 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.493 ' N ' ' HG1' ' A' ' 7' ' ' THR . . . -104.92 102.49 12.01 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.417 ' O ' ' OG ' ' A' ' 36' ' ' SER . 26.1 m0 -96.63 132.61 42.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.213 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.5 tttt -87.43 127.22 35.22 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.76 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.6 mt -81.53 122.51 36.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.213 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.9 m -104.25 -49.09 3.67 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.515 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.3 169.87 30.47 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -88.41 152.82 21.65 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.713 0.292 . . . . 0.0 110.241 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.456 ' O ' ' CG2' ' A' ' 18' ' ' ILE . 38.3 t -82.81 168.77 16.82 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.094 0.474 . . . . 0.0 110.782 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -66.62 -40.03 88.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.362 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' A' ' 17' ' ' GLU . 52.5 mp0 -65.13 -15.47 62.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.657 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.456 ' CG2' ' O ' ' A' ' 15' ' ' SER . 10.6 tp -42.34 146.75 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.598 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.7 p -79.85 141.41 55.25 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.551 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -47.15 -41.42 27.11 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.927 1.751 . . . . 0.0 112.616 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.33 -57.47 9.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.821 0.343 . . . . 0.0 111.296 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -61.95 -46.25 90.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.47 0.652 . . . . 0.0 110.444 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -57.37 -43.63 83.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.114 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.53 ' NE2' ' OG ' ' A' ' 28' ' ' SER . 3.1 tm0? -60.29 -37.94 82.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.111 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -60.7 -41.96 96.25 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.178 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.59 -42.25 99.45 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.201 -0.6 . . . . 0.0 110.276 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mp -73.9 -29.77 62.24 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.474 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.53 ' OG ' ' NE2' ' A' ' 24' ' ' GLN . 49.9 m -58.7 -44.83 90.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.388 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.417 ' H ' HD11 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -115.9 170.97 8.07 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.28 -179.688 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -87.11 -3.22 82.78 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 22.3 mmt -67.26 73.45 0.13 Allowed 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 120.868 0.366 . . . . 0.0 110.118 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.2 mp -99.07 169.85 7.65 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.425 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 32' ' ' LEU . 72.2 Cg_exo -48.63 -168.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.332 2.022 . . . . 0.0 112.462 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.95 7.06 56.73 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.6 m -139.54 -156.65 0.7 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.826 0.346 . . . . 0.0 110.387 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 9' ' ' TRP . 33.4 t -148.8 153.56 38.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.441 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -128.94 155.54 45.15 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.291 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -106.42 143.81 34.01 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.523 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 5' ' ' PRO . 14.5 t -88.12 122.82 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.281 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 p -68.31 -39.99 81.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.878 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.542 ' NH2' ' ND1' ' A' ' 50' ' ' HIS . 38.1 ptt-85 -174.69 159.87 2.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.136 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 36.0 m -133.89 123.84 45.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.68 110.4 49.05 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.686 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -76.42 -11.67 18.93 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.481 2.121 . . . . 0.0 112.176 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.59 -33.15 72.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.645 -177.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.13 20.9 0.49 Allowed Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.03 160.22 29.59 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.33 168.03 5.45 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.878 2.386 . . . . 0.0 111.819 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.405 ' N ' ' O ' ' A' ' 60' ' ' LEU . 5.5 mm -89.63 119.77 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.884 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.542 ' ND1' ' NH2' ' A' ' 41' ' ' ARG . 12.4 m170 -95.47 122.64 38.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.887 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.7 pt -125.87 148.91 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.278 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -130.71 132.36 45.32 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.422 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 55' ' ' ARG . 1.4 p -122.63 137.1 55.0 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.0 ptt-85 -41.17 -21.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.871 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 53' ' ' THR . 33.7 mmt180 -85.3 -50.57 7.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.924 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.434 ' CG1' ' O ' ' A' ' 55' ' ' ARG . 14.8 m -161.01 -176.0 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.515 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.7 p -113.29 145.27 41.32 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.396 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.9 tp -149.75 148.28 29.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.309 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.8 p -136.54 126.69 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.743 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 49' ' ' ILE . 23.3 mt -132.23 165.57 23.84 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.378 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -81.06 148.49 29.65 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.215 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -41.78 -40.81 2.16 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.961 0.41 . . . . 0.0 111.122 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -58.03 -40.58 81.23 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.563 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -62.08 -41.39 98.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.842 0.353 . . . . 0.0 110.53 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.503 ' CD2' ' N ' ' A' ' 65' ' ' LEU . 4.0 mm? -62.14 -42.08 98.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.913 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.18 -41.54 97.07 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.371 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.8 mt -68.33 -43.29 77.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.987 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.5 mt -65.33 133.42 51.36 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.284 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.3 112.2 16.3 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.009 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.53 160.39 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.591 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -144.72 128.31 17.09 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.507 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.74 132.61 47.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.951 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.8 t -88.47 131.86 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.225 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 55.6 m -90.12 40.12 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.791 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.7 m -133.15 142.67 48.77 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.822 0.344 . . . . 0.0 110.386 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 77' ' ' GLU . 55.8 tp -63.5 -44.12 95.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.564 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' A' ' 76' ' ' LEU . 97.8 mt-10 45.45 96.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.664 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -77.06 128.71 34.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.535 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.431 ' ND1' ' N ' ' A' ' 80' ' ' HIS . 52.1 t-80 -63.64 -90.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.691 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.431 ' N ' ' ND1' ' A' ' 79' ' ' HIS . 50.8 t-80 -161.09 -67.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.505 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -76.86 140.21 40.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.495 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -85.01 128.37 34.6 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.588 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.446 ' OXT' ' CG ' ' A' ' 83' ' ' HIS . 52.5 p-80 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.926 -1.035 . . . . 0.0 110.52 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mmt . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.439 ' NE2' ' CZ2' ' A' ' 9' ' ' TRP . 56.0 tp60 -63.5 -53.15 56.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.764 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -102.81 133.1 48.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.902 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.455 ' OG1' ' OG1' ' A' ' 7' ' ' THR . 0.8 OUTLIER -135.24 156.58 77.97 Favored Pre-proline 0 N--CA 1.466 0.351 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.302 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 39' ' ' VAL . 52.4 Cg_exo -51.06 -35.35 50.63 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.907 1.738 . . . . 0.0 112.885 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -135.74 95.93 3.33 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.455 ' OG1' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -131.5 130.82 42.87 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 -179.782 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.89 102.39 15.09 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.439 ' CZ2' ' NE2' ' A' ' 2' ' ' GLN . 22.1 m0 -103.2 144.32 31.48 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.057 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -96.89 140.73 31.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.505 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.9 mt -96.94 122.03 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 O-C-N 123.263 0.352 . . . . 0.0 110.295 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 29.2 p -109.78 -44.7 3.78 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.761 0.315 . . . . 0.0 110.441 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 167.62 -179.33 41.11 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -97.66 152.18 19.35 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.779 0.323 . . . . 0.0 110.649 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 67' ' ' LEU . 2.6 m -80.05 169.87 17.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.718 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -68.8 -39.61 80.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.574 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -65.64 -14.66 61.63 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.694 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.418 ' CG2' ' O ' ' A' ' 15' ' ' SER . 10.5 tp -42.29 147.08 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.465 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.9 m -82.0 150.17 64.57 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.904 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -51.25 -39.31 62.39 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.074 1.849 . . . . 0.0 112.652 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.56 -56.77 15.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 0.0 111.374 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -64.11 -47.02 81.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.513 0.673 . . . . 0.0 110.477 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -56.88 -43.79 81.63 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.029 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -63.51 -33.58 75.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.023 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -59.61 -47.37 85.83 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 29' ' ' LEU . 4.5 mm? -63.06 -42.19 99.64 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.121 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.3 tp -68.8 -34.33 75.35 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.9 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.2 t -59.69 -44.61 93.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.62 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -116.26 168.42 10.14 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.834 0.35 . . . . 0.0 110.219 -179.447 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.02 -1.08 80.11 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.6 mtt -67.78 73.6 0.17 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 120.863 0.363 . . . . 0.0 110.021 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.3 mp -95.78 167.75 12.04 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.261 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 32' ' ' LEU . 75.8 Cg_exo -46.03 -179.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.236 1.957 . . . . 0.0 112.322 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.46 7.16 11.2 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' A' ' 36' ' ' SER . 28.9 t -145.77 -175.59 4.8 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.817 0.341 . . . . 0.0 110.446 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.492 ' N ' ' OG ' ' A' ' 35' ' ' SER . 46.9 m -127.18 156.03 42.46 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.509 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -132.53 150.93 52.08 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.286 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -106.74 146.33 30.96 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.36 0.6 . . . . 0.0 110.401 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' PRO . 6.7 t -83.49 127.3 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.363 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 p -71.13 -38.39 70.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.112 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -172.83 154.13 2.84 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.994 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 73.5 t -126.32 118.91 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.71 111.27 51.91 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.221 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -76.27 -11.2 19.27 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.148 1.899 . . . . 0.0 112.262 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.403 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 10.7 mp -59.89 -31.71 70.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.646 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.7 27.93 0.71 Allowed Glycine 0 N--CA 1.466 0.697 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.84 160.21 29.06 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.23 172.06 1.01 Allowed 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.835 2.356 . . . . 0.0 111.859 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.412 ' N ' ' O ' ' A' ' 60' ' ' LEU . 7.3 mm -90.42 116.93 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.995 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -96.72 121.89 39.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.706 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.5 pt -129.2 147.25 33.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.632 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.429 ' OE1' ' OG ' ' A' ' 57' ' ' SER . 57.0 mm-40 -122.49 114.51 20.79 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.099 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.02 137.5 44.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.685 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -42.89 -40.28 2.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.439 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -66.23 -47.03 75.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.562 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.492 ' CG2' ' H ' ' A' ' 57' ' ' SER . 11.2 p -170.52 173.39 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 120.981 0.42 . . . . 0.0 110.59 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.492 ' H ' ' CG2' ' A' ' 56' ' ' VAL . 4.4 m -95.19 152.8 18.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.38 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.3 tp -155.66 145.33 21.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.019 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.8 p -137.99 126.08 30.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 49' ' ' ILE . 19.0 mt -132.37 -178.63 5.0 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.499 ' N ' ' CD ' ' A' ' 61' ' ' ARG . 9.8 mpt_? -94.85 150.97 19.62 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.348 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -42.07 -43.34 3.21 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.828 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.47 -40.02 85.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.466 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -59.42 -43.08 93.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.51 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.483 ' CD2' ' N ' ' A' ' 65' ' ' LEU . 3.8 mm? -62.81 -41.87 99.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.812 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.3 -46.03 89.68 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.229 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.466 ' O ' ' OG ' ' A' ' 15' ' ' SER . 9.9 mp -67.3 -40.25 86.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.675 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.5 mt -63.47 128.02 33.93 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.204 -0.599 . . . . 0.0 110.173 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.414 ' O ' ' OG1' ' A' ' 12' ' ' THR . 95.2 mt-10 -77.5 104.87 8.28 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.649 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.0 m -125.05 160.3 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.424 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -142.86 134.67 26.81 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.36 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.16 132.78 47.8 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.601 -0.44 . . . . 0.0 109.857 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.0 m -82.11 37.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.553 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 90.7 p -85.39 -7.07 59.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.81 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.5 m -149.53 155.48 40.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.383 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.9 tp -141.1 86.65 2.05 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.516 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -92.36 -9.43 41.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.438 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.542 ' O ' ' N ' ' A' ' 80' ' ' HIS . 96.6 m-70 -59.47 -44.24 93.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.653 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.549 ' CE1' ' NE2' ' A' ' 80' ' ' HIS . 11.1 t-160 54.45 -81.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.789 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.549 ' NE2' ' CE1' ' A' ' 79' ' ' HIS . 54.8 m170 -110.8 145.79 37.53 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.901 0.381 . . . . 0.0 110.413 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -60.94 -43.01 99.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.777 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -131.55 143.2 50.19 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.551 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.573 -179.939 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.4 ptt? . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -66.96 -60.12 2.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.02 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -84.77 136.23 33.78 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 p -130.77 150.52 76.7 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 121.044 -0.263 . . . . 0.0 110.454 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 39' ' ' VAL . 42.6 Cg_exo -50.75 -49.39 16.96 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.794 1.662 . . . . 0.0 113.147 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -134.18 103.35 5.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.065 0.459 . . . . 0.0 111.165 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.403 ' OG1' ' CD1' ' A' ' 9' ' ' TRP . 0.3 OUTLIER -137.72 144.42 41.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.529 179.106 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.46 101.89 14.63 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.574 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.403 ' CD1' ' OG1' ' A' ' 7' ' ' THR . 23.8 m0 -100.36 141.23 33.48 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.015 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -95.25 130.37 42.03 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.3 mt -83.52 121.26 36.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.243 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.6 m -103.06 -49.64 3.71 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.812 0.339 . . . . 0.0 110.648 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.16 169.89 27.25 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -85.34 158.33 20.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.901 0.381 . . . . 0.0 110.396 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.2 t -79.87 169.44 17.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.72 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -69.67 -39.61 76.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.841 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -74.6 -7.62 53.74 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.458 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.4 tp -42.46 148.6 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.648 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.1 m -75.16 154.14 86.37 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.355 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.98 -25.79 51.68 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.516 2.144 . . . . 0.0 112.137 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.0 -55.93 9.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.18 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -63.45 -45.65 89.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.189 0.518 . . . . 0.0 110.596 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -58.11 -45.54 87.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.136 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 17.1 tm0? -62.24 -33.73 75.16 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -59.21 -46.79 87.5 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.695 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -62.03 -39.54 92.67 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.229 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.9 tp -59.95 -42.38 93.91 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.227 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.0 t -82.92 -9.43 59.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.296 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.7 tp -94.91 124.67 39.09 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.937 0.398 . . . . 0.0 110.367 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.6 -19.45 74.76 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 45.1 ttp -89.51 73.13 7.84 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.632 0.73 . . . . 0.0 109.306 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' A' ' 33' ' ' PRO . 9.5 mt -80.51 156.91 73.08 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.983 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 32' ' ' LEU . 75.6 Cg_exo -37.91 162.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.476 2.117 . . . . 0.0 112.444 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.16 3.75 17.02 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 96.4 p -129.3 -156.66 0.77 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.767 0.318 . . . . 0.0 110.346 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.5 t -145.3 151.99 39.21 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.702 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -132.62 159.43 39.57 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.356 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -111.38 146.37 37.26 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.733 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 5' ' ' PRO . 51.2 t -90.45 125.66 43.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.146 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -66.83 -42.22 88.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 50.1 ptt85 -174.28 156.75 2.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.076 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.9 m -128.92 117.23 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.09 110.31 47.32 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 120.951 -0.299 . . . . 0.0 110.413 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.67 -11.58 18.49 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.181 1.921 . . . . 0.0 112.187 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tp -57.15 -31.08 65.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.973 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.62 22.98 0.66 Allowed Glycine 0 N--CA 1.465 0.604 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.35 159.82 30.3 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -59.84 173.46 1.69 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.763 2.309 . . . . 0.0 111.761 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.472 ' N ' ' O ' ' A' ' 60' ' ' LEU . 8.2 mm -92.96 114.63 30.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.093 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -96.0 121.93 38.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.093 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.7 pt -126.26 149.37 31.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.286 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -129.32 135.15 48.37 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.553 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.535 ' HG1' ' H ' ' A' ' 56' ' ' VAL . 1.1 p -126.69 145.59 50.52 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.797 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.627 ' NH1' ' HE2' ' A' ' 83' ' ' HIS . 82.0 mtp180 -50.09 -38.6 39.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.169 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.0 tpm_? -67.74 -43.7 79.31 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.772 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.554 ' CG2' ' H ' ' A' ' 57' ' ' SER . 11.8 p -170.74 176.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.584 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.554 ' H ' ' CG2' ' A' ' 56' ' ' VAL . 47.4 t -105.87 149.2 26.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.43 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.4 tp -152.77 149.4 28.3 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.205 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.2 p -128.93 128.22 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.64 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 49' ' ' ILE . 58.7 mt -132.34 162.59 30.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.269 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -85.58 171.9 11.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.717 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -61.9 -40.07 94.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.625 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.48 -39.26 87.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.467 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -57.17 -47.13 81.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.345 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.62 -40.88 98.35 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.661 -0.416 . . . . 0.0 109.924 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.07 -54.11 48.94 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.499 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.1 mp -69.53 -41.57 75.8 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.153 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 38.7 tp -59.0 130.32 46.44 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -83.84 114.03 21.36 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 110.23 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.26 158.43 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.912 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -144.11 141.81 30.23 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.759 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.1 145.4 51.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.098 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.3 t -104.0 128.09 57.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.149 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.5 t -169.03 73.24 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.396 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.9 m -156.25 168.38 27.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.448 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 77' ' ' GLU . 56.9 tp -62.16 -43.87 97.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.519 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 76' ' ' LEU . 82.6 tt0 58.18 152.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.293 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.608 ' ND1' ' N ' ' A' ' 79' ' ' HIS . 58.6 t-80 -59.92 -111.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.655 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.608 ' N ' ' ND1' ' A' ' 78' ' ' HIS . 52.5 t-80 -160.65 138.03 9.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.36 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -145.5 137.91 25.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.429 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -152.27 162.88 40.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.399 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 42.61 91.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.801 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.627 ' HE2' ' NH1' ' A' ' 54' ' ' ARG . 98.7 m-70 . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.64 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -65.41 -40.24 93.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.628 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -72.71 137.24 45.82 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.453 ' OG1' ' OG1' ' A' ' 7' ' ' THR . 0.1 OUTLIER -136.15 155.29 77.58 Favored Pre-proline 0 N--CA 1.466 0.357 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.19 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 39' ' ' VAL . 50.1 Cg_endo -67.68 -23.12 42.84 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.638 2.225 . . . . 0.0 112.307 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -137.86 94.4 2.89 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.689 0.281 . . . . 0.0 110.582 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.453 ' OG1' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -139.12 130.7 27.26 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.846 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.9 101.94 14.03 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -101.76 145.86 28.56 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.23 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -102.8 128.51 49.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.88 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.0 mt -81.03 123.74 37.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.337 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 7.8 p -111.47 -15.17 13.59 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.55 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.34 178.28 16.84 Favored Glycine 0 N--CA 1.465 0.598 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.421 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.5 p90 -98.58 152.17 19.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.85 0.357 . . . . 0.0 110.119 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.433 ' O ' ' CG2' ' A' ' 18' ' ' ILE . 5.1 t -80.21 168.71 18.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.463 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.1 mtp-105 -68.56 -39.52 81.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.943 0.401 . . . . 0.0 110.662 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -64.24 -17.08 63.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.616 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.433 ' CG2' ' O ' ' A' ' 15' ' ' SER . 10.7 tp -41.92 147.89 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.476 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.5 t -80.96 146.33 59.03 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.699 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -49.67 -41.05 46.61 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.874 1.716 . . . . 0.0 112.755 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.52 -56.27 20.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.244 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -61.94 -46.75 87.97 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.48 0.657 . . . . 0.0 110.396 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -57.34 -44.08 83.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.848 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 28' ' ' SER . 5.9 tm0? -60.12 -38.39 82.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.361 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -57.87 -43.92 86.29 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -63.51 -40.84 98.1 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.269 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.4 mt -80.74 -18.14 48.74 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.885 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 24' ' ' GLN . 38.8 t -61.04 -43.97 98.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.077 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.406 HD13 ' H ' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -115.82 154.53 29.5 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.398 -179.527 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.65 5.97 42.51 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.512 ' N ' ' SD ' ' A' ' 31' ' ' MET . 0.0 OUTLIER -89.27 74.73 7.86 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -82.42 171.24 12.33 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.355 -178.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 32' ' ' LEU . 63.3 Cg_exo -48.47 -171.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.321 2.014 . . . . 0.0 112.206 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.01 11.25 8.46 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 81.8 p -139.24 -156.83 0.71 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.921 0.391 . . . . 0.0 110.413 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.8 p -141.15 163.0 34.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.468 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -139.51 160.93 38.72 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.194 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.413 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 24.2 p30 -119.22 151.19 38.8 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.24 0.543 . . . . 0.0 110.429 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' PRO . 61.0 t -88.15 127.53 41.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.279 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -69.06 -41.3 81.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.069 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -173.56 162.07 4.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.964 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 68.0 t -130.14 124.2 57.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.39 110.56 49.39 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.28 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.72 -11.31 20.22 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.29 1.994 . . . . 0.0 112.331 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.48 ' CD2' ' N ' ' A' ' 45' ' ' LEU . 4.1 mm? -60.65 -31.43 70.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.708 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.5 24.76 0.82 Allowed Glycine 0 N--CA 1.465 0.606 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.1 160.05 29.92 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.05 173.15 0.62 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.805 2.336 . . . . 0.0 111.665 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.437 ' N ' ' O ' ' A' ' 60' ' ' LEU . 8.5 mm -93.48 114.26 29.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -92.17 122.33 34.55 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.891 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 58' ' ' LEU . 44.4 pt -126.84 151.91 34.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.574 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.413 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 95.1 mt-10 -130.95 134.46 46.76 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.248 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.22 141.85 51.63 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.996 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -40.89 -36.53 0.66 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.36 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -65.54 -50.39 65.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.87 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.478 ' CG2' ' H ' ' A' ' 57' ' ' SER . 8.5 p -172.39 174.56 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-O 120.905 0.383 . . . . 0.0 110.808 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.478 ' H ' ' CG2' ' A' ' 56' ' ' VAL . 89.8 p -89.07 150.09 22.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.233 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 51' ' ' ILE . 63.9 tp -159.96 145.42 15.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.783 0.325 . . . . 0.0 110.342 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.8 p -126.5 129.96 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 49' ' ' ILE . 67.2 mt -132.93 161.41 34.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.55 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -85.25 165.29 17.46 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.706 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -59.11 -35.85 74.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.485 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.82 -40.41 95.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.595 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -60.64 -46.4 90.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.723 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.6 mp -62.71 -40.26 96.6 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.67 -38.62 91.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.517 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.1 mt -82.32 -54.97 4.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.031 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 66.2 mt -45.81 137.61 5.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.657 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.43 ' O ' ' OG1' ' A' ' 12' ' ' THR . 97.2 mt-10 -80.02 111.56 16.49 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.295 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.7 m -135.97 159.04 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.395 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -141.54 131.58 24.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.718 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.22 142.36 54.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.115 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t -105.15 123.49 59.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.258 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 74.3 p -124.56 -2.11 7.96 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.606 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.5 t -105.88 115.54 30.41 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.402 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.9 tp -64.43 -41.7 96.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.132 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -41.34 158.81 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.737 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.428 ' O ' ' O ' ' A' ' 79' ' ' HIS . 28.6 p-80 -150.27 165.71 32.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.579 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.428 ' O ' ' O ' ' A' ' 78' ' ' HIS . 57.1 m170 55.06 163.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.403 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.531 ' CE1' ' ND1' ' A' ' 81' ' ' HIS . 51.8 t-80 -133.08 -99.71 0.27 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.491 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.531 ' ND1' ' CE1' ' A' ' 80' ' ' HIS . 80.4 m80 -141.35 151.91 43.95 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.585 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -60.29 -45.26 93.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.73 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.573 179.904 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mmm . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -147.21 -30.16 0.34 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.465 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -79.22 137.12 37.28 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.46 ' OG1' ' OG1' ' A' ' 7' ' ' THR . 0.1 OUTLIER -138.22 156.51 73.71 Favored Pre-proline 0 N--CA 1.466 0.33 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.174 -179.353 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 39' ' ' VAL . 41.4 Cg_endo -66.69 -27.75 44.7 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.683 2.255 . . . . 0.0 112.322 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -136.39 94.91 3.08 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.582 0.229 . . . . 0.0 110.408 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.46 ' OG1' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -139.21 128.77 24.46 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.13 101.52 14.18 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 25.2 m0 -99.57 140.59 33.54 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.213 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -98.26 120.44 38.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.882 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.7 mt -74.65 128.52 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.327 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.2 m -110.13 -47.41 3.32 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.567 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 170.62 166.3 29.31 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -87.42 157.25 19.27 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.84 0.352 . . . . 0.0 110.106 179.673 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 67' ' ' LEU . 13.0 m -73.77 163.85 27.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.519 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -69.82 -40.76 75.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.376 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -68.95 -12.19 61.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.355 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.428 ' CG2' ' O ' ' A' ' 15' ' ' SER . 10.3 tp -41.37 146.95 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.614 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.26 156.97 83.46 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.352 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.61 -30.57 70.49 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.777 2.318 . . . . 0.0 111.756 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.78 -56.8 12.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.881 0.372 . . . . 0.0 111.24 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -61.93 -45.46 93.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.364 0.602 . . . . 0.0 110.442 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -57.26 -43.16 82.75 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.946 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.513 ' O ' ' N ' ' A' ' 28' ' ' SER . 63.5 tp60 -61.51 -38.22 86.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.145 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.435 ' O ' ' OG ' ' A' ' 28' ' ' SER . 97.8 mttt -59.75 -41.47 91.08 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.456 -0.498 . . . . 0.0 109.819 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.04 -39.03 93.18 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.425 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.8 tt -82.34 -24.47 34.54 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.071 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 24' ' ' GLN . 96.5 p -60.84 -45.78 93.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.772 0.32 . . . . 0.0 111.484 -178.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.488 ' H ' HD13 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -103.43 161.69 13.64 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.978 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.98 31.28 3.42 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 65.6 mtt -111.65 73.08 0.8 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.473 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.2 mm? -82.84 153.06 67.09 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.648 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 32' ' ' LEU . 77.8 Cg_exo -39.62 167.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.459 2.106 . . . . 0.0 111.918 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.39 -16.19 12.84 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.811 -0.915 . . . . 0.0 110.811 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.8 m -100.18 -170.76 1.92 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.731 0.301 . . . . 0.0 110.302 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 73.4 m -132.39 156.34 46.84 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.481 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -139.17 157.06 46.61 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.241 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -112.2 146.45 38.08 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.468 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 5' ' ' PRO . 17.5 t -86.3 129.7 37.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.434 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -70.31 -40.24 77.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.146 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -173.77 161.45 3.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.114 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 69.5 t -134.47 110.61 13.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.69 111.55 53.08 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.47 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.551 ' C ' ' H ' ' A' ' 46' ' ' GLY . 60.4 Cg_endo -75.82 -12.13 19.97 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.353 2.035 . . . . 0.0 112.135 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.442 ' N ' ' CD1' ' A' ' 45' ' ' LEU . 10.2 mp -55.09 -3.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.812 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.551 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 103.37 26.62 6.83 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.27 159.58 30.92 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-O 121.028 0.442 . . . . 0.0 109.997 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.415 ' HG2' ' HE2' ' A' ' 50' ' ' HIS . 20.7 Cg_endo -59.95 177.54 0.5 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.758 2.305 . . . . 0.0 111.521 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.41 ' N ' ' O ' ' A' ' 60' ' ' LEU . 10.2 mm -95.92 115.42 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.269 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.415 ' HE2' ' HG2' ' A' ' 48' ' ' PRO . 11.9 m170 -98.71 122.39 41.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.838 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.412 HG21 HD11 ' A' ' 51' ' ' ILE . 35.7 pt -126.77 148.0 31.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.748 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -134.36 111.96 10.61 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.875 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.453 ' HG1' ' H ' ' A' ' 56' ' ' VAL . 1.3 p -83.65 175.26 9.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.683 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 53' ' ' THR . 99.8 mtt180 -33.53 -53.3 0.41 Allowed 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.548 0.53 . . . . 0.0 111.548 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -143.04 31.41 1.4 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.351 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.453 ' H ' ' HG1' ' A' ' 53' ' ' THR . 2.3 t -138.48 134.01 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 120.369 -0.533 . . . . 0.0 110.454 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.7 m -111.12 136.94 49.42 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.195 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.2 tp -156.42 147.27 21.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.245 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.9 p -127.5 126.03 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.846 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 49' ' ' ILE . 50.0 mt -132.18 167.72 19.28 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.289 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -85.72 166.32 16.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.517 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -60.53 -35.79 76.84 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.999 0.428 . . . . 0.0 110.549 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.27 -41.13 98.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.274 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -57.5 -47.13 82.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.535 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.0 mp -61.79 -41.09 97.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.095 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.09 -52.01 67.01 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.598 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.465 ' O ' ' OG ' ' A' ' 15' ' ' SER . 10.8 mp -68.8 -42.34 77.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.038 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 tp -56.43 132.22 50.61 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.286 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -78.91 110.03 13.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.224 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.71 159.05 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.418 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -142.86 133.09 24.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.608 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.23 145.45 54.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.173 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.9 t -109.58 129.41 64.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.191 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 97.6 p -104.64 -1.82 25.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.701 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.9 t -142.05 135.59 29.34 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.344 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.6 tp -62.94 -43.33 99.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.499 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 47.79 -172.26 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.396 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -153.26 -54.68 0.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.501 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -82.83 136.6 34.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.486 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -78.82 140.61 38.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.468 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -148.01 156.67 42.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.605 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -75.47 139.29 42.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.441 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.484 179.957 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.584 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.499 ' NE2' ' CD2' ' A' ' 3' ' ' TYR . 3.1 pt20 -74.47 -101.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.936 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.5 OUTLIER -83.03 150.47 26.32 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.441 ' OG1' ' OG1' ' A' ' 7' ' ' THR . 0.1 OUTLIER -138.68 164.55 39.02 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.912 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 39' ' ' VAL . 31.3 Cg_exo -55.64 -36.14 94.22 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.878 1.719 . . . . 0.0 112.687 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 6' ' ' ASP . 47.0 p-10 -136.74 94.38 2.98 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.796 0.331 . . . . 0.0 110.533 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.441 ' OG1' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -136.29 130.52 33.1 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.716 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.95 102.6 15.37 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -105.96 141.33 37.54 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.912 0.387 . . . . 0.0 110.464 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -94.52 147.86 22.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.838 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.3 mt -101.63 115.83 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.0 m -97.73 -43.58 7.11 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.852 0.358 . . . . 0.0 110.42 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.65 179.52 34.52 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.9 OUTLIER -95.84 149.0 22.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.938 0.399 . . . . 0.0 110.506 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 67' ' ' LEU . 4.3 m -78.28 172.16 13.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.545 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -69.49 -40.54 76.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.618 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -66.8 -13.79 61.91 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.968 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.4 tp -41.53 148.49 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.715 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.05 155.21 86.52 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.302 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.99 -31.02 66.8 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.645 2.23 . . . . 0.0 112.216 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.44 -55.34 18.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.902 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -62.82 -43.51 98.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.435 0.636 . . . . 0.0 110.513 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -58.51 -43.32 89.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.6 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.535 ' O ' ' N ' ' A' ' 28' ' ' SER . 18.8 mm-40 -63.36 -35.18 79.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.043 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -59.74 -41.95 92.08 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.368 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -70.06 -39.0 75.94 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.748 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp -81.91 -15.48 53.76 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.432 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 24' ' ' GLN . 2.8 m -57.14 -29.73 63.83 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.596 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.602 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -134.69 -176.92 4.39 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.696 0.284 . . . . 0.0 110.723 179.513 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.39 -9.2 56.97 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 79.2 mtp -76.08 75.13 2.94 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.5 OUTLIER -83.04 171.82 10.83 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.034 -179.275 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' A' ' 32' ' ' LEU . 77.7 Cg_exo -48.74 -168.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.523 2.149 . . . . 0.0 112.589 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.03 11.99 7.27 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.6 p -136.12 -158.11 0.84 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.761 0.315 . . . . 0.0 110.214 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 82.5 p -138.68 161.56 36.84 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.761 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -141.21 159.4 42.29 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.183 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 47.6 p-10 -117.38 151.16 37.59 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.196 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 5' ' ' PRO . 61.1 t -87.88 126.34 41.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.283 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 p -68.72 -43.31 83.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.941 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -173.23 147.26 1.53 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.391 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.9 m -115.99 125.64 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.36 110.39 48.35 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.805 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.1 -12.19 17.6 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.854 1.703 . . . . 0.0 112.315 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.8 mt -60.6 -31.02 70.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.011 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.34 26.34 0.89 Allowed Glycine 0 N--CA 1.469 0.869 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.02 160.27 28.8 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -54.81 175.24 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.603 2.202 . . . . 0.0 111.645 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.4 mm -94.64 113.68 29.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.018 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 16.2 m170 -93.95 119.65 33.14 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.1 pt -127.17 150.43 33.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.368 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.429 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 8.6 tm-20 -126.25 132.31 51.74 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.214 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.08 138.4 54.46 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.924 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -40.59 -38.58 0.89 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.332 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -67.13 -48.66 67.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.744 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.46 ' CG2' ' H ' ' A' ' 57' ' ' SER . 8.5 p -171.5 172.07 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.933 0.397 . . . . 0.0 110.87 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.46 ' H ' ' CG2' ' A' ' 56' ' ' VAL . 10.7 p -86.26 151.26 23.76 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.461 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.1 tp -155.66 146.45 22.2 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.884 0.373 . . . . 0.0 110.299 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.6 p -125.65 130.9 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.64 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.4 mt -134.71 163.2 30.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.576 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 83.6 mtt85 -92.08 174.8 7.13 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.972 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -62.05 -44.67 96.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.092 0.472 . . . . 0.0 110.623 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -61.63 -38.02 86.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.627 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -59.47 -48.36 81.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.259 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.433 ' CD2' ' CE1' ' A' ' 3' ' ' TYR . 10.5 mp -62.92 -41.77 99.57 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.113 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.36 -50.94 71.85 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.269 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.468 ' O ' ' OG ' ' A' ' 15' ' ' SER . 92.0 mt -68.83 -41.92 77.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.239 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.2 tp -62.19 136.21 57.83 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -84.9 116.37 23.3 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.871 0.367 . . . . 0.0 110.427 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.0 m -133.28 161.45 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.527 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -145.59 145.98 31.2 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.463 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.96 135.92 45.07 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.2 131.63 35.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.787 0.327 . . . . 0.0 110.289 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.0 p -147.79 -44.21 0.16 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.557 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.0 p -76.21 144.83 40.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.075 0.464 . . . . 0.0 110.455 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 77' ' ' GLU . 90.3 mt -63.91 -41.78 97.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.562 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 76' ' ' LEU . 80.2 mm-40 56.27 156.75 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.597 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -79.74 156.45 27.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.434 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -53.38 -77.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.544 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -143.1 141.09 31.14 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.462 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.46 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 48.6 p-80 -76.73 122.04 24.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.509 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -84.1 -16.38 43.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.606 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.471 ' O ' ' CD2' ' A' ' 83' ' ' HIS . 85.0 t60 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.556 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mtp . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -72.65 -70.39 0.35 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.549 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -73.18 90.14 1.56 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.05 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.07 152.34 38.55 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.314 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -49.9 -44.05 38.58 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.852 1.701 . . . . 0.0 112.816 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -135.47 100.64 4.56 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.935 0.398 . . . . 0.0 110.835 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.629 ' HG1' ' HE1' ' A' ' 9' ' ' TRP . 0.3 OUTLIER -137.35 143.45 42.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.389 179.381 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -96.48 102.45 14.24 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.576 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.629 ' HE1' ' HG1' ' A' ' 7' ' ' THR . 26.5 m0 -98.51 145.77 26.45 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.377 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -100.34 132.58 45.64 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.788 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 36.1 mt -82.37 124.56 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.21 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.5 m -108.03 -49.55 3.19 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.81 0.338 . . . . 0.0 110.804 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.11 -178.88 40.54 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 2.3 p90 -102.52 144.29 31.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.909 0.385 . . . . 0.0 110.464 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 67' ' ' LEU . 19.7 m -75.31 171.36 14.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.453 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -68.78 -38.48 80.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.785 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -71.7 -10.27 59.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.482 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.0 tp -41.56 147.51 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.518 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.2 t -78.64 140.72 59.54 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.356 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -48.25 -40.24 35.09 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.902 1.735 . . . . 0.0 112.89 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.53 -58.14 8.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.897 0.379 . . . . 0.0 111.364 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -62.07 -47.2 85.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.55 0.691 . . . . 0.0 110.471 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -56.51 -43.16 79.5 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.878 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -59.73 -37.53 79.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.182 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -59.47 -43.03 93.32 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.633 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 29' ' ' LEU . 4.5 mm? -62.4 -42.62 99.57 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.967 178.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 48.7 mt -70.85 -32.55 69.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.917 0.389 . . . . 0.0 110.928 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 64.7 m -58.0 -44.12 87.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.399 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -117.94 166.24 12.74 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.161 -179.777 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.4 8.49 79.73 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 16.1 mmt -78.4 73.37 4.96 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.5 mp -91.4 167.84 14.79 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.089 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 32' ' ' LEU . 71.6 Cg_exo -44.33 176.69 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 122.292 1.994 . . . . 0.0 112.363 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.34 1.58 15.91 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.439 ' HG ' ' NH2' ' A' ' 54' ' ' ARG . 32.7 t -134.48 -155.85 0.69 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.903 0.382 . . . . 0.0 110.321 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.401 ' N ' ' OG ' ' A' ' 35' ' ' SER . 27.3 p -150.71 161.94 41.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.554 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -138.38 156.49 47.55 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.293 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -108.95 145.72 35.0 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.496 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.7 t -89.85 126.72 42.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.434 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -67.52 -42.31 86.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.114 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -173.87 156.93 2.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.059 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.8 m -126.05 122.11 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.75 110.27 48.43 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.511 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -76.86 -11.88 18.08 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.199 1.933 . . . . 0.0 112.283 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.1 mt -59.69 -31.47 69.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.026 -178.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.83 25.01 0.78 Allowed Glycine 0 N--CA 1.466 0.673 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.52 160.13 29.47 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.4 169.58 2.19 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.898 2.399 . . . . 0.0 111.638 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.454 ' N ' ' O ' ' A' ' 60' ' ' LEU . 6.1 mm -92.77 113.65 28.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.99 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -95.6 121.25 37.09 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.909 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 48.0 pt -127.93 149.87 33.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.428 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.431 ' OE2' ' OG ' ' A' ' 57' ' ' SER . 67.0 mm-40 -118.97 125.51 49.6 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.173 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 56' ' ' VAL . 6.0 p -111.77 136.94 50.36 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.439 ' NH2' ' HG ' ' A' ' 35' ' ' SER . 85.7 mtm180 -39.29 -40.23 0.74 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.804 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.446 ' O ' ' CG1' ' A' ' 56' ' ' VAL . 56.6 ttt85 -67.88 -49.71 60.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.21 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.446 ' CG1' ' O ' ' A' ' 55' ' ' ARG . 4.4 m -164.77 -176.68 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.556 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.431 ' OG ' ' OE2' ' A' ' 52' ' ' GLU . 40.0 t -96.23 136.96 36.0 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.488 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.5 tp -138.04 145.27 41.61 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.987 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.9 p -126.42 130.46 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.694 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 49' ' ' ILE . 80.8 mt -134.3 162.26 32.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.475 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -91.89 165.03 13.44 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.623 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.6 ' HZ3' ' H ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -57.0 -40.93 77.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.072 0.463 . . . . 0.0 110.635 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -62.22 -36.92 83.44 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.793 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.29 -42.85 99.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.278 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.7 mp -63.06 -41.96 99.59 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.884 -0.414 . . . . 0.0 109.884 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.31 -50.77 72.43 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.146 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.433 ' O ' ' OG ' ' A' ' 15' ' ' SER . 97.5 mt -69.2 -40.48 78.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.004 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.3 tp -62.58 134.02 55.76 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -85.13 112.47 20.72 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.003 0.43 . . . . 0.0 110.118 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.0 m -132.5 158.99 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.63 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -142.92 141.68 31.53 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.823 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.61 150.55 42.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.164 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.6 t -117.65 130.69 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.197 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 90.8 p -118.89 1.92 11.53 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.558 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 51.4 m -153.05 163.93 38.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.439 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.8 tp -61.24 -84.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.305 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -164.36 -72.25 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.49 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 45.0 p-80 -151.01 165.7 32.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.32 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -111.37 138.59 47.67 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.32 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -78.9 123.95 27.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.5 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.606 ' N ' ' ND1' ' A' ' 81' ' ' HIS . 0.6 OUTLIER -66.16 -44.48 84.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.453 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -146.83 147.38 30.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.605 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.602 179.927 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.9 mmm . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.684 ' H ' ' NE2' ' A' ' 2' ' ' GLN . 1.4 pm0 -63.73 -38.44 91.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.727 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -97.66 133.55 42.06 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.851 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.456 ' OG1' ' CG2' ' A' ' 7' ' ' THR . 15.4 p -132.39 148.07 68.2 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.484 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 39' ' ' VAL . 44.9 Cg_endo -66.22 -31.29 44.78 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.392 2.062 . . . . 0.0 112.473 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -136.23 93.99 2.97 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.725 0.298 . . . . 0.0 111.318 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.52 ' HG1' ' N ' ' A' ' 8' ' ' ALA . 0.9 OUTLIER -141.77 149.16 40.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.368 178.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.52 ' N ' ' HG1' ' A' ' 7' ' ' THR . . . -102.78 102.05 12.16 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 25.3 m0 -97.46 142.74 28.94 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.894 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -100.68 123.66 45.19 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.5 mt -79.6 120.43 30.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.904 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.6 p -104.08 -15.66 15.5 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.348 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.47 164.66 10.41 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.88 169.51 17.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.9 t -84.03 166.42 17.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.447 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.9 ptt-85 -70.58 -37.03 73.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.556 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -81.09 -5.42 57.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.028 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.6 tp -41.15 141.75 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.386 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.8 m -80.02 150.88 72.52 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.806 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.06 -38.84 60.47 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.9 1.733 . . . . 0.0 112.544 179.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.63 -58.12 8.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.437 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -63.32 -48.65 77.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.346 0.594 . . . . 0.0 110.555 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -57.93 -40.76 81.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.04 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 28' ' ' SER . 12.1 tm0? -61.8 -39.44 91.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.207 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.51 -43.73 96.77 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.253 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.47 -39.21 93.86 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.283 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.5 tt -81.13 -23.18 38.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.958 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.469 ' N ' ' O ' ' A' ' 24' ' ' GLN . 40.3 t -61.22 -45.24 95.38 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.167 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.486 ' H ' HD13 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -107.71 160.47 15.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.173 -179.554 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.04 33.92 2.4 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.404 ' H ' ' C ' ' A' ' 29' ' ' LEU . 36.5 tpp -112.8 74.01 0.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.464 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.2 mm? -81.86 153.58 70.06 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.075 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 32' ' ' LEU . 66.4 Cg_exo -40.12 169.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 122.78 2.32 . . . . 0.0 112.439 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.15 12.11 7.13 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 90.2 p -126.63 -171.36 2.39 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 73.5 m -131.45 157.47 43.39 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.72 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -137.88 159.96 40.58 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.296 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -117.35 145.85 43.77 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.893 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 5' ' ' PRO . 57.5 t -86.06 127.66 40.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.213 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 p -70.65 -41.37 77.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.209 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -176.41 171.31 2.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.818 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.56 130.65 37.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.36 109.61 43.82 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.716 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.545 ' C ' ' H ' ' A' ' 46' ' ' GLY . 33.9 Cg_exo -60.57 -21.86 70.26 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 121.793 1.662 . . . . 0.0 112.334 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.5 mt -52.99 -5.72 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.634 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 90.8 33.95 8.06 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.7 169.75 8.11 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -54.51 -171.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 121.807 1.672 . . . . 0.0 111.939 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.487 ' N ' ' O ' ' A' ' 60' ' ' LEU . 9.5 mm -111.89 109.67 29.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.744 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -85.71 125.73 33.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.161 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.6 pt -127.66 151.22 34.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.524 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.4 ' OE1' ' C ' ' A' ' 52' ' ' GLU . 1.9 pp20? -130.7 136.86 49.19 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.212 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 56' ' ' VAL . 2.9 p -128.87 143.68 50.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.09 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -49.28 -37.45 23.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.659 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -72.74 -37.82 67.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.91 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 53' ' ' THR . 3.5 p -169.53 -176.1 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.824 0.345 . . . . 0.0 110.207 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.454 ' H ' HG21 ' A' ' 56' ' ' VAL . 36.5 p -130.65 150.49 51.81 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.8 tt -163.81 164.95 23.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.354 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 p -126.47 137.79 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.828 0.347 . . . . 0.0 110.419 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 49' ' ' ILE . 11.9 mt -134.11 152.07 51.67 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.704 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -77.83 162.05 27.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.508 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -58.4 -39.49 79.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.862 0.363 . . . . 0.0 110.34 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.89 -39.68 92.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.4 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -59.87 -45.94 90.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.516 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 mp -62.02 -41.8 98.47 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.341 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.12 -51.76 68.0 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.18 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.23 -39.95 82.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.944 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.9 tp -60.02 128.92 39.24 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -75.59 110.28 9.85 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.423 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.6 m -133.24 161.4 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.64 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -143.28 138.35 29.51 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.395 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.81 134.13 44.78 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 80.9 t -89.71 133.8 30.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.383 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 37.8 p -148.8 161.92 40.83 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.853 0.359 . . . . 0.0 110.47 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.4 m -78.04 103.94 8.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.662 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.415 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 10.7 mp -63.1 -41.52 99.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.331 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 57.41 96.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.399 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -149.9 159.64 44.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.362 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -110.91 149.01 31.25 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.486 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -79.47 150.49 31.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.619 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -143.91 140.23 29.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.491 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -80.77 150.9 29.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.589 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 . . . . . 0 C--O 1.219 -0.522 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.518 179.97 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ptm . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -62.9 -44.27 96.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.757 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -106.44 137.42 44.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.848 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 p -130.09 152.49 80.15 Favored Pre-proline 0 N--CA 1.466 0.343 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 39' ' ' VAL . 52.6 Cg_exo -50.45 -41.45 51.96 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.972 1.781 . . . . 0.0 112.586 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -134.37 100.59 4.72 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.003 0.43 . . . . 0.0 111.026 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 t -137.35 144.52 42.56 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.296 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.36 102.43 14.41 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.745 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 14.5 m0 -100.62 142.59 31.89 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.345 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -97.49 139.61 33.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.632 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.4 mt -98.84 114.88 37.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 m -97.26 -40.42 8.77 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.44 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.65 164.77 21.79 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.65 162.32 27.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.78 0.324 . . . . 0.0 110.172 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.428 ' O ' ' CG2' ' A' ' 18' ' ' ILE . 5.8 t -78.69 163.45 25.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.518 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 49.6 ptt85 -68.67 -37.62 79.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -70.08 -14.65 62.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.603 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.428 ' CG2' ' O ' ' A' ' 15' ' ' SER . 10.8 tp -41.94 145.53 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.404 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 t -84.98 149.84 54.13 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.515 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -48.94 -37.12 36.24 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.952 1.768 . . . . 0.0 112.394 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.38 -58.48 7.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.485 -178.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -63.45 -46.61 85.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.427 0.632 . . . . 0.0 110.668 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -57.49 -43.32 84.07 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.936 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -63.42 -37.79 88.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.216 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -59.06 -45.45 90.75 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.884 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.34 -43.52 98.63 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.184 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.3 tp -63.64 -42.42 98.15 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.536 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.6 m -72.32 -39.73 67.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.453 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.54 ' C ' ' H ' ' A' ' 31' ' ' MET . 1.7 tt -82.5 132.1 35.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.774 -178.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -73.26 32.21 0.8 Allowed Glycine 0 N--CA 1.462 0.427 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.54 ' H ' ' C ' ' A' ' 29' ' ' LEU . 11.3 tpt -124.67 72.7 1.22 Allowed 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.0 mm? -81.62 152.01 69.08 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.106 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 32' ' ' LEU . 72.5 Cg_exo -40.77 169.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 122.676 2.251 . . . . 0.0 112.491 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.72 -17.92 15.35 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.5 m -103.36 -169.44 1.65 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.827 0.346 . . . . 0.0 110.269 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.6 m -132.17 155.58 47.94 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.579 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -132.07 155.25 48.41 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.027 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -112.81 145.14 41.14 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.364 0.602 . . . . 0.0 110.858 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 5' ' ' PRO . 58.6 t -83.54 127.43 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.14 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 p -70.42 -39.3 76.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.132 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -173.67 160.56 3.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.564 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 70.5 t -136.17 112.11 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.64 109.81 45.59 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 119.494 -0.289 . . . . 0.0 110.928 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.579 ' C ' ' H ' ' A' ' 46' ' ' GLY . 31.7 Cg_exo -57.81 -12.52 12.09 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 121.838 1.692 . . . . 0.0 112.156 178.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 82.0 mt -51.58 -5.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.819 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.579 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 89.11 31.69 11.64 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.34 162.39 22.8 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -52.96 -170.74 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.885 1.723 . . . . 0.0 111.876 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.426 ' N ' ' O ' ' A' ' 60' ' ' LEU . 6.6 mm -109.64 113.57 44.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.428 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -96.62 127.75 42.91 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.433 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.1 pt -127.33 149.61 32.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.654 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -135.69 131.55 35.82 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.503 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.527 ' HG1' ' H ' ' A' ' 56' ' ' VAL . 2.7 p -125.52 137.48 53.94 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.074 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -39.05 -24.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.755 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.511 ' N ' ' O ' ' A' ' 53' ' ' THR . 84.8 mtt85 -84.96 -49.86 7.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.208 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.527 ' H ' ' HG1' ' A' ' 53' ' ' THR . 16.0 m -161.2 -174.87 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.474 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.8 p -131.05 151.76 51.07 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.637 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.2 tp -154.21 151.91 29.73 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.274 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.0 t -118.91 129.5 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' A' ' 49' ' ' ILE . 94.1 mt -137.79 152.26 48.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.467 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.408 ' HG3' ' H ' ' A' ' 62' ' ' LYS . 7.8 tpp85 -81.22 162.79 23.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.462 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.408 ' H ' ' HG3' ' A' ' 61' ' ' ARG . 21.1 ptmt -57.7 -37.59 73.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.021 0.438 . . . . 0.0 110.502 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -61.57 -41.24 97.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.175 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.13 -46.02 91.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.371 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.6 mp -60.92 -40.96 95.16 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.182 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.56 -51.37 69.74 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.454 -0.499 . . . . 0.0 110.445 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.99 -42.61 80.5 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.382 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.3 mt -60.92 134.55 57.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.304 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -78.01 108.06 11.01 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.758 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.2 m -131.03 160.71 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.806 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -147.72 145.75 28.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.514 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.37 135.77 53.74 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.0 t -86.3 130.48 36.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.854 0.359 . . . . 0.0 110.438 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 37.2 t -153.83 -33.45 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.579 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.6 p -78.07 156.04 30.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.498 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.438 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 10.4 mp -89.69 -2.79 58.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.317 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -58.9 148.24 31.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.465 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 40.1 p-80 -150.98 158.78 44.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.4 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -105.15 153.59 21.32 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.279 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -106.26 123.25 47.75 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.379 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -85.67 126.52 34.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.441 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.554 ' CG ' ' H ' ' A' ' 83' ' ' HIS . 5.2 t60 -73.66 -123.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.524 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.554 ' H ' ' CG ' ' A' ' 82' ' ' HIS . 39.7 p-80 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.529 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 tpp . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -64.28 -32.6 74.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.817 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -66.08 130.97 45.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.737 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.67 154.59 59.62 Favored Pre-proline 0 N--CA 1.467 0.395 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.45 -32.9 59.38 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.477 2.118 . . . . 0.0 112.085 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 6' ' ' ASP . 47.8 p-10 -136.72 93.77 2.9 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.928 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.5 t -140.69 151.04 44.23 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.093 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -100.71 102.45 13.56 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 22.9 m0 -98.93 129.4 45.26 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.247 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -85.66 136.31 33.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.877 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.1 mt -91.2 119.07 37.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.1 m -102.16 -43.01 5.86 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.827 0.346 . . . . 0.0 110.33 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.06 -174.1 33.98 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.7 OUTLIER -95.0 157.1 16.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.901 0.381 . . . . 0.0 110.325 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.463 ' HG ' ' N ' ' A' ' 16' ' ' ARG . 6.8 t -85.23 171.89 11.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.599 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.463 ' N ' ' HG ' ' A' ' 15' ' ' SER . 89.6 mtm180 -68.48 -38.28 80.87 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.869 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.458 ' H ' ' HG ' ' A' ' 15' ' ' SER . 24.1 tp10 -75.81 -6.01 48.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.434 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.3 tp -41.9 147.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.601 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.45 155.66 87.49 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.436 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.32 -30.1 63.44 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.535 2.156 . . . . 0.0 112.028 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.89 -53.46 31.99 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.004 0.43 . . . . 0.0 111.161 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -63.68 -46.33 86.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.342 0.591 . . . . 0.0 110.268 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -56.46 -44.51 80.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.96 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 28' ' ' SER . 39.5 mm-40 -64.07 -31.57 72.8 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -59.09 -48.91 79.87 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.469 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 29' ' ' LEU . 4.5 mm? -64.7 -40.7 95.81 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.104 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.2 tp -69.37 -34.33 74.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.219 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 24' ' ' GLN . 11.9 t -59.44 -44.67 92.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.4 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -116.36 167.9 10.62 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.269 -179.631 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.81 7.91 80.55 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 94.2 mtp -77.6 73.96 4.16 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.4 mp -93.77 169.21 10.41 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.576 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 32' ' ' LEU . 54.0 Cg_exo -48.6 -170.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.317 2.011 . . . . 0.0 112.333 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.83 5.34 20.44 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.0 t -145.43 -172.31 3.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.759 0.314 . . . . 0.0 110.366 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.5 t -130.11 155.75 45.67 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.496 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -131.84 164.57 25.76 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.27 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 38' ' ' ASN . 12.8 p-10 -116.64 149.68 39.35 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.518 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.5 t -88.31 125.21 41.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.501 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.2 p -67.51 -42.54 87.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.348 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.48 ' NH2' ' ND1' ' A' ' 50' ' ' HIS . 37.0 ptt-85 -170.1 160.19 7.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.409 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 86.4 t -129.24 127.58 65.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.39 110.93 49.8 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.507 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -76.28 -11.39 19.21 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.073 1.848 . . . . 0.0 112.415 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.416 ' N ' ' CD1' ' A' ' 45' ' ' LEU . 10.5 mp -59.29 -30.63 68.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.579 -178.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.39 28.23 1.36 Allowed Glycine 0 N--CA 1.468 0.78 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -97.9 178.72 1.25 Allowed Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 47' ' ' ASP . 19.2 Cg_exo -64.13 -179.14 0.73 Allowed 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.974 1.783 . . . . 0.0 111.888 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.0 mm -103.6 117.95 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.528 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.48 ' ND1' ' NH2' ' A' ' 41' ' ' ARG . 10.8 m170 -96.37 117.47 30.91 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.2 pt -118.66 147.38 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.431 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.413 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 84.2 tt0 -134.26 112.04 10.73 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.217 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 54' ' ' ARG . 1.2 p -86.46 172.56 10.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.766 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 53' ' ' THR . 95.5 mtt180 -34.02 -51.84 0.43 Allowed 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.479 0.487 . . . . 0.0 111.929 -178.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.6 tpt85 -142.03 31.68 1.58 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.619 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -141.96 138.08 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.541 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.3 t -116.9 131.91 56.83 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.35 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.1 tp -145.87 146.38 31.09 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.932 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.9 p -136.93 127.2 39.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.8 mt -138.17 165.38 26.8 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.587 0.232 . . . . 0.0 110.428 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -74.0 148.14 42.31 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 120.94 0.4 . . . . 0.0 111.275 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -43.94 -41.77 5.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.184 0.516 . . . . 0.0 110.807 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -57.98 -40.63 81.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.387 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -60.05 -42.66 94.97 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.477 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.477 ' CD2' ' N ' ' A' ' 65' ' ' LEU . 4.0 mm? -62.05 -42.07 98.79 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.59 -48.48 81.51 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.669 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.37 -39.26 85.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.873 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 38.5 mt -62.78 138.99 58.66 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.341 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -83.14 102.15 11.66 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.488 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.1 m -127.07 152.35 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.306 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -144.04 123.46 13.12 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.708 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.11 145.73 53.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.111 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.7 128.21 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.762 0.315 . . . . 0.0 110.671 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.6 t -68.98 -41.77 77.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.184 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 95.8 p -157.66 162.64 38.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.397 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.7 tp -148.99 94.3 2.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.125 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -121.5 129.2 52.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.163 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -103.64 119.45 38.93 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.394 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -94.08 11.14 30.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.498 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -60.39 -42.65 96.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.578 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 86.6 t60 53.48 88.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.63 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.439 ' ND1' ' OXT' ' A' ' 83' ' ' HIS . 34.3 p80 -76.1 148.68 37.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.665 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.439 ' OXT' ' ND1' ' A' ' 82' ' ' HIS . 79.8 m80 . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.543 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 ptt? . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.4 tp60 -62.52 -52.23 64.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.819 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -104.87 135.01 47.03 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.48 157.26 78.76 Favored Pre-proline 0 N--CA 1.466 0.342 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 39' ' ' VAL . 52.2 Cg_exo -50.19 -35.22 42.22 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.03 1.82 . . . . 0.0 112.768 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -136.56 96.54 3.36 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.708 0.29 . . . . 0.0 110.328 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.86 130.99 42.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.982 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.3 102.32 15.04 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 20.1 m0 -105.5 143.67 33.33 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.185 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -95.57 147.75 23.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.817 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 46.9 mt -100.12 123.0 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.8 m -103.86 -47.88 4.08 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.795 0.331 . . . . 0.0 110.405 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 160.6 169.9 24.49 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.9 OUTLIER -83.4 151.22 25.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.916 0.389 . . . . 0.0 110.546 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.2 t -82.46 174.36 11.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.538 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -70.74 -40.09 72.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.0 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -70.77 -10.4 59.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.305 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.3 tp -41.38 149.51 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.776 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.66 154.25 87.38 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.368 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.52 -30.96 51.78 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.528 2.152 . . . . 0.0 112.179 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.43 -54.36 25.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.921 0.391 . . . . 0.0 111.286 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -63.76 -45.72 88.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.351 0.596 . . . . 0.0 110.194 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 68.2 ttp85 -57.89 -44.72 86.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.293 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 69.5 tp60 -61.78 -34.2 75.45 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -59.68 -48.41 81.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.067 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -61.88 -41.38 97.81 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.597 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.0 mt -61.8 -39.81 93.02 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.448 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.1 m -82.66 -12.98 57.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.849 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.4 tp -95.85 124.54 39.91 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.799 0.333 . . . . 0.0 110.15 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.87 13.1 32.44 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.451 ' CE ' HH21 ' A' ' 55' ' ' ARG . 68.6 mtp -118.49 75.66 1.03 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.26 0.552 . . . . 0.0 109.531 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.496 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.7 mp -78.7 166.69 40.8 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.839 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.496 ' O ' ' O ' ' A' ' 32' ' ' LEU . 80.1 Cg_exo -40.56 175.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.666 2.244 . . . . 0.0 112.747 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.71 12.49 6.59 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.6 t -140.8 -156.37 0.67 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.836 0.351 . . . . 0.0 110.266 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.0 t -147.7 153.79 39.75 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.839 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -129.76 149.97 51.27 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.492 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -108.06 144.13 35.82 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.316 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 5' ' ' PRO . 12.5 t -81.05 121.02 33.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.488 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 p -68.34 -37.67 78.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.509 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -171.82 155.66 3.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.366 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.4 t -123.68 114.06 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.3 111.99 54.41 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.403 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.591 ' C ' ' H ' ' A' ' 46' ' ' GLY . 61.4 Cg_endo -75.0 -11.64 21.48 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.916 1.744 . . . . 0.0 112.269 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.438 ' N ' ' CD1' ' A' ' 45' ' ' LEU . 9.9 mp -60.14 5.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.954 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.591 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 88.63 29.51 18.56 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.41 160.01 29.81 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.43 172.44 2.63 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.969 2.446 . . . . 0.0 112.002 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.3 mm -91.48 113.26 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.893 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -94.53 125.09 38.96 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.162 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.3 pt -124.57 146.71 29.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.099 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -136.79 129.06 29.84 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.234 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -130.57 144.45 51.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.519 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -49.19 -33.19 11.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.937 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.451 HH21 ' CE ' ' A' ' 31' ' ' MET . 73.8 mtp85 -69.96 -43.92 70.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.714 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.591 ' CG2' ' H ' ' A' ' 57' ' ' SER . 9.8 p -170.05 -179.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.433 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.591 ' H ' ' CG2' ' A' ' 56' ' ' VAL . 20.7 t -128.49 150.94 49.94 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.247 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 52.7 tp -163.21 157.22 20.14 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.036 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.5 p -130.98 131.79 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.3 mp -126.33 150.6 48.42 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.645 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' A' ' 64' ' ' ASP . 88.6 mtm180 -79.03 143.65 35.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.286 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -40.47 -40.92 1.31 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.125 0.488 . . . . 0.0 111.124 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -61.19 -42.32 98.36 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.368 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 61' ' ' ARG . 98.1 m-20 -61.4 -38.51 87.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.229 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.444 ' N ' ' CD2' ' A' ' 65' ' ' LEU . 4.1 mm? -62.58 -42.72 99.73 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.14 -51.25 70.83 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.154 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' A' ' 67' ' ' LEU . 4.1 mm? -68.56 -39.76 80.91 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.178 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.16 134.11 56.12 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -83.14 114.55 21.41 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.077 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 m -132.09 161.85 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.022 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -146.13 144.77 30.19 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.506 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.66 147.45 52.68 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.1 t -103.93 130.9 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.6 m -157.22 1.81 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.533 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.1 m -68.37 141.98 55.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.495 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.4 mt -96.91 -0.91 46.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.613 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -135.17 148.12 49.61 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.392 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 27.8 p-80 -154.15 160.58 41.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.418 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -94.61 123.85 38.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.485 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.495 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 2.6 p80 -153.43 119.15 5.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.372 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.506 ' O ' ' N ' ' A' ' 83' ' ' HIS . 90.6 m-70 -157.51 -35.43 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.534 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 75.9 m80 47.02 -90.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.616 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 81' ' ' HIS . 66.1 t-80 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.521 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -144.68 -50.64 0.27 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.447 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -70.69 136.39 48.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.652 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -143.3 153.3 59.29 Favored Pre-proline 0 N--CA 1.464 0.264 0 C-N-CA 121.136 -0.226 . . . . 0.0 110.404 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 39' ' ' VAL . 34.9 Cg_exo -50.96 -43.02 49.91 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.626 1.551 . . . . 0.0 112.407 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 6' ' ' ASP . 48.0 p-10 -135.29 98.45 3.97 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.946 0.403 . . . . 0.0 111.526 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 t -131.9 143.92 50.48 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.241 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -87.54 102.68 14.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -103.17 136.09 43.61 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 -178.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.0 tttt -91.88 143.97 25.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.773 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 48.9 mt -101.43 119.13 49.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 6.6 p -108.63 -19.14 13.53 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.773 0.321 . . . . 0.0 110.588 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.04 -177.59 23.39 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.101 -0.799 . . . . 0.0 111.101 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -104.76 150.43 24.77 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.808 0.337 . . . . 0.0 110.41 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.542 ' HG ' ' H ' ' A' ' 16' ' ' ARG . 8.3 t -77.86 170.24 16.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.854 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.542 ' H ' ' HG ' ' A' ' 15' ' ' SER . 40.8 ptt180 -70.7 -39.48 73.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.106 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -66.83 -14.81 63.1 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.002 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.44 ' CG2' ' HE ' ' A' ' 23' ' ' ARG . 10.0 tp -41.23 149.34 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.759 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.35 154.5 88.04 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.981 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.25 -30.09 64.12 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.534 2.156 . . . . 0.0 112.362 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.3 -52.06 45.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.468 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -63.13 -46.7 86.04 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.59 0.71 . . . . 0.0 110.527 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.44 ' HE ' ' CG2' ' A' ' 18' ' ' ILE . 33.9 ttm180 -58.42 -48.51 80.46 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.407 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -59.84 -30.84 69.23 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -57.5 -44.23 84.84 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 29' ' ' LEU . 4.6 mm? -61.8 -42.62 99.24 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 120.071 -0.651 . . . . 0.0 109.647 178.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.428 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 3.9 mm? -67.94 -33.59 74.96 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.788 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.7 t -60.1 -44.26 94.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.73 -178.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -118.19 170.3 8.98 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.033 0.444 . . . . 0.0 110.599 -179.602 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.64 4.18 81.93 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 58.6 mmm -73.34 73.76 1.34 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.1 mp -95.36 170.38 7.91 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.104 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 32' ' ' LEU . 52.9 Cg_exo -50.0 -165.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.402 2.068 . . . . 0.0 113.028 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.33 5.34 55.94 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 76.9 p -143.15 -172.93 3.78 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.733 0.301 . . . . 0.0 110.289 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.8 m -130.04 156.13 45.0 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.745 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -128.5 153.56 47.03 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.989 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 39' ' ' VAL . 59.9 t-20 -108.74 147.07 32.55 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.662 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.525 ' N ' ' OD1' ' A' ' 38' ' ' ASN . 21.4 t -89.58 126.51 42.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.647 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 p -72.24 -41.76 66.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.716 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -173.32 154.98 2.78 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.419 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.9 m -139.56 122.45 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.294 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -95.47 110.07 48.89 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.754 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.602 ' C ' ' H ' ' A' ' 46' ' ' GLY . 38.1 Cg_exo -61.56 -14.63 36.55 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 121.811 1.674 . . . . 0.0 111.869 178.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 78.3 mt -53.73 2.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.863 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.602 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 90.04 26.08 25.07 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.01 162.26 23.48 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.99 170.46 2.12 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.181 1.92 . . . . 0.0 111.39 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 60' ' ' LEU . 6.7 mm -96.85 115.97 37.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.606 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -93.77 120.47 34.07 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.401 ' O ' ' O ' ' A' ' 58' ' ' LEU . 47.0 pt -118.95 148.54 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.461 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.784 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -133.97 128.84 35.24 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.066 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.41 ' O ' ' O ' ' A' ' 56' ' ' VAL . 1.2 p -118.47 137.46 53.16 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -41.34 -35.86 0.72 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.256 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.416 ' O ' ' CG1' ' A' ' 56' ' ' VAL . 78.7 mmt-85 -70.02 -47.43 62.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.955 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.416 ' CG1' ' O ' ' A' ' 55' ' ' ARG . 16.3 m -160.6 -175.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.004 0.43 . . . . 0.0 111.049 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 t -116.6 142.39 46.95 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.551 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.401 ' O ' ' O ' ' A' ' 51' ' ' ILE . 63.6 tp -150.6 150.06 30.69 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.507 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.7 p -125.69 130.54 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 49' ' ' ILE . 94.3 mt -132.41 155.79 47.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.619 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -84.84 168.33 15.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.842 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -59.21 -43.42 92.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.532 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -59.22 -39.3 82.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.725 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -60.11 -45.7 92.07 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.453 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.54 -40.96 98.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.863 0.363 . . . . 0.0 110.15 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.99 -39.08 90.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.483 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.4 mt -82.08 -55.29 4.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.815 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 70.6 mt -46.74 132.88 11.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.398 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.407 ' O ' ' OG1' ' A' ' 12' ' ' THR . 96.8 mt-10 -76.27 108.87 9.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.5 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.36 161.58 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.634 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 31.0 tp10 -145.42 143.05 29.85 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.412 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.31 131.41 41.88 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 75' ' ' SER . 36.0 t -82.98 -80.65 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.409 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.6 t 41.49 16.8 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.261 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.554 ' N ' ' O ' ' A' ' 73' ' ' VAL . 37.3 t -156.03 146.18 21.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.001 0.429 . . . . 0.0 110.458 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.1 mt -103.04 16.29 27.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.527 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -62.12 -40.15 94.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.588 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.536 ' CG ' ' N ' ' A' ' 79' ' ' HIS . 51.4 t-80 44.51 -109.81 0.17 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.614 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.536 ' N ' ' CG ' ' A' ' 78' ' ' HIS . 74.5 m80 -146.73 -97.23 0.09 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.624 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.615 ' CD2' ' CD2' ' A' ' 81' ' ' HIS . 36.9 t60 -154.84 -67.23 0.13 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.494 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.615 ' CD2' ' CD2' ' A' ' 80' ' ' HIS . 60.2 m-70 -138.7 146.7 41.87 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.549 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.659 ' CG ' ' H ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -69.58 -75.51 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.67 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.659 ' H ' ' CG ' ' A' ' 82' ' ' HIS . 86.0 t60 . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.924 -1.036 . . . . 0.0 110.506 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 tpp . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.573 ' NE2' ' CZ ' ' A' ' 3' ' ' TYR . 0.7 OUTLIER -62.62 -51.71 66.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.68 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.573 ' CZ ' ' NE2' ' A' ' 2' ' ' GLN . 67.7 m-85 -89.8 134.83 33.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.699 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.9 151.5 78.32 Favored Pre-proline 0 N--CA 1.468 0.46 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 39' ' ' VAL . 43.3 Cg_endo -66.96 -33.68 31.83 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.659 2.24 . . . . 0.0 112.228 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -136.63 94.65 3.02 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.818 0.342 . . . . 0.0 110.995 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 t -140.4 148.19 40.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.246 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -96.02 102.07 13.82 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 19.2 m0 -99.34 137.46 37.82 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.25 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -93.41 130.29 39.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.863 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.6 mt -83.05 115.84 26.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.0 m -98.73 -43.72 6.68 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.849 0.357 . . . . 0.0 110.422 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.06 -179.79 31.7 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.8 p90 -95.89 147.67 23.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.855 0.359 . . . . 0.0 110.475 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 67' ' ' LEU . 5.7 m -78.47 172.93 12.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.517 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 85.6 mmt-85 -70.06 -40.35 75.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.607 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -65.72 -15.18 62.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.628 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.429 ' CG2' ' O ' ' A' ' 15' ' ' SER . 10.5 tp -41.58 148.43 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.636 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 92.6 p -83.05 144.83 48.08 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.713 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -50.17 -37.18 48.18 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.051 1.834 . . . . 0.0 112.692 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.24 -58.51 7.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.891 0.377 . . . . 0.0 111.414 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -64.33 -47.18 80.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.261 0.553 . . . . 0.0 110.681 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -57.56 -47.55 81.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.371 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 68.3 tp60 -60.18 -32.27 70.91 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -60.8 -44.36 96.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.895 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -62.25 -42.94 99.77 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.368 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.16 -39.9 96.0 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.743 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.1 t -60.71 -45.2 95.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.039 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 pp -92.74 133.94 35.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.502 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.7 -1.67 72.81 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 67.2 mtt -86.66 74.46 9.85 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -82.23 168.54 23.03 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.336 -179.096 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 32' ' ' LEU . 72.7 Cg_exo -43.4 177.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 122.451 2.101 . . . . 0.0 112.312 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.42 11.88 7.09 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 99.0 p -146.43 -161.94 1.42 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.845 0.355 . . . . 0.0 110.306 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.5 m -135.3 158.34 44.62 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.632 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -136.6 156.05 49.09 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.147 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -110.56 146.33 36.25 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.485 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.428 ' O ' ' O ' ' A' ' 5' ' ' PRO . 21.5 t -86.7 126.33 40.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.494 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 p -68.02 -41.21 84.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.95 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -174.74 160.56 2.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.083 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.4 t -133.31 118.23 30.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.2 110.39 48.02 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.474 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -76.4 -11.55 18.99 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.292 1.995 . . . . 0.0 112.271 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.0 mt -56.98 -30.45 64.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.686 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.98 21.98 0.68 Allowed Glycine 0 N--CA 1.465 0.609 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.16 159.81 30.46 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -60.55 173.9 1.86 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.761 2.307 . . . . 0.0 111.819 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 60' ' ' LEU . 8.0 mm -93.07 114.1 29.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.325 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -93.63 125.47 38.27 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.296 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.4 pt -127.1 150.25 32.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.571 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -127.07 137.97 53.13 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.356 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 56' ' ' VAL . 0.8 OUTLIER -131.53 137.95 48.71 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.9 ptt-85 -42.73 -44.65 4.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.793 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 76.2 mmt-85 -65.12 -42.08 94.27 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.675 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.604 ' CG2' ' H ' ' A' ' 57' ' ' SER . 11.1 p -169.46 179.43 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.239 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.604 ' H ' ' CG2' ' A' ' 56' ' ' VAL . 8.1 p -123.16 150.6 43.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.165 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.1 tt -159.68 162.82 35.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.395 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.1 p -122.14 132.49 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.096 0.474 . . . . 0.0 110.661 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 49' ' ' ILE . 51.5 mt -124.79 157.58 35.44 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.36 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -91.01 170.95 9.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.011 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -61.08 -44.37 97.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.201 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -62.42 -37.35 85.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.564 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -59.96 -46.0 90.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.447 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.31 -42.16 98.99 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.083 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.47 -49.44 77.34 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.2 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' OG ' ' A' ' 15' ' ' SER . 96.2 mt -69.71 -41.8 74.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.314 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.1 tp -63.12 134.19 55.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.27 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -83.24 115.01 21.77 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.227 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.1 m -134.04 155.34 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.554 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -141.15 142.45 34.06 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.675 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.74 145.73 46.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.255 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.9 t -104.1 128.93 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.231 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.0 t -148.12 -61.55 0.26 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.519 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.3 t -64.24 -31.9 73.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.571 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.1 tp 58.32 97.13 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.31 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -123.87 131.68 53.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.193 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -103.13 120.63 41.05 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.15 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -74.66 128.07 34.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.241 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -158.71 86.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.452 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 78.9 m80 50.07 86.64 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.635 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -82.01 130.51 35.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.5 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.473 -179.974 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.0 mtm . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.591 ' NE2' ' N ' ' A' ' 2' ' ' GLN . 3.7 mm-40 -66.61 -31.43 72.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.469 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 5.0 m-85 -77.5 101.09 6.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.966 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.447 ' OG1' ' OG1' ' A' ' 7' ' ' THR . 0.1 OUTLIER -117.68 158.46 45.35 Favored Pre-proline 0 N--CA 1.469 0.503 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -51.14 -38.73 61.05 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.996 1.798 . . . . 0.0 112.735 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -136.79 94.62 3.0 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.447 ' OG1' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -129.76 129.22 43.85 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.852 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.16 102.13 14.85 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 24.4 m0 -100.86 141.39 33.81 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.292 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -97.16 129.11 44.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.781 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.2 mt -80.62 122.56 36.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.061 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 6.2 p -109.12 -15.33 14.35 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.342 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.81 178.41 15.64 Favored Glycine 0 N--CA 1.466 0.686 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.5 p90 -99.36 153.36 19.04 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.583 ' HG ' ' N ' ' A' ' 16' ' ' ARG . 1.9 t -82.29 171.97 13.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.647 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.583 ' N ' ' HG ' ' A' ' 15' ' ' SER . 99.6 mtt180 -69.89 -40.67 75.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.835 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -66.19 -14.94 62.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.297 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.436 ' CG2' ' O ' ' A' ' 15' ' ' SER . 10.5 tp -41.06 147.33 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.729 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.76 155.23 87.09 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.521 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.12 -31.57 64.79 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.577 2.185 . . . . 0.0 112.016 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.66 -54.39 32.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.892 0.377 . . . . 0.0 111.129 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -62.62 -45.5 92.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.466 0.65 . . . . 0.0 110.34 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -57.64 -42.7 83.95 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.811 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 28' ' ' SER . 58.3 tp60 -61.77 -37.3 83.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.063 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.434 ' HZ2' ' CD1' ' A' ' 58' ' ' LEU . 54.8 mtpt -60.54 -43.25 97.39 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 120.081 -0.647 . . . . 0.0 110.025 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.43 -40.12 96.33 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.401 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.4 tt -80.3 -26.45 38.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.437 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.46 ' N ' ' O ' ' A' ' 24' ' ' GLN . 15.0 t -60.59 -45.53 93.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.336 -178.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.467 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -107.16 163.55 12.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.247 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.63 34.24 4.11 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.409 ' H ' HD11 ' A' ' 29' ' ' LEU . 94.7 mtp -108.71 73.92 0.89 Allowed 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 33' ' ' PRO . 3.3 mm? -81.59 154.55 71.18 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.142 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.471 ' O ' ' O ' ' A' ' 32' ' ' LEU . 77.3 Cg_exo -42.48 176.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 122.742 2.295 . . . . 0.0 112.537 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.24 12.05 7.11 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 95.7 p -136.94 -156.93 0.74 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.863 0.363 . . . . 0.0 110.268 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 97.3 p -146.61 161.36 40.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.459 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -138.05 155.09 49.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.29 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 27.4 p30 -109.85 152.35 25.87 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.534 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.6 t -92.96 125.26 45.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.503 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.7 p -67.14 -41.69 87.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.026 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.607 ' NH2' ' ND1' ' A' ' 50' ' ' HIS . 37.7 ptt-85 -172.12 157.2 4.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.252 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.6 t -126.33 120.21 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.22 110.56 49.08 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.355 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -76.53 -12.24 18.62 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.008 1.805 . . . . 0.0 112.213 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.1 tp -57.63 -31.29 66.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.873 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.87 25.97 0.8 Allowed Glycine 0 N--CA 1.464 0.532 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.2 159.69 30.7 Favored Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -56.56 175.7 0.26 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.838 2.359 . . . . 0.0 111.764 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.473 ' N ' ' O ' ' A' ' 60' ' ' LEU . 7.2 mm -92.5 114.21 29.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.936 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.607 ' ND1' ' NH2' ' A' ' 41' ' ' ARG . 15.8 m170 -94.32 119.91 33.78 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.872 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 58' ' ' LEU . 48.2 pt -126.11 149.87 31.26 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.221 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 12.5 tm-20 -132.68 130.11 39.67 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.188 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.4 p -116.06 137.14 52.38 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.701 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -39.08 -36.76 0.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.818 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.422 ' O ' ' CG1' ' A' ' 56' ' ' VAL . 32.9 mmt180 -71.11 -49.05 48.45 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.147 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.422 ' CG1' ' O ' ' A' ' 55' ' ' ARG . 15.2 m -160.81 -176.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.95 0.405 . . . . 0.0 110.501 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 m -109.06 148.18 31.2 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.741 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.434 ' CD1' ' HZ2' ' A' ' 25' ' ' LYS . 63.0 tp -152.61 149.16 28.17 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.4 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 p -128.84 129.76 68.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.624 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.473 ' O ' ' N ' ' A' ' 49' ' ' ILE . 76.3 mt -133.59 163.8 28.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.325 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -93.66 164.23 13.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.492 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -55.91 -39.09 71.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.035 0.445 . . . . 0.0 110.288 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -62.0 -40.94 97.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.729 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -60.43 -43.86 96.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.151 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.64 -42.22 99.48 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.31 -50.32 74.04 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.243 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.3 mt -68.79 -41.1 79.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.2 tp -65.1 131.22 45.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.107 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.444 ' O ' ' OG1' ' A' ' 12' ' ' THR . 94.3 mt-10 -78.19 115.29 17.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.181 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.4 160.2 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.419 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -141.0 132.34 26.69 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.156 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.31 135.33 54.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.884 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 85.0 t -93.98 128.29 45.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.176 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.4 m -142.42 -19.97 0.69 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.492 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 70.7 m -70.82 145.36 50.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.428 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.3 tp -159.75 100.13 1.43 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.169 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -140.52 154.53 46.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.268 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -132.69 140.17 48.0 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.38 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.456 ' H ' ' CD2' ' A' ' 79' ' ' HIS . 9.4 p80 -97.86 92.58 5.9 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.491 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -97.34 -13.24 22.02 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.615 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -92.3 123.82 35.91 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.431 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -79.73 130.69 35.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.439 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 85.3 t60 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.538 179.957 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 tpt . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.455 ' CD ' ' CE2' ' A' ' 3' ' ' TYR . 10.3 tt0 -74.1 -90.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.773 -179.692 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.455 ' CE2' ' CD ' ' A' ' 2' ' ' GLN . 94.3 m-85 -84.51 90.76 7.7 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.586 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.459 ' OG1' ' OG1' ' A' ' 7' ' ' THR . 1.0 OUTLIER -123.22 154.92 65.41 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.47 -179.312 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' A' ' 39' ' ' VAL . 51.8 Cg_exo -51.18 -36.51 56.11 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.075 1.85 . . . . 0.0 112.793 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -131.98 98.64 4.5 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.748 0.308 . . . . 0.0 110.371 -179.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.459 ' OG1' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -136.55 129.71 31.31 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.992 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -88.47 102.1 14.57 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 22.4 m0 -105.13 144.39 31.99 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.118 -179.092 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -100.46 132.05 46.05 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.185 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 34.2 mt -82.03 120.54 33.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.5 m -102.39 -40.49 6.7 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.374 179.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 161.14 175.34 32.06 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -96.47 143.55 27.39 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.48 ' OG ' ' O ' ' A' ' 67' ' ' LEU . 3.6 m -72.0 167.01 21.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.677 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -66.49 -39.02 88.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.333 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.98 -17.61 64.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.812 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.455 ' CG2' ' O ' ' A' ' 15' ' ' SER . 10.6 tp -41.88 146.36 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.398 -179.399 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.0 p -81.9 147.98 59.71 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.561 -179.324 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -49.85 -41.97 45.64 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.848 1.699 . . . . 0.0 112.644 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.95 -57.87 7.46 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.158 -178.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -63.23 -44.41 95.32 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.469 0.652 . . . . 0.0 110.734 -179.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -57.8 -46.09 85.14 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.989 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 28' ' ' SER . 78.0 mt-30 -64.59 -31.98 73.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.752 179.205 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.6 mmtt -59.77 -42.64 93.76 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 119.891 -0.723 . . . . 0.0 109.241 179.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.51 -41.29 96.51 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.794 178.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 45.0 mt -79.68 -16.12 56.3 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.895 0.379 . . . . 0.0 110.945 -179.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 24' ' ' GLN . 37.2 t -59.45 -41.56 89.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.035 -179.045 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.553 ' CD2' ' H ' ' A' ' 29' ' ' LEU . 0.6 OUTLIER -124.16 -171.16 2.27 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.948 -179.498 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.13 43.2 2.04 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -179.334 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 64.1 mtt -120.12 71.98 0.92 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.485 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.1 mm? -82.98 152.05 64.88 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.333 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 32' ' ' LEU . 77.2 Cg_exo -41.88 171.6 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.586 2.191 . . . . 0.0 112.366 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.51 -12.94 18.47 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 179.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.2 m -96.11 -156.68 0.54 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.893 0.378 . . . . 0.0 110.347 179.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.7 p -150.37 160.57 43.64 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.447 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -146.21 165.96 27.63 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.507 -179.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -126.13 143.88 50.96 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.267 0.556 . . . . 0.0 110.57 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.443 ' O ' ' O ' ' A' ' 5' ' ' PRO . 61.5 t -78.54 128.97 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.219 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.9 p -76.1 -40.44 37.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.09 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -173.16 160.95 4.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.097 -179.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 55.2 t -126.25 131.19 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -92.82 111.29 50.54 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-O 119.451 -0.309 . . . . 0.0 110.321 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.29 -13.11 18.94 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.923 1.748 . . . . 0.0 112.056 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.1 tp -61.98 -32.08 72.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.646 -179.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 127.79 30.01 0.78 Allowed Glycine 0 N--CA 1.464 0.542 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.89 173.29 4.08 Favored Pre-proline 0 CA--C 1.534 0.327 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -179.35 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -61.46 -170.94 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.141 1.894 . . . . 0.0 111.503 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 60' ' ' LEU . 10.4 mm -108.17 114.48 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -88.45 124.5 34.03 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.285 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.2 pt -129.21 144.25 38.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.397 179.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -124.17 114.34 19.51 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.125 179.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.527 ' HG1' ' H ' ' A' ' 56' ' ' VAL . 0.7 OUTLIER -105.83 137.82 43.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.895 -179.585 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -41.43 -42.42 2.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.474 -179.503 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -67.12 -44.6 79.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.718 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.527 ' H ' ' HG1' ' A' ' 53' ' ' THR . 14.8 p -170.28 172.85 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.499 -179.71 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.512 ' H ' ' CG2' ' A' ' 56' ' ' VAL . 94.2 p -111.52 153.8 25.68 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.561 179.409 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.2 tt -161.35 159.66 28.66 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.585 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.9 p -114.96 130.45 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.824 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' A' ' 49' ' ' ILE . 1.3 tp -133.53 152.34 51.89 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.035 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -82.63 161.64 22.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.626 -179.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.1 -45.94 91.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.644 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.69 -40.4 87.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.853 -179.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.46 -40.32 96.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.262 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.3 mp -61.64 -44.47 96.92 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.62 -42.45 98.9 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.28 -179.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.48 ' O ' ' OG ' ' A' ' 15' ' ' SER . 94.2 mt -68.02 -41.13 82.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.669 179.698 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.1 tp -64.95 131.03 45.54 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.066 -179.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -74.76 114.47 13.24 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.154 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.9 m -132.57 158.19 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.647 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -143.55 135.69 26.81 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.694 -179.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.37 129.29 37.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.345 179.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 75' ' ' SER . 15.3 t -76.78 -76.9 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.854 -179.739 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.2 p 39.71 22.55 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 73' ' ' VAL . 48.0 p -154.98 156.09 35.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.544 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.2 mt -120.43 19.96 11.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.454 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -48.03 -75.22 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.403 -179.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 44.94 -162.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.535 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.2 t60 49.34 92.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.669 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -78.11 147.61 34.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.518 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -61.01 -41.89 97.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.643 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -83.49 128.17 34.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.513 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 78.9 m80 . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.565 179.982 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mtp . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -64.94 -41.46 95.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.769 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -70.53 136.2 49.16 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -179.34 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.417 ' OG1' ' OG1' ' A' ' 7' ' ' THR . 0.1 OUTLIER -139.18 155.71 72.4 Favored Pre-proline 0 N--CA 1.466 0.325 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.154 -179.44 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 39' ' ' VAL . 40.9 Cg_endo -66.43 -22.1 52.63 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.653 2.235 . . . . 0.0 112.192 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.43 ' C ' ' HG1' ' A' ' 7' ' ' THR . 37.0 t70 -137.11 93.4 2.82 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.709 0.29 . . . . 0.0 110.325 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.43 ' HG1' ' C ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -139.92 130.71 25.94 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.995 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.12 102.46 15.0 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 18.3 m0 -102.22 140.63 36.24 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.884 0.373 . . . . 0.0 110.17 -179.211 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -98.15 128.51 44.68 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.536 179.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.7 mt -81.85 124.49 39.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.232 -179.302 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -109.35 -44.06 3.99 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.49 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.32 -176.68 39.47 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -100.63 150.15 23.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.854 0.359 . . . . 0.0 110.479 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.3 t -78.24 169.86 17.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.564 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -69.74 -39.24 76.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.925 0.393 . . . . 0.0 110.784 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -66.83 -14.94 63.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.451 -179.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.5 tp -40.63 146.86 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.545 -179.473 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.9 m -79.5 143.84 60.25 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.507 -179.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -47.99 -41.06 33.41 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.917 1.745 . . . . 0.0 112.663 179.209 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.13 -55.99 19.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.86 0.362 . . . . 0.0 111.492 -178.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -63.24 -47.26 83.2 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.476 0.655 . . . . 0.0 110.623 -179.592 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -56.78 -44.87 82.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.999 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -60.43 -35.81 76.69 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.024 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -56.73 -46.71 81.16 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 29' ' ' LEU . 4.5 mm? -63.05 -43.44 98.63 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.506 179.488 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.58 -31.3 68.26 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.721 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.0 t -58.94 -45.03 91.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.228 -179.163 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -119.22 174.84 6.1 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.39 -179.697 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -90.67 0.16 76.57 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 46.3 tpp -66.85 73.7 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.5 mp -99.59 169.47 8.05 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.369 -179.041 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 32' ' ' LEU . 61.7 Cg_exo -49.96 -166.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.242 1.961 . . . . 0.0 112.256 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.94 4.98 51.04 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.1 m -140.65 -169.92 2.9 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.925 0.393 . . . . 0.0 110.259 179.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.2 p -134.04 158.74 42.8 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.194 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -137.72 163.87 30.25 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.218 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.491 ' OD1' ' N ' ' A' ' 38' ' ' ASN . 12.1 p-10 -121.66 150.28 41.98 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.314 0.578 . . . . 0.0 110.387 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.438 ' O ' ' O ' ' A' ' 5' ' ' PRO . 14.8 t -85.41 128.73 38.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.504 -179.651 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 p -68.95 -40.93 81.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.248 179.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -174.85 167.27 3.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.994 -179.198 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.6 m -133.51 125.1 49.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.084 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.76 111.21 51.76 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.582 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -76.24 -11.91 19.21 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.051 1.834 . . . . 0.0 112.311 179.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.419 ' N ' ' CD1' ' A' ' 45' ' ' LEU . 10.6 mp -61.52 -32.23 72.27 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.809 -178.882 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.2 26.48 0.82 Allowed Glycine 0 N--CA 1.466 0.669 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.27 160.32 29.18 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -55.71 173.72 0.35 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.698 2.265 . . . . 0.0 111.855 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.4 mm -92.84 118.0 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.771 -179.376 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -97.02 123.7 40.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.03 179.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.412 HD13 HG23 ' A' ' 51' ' ' ILE . 33.8 pt -127.33 148.88 32.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.719 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 97.0 mt-10 -134.95 112.16 10.4 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.094 179.593 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.425 ' O ' ' C ' ' A' ' 54' ' ' ARG . 1.2 p -85.52 173.93 9.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.889 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 53' ' ' THR . 99.9 mtt180 -33.55 -52.95 0.41 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.708 -178.186 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 57.4 ttp85 -142.93 32.29 1.4 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.016 179.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -140.62 136.98 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.489 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.6 t -113.7 130.47 56.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.237 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.9 tp -145.62 148.09 32.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.111 -179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.8 p -136.4 123.6 32.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.32 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.4 mt -140.68 173.16 11.76 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.443 -179.513 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.9 mtm-85 -84.05 163.31 19.96 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.922 0.391 . . . . 0.0 110.91 -179.519 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -58.73 -34.37 71.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.517 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -60.6 -40.25 91.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.546 179.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -61.56 -43.84 98.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.512 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 mp -61.58 -42.12 98.4 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.79 -44.24 97.26 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.326 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.6 mt -68.75 -41.19 79.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.042 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 63.7 mt -64.06 137.64 58.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.875 0.369 . . . . 0.0 110.611 -179.477 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -79.39 108.58 13.02 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.215 -179.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.4 m -134.95 156.54 39.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.479 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -138.92 128.06 23.97 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.595 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.1 134.58 48.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.095 179.675 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.8 m -120.45 131.11 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 121.029 0.443 . . . . 0.0 110.348 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.8 t -83.81 -42.6 16.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.6 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.7 p -156.07 132.26 10.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.45 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 77' ' ' GLU . 10.6 mp -63.18 -41.99 99.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.327 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 76' ' ' LEU . 45.2 tp10 49.64 100.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.254 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -153.4 154.24 34.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.573 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -168.57 83.67 0.16 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.548 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 51.1 p-80 -153.46 166.66 32.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.547 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.449 ' ND1' ' N ' ' A' ' 83' ' ' HIS . 57.9 t-80 -145.48 138.44 26.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.419 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -59.65 -43.41 93.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.63 -179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.449 ' N ' ' ND1' ' A' ' 81' ' ' HIS . 99.1 m-70 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.389 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -62.8 -43.63 98.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.644 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -75.34 90.51 2.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.152 -179.62 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.07 154.44 40.63 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.424 -179.101 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 39' ' ' VAL . 41.2 Cg_endo -67.33 -37.42 17.89 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.672 2.248 . . . . 0.0 112.243 179.733 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -136.56 95.95 3.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.626 -179.596 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -140.07 147.76 40.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.383 179.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -97.25 101.8 13.43 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.632 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 28.7 m0 -98.02 142.95 29.1 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.341 -179.34 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -99.78 131.37 45.8 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.881 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.0 mt -80.98 125.58 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.467 -179.386 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.4 m -104.93 -51.95 2.95 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.475 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 168.14 167.78 29.29 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.0 OUTLIER -87.7 148.26 24.85 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 179.616 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.468 ' O ' ' CG2' ' A' ' 18' ' ' ILE . 43.7 t -80.68 171.05 15.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.659 179.874 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -67.16 -38.85 86.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.343 179.673 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -65.4 -18.31 65.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.689 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.468 ' CG2' ' O ' ' A' ' 15' ' ' SER . 10.8 tp -41.91 147.27 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.822 -179.698 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.58 158.19 81.37 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.28 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.88 -32.39 45.62 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.663 2.242 . . . . 0.0 111.958 179.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.15 -57.42 11.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.018 0.437 . . . . 0.0 110.979 -179.465 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -61.27 -45.29 95.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.603 0.716 . . . . 0.0 110.322 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -56.51 -42.86 79.08 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.192 -179.65 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 28' ' ' SER . 62.8 mt-30 -62.15 -37.2 84.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.414 179.41 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -58.81 -43.34 90.58 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.811 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.68 -41.71 95.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.262 0.553 . . . . 0.0 110.575 179.638 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.4 tt -78.73 -26.21 44.67 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.19 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 24' ' ' GLN . 14.4 t -61.19 -45.18 95.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.273 -178.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.504 HD13 ' H ' ' A' ' 31' ' ' MET . 0.3 OUTLIER -112.03 169.27 8.97 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.237 -179.742 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.05 40.76 2.95 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.571 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.549 ' SD ' ' CZ ' ' A' ' 55' ' ' ARG . 38.0 ttp -108.82 72.11 0.81 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.188 0.518 . . . . 0.0 109.793 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.506 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.2 mm? -82.74 151.88 65.31 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.566 -179.276 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 32' ' ' LEU . 73.9 Cg_exo -41.96 175.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 122.49 2.126 . . . . 0.0 112.009 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.5 -21.22 9.27 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.783 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.8 m -97.63 -174.43 2.9 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.8 m -133.6 151.68 51.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.332 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -133.17 155.04 50.02 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.109 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -109.05 145.0 36.33 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.318 0.58 . . . . 0.0 110.713 -179.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.446 ' O ' ' O ' ' A' ' 5' ' ' PRO . 48.8 t -89.45 125.05 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.18 -179.908 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 p -69.11 -40.44 80.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.965 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.2 ptt-85 -176.82 166.84 2.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.006 -178.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.9 m -132.67 122.31 46.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.031 179.299 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.89 111.98 56.47 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.577 ' C ' ' H ' ' A' ' 46' ' ' GLY . 59.2 Cg_endo -75.75 -11.98 20.12 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.642 2.228 . . . . 0.0 112.013 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.9 mt -61.83 4.91 0.1 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.955 -179.191 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.577 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 91.07 24.98 25.66 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.42 160.07 30.46 Favored Pre-proline 0 C--N 1.332 -0.176 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.62 168.01 4.55 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.809 2.339 . . . . 0.0 111.749 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 60' ' ' LEU . 5.9 mm -90.12 118.23 34.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.097 0.475 . . . . 0.0 110.074 -179.362 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -96.72 121.52 38.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.064 179.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.1 pt -123.84 147.73 28.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.141 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -129.85 135.27 48.19 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.471 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.753 ' HG1' ' H ' ' A' ' 56' ' ' VAL . 1.7 p -123.94 143.57 50.3 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.911 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -54.27 -18.32 3.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.771 -178.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.549 ' CZ ' ' SD ' ' A' ' 31' ' ' MET . 16.8 ptm180 -97.97 -31.31 12.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.891 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.753 ' H ' ' HG1' ' A' ' 53' ' ' THR . 4.2 p -170.22 179.37 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.969 0.414 . . . . 0.0 110.393 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.445 ' H ' HG21 ' A' ' 56' ' ' VAL . 54.3 m -124.25 155.91 37.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.478 178.711 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.4 tp -158.66 151.71 22.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.292 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 p -135.82 126.68 43.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.025 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 49' ' ' ILE . 35.8 mt -131.56 161.8 31.78 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.505 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -78.23 150.86 33.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.569 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -44.71 -47.22 10.66 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.279 0.561 . . . . 0.0 110.857 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -52.96 -34.63 56.58 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.263 -179.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -63.6 -40.78 97.8 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.348 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.513 ' CD2' ' N ' ' A' ' 65' ' ' LEU . 4.0 mm? -63.33 -43.21 98.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.076 -179.285 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.84 -47.25 85.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.207 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.8 mt -68.31 -41.81 80.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.567 179.77 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 49.7 tp -64.63 131.47 47.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.26 -179.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -81.55 114.32 20.18 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.441 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.4 m -130.98 156.42 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.335 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -137.39 125.55 23.04 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.444 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.03 138.98 52.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.281 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.0 t -97.99 129.21 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 120.886 0.374 . . . . 0.0 110.285 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.2 m -162.62 9.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.55 -179.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.1 m -73.73 151.89 40.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.394 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.438 ' C ' ' N ' ' A' ' 78' ' ' HIS . 0.3 OUTLIER -90.38 23.76 2.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.224 -179.618 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -47.15 -17.52 0.06 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.641 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.438 ' N ' ' C ' ' A' ' 76' ' ' LEU . 79.5 m80 -70.27 139.18 52.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.334 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -150.77 166.96 28.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.261 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -105.0 148.7 26.44 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.43 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -64.44 -39.34 93.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.422 -179.701 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -137.28 143.86 42.38 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.498 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.559 -179.886 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.3 mtt . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -65.0 -44.42 89.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.834 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -105.12 133.64 49.57 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 p -128.45 152.17 77.84 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.491 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.57 -40.82 54.66 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.944 1.763 . . . . 0.0 112.765 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -135.24 101.22 4.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.021 0.439 . . . . 0.0 111.036 -179.297 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.407 ' OG1' ' CD1' ' A' ' 9' ' ' TRP . 0.9 OUTLIER -137.86 142.8 40.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.393 179.143 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.66 102.21 14.38 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.565 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.407 ' CD1' ' OG1' ' A' ' 7' ' ' THR . 18.9 m0 -100.65 137.04 39.58 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.394 -179.254 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -91.57 143.89 26.11 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.768 179.515 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.5 mt -97.2 117.01 41.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.316 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.9 m -101.7 -47.04 4.75 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.597 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 162.16 176.63 34.44 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.4 p90 -92.11 148.4 22.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.219 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.442 ' OG ' ' N ' ' A' ' 16' ' ' ARG . 1.9 t -75.89 172.18 13.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.528 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.442 ' N ' ' OG ' ' A' ' 15' ' ' SER . 35.8 ptt-85 -71.54 -37.13 71.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.665 179.712 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -69.67 -13.84 62.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.327 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.6 tp -41.35 149.44 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.516 -179.566 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.4 p -79.21 140.65 57.05 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.522 -179.541 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -47.44 -40.95 29.46 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 121.941 1.761 . . . . 0.0 112.703 179.061 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.98 -56.71 16.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.903 0.383 . . . . 0.0 111.19 -178.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -61.7 -44.35 97.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.285 0.564 . . . . 0.0 110.484 -179.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -58.62 -43.19 89.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.935 -179.386 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -62.81 -37.07 85.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.977 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -58.4 -47.35 84.17 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -63.21 -38.98 93.31 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.098 179.627 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.6 tp -60.34 -44.26 95.67 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.108 -179.39 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.5 m -75.97 -33.15 59.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.805 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.4 tp -71.34 129.47 38.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.259 -179.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.63 2.49 87.26 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 24.0 tpp -109.39 75.78 0.97 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.068 0.461 . . . . 0.0 109.854 179.484 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.2 mp -79.42 165.82 45.68 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.858 -179.213 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.479 ' O ' ' O ' ' A' ' 32' ' ' LEU . 71.4 Cg_exo -40.34 172.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.578 2.185 . . . . 0.0 112.393 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.42 8.64 9.09 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 t -137.2 -157.52 0.78 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.903 0.382 . . . . 0.0 110.207 179.563 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.9 m -145.33 157.96 43.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.445 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -139.35 153.75 47.74 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.378 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -107.06 147.95 29.35 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.342 0.591 . . . . 0.0 110.682 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.6 t -88.12 126.49 41.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.241 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 p -64.66 -39.9 87.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.891 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -174.08 161.13 3.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.096 -179.474 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 55.8 t -126.39 125.23 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.02 111.69 54.13 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.43 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.67 -11.99 20.26 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.202 1.934 . . . . 0.0 112.0 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.8 tp -58.68 -31.55 68.32 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.832 -178.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.71 32.98 1.13 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -100.24 179.45 1.02 Allowed Pre-proline 0 N--CA 1.466 0.343 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.463 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 47' ' ' ASP . 24.0 Cg_exo -62.7 -178.19 0.37 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.36 2.04 . . . . 0.0 111.71 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.3 mm -107.87 119.9 58.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.449 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -102.31 123.09 45.49 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.816 179.644 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.8 pt -127.81 152.13 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.054 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -123.52 135.61 54.12 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.08 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 56' ' ' VAL . 1.4 p -131.45 140.88 49.7 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -38.85 -37.3 0.33 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.565 -179.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.3 ttp85 -75.34 -49.4 19.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.777 179.608 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.607 ' CG2' ' H ' ' A' ' 57' ' ' SER . 10.2 p -171.73 -179.59 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.621 -179.564 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.607 ' H ' ' CG2' ' A' ' 56' ' ' VAL . 1.7 t -107.72 164.08 12.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.13 178.724 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.8 tp -149.15 146.31 27.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.205 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.4 t -127.9 124.41 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.79 178.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.6 mt -144.55 167.32 22.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.71 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -81.94 147.91 29.0 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.036 0.446 . . . . 0.0 111.424 -179.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -42.2 -40.99 2.56 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.701 -179.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -55.44 -38.81 69.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.547 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -61.75 -41.01 97.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.431 179.869 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.527 ' CD2' ' N ' ' A' ' 65' ' ' LEU . 3.3 mm? -62.84 -42.14 99.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.972 -179.301 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.65 98.13 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.048 179.608 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.36 -41.96 79.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.035 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.0 mt -68.36 135.71 52.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.861 0.362 . . . . 0.0 110.222 -179.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -81.31 111.35 17.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.283 -179.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.4 m -130.97 156.36 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.632 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -144.07 146.82 33.08 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.907 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.65 143.0 56.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.105 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.9 t -98.7 130.28 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.343 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.1 p -149.49 -66.08 0.22 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.463 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 66.6 m -87.12 143.55 27.26 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.542 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.9 tt -62.75 -46.18 89.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.875 0.369 . . . . 0.0 110.128 -179.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 51.71 95.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.286 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -80.31 155.32 27.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.331 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -133.1 140.69 47.79 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.512 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -142.09 150.97 41.89 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.508 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -78.71 141.28 38.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.498 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -65.8 -40.08 91.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.517 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.613 -179.971 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.9 mtm . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -64.18 -43.98 93.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.559 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -70.09 137.43 51.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.045 -179.467 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.01 156.91 70.23 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.092 -179.371 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -67.73 -50.25 0.93 Allowed 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.708 2.272 . . . . 0.0 112.196 -179.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -129.06 97.58 4.66 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.81 -179.599 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.479 ' HG1' ' N ' ' A' ' 8' ' ' ALA . 1.9 t -139.49 151.87 46.52 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.273 179.485 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.479 ' N ' ' HG1' ' A' ' 7' ' ' THR . . . -101.61 102.73 13.48 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.126 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -99.53 133.8 43.33 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.889 0.376 . . . . 0.0 110.152 -179.104 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -92.18 133.49 35.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.98 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.3 mt -85.34 123.31 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.303 -179.242 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.8 m -106.33 -47.74 3.73 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.874 0.369 . . . . 0.0 110.563 179.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 164.79 170.73 30.14 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.8 p90 -89.91 146.04 24.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.874 0.369 . . . . 0.0 110.412 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 67' ' ' LEU . 3.8 m -74.63 170.1 16.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.537 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -69.13 -37.74 78.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.481 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -72.06 -10.01 59.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.543 -179.581 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.8 tp -41.5 146.99 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.517 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.04 153.92 95.01 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.325 -179.586 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.14 -33.16 62.17 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.382 2.055 . . . . 0.0 112.117 -179.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.29 -55.29 22.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.827 0.346 . . . . 0.0 111.278 -179.42 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.406 ' CE1' ' CD2' ' A' ' 26' ' ' LEU . 31.5 t80 -61.64 -42.3 98.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.569 0.7 . . . . 0.0 110.338 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 68.5 ttp85 -58.07 -44.11 87.35 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.838 179.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 28' ' ' SER . 73.2 mt-30 -62.41 -36.3 81.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.252 179.115 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.414 ' O ' ' CD1' ' A' ' 29' ' ' LEU . 26.7 mmtp -59.27 -45.65 90.67 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.954 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 29' ' ' LEU . 4.6 mm? -63.62 -43.5 96.68 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.519 179.027 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 tt -70.71 -33.77 71.22 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.28 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 24' ' ' GLN . 74.8 m -58.86 -43.61 90.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.293 -178.729 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.416 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -119.72 176.92 5.16 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.475 -179.559 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -90.51 -2.96 72.33 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.552 ' CE ' ' HE ' ' A' ' 55' ' ' ARG . 35.4 tpp -61.89 73.85 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.783 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 30' ' ' GLY . 1.6 mp -101.12 169.9 7.21 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.34 -179.058 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.479 ' O ' ' O ' ' A' ' 32' ' ' LEU . 57.3 Cg_exo -50.19 -160.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.381 2.054 . . . . 0.0 112.584 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.22 10.66 59.35 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.1 t -142.41 -156.53 0.69 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.755 0.312 . . . . 0.0 110.376 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.3 p -151.86 164.02 37.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.591 -179.782 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -143.62 162.09 36.83 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.552 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 38' ' ' ASN . 7.9 p-10 -114.18 147.95 38.08 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.258 0.551 . . . . 0.0 110.84 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.8 t -88.7 123.11 40.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.234 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 p -66.47 -41.61 88.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.209 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -174.17 166.78 4.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.913 -179.453 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.6 m -128.72 130.12 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.0 110.95 49.21 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.545 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -76.65 -13.21 18.16 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.922 1.748 . . . . 0.0 112.392 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.3 mt -62.45 -30.99 71.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.768 -178.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.52 28.69 0.96 Allowed Glycine 0 N--CA 1.466 0.698 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.94 163.93 18.42 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.87 -173.8 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.913 1.742 . . . . 0.0 111.902 179.431 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.2 mm -103.07 115.08 44.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.775 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -92.02 119.1 31.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.174 -0.467 . . . . 0.0 109.779 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.6 pt -125.06 146.88 29.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.274 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.415 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 93.6 mt-10 -127.38 128.41 45.8 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.464 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 56' ' ' VAL . 0.8 OUTLIER -119.69 138.26 53.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.562 179.991 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.6 mmm-85 -45.25 -38.29 5.38 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.382 -179.342 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.552 ' HE ' ' CE ' ' A' ' 31' ' ' MET . 74.6 mtp85 -69.95 -43.38 71.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.849 179.679 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.483 ' CG2' ' H ' ' A' ' 57' ' ' SER . 14.7 p -170.38 171.11 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-O 120.93 0.395 . . . . 0.0 110.648 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.483 ' H ' ' CG2' ' A' ' 56' ' ' VAL . 28.4 t -98.62 161.08 13.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.7 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 64.8 tp -163.56 149.25 11.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.11 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.3 p -134.48 127.81 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.4 mp -133.33 155.82 48.74 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.399 -179.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.445 ' O ' ' N ' ' A' ' 64' ' ' ASP . 95.3 mtm-85 -78.4 143.92 36.36 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.123 179.91 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -39.5 -43.4 1.26 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.479 -179.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -58.54 -41.83 86.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.353 179.821 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 61' ' ' ARG . 97.3 m-20 -62.75 -40.17 96.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.354 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.429 ' N ' ' CD2' ' A' ' 65' ' ' LEU . 4.2 mm? -61.28 -42.38 98.55 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.3 -40.17 96.6 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.15 179.585 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.454 ' O ' ' OG ' ' A' ' 15' ' ' SER . 96.8 mt -67.32 -41.36 85.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.196 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.5 mt -71.05 141.38 50.91 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.618 -179.733 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -84.19 103.42 13.38 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.093 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.8 m -122.85 154.8 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.279 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.531 ' N ' ' OE1' ' A' ' 71' ' ' GLU . 56.6 mp0 -142.57 125.6 16.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.575 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.03 132.35 48.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.911 179.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.7 m -133.9 159.66 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.362 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 28.9 t -82.49 -68.85 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.628 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 45.0 t -73.64 137.59 44.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.467 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.2 -4.57 14.35 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.153 -179.861 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -58.42 146.65 34.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.62 -179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -79.24 114.67 18.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.388 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -66.25 -42.83 88.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.65 -179.905 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -83.97 121.28 27.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.408 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -66.54 -40.4 89.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.575 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -71.36 144.04 50.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.553 -179.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 60.9 m170 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.576 -179.889 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 3' ' ' TYR . 80.1 mmm . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 51.84 -86.85 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.708 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.496 ' N ' ' O ' ' A' ' 1' ' ' MET . 65.9 m-85 -79.73 99.32 7.38 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.808 -179.626 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.448 ' OG1' ' OG1' ' A' ' 7' ' ' THR . 0.6 OUTLIER -106.31 156.99 35.97 Favored Pre-proline 0 N--CA 1.464 0.262 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.559 -179.448 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 39' ' ' VAL . 51.3 Cg_exo -50.95 -38.64 58.96 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.164 1.909 . . . . 0.0 112.616 179.358 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -136.8 95.82 3.2 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -179.546 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.448 ' OG1' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -126.75 129.21 47.93 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.84 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.21 101.55 13.13 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.235 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -102.29 148.06 25.91 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.333 -179.101 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -100.39 128.9 46.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.761 179.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.456 ' CD1' ' NH2' ' A' ' 55' ' ' ARG . 32.3 mt -83.85 122.53 37.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.24 -179.47 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.3 m -108.31 -46.17 3.77 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.87 0.367 . . . . 0.0 110.502 179.796 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.6 -179.44 39.95 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.87 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -90.57 160.09 16.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 0.0 110.435 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.8 t -82.25 169.21 16.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.614 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -69.74 -38.5 76.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.531 179.377 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -74.0 -6.59 48.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.881 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.0 tp -42.55 147.04 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.524 -179.532 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.9 p -82.73 149.19 59.67 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.754 -179.563 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.11 -38.81 50.99 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 122.303 2.002 . . . . 0.0 112.554 178.913 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.43 -57.11 13.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.859 0.361 . . . . 0.0 111.153 -179.081 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -63.58 -49.08 74.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.287 0.565 . . . . 0.0 110.578 -179.841 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -57.0 -43.86 82.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.237 -179.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -63.2 -33.11 74.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.755 179.293 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -59.76 -49.01 79.38 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.543 -0.463 . . . . 0.0 109.941 179.668 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.87 -38.94 92.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.278 179.593 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.4 tp -60.55 -41.13 93.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.335 -179.353 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.3 m -83.65 -11.78 56.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.897 -179.398 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.5 tp -97.27 123.25 41.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.888 0.375 . . . . 0.0 110.261 -179.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.27 3.81 61.12 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 66.7 mtt -108.48 75.83 1.0 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.21 0.529 . . . . 0.0 109.803 179.575 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.503 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.9 OUTLIER -78.51 167.9 31.58 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.093 -178.942 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.503 ' O ' ' O ' ' A' ' 32' ' ' LEU . 72.9 Cg_exo -42.2 177.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.509 2.139 . . . . 0.0 112.416 -179.551 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.74 11.06 7.33 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 179.784 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.9 m -143.5 -169.54 3.09 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.736 0.303 . . . . 0.0 110.37 179.587 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.45 ' O ' ' NH1' ' A' ' 54' ' ' ARG . 69.0 m -131.41 157.42 43.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.449 -179.74 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -133.52 157.72 44.95 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.212 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -112.93 147.16 37.66 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.447 -179.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 5' ' ' PRO . 14.5 t -85.27 127.03 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.171 179.867 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 p -68.26 -40.11 82.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.839 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -173.98 157.35 2.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.14 -179.072 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 73.8 t -131.82 105.93 10.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.72 111.4 52.47 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.525 -179.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.89 -9.2 19.47 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.952 2.435 . . . . 0.0 112.275 -179.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 51.8 mt -50.73 -29.62 11.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.733 -178.149 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 132.29 20.55 1.01 Allowed Glycine 0 N--CA 1.467 0.723 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.362 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -97.4 160.89 27.75 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.647 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -60.17 175.31 1.08 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.749 2.3 . . . . 0.0 111.671 179.708 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.7 mm -94.55 115.73 34.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.185 -179.593 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -96.13 122.65 39.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.077 179.59 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.6 pt -128.37 147.26 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.361 179.71 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -122.87 121.03 35.23 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.019 179.635 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 55' ' ' ARG . 1.4 p -108.74 135.85 49.29 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.45 ' NH1' ' O ' ' A' ' 36' ' ' SER . 8.1 ptp85 -43.13 -18.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.62 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.516 ' N ' ' O ' ' A' ' 53' ' ' THR . 88.5 mtm180 -87.36 -51.38 5.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.967 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.446 ' CG1' ' O ' ' A' ' 55' ' ' ARG . 13.2 m -162.25 177.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.652 -179.547 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.3 p -97.63 143.14 28.61 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.337 179.539 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.1 tp -147.49 144.33 28.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.253 179.549 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.8 p -136.9 124.14 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.864 179.2 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.7 mt -138.8 178.81 6.88 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.561 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -88.35 161.89 16.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.806 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -58.71 -32.52 69.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.503 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.87 -42.19 99.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.501 179.926 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -60.9 -44.57 96.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.504 -179.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.8 mp -62.81 -41.65 99.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.218 179.652 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.94 -51.36 69.45 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.304 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.98 -43.45 78.92 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.864 179.759 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.8 tp -53.0 132.67 38.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.36 -179.004 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -75.43 108.2 8.06 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.442 -179.557 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.8 m -134.22 160.36 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.733 179.812 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -145.19 136.93 25.47 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.598 179.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -76.31 129.5 36.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.145 179.467 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.1 t -83.93 130.01 36.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.254 -179.785 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.7 m -154.85 40.66 0.44 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.609 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 78.6 p -147.45 127.31 13.53 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.263 -179.919 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.437 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 10.3 mp -96.25 69.87 2.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.174 -179.969 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.81 -40.79 98.47 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.273 179.838 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.471 ' CG ' ' N ' ' A' ' 79' ' ' HIS . 30.9 t-80 43.57 -101.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.743 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.53 ' CG ' ' N ' ' A' ' 80' ' ' HIS . 85.8 t60 54.52 165.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.521 -179.978 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.53 ' N ' ' CG ' ' A' ' 79' ' ' HIS . 6.7 p80 -151.91 144.38 24.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.401 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -96.45 131.8 42.66 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.432 179.801 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -147.74 149.39 32.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.349 -179.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 77.5 t60 . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.598 -179.945 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.525 ' H1 ' ' NE2' ' A' ' 2' ' ' GLN . 55.1 ttm . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.627 ' NE2' ' N ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -88.48 -6.17 57.78 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.461 -179.984 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.422 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 41.5 m-85 -87.06 90.25 8.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.934 -179.894 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.44 156.33 41.56 Favored Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.99 -179.512 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 39' ' ' VAL . 40.5 Cg_endo -66.09 -20.1 56.97 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.522 2.148 . . . . 0.0 112.211 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -136.62 93.53 2.88 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.393 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.96 131.52 27.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.203 -179.544 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.02 102.41 14.48 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.056 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 24.4 m0 -101.37 135.71 42.4 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.362 -179.213 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -90.25 131.79 35.87 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.5 mt -84.73 117.78 30.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.765 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 11.0 p -102.43 -19.34 14.97 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.745 0.307 . . . . 0.0 110.187 179.735 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 137.63 179.04 16.52 Favored Glycine 0 N--CA 1.463 0.474 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 179.425 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -96.06 147.77 23.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.625 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.406 ' O ' ' CG2' ' A' ' 18' ' ' ILE . 10.1 t -76.92 170.46 16.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.578 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -69.01 -38.85 79.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.543 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -69.62 -13.23 62.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.634 -179.431 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.406 ' CG2' ' O ' ' A' ' 15' ' ' SER . 10.2 tp -41.45 147.1 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.725 -179.911 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.02 154.48 90.76 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.114 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.11 -29.72 56.13 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.456 2.104 . . . . 0.0 112.276 -179.607 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.33 -55.6 17.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.629 -179.206 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -62.25 -44.12 97.27 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.449 0.642 . . . . 0.0 110.346 -179.569 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -59.1 -45.7 90.21 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.999 179.758 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -59.28 -37.98 79.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.959 179.584 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -60.36 -41.66 94.15 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.839 179.367 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.73 -43.91 97.93 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.269 179.39 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.27 -38.89 92.67 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.375 179.418 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.0 m -61.12 -42.39 98.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.367 -179.191 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.47 ' CD1' ' O ' ' A' ' 31' ' ' MET . 2.5 pp -96.81 131.15 43.84 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.957 0.408 . . . . 0.0 110.675 -179.351 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.01 -22.95 72.68 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.47 ' O ' ' CD1' ' A' ' 29' ' ' LEU . 63.6 ttp -69.89 73.99 0.44 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.306 0.574 . . . . 0.0 109.789 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -82.03 169.45 18.46 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.815 -179.178 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 32' ' ' LEU . 61.0 Cg_exo -44.11 176.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.551 2.167 . . . . 0.0 112.946 -178.961 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.83 11.34 9.31 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.769 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 m -138.35 -156.16 0.66 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.754 0.311 . . . . 0.0 110.483 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.4 p -144.68 162.28 37.09 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.414 -179.75 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -139.37 163.47 32.42 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.284 -179.708 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -122.22 144.38 49.01 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.309 0.575 . . . . 0.0 110.731 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' PRO . 19.4 t -82.32 125.67 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.535 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 p -68.77 -39.75 80.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.728 179.386 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.3 ptt-85 -173.24 160.9 4.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.732 -179.44 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 62.4 t -129.55 118.71 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.007 179.087 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.61 111.15 51.27 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.463 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.91 -11.25 19.88 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.065 1.843 . . . . 0.0 112.357 179.843 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.472 ' CD2' ' N ' ' A' ' 45' ' ' LEU . 4.0 mm? -59.43 -31.59 69.42 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.842 -178.624 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.55 26.32 0.8 Allowed Glycine 0 N--CA 1.469 0.838 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.747 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -97.59 159.9 29.98 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.78 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.45 175.39 0.55 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.308 2.005 . . . . 0.0 111.628 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.503 ' N ' ' O ' ' A' ' 60' ' ' LEU . 8.3 mm -94.27 115.33 32.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.794 -179.579 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -94.6 125.44 39.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.156 -179.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.1 pt -127.15 148.58 31.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.474 179.737 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -130.91 130.33 43.36 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.488 179.784 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.38 138.06 54.4 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.511 -179.697 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -42.95 -34.62 1.01 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.437 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -69.73 -46.49 65.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.647 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.467 ' CG2' ' N ' ' A' ' 57' ' ' SER . 14.8 p -170.86 167.57 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 120.922 0.391 . . . . 0.0 111.177 -179.918 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.467 ' N ' ' CG2' ' A' ' 56' ' ' VAL . 9.9 p -93.25 154.79 17.82 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.599 178.994 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 64.2 tp -163.3 148.43 11.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.331 179.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.9 p -128.58 131.4 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 49' ' ' ILE . 91.7 mt -135.05 161.15 36.13 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.519 -179.428 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -86.33 164.82 16.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.571 179.734 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -59.0 -39.16 80.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.988 0.423 . . . . 0.0 110.542 -179.604 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -61.78 -40.15 94.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.59 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -59.66 -44.88 93.4 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.804 -0.359 . . . . 0.0 110.375 -179.581 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.2 mp -62.62 -41.42 98.99 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.275 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.22 -52.32 65.78 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.403 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.14 -40.69 78.09 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.301 179.609 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.9 tp -59.87 135.63 57.76 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.331 -179.309 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.445 ' O ' ' OG1' ' A' ' 12' ' ' THR . 70.7 mm-40 -81.51 113.69 19.73 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.547 -179.545 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.0 m -133.93 160.43 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.692 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -143.75 139.53 29.48 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.442 179.761 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.5 136.22 51.16 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.002 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 51.7 t -89.74 131.76 36.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.154 -179.657 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.403 ' OG ' ' N ' ' A' ' 75' ' ' SER . 78.7 p -88.65 -85.15 0.2 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.863 0.363 . . . . 0.0 110.694 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.403 ' N ' ' OG ' ' A' ' 74' ' ' SER . 90.1 p -155.26 111.55 3.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.556 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.485 ' CD2' ' N ' ' A' ' 76' ' ' LEU . 4.0 mm? -63.4 -41.0 98.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.261 179.829 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.448 ' O ' ' O ' ' A' ' 78' ' ' HIS . 79.5 mm-40 56.26 -106.1 0.31 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.417 -179.777 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.448 ' O ' ' O ' ' A' ' 77' ' ' GLU . 56.7 t-80 44.29 98.48 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.869 179.997 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -144.44 -161.68 1.33 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.567 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 49.58 89.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.693 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 51.1 p-80 -152.22 160.8 43.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.372 179.83 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.424 ' O ' ' OXT' ' A' ' 83' ' ' HIS . 97.1 m-70 -112.89 139.87 48.17 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.525 179.957 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.424 ' OXT' ' O ' ' A' ' 82' ' ' HIS . 51.6 p-80 . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.629 179.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -64.69 -28.23 69.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.818 -179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -68.79 136.65 53.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.864 -179.161 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.421 ' OG1' ' OG1' ' A' ' 7' ' ' THR . 0.1 OUTLIER -142.77 155.93 62.9 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.136 -179.2 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 39' ' ' VAL . 39.1 Cg_endo -65.63 -23.45 56.73 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.596 2.197 . . . . 0.0 112.348 179.91 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -137.36 93.86 2.86 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.421 ' OG1' ' OG1' ' A' ' 4' ' ' THR . 0.2 OUTLIER -139.66 131.46 27.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.36 -0.382 . . . . 0.0 109.995 -179.969 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.11 101.74 14.27 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.252 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 22.2 m0 -102.85 142.06 34.61 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.083 -179.001 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -94.25 143.41 26.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.899 179.605 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.6 mt -96.66 115.59 36.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 O-C-N 123.23 0.332 . . . . 0.0 110.112 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.5 m -98.81 -44.12 6.5 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.558 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.67 177.34 27.05 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.865 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.497 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.7 OUTLIER -86.38 154.09 21.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.875 0.369 . . . . 0.0 110.466 -179.933 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.441 ' O ' ' CG2' ' A' ' 18' ' ' ILE . 8.1 t -85.11 172.44 11.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.467 179.543 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.401 ' N ' ' OG ' ' A' ' 15' ' ' SER . 99.7 mtt180 -68.11 -39.09 82.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.777 179.712 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 17' ' ' GLU . 3.0 tm-20 -69.27 -15.7 63.41 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.561 -179.844 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.441 ' CG2' ' O ' ' A' ' 15' ' ' SER . 10.6 tp -40.81 146.72 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.427 -179.567 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.4 m -80.61 143.7 55.34 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.741 -179.375 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -49.31 -39.14 43.5 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.801 1.667 . . . . 0.0 112.609 179.056 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.43 -57.83 9.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.866 0.365 . . . . 0.0 111.043 -178.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -63.69 -43.71 95.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.447 0.642 . . . . 0.0 110.551 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -57.85 -44.97 86.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.956 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -62.7 -35.72 80.62 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.541 179.178 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.2 mmtt -59.46 -44.15 93.05 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.714 179.667 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -63.32 -42.16 98.97 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.163 178.725 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.84 -39.49 94.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.745 179.901 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.7 m -61.43 -44.64 96.77 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.317 -179.461 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 pp -92.85 138.07 31.81 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.521 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.85 -2.19 90.04 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.216 -0.753 . . . . 0.0 111.216 -179.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 48.3 ttp -86.82 75.29 9.63 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.681 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -82.56 169.96 16.33 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.034 -179.262 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' A' ' 32' ' ' LEU . 73.7 Cg_exo -44.76 -179.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.531 2.154 . . . . 0.0 112.454 -179.652 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.96 11.67 7.5 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 179.609 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 86.7 p -144.33 -157.76 0.82 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.673 0.273 . . . . 0.0 110.306 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 82.8 p -140.83 164.62 29.75 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.628 -179.822 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -143.14 162.12 36.41 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.373 -179.696 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.445 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 22.2 p-10 -119.38 148.19 43.49 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.429 0.633 . . . . 0.0 110.638 179.692 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 5' ' ' PRO . 5.9 t -84.43 127.09 40.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.448 -179.716 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 p -68.67 -39.21 80.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.813 179.464 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -172.82 160.65 4.47 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.132 -179.377 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 67.4 t -125.67 126.36 70.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.129 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.8 111.56 53.3 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.582 -179.787 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -75.74 -11.77 20.15 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.181 1.921 . . . . 0.0 112.314 -179.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.9 mt -58.46 -29.91 66.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.805 -178.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.96 27.42 2.08 Favored Glycine 0 N--CA 1.467 0.72 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -97.51 178.31 1.39 Allowed Pre-proline 0 CA--C 1.531 0.237 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.817 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 47' ' ' ASP . 19.5 Cg_exo -64.28 -177.88 0.56 Allowed 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.047 1.832 . . . . 0.0 112.265 -179.888 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.8 mm -106.57 117.84 53.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.885 -179.186 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -96.62 125.05 40.82 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.261 179.788 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.7 pt -123.63 147.85 27.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.134 179.49 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.445 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 13.3 tm-20 -132.59 130.09 39.81 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.182 -179.603 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.522 ' O ' ' N ' ' A' ' 55' ' ' ARG . 1.0 OUTLIER -122.44 136.78 54.97 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.883 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.8 ptt85 -40.4 -22.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.865 -179.632 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 53' ' ' THR . 94.1 mtm-85 -86.07 -49.88 7.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.101 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.41 ' CG1' ' O ' ' A' ' 55' ' ' ARG . 16.6 m -160.43 -175.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.456 -179.224 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.3 p -128.5 150.88 49.97 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.707 179.601 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.0 tp -154.28 150.5 28.07 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.16 -179.831 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.0 t -117.45 130.4 72.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 98.1 mt -135.92 139.74 43.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.979 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.564 ' O ' ' N ' ' A' ' 64' ' ' ASP . 81.8 mtp180 -78.34 142.18 37.88 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.576 179.635 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 61' ' ' ARG . 16.8 ptpt -35.22 -35.18 0.04 OUTLIER 'General case' 0 C--O 1.235 0.301 0 O-C-N 123.313 0.383 . . . . 0.0 111.385 179.799 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 61' ' ' ARG . 54.9 mtpt -62.82 -44.78 95.24 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.159 179.149 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.564 ' N ' ' O ' ' A' ' 61' ' ' ARG . 10.6 m-20 -64.13 -36.27 83.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.233 179.024 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.479 ' CD2' ' N ' ' A' ' 65' ' ' LEU . 4.0 mm? -62.22 -42.86 99.69 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.725 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.16 -44.1 93.11 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.994 0.426 . . . . 0.0 110.088 179.433 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.9 mt -68.23 -38.97 82.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.658 179.559 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.5 tp -69.78 125.09 25.7 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.849 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -76.03 115.48 15.79 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.091 -179.674 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.9 m -131.87 158.73 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.731 -179.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -143.32 144.58 32.15 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.429 179.645 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.27 140.77 54.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.924 179.274 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.4 t -95.24 128.96 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.385 -179.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.2 t -160.21 -28.14 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.474 179.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.5 t -74.21 149.85 40.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.568 179.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.36 64.65 3.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.978 -179.881 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.1 -32.75 72.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.458 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -64.26 140.55 58.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.686 -179.651 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -65.67 -40.3 92.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.604 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -58.1 -42.99 86.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.516 -179.768 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -78.82 145.76 34.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.446 179.817 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.2 p-80 -152.09 163.6 39.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.665 -179.796 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 84.2 t60 . . . . . 0 C--O 1.219 -0.53 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.563 179.919 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 3' ' ' TYR . 26.1 ttt . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 55.14 -83.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.795 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.496 ' N ' ' O ' ' A' ' 1' ' ' MET . 71.0 m-85 -81.1 137.83 35.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.909 -179.581 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.81 159.34 47.38 Favored Pre-proline 0 N--CA 1.465 0.314 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.203 -179.525 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 39' ' ' VAL . 43.8 Cg_endo -66.82 -32.63 36.19 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.688 2.259 . . . . 0.0 112.119 -179.826 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -136.62 95.5 3.16 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.906 -179.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 t -140.11 148.79 42.22 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.382 179.313 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -101.04 102.09 13.0 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.156 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.41 ' O ' ' OG ' ' A' ' 36' ' ' SER . 19.8 m0 -98.48 136.41 38.64 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.178 -179.008 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -95.45 129.5 42.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.969 179.805 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.6 mt -81.86 123.67 38.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.21 -179.296 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 11.7 p -108.14 -17.94 13.9 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.498 179.845 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 136.2 -179.04 18.28 Favored Glycine 0 N--CA 1.464 0.539 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -98.68 150.87 21.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.879 0.371 . . . . 0.0 110.472 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.402 ' OG ' ' N ' ' A' ' 16' ' ' ARG . 5.6 t -77.13 171.64 14.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.491 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.402 ' N ' ' OG ' ' A' ' 15' ' ' SER . 9.1 mpt_? -71.78 -40.64 69.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.503 -179.802 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -66.37 -13.1 60.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.248 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.4 ' CG2' ' O ' ' A' ' 15' ' ' SER . 10.1 tp -40.61 148.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.618 -179.828 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 72.0 p -81.16 142.78 51.61 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.687 -179.46 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -49.04 -38.15 39.12 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.916 1.744 . . . . 0.0 112.638 178.938 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.97 -57.4 12.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.877 0.37 . . . . 0.0 111.451 -178.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -63.02 -48.48 78.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.271 0.558 . . . . 0.0 110.579 -179.623 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.5 ttp85 -58.43 -46.37 86.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.168 0.509 . . . . 0.0 110.243 -179.677 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -60.46 -31.04 70.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.576 179.382 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.407 ' HZ3' ' CD2' ' A' ' 58' ' ' LEU . 29.6 ttpt -61.18 -44.95 96.48 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.867 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' A' ' 29' ' ' LEU . 4.6 mm? -61.77 -43.1 99.52 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.308 179.621 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.75 -38.71 92.13 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.692 179.554 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.0 t -60.46 -43.92 96.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.023 -179.212 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.475 ' CD1' ' O ' ' A' ' 31' ' ' MET . 2.3 pp -97.5 131.53 44.03 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.475 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.5 -21.53 74.51 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.475 ' O ' ' CD1' ' A' ' 29' ' ' LEU . 26.0 mmt -69.48 76.29 0.4 Allowed 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -82.2 169.69 17.48 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.324 -178.984 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 32' ' ' LEU . 71.3 Cg_exo -46.5 -178.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.435 2.09 . . . . 0.0 112.275 -179.475 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.89 8.91 9.34 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 179.665 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 m -138.03 -158.25 0.84 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.784 0.326 . . . . 0.0 110.256 179.657 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 9' ' ' TRP . 31.7 t -141.6 153.06 44.55 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.46 -179.838 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -128.37 157.41 41.09 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.339 -179.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 39' ' ' VAL . 50.0 t-20 -110.05 146.94 34.51 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.543 -179.803 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.529 ' N ' ' OD1' ' A' ' 38' ' ' ASN . 54.3 t -88.22 126.52 41.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.041 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 p -70.27 -40.64 78.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.075 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -173.73 159.25 3.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.152 -179.279 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.4 t -131.31 120.93 47.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.772 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.49 110.75 50.69 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.444 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -76.7 -11.69 18.42 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.2 1.933 . . . . 0.0 112.299 179.805 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.8 mt -59.39 -30.91 68.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.956 -178.551 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.24 22.77 0.7 Allowed Glycine 0 N--CA 1.465 0.568 0 N-CA-C 111.006 -0.837 . . . . 0.0 111.006 179.755 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.6 159.8 30.19 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.11 171.7 2.12 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.795 2.33 . . . . 0.0 111.939 -179.814 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.407 ' N ' ' O ' ' A' ' 60' ' ' LEU . 8.4 mm -92.56 114.27 29.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.799 -179.255 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -92.0 122.21 34.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.893 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.422 ' O ' ' O ' ' A' ' 58' ' ' LEU . 45.6 pt -127.54 149.17 32.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.326 -179.966 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -126.85 129.87 49.1 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.375 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.95 138.87 54.56 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.847 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -41.16 -37.03 0.83 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.346 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -65.47 -49.02 70.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.555 179.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.461 ' CG2' ' H ' ' A' ' 57' ' ' SER . 7.1 p -171.13 173.1 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.803 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.461 ' H ' ' CG2' ' A' ' 56' ' ' VAL . 40.0 t -92.11 136.71 32.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.151 178.812 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 51' ' ' ILE . 64.1 tp -143.03 148.72 37.21 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.791 0.329 . . . . 0.0 110.154 -179.877 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 p -130.13 130.54 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.099 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 49' ' ' ILE . 80.4 mt -134.59 155.69 50.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.323 -179.506 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -77.63 170.15 17.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.683 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.15 -47.07 87.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.132 0.492 . . . . 0.0 110.578 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -58.41 -38.23 76.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.733 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -58.07 -46.56 85.24 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.37 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.0 mp -62.75 -41.49 99.24 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.175 179.172 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.68 -53.11 59.14 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.365 -179.711 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.421 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 4.2 mm? -68.57 -41.11 80.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.146 179.482 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.2 tp -58.15 133.13 55.33 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.185 -179.038 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.429 ' O ' ' OG1' ' A' ' 12' ' ' THR . 47.6 mm-40 -77.85 110.42 12.72 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.312 -179.46 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.36 156.9 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.472 179.608 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -141.79 137.05 31.27 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.493 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.45 117.48 27.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.203 179.768 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.404 ' O ' ' OG ' ' A' ' 74' ' ' SER . 0.6 OUTLIER -65.06 -149.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.343 -179.671 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 73' ' ' VAL . 4.8 p 48.75 52.1 14.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.403 179.876 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.7 p -153.1 162.81 40.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.653 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.1 tp 59.82 42.04 17.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.378 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -65.9 -32.88 74.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.609 -179.808 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 44.0 p-80 -145.31 168.4 20.57 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.63 -179.616 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -60.18 133.31 55.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.577 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -85.0 130.73 34.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.582 -179.833 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 43.0 p-80 -150.75 148.57 28.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.478 179.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -154.07 143.7 21.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.57 -179.924 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.461 179.975 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.9 tpp . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -72.16 -12.66 61.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.868 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -79.4 91.78 5.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.977 -179.641 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.66 159.13 32.4 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.12 -179.257 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 39' ' ' VAL . 42.6 Cg_endo -67.5 -20.19 47.97 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.697 2.264 . . . . 0.0 112.078 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.408 ' C ' ' HG1' ' A' ' 7' ' ' THR . 99.3 m-20 -136.47 93.81 2.93 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.823 0.344 . . . . 0.0 110.121 179.976 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.408 ' HG1' ' C ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -139.51 131.64 28.05 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.838 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.88 102.12 14.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.228 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 21.1 m0 -100.04 140.37 34.35 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.118 -179.353 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -101.39 125.23 48.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.733 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.2 mt -81.14 123.6 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.393 -179.169 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.9 p -105.29 -16.16 14.84 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.436 179.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.39 163.08 9.64 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.516 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.84 159.54 33.59 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.56 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 p -77.35 167.41 21.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.643 -179.733 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.25 -40.44 74.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.863 0.363 . . . . 0.0 110.7 179.508 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -80.47 -2.39 45.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.145 -179.725 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.6 tp -40.42 146.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.561 -179.406 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.2 p -76.23 137.95 68.3 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.461 -179.258 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -46.92 -41.97 25.42 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.883 1.722 . . . . 0.0 112.666 179.195 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.83 -54.28 44.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.912 0.387 . . . . 0.0 111.228 -179.181 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -63.07 -49.24 75.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.355 0.598 . . . . 0.0 110.557 -179.859 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.1 ttt-85 -57.2 -42.67 81.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.088 -179.247 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.524 ' NE2' ' OG ' ' A' ' 28' ' ' SER . 12.4 tm0? -62.52 -34.99 78.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.02 179.332 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -59.22 -46.47 88.36 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.942 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -65.19 -37.79 88.46 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.821 179.557 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 tt -75.66 -23.83 56.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.082 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.524 ' OG ' ' NE2' ' A' ' 24' ' ' GLN . 49.1 m -58.11 -44.09 87.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.903 0.382 . . . . 0.0 111.317 -179.2 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.438 ' H ' HD13 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -116.9 156.65 27.0 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.162 -179.675 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -63.16 -26.24 69.04 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.769 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 86.9 mtp -61.55 73.96 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.006 0.432 . . . . 0.0 110.109 -179.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -85.38 169.2 16.72 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.585 -178.357 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 32' ' ' LEU . 55.7 Cg_exo -47.69 -177.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.075 1.85 . . . . 0.0 112.009 -179.764 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.63 -4.63 39.95 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.537 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.8 m -101.18 -169.6 1.72 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.713 0.292 . . . . 0.0 110.25 179.544 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.1 t -133.05 151.26 52.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.383 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -138.11 163.53 31.42 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.228 -179.654 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -122.57 146.67 47.21 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.446 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 5' ' ' PRO . 62.1 t -85.48 126.75 40.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.295 -179.83 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 p -70.04 -41.1 79.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.16 179.736 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.3 ptt-85 -174.25 169.42 3.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.966 -179.209 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.6 m -136.12 116.62 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.123 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.31 111.3 51.39 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.311 -179.745 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.532 ' C ' ' H ' ' A' ' 46' ' ' GLY . 60.3 Cg_endo -75.45 -11.76 20.68 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.287 1.991 . . . . 0.0 112.054 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.465 ' CD2' ' N ' ' A' ' 45' ' ' LEU . 4.2 mm? -53.0 -6.69 0.06 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.58 -178.978 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.532 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 104.37 23.69 7.88 Favored Glycine 0 N--CA 1.462 0.418 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.613 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.73 165.01 16.31 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 -179.491 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -58.06 -170.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.025 1.817 . . . . 0.0 111.704 179.257 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.8 mm -106.36 112.9 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -88.19 120.49 29.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.958 -179.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 58' ' ' LEU . 48.6 pt -126.33 147.99 31.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.144 179.901 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -127.97 129.43 46.76 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.306 179.649 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.567 ' HG1' ' H ' ' A' ' 56' ' ' VAL . 1.5 p -114.19 136.7 52.67 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.807 -179.945 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -39.04 -35.39 0.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.808 -179.433 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.417 ' O ' ' CG1' ' A' ' 56' ' ' VAL . 18.9 mmm180 -73.3 -49.29 28.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.109 -179.537 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.567 ' H ' ' HG1' ' A' ' 53' ' ' THR . 15.6 m -160.94 -176.84 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.517 -179.472 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 p -106.58 148.21 28.55 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.699 179.721 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' A' ' 51' ' ' ILE . 61.0 tp -154.6 150.31 27.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.473 179.896 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.1 p -127.57 131.33 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.82 179.194 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.6 mt -136.69 159.71 41.02 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.308 -179.445 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -85.06 166.63 16.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.339 -179.583 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -58.49 -44.43 89.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.856 0.36 . . . . 0.0 110.588 179.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -57.38 -39.92 77.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.723 -179.719 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -60.27 -45.15 94.3 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.394 179.992 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.5 -41.04 98.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.786 0.326 . . . . 0.0 110.127 179.47 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.06 -40.79 98.73 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.565 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.9 mt -75.8 -48.82 20.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.355 -179.641 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.2 mt -55.74 133.09 50.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.351 -179.151 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -74.27 109.38 7.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.192 -179.401 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.48 159.74 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.436 179.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -139.82 126.34 20.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.513 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.92 124.13 22.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.91 179.771 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.3 m -130.95 159.31 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.42 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.5 t -156.6 175.75 13.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.56 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.432 ' O ' ' OE1' ' A' ' 77' ' ' GLU . 2.0 t 68.27 33.52 4.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.547 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.8 tp -91.97 54.7 2.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.552 -179.817 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.432 ' OE1' ' O ' ' A' ' 75' ' ' SER . 57.8 mp0 -68.66 -35.55 77.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.447 179.955 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -139.58 146.53 39.95 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.425 -179.821 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -75.75 -152.91 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.175 -179.938 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -146.8 147.92 31.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.272 -179.955 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -81.29 154.83 26.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.555 -179.881 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -64.56 -42.08 95.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.506 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.524 ' O ' ' CG ' ' A' ' 83' ' ' HIS . 57.0 p-80 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.597 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 . . . . . 0 N--CA 1.465 0.286 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.9 158.87 74.41 Favored Pre-proline 0 N--CA 1.468 0.441 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 39' ' ' VAL . 44.1 Cg_endo -66.97 -19.41 52.05 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.549 2.166 . . . . 0.0 112.369 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -136.98 92.63 2.75 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.83 131.81 26.14 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.63 102.22 14.39 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.447 ' CZ3' HD12 ' A' ' 65' ' ' LEU . 22.4 m0 -101.44 132.04 47.24 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.191 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -86.84 136.63 32.9 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.8 mt -92.4 117.93 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 12.5 p -104.21 -32.24 9.22 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.73 0.3 . . . . 0.0 110.25 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.72 174.48 21.79 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -90.15 153.49 20.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.801 0.334 . . . . 0.0 110.334 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.464 ' O ' HG22 ' A' ' 18' ' ' ILE . 1.5 t -80.73 168.32 18.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.659 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -68.36 -40.57 81.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.877 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -63.63 -17.4 62.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.419 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 15' ' ' SER . 10.8 tp -41.89 147.42 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.587 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.98 155.15 84.78 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.343 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.98 -31.03 66.86 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.562 2.175 . . . . 0.0 112.213 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.24 -56.82 12.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.142 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -61.44 -44.2 97.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.65 0.738 . . . . 0.0 110.543 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -58.0 -47.62 82.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.589 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 45.4 tp60 -57.98 -37.27 73.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.532 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -57.91 -40.82 81.33 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.388 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.506 HD13 HD11 ' A' ' 29' ' ' LEU . 4.4 mm? -61.38 -42.86 99.39 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.81 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.92 -39.95 96.11 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.199 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.5 m -60.47 -44.11 96.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.795 0.331 . . . . 0.0 111.205 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.506 HD11 HD13 ' A' ' 26' ' ' LEU . 2.2 pp -93.5 132.65 37.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.555 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.94 -2.02 69.86 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 71.8 mtm -86.95 75.0 9.62 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -82.6 168.62 22.08 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.127 -179.199 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.451 ' O ' ' O ' ' A' ' 32' ' ' LEU . 77.5 Cg_exo -43.47 177.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.603 2.202 . . . . 0.0 112.412 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.95 11.96 7.34 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.487 ' OG ' ' N ' ' A' ' 36' ' ' SER . 34.9 t -144.2 -172.0 3.69 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.848 0.356 . . . . 0.0 110.344 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.487 ' N ' ' OG ' ' A' ' 35' ' ' SER . 67.7 m -128.28 155.7 44.18 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.517 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -135.53 159.14 42.55 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.349 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -111.97 150.64 30.28 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.572 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' PRO . 13.1 t -86.1 126.82 40.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.526 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 p -67.86 -41.46 84.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.825 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -173.78 161.51 3.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.994 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.471 ' O ' HG23 ' A' ' 42' ' ' VAL . 33.2 m -129.86 121.99 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.33 110.57 49.37 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.507 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -76.65 -11.74 18.5 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.042 1.828 . . . . 0.0 112.327 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.0 mt -59.67 -31.04 69.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.996 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 132.12 24.83 0.77 Allowed Glycine 0 N--CA 1.468 0.772 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.71 160.36 28.8 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.93 175.42 0.46 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.86 2.374 . . . . 0.0 112.02 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.6 mm -92.05 114.81 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.885 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -92.74 122.16 34.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.872 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.5 pt -127.5 150.69 33.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.801 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -128.83 137.64 51.61 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.128 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 55' ' ' ARG . 0.7 OUTLIER -129.49 138.27 51.29 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.753 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -43.78 -21.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.59 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 53' ' ' THR . 85.0 mtt85 -82.81 -48.81 10.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.533 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.635 HG22 ' N ' ' A' ' 57' ' ' SER . 14.9 p -169.66 168.55 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.665 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.635 ' N ' HG22 ' A' ' 56' ' ' VAL . 5.3 p -99.6 146.15 26.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.551 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.7 tp -155.96 147.86 23.18 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.335 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.669 ' O ' HD12 ' A' ' 60' ' ' LEU . 3.3 p -126.68 131.43 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.615 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.669 HD12 ' O ' ' A' ' 59' ' ' VAL . 2.6 mp -132.95 155.05 49.82 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.056 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -72.91 162.09 29.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.941 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -54.55 -45.9 73.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.869 0.366 . . . . 0.0 110.807 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -59.98 -40.67 89.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.526 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -61.12 -40.76 95.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.495 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.447 HD12 ' CZ3' ' A' ' 9' ' ' TRP . 2.2 mm? -63.06 -42.12 99.63 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.24 93.52 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.214 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.27 -42.13 84.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.221 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.5 mt -66.81 135.74 54.39 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.626 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.453 ' O ' ' OG1' ' A' ' 12' ' ' THR . 94.6 mt-10 -79.97 113.25 17.99 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.142 0.496 . . . . 0.0 110.175 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.9 m -132.16 155.94 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.747 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -142.54 137.9 30.48 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.754 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.9 148.03 51.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.145 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 38.7 t . . . . . 0 N--CA 1.466 0.372 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.347 -179.555 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 . . . . . 0 N--CA 1.456 -0.147 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.91 155.99 74.46 Favored Pre-proline 0 N--CA 1.467 0.38 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 39' ' ' VAL . 43.3 Cg_endo -66.79 -22.19 49.95 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.51 2.14 . . . . 0.0 112.288 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 6' ' ' ASP . 39.1 p-10 -137.42 93.61 2.83 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.735 0.302 . . . . 0.0 110.304 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.51 129.81 25.4 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.6 102.44 15.18 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 18.1 m0 -101.57 137.52 39.78 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.933 0.397 . . . . 0.0 110.322 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -95.24 129.57 42.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.038 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.2 mt -82.42 122.62 37.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.123 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 8.9 p -110.75 -19.33 12.89 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.559 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.72 -179.95 22.41 Favored Glycine 0 N--CA 1.464 0.559 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -100.12 157.42 16.58 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.848 0.356 . . . . 0.0 110.321 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 67' ' ' LEU . 15.5 m -74.8 165.76 24.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.765 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -70.54 -38.99 74.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.56 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -74.15 -6.34 47.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.383 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.6 tp -41.41 146.58 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.449 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.42 155.2 93.04 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.248 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.82 -31.27 68.23 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.415 2.077 . . . . 0.0 112.13 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.46 -53.47 42.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.224 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -63.06 -46.4 87.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.745 0.783 . . . . 0.0 110.652 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 67.0 ttp85 -57.99 -44.18 86.99 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.729 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -61.09 -36.12 78.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.08 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -59.22 -43.0 92.32 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.437 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.6 mm? -62.43 -43.66 98.28 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.032 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 49.1 mt -70.35 -32.56 70.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.81 0.338 . . . . 0.0 111.091 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.5 m -58.91 -44.03 91.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.334 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.495 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -118.73 173.21 7.0 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.295 -179.691 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -88.92 -3.14 77.11 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 33.2 ttm -64.6 74.18 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.2 mp -99.8 169.96 7.38 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.289 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 32' ' ' LEU . 62.9 Cg_exo -49.67 -164.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.331 2.021 . . . . 0.0 112.564 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.77 5.1 56.74 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.9 m -138.63 -156.28 0.67 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.813 0.34 . . . . 0.0 110.2 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.5 p -146.38 164.23 33.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.505 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -139.21 151.54 46.64 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.232 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -108.84 146.98 32.81 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.431 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' PRO . 10.0 t -87.03 127.15 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.597 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 50' ' ' HIS . 2.2 p -69.93 -39.05 77.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.885 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -173.44 166.93 4.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.284 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.518 ' O ' HG23 ' A' ' 42' ' ' VAL . 36.0 m -139.29 117.02 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.62 110.91 50.04 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.492 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.19 -11.68 19.34 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.135 1.89 . . . . 0.0 112.312 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.2 mt -58.58 -30.54 67.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.744 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.48 25.37 0.78 Allowed Glycine 0 N--CA 1.467 0.712 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.68 160.25 29.08 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -60.2 172.06 2.73 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.754 2.302 . . . . 0.0 111.88 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.2 mm -96.87 119.06 44.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.163 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.47 ' CD2' HG23 ' A' ' 59' ' ' VAL . 11.8 m170 -101.97 131.02 48.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.117 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.7 pt -127.26 149.84 32.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.5 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -138.91 144.42 39.09 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.034 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 56' ' ' VAL . 1.0 OUTLIER -132.5 173.15 11.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.515 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 53' ' ' THR . 99.8 mtt180 -33.6 -52.25 0.4 Allowed 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.35 0.406 . . . . 0.0 111.788 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -142.93 32.44 1.39 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.008 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 53' ' ' THR . 2.3 t -141.54 139.13 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.82 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.0 m -137.53 143.22 41.53 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.45 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.6 tp -161.57 152.49 18.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.203 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.47 HG23 ' CD2' ' A' ' 50' ' ' HIS . 4.2 p -122.32 128.87 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.7 mt -136.66 161.52 35.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.366 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -85.47 162.55 18.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.801 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -58.09 -37.55 74.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.605 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -61.8 -41.1 97.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.535 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -59.84 -45.86 91.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.347 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.2 mp -62.02 -41.08 97.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.264 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.03 -47.27 83.57 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.276 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.476 ' O ' ' OG ' ' A' ' 15' ' ' SER . 11.1 mp -75.98 -52.52 10.07 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.336 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.6 tp -43.03 128.66 4.42 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.479 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.45 ' O ' ' OG1' ' A' ' 12' ' ' THR . 78.8 mm-40 -70.28 109.52 4.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.237 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.0 m -137.88 159.36 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.544 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -141.31 124.66 16.58 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.518 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.9 132.4 49.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.873 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.418 179.881 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 . . . . . 0 CA--C 1.519 -0.236 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.431 ' OG1' HG21 ' A' ' 7' ' ' THR . 13.0 p -138.46 148.94 61.11 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.773 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 39' ' ' VAL . 42.8 Cg_endo -66.56 -52.46 0.76 Allowed 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.438 2.092 . . . . 0.0 112.34 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -117.14 94.47 4.58 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.873 0.368 . . . . 0.0 110.917 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.431 HG21 ' OG1' ' A' ' 4' ' ' THR . 1.5 t -141.39 150.3 42.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.13 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -99.6 102.21 13.66 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 18.4 m0 -97.8 137.62 36.39 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.285 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -93.55 140.91 29.06 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.4 mt -93.79 119.46 41.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 123.357 0.411 . . . . 0.0 110.248 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.5 m -102.21 -46.99 4.66 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.494 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.57 177.07 32.33 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.2 p90 -95.84 146.48 24.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.809 0.338 . . . . 0.0 110.322 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.47 ' O ' HG22 ' A' ' 18' ' ' ILE . 40.0 t -77.55 172.2 13.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.485 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -69.68 -39.61 76.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.882 0.372 . . . . 0.0 110.806 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -67.44 -14.36 62.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.386 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 15' ' ' SER . 10.4 tp -41.5 147.41 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.751 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.41 154.72 87.9 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.354 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.91 -31.3 67.33 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.67 2.247 . . . . 0.0 111.989 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.99 -54.78 25.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.984 0.421 . . . . 0.0 111.116 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -62.58 -44.98 94.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.594 0.711 . . . . 0.0 110.308 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -57.82 -39.93 78.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.821 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 28' ' ' SER . 15.9 mm-40 -63.77 -36.25 83.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.948 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -60.31 -44.81 95.09 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.55 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.407 ' N ' HD22 ' A' ' 26' ' ' LEU . 4.5 mm? -64.2 -41.56 97.02 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.175 178.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 tt -75.16 -28.1 59.96 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.107 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.527 ' N ' ' O ' ' A' ' 24' ' ' GLN . 14.5 t -61.2 -44.67 96.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.171 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.522 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -115.45 169.21 9.34 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.257 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.53 5.86 84.23 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.2 tpt -76.89 73.82 3.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.898 0.38 . . . . 0.0 110.05 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.8 mp -95.8 166.73 13.93 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.424 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 32' ' ' LEU . 77.9 Cg_exo -45.11 178.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.265 1.977 . . . . 0.0 112.162 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.43 3.4 14.61 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 m -141.31 -157.05 0.73 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.818 0.342 . . . . 0.0 110.26 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 89.3 p -143.78 163.29 33.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.397 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -140.93 159.79 41.46 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.332 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -113.26 144.76 42.17 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.567 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 5' ' ' PRO . 99.2 t -85.98 129.13 38.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.287 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.401 HG22 ' HE ' ' A' ' 41' ' ' ARG . 2.4 p -67.29 -41.84 87.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.187 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.401 ' HE ' HG22 ' A' ' 40' ' ' VAL . 20.1 ptp180 -174.9 161.13 2.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.94 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.2 t -131.88 122.47 49.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.1 110.82 50.38 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.406 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.61 -11.22 20.41 Favored 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 122.287 1.992 . . . . 0.0 112.226 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.533 ' N ' HD22 ' A' ' 45' ' ' LEU . 4.1 mm? -60.65 -31.8 71.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.986 -178.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 132.72 24.69 0.73 Allowed Glycine 0 N--CA 1.465 0.611 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.23 160.17 29.56 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.57 170.09 2.04 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.682 2.254 . . . . 0.0 111.78 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.5 mm -95.46 114.42 32.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.872 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.578 ' CD2' HG23 ' A' ' 59' ' ' VAL . 12.3 m170 -97.13 125.85 41.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.709 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.445 HG22 HG22 ' A' ' 39' ' ' VAL . 44.8 pt -125.99 150.05 31.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.699 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -134.98 111.97 10.23 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.987 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 54' ' ' ARG . 1.3 p -83.5 173.89 11.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.511 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 53' ' ' THR . 91.2 mtm180 -33.68 -53.14 0.43 Allowed 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.409 0.443 . . . . 0.0 111.779 -178.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -142.53 31.67 1.49 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.323 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 t -140.57 136.95 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.499 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.1 p -112.0 138.81 48.12 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.181 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.8 tp -155.22 149.88 26.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.079 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.578 HG23 ' CD2' ' A' ' 50' ' ' HIS . 9.1 p -124.24 128.44 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.79 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.6 mt -133.62 161.16 35.38 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.417 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -94.74 160.47 14.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.418 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -53.32 -37.31 62.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.916 0.389 . . . . 0.0 110.642 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.43 -42.18 99.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.39 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -60.83 -42.1 97.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.342 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.2 -41.81 98.71 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.074 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.72 -51.7 68.83 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.35 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.1 mm? -69.17 -40.18 78.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.019 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.7 tp -60.16 136.08 57.92 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -86.86 109.9 19.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.038 0.447 . . . . 0.0 110.37 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 m -132.6 157.11 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.628 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -142.4 143.93 32.89 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.854 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.17 147.09 53.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.041 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.465 0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.198 -179.7 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 . . . . . 0 CA--C 1.523 -0.072 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.32 151.66 56.84 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.321 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 39' ' ' VAL . 42.5 Cg_endo -66.11 -27.49 49.4 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.513 2.142 . . . . 0.0 111.876 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -135.69 94.52 3.09 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.907 0.384 . . . . 0.0 110.703 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.4 ' HG1' ' HE1' ' A' ' 9' ' ' TRP . 1.8 t -140.44 152.24 45.53 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.137 179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.74 102.79 14.64 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.4 ' HE1' ' HG1' ' A' ' 7' ' ' THR . 12.9 m0 -99.69 134.32 42.74 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.217 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -97.79 130.44 44.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.816 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.9 mt -84.03 118.33 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.265 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.5 m -99.12 -35.63 9.95 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.032 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 144.75 176.89 19.15 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -89.03 146.29 24.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.818 0.342 . . . . 0.0 110.33 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.5 m -74.99 171.19 14.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.429 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.1 ttm-85 -69.31 -41.32 76.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.549 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -72.44 -4.72 31.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.664 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.1 tp -41.84 147.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.665 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 m -68.12 152.11 96.71 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.058 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.97 -31.22 56.4 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.427 2.085 . . . . 0.0 112.075 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.74 -53.93 23.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.492 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.404 ' CE1' ' CD2' ' A' ' 26' ' ' LEU . 33.4 t80 -61.65 -44.25 97.32 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.295 0.569 . . . . 0.0 110.335 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -59.7 -42.78 93.76 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.825 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.4 HE22 ' HB3' ' A' ' 28' ' ' SER . 19.6 tm0? -61.8 -37.21 83.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.641 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -59.9 -45.67 91.79 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.746 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.414 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.6 mm? -62.86 -41.33 99.33 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.497 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.2 mt -62.18 -38.75 90.26 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.392 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.4 ' HB3' HE22 ' A' ' 24' ' ' GLN . 3.3 p -80.13 -10.24 59.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.835 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.1 tp -100.16 126.87 46.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.482 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.28 1.9 73.71 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 77.3 mtm -108.81 74.82 0.93 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.259 0.552 . . . . 0.0 109.701 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.3 mp -78.87 165.94 45.79 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.831 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 32' ' ' LEU . 68.1 Cg_exo -42.65 179.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.788 2.325 . . . . 0.0 113.043 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.0 11.86 7.36 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.2 p -143.07 -160.38 1.1 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.72 0.295 . . . . 0.0 110.396 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 97.6 p -139.98 165.15 28.1 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.542 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -143.63 169.12 18.33 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.438 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 16.4 p-10 -124.88 151.64 45.06 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.306 0.574 . . . . 0.0 110.279 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' PRO . 16.6 t -87.06 124.94 40.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.425 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.458 ' H ' HG12 ' A' ' 40' ' ' VAL . 2.0 p -71.63 -39.81 70.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.913 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -172.99 166.76 5.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.672 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.645 ' O ' HG23 ' A' ' 42' ' ' VAL . 33.3 m -149.31 104.65 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.894 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.83 111.29 53.84 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.405 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -75.87 -9.96 19.69 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.455 2.103 . . . . 0.0 112.348 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.518 ' N ' HD12 ' A' ' 45' ' ' LEU . 10.6 mp -52.12 -30.15 25.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.768 -178.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 147.36 16.15 0.13 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -97.96 153.05 38.33 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.26 -175.03 0.47 Allowed 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.216 1.944 . . . . 0.0 111.778 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.43 HG21 ' CD2' ' A' ' 65' ' ' LEU . 12.8 mm -91.49 114.55 28.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.716 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.462 ' CD2' HG23 ' A' ' 59' ' ' VAL . 12.0 m170 -95.71 120.49 36.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.233 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.4 pt -125.18 144.42 35.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.229 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.435 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 13.1 tm-20 -123.62 124.66 43.28 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.187 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.49 141.25 48.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.336 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.415 ' H ' ' HG2' ' A' ' 54' ' ' ARG . 21.5 mmt85 -50.11 -38.94 41.19 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.978 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -67.77 -41.06 83.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.756 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.746 HG22 ' H ' ' A' ' 57' ' ' SER . 13.1 p -170.7 177.18 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.578 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.746 ' H ' HG22 ' A' ' 56' ' ' VAL . 47.8 t -111.48 145.11 39.6 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.273 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.416 HD21 HD11 ' A' ' 60' ' ' LEU . 62.3 tp -147.76 149.21 31.95 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.552 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 59' ' ' VAL . 7.7 p -137.19 122.98 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.416 HD11 HD21 ' A' ' 58' ' ' LEU . 96.7 mt -140.98 175.95 9.2 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.442 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -86.64 162.69 17.82 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.07 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -58.37 -32.91 69.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.611 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.06 -41.6 98.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.209 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -60.08 -44.62 94.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.496 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.43 ' CD2' HG21 ' A' ' 49' ' ' ILE . 7.8 mp -62.01 -40.91 97.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.976 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.85 -48.86 78.57 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.455 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.14 -40.24 86.68 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.888 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 77.1 mt -66.62 140.64 57.94 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.511 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -84.29 108.66 17.27 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.443 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.1 m -132.38 158.91 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.296 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -143.09 129.57 20.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.48 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.61 129.21 36.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.683 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.7 m . . . . . 0 N--CA 1.464 0.246 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.19 179.776 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 . . . . . 0 CA--C 1.517 -0.293 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.06 153.15 76.63 Favored Pre-proline 0 N--CA 1.465 0.297 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.396 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 39' ' ' VAL . 40.1 Cg_endo -66.52 -33.96 35.04 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.518 2.145 . . . . 0.0 112.22 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -136.7 95.2 3.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.702 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -140.03 148.17 41.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.277 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -103.2 102.0 11.97 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 27.4 m0 -96.37 147.33 23.92 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.396 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -105.1 125.7 51.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.743 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.2 mt -82.86 120.33 34.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.194 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.2 p -104.55 -10.48 17.58 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.495 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 142.09 167.46 11.33 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.15 161.86 25.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.399 . . . . 0.0 110.074 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.6 p -72.64 163.29 28.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.555 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 85.4 mtm-85 -69.89 -39.78 76.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.588 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -79.78 -3.38 47.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.183 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.1 tp -41.25 144.81 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.683 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 57.3 m -80.17 148.72 68.08 Favored Pre-proline 0 C--N 1.327 -0.383 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.934 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -50.09 -40.18 50.69 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.299 1.999 . . . . 0.0 112.35 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.38 -56.53 17.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.002 0.43 . . . . 0.0 111.201 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -63.36 -51.22 66.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.405 0.622 . . . . 0.0 110.517 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 68.6 ttt-85 -55.51 -44.12 76.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.482 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 28' ' ' SER . 68.9 tp60 -62.82 -32.6 73.83 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.818 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -59.4 -47.03 87.02 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.456 -0.497 . . . . 0.0 109.837 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.532 HD22 ' N ' ' A' ' 26' ' ' LEU . 4.4 mm? -65.54 -37.85 87.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.151 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.5 tp -74.62 -28.44 60.88 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.871 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 24' ' ' GLN . 68.7 m -57.61 -44.41 85.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.05 -178.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.607 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -114.54 153.13 30.61 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.114 -179.743 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -61.79 -24.59 64.67 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 67.6 mtt -61.13 73.67 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 120.976 0.417 . . . . 0.0 109.994 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 30' ' ' GLY . 0.5 OUTLIER -86.66 168.57 17.9 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.826 -179.167 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.457 ' HD3' HD12 ' A' ' 26' ' ' LEU . 67.6 Cg_exo -46.52 -178.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.29 1.993 . . . . 0.0 111.97 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.77 -11.78 45.87 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.2 m -100.73 -171.82 2.08 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.984 0.421 . . . . 0.0 110.238 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.3 m -130.19 157.59 42.04 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.427 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -138.65 158.38 44.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.215 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -112.38 145.03 40.83 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.562 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 5' ' ' PRO . 51.7 t -89.81 124.56 42.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.135 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.42 HG12 ' H ' ' A' ' 40' ' ' VAL . 2.0 p -68.61 -41.22 82.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.069 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -173.68 164.22 4.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.119 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 42' ' ' VAL . 27.6 m -135.99 124.15 36.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.045 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.98 110.76 51.65 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.736 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.32 -12.02 19.06 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.781 2.321 . . . . 0.0 112.184 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.53 ' N ' HD12 ' A' ' 45' ' ' LEU . 10.9 mp -60.6 -32.34 71.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.626 -178.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 135.33 22.03 0.65 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.97 160.03 30.08 Favored Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.46 169.08 3.35 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.77 2.313 . . . . 0.0 111.808 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.511 ' N ' ' O ' ' A' ' 60' ' ' LEU . 8.3 mm -93.48 114.41 30.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.976 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -91.3 122.88 34.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.856 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' A' ' 58' ' ' LEU . 44.9 pt -125.65 147.43 30.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.266 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -127.65 129.66 47.6 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.27 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.76 137.56 54.72 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.795 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.618 ' HE ' ' NH1' ' A' ' 55' ' ' ARG . 35.1 ptt180 -44.99 -31.46 1.3 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.245 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.618 ' NH1' ' HE ' ' A' ' 54' ' ' ARG . 86.5 mmt-85 -71.88 -46.37 58.07 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.599 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.625 HG22 ' N ' ' A' ' 57' ' ' SER . 13.9 p -170.97 168.46 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.794 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.625 ' N ' HG22 ' A' ' 56' ' ' VAL . 97.5 p -89.18 153.52 20.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.609 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 51' ' ' ILE . 61.1 tp -162.62 149.16 12.9 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.332 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 p -130.29 131.39 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 49' ' ' ILE . 89.7 mt -134.91 161.39 35.36 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.47 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -88.14 161.85 17.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.749 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.405 ' CG ' ' N ' ' A' ' 63' ' ' LYS . 20.4 ptmt -55.32 -41.0 71.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.965 0.412 . . . . 0.0 110.777 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.405 ' N ' ' CG ' ' A' ' 62' ' ' LYS . 21.0 ptmt -60.36 -40.21 89.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.67 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.92 -44.4 97.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.549 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.42 -41.86 97.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.703 0.287 . . . . 0.0 110.232 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.65 -50.51 73.57 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.395 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.27 -40.45 81.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.752 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.7 tp -61.76 129.71 42.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.338 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -74.53 107.58 6.75 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.64 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.2 m -132.68 161.89 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.607 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -143.0 140.74 31.14 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.37 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.03 112.59 20.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.301 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 63.0 t . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.518 -179.627 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 . . . . . 0 N--CA 1.455 -0.22 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.83 156.63 68.68 Favored Pre-proline 0 N--CA 1.467 0.411 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 39' ' ' VAL . 45.3 Cg_endo -67.09 -21.72 48.56 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.45 2.1 . . . . 0.0 112.289 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -137.01 93.06 2.79 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.41 HG21 ' HE1' ' A' ' 9' ' ' TRP . 0.2 OUTLIER -140.3 131.83 27.04 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.85 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.55 103.05 15.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.41 ' HE1' HG21 ' A' ' 7' ' ' THR . 10.4 m0 -101.63 136.32 41.67 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.287 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -101.13 130.98 47.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.828 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.3 mt -83.97 124.29 39.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.723 -178.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.1 m -109.91 -41.34 4.52 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.812 0.339 . . . . 0.0 110.489 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 160.53 -174.31 37.21 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -103.74 147.1 27.66 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.815 0.34 . . . . 0.0 110.982 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.41 ' O ' HG22 ' A' ' 18' ' ' ILE . 3.5 m -78.84 173.16 12.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.604 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.415 ' N ' ' CD ' ' A' ' 16' ' ' ARG . 3.0 mpt_? -69.79 -40.37 76.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.61 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -68.66 -11.98 60.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.724 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 15' ' ' SER . 10.0 tp -41.16 148.35 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.625 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.9 p -76.35 141.16 69.67 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.57 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -49.49 -40.0 45.17 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 121.605 1.537 . . . . 0.0 112.952 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.62 -54.99 37.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 111.689 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -63.55 -45.79 88.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.451 0.643 . . . . 0.0 110.382 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -58.3 -44.55 88.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.945 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.482 ' O ' ' N ' ' A' ' 28' ' ' SER . 62.3 tp60 -61.57 -33.96 74.78 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -59.64 -47.29 86.18 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.904 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.6 mm? -62.68 -42.19 99.5 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.102 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.5 tt -72.99 -30.7 63.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.88 0.372 . . . . 0.0 110.871 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 24' ' ' GLN . 74.6 m -60.18 -43.28 95.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.395 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.505 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -118.66 171.96 7.83 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.398 -179.574 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.77 6.79 73.88 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 97.1 mtp -77.94 74.9 4.48 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.9 OUTLIER -92.96 169.89 9.72 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.131 -179.173 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 32' ' ' LEU . 51.4 Cg_exo -49.38 -169.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.123 1.882 . . . . 0.0 112.595 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.91 0.87 19.54 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.1 m -139.8 -173.25 3.58 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.728 0.299 . . . . 0.0 110.266 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 73.0 m -128.82 155.93 44.42 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.817 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -130.14 157.12 43.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.42 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -113.58 152.41 30.34 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.297 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 5' ' ' PRO . 20.8 t -87.95 123.0 40.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.479 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.403 ' H ' HG12 ' A' ' 40' ' ' VAL . 1.6 p -66.67 -42.01 89.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.689 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.548 ' NH2' ' CE1' ' A' ' 50' ' ' HIS . 50.7 ptt85 -172.94 162.94 4.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.489 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.8 t -128.06 127.95 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.418 ' HB1' ' OD1' ' A' ' 47' ' ' ASP . . . -93.39 110.77 48.78 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.366 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.05 -12.62 19.48 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.813 1.675 . . . . 0.0 112.516 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.2 tp -57.85 -30.52 65.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.959 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.81 30.51 1.24 Allowed Glycine 0 N--CA 1.467 0.753 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -98.74 -179.16 0.8 Allowed Pre-proline 0 N--CA 1.467 0.378 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.425 ' CD ' ' CB ' ' A' ' 47' ' ' ASP . 15.5 Cg_exo -65.53 -173.12 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.762 1.641 . . . . 0.0 111.594 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.402 HG21 ' CD2' ' A' ' 65' ' ' LEU . 10.8 mm -105.62 114.26 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.801 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.548 ' CE1' ' NH2' ' A' ' 41' ' ' ARG . 15.2 m170 -89.63 116.95 28.15 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.404 ' O ' ' O ' ' A' ' 58' ' ' LEU . 44.8 pt -124.41 148.25 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.147 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -125.81 123.96 39.88 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.865 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 p -107.44 137.03 46.23 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.765 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -38.46 -35.7 0.2 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.869 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.576 ' O ' HG13 ' A' ' 56' ' ' VAL . 3.6 mpt_? -72.51 -49.35 33.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.079 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 55' ' ' ARG . 15.7 m -162.55 -176.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 120.977 0.417 . . . . 0.0 110.991 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.2 m -99.78 145.84 27.25 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.792 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.404 ' O ' ' O ' ' A' ' 51' ' ' ILE . 60.3 tp -153.78 144.8 22.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.374 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.0 p -130.72 128.72 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.6 mt -136.95 166.19 24.22 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.85 0.357 . . . . 0.0 110.514 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -82.33 160.71 22.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.867 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -57.34 -34.59 68.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.746 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.7 -40.61 97.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.109 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -61.05 -45.9 92.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.812 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.402 ' CD2' HG21 ' A' ' 49' ' ' ILE . 10.4 mp -62.0 -42.3 99.0 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.141 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.01 -49.68 76.72 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.083 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.8 mt -68.81 -41.41 78.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.487 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.2 tp -60.48 132.11 52.86 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.715 -0.394 . . . . 0.0 109.94 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -74.73 110.87 9.38 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.446 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.3 m -137.23 162.25 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.813 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -138.84 127.42 23.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.329 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.78 125.21 28.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.856 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.464 0.259 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.082 -179.949 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.985 0.421 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.73 156.45 36.53 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.982 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 39' ' ' VAL . 37.1 Cg_endo -65.13 -31.52 54.32 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.697 2.264 . . . . 0.0 111.925 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -136.78 94.66 3.01 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.696 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.5 t -140.53 151.15 44.53 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.922 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -104.92 102.49 12.01 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.406 ' O ' ' OG ' ' A' ' 36' ' ' SER . 26.1 m0 -96.63 132.61 42.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.213 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.5 tttt -87.43 127.22 35.22 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.76 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.6 mt -81.53 122.51 36.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.213 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.9 m -104.25 -49.09 3.67 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.515 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.3 169.87 30.47 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -88.41 152.82 21.65 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.713 0.292 . . . . 0.0 110.241 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.517 ' O ' HG22 ' A' ' 18' ' ' ILE . 38.3 t -82.81 168.77 16.82 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.094 0.474 . . . . 0.0 110.782 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -66.62 -40.03 88.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.362 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.47 ' OE1' ' N ' ' A' ' 17' ' ' GLU . 52.5 mp0 -65.13 -15.47 62.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.657 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.517 HG22 ' O ' ' A' ' 15' ' ' SER . 10.6 tp -42.34 146.75 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.598 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.7 p -79.85 141.41 55.25 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.551 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -47.15 -41.42 27.11 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.927 1.751 . . . . 0.0 112.616 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.33 -57.47 9.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.821 0.343 . . . . 0.0 111.296 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -61.95 -46.25 90.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.47 0.652 . . . . 0.0 110.444 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -57.37 -43.63 83.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.114 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.593 ' NE2' ' OG ' ' A' ' 28' ' ' SER . 0.7 OUTLIER -60.29 -37.94 82.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.111 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -60.7 -41.96 96.25 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.178 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.447 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.4 mm? -62.59 -42.25 99.45 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.201 -0.6 . . . . 0.0 110.276 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mp -73.9 -29.77 62.24 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.474 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.593 ' OG ' ' NE2' ' A' ' 24' ' ' GLN . 49.9 m -58.7 -44.83 90.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.388 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.514 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -115.9 170.97 8.07 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.28 -179.688 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -87.11 -3.22 82.78 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 22.3 mmt -67.26 73.45 0.13 Allowed 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 120.868 0.366 . . . . 0.0 110.118 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.2 mp -99.07 169.85 7.65 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.425 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 32' ' ' LEU . 72.2 Cg_exo -48.63 -168.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.332 2.022 . . . . 0.0 112.462 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.95 7.06 56.73 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.6 m -139.54 -156.65 0.7 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.826 0.346 . . . . 0.0 110.387 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 9' ' ' TRP . 33.4 t -148.8 153.56 38.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.441 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.407 ' HB2' HG22 ' A' ' 53' ' ' THR . 45.0 p90 -128.94 155.54 45.15 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.291 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -106.42 143.81 34.01 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.523 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 5' ' ' PRO . 14.5 t -88.12 122.82 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.281 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.43 HG12 ' H ' ' A' ' 40' ' ' VAL . 2.2 p -68.31 -39.99 81.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.878 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.542 ' NH2' ' ND1' ' A' ' 50' ' ' HIS . 38.1 ptt-85 -174.69 159.87 2.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.136 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 42' ' ' VAL . 36.0 m -133.89 123.84 45.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.68 110.4 49.05 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.686 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -76.42 -11.67 18.93 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.481 2.121 . . . . 0.0 112.176 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.632 ' O ' HD23 ' A' ' 45' ' ' LEU . 1.1 tt -60.59 -33.15 72.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.645 -177.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.13 20.9 0.49 Allowed Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.03 160.22 29.59 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.33 168.03 5.45 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.878 2.386 . . . . 0.0 111.819 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.405 ' N ' ' O ' ' A' ' 60' ' ' LEU . 5.5 mm -89.63 119.77 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.884 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.542 ' ND1' ' NH2' ' A' ' 41' ' ' ARG . 12.4 m170 -95.47 122.64 38.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.887 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.7 pt -125.87 148.91 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.278 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -130.71 132.36 45.32 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.422 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 55' ' ' ARG . 1.4 p -122.63 137.1 55.0 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.0 ptt-85 -41.17 -21.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.871 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.566 ' O ' HG13 ' A' ' 56' ' ' VAL . 33.7 mmt180 -85.3 -50.57 7.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.924 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 55' ' ' ARG . 14.8 m -161.01 -176.0 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.515 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.7 p -113.29 145.27 41.32 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.396 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.9 tp -149.75 148.28 29.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.309 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.8 p -136.54 126.69 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.743 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 49' ' ' ILE . 23.3 mt -132.23 165.57 23.84 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.378 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -81.06 148.49 29.65 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.215 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -41.78 -40.81 2.16 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.961 0.41 . . . . 0.0 111.122 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -58.03 -40.58 81.23 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.563 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -62.08 -41.39 98.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.842 0.353 . . . . 0.0 110.53 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.556 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.0 mm? -62.14 -42.08 98.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.913 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.18 -41.54 97.07 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.371 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.8 mt -68.33 -43.29 77.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.987 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.5 mt -65.33 133.42 51.36 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.284 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.3 112.2 16.3 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.009 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.406 HG21 ' CE3' ' A' ' 9' ' ' TRP . 26.9 m -129.53 160.39 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.591 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -144.72 128.31 17.09 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.507 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.74 132.61 47.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.951 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.8 t . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.225 -179.618 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 . . . . . 0 CA--C 1.518 -0.261 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.24 156.58 77.97 Favored Pre-proline 0 N--CA 1.466 0.351 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.302 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 39' ' ' VAL . 52.4 Cg_exo -51.06 -35.35 50.63 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.907 1.738 . . . . 0.0 112.885 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -135.74 95.93 3.33 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.5 130.82 42.87 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.89 102.39 15.09 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.431 ' CE3' HG21 ' A' ' 70' ' ' VAL . 22.1 m0 -103.2 144.32 31.48 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.057 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -96.89 140.73 31.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.505 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.9 mt -96.94 122.03 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 O-C-N 123.263 0.352 . . . . 0.0 110.295 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.2 p -109.78 -44.7 3.78 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.761 0.315 . . . . 0.0 110.441 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 167.62 -179.33 41.11 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -97.66 152.18 19.35 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.779 0.323 . . . . 0.0 110.649 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.464 ' O ' HG22 ' A' ' 18' ' ' ILE . 2.6 m -80.05 169.87 17.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.718 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -68.8 -39.61 80.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.574 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -65.64 -14.66 61.63 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.694 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 15' ' ' SER . 10.5 tp -42.29 147.08 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.465 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.9 m -82.0 150.17 64.57 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.904 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -51.25 -39.31 62.39 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.074 1.849 . . . . 0.0 112.652 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.56 -56.77 15.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 0.0 111.374 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.576 ' CZ ' HD21 ' A' ' 68' ' ' LEU . 35.6 t80 -64.11 -47.02 81.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.513 0.673 . . . . 0.0 110.477 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -56.88 -43.79 81.63 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.029 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -63.51 -33.58 75.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.023 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -59.61 -47.37 85.83 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 29' ' ' LEU . 4.5 mm? -63.06 -42.19 99.64 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.121 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.3 tp -68.8 -34.33 75.35 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.9 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.2 t -59.69 -44.61 93.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.62 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.547 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -116.26 168.42 10.14 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.834 0.35 . . . . 0.0 110.219 -179.447 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.02 -1.08 80.11 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.6 mtt -67.78 73.6 0.17 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 120.863 0.363 . . . . 0.0 110.021 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.3 mp -95.78 167.75 12.04 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.261 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 32' ' ' LEU . 75.8 Cg_exo -46.03 -179.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.236 1.957 . . . . 0.0 112.322 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.46 7.16 11.2 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' A' ' 36' ' ' SER . 28.9 t -145.77 -175.59 4.8 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.817 0.341 . . . . 0.0 110.446 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.492 ' N ' ' OG ' ' A' ' 35' ' ' SER . 46.9 m -127.18 156.03 42.46 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.509 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -132.53 150.93 52.08 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.286 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -106.74 146.33 30.96 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.36 0.6 . . . . 0.0 110.401 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' PRO . 6.7 t -83.49 127.3 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.363 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.425 HG12 ' H ' ' A' ' 40' ' ' VAL . 2.2 p -71.13 -38.39 70.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.112 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -172.83 154.13 2.84 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.994 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 73.5 t -126.32 118.91 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.71 111.27 51.91 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.221 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -76.27 -11.2 19.27 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.148 1.899 . . . . 0.0 112.262 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 45' ' ' LEU . 10.7 mp -59.89 -31.71 70.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.646 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.7 27.93 0.71 Allowed Glycine 0 N--CA 1.466 0.697 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.84 160.21 29.06 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.23 172.06 1.01 Allowed 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.835 2.356 . . . . 0.0 111.859 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.412 ' N ' ' O ' ' A' ' 60' ' ' LEU . 7.3 mm -90.42 116.93 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.995 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.407 ' CD2' HG23 ' A' ' 59' ' ' VAL . 12.1 m170 -96.72 121.89 39.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.706 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.5 pt -129.2 147.25 33.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.632 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.414 ' OE1' ' OG ' ' A' ' 57' ' ' SER . 57.0 mm-40 -122.49 114.51 20.79 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.099 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.02 137.5 44.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.685 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -42.89 -40.28 2.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.439 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -66.23 -47.03 75.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.562 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.657 HG22 ' N ' ' A' ' 57' ' ' SER . 11.2 p -170.52 173.39 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 120.981 0.42 . . . . 0.0 110.59 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.657 ' N ' HG22 ' A' ' 56' ' ' VAL . 4.4 m -95.19 152.8 18.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.38 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.3 tp -155.66 145.33 21.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.019 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.407 HG23 ' CD2' ' A' ' 50' ' ' HIS . 4.8 p -137.99 126.08 30.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 49' ' ' ILE . 19.0 mt -132.37 -178.63 5.0 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.499 ' CD ' ' N ' ' A' ' 61' ' ' ARG . 9.8 mpt_? -94.85 150.97 19.62 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.348 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -42.07 -43.34 3.21 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.828 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.47 -40.02 85.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.466 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -59.42 -43.08 93.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.51 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.532 HD22 ' N ' ' A' ' 65' ' ' LEU . 3.8 mm? -62.81 -41.87 99.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.812 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.3 -46.03 89.68 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.229 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.9 mp -67.3 -40.25 86.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.675 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.576 HD21 ' CZ ' ' A' ' 22' ' ' TYR . 21.5 mt -63.47 128.02 33.93 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.204 -0.599 . . . . 0.0 110.173 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -77.5 104.87 8.28 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.649 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.431 HG21 ' CE3' ' A' ' 9' ' ' TRP . 31.0 m -125.05 160.3 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.424 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -142.86 134.67 26.81 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.36 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.16 132.78 47.8 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.601 -0.44 . . . . 0.0 109.857 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.553 -179.701 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 . . . . . 0 CA--C 1.518 -0.288 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 p -130.77 150.52 76.7 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 121.044 -0.263 . . . . 0.0 110.454 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 39' ' ' VAL . 42.6 Cg_exo -50.75 -49.39 16.96 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.794 1.662 . . . . 0.0 113.147 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -134.18 103.35 5.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.065 0.459 . . . . 0.0 111.165 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.72 144.42 41.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.529 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.46 101.89 14.63 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.574 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 23.8 m0 -100.36 141.23 33.48 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.015 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -95.25 130.37 42.03 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.3 mt -83.52 121.26 36.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.243 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.6 m -103.06 -49.64 3.71 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.812 0.339 . . . . 0.0 110.648 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.16 169.89 27.25 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -85.34 158.33 20.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.901 0.381 . . . . 0.0 110.396 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.413 ' O ' HG22 ' A' ' 18' ' ' ILE . 47.2 t -79.87 169.44 17.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.72 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -69.67 -39.61 76.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.841 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -74.6 -7.62 53.74 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.458 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.413 HG22 ' O ' ' A' ' 15' ' ' SER . 10.4 tp -42.46 148.6 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.648 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.1 m -75.16 154.14 86.37 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.355 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.98 -25.79 51.68 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.516 2.144 . . . . 0.0 112.137 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.0 -55.93 9.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.18 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -63.45 -45.65 89.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.189 0.518 . . . . 0.0 110.596 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -58.11 -45.54 87.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.136 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 17.1 tm0? -62.24 -33.73 75.16 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -59.21 -46.79 87.5 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.695 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.6 mm? -62.03 -39.54 92.67 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.229 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.9 tp -59.95 -42.38 93.91 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.227 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.0 t -82.92 -9.43 59.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.296 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.7 tp -94.91 124.67 39.09 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.937 0.398 . . . . 0.0 110.367 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.6 -19.45 74.76 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 45.1 ttp -89.51 73.13 7.84 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.632 0.73 . . . . 0.0 109.306 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' A' ' 33' ' ' PRO . 9.5 mt -80.51 156.91 73.08 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.983 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 32' ' ' LEU . 75.6 Cg_exo -37.91 162.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.476 2.117 . . . . 0.0 112.444 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.16 3.75 17.02 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 96.4 p -129.3 -156.66 0.77 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.767 0.318 . . . . 0.0 110.346 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.5 t -145.3 151.99 39.21 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.702 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -132.62 159.43 39.57 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.356 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -111.38 146.37 37.26 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.733 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 5' ' ' PRO . 51.2 t -90.45 125.66 43.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.146 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -66.83 -42.22 88.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 50.1 ptt85 -174.28 156.75 2.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.076 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.57 ' O ' HG23 ' A' ' 42' ' ' VAL . 32.9 m -128.92 117.23 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.09 110.31 47.32 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 120.951 -0.299 . . . . 0.0 110.413 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.67 -11.58 18.49 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.181 1.921 . . . . 0.0 112.187 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tp -57.15 -31.08 65.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.973 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.62 22.98 0.66 Allowed Glycine 0 N--CA 1.465 0.604 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.35 159.82 30.3 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -59.84 173.46 1.69 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.763 2.309 . . . . 0.0 111.761 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 60' ' ' LEU . 8.2 mm -92.96 114.63 30.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.093 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.499 ' CD2' HG23 ' A' ' 59' ' ' VAL . 12.4 m170 -96.0 121.93 38.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.093 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.7 pt -126.26 149.37 31.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.286 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -129.32 135.15 48.37 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.553 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -126.69 145.59 50.52 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.797 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -50.09 -38.6 39.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.169 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.0 tpm_? -67.74 -43.7 79.31 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.772 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.723 HG22 ' H ' ' A' ' 57' ' ' SER . 11.8 p -170.74 176.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.584 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.723 ' H ' HG22 ' A' ' 56' ' ' VAL . 47.4 t -105.87 149.2 26.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.43 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.4 tp -152.77 149.4 28.3 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.205 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.499 HG23 ' CD2' ' A' ' 50' ' ' HIS . 10.2 p -128.93 128.22 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.64 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.424 HD13 ' OD1' ' A' ' 64' ' ' ASP . 58.7 mt -132.34 162.59 30.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.269 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -85.58 171.9 11.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.717 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -61.9 -40.07 94.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.625 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.48 -39.26 87.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.467 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.424 ' OD1' HD13 ' A' ' 60' ' ' LEU . 6.5 t70 -57.17 -47.13 81.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.345 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.62 -40.88 98.35 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.661 -0.416 . . . . 0.0 109.924 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.07 -54.11 48.94 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.499 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 67' ' ' LEU . 11.1 mp -69.53 -41.57 75.8 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.153 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 38.7 tp -59.0 130.32 46.44 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -83.84 114.03 21.36 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 110.23 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.26 158.43 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.912 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -144.11 141.81 30.23 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.759 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.1 145.4 51.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.098 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.149 -179.741 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 . . . . . 0 CA--C 1.52 -0.197 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.15 155.29 77.58 Favored Pre-proline 0 N--CA 1.466 0.357 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.19 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 39' ' ' VAL . 50.1 Cg_endo -67.68 -23.12 42.84 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.638 2.225 . . . . 0.0 112.307 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -137.86 94.4 2.89 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.689 0.281 . . . . 0.0 110.582 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.12 130.7 27.26 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.9 101.94 14.03 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.443 ' CE3' HG21 ' A' ' 70' ' ' VAL . 23.0 m0 -101.76 145.86 28.56 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.23 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -102.8 128.51 49.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.88 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.0 mt -81.03 123.74 37.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.337 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 7.8 p -111.47 -15.17 13.59 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.55 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.34 178.28 16.84 Favored Glycine 0 N--CA 1.465 0.598 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.421 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.5 p90 -98.58 152.17 19.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.85 0.357 . . . . 0.0 110.119 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.478 ' O ' HG22 ' A' ' 18' ' ' ILE . 5.1 t -80.21 168.71 18.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.463 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 16' ' ' ARG . 37.1 mtp-105 -68.56 -39.52 81.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.943 0.401 . . . . 0.0 110.662 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -64.24 -17.08 63.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.616 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.478 HG22 ' O ' ' A' ' 15' ' ' SER . 10.7 tp -41.92 147.89 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.476 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.5 t -80.96 146.33 59.03 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.699 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -49.67 -41.05 46.61 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.874 1.716 . . . . 0.0 112.755 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.52 -56.27 20.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.244 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -61.94 -46.75 87.97 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.48 0.657 . . . . 0.0 110.396 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -57.34 -44.08 83.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.848 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 28' ' ' SER . 5.9 tm0? -60.12 -38.39 82.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.361 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -57.87 -43.92 86.29 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.538 HD12 ' HD3' ' A' ' 33' ' ' PRO . 4.6 mm? -63.51 -40.84 98.1 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.269 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.4 mt -80.74 -18.14 48.74 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.885 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 24' ' ' GLN . 38.8 t -61.04 -43.97 98.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.077 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.596 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -115.82 154.53 29.5 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.398 -179.527 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.65 5.97 42.51 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.512 ' N ' ' SD ' ' A' ' 31' ' ' MET . 0.0 OUTLIER -89.27 74.73 7.86 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.713 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -82.42 171.24 12.33 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.355 -178.903 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.538 ' HD3' HD12 ' A' ' 26' ' ' LEU . 63.3 Cg_exo -48.47 -171.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.321 2.014 . . . . 0.0 112.206 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.01 11.25 8.46 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 81.8 p -139.24 -156.83 0.71 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.921 0.391 . . . . 0.0 110.413 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.8 p -141.15 163.0 34.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.468 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -139.51 160.93 38.72 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.194 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.413 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 24.2 p30 -119.22 151.19 38.8 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.24 0.543 . . . . 0.0 110.429 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' PRO . 61.0 t -88.15 127.53 41.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.279 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -69.06 -41.3 81.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.069 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -173.56 162.07 4.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.964 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 68.0 t -130.14 124.2 57.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.39 110.56 49.39 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.28 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.72 -11.31 20.22 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.29 1.994 . . . . 0.0 112.331 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.529 HD22 ' N ' ' A' ' 45' ' ' LEU . 4.1 mm? -60.65 -31.43 70.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.708 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.5 24.76 0.82 Allowed Glycine 0 N--CA 1.465 0.606 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.1 160.05 29.92 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.05 173.15 0.62 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.805 2.336 . . . . 0.0 111.665 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.437 ' N ' ' O ' ' A' ' 60' ' ' LEU . 8.5 mm -93.48 114.26 29.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -92.17 122.33 34.55 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.891 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 58' ' ' LEU . 44.4 pt -126.84 151.91 34.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.574 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.413 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 95.1 mt-10 -130.95 134.46 46.76 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.248 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.22 141.85 51.63 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.996 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.406 ' H ' ' HG3' ' A' ' 54' ' ' ARG . 84.0 mtm180 -40.89 -36.53 0.66 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.36 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -65.54 -50.39 65.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.87 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.685 HG22 ' H ' ' A' ' 57' ' ' SER . 8.5 p -172.39 174.56 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-O 120.905 0.383 . . . . 0.0 110.808 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.685 ' H ' HG22 ' A' ' 56' ' ' VAL . 89.8 p -89.07 150.09 22.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.233 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 51' ' ' ILE . 63.9 tp -159.96 145.42 15.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.783 0.325 . . . . 0.0 110.342 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.8 p -126.5 129.96 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 49' ' ' ILE . 67.2 mt -132.93 161.41 34.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.55 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -85.25 165.29 17.46 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.706 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -59.11 -35.85 74.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.485 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.82 -40.41 95.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.595 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -60.64 -46.4 90.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.723 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.406 ' N ' HD12 ' A' ' 65' ' ' LEU . 9.6 mp -62.71 -40.26 96.6 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.67 -38.62 91.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.517 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.1 mt -82.32 -54.97 4.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.031 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 66.2 mt -45.81 137.61 5.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.657 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.43 ' O ' ' OG1' ' A' ' 12' ' ' THR . 97.2 mt-10 -80.02 111.56 16.49 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.295 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.443 HG21 ' CE3' ' A' ' 9' ' ' TRP . 25.7 m -135.97 159.04 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.395 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -141.54 131.58 24.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.718 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.22 142.36 54.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.115 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t . . . . . 0 C--N 1.332 -0.187 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.258 -179.964 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 . . . . . 0 CA--C 1.52 -0.185 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.22 156.51 73.71 Favored Pre-proline 0 N--CA 1.466 0.33 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.174 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 39' ' ' VAL . 41.4 Cg_endo -66.69 -27.75 44.7 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.683 2.255 . . . . 0.0 112.322 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -136.39 94.91 3.08 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.582 0.229 . . . . 0.0 110.408 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.21 128.77 24.46 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.13 101.52 14.18 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 25.2 m0 -99.57 140.59 33.54 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.213 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -98.26 120.44 38.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.882 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.7 mt -74.65 128.52 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.327 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.2 m -110.13 -47.41 3.32 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.567 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 170.62 166.3 29.31 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -87.42 157.25 19.27 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.84 0.352 . . . . 0.0 110.106 179.673 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 67' ' ' LEU . 13.0 m -73.77 163.85 27.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.519 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -69.82 -40.76 75.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.376 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -68.95 -12.19 61.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.355 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.456 HG22 ' O ' ' A' ' 15' ' ' SER . 10.3 tp -41.37 146.95 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.614 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.26 156.97 83.46 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.352 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.61 -30.57 70.49 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.777 2.318 . . . . 0.0 111.756 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.78 -56.8 12.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.881 0.372 . . . . 0.0 111.24 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -61.93 -45.46 93.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.364 0.602 . . . . 0.0 110.442 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -57.26 -43.16 82.75 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.946 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.513 ' O ' ' N ' ' A' ' 28' ' ' SER . 63.5 tp60 -61.51 -38.22 86.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.145 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -59.75 -41.47 91.08 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.456 -0.498 . . . . 0.0 109.819 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.608 HD12 ' HD3' ' A' ' 33' ' ' PRO . 4.4 mm? -64.04 -39.03 93.18 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.425 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.8 tt -82.34 -24.47 34.54 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.071 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 24' ' ' GLN . 96.5 p -60.84 -45.78 93.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.772 0.32 . . . . 0.0 111.484 -178.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.5 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -103.43 161.69 13.64 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.978 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.98 31.28 3.42 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 65.6 mtt -111.65 73.08 0.8 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.473 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.2 mm? -82.84 153.06 67.09 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.648 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.608 ' HD3' HD12 ' A' ' 26' ' ' LEU . 77.8 Cg_exo -39.62 167.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.459 2.106 . . . . 0.0 111.918 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.39 -16.19 12.84 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.811 -0.915 . . . . 0.0 110.811 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.8 m -100.18 -170.76 1.92 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.731 0.301 . . . . 0.0 110.302 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 73.4 m -132.39 156.34 46.84 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.481 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -139.17 157.06 46.61 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.241 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -112.2 146.45 38.08 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.468 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 5' ' ' PRO . 17.5 t -86.3 129.7 37.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.434 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -70.31 -40.24 77.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.146 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -173.77 161.45 3.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.114 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 69.5 t -134.47 110.61 13.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.69 111.55 53.08 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.47 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.518 ' C ' ' H ' ' A' ' 46' ' ' GLY . 60.4 Cg_endo -75.82 -12.13 19.97 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.353 2.035 . . . . 0.0 112.135 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.584 ' N ' HD12 ' A' ' 45' ' ' LEU . 10.2 mp -55.09 -3.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.812 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 103.37 26.62 6.83 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.27 159.58 30.92 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-O 121.028 0.442 . . . . 0.0 109.997 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.95 177.54 0.5 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.758 2.305 . . . . 0.0 111.521 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.473 HG21 ' CD2' ' A' ' 65' ' ' LEU . 10.2 mm -95.92 115.42 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.269 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.455 ' CD2' HG23 ' A' ' 59' ' ' VAL . 11.9 m170 -98.71 122.39 41.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.838 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 35.7 pt -126.77 148.0 31.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.748 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -134.36 111.96 10.61 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.875 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 54' ' ' ARG . 1.3 p -83.65 175.26 9.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.683 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 53' ' ' THR . 99.8 mtt180 -33.53 -53.3 0.41 Allowed 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.548 0.53 . . . . 0.0 111.548 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -143.04 31.41 1.4 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.351 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 t -138.48 134.01 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 120.369 -0.533 . . . . 0.0 110.454 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.7 m -111.12 136.94 49.42 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.195 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.2 tp -156.42 147.27 21.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.245 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.455 HG23 ' CD2' ' A' ' 50' ' ' HIS . 5.9 p -127.5 126.03 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.846 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.0 mt -132.18 167.72 19.28 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.289 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -85.72 166.32 16.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.517 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -60.53 -35.79 76.84 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.999 0.428 . . . . 0.0 110.549 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.27 -41.13 98.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.274 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -57.5 -47.13 82.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.535 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.473 ' CD2' HG21 ' A' ' 49' ' ' ILE . 11.0 mp -61.79 -41.09 97.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.095 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.09 -52.01 67.01 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.598 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.465 ' O ' ' OG ' ' A' ' 15' ' ' SER . 10.8 mp -68.8 -42.34 77.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.038 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 tp -56.43 132.22 50.61 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.286 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -78.91 110.03 13.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.224 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.71 159.05 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.418 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -142.86 133.09 24.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.608 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.23 145.45 54.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.173 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.9 t . . . . . 0 C--N 1.332 -0.17 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.191 -179.959 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.5 OUTLIER . . . . . 0 CA--C 1.519 -0.226 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.68 164.55 39.02 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 39' ' ' VAL . 31.3 Cg_exo -55.64 -36.14 94.22 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.878 1.719 . . . . 0.0 112.687 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 6' ' ' ASP . 47.0 p-10 -136.74 94.38 2.98 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.796 0.331 . . . . 0.0 110.533 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.29 130.52 33.1 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.95 102.6 15.37 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -105.96 141.33 37.54 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.912 0.387 . . . . 0.0 110.464 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -94.52 147.86 22.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.838 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.3 mt -101.63 115.83 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.0 m -97.73 -43.58 7.11 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.852 0.358 . . . . 0.0 110.42 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.65 179.52 34.52 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.9 OUTLIER -95.84 149.0 22.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.938 0.399 . . . . 0.0 110.506 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.425 ' O ' HG22 ' A' ' 18' ' ' ILE . 4.3 m -78.28 172.16 13.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.545 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -69.49 -40.54 76.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.618 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -66.8 -13.79 61.91 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.968 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.425 HG22 ' O ' ' A' ' 15' ' ' SER . 10.4 tp -41.53 148.49 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.715 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.05 155.21 86.52 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.302 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.99 -31.02 66.8 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.645 2.23 . . . . 0.0 112.216 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.44 -55.34 18.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.902 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -62.82 -43.51 98.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.435 0.636 . . . . 0.0 110.513 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -58.51 -43.32 89.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.6 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.535 ' O ' ' N ' ' A' ' 28' ' ' SER . 18.8 mm-40 -63.36 -35.18 79.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.043 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -59.74 -41.95 92.08 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.368 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.534 HD12 ' HD3' ' A' ' 33' ' ' PRO . 4.6 mm? -70.06 -39.0 75.94 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.748 178.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp -81.91 -15.48 53.76 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.432 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 24' ' ' GLN . 2.8 m -57.14 -29.73 63.83 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.596 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.886 HD13 ' N ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -134.69 -176.92 4.39 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.696 0.284 . . . . 0.0 110.723 179.513 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.39 -9.2 56.97 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 79.2 mtp -76.08 75.13 2.94 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.5 OUTLIER -83.04 171.82 10.83 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.034 -179.275 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.534 ' HD3' HD12 ' A' ' 26' ' ' LEU . 77.7 Cg_exo -48.74 -168.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.523 2.149 . . . . 0.0 112.589 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.03 11.99 7.27 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.6 p -136.12 -158.11 0.84 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.761 0.315 . . . . 0.0 110.214 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 82.5 p -138.68 161.56 36.84 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.761 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -141.21 159.4 42.29 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.183 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 47.6 p-10 -117.38 151.16 37.59 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.196 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 5' ' ' PRO . 61.1 t -87.88 126.34 41.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.283 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.413 HG12 ' H ' ' A' ' 40' ' ' VAL . 1.8 p -68.72 -43.31 83.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.941 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -173.23 147.26 1.53 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.391 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 42' ' ' VAL . 20.9 m -115.99 125.64 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.36 110.39 48.35 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.805 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.1 -12.19 17.6 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.854 1.703 . . . . 0.0 112.315 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.8 mt -60.6 -31.02 70.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.011 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.34 26.34 0.89 Allowed Glycine 0 N--CA 1.469 0.869 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.02 160.27 28.8 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -54.81 175.24 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.603 2.202 . . . . 0.0 111.645 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.4 mm -94.64 113.68 29.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.018 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 16.2 m170 -93.95 119.65 33.14 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.1 pt -127.17 150.43 33.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.368 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.429 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 8.6 tm-20 -126.25 132.31 51.74 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.214 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.08 138.4 54.46 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.924 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -40.59 -38.58 0.89 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.332 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -67.13 -48.66 67.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.744 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.637 HG22 ' N ' ' A' ' 57' ' ' SER . 8.5 p -171.5 172.07 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.933 0.397 . . . . 0.0 110.87 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.637 ' N ' HG22 ' A' ' 56' ' ' VAL . 10.7 p -86.26 151.26 23.76 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.461 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.1 tp -155.66 146.45 22.2 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.884 0.373 . . . . 0.0 110.299 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.6 p -125.65 130.9 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.64 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.4 mt -134.71 163.2 30.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.576 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 83.6 mtt85 -92.08 174.8 7.13 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.972 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -62.05 -44.67 96.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.092 0.472 . . . . 0.0 110.623 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -61.63 -38.02 86.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.627 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -59.47 -48.36 81.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.259 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.433 ' CD2' ' CE1' ' A' ' 3' ' ' TYR . 10.5 mp -62.92 -41.77 99.57 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.113 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.36 -50.94 71.85 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.269 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.0 mt -68.83 -41.92 77.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.239 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.2 tp -62.19 136.21 57.83 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -84.9 116.37 23.3 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.871 0.367 . . . . 0.0 110.427 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.0 m -133.28 161.45 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.527 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -145.59 145.98 31.2 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.463 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.96 135.92 45.07 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.8 t . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.787 0.327 . . . . 0.0 110.289 -179.742 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 . . . . . 0 CA--C 1.52 -0.196 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.07 152.34 38.55 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.314 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -49.9 -44.05 38.58 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.852 1.701 . . . . 0.0 112.816 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -135.47 100.64 4.56 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.935 0.398 . . . . 0.0 110.835 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.35 143.45 42.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.389 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -96.48 102.45 14.24 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.576 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 26.5 m0 -98.51 145.77 26.45 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.377 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -100.34 132.58 45.64 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.788 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 36.1 mt -82.37 124.56 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.21 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.5 m -108.03 -49.55 3.19 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.81 0.338 . . . . 0.0 110.804 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.11 -178.88 40.54 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 2.3 p90 -102.52 144.29 31.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.909 0.385 . . . . 0.0 110.464 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.41 ' O ' HG22 ' A' ' 18' ' ' ILE . 19.7 m -75.31 171.36 14.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.453 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -68.78 -38.48 80.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.785 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -71.7 -10.27 59.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.482 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 15' ' ' SER . 10.0 tp -41.56 147.51 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.518 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.2 t -78.64 140.72 59.54 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.356 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -48.25 -40.24 35.09 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.902 1.735 . . . . 0.0 112.89 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.53 -58.14 8.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.897 0.379 . . . . 0.0 111.364 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -62.07 -47.2 85.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.55 0.691 . . . . 0.0 110.471 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -56.51 -43.16 79.5 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.878 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -59.73 -37.53 79.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.182 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -59.47 -43.03 93.32 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.633 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.5 mm? -62.4 -42.62 99.57 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.967 178.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 48.7 mt -70.85 -32.55 69.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.917 0.389 . . . . 0.0 110.928 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 64.7 m -58.0 -44.12 87.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.399 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.564 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -117.94 166.24 12.74 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.161 -179.777 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.4 8.49 79.73 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 16.1 mmt -78.4 73.37 4.96 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.5 mp -91.4 167.84 14.79 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.089 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 32' ' ' LEU . 71.6 Cg_exo -44.33 176.69 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 122.292 1.994 . . . . 0.0 112.363 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.34 1.58 15.91 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.434 ' OG ' ' N ' ' A' ' 36' ' ' SER . 32.7 t -134.48 -155.85 0.69 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.903 0.382 . . . . 0.0 110.321 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.434 ' N ' ' OG ' ' A' ' 35' ' ' SER . 27.3 p -150.71 161.94 41.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.554 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -138.38 156.49 47.55 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.293 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -108.95 145.72 35.0 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.496 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.7 t -89.85 126.72 42.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.434 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -67.52 -42.31 86.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.114 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -173.87 156.93 2.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.059 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.539 ' O ' HG23 ' A' ' 42' ' ' VAL . 30.8 m -126.05 122.11 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.75 110.27 48.43 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.511 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -76.86 -11.88 18.08 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.199 1.933 . . . . 0.0 112.283 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.1 mt -59.69 -31.47 69.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.026 -178.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.83 25.01 0.78 Allowed Glycine 0 N--CA 1.466 0.673 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.52 160.13 29.47 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.4 169.58 2.19 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.898 2.399 . . . . 0.0 111.638 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.1 mm -92.77 113.65 28.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.99 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.479 ' CD2' HG23 ' A' ' 59' ' ' VAL . 13.2 m170 -95.6 121.25 37.09 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.909 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 48.0 pt -127.93 149.87 33.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.428 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -118.97 125.51 49.6 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.173 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.0 p -111.77 136.94 50.36 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -39.29 -40.23 0.74 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.804 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.667 ' O ' HG13 ' A' ' 56' ' ' VAL . 56.6 ttt85 -67.88 -49.71 60.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.21 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 55' ' ' ARG . 4.4 m -164.77 -176.68 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.556 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.0 t -96.23 136.96 36.0 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.488 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.5 tp -138.04 145.27 41.61 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.987 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.479 HG23 ' CD2' ' A' ' 50' ' ' HIS . 12.9 p -126.42 130.46 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.694 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.8 mt -134.3 162.26 32.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.475 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -91.89 165.03 13.44 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.623 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.698 ' HB3' ' HZ2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -57.0 -40.93 77.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.072 0.463 . . . . 0.0 110.635 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -62.22 -36.92 83.44 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.793 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.29 -42.85 99.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.278 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.7 mp -63.06 -41.96 99.59 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.884 -0.414 . . . . 0.0 109.884 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.31 -50.77 72.43 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.146 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.5 mt -69.2 -40.48 78.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.004 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.3 tp -62.58 134.02 55.76 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -85.13 112.47 20.72 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.003 0.43 . . . . 0.0 110.118 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.0 m -132.5 158.99 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.63 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -142.92 141.68 31.53 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.823 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.61 150.55 42.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.164 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.6 t . . . . . 0 N--CA 1.466 0.375 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.197 -179.933 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 . . . . . 0 CA--C 1.518 -0.26 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.456 ' OG1' ' CG2' ' A' ' 7' ' ' THR . 15.4 p -132.39 148.07 68.2 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.484 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 39' ' ' VAL . 44.9 Cg_endo -66.22 -31.29 44.78 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.392 2.062 . . . . 0.0 112.473 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -136.23 93.99 2.97 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.725 0.298 . . . . 0.0 111.318 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.456 ' CG2' ' OG1' ' A' ' 4' ' ' THR . 0.9 OUTLIER -141.77 149.16 40.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.368 178.825 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -102.78 102.05 12.16 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 25.3 m0 -97.46 142.74 28.94 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.894 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -100.68 123.66 45.19 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.5 mt -79.6 120.43 30.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.904 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.6 p -104.08 -15.66 15.5 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.348 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.47 164.66 10.41 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.88 169.51 17.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.9 t -84.03 166.42 17.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.447 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.9 ptt-85 -70.58 -37.03 73.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.556 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -81.09 -5.42 57.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.028 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.6 tp -41.15 141.75 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.386 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.8 m -80.02 150.88 72.52 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.806 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.06 -38.84 60.47 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.9 1.733 . . . . 0.0 112.544 179.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.63 -58.12 8.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.437 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -63.32 -48.65 77.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.346 0.594 . . . . 0.0 110.555 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -57.93 -40.76 81.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.04 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 28' ' ' SER . 12.1 tm0? -61.8 -39.44 91.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.207 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.51 -43.73 96.77 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.253 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.602 HD12 ' HD3' ' A' ' 33' ' ' PRO . 4.5 mm? -63.47 -39.21 93.86 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.283 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.5 tt -81.13 -23.18 38.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.958 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.469 ' N ' ' O ' ' A' ' 24' ' ' GLN . 40.3 t -61.22 -45.24 95.38 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.167 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.515 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -107.71 160.47 15.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.173 -179.554 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.04 33.92 2.4 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 36.5 tpp -112.8 74.01 0.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.464 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.2 mm? -81.86 153.58 70.06 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.075 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.602 ' HD3' HD12 ' A' ' 26' ' ' LEU . 66.4 Cg_exo -40.12 169.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 122.78 2.32 . . . . 0.0 112.439 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.15 12.11 7.13 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 90.2 p -126.63 -171.36 2.39 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 73.5 m -131.45 157.47 43.39 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.72 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -137.88 159.96 40.58 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.296 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -117.35 145.85 43.77 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.893 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 5' ' ' PRO . 57.5 t -86.06 127.66 40.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.213 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.417 ' H ' HG12 ' A' ' 40' ' ' VAL . 2.4 p -70.65 -41.37 77.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.209 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -176.41 171.31 2.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.818 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.56 130.65 37.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.36 109.61 43.82 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.716 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.511 ' C ' ' H ' ' A' ' 46' ' ' GLY . 33.9 Cg_exo -60.57 -21.86 70.26 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 121.793 1.662 . . . . 0.0 112.334 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.5 mt -52.99 -5.72 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.634 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 90.8 33.95 8.06 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.7 169.75 8.11 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -54.51 -171.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 121.807 1.672 . . . . 0.0 111.939 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 60' ' ' LEU . 9.5 mm -111.89 109.67 29.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.744 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.406 ' O ' HG12 ' A' ' 40' ' ' VAL . 2.7 m80 -85.71 125.73 33.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.161 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.6 pt -127.66 151.22 34.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.524 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.4 ' OE1' ' C ' ' A' ' 52' ' ' GLU . 1.9 pp20? -130.7 136.86 49.19 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.212 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 56' ' ' VAL . 2.9 p -128.87 143.68 50.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.09 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -49.28 -37.45 23.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.659 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -72.74 -37.82 67.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.91 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.779 HG22 ' H ' ' A' ' 57' ' ' SER . 3.5 p -169.53 -176.1 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.824 0.345 . . . . 0.0 110.207 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.779 ' H ' HG22 ' A' ' 56' ' ' VAL . 36.5 p -130.65 150.49 51.81 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 59' ' ' VAL . 5.8 tt -163.81 164.95 23.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.354 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.514 ' N ' HD23 ' A' ' 58' ' ' LEU . 3.6 p -126.47 137.79 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.828 0.347 . . . . 0.0 110.419 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 49' ' ' ILE . 11.9 mt -134.11 152.07 51.67 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.704 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -77.83 162.05 27.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.508 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -58.4 -39.49 79.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.862 0.363 . . . . 0.0 110.34 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.89 -39.68 92.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.4 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -59.87 -45.94 90.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.516 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 mp -62.02 -41.8 98.47 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.341 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.12 -51.76 68.0 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.18 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.23 -39.95 82.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.944 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.9 tp -60.02 128.92 39.24 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -75.59 110.28 9.85 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.423 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.6 m -133.24 161.4 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.64 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -143.28 138.35 29.51 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.395 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.81 134.13 44.78 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 80.9 t . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.383 -179.868 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 . . . . . 0 CA--C 1.518 -0.274 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 p -130.09 152.49 80.15 Favored Pre-proline 0 N--CA 1.466 0.343 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 39' ' ' VAL . 52.6 Cg_exo -50.45 -41.45 51.96 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.972 1.781 . . . . 0.0 112.586 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.446 ' OD1' ' ND2' ' A' ' 38' ' ' ASN . 67.0 t0 -134.37 100.59 4.72 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.003 0.43 . . . . 0.0 111.026 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 t -137.35 144.52 42.56 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.296 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.36 102.43 14.41 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.745 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 14.5 m0 -100.62 142.59 31.89 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.345 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -97.49 139.61 33.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.632 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.4 mt -98.84 114.88 37.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 m -97.26 -40.42 8.77 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.44 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.65 164.77 21.79 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.65 162.32 27.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.78 0.324 . . . . 0.0 110.172 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.487 ' O ' HG22 ' A' ' 18' ' ' ILE . 5.8 t -78.69 163.45 25.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.518 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 49.6 ptt85 -68.67 -37.62 79.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -70.08 -14.65 62.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.603 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 15' ' ' SER . 10.8 tp -41.94 145.53 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.404 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 t -84.98 149.84 54.13 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.515 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -48.94 -37.12 36.24 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.952 1.768 . . . . 0.0 112.394 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.38 -58.48 7.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.485 -178.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -63.45 -46.61 85.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.427 0.632 . . . . 0.0 110.668 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -57.49 -43.32 84.07 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.936 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -63.42 -37.79 88.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.216 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -59.06 -45.45 90.75 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.884 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.446 ' HA ' HD13 ' A' ' 26' ' ' LEU . 4.4 mm? -62.34 -43.52 98.63 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.184 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.3 tp -63.64 -42.42 98.15 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.536 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.6 m -72.32 -39.73 67.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.453 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.734 HD23 ' N ' ' A' ' 30' ' ' GLY . 1.7 tt -82.5 132.1 35.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.774 -178.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.734 ' N ' HD23 ' A' ' 29' ' ' LEU . . . -73.26 32.21 0.8 Allowed Glycine 0 N--CA 1.462 0.427 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.526 ' CB ' HD22 ' A' ' 29' ' ' LEU . 11.3 tpt -124.67 72.7 1.22 Allowed 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.0 mm? -81.62 152.01 69.08 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.106 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 32' ' ' LEU . 72.5 Cg_exo -40.77 169.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 122.676 2.251 . . . . 0.0 112.491 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.72 -17.92 15.35 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.5 m -103.36 -169.44 1.65 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.827 0.346 . . . . 0.0 110.269 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.6 m -132.17 155.58 47.94 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.579 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -132.07 155.25 48.41 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.027 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.446 ' ND2' ' OD1' ' A' ' 6' ' ' ASP . 3.2 t-20 -112.81 145.14 41.14 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.364 0.602 . . . . 0.0 110.858 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 5' ' ' PRO . 58.6 t -83.54 127.43 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.14 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 50' ' ' HIS . 2.3 p -70.42 -39.3 76.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.132 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -173.67 160.56 3.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.564 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 70.5 t -136.17 112.11 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.64 109.81 45.59 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 119.494 -0.289 . . . . 0.0 110.928 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.542 ' C ' ' H ' ' A' ' 46' ' ' GLY . 31.7 Cg_exo -57.81 -12.52 12.09 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 121.838 1.692 . . . . 0.0 112.156 178.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 82.0 mt -51.58 -5.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.819 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.542 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 89.11 31.69 11.64 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.34 162.39 22.8 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -52.96 -170.74 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.885 1.723 . . . . 0.0 111.876 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.6 mm -109.64 113.57 44.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.428 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.489 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -96.62 127.75 42.91 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.433 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.1 pt -127.33 149.61 32.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.654 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -135.69 131.55 35.82 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.503 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 55' ' ' ARG . 2.7 p -125.52 137.48 53.94 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.074 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -39.05 -24.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.755 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.539 ' O ' HG13 ' A' ' 56' ' ' VAL . 84.8 mtt85 -84.96 -49.86 7.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.208 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 55' ' ' ARG . 16.0 m -161.2 -174.87 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.474 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.8 p -131.05 151.76 51.07 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.637 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.2 tp -154.21 151.91 29.73 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.274 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.407 HG22 ' CG ' ' A' ' 50' ' ' HIS . 45.0 t -118.91 129.5 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.1 mt -137.79 152.26 48.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.467 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.8 tpp85 -81.22 162.79 23.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.462 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -57.7 -37.59 73.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.021 0.438 . . . . 0.0 110.502 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -61.57 -41.24 97.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.175 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.13 -46.02 91.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.371 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.6 mp -60.92 -40.96 95.16 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.182 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.56 -51.37 69.74 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.454 -0.499 . . . . 0.0 110.445 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.99 -42.61 80.5 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.382 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.3 mt -60.92 134.55 57.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.304 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -78.01 108.06 11.01 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.758 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.2 m -131.03 160.71 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.806 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -147.72 145.75 28.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.514 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.37 135.77 53.74 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 C--N 1.331 -0.226 0 CA-C-O 120.854 0.359 . . . . 0.0 110.438 -179.499 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.67 154.59 59.62 Favored Pre-proline 0 N--CA 1.467 0.395 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.45 -32.9 59.38 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.477 2.118 . . . . 0.0 112.085 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 6' ' ' ASP . 47.8 p-10 -136.72 93.77 2.9 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.928 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.5 t -140.69 151.04 44.23 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.093 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -100.71 102.45 13.56 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 22.9 m0 -98.93 129.4 45.26 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.247 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -85.66 136.31 33.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.877 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.1 mt -91.2 119.07 37.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.1 m -102.16 -43.01 5.86 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.827 0.346 . . . . 0.0 110.33 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.06 -174.1 33.98 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.7 OUTLIER -95.0 157.1 16.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.901 0.381 . . . . 0.0 110.325 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.413 ' O ' HG22 ' A' ' 18' ' ' ILE . 6.8 t -85.23 171.89 11.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.599 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.409 ' N ' ' OG ' ' A' ' 15' ' ' SER . 89.6 mtm180 -68.48 -38.28 80.87 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.869 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -75.81 -6.01 48.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.434 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.413 HG22 ' O ' ' A' ' 15' ' ' SER . 9.3 tp -41.9 147.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.601 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.45 155.66 87.49 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.436 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.32 -30.1 63.44 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.535 2.156 . . . . 0.0 112.028 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.89 -53.46 31.99 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.004 0.43 . . . . 0.0 111.161 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -63.68 -46.33 86.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.342 0.591 . . . . 0.0 110.268 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -56.46 -44.51 80.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.96 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 28' ' ' SER . 39.5 mm-40 -64.07 -31.57 72.8 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -59.09 -48.91 79.87 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.469 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.453 HD22 ' N ' ' A' ' 26' ' ' LEU . 4.5 mm? -64.7 -40.7 95.81 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.104 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.2 tp -69.37 -34.33 74.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.219 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 24' ' ' GLN . 11.9 t -59.44 -44.67 92.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.4 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.548 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -116.36 167.9 10.62 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.269 -179.631 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.81 7.91 80.55 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 94.2 mtp -77.6 73.96 4.16 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.4 mp -93.77 169.21 10.41 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.576 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 32' ' ' LEU . 54.0 Cg_exo -48.6 -170.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.317 2.011 . . . . 0.0 112.333 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.83 5.34 20.44 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.0 t -145.43 -172.31 3.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.759 0.314 . . . . 0.0 110.366 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.5 t -130.11 155.75 45.67 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.496 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -131.84 164.57 25.76 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.27 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 38' ' ' ASN . 12.8 p-10 -116.64 149.68 39.35 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.518 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.5 t -88.31 125.21 41.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.501 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.2 p -67.51 -42.54 87.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.348 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.48 ' NH2' ' ND1' ' A' ' 50' ' ' HIS . 37.0 ptt-85 -170.1 160.19 7.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.409 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 86.4 t -129.24 127.58 65.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.407 ' HB1' ' OD1' ' A' ' 47' ' ' ASP . . . -93.39 110.93 49.8 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.507 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -76.28 -11.39 19.21 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.073 1.848 . . . . 0.0 112.415 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.522 ' N ' HD12 ' A' ' 45' ' ' LEU . 10.5 mp -59.29 -30.63 68.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.579 -178.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.39 28.23 1.36 Allowed Glycine 0 N--CA 1.468 0.78 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -97.9 178.72 1.25 Allowed Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 47' ' ' ASP . 19.2 Cg_exo -64.13 -179.14 0.73 Allowed 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.974 1.783 . . . . 0.0 111.888 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.0 mm -103.6 117.95 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.528 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.48 ' ND1' ' NH2' ' A' ' 41' ' ' ARG . 10.8 m170 -96.37 117.47 30.91 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.2 pt -118.66 147.38 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.431 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.413 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 84.2 tt0 -134.26 112.04 10.73 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.217 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 54' ' ' ARG . 1.2 p -86.46 172.56 10.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.766 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 53' ' ' THR . 95.5 mtt180 -34.02 -51.84 0.43 Allowed 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.479 0.487 . . . . 0.0 111.929 -178.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.6 tpt85 -142.03 31.68 1.58 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.619 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -141.96 138.08 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.541 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.3 t -116.9 131.91 56.83 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.35 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.1 tp -145.87 146.38 31.09 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.932 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.427 HG23 ' CD2' ' A' ' 50' ' ' HIS . 4.9 p -136.93 127.2 39.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.8 mt -138.17 165.38 26.8 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.587 0.232 . . . . 0.0 110.428 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -74.0 148.14 42.31 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 120.94 0.4 . . . . 0.0 111.275 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -43.94 -41.77 5.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.184 0.516 . . . . 0.0 110.807 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -57.98 -40.63 81.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.387 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -60.05 -42.66 94.97 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.477 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.554 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.0 mm? -62.05 -42.07 98.79 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.59 -48.48 81.51 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.669 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.37 -39.26 85.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.873 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 38.5 mt -62.78 138.99 58.66 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.341 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -83.14 102.15 11.66 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.488 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.1 m -127.07 152.35 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.306 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -144.04 123.46 13.12 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.708 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.11 145.73 53.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.111 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.466 0.349 0 CA-C-O 120.762 0.315 . . . . 0.0 110.671 -179.905 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 . . . . . 0 CA--C 1.519 -0.217 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.48 157.26 78.76 Favored Pre-proline 0 N--CA 1.466 0.342 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 39' ' ' VAL . 52.2 Cg_exo -50.19 -35.22 42.22 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.03 1.82 . . . . 0.0 112.768 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -136.56 96.54 3.36 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.708 0.29 . . . . 0.0 110.328 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.86 130.99 42.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.982 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.3 102.32 15.04 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 20.1 m0 -105.5 143.67 33.33 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.185 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -95.57 147.75 23.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.817 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 46.9 mt -100.12 123.0 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.8 m -103.86 -47.88 4.08 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.795 0.331 . . . . 0.0 110.405 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 160.6 169.9 24.49 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.9 OUTLIER -83.4 151.22 25.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.916 0.389 . . . . 0.0 110.546 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.2 t -82.46 174.36 11.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.538 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -70.74 -40.09 72.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.0 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -70.77 -10.4 59.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.305 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.3 tp -41.38 149.51 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.776 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.66 154.25 87.38 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.368 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.52 -30.96 51.78 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.528 2.152 . . . . 0.0 112.179 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.43 -54.36 25.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.921 0.391 . . . . 0.0 111.286 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -63.76 -45.72 88.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.351 0.596 . . . . 0.0 110.194 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.404 ' NH1' HD11 ' A' ' 27' ' ' LEU . 68.2 ttp85 -57.89 -44.72 86.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.293 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 69.5 tp60 -61.78 -34.2 75.45 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -59.68 -48.41 81.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.067 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.417 ' HA ' HD13 ' A' ' 26' ' ' LEU . 4.5 mm? -61.88 -41.38 97.81 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.597 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.404 HD11 ' NH1' ' A' ' 23' ' ' ARG . 87.0 mt -61.8 -39.81 93.02 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.448 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.1 m -82.66 -12.98 57.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.849 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.446 ' HG ' ' H ' ' A' ' 31' ' ' MET . 12.4 tp -95.85 124.54 39.91 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.799 0.333 . . . . 0.0 110.15 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.87 13.1 32.44 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.464 ' CE ' HH21 ' A' ' 55' ' ' ARG . 68.6 mtp -118.49 75.66 1.03 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.26 0.552 . . . . 0.0 109.531 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.496 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.7 mp -78.7 166.69 40.8 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.839 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.496 ' O ' ' O ' ' A' ' 32' ' ' LEU . 80.1 Cg_exo -40.56 175.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.666 2.244 . . . . 0.0 112.747 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.71 12.49 6.59 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.6 t -140.8 -156.37 0.67 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.836 0.351 . . . . 0.0 110.266 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.0 t -147.7 153.79 39.75 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.839 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.45 ' CE1' HG21 ' A' ' 51' ' ' ILE . 45.3 p90 -129.76 149.97 51.27 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.492 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -108.06 144.13 35.82 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.316 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 5' ' ' PRO . 12.5 t -81.05 121.02 33.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.488 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 50' ' ' HIS . 2.0 p -68.34 -37.67 78.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.509 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -171.82 155.66 3.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.366 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.4 t -123.68 114.06 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.3 111.99 54.41 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.403 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.548 ' C ' ' H ' ' A' ' 46' ' ' GLY . 61.4 Cg_endo -75.0 -11.64 21.48 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.916 1.744 . . . . 0.0 112.269 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 45' ' ' LEU . 9.9 mp -60.14 5.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.954 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.548 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 88.63 29.51 18.56 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.41 160.01 29.81 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.43 172.44 2.63 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.969 2.446 . . . . 0.0 112.002 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.3 mm -91.48 113.26 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.893 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.429 ' O ' HG12 ' A' ' 40' ' ' VAL . 12.1 m-70 -94.53 125.09 38.96 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.162 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.45 HG21 ' CE1' ' A' ' 37' ' ' PHE . 36.3 pt -124.57 146.71 29.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.099 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -136.79 129.06 29.84 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.234 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -130.57 144.45 51.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.519 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -49.19 -33.19 11.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.937 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.464 HH21 ' CE ' ' A' ' 31' ' ' MET . 73.8 mtp85 -69.96 -43.92 70.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.714 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.835 HG22 ' H ' ' A' ' 57' ' ' SER . 9.8 p -170.05 -179.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.433 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.835 ' H ' HG22 ' A' ' 56' ' ' VAL . 20.7 t -128.49 150.94 49.94 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.247 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 52.7 tp -163.21 157.22 20.14 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.036 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.609 ' C ' HD12 ' A' ' 60' ' ' LEU . 3.5 p -130.98 131.79 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.609 HD12 ' C ' ' A' ' 59' ' ' VAL . 10.3 mp -126.33 150.6 48.42 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.645 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' A' ' 64' ' ' ASP . 88.6 mtm180 -79.03 143.65 35.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.286 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -40.47 -40.92 1.31 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.125 0.488 . . . . 0.0 111.124 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -61.19 -42.32 98.36 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.368 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 61' ' ' ARG . 98.1 m-20 -61.4 -38.51 87.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.229 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.498 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.1 mm? -62.58 -42.72 99.73 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.14 -51.25 70.83 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.154 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.426 ' N ' HD22 ' A' ' 67' ' ' LEU . 4.1 mm? -68.56 -39.76 80.91 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.178 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.16 134.11 56.12 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -83.14 114.55 21.41 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.077 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 m -132.09 161.85 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.022 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -146.13 144.77 30.19 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.506 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.66 147.45 52.68 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.1 t . . . . . 0 N--CA 1.464 0.253 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.512 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 . . . . . 0 C--O 1.232 0.16 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -143.3 153.3 59.29 Favored Pre-proline 0 N--CA 1.464 0.264 0 C-N-CA 121.136 -0.226 . . . . 0.0 110.404 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 39' ' ' VAL . 34.9 Cg_exo -50.96 -43.02 49.91 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.626 1.551 . . . . 0.0 112.407 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 6' ' ' ASP . 48.0 p-10 -135.29 98.45 3.97 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.946 0.403 . . . . 0.0 111.526 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.516 ' HG1' ' HD1' ' A' ' 9' ' ' TRP . 1.2 t -131.9 143.92 50.48 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.241 178.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -87.54 102.68 14.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.516 ' HD1' ' HG1' ' A' ' 7' ' ' THR . 11.5 m0 -103.17 136.09 43.61 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 -178.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.0 tttt -91.88 143.97 25.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.773 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 48.9 mt -101.43 119.13 49.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 6.6 p -108.63 -19.14 13.53 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.773 0.321 . . . . 0.0 110.588 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.04 -177.59 23.39 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.101 -0.799 . . . . 0.0 111.101 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -104.76 150.43 24.77 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.808 0.337 . . . . 0.0 110.41 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.471 ' O ' HG22 ' A' ' 18' ' ' ILE . 8.3 t -77.86 170.24 16.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.854 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -70.7 -39.48 73.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.106 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -66.83 -14.81 63.1 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.002 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.478 ' CG2' ' HE ' ' A' ' 23' ' ' ARG . 10.0 tp -41.23 149.34 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.759 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.35 154.5 88.04 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.981 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.25 -30.09 64.12 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.534 2.156 . . . . 0.0 112.362 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.3 -52.06 45.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.468 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -63.13 -46.7 86.04 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.59 0.71 . . . . 0.0 110.527 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.478 ' HE ' ' CG2' ' A' ' 18' ' ' ILE . 33.9 ttm180 -58.42 -48.51 80.46 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.407 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -59.84 -30.84 69.23 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -57.5 -44.23 84.84 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 29' ' ' LEU . 4.6 mm? -61.8 -42.62 99.24 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 120.071 -0.651 . . . . 0.0 109.647 178.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.45 HD22 ' N ' ' A' ' 27' ' ' LEU . 3.9 mm? -67.94 -33.59 74.96 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.788 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.7 t -60.1 -44.26 94.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.73 -178.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.524 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -118.19 170.3 8.98 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.033 0.444 . . . . 0.0 110.599 -179.602 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.64 4.18 81.93 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 58.6 mmm -73.34 73.76 1.34 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.1 mp -95.36 170.38 7.91 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.104 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 32' ' ' LEU . 52.9 Cg_exo -50.0 -165.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.402 2.068 . . . . 0.0 113.028 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.33 5.34 55.94 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 76.9 p -143.15 -172.93 3.78 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.733 0.301 . . . . 0.0 110.289 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.8 m -130.04 156.13 45.0 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.745 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.42 ' HB2' HG22 ' A' ' 53' ' ' THR . 42.5 p90 -128.5 153.56 47.03 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.989 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 39' ' ' VAL . 59.9 t-20 -108.74 147.07 32.55 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.662 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.525 ' N ' ' OD1' ' A' ' 38' ' ' ASN . 21.4 t -89.58 126.51 42.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.647 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 p -72.24 -41.76 66.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.716 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -173.32 154.98 2.78 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.419 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 42' ' ' VAL . 17.9 m -139.56 122.45 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.294 178.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -95.47 110.07 48.89 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.754 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.57 ' C ' ' H ' ' A' ' 46' ' ' GLY . 38.1 Cg_exo -61.56 -14.63 36.55 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 121.811 1.674 . . . . 0.0 111.869 178.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 78.3 mt -53.73 2.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.863 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.57 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 90.04 26.08 25.07 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.01 162.26 23.48 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.99 170.46 2.12 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.181 1.92 . . . . 0.0 111.39 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 60' ' ' LEU . 6.7 mm -96.85 115.97 37.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.606 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.456 ' CD2' HG23 ' A' ' 59' ' ' VAL . 13.6 m170 -93.77 120.47 34.07 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.401 ' O ' ' O ' ' A' ' 58' ' ' LEU . 47.0 pt -118.95 148.54 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.461 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.784 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -133.97 128.84 35.24 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.066 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.42 HG22 ' HB2' ' A' ' 37' ' ' PHE . 1.2 p -118.47 137.46 53.16 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -41.34 -35.86 0.72 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.256 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.54 ' O ' HG13 ' A' ' 56' ' ' VAL . 78.7 mmt-85 -70.02 -47.43 62.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.955 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 55' ' ' ARG . 16.3 m -160.6 -175.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.004 0.43 . . . . 0.0 111.049 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 t -116.6 142.39 46.95 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.551 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.401 ' O ' ' O ' ' A' ' 51' ' ' ILE . 63.6 tp -150.6 150.06 30.69 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.507 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.456 HG23 ' CD2' ' A' ' 50' ' ' HIS . 7.7 p -125.69 130.54 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 49' ' ' ILE . 94.3 mt -132.41 155.79 47.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.619 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -84.84 168.33 15.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.842 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -59.21 -43.42 92.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.532 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -59.22 -39.3 82.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.725 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -60.11 -45.7 92.07 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.453 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.54 -40.96 98.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.863 0.363 . . . . 0.0 110.15 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.99 -39.08 90.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.483 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.4 mt -82.08 -55.29 4.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.815 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 70.6 mt -46.74 132.88 11.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.398 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.407 ' O ' ' OG1' ' A' ' 12' ' ' THR . 96.8 mt-10 -76.27 108.87 9.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.5 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.36 161.58 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.634 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 31.0 tp10 -145.42 143.05 29.85 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.412 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.31 131.41 41.88 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 36.0 t . . . . . 0 C--N 1.327 -0.371 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.409 -179.506 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 . . . . . 0 CA--C 1.521 -0.135 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.9 151.5 78.32 Favored Pre-proline 0 N--CA 1.468 0.46 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 39' ' ' VAL . 43.3 Cg_endo -66.96 -33.68 31.83 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.659 2.24 . . . . 0.0 112.228 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -136.63 94.65 3.02 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.818 0.342 . . . . 0.0 110.995 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 t -140.4 148.19 40.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.246 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -96.02 102.07 13.82 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 19.2 m0 -99.34 137.46 37.82 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.25 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -93.41 130.29 39.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.863 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.6 mt -83.05 115.84 26.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.0 m -98.73 -43.72 6.68 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.849 0.357 . . . . 0.0 110.422 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.06 -179.79 31.7 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.8 p90 -95.89 147.67 23.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.855 0.359 . . . . 0.0 110.475 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.476 ' O ' HG22 ' A' ' 18' ' ' ILE . 5.7 m -78.47 172.93 12.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.517 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 85.6 mmt-85 -70.06 -40.35 75.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.607 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -65.72 -15.18 62.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.628 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.476 HG22 ' O ' ' A' ' 15' ' ' SER . 10.5 tp -41.58 148.43 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.636 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 92.6 p -83.05 144.83 48.08 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.713 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -50.17 -37.18 48.18 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.051 1.834 . . . . 0.0 112.692 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.24 -58.51 7.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.891 0.377 . . . . 0.0 111.414 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -64.33 -47.18 80.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.261 0.553 . . . . 0.0 110.681 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -57.56 -47.55 81.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.371 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 68.3 tp60 -60.18 -32.27 70.91 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.459 ' NZ ' HD11 ' A' ' 58' ' ' LEU . 31.1 ttmt -60.8 -44.36 96.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.895 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.53 HD13 HD11 ' A' ' 29' ' ' LEU . 4.6 mm? -62.25 -42.94 99.77 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.368 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.16 -39.9 96.0 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.743 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.1 t -60.71 -45.2 95.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.039 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.53 HD11 HD13 ' A' ' 26' ' ' LEU . 2.0 pp -92.74 133.94 35.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.502 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.7 -1.67 72.81 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 67.2 mtt -86.66 74.46 9.85 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -82.23 168.54 23.03 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.336 -179.096 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 32' ' ' LEU . 72.7 Cg_exo -43.4 177.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 122.451 2.101 . . . . 0.0 112.312 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.42 11.88 7.09 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 99.0 p -146.43 -161.94 1.42 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.845 0.355 . . . . 0.0 110.306 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.5 m -135.3 158.34 44.62 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.632 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -136.6 156.05 49.09 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.147 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -110.56 146.33 36.25 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.485 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.428 ' O ' ' O ' ' A' ' 5' ' ' PRO . 21.5 t -86.7 126.33 40.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.494 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.407 HG12 ' H ' ' A' ' 40' ' ' VAL . 2.2 p -68.02 -41.21 84.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.95 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -174.74 160.56 2.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.083 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.4 t -133.31 118.23 30.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.2 110.39 48.02 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.474 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -76.4 -11.55 18.99 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.292 1.995 . . . . 0.0 112.271 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.0 mt -56.98 -30.45 64.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.686 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.98 21.98 0.68 Allowed Glycine 0 N--CA 1.465 0.609 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.16 159.81 30.46 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -60.55 173.9 1.86 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.761 2.307 . . . . 0.0 111.819 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 60' ' ' LEU . 8.0 mm -93.07 114.1 29.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.325 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -93.63 125.47 38.27 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.296 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.4 pt -127.1 150.25 32.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.571 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -127.07 137.97 53.13 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.356 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 56' ' ' VAL . 0.8 OUTLIER -131.53 137.95 48.71 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.9 ptt-85 -42.73 -44.65 4.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.793 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 76.2 mmt-85 -65.12 -42.08 94.27 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.675 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.807 HG22 ' H ' ' A' ' 57' ' ' SER . 11.1 p -169.46 179.43 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.239 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.807 ' H ' HG22 ' A' ' 56' ' ' VAL . 8.1 p -123.16 150.6 43.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.165 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.528 HD23 ' N ' ' A' ' 59' ' ' VAL . 7.1 tt -159.68 162.82 35.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.395 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.528 ' N ' HD23 ' A' ' 58' ' ' LEU . 4.1 p -122.14 132.49 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.096 0.474 . . . . 0.0 110.661 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 49' ' ' ILE . 51.5 mt -124.79 157.58 35.44 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.36 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -91.01 170.95 9.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.011 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -61.08 -44.37 97.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.201 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -62.42 -37.35 85.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.564 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -59.96 -46.0 90.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.447 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.31 -42.16 98.99 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.083 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.47 -49.44 77.34 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.2 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.2 mt -69.71 -41.8 74.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.314 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.1 tp -63.12 134.19 55.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.27 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -83.24 115.01 21.77 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.227 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.1 m -134.04 155.34 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.554 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -141.15 142.45 34.06 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.675 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.74 145.73 46.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.255 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.465 0.298 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.231 -179.77 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 5.0 m-85 . . . . . 0 CA--C 1.519 -0.249 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.68 158.46 45.35 Favored Pre-proline 0 N--CA 1.469 0.503 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -51.14 -38.73 61.05 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.996 1.798 . . . . 0.0 112.735 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -136.79 94.62 3.0 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.76 129.22 43.85 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.16 102.13 14.85 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.423 ' CZ3' HD23 ' A' ' 65' ' ' LEU . 24.4 m0 -100.86 141.39 33.81 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.292 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -97.16 129.11 44.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.781 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.2 mt -80.62 122.56 36.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.061 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 6.2 p -109.12 -15.33 14.35 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.342 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.81 178.41 15.64 Favored Glycine 0 N--CA 1.466 0.686 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.5 p90 -99.36 153.36 19.04 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.464 ' O ' HG22 ' A' ' 18' ' ' ILE . 1.9 t -82.29 171.97 13.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.647 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.436 ' N ' ' OG ' ' A' ' 15' ' ' SER . 99.6 mtt180 -69.89 -40.67 75.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.835 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.425 ' HB3' HD22 ' A' ' 67' ' ' LEU . 31.5 tp10 -66.19 -14.94 62.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.297 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 15' ' ' SER . 10.5 tp -41.06 147.33 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.729 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.76 155.23 87.09 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.521 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.12 -31.57 64.79 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.577 2.185 . . . . 0.0 112.016 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.66 -54.39 32.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.892 0.377 . . . . 0.0 111.129 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -62.62 -45.5 92.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.466 0.65 . . . . 0.0 110.34 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -57.64 -42.7 83.95 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.811 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 28' ' ' SER . 58.3 tp60 -61.77 -37.3 83.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.063 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -60.54 -43.25 97.39 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 120.081 -0.647 . . . . 0.0 110.025 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.421 ' HA ' HD13 ' A' ' 26' ' ' LEU . 4.5 mm? -63.43 -40.12 96.33 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.401 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.4 tt -80.3 -26.45 38.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.437 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.46 ' N ' ' O ' ' A' ' 24' ' ' GLN . 15.0 t -60.59 -45.53 93.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.336 -178.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.512 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -107.16 163.55 12.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.247 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.63 34.24 4.11 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 94.7 mtp -108.71 73.92 0.89 Allowed 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 33' ' ' PRO . 3.3 mm? -81.59 154.55 71.18 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.142 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.471 ' O ' ' O ' ' A' ' 32' ' ' LEU . 77.3 Cg_exo -42.48 176.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 122.742 2.295 . . . . 0.0 112.537 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.24 12.05 7.11 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 95.7 p -136.94 -156.93 0.74 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.863 0.363 . . . . 0.0 110.268 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 97.3 p -146.61 161.36 40.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.459 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.429 ' HB2' HG22 ' A' ' 53' ' ' THR . 48.5 p90 -138.05 155.09 49.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.29 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 27.4 p30 -109.85 152.35 25.87 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.534 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.6 t -92.96 125.26 45.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.503 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.408 ' H ' HG12 ' A' ' 40' ' ' VAL . 1.7 p -67.14 -41.69 87.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.026 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.607 ' NH2' ' ND1' ' A' ' 50' ' ' HIS . 37.7 ptt-85 -172.12 157.2 4.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.252 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.6 t -126.33 120.21 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.22 110.56 49.08 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.355 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -76.53 -12.24 18.62 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.008 1.805 . . . . 0.0 112.213 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.1 tp -57.63 -31.29 66.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.873 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.87 25.97 0.8 Allowed Glycine 0 N--CA 1.464 0.532 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.2 159.69 30.7 Favored Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.432 ' HG2' ' HE2' ' A' ' 50' ' ' HIS . 17.5 Cg_endo -56.56 175.7 0.26 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.838 2.359 . . . . 0.0 111.764 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.454 ' N ' ' O ' ' A' ' 60' ' ' LEU . 7.2 mm -92.5 114.21 29.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.936 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.607 ' ND1' ' NH2' ' A' ' 41' ' ' ARG . 15.8 m170 -94.32 119.91 33.78 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.872 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 58' ' ' LEU . 48.2 pt -126.11 149.87 31.26 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.221 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 12.5 tm-20 -132.68 130.11 39.67 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.188 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.429 HG22 ' HB2' ' A' ' 37' ' ' PHE . 1.4 p -116.06 137.14 52.38 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.701 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.414 ' H ' ' HG3' ' A' ' 54' ' ' ARG . 79.5 mtp180 -39.08 -36.76 0.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.818 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.548 ' O ' HG13 ' A' ' 56' ' ' VAL . 32.9 mmt180 -71.11 -49.05 48.45 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.147 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 55' ' ' ARG . 15.2 m -160.81 -176.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.95 0.405 . . . . 0.0 110.501 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 m -109.06 148.18 31.2 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.741 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' A' ' 51' ' ' ILE . 63.0 tp -152.61 149.16 28.17 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.4 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 59' ' ' VAL . 13.4 p -128.84 129.76 68.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.624 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 49' ' ' ILE . 76.3 mt -133.59 163.8 28.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.325 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -93.66 164.23 13.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.492 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -55.91 -39.09 71.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.035 0.445 . . . . 0.0 110.288 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -62.0 -40.94 97.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.729 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -60.43 -43.86 96.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.151 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.423 HD23 ' CZ3' ' A' ' 9' ' ' TRP . 10.8 mp -62.64 -42.22 99.48 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.31 -50.32 74.04 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.243 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.425 HD22 ' HB3' ' A' ' 17' ' ' GLU . 98.3 mt -68.79 -41.1 79.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.2 tp -65.1 131.22 45.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.107 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.444 ' O ' ' OG1' ' A' ' 12' ' ' THR . 94.3 mt-10 -78.19 115.29 17.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.181 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.418 HG21 ' CE3' ' A' ' 9' ' ' TRP . 27.0 m -136.4 160.2 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.419 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -141.0 132.34 26.69 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.156 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.31 135.33 54.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.884 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 85.0 t . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.176 -179.906 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 . . . . . 0 CA--C 1.516 -0.336 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.22 154.92 65.41 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.47 -179.312 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' A' ' 39' ' ' VAL . 51.8 Cg_exo -51.18 -36.51 56.11 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.075 1.85 . . . . 0.0 112.793 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -131.98 98.64 4.5 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.748 0.308 . . . . 0.0 110.371 -179.201 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.55 129.71 31.31 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -88.47 102.1 14.57 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 22.4 m0 -105.13 144.39 31.99 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.118 -179.092 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -100.46 132.05 46.05 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.185 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 34.2 mt -82.03 120.54 33.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.672 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.5 m -102.39 -40.49 6.7 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.374 179.696 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 161.14 175.34 32.06 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -96.47 143.55 27.39 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.619 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.536 ' O ' HG22 ' A' ' 18' ' ' ILE . 3.6 m -72.0 167.01 21.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.677 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -66.49 -39.02 88.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.333 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.98 -17.61 64.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.812 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 15' ' ' SER . 10.6 tp -41.88 146.36 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.398 -179.399 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.0 p -81.9 147.98 59.71 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.561 -179.324 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -49.85 -41.97 45.64 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.848 1.699 . . . . 0.0 112.644 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.95 -57.87 7.46 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.158 -178.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -63.23 -44.41 95.32 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.469 0.652 . . . . 0.0 110.734 -179.617 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -57.8 -46.09 85.14 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.989 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 28' ' ' SER . 78.0 mt-30 -64.59 -31.98 73.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.752 179.205 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.6 mmtt -59.77 -42.64 93.76 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 119.891 -0.723 . . . . 0.0 109.241 179.277 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.512 HD12 ' HD3' ' A' ' 33' ' ' PRO . 4.6 mm? -64.51 -41.29 96.51 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.794 178.43 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 45.0 mt -79.68 -16.12 56.3 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.895 0.379 . . . . 0.0 110.945 -179.465 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 24' ' ' GLN . 37.2 t -59.45 -41.56 89.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.035 -179.045 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.773 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -124.16 -171.16 2.27 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.948 -179.498 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.13 43.2 2.04 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -179.334 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.481 ' SD ' HD11 ' A' ' 29' ' ' LEU . 64.1 mtt -120.12 71.98 0.92 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.883 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.485 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.1 mm? -82.98 152.05 64.88 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.333 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.512 ' HD3' HD12 ' A' ' 26' ' ' LEU . 77.2 Cg_exo -41.88 171.6 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.586 2.191 . . . . 0.0 112.366 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.51 -12.94 18.47 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 179.311 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.2 m -96.11 -156.68 0.54 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.893 0.378 . . . . 0.0 110.347 179.719 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.7 p -150.37 160.57 43.64 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.447 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -146.21 165.96 27.63 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.507 -179.68 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -126.13 143.88 50.96 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.267 0.556 . . . . 0.0 110.57 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.443 ' O ' ' O ' ' A' ' 5' ' ' PRO . 61.5 t -78.54 128.97 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.219 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.9 p -76.1 -40.44 37.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.09 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -173.16 160.95 4.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.097 -179.055 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 55.2 t -126.25 131.19 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -92.82 111.29 50.54 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-O 119.451 -0.309 . . . . 0.0 110.321 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.29 -13.11 18.94 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.923 1.748 . . . . 0.0 112.056 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.1 tp -61.98 -32.08 72.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.646 -179.001 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 127.79 30.01 0.78 Allowed Glycine 0 N--CA 1.464 0.542 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.89 173.29 4.08 Favored Pre-proline 0 CA--C 1.534 0.327 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -179.35 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -61.46 -170.94 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.141 1.894 . . . . 0.0 111.503 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.4 mm -108.17 114.48 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -88.45 124.5 34.03 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.285 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.2 pt -129.21 144.25 38.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.397 179.691 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -124.17 114.34 19.51 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.125 179.626 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 56' ' ' VAL . 0.7 OUTLIER -105.83 137.82 43.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.895 -179.585 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -41.43 -42.42 2.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.474 -179.503 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -67.12 -44.6 79.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.718 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.683 HG22 ' N ' ' A' ' 57' ' ' SER . 14.8 p -170.28 172.85 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.499 -179.71 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.683 ' N ' HG22 ' A' ' 56' ' ' VAL . 94.2 p -111.52 153.8 25.68 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.561 179.409 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.2 tt -161.35 159.66 28.66 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.585 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 59' ' ' VAL . 11.9 p -114.96 130.45 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.824 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.628 HD23 HD12 ' A' ' 65' ' ' LEU . 1.3 tp -133.53 152.34 51.89 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.035 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -82.63 161.64 22.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.626 -179.617 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.1 -45.94 91.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.644 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.69 -40.4 87.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.853 -179.7 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.46 -40.32 96.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.262 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.628 HD12 HD23 ' A' ' 60' ' ' LEU . 2.3 mp -61.64 -44.47 96.92 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.62 -42.45 98.9 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.28 -179.809 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.425 ' O ' ' OG ' ' A' ' 15' ' ' SER . 94.2 mt -68.02 -41.13 82.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.669 179.698 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.1 tp -64.95 131.03 45.54 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.066 -179.625 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -74.76 114.47 13.24 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.154 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.9 m -132.57 158.19 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.647 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -143.55 135.69 26.81 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.694 -179.766 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.37 129.29 37.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.345 179.782 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.3 t . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.854 -179.739 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 . . . . . 0 N--CA 1.456 -0.142 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.18 155.71 72.4 Favored Pre-proline 0 N--CA 1.466 0.325 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.154 -179.44 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 39' ' ' VAL . 40.9 Cg_endo -66.43 -22.1 52.63 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.653 2.235 . . . . 0.0 112.192 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -137.11 93.4 2.82 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.709 0.29 . . . . 0.0 110.325 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.92 130.71 25.94 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.12 102.46 15.0 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 18.3 m0 -102.22 140.63 36.24 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.884 0.373 . . . . 0.0 110.17 -179.211 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -98.15 128.51 44.68 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.536 179.702 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.7 mt -81.85 124.49 39.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.232 -179.302 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -109.35 -44.06 3.99 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.49 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.32 -176.68 39.47 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -100.63 150.15 23.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.854 0.359 . . . . 0.0 110.479 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.414 ' O ' HG22 ' A' ' 18' ' ' ILE . 2.3 t -78.24 169.86 17.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.564 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -69.74 -39.24 76.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.925 0.393 . . . . 0.0 110.784 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -66.83 -14.94 63.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.451 -179.707 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.414 HG22 ' O ' ' A' ' 15' ' ' SER . 10.5 tp -40.63 146.86 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.545 -179.473 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.9 m -79.5 143.84 60.25 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.507 -179.391 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -47.99 -41.06 33.41 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.917 1.745 . . . . 0.0 112.663 179.209 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.13 -55.99 19.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.86 0.362 . . . . 0.0 111.492 -178.888 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -63.24 -47.26 83.2 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.476 0.655 . . . . 0.0 110.623 -179.592 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -56.78 -44.87 82.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.999 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -60.43 -35.81 76.69 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.024 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -56.73 -46.71 81.16 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 29' ' ' LEU . 4.5 mm? -63.05 -43.44 98.63 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.506 179.488 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.58 -31.3 68.26 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.721 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.0 t -58.94 -45.03 91.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.228 -179.163 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.471 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -119.22 174.84 6.1 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.39 -179.697 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -90.67 0.16 76.57 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 46.3 tpp -66.85 73.7 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.5 mp -99.59 169.47 8.05 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.369 -179.041 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 32' ' ' LEU . 61.7 Cg_exo -49.96 -166.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.242 1.961 . . . . 0.0 112.256 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.94 4.98 51.04 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.728 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.1 m -140.65 -169.92 2.9 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.925 0.393 . . . . 0.0 110.259 179.794 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.2 p -134.04 158.74 42.8 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.194 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -137.72 163.87 30.25 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.218 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.46 ' OD1' ' N ' ' A' ' 38' ' ' ASN . 12.1 p-10 -121.66 150.28 41.98 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.314 0.578 . . . . 0.0 110.387 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.438 ' O ' ' O ' ' A' ' 5' ' ' PRO . 14.8 t -85.41 128.73 38.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.504 -179.651 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 p -68.95 -40.93 81.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.248 179.682 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -174.85 167.27 3.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.994 -179.198 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.6 m -133.51 125.1 49.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.084 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.76 111.21 51.76 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.582 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -76.24 -11.91 19.21 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.051 1.834 . . . . 0.0 112.311 179.798 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.526 ' N ' HD12 ' A' ' 45' ' ' LEU . 10.6 mp -61.52 -32.23 72.27 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.809 -178.882 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.2 26.48 0.82 Allowed Glycine 0 N--CA 1.466 0.669 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.27 160.32 29.18 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -55.71 173.72 0.35 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.698 2.265 . . . . 0.0 111.855 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.4 mm -92.84 118.0 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.771 -179.376 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.435 ' CD2' HG23 ' A' ' 59' ' ' VAL . 12.7 m170 -97.02 123.7 40.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.03 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.8 pt -127.33 148.88 32.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.719 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 97.0 mt-10 -134.95 112.16 10.4 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.094 179.593 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.425 ' O ' ' C ' ' A' ' 54' ' ' ARG . 1.2 p -85.52 173.93 9.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.889 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 53' ' ' THR . 99.9 mtt180 -33.55 -52.95 0.41 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.708 -178.186 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 57.4 ttp85 -142.93 32.29 1.4 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.016 179.431 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -140.62 136.98 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.489 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.6 t -113.7 130.47 56.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.237 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.403 HD21 HD11 ' A' ' 60' ' ' LEU . 59.9 tp -145.62 148.09 32.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.111 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.435 HG23 ' CD2' ' A' ' 50' ' ' HIS . 3.8 p -136.4 123.6 32.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.32 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.403 HD11 HD21 ' A' ' 58' ' ' LEU . 94.4 mt -140.68 173.16 11.76 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.443 -179.513 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.9 mtm-85 -84.05 163.31 19.96 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.922 0.391 . . . . 0.0 110.91 -179.519 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -58.73 -34.37 71.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.517 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -60.6 -40.25 91.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.546 179.78 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -61.56 -43.84 98.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.512 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 mp -61.58 -42.12 98.4 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.897 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.79 -44.24 97.26 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.326 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.6 mt -68.75 -41.19 79.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.042 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 63.7 mt -64.06 137.64 58.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.875 0.369 . . . . 0.0 110.611 -179.477 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -79.39 108.58 13.02 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.215 -179.465 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.4 m -134.95 156.54 39.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.479 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -138.92 128.06 23.97 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.595 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.1 134.58 48.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.095 179.675 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.8 m . . . . . 0 N--CA 1.466 0.333 0 CA-C-O 121.029 0.443 . . . . 0.0 110.348 179.975 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 . . . . . 0 CA--C 1.516 -0.351 0 CA-C-O 120.917 0.389 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.07 154.44 40.63 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.424 -179.101 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 39' ' ' VAL . 41.2 Cg_endo -67.33 -37.42 17.89 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.672 2.248 . . . . 0.0 112.243 179.733 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -136.56 95.95 3.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.626 -179.596 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -140.07 147.76 40.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.383 179.651 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -97.25 101.8 13.43 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.632 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 28.7 m0 -98.02 142.95 29.1 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.341 -179.34 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -99.78 131.37 45.8 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.881 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.0 mt -80.98 125.58 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.467 -179.386 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.4 m -104.93 -51.95 2.95 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.475 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 168.14 167.78 29.29 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.0 OUTLIER -87.7 148.26 24.85 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 179.616 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.528 ' O ' HG22 ' A' ' 18' ' ' ILE . 43.7 t -80.68 171.05 15.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.659 179.874 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -67.16 -38.85 86.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.343 179.673 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -65.4 -18.31 65.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.689 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.528 HG22 ' O ' ' A' ' 15' ' ' SER . 10.8 tp -41.91 147.27 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.822 -179.698 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.58 158.19 81.37 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.28 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.88 -32.39 45.62 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.663 2.242 . . . . 0.0 111.958 179.63 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.15 -57.42 11.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.018 0.437 . . . . 0.0 110.979 -179.465 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -61.27 -45.29 95.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.603 0.716 . . . . 0.0 110.322 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -56.51 -42.86 79.08 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.192 -179.65 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 28' ' ' SER . 62.8 mt-30 -62.15 -37.2 84.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.414 179.41 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -58.81 -43.34 90.58 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.811 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.6 mm? -64.68 -41.71 95.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.262 0.553 . . . . 0.0 110.575 179.638 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.4 tt -78.73 -26.21 44.67 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.19 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 24' ' ' GLN . 14.4 t -61.19 -45.18 95.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.273 -178.994 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.5 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -112.03 169.27 8.97 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.237 -179.742 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.05 40.76 2.95 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.571 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.549 ' SD ' ' CZ ' ' A' ' 55' ' ' ARG . 38.0 ttp -108.82 72.11 0.81 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.188 0.518 . . . . 0.0 109.793 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.506 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.2 mm? -82.74 151.88 65.31 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.566 -179.276 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 32' ' ' LEU . 73.9 Cg_exo -41.96 175.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 122.49 2.126 . . . . 0.0 112.009 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.5 -21.22 9.27 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.783 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.8 m -97.63 -174.43 2.9 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.514 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.8 m -133.6 151.68 51.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.332 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.424 ' HB2' HG22 ' A' ' 53' ' ' THR . 52.2 p90 -133.17 155.04 50.02 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.109 -179.925 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -109.05 145.0 36.33 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.318 0.58 . . . . 0.0 110.713 -179.669 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.446 ' O ' ' O ' ' A' ' 5' ' ' PRO . 48.8 t -89.45 125.05 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.18 -179.908 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.428 HG12 ' H ' ' A' ' 40' ' ' VAL . 2.2 p -69.11 -40.44 80.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.965 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.2 ptt-85 -176.82 166.84 2.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.006 -178.918 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 42' ' ' VAL . 27.9 m -132.67 122.31 46.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.031 179.299 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.89 111.98 56.47 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.543 ' C ' ' H ' ' A' ' 46' ' ' GLY . 59.2 Cg_endo -75.75 -11.98 20.12 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.642 2.228 . . . . 0.0 112.013 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.9 mt -61.83 4.91 0.1 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.955 -179.191 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.543 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 91.07 24.98 25.66 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.42 160.07 30.46 Favored Pre-proline 0 C--N 1.332 -0.176 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.62 168.01 4.55 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.809 2.339 . . . . 0.0 111.749 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.9 mm -90.12 118.23 34.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.097 0.475 . . . . 0.0 110.074 -179.362 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.414 ' O ' HG12 ' A' ' 40' ' ' VAL . 12.5 m170 -96.72 121.52 38.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.064 179.535 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.1 pt -123.84 147.73 28.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.141 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -129.85 135.27 48.19 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.471 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 56' ' ' VAL . 1.7 p -123.94 143.57 50.3 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.911 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -54.27 -18.32 3.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.771 -178.726 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.549 ' CZ ' ' SD ' ' A' ' 31' ' ' MET . 16.8 ptm180 -97.97 -31.31 12.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.891 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.716 HG22 ' H ' ' A' ' 57' ' ' SER . 4.2 p -170.22 179.37 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.969 0.414 . . . . 0.0 110.393 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.716 ' H ' HG22 ' A' ' 56' ' ' VAL . 54.3 m -124.25 155.91 37.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.478 178.711 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.4 tp -158.66 151.71 22.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.292 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.414 HG23 ' CD2' ' A' ' 50' ' ' HIS . 4.4 p -135.82 126.68 43.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.025 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.8 mt -131.56 161.8 31.78 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.505 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -78.23 150.86 33.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.569 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -44.71 -47.22 10.66 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.279 0.561 . . . . 0.0 110.857 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -52.96 -34.63 56.58 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.263 -179.764 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -63.6 -40.78 97.8 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.348 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.61 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.0 mm? -63.33 -43.21 98.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.076 -179.285 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.84 -47.25 85.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.207 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.8 mt -68.31 -41.81 80.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.567 179.77 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 49.7 tp -64.63 131.47 47.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.26 -179.661 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -81.55 114.32 20.18 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.441 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.4 m -130.98 156.42 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.335 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -137.39 125.55 23.04 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.444 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.03 138.98 52.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.281 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.463 0.21 0 CA-C-O 120.886 0.374 . . . . 0.0 110.285 -179.875 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 . . . . . 0 CA--C 1.519 -0.232 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 p -128.45 152.17 77.84 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.491 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.57 -40.82 54.66 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.944 1.763 . . . . 0.0 112.765 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -135.24 101.22 4.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.021 0.439 . . . . 0.0 111.036 -179.297 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -137.86 142.8 40.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.393 179.143 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.66 102.21 14.38 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.565 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 18.9 m0 -100.65 137.04 39.58 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.394 -179.254 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -91.57 143.89 26.11 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.768 179.515 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.5 mt -97.2 117.01 41.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.316 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.9 m -101.7 -47.04 4.75 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.597 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 162.16 176.63 34.44 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.4 p90 -92.11 148.4 22.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.219 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.442 ' OG ' ' N ' ' A' ' 16' ' ' ARG . 1.9 t -75.89 172.18 13.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.528 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.442 ' N ' ' OG ' ' A' ' 15' ' ' SER . 35.8 ptt-85 -71.54 -37.13 71.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.665 179.712 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -69.67 -13.84 62.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.327 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 15' ' ' SER . 10.6 tp -41.35 149.44 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.516 -179.566 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.4 p -79.21 140.65 57.05 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.522 -179.541 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -47.44 -40.95 29.46 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 121.941 1.761 . . . . 0.0 112.703 179.061 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.98 -56.71 16.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.903 0.383 . . . . 0.0 111.19 -178.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -61.7 -44.35 97.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.285 0.564 . . . . 0.0 110.484 -179.708 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -58.62 -43.19 89.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.935 -179.386 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -62.81 -37.07 85.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.977 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -58.4 -47.35 84.17 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -63.21 -38.98 93.31 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.098 179.627 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.6 tp -60.34 -44.26 95.67 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.108 -179.39 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.5 m -75.97 -33.15 59.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.805 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.453 ' HG ' ' H ' ' A' ' 31' ' ' MET . 8.4 tp -71.34 129.47 38.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.259 -179.327 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.63 2.49 87.26 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.453 ' H ' ' HG ' ' A' ' 29' ' ' LEU . 24.0 tpp -109.39 75.78 0.97 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.068 0.461 . . . . 0.0 109.854 179.484 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.2 mp -79.42 165.82 45.68 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.858 -179.213 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.479 ' O ' ' O ' ' A' ' 32' ' ' LEU . 71.4 Cg_exo -40.34 172.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.578 2.185 . . . . 0.0 112.393 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.42 8.64 9.09 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.551 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 t -137.2 -157.52 0.78 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.903 0.382 . . . . 0.0 110.207 179.563 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.9 m -145.33 157.96 43.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.445 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -139.35 153.75 47.74 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.378 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -107.06 147.95 29.35 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.342 0.591 . . . . 0.0 110.682 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.6 t -88.12 126.49 41.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.241 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 50' ' ' HIS . 2.4 p -64.66 -39.9 87.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.891 179.899 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -174.08 161.13 3.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.096 -179.474 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 55.8 t -126.39 125.23 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.773 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.02 111.69 54.13 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.43 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.67 -11.99 20.26 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.202 1.934 . . . . 0.0 112.0 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.8 tp -58.68 -31.55 68.32 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.832 -178.97 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.71 32.98 1.13 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -100.24 179.45 1.02 Allowed Pre-proline 0 N--CA 1.466 0.343 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.463 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 47' ' ' ASP . 24.0 Cg_exo -62.7 -178.19 0.37 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.36 2.04 . . . . 0.0 111.71 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.3 mm -107.87 119.9 58.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.449 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.416 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -102.31 123.09 45.49 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.816 179.644 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.8 pt -127.81 152.13 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.054 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -123.52 135.61 54.12 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.08 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 56' ' ' VAL . 1.4 p -131.45 140.88 49.7 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.859 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -38.85 -37.3 0.33 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.565 -179.469 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.3 ttp85 -75.34 -49.4 19.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.777 179.608 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.844 HG22 ' H ' ' A' ' 57' ' ' SER . 10.2 p -171.73 -179.59 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.621 -179.564 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.844 ' H ' HG22 ' A' ' 56' ' ' VAL . 1.7 t -107.72 164.08 12.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.13 178.724 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.417 HD21 HD11 ' A' ' 60' ' ' LEU . 58.8 tp -149.15 146.31 27.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.205 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.4 t -127.9 124.41 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.79 178.969 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.417 HD11 HD21 ' A' ' 58' ' ' LEU . 89.6 mt -144.55 167.32 22.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.71 179.813 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -81.94 147.91 29.0 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.036 0.446 . . . . 0.0 111.424 -179.668 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -42.2 -40.99 2.56 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.701 -179.684 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -55.44 -38.81 69.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.547 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -61.75 -41.01 97.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.431 179.869 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.637 HD22 ' N ' ' A' ' 65' ' ' LEU . 3.3 mm? -62.84 -42.14 99.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.972 -179.301 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.65 98.13 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.048 179.608 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.36 -41.96 79.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.035 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.0 mt -68.36 135.71 52.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.861 0.362 . . . . 0.0 110.222 -179.65 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -81.31 111.35 17.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.283 -179.693 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.4 m -130.97 156.36 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.632 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -144.07 146.82 33.08 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.907 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.65 143.0 56.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.105 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.9 t . . . . . 0 N--CA 1.463 0.218 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.343 -179.775 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 . . . . . 0 N--CA 1.456 -0.139 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.01 156.91 70.23 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.092 -179.371 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -67.73 -50.25 0.93 Allowed 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.708 2.272 . . . . 0.0 112.196 -179.796 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -129.06 97.58 4.66 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.81 -179.599 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 t -139.49 151.87 46.52 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.273 179.485 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -101.61 102.73 13.48 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.126 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -99.53 133.8 43.33 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.889 0.376 . . . . 0.0 110.152 -179.104 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -92.18 133.49 35.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.98 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.3 mt -85.34 123.31 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.303 -179.242 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.8 m -106.33 -47.74 3.73 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.874 0.369 . . . . 0.0 110.563 179.64 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 164.79 170.73 30.14 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.8 p90 -89.91 146.04 24.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.874 0.369 . . . . 0.0 110.412 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.419 ' O ' HG22 ' A' ' 18' ' ' ILE . 3.8 m -74.63 170.1 16.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.537 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -69.13 -37.74 78.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.481 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -72.06 -10.01 59.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.543 -179.581 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.419 HG22 ' O ' ' A' ' 15' ' ' SER . 9.8 tp -41.5 146.99 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.517 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.04 153.92 95.01 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.325 -179.586 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.14 -33.16 62.17 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.382 2.055 . . . . 0.0 112.117 -179.912 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.29 -55.29 22.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.827 0.346 . . . . 0.0 111.278 -179.42 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.457 ' CD2' HD21 ' A' ' 60' ' ' LEU . 31.5 t80 -61.64 -42.3 98.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.569 0.7 . . . . 0.0 110.338 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 68.5 ttp85 -58.07 -44.11 87.35 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.838 179.633 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 28' ' ' SER . 73.2 mt-30 -62.41 -36.3 81.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.252 179.115 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.414 ' O ' ' CD1' ' A' ' 29' ' ' LEU . 26.7 mmtp -59.27 -45.65 90.67 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.954 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.6 mm? -63.62 -43.5 96.68 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.519 179.027 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 tt -70.71 -33.77 71.22 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.28 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 24' ' ' GLN . 74.8 m -58.86 -43.61 90.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.293 -178.729 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.452 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -119.72 176.92 5.16 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.475 -179.559 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -90.51 -2.96 72.33 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.595 ' CE ' ' HE ' ' A' ' 55' ' ' ARG . 35.4 tpp -61.89 73.85 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.783 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 30' ' ' GLY . 1.6 mp -101.12 169.9 7.21 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.34 -179.058 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.479 ' O ' ' O ' ' A' ' 32' ' ' LEU . 57.3 Cg_exo -50.19 -160.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.381 2.054 . . . . 0.0 112.584 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.22 10.66 59.35 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.1 t -142.41 -156.53 0.69 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.755 0.312 . . . . 0.0 110.376 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.3 p -151.86 164.02 37.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.591 -179.782 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -143.62 162.09 36.83 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.552 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 38' ' ' ASN . 7.9 p-10 -114.18 147.95 38.08 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.258 0.551 . . . . 0.0 110.84 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.8 t -88.7 123.11 40.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.234 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.404 HG22 ' HE ' ' A' ' 41' ' ' ARG . 2.3 p -66.47 -41.61 88.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.209 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.404 ' HE ' HG22 ' A' ' 40' ' ' VAL . 20.1 ptp180 -174.17 166.78 4.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.913 -179.453 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.6 m -128.72 130.12 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.994 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.0 110.95 49.21 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.545 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -76.65 -13.21 18.16 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.922 1.748 . . . . 0.0 112.392 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.3 mt -62.45 -30.99 71.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.768 -178.813 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.52 28.69 0.96 Allowed Glycine 0 N--CA 1.466 0.698 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.94 163.93 18.42 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.87 -173.8 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.913 1.742 . . . . 0.0 111.902 179.431 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.2 mm -103.07 115.08 44.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.775 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -92.02 119.1 31.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.174 -0.467 . . . . 0.0 109.779 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.6 pt -125.06 146.88 29.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.274 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.415 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 93.6 mt-10 -127.38 128.41 45.8 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.464 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 56' ' ' VAL . 0.8 OUTLIER -119.69 138.26 53.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.562 179.991 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.417 ' H ' ' HG2' ' A' ' 54' ' ' ARG . 35.6 mmm-85 -45.25 -38.29 5.38 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.382 -179.342 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.595 ' HE ' ' CE ' ' A' ' 31' ' ' MET . 74.6 mtp85 -69.95 -43.38 71.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.849 179.679 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.677 HG22 ' N ' ' A' ' 57' ' ' SER . 14.7 p -170.38 171.11 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-O 120.93 0.395 . . . . 0.0 110.648 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.677 ' N ' HG22 ' A' ' 56' ' ' VAL . 28.4 t -98.62 161.08 13.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.7 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 64.8 tp -163.56 149.25 11.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.11 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.681 ' O ' HD12 ' A' ' 60' ' ' LEU . 6.3 p -134.48 127.81 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.87 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.681 HD12 ' O ' ' A' ' 59' ' ' VAL . 2.4 mp -133.33 155.82 48.74 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.399 -179.669 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.445 ' O ' ' N ' ' A' ' 64' ' ' ASP . 95.3 mtm-85 -78.4 143.92 36.36 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.123 179.91 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -39.5 -43.4 1.26 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.479 -179.849 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.415 ' HG2' ' H ' ' A' ' 63' ' ' LYS . 13.3 ptpt -58.54 -41.83 86.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.353 179.821 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 61' ' ' ARG . 97.3 m-20 -62.75 -40.17 96.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.354 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.468 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.2 mm? -61.28 -42.38 98.55 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.3 -40.17 96.6 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.15 179.585 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.8 mt -67.32 -41.36 85.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.196 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.5 mt -71.05 141.38 50.91 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.618 -179.733 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -84.19 103.42 13.38 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.093 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.8 m -122.85 154.8 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.279 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.531 ' N ' ' OE1' ' A' ' 71' ' ' GLU . 56.6 mp0 -142.57 125.6 16.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.575 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.03 132.35 48.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.911 179.769 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.464 0.248 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.362 179.928 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 . . . . . 0 CA--C 1.516 -0.335 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.31 156.99 35.97 Favored Pre-proline 0 N--CA 1.464 0.262 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.559 -179.448 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 39' ' ' VAL . 51.3 Cg_exo -50.95 -38.64 58.96 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.164 1.909 . . . . 0.0 112.616 179.358 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -136.8 95.82 3.2 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -179.546 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.75 129.21 47.93 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.84 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.21 101.55 13.13 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.235 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -102.29 148.06 25.91 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.333 -179.101 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -100.39 128.9 46.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.761 179.686 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.456 ' CD1' ' NH2' ' A' ' 55' ' ' ARG . 32.3 mt -83.85 122.53 37.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.24 -179.47 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.3 m -108.31 -46.17 3.77 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.87 0.367 . . . . 0.0 110.502 179.796 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.6 -179.44 39.95 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.87 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -90.57 160.09 16.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 0.0 110.435 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.8 t -82.25 169.21 16.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.614 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -69.74 -38.5 76.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.531 179.377 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -74.0 -6.59 48.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.881 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.0 tp -42.55 147.04 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.524 -179.532 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.9 p -82.73 149.19 59.67 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.754 -179.563 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.11 -38.81 50.99 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 122.303 2.002 . . . . 0.0 112.554 178.913 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.43 -57.11 13.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.859 0.361 . . . . 0.0 111.153 -179.081 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -63.58 -49.08 74.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.287 0.565 . . . . 0.0 110.578 -179.841 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -57.0 -43.86 82.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.237 -179.24 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -63.2 -33.11 74.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.755 179.293 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -59.76 -49.01 79.38 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.543 -0.463 . . . . 0.0 109.941 179.668 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.449 HD22 ' N ' ' A' ' 26' ' ' LEU . 4.5 mm? -63.87 -38.94 92.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.278 179.593 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.4 tp -60.55 -41.13 93.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.335 -179.353 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.3 m -83.65 -11.78 56.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.897 -179.398 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.452 ' HG ' ' H ' ' A' ' 31' ' ' MET . 9.5 tp -97.27 123.25 41.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.888 0.375 . . . . 0.0 110.261 -179.731 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.27 3.81 61.12 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.452 ' H ' ' HG ' ' A' ' 29' ' ' LEU . 66.7 mtt -108.48 75.83 1.0 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.21 0.529 . . . . 0.0 109.803 179.575 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.503 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.9 OUTLIER -78.51 167.9 31.58 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.093 -178.942 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.503 ' O ' ' O ' ' A' ' 32' ' ' LEU . 72.9 Cg_exo -42.2 177.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.509 2.139 . . . . 0.0 112.416 -179.551 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.74 11.06 7.33 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 179.784 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.9 m -143.5 -169.54 3.09 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.736 0.303 . . . . 0.0 110.37 179.587 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.45 ' O ' ' NH1' ' A' ' 54' ' ' ARG . 69.0 m -131.41 157.42 43.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.449 -179.74 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -133.52 157.72 44.95 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.212 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -112.93 147.16 37.66 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.447 -179.943 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 5' ' ' PRO . 14.5 t -85.27 127.03 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.171 179.867 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 p -68.26 -40.11 82.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.839 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -173.98 157.35 2.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.14 -179.072 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 73.8 t -131.82 105.93 10.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.968 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.467 ' HB3' ' OD1' ' A' ' 47' ' ' ASP . . . -93.72 111.4 52.47 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.525 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.89 -9.2 19.47 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.952 2.435 . . . . 0.0 112.275 -179.95 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 51.8 mt -50.73 -29.62 11.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.733 -178.149 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 132.29 20.55 1.01 Allowed Glycine 0 N--CA 1.467 0.723 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.362 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -97.4 160.89 27.75 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.647 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -60.17 175.31 1.08 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.749 2.3 . . . . 0.0 111.671 179.708 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.409 HG21 ' CD2' ' A' ' 65' ' ' LEU . 10.7 mm -94.55 115.73 34.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.185 -179.593 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -96.13 122.65 39.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.077 179.59 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.6 pt -128.37 147.26 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.361 179.71 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -122.87 121.03 35.23 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.019 179.635 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 55' ' ' ARG . 1.4 p -108.74 135.85 49.29 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.45 ' NH1' ' O ' ' A' ' 36' ' ' SER . 8.1 ptp85 -43.13 -18.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.62 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.613 ' O ' HG13 ' A' ' 56' ' ' VAL . 88.5 mtm180 -87.36 -51.38 5.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.967 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 55' ' ' ARG . 13.2 m -162.25 177.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.652 -179.547 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.3 p -97.63 143.14 28.61 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.337 179.539 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.1 tp -147.49 144.33 28.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.253 179.549 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 59' ' ' VAL . 4.8 p -136.9 124.14 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.864 179.2 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.7 mt -138.8 178.81 6.88 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.561 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -88.35 161.89 16.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.806 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -58.71 -32.52 69.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.503 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.87 -42.19 99.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.501 179.926 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -60.9 -44.57 96.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.504 -179.962 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.409 ' CD2' HG21 ' A' ' 49' ' ' ILE . 8.8 mp -62.81 -41.65 99.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.218 179.652 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.94 -51.36 69.45 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.304 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.98 -43.45 78.92 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.864 179.759 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.8 tp -53.0 132.67 38.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.36 -179.004 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -75.43 108.2 8.06 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.442 -179.557 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.8 m -134.22 160.36 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.733 179.812 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -145.19 136.93 25.47 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.598 179.836 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -76.31 129.5 36.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.145 179.467 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.1 t . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.254 -179.785 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.422 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 41.5 m-85 . . . . . 0 C--O 1.231 0.128 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.44 156.33 41.56 Favored Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.99 -179.512 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 39' ' ' VAL . 40.5 Cg_endo -66.09 -20.1 56.97 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.522 2.148 . . . . 0.0 112.211 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -136.62 93.53 2.88 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.393 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.96 131.52 27.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.203 -179.544 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.02 102.41 14.48 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.056 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 24.4 m0 -101.37 135.71 42.4 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.362 -179.213 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -90.25 131.79 35.87 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.5 mt -84.73 117.78 30.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.765 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 11.0 p -102.43 -19.34 14.97 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.745 0.307 . . . . 0.0 110.187 179.735 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 137.63 179.04 16.52 Favored Glycine 0 N--CA 1.463 0.474 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 179.425 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -96.06 147.77 23.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.625 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.451 ' O ' HG22 ' A' ' 18' ' ' ILE . 10.1 t -76.92 170.46 16.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.578 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -69.01 -38.85 79.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.543 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.465 ' HB3' HD12 ' A' ' 67' ' ' LEU . 75.3 tt0 -69.62 -13.23 62.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.634 -179.431 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 15' ' ' SER . 10.2 tp -41.45 147.1 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.725 -179.911 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.02 154.48 90.76 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.114 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.11 -29.72 56.13 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.456 2.104 . . . . 0.0 112.276 -179.607 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.33 -55.6 17.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.629 -179.206 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -62.25 -44.12 97.27 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.449 0.642 . . . . 0.0 110.346 -179.569 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -59.1 -45.7 90.21 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.999 179.758 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -59.28 -37.98 79.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.959 179.584 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -60.36 -41.66 94.15 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.839 179.367 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.4 mm? -61.73 -43.91 97.93 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.269 179.39 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.27 -38.89 92.67 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.375 179.418 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.0 m -61.12 -42.39 98.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.367 -179.191 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.47 ' CD1' ' O ' ' A' ' 31' ' ' MET . 2.5 pp -96.81 131.15 43.84 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.957 0.408 . . . . 0.0 110.675 -179.351 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.01 -22.95 72.68 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.47 ' O ' ' CD1' ' A' ' 29' ' ' LEU . 63.6 ttp -69.89 73.99 0.44 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.306 0.574 . . . . 0.0 109.789 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -82.03 169.45 18.46 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.815 -179.178 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 32' ' ' LEU . 61.0 Cg_exo -44.11 176.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.551 2.167 . . . . 0.0 112.946 -178.961 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.83 11.34 9.31 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.769 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 m -138.35 -156.16 0.66 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.754 0.311 . . . . 0.0 110.483 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.4 p -144.68 162.28 37.09 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.414 -179.75 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.401 ' HB2' HG22 ' A' ' 53' ' ' THR . 41.9 p90 -139.37 163.47 32.42 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.284 -179.708 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -122.22 144.38 49.01 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.309 0.575 . . . . 0.0 110.731 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' PRO . 19.4 t -82.32 125.67 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.535 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 p -68.77 -39.75 80.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.728 179.386 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.456 ' NH2' ' HD1' ' A' ' 50' ' ' HIS . 38.3 ptt-85 -173.24 160.9 4.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.732 -179.44 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 62.4 t -129.55 118.71 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.007 179.087 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.61 111.15 51.27 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.463 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.91 -11.25 19.88 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.065 1.843 . . . . 0.0 112.357 179.843 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.514 ' N ' HD22 ' A' ' 45' ' ' LEU . 4.0 mm? -59.43 -31.59 69.42 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.842 -178.624 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.55 26.32 0.8 Allowed Glycine 0 N--CA 1.469 0.838 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.747 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -97.59 159.9 29.98 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.78 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.45 175.39 0.55 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.308 2.005 . . . . 0.0 111.628 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 60' ' ' LEU . 8.3 mm -94.27 115.33 32.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.794 -179.579 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.456 ' HD1' ' NH2' ' A' ' 41' ' ' ARG . 12.4 m170 -94.6 125.44 39.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.156 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.1 pt -127.15 148.58 31.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.474 179.737 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -130.91 130.33 43.36 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.488 179.784 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.401 HG22 ' HB2' ' A' ' 37' ' ' PHE . 0.7 OUTLIER -124.38 138.06 54.4 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.511 -179.697 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -42.95 -34.62 1.01 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.437 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -69.73 -46.49 65.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.647 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.648 HG22 ' N ' ' A' ' 57' ' ' SER . 14.8 p -170.86 167.57 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 120.922 0.391 . . . . 0.0 111.177 -179.918 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.648 ' N ' HG22 ' A' ' 56' ' ' VAL . 9.9 p -93.25 154.79 17.82 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.599 178.994 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 64.2 tp -163.3 148.43 11.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.331 179.712 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.45 HG23 ' CD2' ' A' ' 50' ' ' HIS . 4.9 p -128.58 131.4 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.954 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 49' ' ' ILE . 91.7 mt -135.05 161.15 36.13 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.519 -179.428 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -86.33 164.82 16.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.571 179.734 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -59.0 -39.16 80.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.988 0.423 . . . . 0.0 110.542 -179.604 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -61.78 -40.15 94.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.59 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -59.66 -44.88 93.4 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.804 -0.359 . . . . 0.0 110.375 -179.581 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.2 mp -62.62 -41.42 98.99 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.275 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.22 -52.32 65.78 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.403 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.465 HD12 ' HB3' ' A' ' 17' ' ' GLU . 4.0 mm? -69.14 -40.69 78.09 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.301 179.609 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.9 tp -59.87 135.63 57.76 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.331 -179.309 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.445 ' O ' ' OG1' ' A' ' 12' ' ' THR . 70.7 mm-40 -81.51 113.69 19.73 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.547 -179.545 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.0 m -133.93 160.43 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.692 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -143.75 139.53 29.48 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.442 179.761 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.5 136.22 51.16 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.002 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 51.7 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.154 -179.657 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.77 155.93 62.9 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.136 -179.2 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 39' ' ' VAL . 39.1 Cg_endo -65.63 -23.45 56.73 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.596 2.197 . . . . 0.0 112.348 179.91 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -137.36 93.86 2.86 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.66 131.46 27.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.36 -0.382 . . . . 0.0 109.995 -179.969 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.11 101.74 14.27 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.252 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 22.2 m0 -102.85 142.06 34.61 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.083 -179.001 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -94.25 143.41 26.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.899 179.605 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.6 mt -96.66 115.59 36.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 O-C-N 123.23 0.332 . . . . 0.0 110.112 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.5 m -98.81 -44.12 6.5 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.558 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.67 177.34 27.05 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.865 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.7 OUTLIER -86.38 154.09 21.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.875 0.369 . . . . 0.0 110.466 -179.933 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.507 ' O ' HG22 ' A' ' 18' ' ' ILE . 8.1 t -85.11 172.44 11.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.467 179.543 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.401 ' N ' ' OG ' ' A' ' 15' ' ' SER . 99.7 mtt180 -68.11 -39.09 82.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.777 179.712 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.431 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 3.0 tm-20 -69.27 -15.7 63.41 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.561 -179.844 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 15' ' ' SER . 10.6 tp -40.81 146.72 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.427 -179.567 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.4 m -80.61 143.7 55.34 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.741 -179.375 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -49.31 -39.14 43.5 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.801 1.667 . . . . 0.0 112.609 179.056 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.43 -57.83 9.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.866 0.365 . . . . 0.0 111.043 -178.976 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -63.69 -43.71 95.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.447 0.642 . . . . 0.0 110.551 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -57.85 -44.97 86.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.956 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -62.7 -35.72 80.62 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.541 179.178 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.2 mmtt -59.46 -44.15 93.05 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.714 179.667 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.517 HD13 HD11 ' A' ' 29' ' ' LEU . 4.6 mm? -63.32 -42.16 98.97 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.163 178.725 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.84 -39.49 94.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.745 179.901 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.7 m -61.43 -44.64 96.77 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.317 -179.461 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.517 HD11 HD13 ' A' ' 26' ' ' LEU . 2.1 pp -92.85 138.07 31.81 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.521 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.85 -2.19 90.04 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.216 -0.753 . . . . 0.0 111.216 -179.648 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 48.3 ttp -86.82 75.29 9.63 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.681 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -82.56 169.96 16.33 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.034 -179.262 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' A' ' 32' ' ' LEU . 73.7 Cg_exo -44.76 -179.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.531 2.154 . . . . 0.0 112.454 -179.652 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.96 11.67 7.5 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 179.609 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 86.7 p -144.33 -157.76 0.82 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.673 0.273 . . . . 0.0 110.306 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 82.8 p -140.83 164.62 29.75 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.628 -179.822 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.447 ' HB2' HG22 ' A' ' 53' ' ' THR . 41.9 p90 -143.14 162.12 36.41 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.373 -179.696 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.445 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 22.2 p-10 -119.38 148.19 43.49 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.429 0.633 . . . . 0.0 110.638 179.692 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 5' ' ' PRO . 5.9 t -84.43 127.09 40.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.448 -179.716 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.416 ' H ' HG12 ' A' ' 40' ' ' VAL . 1.8 p -68.67 -39.21 80.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.813 179.464 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.412 ' HE ' HG22 ' A' ' 40' ' ' VAL . 19.3 ptp180 -172.82 160.65 4.47 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.132 -179.377 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 67.4 t -125.67 126.36 70.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.129 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.8 111.56 53.3 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.582 -179.787 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -75.74 -11.77 20.15 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.181 1.921 . . . . 0.0 112.314 -179.946 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.9 mt -58.46 -29.91 66.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.805 -178.842 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.96 27.42 2.08 Favored Glycine 0 N--CA 1.467 0.72 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.924 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -97.51 178.31 1.39 Allowed Pre-proline 0 CA--C 1.531 0.237 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.817 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 47' ' ' ASP . 19.5 Cg_exo -64.28 -177.88 0.56 Allowed 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.047 1.832 . . . . 0.0 112.265 -179.888 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.8 mm -106.57 117.84 53.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.885 -179.186 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.412 ' CG ' HG22 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -96.62 125.05 40.82 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.261 179.788 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.7 pt -123.63 147.85 27.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.134 179.49 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.445 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 13.3 tm-20 -132.59 130.09 39.81 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.182 -179.603 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.522 ' O ' ' N ' ' A' ' 55' ' ' ARG . 1.0 OUTLIER -122.44 136.78 54.97 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.883 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.8 ptt85 -40.4 -22.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.865 -179.632 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.527 ' O ' HG13 ' A' ' 56' ' ' VAL . 94.1 mtm-85 -86.07 -49.88 7.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.101 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 55' ' ' ARG . 16.6 m -160.43 -175.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.456 -179.224 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.3 p -128.5 150.88 49.97 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.707 179.601 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.0 tp -154.28 150.5 28.07 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.16 -179.831 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.412 HG22 ' CG ' ' A' ' 50' ' ' HIS . 56.0 t -117.45 130.4 72.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.954 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 98.1 mt -135.92 139.74 43.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.979 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.564 ' O ' ' N ' ' A' ' 64' ' ' ASP . 81.8 mtp180 -78.34 142.18 37.88 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.576 179.635 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 61' ' ' ARG . 16.8 ptpt -35.22 -35.18 0.04 OUTLIER 'General case' 0 C--O 1.235 0.301 0 O-C-N 123.313 0.383 . . . . 0.0 111.385 179.799 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 61' ' ' ARG . 54.9 mtpt -62.82 -44.78 95.24 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.159 179.149 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.564 ' N ' ' O ' ' A' ' 61' ' ' ARG . 10.6 m-20 -64.13 -36.27 83.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.233 179.024 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.542 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.0 mm? -62.22 -42.86 99.69 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.725 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.16 -44.1 93.11 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.994 0.426 . . . . 0.0 110.088 179.433 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.409 HD22 ' HB3' ' A' ' 17' ' ' GLU . 97.9 mt -68.23 -38.97 82.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.658 179.559 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.5 tp -69.78 125.09 25.7 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.849 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -76.03 115.48 15.79 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.091 -179.674 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.9 m -131.87 158.73 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.731 -179.998 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -143.32 144.58 32.15 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.429 179.645 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.27 140.77 54.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.924 179.274 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.4 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.385 -179.927 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 C--O 1.231 0.112 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.81 159.34 47.38 Favored Pre-proline 0 N--CA 1.465 0.314 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.203 -179.525 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 39' ' ' VAL . 43.8 Cg_endo -66.82 -32.63 36.19 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.688 2.259 . . . . 0.0 112.119 -179.826 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -136.62 95.5 3.16 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.906 -179.758 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 t -140.11 148.79 42.22 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.382 179.313 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -101.04 102.09 13.0 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.156 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 19.8 m0 -98.48 136.41 38.64 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.178 -179.008 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -95.45 129.5 42.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.969 179.805 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.6 mt -81.86 123.67 38.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.21 -179.296 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 11.7 p -108.14 -17.94 13.9 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.498 179.845 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 136.2 -179.04 18.28 Favored Glycine 0 N--CA 1.464 0.539 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.852 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -98.68 150.87 21.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.879 0.371 . . . . 0.0 110.472 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.412 ' O ' HG22 ' A' ' 18' ' ' ILE . 5.6 t -77.13 171.64 14.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.491 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.402 ' N ' ' OG ' ' A' ' 15' ' ' SER . 9.1 mpt_? -71.78 -40.64 69.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.503 -179.802 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -66.37 -13.1 60.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.248 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 15' ' ' SER . 10.1 tp -40.61 148.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.618 -179.828 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 72.0 p -81.16 142.78 51.61 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.687 -179.46 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -49.04 -38.15 39.12 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.916 1.744 . . . . 0.0 112.638 178.938 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.97 -57.4 12.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.877 0.37 . . . . 0.0 111.451 -178.909 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -63.02 -48.48 78.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.271 0.558 . . . . 0.0 110.579 -179.623 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.5 ttp85 -58.43 -46.37 86.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.168 0.509 . . . . 0.0 110.243 -179.677 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -60.46 -31.04 70.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.576 179.382 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -61.18 -44.95 96.48 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.867 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.6 mm? -61.77 -43.1 99.52 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.308 179.621 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.75 -38.71 92.13 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.692 179.554 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.0 t -60.46 -43.92 96.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.023 -179.212 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.475 ' CD1' ' O ' ' A' ' 31' ' ' MET . 2.3 pp -97.5 131.53 44.03 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.475 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.5 -21.53 74.51 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.475 ' O ' ' CD1' ' A' ' 29' ' ' LEU . 26.0 mmt -69.48 76.29 0.4 Allowed 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -82.2 169.69 17.48 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.324 -178.984 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 32' ' ' LEU . 71.3 Cg_exo -46.5 -178.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.435 2.09 . . . . 0.0 112.275 -179.475 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.89 8.91 9.34 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 179.665 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 m -138.03 -158.25 0.84 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.784 0.326 . . . . 0.0 110.256 179.657 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.7 t -141.6 153.06 44.55 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.46 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -128.37 157.41 41.09 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.339 -179.819 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 39' ' ' VAL . 50.0 t-20 -110.05 146.94 34.51 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.543 -179.803 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.529 ' N ' ' OD1' ' A' ' 38' ' ' ASN . 54.3 t -88.22 126.52 41.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.041 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 p -70.27 -40.64 78.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.075 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -173.73 159.25 3.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.152 -179.279 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.4 t -131.31 120.93 47.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.772 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.49 110.75 50.69 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.444 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -76.7 -11.69 18.42 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.2 1.933 . . . . 0.0 112.299 179.805 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.8 mt -59.39 -30.91 68.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.956 -178.551 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.24 22.77 0.7 Allowed Glycine 0 N--CA 1.465 0.568 0 N-CA-C 111.006 -0.837 . . . . 0.0 111.006 179.755 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.6 159.8 30.19 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.11 171.7 2.12 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.795 2.33 . . . . 0.0 111.939 -179.814 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.4 mm -92.56 114.27 29.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.799 -179.255 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -92.0 122.21 34.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.893 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.422 ' O ' ' O ' ' A' ' 58' ' ' LEU . 45.6 pt -127.54 149.17 32.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.326 -179.966 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -126.85 129.87 49.1 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.375 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.95 138.87 54.56 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.847 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -41.16 -37.03 0.83 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.346 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.404 HH11 ' HB3' ' A' ' 31' ' ' MET . 57.9 ttp180 -65.47 -49.02 70.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.555 179.836 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.63 HG22 ' H ' ' A' ' 57' ' ' SER . 7.1 p -171.13 173.1 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.803 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.63 ' H ' HG22 ' A' ' 56' ' ' VAL . 40.0 t -92.11 136.71 32.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.151 178.812 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 51' ' ' ILE . 64.1 tp -143.03 148.72 37.21 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.791 0.329 . . . . 0.0 110.154 -179.877 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 p -130.13 130.54 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.099 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.4 mt -134.59 155.69 50.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.323 -179.506 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -77.63 170.15 17.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.683 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.15 -47.07 87.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.132 0.492 . . . . 0.0 110.578 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -58.41 -38.23 76.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.733 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -58.07 -46.56 85.24 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.37 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.0 mp -62.75 -41.49 99.24 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.175 179.172 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.68 -53.11 59.14 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.365 -179.711 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.2 mm? -68.57 -41.11 80.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.146 179.482 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.2 tp -58.15 133.13 55.33 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.185 -179.038 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.429 ' O ' ' OG1' ' A' ' 12' ' ' THR . 47.6 mm-40 -77.85 110.42 12.72 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.312 -179.46 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.36 156.9 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.472 179.608 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -141.79 137.05 31.27 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.493 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.45 117.48 27.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.203 179.768 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.454 HG23 ' H ' ' A' ' 73' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.343 -179.671 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 . . . . . 0 CA--C 1.522 -0.13 0 CA-C-O 120.907 0.384 . . . . 0.0 109.977 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.66 159.13 32.4 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.12 -179.257 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 39' ' ' VAL . 42.6 Cg_endo -67.5 -20.19 47.97 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.697 2.264 . . . . 0.0 112.078 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -136.47 93.81 2.93 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.823 0.344 . . . . 0.0 110.121 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.51 131.64 28.05 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.838 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.88 102.12 14.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.228 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 21.1 m0 -100.04 140.37 34.35 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.118 -179.353 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -101.39 125.23 48.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.733 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.2 mt -81.14 123.6 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.393 -179.169 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.9 p -105.29 -16.16 14.84 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.436 179.933 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.39 163.08 9.64 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.516 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.84 159.54 33.59 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.56 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 p -77.35 167.41 21.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.643 -179.733 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.25 -40.44 74.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.863 0.363 . . . . 0.0 110.7 179.508 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -80.47 -2.39 45.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.145 -179.725 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.6 tp -40.42 146.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.561 -179.406 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.2 p -76.23 137.95 68.3 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.461 -179.258 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -46.92 -41.97 25.42 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.883 1.722 . . . . 0.0 112.666 179.195 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.83 -54.28 44.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.912 0.387 . . . . 0.0 111.228 -179.181 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -63.07 -49.24 75.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.355 0.598 . . . . 0.0 110.557 -179.859 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.1 ttt-85 -57.2 -42.67 81.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.088 -179.247 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.524 ' NE2' ' OG ' ' A' ' 28' ' ' SER . 12.4 tm0? -62.52 -34.99 78.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.02 179.332 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -59.22 -46.47 88.36 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.942 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.492 HD22 ' N ' ' A' ' 26' ' ' LEU . 4.6 mm? -65.19 -37.79 88.46 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.821 179.557 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 tt -75.66 -23.83 56.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.082 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.524 ' OG ' ' NE2' ' A' ' 24' ' ' GLN . 49.1 m -58.11 -44.09 87.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.903 0.382 . . . . 0.0 111.317 -179.2 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.588 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -116.9 156.65 27.0 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.162 -179.675 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -63.16 -26.24 69.04 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.769 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 86.9 mtp -61.55 73.96 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.006 0.432 . . . . 0.0 110.109 -179.884 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -85.38 169.2 16.72 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.585 -178.357 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 32' ' ' LEU . 55.7 Cg_exo -47.69 -177.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.075 1.85 . . . . 0.0 112.009 -179.764 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.63 -4.63 39.95 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.537 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.8 m -101.18 -169.6 1.72 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.713 0.292 . . . . 0.0 110.25 179.544 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.1 t -133.05 151.26 52.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.383 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -138.11 163.53 31.42 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.228 -179.654 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -122.57 146.67 47.21 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.446 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 5' ' ' PRO . 62.1 t -85.48 126.75 40.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.295 -179.83 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 40' ' ' VAL . 2.2 p -70.04 -41.1 79.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.16 179.736 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.3 ptt-85 -174.25 169.42 3.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.966 -179.209 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.6 m -136.12 116.62 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.123 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.31 111.3 51.39 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.311 -179.745 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.497 ' C ' ' H ' ' A' ' 46' ' ' GLY . 60.3 Cg_endo -75.45 -11.76 20.68 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.287 1.991 . . . . 0.0 112.054 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.524 HD22 ' N ' ' A' ' 45' ' ' LEU . 4.2 mm? -53.0 -6.69 0.06 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.58 -178.978 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.497 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 104.37 23.69 7.88 Favored Glycine 0 N--CA 1.462 0.418 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.613 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.73 165.01 16.31 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 -179.491 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -58.06 -170.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.025 1.817 . . . . 0.0 111.704 179.257 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.8 mm -106.36 112.9 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -88.19 120.49 29.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.958 -179.806 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 58' ' ' LEU . 48.6 pt -126.33 147.99 31.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.144 179.901 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -127.97 129.43 46.76 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.306 179.649 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 p -114.19 136.7 52.67 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.807 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -39.04 -35.39 0.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.808 -179.433 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.556 ' O ' HG13 ' A' ' 56' ' ' VAL . 18.9 mmm180 -73.3 -49.29 28.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.109 -179.537 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 55' ' ' ARG . 15.6 m -160.94 -176.84 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.517 -179.472 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 p -106.58 148.21 28.55 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.699 179.721 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' A' ' 51' ' ' ILE . 61.0 tp -154.6 150.31 27.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.473 179.896 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 59' ' ' VAL . 12.1 p -127.57 131.33 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.82 179.194 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.6 mt -136.69 159.71 41.02 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.308 -179.445 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.405 ' HG2' ' N ' ' A' ' 62' ' ' LYS . 69.1 ttt180 -85.06 166.63 16.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.339 -179.583 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.405 ' N ' ' HG2' ' A' ' 61' ' ' ARG . 88.2 tttt -58.49 -44.43 89.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.856 0.36 . . . . 0.0 110.588 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -57.38 -39.92 77.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.723 -179.719 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -60.27 -45.15 94.3 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.394 179.992 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.5 -41.04 98.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.786 0.326 . . . . 0.0 110.127 179.47 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.06 -40.79 98.73 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.565 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.9 mt -75.8 -48.82 20.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.355 -179.641 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.2 mt -55.74 133.09 50.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.351 -179.151 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -74.27 109.38 7.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.192 -179.401 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.48 159.74 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.436 179.994 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -139.82 126.34 20.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.513 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.92 124.13 22.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.91 179.771 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.464 0.233 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.42 179.846 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.44 ' SD ' ' N ' ' A' ' 1' ' ' MET . 2.6 mpt? . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -62.82 -44.22 96.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.547 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -105.75 137.11 44.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.922 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.9 158.87 74.41 Favored Pre-proline 0 N--CA 1.468 0.441 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 39' ' ' VAL . 44.1 Cg_endo -66.97 -19.41 52.05 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.549 2.166 . . . . 0.0 112.369 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -136.98 92.63 2.75 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.83 131.81 26.14 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.63 102.22 14.39 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.447 ' CZ3' HD12 ' A' ' 65' ' ' LEU . 22.4 m0 -101.44 132.04 47.24 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.191 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -86.84 136.63 32.9 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.8 mt -92.4 117.93 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 12.5 p -104.21 -32.24 9.22 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.73 0.3 . . . . 0.0 110.25 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.72 174.48 21.79 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -90.15 153.49 20.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.801 0.334 . . . . 0.0 110.334 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.464 ' O ' HG22 ' A' ' 18' ' ' ILE . 1.5 t -80.73 168.32 18.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.659 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -68.36 -40.57 81.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.877 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -63.63 -17.4 62.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.419 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 15' ' ' SER . 10.8 tp -41.89 147.42 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.587 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.98 155.15 84.78 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.343 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.98 -31.03 66.86 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.562 2.175 . . . . 0.0 112.213 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.24 -56.82 12.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.142 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -61.44 -44.2 97.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.65 0.738 . . . . 0.0 110.543 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -58.0 -47.62 82.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.589 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 45.4 tp60 -57.98 -37.27 73.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.532 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -57.91 -40.82 81.33 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.388 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.506 HD13 HD11 ' A' ' 29' ' ' LEU . 4.4 mm? -61.38 -42.86 99.39 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.81 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.92 -39.95 96.11 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.199 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.5 m -60.47 -44.11 96.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.795 0.331 . . . . 0.0 111.205 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.506 HD11 HD13 ' A' ' 26' ' ' LEU . 2.2 pp -93.5 132.65 37.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.555 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.94 -2.02 69.86 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 71.8 mtm -86.95 75.0 9.62 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -82.6 168.62 22.08 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.127 -179.199 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.451 ' O ' ' O ' ' A' ' 32' ' ' LEU . 77.5 Cg_exo -43.47 177.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.603 2.202 . . . . 0.0 112.412 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.95 11.96 7.34 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.487 ' OG ' ' N ' ' A' ' 36' ' ' SER . 34.9 t -144.2 -172.0 3.69 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.848 0.356 . . . . 0.0 110.344 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.487 ' N ' ' OG ' ' A' ' 35' ' ' SER . 67.7 m -128.28 155.7 44.18 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.517 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -135.53 159.14 42.55 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.349 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -111.97 150.64 30.28 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.572 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' PRO . 13.1 t -86.1 126.82 40.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.526 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 p -67.86 -41.46 84.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.825 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -173.78 161.51 3.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.994 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.471 ' O ' HG23 ' A' ' 42' ' ' VAL . 33.2 m -129.86 121.99 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.33 110.57 49.37 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.507 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -76.65 -11.74 18.5 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.042 1.828 . . . . 0.0 112.327 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.0 mt -59.67 -31.04 69.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.996 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 132.12 24.83 0.77 Allowed Glycine 0 N--CA 1.468 0.772 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.71 160.36 28.8 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.93 175.42 0.46 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.86 2.374 . . . . 0.0 112.02 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.6 mm -92.05 114.81 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.885 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -92.74 122.16 34.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.872 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.5 pt -127.5 150.69 33.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.801 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -128.83 137.64 51.61 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.128 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 55' ' ' ARG . 0.7 OUTLIER -129.49 138.27 51.29 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.753 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -43.78 -21.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.59 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 53' ' ' THR . 85.0 mtt85 -82.81 -48.81 10.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.533 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.635 HG22 ' N ' ' A' ' 57' ' ' SER . 14.9 p -169.66 168.55 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.665 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.635 ' N ' HG22 ' A' ' 56' ' ' VAL . 5.3 p -99.6 146.15 26.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.551 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.7 tp -155.96 147.86 23.18 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.335 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.669 ' O ' HD12 ' A' ' 60' ' ' LEU . 3.3 p -126.68 131.43 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.615 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.669 HD12 ' O ' ' A' ' 59' ' ' VAL . 2.6 mp -132.95 155.05 49.82 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.056 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -72.91 162.09 29.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.941 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -54.55 -45.9 73.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.869 0.366 . . . . 0.0 110.807 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -59.98 -40.67 89.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.526 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -61.12 -40.76 95.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.495 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.447 HD12 ' CZ3' ' A' ' 9' ' ' TRP . 2.2 mm? -63.06 -42.12 99.63 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.24 93.52 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.214 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.27 -42.13 84.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.221 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.5 mt -66.81 135.74 54.39 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.626 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.453 ' O ' ' OG1' ' A' ' 12' ' ' THR . 94.6 mt-10 -79.97 113.25 17.99 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.142 0.496 . . . . 0.0 110.175 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.9 m -132.16 155.94 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.747 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -142.54 137.9 30.48 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.754 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.9 148.03 51.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.145 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 38.7 t -113.28 132.43 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.347 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 65.4 p -150.21 11.88 0.73 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.549 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.3 t -61.86 -42.48 99.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.427 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.0 mt 49.18 87.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.226 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -136.64 140.49 42.81 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.109 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -140.05 144.57 36.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.185 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -114.85 143.33 45.28 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.289 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -91.83 125.04 36.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.454 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -59.86 -45.69 91.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.651 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -150.23 152.82 35.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.511 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 78.9 m80 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.624 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.6 mtp . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -66.51 -24.49 66.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -71.73 138.2 48.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.566 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.91 155.99 74.46 Favored Pre-proline 0 N--CA 1.467 0.38 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 39' ' ' VAL . 43.3 Cg_endo -66.79 -22.19 49.95 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.51 2.14 . . . . 0.0 112.288 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 6' ' ' ASP . 39.1 p-10 -137.42 93.61 2.83 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.735 0.302 . . . . 0.0 110.304 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.51 129.81 25.4 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.6 102.44 15.18 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 18.1 m0 -101.57 137.52 39.78 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.933 0.397 . . . . 0.0 110.322 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -95.24 129.57 42.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.038 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.2 mt -82.42 122.62 37.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.123 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 8.9 p -110.75 -19.33 12.89 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.559 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.72 -179.95 22.41 Favored Glycine 0 N--CA 1.464 0.559 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -100.12 157.42 16.58 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.848 0.356 . . . . 0.0 110.321 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 67' ' ' LEU . 15.5 m -74.8 165.76 24.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.765 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -70.54 -38.99 74.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.56 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -74.15 -6.34 47.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.383 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.6 tp -41.41 146.58 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.449 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.42 155.2 93.04 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.248 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.82 -31.27 68.23 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.415 2.077 . . . . 0.0 112.13 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.46 -53.47 42.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.224 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -63.06 -46.4 87.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.745 0.783 . . . . 0.0 110.652 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 67.0 ttp85 -57.99 -44.18 86.99 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.729 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -61.09 -36.12 78.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.08 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -59.22 -43.0 92.32 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.437 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.6 mm? -62.43 -43.66 98.28 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.032 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 49.1 mt -70.35 -32.56 70.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.81 0.338 . . . . 0.0 111.091 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.5 m -58.91 -44.03 91.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.334 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.495 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -118.73 173.21 7.0 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.295 -179.691 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -88.92 -3.14 77.11 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 33.2 ttm -64.6 74.18 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.2 mp -99.8 169.96 7.38 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.289 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 32' ' ' LEU . 62.9 Cg_exo -49.67 -164.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.331 2.021 . . . . 0.0 112.564 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.77 5.1 56.74 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.9 m -138.63 -156.28 0.67 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.813 0.34 . . . . 0.0 110.2 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.5 p -146.38 164.23 33.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.505 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -139.21 151.54 46.64 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.232 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -108.84 146.98 32.81 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.431 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' PRO . 10.0 t -87.03 127.15 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.597 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 50' ' ' HIS . 2.2 p -69.93 -39.05 77.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.885 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -173.44 166.93 4.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.284 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.518 ' O ' HG23 ' A' ' 42' ' ' VAL . 36.0 m -139.29 117.02 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.62 110.91 50.04 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.492 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.19 -11.68 19.34 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.135 1.89 . . . . 0.0 112.312 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.2 mt -58.58 -30.54 67.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.744 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.48 25.37 0.78 Allowed Glycine 0 N--CA 1.467 0.712 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.68 160.25 29.08 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -60.2 172.06 2.73 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.754 2.302 . . . . 0.0 111.88 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.2 mm -96.87 119.06 44.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.163 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.47 ' CD2' HG23 ' A' ' 59' ' ' VAL . 11.8 m170 -101.97 131.02 48.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.117 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.7 pt -127.26 149.84 32.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.5 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -138.91 144.42 39.09 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.034 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 56' ' ' VAL . 1.0 OUTLIER -132.5 173.15 11.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.515 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 53' ' ' THR . 99.8 mtt180 -33.6 -52.25 0.4 Allowed 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.35 0.406 . . . . 0.0 111.788 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -142.93 32.44 1.39 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.008 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 53' ' ' THR . 2.3 t -141.54 139.13 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.82 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.0 m -137.53 143.22 41.53 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.45 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.6 tp -161.57 152.49 18.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.203 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.47 HG23 ' CD2' ' A' ' 50' ' ' HIS . 4.2 p -122.32 128.87 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.7 mt -136.66 161.52 35.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.366 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -85.47 162.55 18.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.801 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -58.09 -37.55 74.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.605 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -61.8 -41.1 97.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.535 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -59.84 -45.86 91.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.347 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.2 mp -62.02 -41.08 97.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.264 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.03 -47.27 83.57 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.276 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.476 ' O ' ' OG ' ' A' ' 15' ' ' SER . 11.1 mp -75.98 -52.52 10.07 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.336 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.6 tp -43.03 128.66 4.42 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.479 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.45 ' O ' ' OG1' ' A' ' 12' ' ' THR . 78.8 mm-40 -70.28 109.52 4.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.237 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.0 m -137.88 159.36 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.544 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -141.31 124.66 16.58 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.518 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.9 132.4 49.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.873 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.9 m -134.89 160.26 41.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.418 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.0 m -139.38 36.91 2.07 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.575 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 63.2 m -130.96 120.53 23.66 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.968 0.414 . . . . 0.0 110.375 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 77.8 mt -93.95 -2.73 52.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.511 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -133.04 149.75 52.16 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.306 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -143.8 65.15 1.31 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.343 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 61.1 m170 44.97 79.02 0.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.672 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.43 ' O ' ' O ' ' A' ' 81' ' ' HIS . 26.3 p80 -60.37 -44.15 95.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.611 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.43 ' O ' ' O ' ' A' ' 80' ' ' HIS . 85.9 t60 44.59 96.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.728 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -70.71 135.92 48.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.532 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.625 179.952 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.6 mtp . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.529 ' NE2' ' CZ2' ' A' ' 9' ' ' TRP . 14.7 tm0? -64.54 -46.13 84.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.961 0.41 . . . . 0.0 110.966 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -78.21 140.41 38.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.637 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.431 ' OG1' HG21 ' A' ' 7' ' ' THR . 13.0 p -138.46 148.94 61.11 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.773 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 39' ' ' VAL . 42.8 Cg_endo -66.56 -52.46 0.76 Allowed 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.438 2.092 . . . . 0.0 112.34 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -117.14 94.47 4.58 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.873 0.368 . . . . 0.0 110.917 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.431 HG21 ' OG1' ' A' ' 4' ' ' THR . 1.5 t -141.39 150.3 42.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.13 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -99.6 102.21 13.66 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.529 ' CZ2' ' NE2' ' A' ' 2' ' ' GLN . 18.4 m0 -97.8 137.62 36.39 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.285 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -93.55 140.91 29.06 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.4 mt -93.79 119.46 41.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 123.357 0.411 . . . . 0.0 110.248 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.5 m -102.21 -46.99 4.66 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.494 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.57 177.07 32.33 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.2 p90 -95.84 146.48 24.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.809 0.338 . . . . 0.0 110.322 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.47 ' O ' HG22 ' A' ' 18' ' ' ILE . 40.0 t -77.55 172.2 13.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.485 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -69.68 -39.61 76.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.882 0.372 . . . . 0.0 110.806 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -67.44 -14.36 62.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.386 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 15' ' ' SER . 10.4 tp -41.5 147.41 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.751 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.41 154.72 87.9 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.354 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.91 -31.3 67.33 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.67 2.247 . . . . 0.0 111.989 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.99 -54.78 25.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.984 0.421 . . . . 0.0 111.116 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -62.58 -44.98 94.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.594 0.711 . . . . 0.0 110.308 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -57.82 -39.93 78.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.821 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 28' ' ' SER . 15.9 mm-40 -63.77 -36.25 83.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.948 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -60.31 -44.81 95.09 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.55 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.407 ' N ' HD22 ' A' ' 26' ' ' LEU . 4.5 mm? -64.2 -41.56 97.02 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.175 178.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 tt -75.16 -28.1 59.96 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.107 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.527 ' N ' ' O ' ' A' ' 24' ' ' GLN . 14.5 t -61.2 -44.67 96.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.171 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.522 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -115.45 169.21 9.34 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.257 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.53 5.86 84.23 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.2 tpt -76.89 73.82 3.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.898 0.38 . . . . 0.0 110.05 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.8 mp -95.8 166.73 13.93 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.424 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 32' ' ' LEU . 77.9 Cg_exo -45.11 178.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.265 1.977 . . . . 0.0 112.162 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.43 3.4 14.61 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 m -141.31 -157.05 0.73 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.818 0.342 . . . . 0.0 110.26 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 89.3 p -143.78 163.29 33.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.397 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -140.93 159.79 41.46 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.332 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -113.26 144.76 42.17 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.567 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 5' ' ' PRO . 99.2 t -85.98 129.13 38.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.287 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.401 HG22 ' HE ' ' A' ' 41' ' ' ARG . 2.4 p -67.29 -41.84 87.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.187 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.401 ' HE ' HG22 ' A' ' 40' ' ' VAL . 20.1 ptp180 -174.9 161.13 2.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.94 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.2 t -131.88 122.47 49.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.1 110.82 50.38 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.406 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.61 -11.22 20.41 Favored 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 122.287 1.992 . . . . 0.0 112.226 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.533 HD22 ' N ' ' A' ' 45' ' ' LEU . 4.1 mm? -60.65 -31.8 71.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.986 -178.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 132.72 24.69 0.73 Allowed Glycine 0 N--CA 1.465 0.611 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.23 160.17 29.56 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.57 170.09 2.04 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.682 2.254 . . . . 0.0 111.78 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.5 mm -95.46 114.42 32.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.872 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.578 ' CD2' HG23 ' A' ' 59' ' ' VAL . 12.3 m170 -97.13 125.85 41.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.709 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.445 HG22 HG22 ' A' ' 39' ' ' VAL . 44.8 pt -125.99 150.05 31.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.699 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -134.98 111.97 10.23 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.987 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 54' ' ' ARG . 1.3 p -83.5 173.89 11.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.511 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 53' ' ' THR . 91.2 mtm180 -33.68 -53.14 0.43 Allowed 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.409 0.443 . . . . 0.0 111.779 -178.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -142.53 31.67 1.49 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.323 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 t -140.57 136.95 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.499 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.1 p -112.0 138.81 48.12 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.181 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.8 tp -155.22 149.88 26.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.079 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.578 HG23 ' CD2' ' A' ' 50' ' ' HIS . 9.1 p -124.24 128.44 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.79 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.6 mt -133.62 161.16 35.38 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.417 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -94.74 160.47 14.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.418 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -53.32 -37.31 62.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.916 0.389 . . . . 0.0 110.642 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.43 -42.18 99.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.39 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -60.83 -42.1 97.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.342 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.2 -41.81 98.71 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.074 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.72 -51.7 68.83 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.35 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.1 mm? -69.17 -40.18 78.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.019 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.7 tp -60.16 136.08 57.92 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -86.86 109.9 19.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.038 0.447 . . . . 0.0 110.37 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 m -132.6 157.11 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.628 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -142.4 143.93 32.89 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.854 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.17 147.09 53.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.041 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.8 t -108.44 130.42 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.198 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.1 p -155.51 156.96 36.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.264 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.9 m 38.6 80.79 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.812 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 56.5 tp -62.67 -43.09 99.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.273 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.525 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 96.5 mt-10 42.63 76.05 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.57 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.525 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 38.7 p-80 41.27 -164.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.547 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -101.97 122.73 44.62 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.869 0.366 . . . . 0.0 110.27 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -85.07 136.71 33.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.282 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.493 ' CG ' ' O ' ' A' ' 81' ' ' HIS . 42.5 p-80 -87.61 86.64 7.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.498 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -65.68 -43.64 88.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.448 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.512 ' ND1' ' OXT' ' A' ' 83' ' ' HIS . 60.1 t-80 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.536 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -150.35 -7.94 0.29 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.858 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -85.66 90.89 8.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.806 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.32 151.66 56.84 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.321 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 39' ' ' VAL . 42.5 Cg_endo -66.11 -27.49 49.4 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.513 2.142 . . . . 0.0 111.876 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -135.69 94.52 3.09 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.907 0.384 . . . . 0.0 110.703 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.4 ' HG1' ' HE1' ' A' ' 9' ' ' TRP . 1.8 t -140.44 152.24 45.53 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.137 179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.74 102.79 14.64 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.4 ' HE1' ' HG1' ' A' ' 7' ' ' THR . 12.9 m0 -99.69 134.32 42.74 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.217 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -97.79 130.44 44.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.816 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.9 mt -84.03 118.33 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.265 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.5 m -99.12 -35.63 9.95 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.032 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 144.75 176.89 19.15 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -89.03 146.29 24.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.818 0.342 . . . . 0.0 110.33 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.5 m -74.99 171.19 14.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.429 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.1 ttm-85 -69.31 -41.32 76.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.549 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -72.44 -4.72 31.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.664 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.1 tp -41.84 147.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.665 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 m -68.12 152.11 96.71 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.058 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.97 -31.22 56.4 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.427 2.085 . . . . 0.0 112.075 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.74 -53.93 23.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.492 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.404 ' CE1' ' CD2' ' A' ' 26' ' ' LEU . 33.4 t80 -61.65 -44.25 97.32 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.295 0.569 . . . . 0.0 110.335 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -59.7 -42.78 93.76 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.825 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.4 HE22 ' HB3' ' A' ' 28' ' ' SER . 19.6 tm0? -61.8 -37.21 83.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.641 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -59.9 -45.67 91.79 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.746 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.414 ' HA ' HD13 ' A' ' 26' ' ' LEU . 4.6 mm? -62.86 -41.33 99.33 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.497 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.2 mt -62.18 -38.75 90.26 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.392 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.4 ' HB3' HE22 ' A' ' 24' ' ' GLN . 3.3 p -80.13 -10.24 59.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.835 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.1 tp -100.16 126.87 46.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.482 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.28 1.9 73.71 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 77.3 mtm -108.81 74.82 0.93 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.259 0.552 . . . . 0.0 109.701 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.3 mp -78.87 165.94 45.79 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.831 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 32' ' ' LEU . 68.1 Cg_exo -42.65 179.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.788 2.325 . . . . 0.0 113.043 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.0 11.86 7.36 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.2 p -143.07 -160.38 1.1 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.72 0.295 . . . . 0.0 110.396 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 97.6 p -139.98 165.15 28.1 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.542 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -143.63 169.12 18.33 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.438 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 16.4 p-10 -124.88 151.64 45.06 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.306 0.574 . . . . 0.0 110.279 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' PRO . 16.6 t -87.06 124.94 40.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.425 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.458 ' H ' HG12 ' A' ' 40' ' ' VAL . 2.0 p -71.63 -39.81 70.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.913 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -172.99 166.76 5.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.672 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 42' ' ' VAL . 33.3 m -149.31 104.65 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.894 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.83 111.29 53.84 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.405 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -75.87 -9.96 19.69 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.455 2.103 . . . . 0.0 112.348 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.518 ' N ' HD12 ' A' ' 45' ' ' LEU . 10.6 mp -52.12 -30.15 25.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.768 -178.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 147.36 16.15 0.13 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -97.96 153.05 38.33 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.26 -175.03 0.47 Allowed 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.216 1.944 . . . . 0.0 111.778 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.43 HG21 ' CD2' ' A' ' 65' ' ' LEU . 12.8 mm -91.49 114.55 28.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.716 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.462 ' CD2' HG23 ' A' ' 59' ' ' VAL . 12.0 m170 -95.71 120.49 36.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.233 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.4 pt -125.18 144.42 35.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.229 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.435 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 13.1 tm-20 -123.62 124.66 43.28 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.187 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.49 141.25 48.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.336 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.415 ' H ' ' HG2' ' A' ' 54' ' ' ARG . 21.5 mmt85 -50.11 -38.94 41.19 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.978 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -67.77 -41.06 83.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.756 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.746 HG22 ' H ' ' A' ' 57' ' ' SER . 13.1 p -170.7 177.18 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.578 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.746 ' H ' HG22 ' A' ' 56' ' ' VAL . 47.8 t -111.48 145.11 39.6 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.273 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.416 HD21 HD11 ' A' ' 60' ' ' LEU . 62.3 tp -147.76 149.21 31.95 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.552 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 59' ' ' VAL . 7.7 p -137.19 122.98 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.416 HD11 HD21 ' A' ' 58' ' ' LEU . 96.7 mt -140.98 175.95 9.2 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.442 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -86.64 162.69 17.82 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.07 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -58.37 -32.91 69.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.611 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.06 -41.6 98.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.209 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -60.08 -44.62 94.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.496 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.43 ' CD2' HG21 ' A' ' 49' ' ' ILE . 7.8 mp -62.01 -40.91 97.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.976 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.85 -48.86 78.57 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.455 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.14 -40.24 86.68 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.888 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 77.1 mt -66.62 140.64 57.94 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.511 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -84.29 108.66 17.27 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.443 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.1 m -132.38 158.91 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.296 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -143.09 129.57 20.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.48 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.61 129.21 36.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.683 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.7 m -128.45 155.87 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.19 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.1 t -106.31 -32.91 7.96 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.666 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.4 p -72.92 143.42 47.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.555 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 77' ' ' GLU . 45.9 tp -64.25 -51.36 63.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.14 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 76' ' ' LEU . 96.7 mt-10 35.59 52.87 0.78 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.408 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.494 ' O ' ' N ' ' A' ' 80' ' ' HIS . 18.5 t-80 -63.96 -44.12 93.73 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.841 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 74.1 m80 43.12 -92.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.756 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 78' ' ' HIS . 86.6 t60 47.51 71.66 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.596 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -84.75 -11.07 56.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.477 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.551 ' CG ' ' N ' ' A' ' 83' ' ' HIS . 41.8 t-80 48.39 -108.45 0.26 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.592 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.551 ' N ' ' CG ' ' A' ' 82' ' ' HIS . 54.4 t-80 . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.561 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mtp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -64.76 -40.16 94.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.475 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -75.81 137.8 40.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.929 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.06 153.15 76.63 Favored Pre-proline 0 N--CA 1.465 0.297 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.396 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 39' ' ' VAL . 40.1 Cg_endo -66.52 -33.96 35.04 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.518 2.145 . . . . 0.0 112.22 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -136.7 95.2 3.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.702 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -140.03 148.17 41.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.277 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -103.2 102.0 11.97 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 27.4 m0 -96.37 147.33 23.92 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.396 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -105.1 125.7 51.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.743 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.2 mt -82.86 120.33 34.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.194 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.2 p -104.55 -10.48 17.58 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.495 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 142.09 167.46 11.33 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.15 161.86 25.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.399 . . . . 0.0 110.074 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.6 p -72.64 163.29 28.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.555 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 85.4 mtm-85 -69.89 -39.78 76.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.588 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -79.78 -3.38 47.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.183 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.1 tp -41.25 144.81 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.683 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 57.3 m -80.17 148.72 68.08 Favored Pre-proline 0 C--N 1.327 -0.383 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.934 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -50.09 -40.18 50.69 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.299 1.999 . . . . 0.0 112.35 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.38 -56.53 17.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.002 0.43 . . . . 0.0 111.201 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -63.36 -51.22 66.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.405 0.622 . . . . 0.0 110.517 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 68.6 ttt-85 -55.51 -44.12 76.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.482 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 28' ' ' SER . 68.9 tp60 -62.82 -32.6 73.83 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.818 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -59.4 -47.03 87.02 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.456 -0.497 . . . . 0.0 109.837 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.532 HD22 ' N ' ' A' ' 26' ' ' LEU . 4.4 mm? -65.54 -37.85 87.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.151 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.5 tp -74.62 -28.44 60.88 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.871 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 24' ' ' GLN . 68.7 m -57.61 -44.41 85.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.05 -178.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.607 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -114.54 153.13 30.61 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.114 -179.743 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -61.79 -24.59 64.67 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 67.6 mtt -61.13 73.67 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 120.976 0.417 . . . . 0.0 109.994 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 30' ' ' GLY . 0.5 OUTLIER -86.66 168.57 17.9 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.826 -179.167 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.457 ' HD3' HD12 ' A' ' 26' ' ' LEU . 67.6 Cg_exo -46.52 -178.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.29 1.993 . . . . 0.0 111.97 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.77 -11.78 45.87 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.2 m -100.73 -171.82 2.08 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.984 0.421 . . . . 0.0 110.238 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.3 m -130.19 157.59 42.04 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.427 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -138.65 158.38 44.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.215 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -112.38 145.03 40.83 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.562 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 5' ' ' PRO . 51.7 t -89.81 124.56 42.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.135 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.42 HG12 ' H ' ' A' ' 40' ' ' VAL . 2.0 p -68.61 -41.22 82.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.069 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -173.68 164.22 4.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.119 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 42' ' ' VAL . 27.6 m -135.99 124.15 36.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.045 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.98 110.76 51.65 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.736 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.32 -12.02 19.06 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.781 2.321 . . . . 0.0 112.184 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.53 ' N ' HD12 ' A' ' 45' ' ' LEU . 10.9 mp -60.6 -32.34 71.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.626 -178.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 135.33 22.03 0.65 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.97 160.03 30.08 Favored Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.46 169.08 3.35 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.77 2.313 . . . . 0.0 111.808 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.511 ' N ' ' O ' ' A' ' 60' ' ' LEU . 8.3 mm -93.48 114.41 30.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.976 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -91.3 122.88 34.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.856 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' A' ' 58' ' ' LEU . 44.9 pt -125.65 147.43 30.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.266 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -127.65 129.66 47.6 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.27 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.76 137.56 54.72 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.795 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.618 ' HE ' ' NH1' ' A' ' 55' ' ' ARG . 35.1 ptt180 -44.99 -31.46 1.3 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.245 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.618 ' NH1' ' HE ' ' A' ' 54' ' ' ARG . 86.5 mmt-85 -71.88 -46.37 58.07 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.599 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.625 HG22 ' N ' ' A' ' 57' ' ' SER . 13.9 p -170.97 168.46 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.794 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.625 ' N ' HG22 ' A' ' 56' ' ' VAL . 97.5 p -89.18 153.52 20.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.609 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 51' ' ' ILE . 61.1 tp -162.62 149.16 12.9 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.332 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 p -130.29 131.39 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 49' ' ' ILE . 89.7 mt -134.91 161.39 35.36 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.47 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -88.14 161.85 17.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.749 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.405 ' CG ' ' N ' ' A' ' 63' ' ' LYS . 20.4 ptmt -55.32 -41.0 71.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.965 0.412 . . . . 0.0 110.777 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.405 ' N ' ' CG ' ' A' ' 62' ' ' LYS . 21.0 ptmt -60.36 -40.21 89.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.67 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.92 -44.4 97.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.549 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.42 -41.86 97.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.703 0.287 . . . . 0.0 110.232 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.65 -50.51 73.57 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.395 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.27 -40.45 81.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.752 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.7 tp -61.76 129.71 42.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.338 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -74.53 107.58 6.75 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.64 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.2 m -132.68 161.89 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.607 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -143.0 140.74 31.14 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.37 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.03 112.59 20.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.301 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.42 HG12 ' H ' ' A' ' 75' ' ' SER . 63.0 t -63.48 -46.0 96.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.518 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.2 m 46.69 28.64 0.82 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.7 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.42 ' H ' HG12 ' A' ' 73' ' ' VAL . 8.8 p -149.52 127.9 12.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.4 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 56.9 tp -63.02 -48.33 79.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.744 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -174.32 153.52 1.98 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.442 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -151.49 64.01 0.88 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.622 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.507 ' CG ' ' O ' ' A' ' 79' ' ' HIS . 21.6 t-160 -101.25 53.19 0.83 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.457 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -157.51 81.26 0.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.542 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.558 ' CG ' ' N ' ' A' ' 82' ' ' HIS . 52.5 t-80 44.22 -114.21 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.586 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.558 ' N ' ' CG ' ' A' ' 81' ' ' HIS . 71.8 m80 43.31 -168.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.648 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 79.4 m80 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.56 -179.97 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -65.05 -39.09 92.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.648 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -69.54 136.91 51.98 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.83 156.63 68.68 Favored Pre-proline 0 N--CA 1.467 0.411 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 39' ' ' VAL . 45.3 Cg_endo -67.09 -21.72 48.56 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.45 2.1 . . . . 0.0 112.289 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -137.01 93.06 2.79 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.41 HG21 ' HE1' ' A' ' 9' ' ' TRP . 0.2 OUTLIER -140.3 131.83 27.04 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.85 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.55 103.05 15.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.41 ' HE1' HG21 ' A' ' 7' ' ' THR . 10.4 m0 -101.63 136.32 41.67 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.287 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -101.13 130.98 47.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.828 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.3 mt -83.97 124.29 39.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.723 -178.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.1 m -109.91 -41.34 4.52 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.812 0.339 . . . . 0.0 110.489 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 160.53 -174.31 37.21 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -103.74 147.1 27.66 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.815 0.34 . . . . 0.0 110.982 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.41 ' O ' HG22 ' A' ' 18' ' ' ILE . 3.5 m -78.84 173.16 12.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.604 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.415 ' N ' ' CD ' ' A' ' 16' ' ' ARG . 3.0 mpt_? -69.79 -40.37 76.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.61 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -68.66 -11.98 60.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.724 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 15' ' ' SER . 10.0 tp -41.16 148.35 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.625 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.9 p -76.35 141.16 69.67 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.57 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -49.49 -40.0 45.17 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 121.605 1.537 . . . . 0.0 112.952 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.62 -54.99 37.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 111.689 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -63.55 -45.79 88.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.451 0.643 . . . . 0.0 110.382 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -58.3 -44.55 88.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.945 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.482 ' O ' ' N ' ' A' ' 28' ' ' SER . 62.3 tp60 -61.57 -33.96 74.78 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -59.64 -47.29 86.18 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.904 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.6 mm? -62.68 -42.19 99.5 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.102 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.5 tt -72.99 -30.7 63.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.88 0.372 . . . . 0.0 110.871 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 24' ' ' GLN . 74.6 m -60.18 -43.28 95.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.395 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.505 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -118.66 171.96 7.83 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.398 -179.574 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.77 6.79 73.88 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 97.1 mtp -77.94 74.9 4.48 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.9 OUTLIER -92.96 169.89 9.72 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.131 -179.173 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 32' ' ' LEU . 51.4 Cg_exo -49.38 -169.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.123 1.882 . . . . 0.0 112.595 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.91 0.87 19.54 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.1 m -139.8 -173.25 3.58 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.728 0.299 . . . . 0.0 110.266 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 73.0 m -128.82 155.93 44.42 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.817 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -130.14 157.12 43.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.42 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -113.58 152.41 30.34 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.297 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 5' ' ' PRO . 20.8 t -87.95 123.0 40.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.479 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.403 HG12 ' H ' ' A' ' 40' ' ' VAL . 1.6 p -66.67 -42.01 89.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.689 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.548 ' NH2' ' CE1' ' A' ' 50' ' ' HIS . 50.7 ptt85 -172.94 162.94 4.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.489 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.8 t -128.06 127.95 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.418 ' HB1' ' OD1' ' A' ' 47' ' ' ASP . . . -93.39 110.77 48.78 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.366 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.05 -12.62 19.48 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.813 1.675 . . . . 0.0 112.516 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.2 tp -57.85 -30.52 65.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.959 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.81 30.51 1.24 Allowed Glycine 0 N--CA 1.467 0.753 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -98.74 -179.16 0.8 Allowed Pre-proline 0 N--CA 1.467 0.378 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.425 ' CD ' ' CB ' ' A' ' 47' ' ' ASP . 15.5 Cg_exo -65.53 -173.12 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.762 1.641 . . . . 0.0 111.594 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.402 HG21 ' CD2' ' A' ' 65' ' ' LEU . 10.8 mm -105.62 114.26 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.801 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.548 ' CE1' ' NH2' ' A' ' 41' ' ' ARG . 15.2 m170 -89.63 116.95 28.15 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.404 ' O ' ' O ' ' A' ' 58' ' ' LEU . 44.8 pt -124.41 148.25 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.147 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -125.81 123.96 39.88 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.865 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 p -107.44 137.03 46.23 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.765 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -38.46 -35.7 0.2 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.869 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.576 ' O ' HG13 ' A' ' 56' ' ' VAL . 3.6 mpt_? -72.51 -49.35 33.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.079 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 55' ' ' ARG . 15.7 m -162.55 -176.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 120.977 0.417 . . . . 0.0 110.991 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.2 m -99.78 145.84 27.25 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.792 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.404 ' O ' ' O ' ' A' ' 51' ' ' ILE . 60.3 tp -153.78 144.8 22.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.374 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.0 p -130.72 128.72 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.6 mt -136.95 166.19 24.22 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.85 0.357 . . . . 0.0 110.514 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -82.33 160.71 22.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.867 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -57.34 -34.59 68.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.746 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.7 -40.61 97.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.109 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -61.05 -45.9 92.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.812 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.402 ' CD2' HG21 ' A' ' 49' ' ' ILE . 10.4 mp -62.0 -42.3 99.0 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.141 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.01 -49.68 76.72 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.083 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.8 mt -68.81 -41.41 78.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.487 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.2 tp -60.48 132.11 52.86 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.715 -0.394 . . . . 0.0 109.94 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -74.73 110.87 9.38 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.446 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.3 m -137.23 162.25 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.813 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -138.84 127.42 23.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.329 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.78 125.21 28.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.856 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.3 m -123.24 131.22 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.082 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.5 m -88.13 -8.55 55.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.517 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.0 p -74.38 156.63 36.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.48 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.1 tp -164.02 55.32 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.277 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -151.64 136.98 17.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.594 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.464 ' O ' ' N ' ' A' ' 80' ' ' HIS . 44.9 p-80 -156.42 154.48 30.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.328 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 78.7 m80 39.85 25.91 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.832 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.464 ' N ' ' O ' ' A' ' 78' ' ' HIS . 85.8 t60 -59.2 -44.73 92.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.459 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -88.5 135.72 33.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.472 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -65.78 -39.64 91.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.548 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.475 179.986 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.43 ' O ' ' N ' ' A' ' 3' ' ' TYR . 66.5 mtm . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.429 ' NE2' ' CZ2' ' A' ' 9' ' ' TRP . 71.3 tp60 48.93 -92.86 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.732 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.43 ' N ' ' O ' ' A' ' 1' ' ' MET . 76.1 m-85 -72.13 89.8 1.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.985 0.421 . . . . 0.0 110.17 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.73 156.45 36.53 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.982 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 39' ' ' VAL . 37.1 Cg_endo -65.13 -31.52 54.32 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.697 2.264 . . . . 0.0 111.925 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -136.78 94.66 3.01 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.696 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.5 t -140.53 151.15 44.53 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.922 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -104.92 102.49 12.01 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.429 ' CZ2' ' NE2' ' A' ' 2' ' ' GLN . 26.1 m0 -96.63 132.61 42.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.213 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.5 tttt -87.43 127.22 35.22 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.76 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.6 mt -81.53 122.51 36.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.213 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.9 m -104.25 -49.09 3.67 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.515 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.3 169.87 30.47 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -88.41 152.82 21.65 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.713 0.292 . . . . 0.0 110.241 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.517 ' O ' HG22 ' A' ' 18' ' ' ILE . 38.3 t -82.81 168.77 16.82 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.094 0.474 . . . . 0.0 110.782 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -66.62 -40.03 88.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.362 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.47 ' OE1' ' N ' ' A' ' 17' ' ' GLU . 52.5 mp0 -65.13 -15.47 62.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.657 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.517 HG22 ' O ' ' A' ' 15' ' ' SER . 10.6 tp -42.34 146.75 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.598 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.7 p -79.85 141.41 55.25 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.551 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -47.15 -41.42 27.11 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.927 1.751 . . . . 0.0 112.616 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.33 -57.47 9.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.821 0.343 . . . . 0.0 111.296 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -61.95 -46.25 90.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.47 0.652 . . . . 0.0 110.444 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -57.37 -43.63 83.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.114 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.593 ' NE2' ' OG ' ' A' ' 28' ' ' SER . 0.7 OUTLIER -60.29 -37.94 82.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.111 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -60.7 -41.96 96.25 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.178 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.447 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.4 mm? -62.59 -42.25 99.45 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.201 -0.6 . . . . 0.0 110.276 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mp -73.9 -29.77 62.24 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.474 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.593 ' OG ' ' NE2' ' A' ' 24' ' ' GLN . 49.9 m -58.7 -44.83 90.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.388 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.514 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -115.9 170.97 8.07 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.28 -179.688 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -87.11 -3.22 82.78 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 22.3 mmt -67.26 73.45 0.13 Allowed 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 120.868 0.366 . . . . 0.0 110.118 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.2 mp -99.07 169.85 7.65 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.425 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 32' ' ' LEU . 72.2 Cg_exo -48.63 -168.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.332 2.022 . . . . 0.0 112.462 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.95 7.06 56.73 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.6 m -139.54 -156.65 0.7 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.826 0.346 . . . . 0.0 110.387 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 9' ' ' TRP . 33.4 t -148.8 153.56 38.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.441 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.407 ' HB2' HG22 ' A' ' 53' ' ' THR . 45.0 p90 -128.94 155.54 45.15 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.291 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -106.42 143.81 34.01 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.523 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 5' ' ' PRO . 14.5 t -88.12 122.82 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.281 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.43 HG12 ' H ' ' A' ' 40' ' ' VAL . 2.2 p -68.31 -39.99 81.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.878 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.542 ' NH2' ' ND1' ' A' ' 50' ' ' HIS . 38.1 ptt-85 -174.69 159.87 2.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.136 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 42' ' ' VAL . 36.0 m -133.89 123.84 45.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.68 110.4 49.05 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.686 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -76.42 -11.67 18.93 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.481 2.121 . . . . 0.0 112.176 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.632 ' O ' HD23 ' A' ' 45' ' ' LEU . 1.1 tt -60.59 -33.15 72.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.645 -177.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.13 20.9 0.49 Allowed Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.03 160.22 29.59 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.33 168.03 5.45 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.878 2.386 . . . . 0.0 111.819 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.405 ' N ' ' O ' ' A' ' 60' ' ' LEU . 5.5 mm -89.63 119.77 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.884 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.542 ' ND1' ' NH2' ' A' ' 41' ' ' ARG . 12.4 m170 -95.47 122.64 38.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.887 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.7 pt -125.87 148.91 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.278 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -130.71 132.36 45.32 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.422 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 55' ' ' ARG . 1.4 p -122.63 137.1 55.0 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.0 ptt-85 -41.17 -21.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.871 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.566 ' O ' HG13 ' A' ' 56' ' ' VAL . 33.7 mmt180 -85.3 -50.57 7.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.924 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 55' ' ' ARG . 14.8 m -161.01 -176.0 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.515 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.7 p -113.29 145.27 41.32 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.396 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.9 tp -149.75 148.28 29.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.309 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.8 p -136.54 126.69 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.743 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 49' ' ' ILE . 23.3 mt -132.23 165.57 23.84 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.378 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -81.06 148.49 29.65 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.215 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -41.78 -40.81 2.16 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.961 0.41 . . . . 0.0 111.122 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -58.03 -40.58 81.23 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.563 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -62.08 -41.39 98.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.842 0.353 . . . . 0.0 110.53 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.556 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.0 mm? -62.14 -42.08 98.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.913 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.18 -41.54 97.07 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.371 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.8 mt -68.33 -43.29 77.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.987 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.5 mt -65.33 133.42 51.36 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.284 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.3 112.2 16.3 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.009 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.406 HG21 ' CE3' ' A' ' 9' ' ' TRP . 26.9 m -129.53 160.39 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.591 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -144.72 128.31 17.09 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.507 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.74 132.61 47.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.951 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.8 t -88.47 131.86 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.225 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 55.6 m -90.12 40.12 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.791 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.7 m -133.15 142.67 48.77 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.822 0.344 . . . . 0.0 110.386 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 77' ' ' GLU . 55.8 tp -63.5 -44.12 95.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.564 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' A' ' 76' ' ' LEU . 97.8 mt-10 45.45 96.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.664 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -77.06 128.71 34.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.535 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.431 ' ND1' ' N ' ' A' ' 80' ' ' HIS . 52.1 t-80 -63.64 -90.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.691 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.431 ' N ' ' ND1' ' A' ' 79' ' ' HIS . 50.8 t-80 -161.09 -67.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.505 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -76.86 140.21 40.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.495 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -85.01 128.37 34.6 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.588 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.446 ' OXT' ' CG ' ' A' ' 83' ' ' HIS . 52.5 p-80 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.926 -1.035 . . . . 0.0 110.52 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mmt . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.439 ' NE2' ' CZ2' ' A' ' 9' ' ' TRP . 56.0 tp60 -63.5 -53.15 56.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.764 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -102.81 133.1 48.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.902 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.24 156.58 77.97 Favored Pre-proline 0 N--CA 1.466 0.351 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.302 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 39' ' ' VAL . 52.4 Cg_exo -51.06 -35.35 50.63 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.907 1.738 . . . . 0.0 112.885 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -135.74 95.93 3.33 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.5 130.82 42.87 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.89 102.39 15.09 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.439 ' CZ2' ' NE2' ' A' ' 2' ' ' GLN . 22.1 m0 -103.2 144.32 31.48 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.057 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -96.89 140.73 31.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.505 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.9 mt -96.94 122.03 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 O-C-N 123.263 0.352 . . . . 0.0 110.295 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.2 p -109.78 -44.7 3.78 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.761 0.315 . . . . 0.0 110.441 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 167.62 -179.33 41.11 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -97.66 152.18 19.35 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.779 0.323 . . . . 0.0 110.649 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.464 ' O ' HG22 ' A' ' 18' ' ' ILE . 2.6 m -80.05 169.87 17.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.718 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -68.8 -39.61 80.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.574 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -65.64 -14.66 61.63 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.694 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 15' ' ' SER . 10.5 tp -42.29 147.08 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.465 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.9 m -82.0 150.17 64.57 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.904 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -51.25 -39.31 62.39 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.074 1.849 . . . . 0.0 112.652 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.56 -56.77 15.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 0.0 111.374 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.576 ' CZ ' HD21 ' A' ' 68' ' ' LEU . 35.6 t80 -64.11 -47.02 81.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.513 0.673 . . . . 0.0 110.477 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -56.88 -43.79 81.63 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.029 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -63.51 -33.58 75.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.023 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -59.61 -47.37 85.83 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 29' ' ' LEU . 4.5 mm? -63.06 -42.19 99.64 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.121 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.3 tp -68.8 -34.33 75.35 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.9 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.2 t -59.69 -44.61 93.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.62 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.547 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -116.26 168.42 10.14 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.834 0.35 . . . . 0.0 110.219 -179.447 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.02 -1.08 80.11 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.6 mtt -67.78 73.6 0.17 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 120.863 0.363 . . . . 0.0 110.021 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.3 mp -95.78 167.75 12.04 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.261 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 32' ' ' LEU . 75.8 Cg_exo -46.03 -179.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.236 1.957 . . . . 0.0 112.322 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.46 7.16 11.2 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' A' ' 36' ' ' SER . 28.9 t -145.77 -175.59 4.8 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.817 0.341 . . . . 0.0 110.446 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.492 ' N ' ' OG ' ' A' ' 35' ' ' SER . 46.9 m -127.18 156.03 42.46 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.509 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -132.53 150.93 52.08 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.286 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -106.74 146.33 30.96 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.36 0.6 . . . . 0.0 110.401 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' PRO . 6.7 t -83.49 127.3 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.363 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.425 HG12 ' H ' ' A' ' 40' ' ' VAL . 2.2 p -71.13 -38.39 70.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.112 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -172.83 154.13 2.84 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.994 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 73.5 t -126.32 118.91 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.71 111.27 51.91 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.221 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -76.27 -11.2 19.27 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.148 1.899 . . . . 0.0 112.262 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 45' ' ' LEU . 10.7 mp -59.89 -31.71 70.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.646 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.7 27.93 0.71 Allowed Glycine 0 N--CA 1.466 0.697 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.84 160.21 29.06 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.23 172.06 1.01 Allowed 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.835 2.356 . . . . 0.0 111.859 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.412 ' N ' ' O ' ' A' ' 60' ' ' LEU . 7.3 mm -90.42 116.93 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.995 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.407 ' CD2' HG23 ' A' ' 59' ' ' VAL . 12.1 m170 -96.72 121.89 39.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.706 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.5 pt -129.2 147.25 33.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.632 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.414 ' OE1' ' OG ' ' A' ' 57' ' ' SER . 57.0 mm-40 -122.49 114.51 20.79 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.099 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.02 137.5 44.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.685 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -42.89 -40.28 2.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.439 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -66.23 -47.03 75.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.562 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.657 HG22 ' N ' ' A' ' 57' ' ' SER . 11.2 p -170.52 173.39 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 120.981 0.42 . . . . 0.0 110.59 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.657 ' N ' HG22 ' A' ' 56' ' ' VAL . 4.4 m -95.19 152.8 18.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.38 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.3 tp -155.66 145.33 21.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.019 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.407 HG23 ' CD2' ' A' ' 50' ' ' HIS . 4.8 p -137.99 126.08 30.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 49' ' ' ILE . 19.0 mt -132.37 -178.63 5.0 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.499 ' CD ' ' N ' ' A' ' 61' ' ' ARG . 9.8 mpt_? -94.85 150.97 19.62 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.348 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -42.07 -43.34 3.21 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.828 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.47 -40.02 85.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.466 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -59.42 -43.08 93.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.51 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.532 HD22 ' N ' ' A' ' 65' ' ' LEU . 3.8 mm? -62.81 -41.87 99.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.812 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.3 -46.03 89.68 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.229 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.9 mp -67.3 -40.25 86.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.675 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.576 HD21 ' CZ ' ' A' ' 22' ' ' TYR . 21.5 mt -63.47 128.02 33.93 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.204 -0.599 . . . . 0.0 110.173 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -77.5 104.87 8.28 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.649 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.431 HG21 ' CE3' ' A' ' 9' ' ' TRP . 31.0 m -125.05 160.3 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.424 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -142.86 134.67 26.81 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.36 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.16 132.78 47.8 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.601 -0.44 . . . . 0.0 109.857 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.0 m -82.11 37.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.553 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 90.7 p -85.39 -7.07 59.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.81 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.5 m -149.53 155.48 40.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.383 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.9 tp -141.1 86.65 2.05 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.516 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -92.36 -9.43 41.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.438 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.542 ' O ' ' N ' ' A' ' 80' ' ' HIS . 96.6 m-70 -59.47 -44.24 93.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.653 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.481 ' CE1' ' NE2' ' A' ' 80' ' ' HIS . 20.0 t60 54.45 -81.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.789 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.542 ' N ' ' O ' ' A' ' 78' ' ' HIS . 54.8 m170 -110.8 145.79 37.53 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.901 0.381 . . . . 0.0 110.413 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -60.94 -43.01 99.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.777 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -131.55 143.2 50.19 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.551 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.573 -179.939 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.4 ptt? . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -66.96 -60.12 2.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.02 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -84.77 136.23 33.78 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 p -130.77 150.52 76.7 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 121.044 -0.263 . . . . 0.0 110.454 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 39' ' ' VAL . 42.6 Cg_exo -50.75 -49.39 16.96 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.794 1.662 . . . . 0.0 113.147 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -134.18 103.35 5.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.065 0.459 . . . . 0.0 111.165 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.72 144.42 41.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.529 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.46 101.89 14.63 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.574 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 23.8 m0 -100.36 141.23 33.48 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.015 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -95.25 130.37 42.03 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.3 mt -83.52 121.26 36.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.243 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.6 m -103.06 -49.64 3.71 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.812 0.339 . . . . 0.0 110.648 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.16 169.89 27.25 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -85.34 158.33 20.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.901 0.381 . . . . 0.0 110.396 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.413 ' O ' HG22 ' A' ' 18' ' ' ILE . 47.2 t -79.87 169.44 17.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.72 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -69.67 -39.61 76.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.841 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -74.6 -7.62 53.74 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.458 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.413 HG22 ' O ' ' A' ' 15' ' ' SER . 10.4 tp -42.46 148.6 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.648 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.1 m -75.16 154.14 86.37 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.355 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.98 -25.79 51.68 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.516 2.144 . . . . 0.0 112.137 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.0 -55.93 9.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.18 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -63.45 -45.65 89.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.189 0.518 . . . . 0.0 110.596 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -58.11 -45.54 87.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.136 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 17.1 tm0? -62.24 -33.73 75.16 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -59.21 -46.79 87.5 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.695 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.6 mm? -62.03 -39.54 92.67 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.229 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.9 tp -59.95 -42.38 93.91 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.227 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.0 t -82.92 -9.43 59.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.296 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.7 tp -94.91 124.67 39.09 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.937 0.398 . . . . 0.0 110.367 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.6 -19.45 74.76 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 45.1 ttp -89.51 73.13 7.84 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.632 0.73 . . . . 0.0 109.306 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' A' ' 33' ' ' PRO . 9.5 mt -80.51 156.91 73.08 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.983 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 32' ' ' LEU . 75.6 Cg_exo -37.91 162.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.476 2.117 . . . . 0.0 112.444 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.16 3.75 17.02 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 96.4 p -129.3 -156.66 0.77 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.767 0.318 . . . . 0.0 110.346 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.5 t -145.3 151.99 39.21 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.702 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -132.62 159.43 39.57 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.356 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -111.38 146.37 37.26 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.733 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 5' ' ' PRO . 51.2 t -90.45 125.66 43.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.146 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -66.83 -42.22 88.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 50.1 ptt85 -174.28 156.75 2.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.076 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.57 ' O ' HG23 ' A' ' 42' ' ' VAL . 32.9 m -128.92 117.23 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.09 110.31 47.32 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 120.951 -0.299 . . . . 0.0 110.413 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.67 -11.58 18.49 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.181 1.921 . . . . 0.0 112.187 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tp -57.15 -31.08 65.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.973 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.62 22.98 0.66 Allowed Glycine 0 N--CA 1.465 0.604 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.35 159.82 30.3 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -59.84 173.46 1.69 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.763 2.309 . . . . 0.0 111.761 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 60' ' ' LEU . 8.2 mm -92.96 114.63 30.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.093 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.499 ' CD2' HG23 ' A' ' 59' ' ' VAL . 12.4 m170 -96.0 121.93 38.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.093 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.7 pt -126.26 149.37 31.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.286 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -129.32 135.15 48.37 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.553 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -126.69 145.59 50.52 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.797 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -50.09 -38.6 39.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.169 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.0 tpm_? -67.74 -43.7 79.31 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.772 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.723 HG22 ' H ' ' A' ' 57' ' ' SER . 11.8 p -170.74 176.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.584 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.723 ' H ' HG22 ' A' ' 56' ' ' VAL . 47.4 t -105.87 149.2 26.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.43 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.4 tp -152.77 149.4 28.3 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.205 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.499 HG23 ' CD2' ' A' ' 50' ' ' HIS . 10.2 p -128.93 128.22 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.64 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.424 HD13 ' OD1' ' A' ' 64' ' ' ASP . 58.7 mt -132.34 162.59 30.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.269 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -85.58 171.9 11.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.717 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -61.9 -40.07 94.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.625 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.48 -39.26 87.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.467 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.424 ' OD1' HD13 ' A' ' 60' ' ' LEU . 6.5 t70 -57.17 -47.13 81.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.345 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.62 -40.88 98.35 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.661 -0.416 . . . . 0.0 109.924 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.07 -54.11 48.94 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.499 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 67' ' ' LEU . 11.1 mp -69.53 -41.57 75.8 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.153 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 38.7 tp -59.0 130.32 46.44 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -83.84 114.03 21.36 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 110.23 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.26 158.43 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.912 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -144.11 141.81 30.23 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.759 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.1 145.4 51.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.098 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.3 t -104.0 128.09 57.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.149 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.5 t -169.03 73.24 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.396 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.9 m -156.25 168.38 27.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.448 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 77' ' ' GLU . 56.9 tp -62.16 -43.87 97.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.519 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 76' ' ' LEU . 82.6 tt0 58.18 152.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.293 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.608 ' ND1' ' N ' ' A' ' 79' ' ' HIS . 58.6 t-80 -59.92 -111.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.655 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.608 ' N ' ' ND1' ' A' ' 78' ' ' HIS . 52.5 t-80 -160.65 138.03 9.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.36 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -145.5 137.91 25.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.429 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -152.27 162.88 40.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.399 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 42.61 91.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.801 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.64 -179.925 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -65.41 -40.24 93.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.628 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -72.71 137.24 45.82 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.15 155.29 77.58 Favored Pre-proline 0 N--CA 1.466 0.357 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.19 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 39' ' ' VAL . 50.1 Cg_endo -67.68 -23.12 42.84 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.638 2.225 . . . . 0.0 112.307 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -137.86 94.4 2.89 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.689 0.281 . . . . 0.0 110.582 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.12 130.7 27.26 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.9 101.94 14.03 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.443 ' CE3' HG21 ' A' ' 70' ' ' VAL . 23.0 m0 -101.76 145.86 28.56 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.23 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -102.8 128.51 49.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.88 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.0 mt -81.03 123.74 37.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.337 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 7.8 p -111.47 -15.17 13.59 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.55 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.34 178.28 16.84 Favored Glycine 0 N--CA 1.465 0.598 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.421 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.5 p90 -98.58 152.17 19.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.85 0.357 . . . . 0.0 110.119 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.478 ' O ' HG22 ' A' ' 18' ' ' ILE . 5.1 t -80.21 168.71 18.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.463 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 16' ' ' ARG . 37.1 mtp-105 -68.56 -39.52 81.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.943 0.401 . . . . 0.0 110.662 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -64.24 -17.08 63.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.616 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.478 HG22 ' O ' ' A' ' 15' ' ' SER . 10.7 tp -41.92 147.89 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.476 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.5 t -80.96 146.33 59.03 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.699 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -49.67 -41.05 46.61 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.874 1.716 . . . . 0.0 112.755 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.52 -56.27 20.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.244 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -61.94 -46.75 87.97 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.48 0.657 . . . . 0.0 110.396 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -57.34 -44.08 83.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.848 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 28' ' ' SER . 5.9 tm0? -60.12 -38.39 82.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.361 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -57.87 -43.92 86.29 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.538 HD12 ' HD3' ' A' ' 33' ' ' PRO . 4.6 mm? -63.51 -40.84 98.1 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.269 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.4 mt -80.74 -18.14 48.74 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.885 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 24' ' ' GLN . 38.8 t -61.04 -43.97 98.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.077 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.596 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -115.82 154.53 29.5 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.398 -179.527 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.65 5.97 42.51 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.512 ' N ' ' SD ' ' A' ' 31' ' ' MET . 0.0 OUTLIER -89.27 74.73 7.86 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.713 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -82.42 171.24 12.33 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.355 -178.903 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.538 ' HD3' HD12 ' A' ' 26' ' ' LEU . 63.3 Cg_exo -48.47 -171.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.321 2.014 . . . . 0.0 112.206 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.01 11.25 8.46 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 81.8 p -139.24 -156.83 0.71 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.921 0.391 . . . . 0.0 110.413 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.8 p -141.15 163.0 34.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.468 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -139.51 160.93 38.72 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.194 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.413 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 24.2 p30 -119.22 151.19 38.8 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.24 0.543 . . . . 0.0 110.429 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' PRO . 61.0 t -88.15 127.53 41.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.279 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -69.06 -41.3 81.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.069 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -173.56 162.07 4.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.964 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 68.0 t -130.14 124.2 57.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.39 110.56 49.39 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.28 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.72 -11.31 20.22 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.29 1.994 . . . . 0.0 112.331 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.529 HD22 ' N ' ' A' ' 45' ' ' LEU . 4.1 mm? -60.65 -31.43 70.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.708 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.5 24.76 0.82 Allowed Glycine 0 N--CA 1.465 0.606 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.1 160.05 29.92 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.05 173.15 0.62 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.805 2.336 . . . . 0.0 111.665 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.437 ' N ' ' O ' ' A' ' 60' ' ' LEU . 8.5 mm -93.48 114.26 29.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -92.17 122.33 34.55 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.891 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 58' ' ' LEU . 44.4 pt -126.84 151.91 34.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.574 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.413 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 95.1 mt-10 -130.95 134.46 46.76 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.248 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.22 141.85 51.63 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.996 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.406 ' H ' ' HG3' ' A' ' 54' ' ' ARG . 84.0 mtm180 -40.89 -36.53 0.66 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.36 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -65.54 -50.39 65.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.87 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.685 HG22 ' H ' ' A' ' 57' ' ' SER . 8.5 p -172.39 174.56 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-O 120.905 0.383 . . . . 0.0 110.808 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.685 ' H ' HG22 ' A' ' 56' ' ' VAL . 89.8 p -89.07 150.09 22.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.233 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 51' ' ' ILE . 63.9 tp -159.96 145.42 15.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.783 0.325 . . . . 0.0 110.342 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.8 p -126.5 129.96 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 49' ' ' ILE . 67.2 mt -132.93 161.41 34.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.55 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -85.25 165.29 17.46 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.706 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -59.11 -35.85 74.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.485 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.82 -40.41 95.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.595 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -60.64 -46.4 90.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.723 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.406 ' N ' HD12 ' A' ' 65' ' ' LEU . 9.6 mp -62.71 -40.26 96.6 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.67 -38.62 91.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.517 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.1 mt -82.32 -54.97 4.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.031 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 66.2 mt -45.81 137.61 5.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.657 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.43 ' O ' ' OG1' ' A' ' 12' ' ' THR . 97.2 mt-10 -80.02 111.56 16.49 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.295 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.443 HG21 ' CE3' ' A' ' 9' ' ' TRP . 25.7 m -135.97 159.04 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.395 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -141.54 131.58 24.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.718 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.22 142.36 54.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.115 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t -105.15 123.49 59.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.258 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 74.3 p -124.56 -2.11 7.96 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.606 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.5 t -105.88 115.54 30.41 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.402 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.9 tp -64.43 -41.7 96.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.132 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -41.34 158.81 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.737 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.428 ' O ' ' O ' ' A' ' 79' ' ' HIS . 28.6 p-80 -150.27 165.71 32.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.579 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.428 ' O ' ' O ' ' A' ' 78' ' ' HIS . 57.1 m170 55.06 163.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.403 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.531 ' CE1' ' ND1' ' A' ' 81' ' ' HIS . 51.8 t-80 -133.08 -99.71 0.27 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.491 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.531 ' ND1' ' CE1' ' A' ' 80' ' ' HIS . 80.4 m80 -141.35 151.91 43.95 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.585 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -60.29 -45.26 93.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.73 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.573 179.904 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mmm . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -147.21 -30.16 0.34 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.465 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -79.22 137.12 37.28 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.22 156.51 73.71 Favored Pre-proline 0 N--CA 1.466 0.33 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.174 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 39' ' ' VAL . 41.4 Cg_endo -66.69 -27.75 44.7 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.683 2.255 . . . . 0.0 112.322 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -136.39 94.91 3.08 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.582 0.229 . . . . 0.0 110.408 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.21 128.77 24.46 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.13 101.52 14.18 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 25.2 m0 -99.57 140.59 33.54 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.213 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -98.26 120.44 38.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.882 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.7 mt -74.65 128.52 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.327 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.2 m -110.13 -47.41 3.32 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.567 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 170.62 166.3 29.31 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -87.42 157.25 19.27 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.84 0.352 . . . . 0.0 110.106 179.673 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 67' ' ' LEU . 13.0 m -73.77 163.85 27.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.519 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -69.82 -40.76 75.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.376 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -68.95 -12.19 61.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.355 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.456 HG22 ' O ' ' A' ' 15' ' ' SER . 10.3 tp -41.37 146.95 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.614 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.26 156.97 83.46 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.352 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.61 -30.57 70.49 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.777 2.318 . . . . 0.0 111.756 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.78 -56.8 12.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.881 0.372 . . . . 0.0 111.24 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -61.93 -45.46 93.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.364 0.602 . . . . 0.0 110.442 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -57.26 -43.16 82.75 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.946 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.513 ' O ' ' N ' ' A' ' 28' ' ' SER . 63.5 tp60 -61.51 -38.22 86.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.145 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -59.75 -41.47 91.08 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.456 -0.498 . . . . 0.0 109.819 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.608 HD12 ' HD3' ' A' ' 33' ' ' PRO . 4.4 mm? -64.04 -39.03 93.18 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.425 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.8 tt -82.34 -24.47 34.54 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.071 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 24' ' ' GLN . 96.5 p -60.84 -45.78 93.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.772 0.32 . . . . 0.0 111.484 -178.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.5 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -103.43 161.69 13.64 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.978 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.98 31.28 3.42 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 65.6 mtt -111.65 73.08 0.8 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.473 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.2 mm? -82.84 153.06 67.09 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.648 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.608 ' HD3' HD12 ' A' ' 26' ' ' LEU . 77.8 Cg_exo -39.62 167.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.459 2.106 . . . . 0.0 111.918 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.39 -16.19 12.84 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.811 -0.915 . . . . 0.0 110.811 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.8 m -100.18 -170.76 1.92 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.731 0.301 . . . . 0.0 110.302 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 73.4 m -132.39 156.34 46.84 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.481 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -139.17 157.06 46.61 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.241 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -112.2 146.45 38.08 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.468 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 5' ' ' PRO . 17.5 t -86.3 129.7 37.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.434 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -70.31 -40.24 77.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.146 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -173.77 161.45 3.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.114 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 69.5 t -134.47 110.61 13.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.69 111.55 53.08 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.47 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.518 ' C ' ' H ' ' A' ' 46' ' ' GLY . 60.4 Cg_endo -75.82 -12.13 19.97 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.353 2.035 . . . . 0.0 112.135 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.584 ' N ' HD12 ' A' ' 45' ' ' LEU . 10.2 mp -55.09 -3.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.812 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 103.37 26.62 6.83 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.27 159.58 30.92 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-O 121.028 0.442 . . . . 0.0 109.997 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.95 177.54 0.5 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.758 2.305 . . . . 0.0 111.521 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.473 HG21 ' CD2' ' A' ' 65' ' ' LEU . 10.2 mm -95.92 115.42 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.269 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.455 ' CD2' HG23 ' A' ' 59' ' ' VAL . 11.9 m170 -98.71 122.39 41.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.838 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 35.7 pt -126.77 148.0 31.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.748 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -134.36 111.96 10.61 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.875 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 54' ' ' ARG . 1.3 p -83.65 175.26 9.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.683 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 53' ' ' THR . 99.8 mtt180 -33.53 -53.3 0.41 Allowed 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.548 0.53 . . . . 0.0 111.548 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -143.04 31.41 1.4 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.351 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 t -138.48 134.01 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 120.369 -0.533 . . . . 0.0 110.454 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.7 m -111.12 136.94 49.42 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.195 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.2 tp -156.42 147.27 21.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.245 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.455 HG23 ' CD2' ' A' ' 50' ' ' HIS . 5.9 p -127.5 126.03 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.846 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.0 mt -132.18 167.72 19.28 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.289 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -85.72 166.32 16.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.517 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -60.53 -35.79 76.84 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.999 0.428 . . . . 0.0 110.549 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.27 -41.13 98.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.274 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -57.5 -47.13 82.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.535 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.473 ' CD2' HG21 ' A' ' 49' ' ' ILE . 11.0 mp -61.79 -41.09 97.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.095 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.09 -52.01 67.01 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.598 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.465 ' O ' ' OG ' ' A' ' 15' ' ' SER . 10.8 mp -68.8 -42.34 77.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.038 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 tp -56.43 132.22 50.61 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.286 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -78.91 110.03 13.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.224 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.71 159.05 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.418 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -142.86 133.09 24.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.608 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.23 145.45 54.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.173 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 75' ' ' SER . 62.9 t -109.58 129.41 64.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.191 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 97.6 p -104.64 -1.82 25.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.701 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.4 ' H ' HG12 ' A' ' 73' ' ' VAL . 37.9 t -142.05 135.59 29.34 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.344 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.6 tp -62.94 -43.33 99.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.499 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 47.79 -172.26 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.396 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -153.26 -54.68 0.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.501 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -82.83 136.6 34.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.486 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -78.82 140.61 38.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.468 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -148.01 156.67 42.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.605 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -75.47 139.29 42.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.441 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.484 179.957 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.584 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.424 ' CG ' ' H ' ' A' ' 3' ' ' TYR . 1.5 pt20 -74.47 -101.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.936 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.5 OUTLIER -83.03 150.47 26.32 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.68 164.55 39.02 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 39' ' ' VAL . 31.3 Cg_exo -55.64 -36.14 94.22 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.878 1.719 . . . . 0.0 112.687 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 6' ' ' ASP . 47.0 p-10 -136.74 94.38 2.98 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.796 0.331 . . . . 0.0 110.533 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.29 130.52 33.1 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.95 102.6 15.37 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -105.96 141.33 37.54 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.912 0.387 . . . . 0.0 110.464 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -94.52 147.86 22.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.838 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.3 mt -101.63 115.83 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.0 m -97.73 -43.58 7.11 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.852 0.358 . . . . 0.0 110.42 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.65 179.52 34.52 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.9 OUTLIER -95.84 149.0 22.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.938 0.399 . . . . 0.0 110.506 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.425 ' O ' HG22 ' A' ' 18' ' ' ILE . 4.3 m -78.28 172.16 13.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.545 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -69.49 -40.54 76.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.618 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -66.8 -13.79 61.91 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.968 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.425 HG22 ' O ' ' A' ' 15' ' ' SER . 10.4 tp -41.53 148.49 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.715 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.05 155.21 86.52 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.302 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.99 -31.02 66.8 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.645 2.23 . . . . 0.0 112.216 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.44 -55.34 18.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.902 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -62.82 -43.51 98.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.435 0.636 . . . . 0.0 110.513 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -58.51 -43.32 89.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.6 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.535 ' O ' ' N ' ' A' ' 28' ' ' SER . 18.8 mm-40 -63.36 -35.18 79.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.043 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -59.74 -41.95 92.08 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.368 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.534 HD12 ' HD3' ' A' ' 33' ' ' PRO . 4.6 mm? -70.06 -39.0 75.94 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.748 178.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp -81.91 -15.48 53.76 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.432 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 24' ' ' GLN . 2.8 m -57.14 -29.73 63.83 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.596 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.886 HD13 ' N ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -134.69 -176.92 4.39 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.696 0.284 . . . . 0.0 110.723 179.513 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.39 -9.2 56.97 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 79.2 mtp -76.08 75.13 2.94 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.5 OUTLIER -83.04 171.82 10.83 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.034 -179.275 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.534 ' HD3' HD12 ' A' ' 26' ' ' LEU . 77.7 Cg_exo -48.74 -168.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.523 2.149 . . . . 0.0 112.589 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.03 11.99 7.27 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.6 p -136.12 -158.11 0.84 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.761 0.315 . . . . 0.0 110.214 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 82.5 p -138.68 161.56 36.84 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.761 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -141.21 159.4 42.29 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.183 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 47.6 p-10 -117.38 151.16 37.59 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.196 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 5' ' ' PRO . 61.1 t -87.88 126.34 41.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.283 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.413 HG12 ' H ' ' A' ' 40' ' ' VAL . 1.8 p -68.72 -43.31 83.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.941 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -173.23 147.26 1.53 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.391 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 42' ' ' VAL . 20.9 m -115.99 125.64 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.36 110.39 48.35 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.805 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.1 -12.19 17.6 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.854 1.703 . . . . 0.0 112.315 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.8 mt -60.6 -31.02 70.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.011 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.34 26.34 0.89 Allowed Glycine 0 N--CA 1.469 0.869 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.02 160.27 28.8 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -54.81 175.24 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.603 2.202 . . . . 0.0 111.645 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.4 mm -94.64 113.68 29.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.018 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 16.2 m170 -93.95 119.65 33.14 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.1 pt -127.17 150.43 33.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.368 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.429 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 8.6 tm-20 -126.25 132.31 51.74 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.214 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.08 138.4 54.46 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.924 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -40.59 -38.58 0.89 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.332 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -67.13 -48.66 67.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.744 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.637 HG22 ' N ' ' A' ' 57' ' ' SER . 8.5 p -171.5 172.07 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.933 0.397 . . . . 0.0 110.87 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.637 ' N ' HG22 ' A' ' 56' ' ' VAL . 10.7 p -86.26 151.26 23.76 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.461 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.1 tp -155.66 146.45 22.2 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.884 0.373 . . . . 0.0 110.299 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.6 p -125.65 130.9 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.64 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.4 mt -134.71 163.2 30.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.576 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 83.6 mtt85 -92.08 174.8 7.13 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.972 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -62.05 -44.67 96.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.092 0.472 . . . . 0.0 110.623 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -61.63 -38.02 86.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.627 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -59.47 -48.36 81.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.259 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.433 ' CD2' ' CE1' ' A' ' 3' ' ' TYR . 10.5 mp -62.92 -41.77 99.57 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.113 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.36 -50.94 71.85 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.269 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.0 mt -68.83 -41.92 77.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.239 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.2 tp -62.19 136.21 57.83 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -84.9 116.37 23.3 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.871 0.367 . . . . 0.0 110.427 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.0 m -133.28 161.45 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.527 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -145.59 145.98 31.2 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.463 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.96 135.92 45.07 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.2 131.63 35.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.787 0.327 . . . . 0.0 110.289 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.0 p -147.79 -44.21 0.16 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.557 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.0 p -76.21 144.83 40.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.075 0.464 . . . . 0.0 110.455 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 77' ' ' GLU . 90.3 mt -63.91 -41.78 97.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.562 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 76' ' ' LEU . 80.2 mm-40 56.27 156.75 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.597 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -79.74 156.45 27.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.434 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -53.38 -77.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.544 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -143.1 141.09 31.14 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.462 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.46 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 48.6 p-80 -76.73 122.04 24.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.509 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -84.1 -16.38 43.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.606 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.452 ' CG ' ' O ' ' A' ' 83' ' ' HIS . 51.1 t-80 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.556 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mtp . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.479 ' O ' HG23 ' A' ' 4' ' ' THR . 7.9 mp0 -72.65 -70.39 0.35 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.549 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -73.18 90.14 1.56 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.05 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 2' ' ' GLN . 0.8 OUTLIER -103.07 152.34 38.55 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.314 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -49.9 -44.05 38.58 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.852 1.701 . . . . 0.0 112.816 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -135.47 100.64 4.56 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.935 0.398 . . . . 0.0 110.835 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.35 143.45 42.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.389 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -96.48 102.45 14.24 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.576 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 26.5 m0 -98.51 145.77 26.45 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.377 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -100.34 132.58 45.64 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.788 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 36.1 mt -82.37 124.56 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.21 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.5 m -108.03 -49.55 3.19 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.81 0.338 . . . . 0.0 110.804 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.11 -178.88 40.54 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 2.3 p90 -102.52 144.29 31.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.909 0.385 . . . . 0.0 110.464 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.41 ' O ' HG22 ' A' ' 18' ' ' ILE . 19.7 m -75.31 171.36 14.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.453 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -68.78 -38.48 80.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.785 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -71.7 -10.27 59.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.482 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 15' ' ' SER . 10.0 tp -41.56 147.51 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.518 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.2 t -78.64 140.72 59.54 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.356 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -48.25 -40.24 35.09 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.902 1.735 . . . . 0.0 112.89 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.53 -58.14 8.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.897 0.379 . . . . 0.0 111.364 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -62.07 -47.2 85.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.55 0.691 . . . . 0.0 110.471 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -56.51 -43.16 79.5 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.878 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -59.73 -37.53 79.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.182 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -59.47 -43.03 93.32 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.633 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.5 mm? -62.4 -42.62 99.57 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.967 178.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 48.7 mt -70.85 -32.55 69.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.917 0.389 . . . . 0.0 110.928 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 64.7 m -58.0 -44.12 87.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.399 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.564 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -117.94 166.24 12.74 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.161 -179.777 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.4 8.49 79.73 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 16.1 mmt -78.4 73.37 4.96 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.5 mp -91.4 167.84 14.79 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.089 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 32' ' ' LEU . 71.6 Cg_exo -44.33 176.69 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 122.292 1.994 . . . . 0.0 112.363 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.34 1.58 15.91 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.434 ' OG ' ' N ' ' A' ' 36' ' ' SER . 32.7 t -134.48 -155.85 0.69 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.903 0.382 . . . . 0.0 110.321 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.434 ' N ' ' OG ' ' A' ' 35' ' ' SER . 27.3 p -150.71 161.94 41.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.554 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -138.38 156.49 47.55 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.293 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -108.95 145.72 35.0 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.496 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.7 t -89.85 126.72 42.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.434 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -67.52 -42.31 86.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.114 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -173.87 156.93 2.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.059 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.539 ' O ' HG23 ' A' ' 42' ' ' VAL . 30.8 m -126.05 122.11 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.75 110.27 48.43 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.511 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -76.86 -11.88 18.08 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.199 1.933 . . . . 0.0 112.283 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.1 mt -59.69 -31.47 69.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.026 -178.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.83 25.01 0.78 Allowed Glycine 0 N--CA 1.466 0.673 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.52 160.13 29.47 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.4 169.58 2.19 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.898 2.399 . . . . 0.0 111.638 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.1 mm -92.77 113.65 28.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.99 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.479 ' CD2' HG23 ' A' ' 59' ' ' VAL . 13.2 m170 -95.6 121.25 37.09 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.909 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 48.0 pt -127.93 149.87 33.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.428 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -118.97 125.51 49.6 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.173 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.0 p -111.77 136.94 50.36 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -39.29 -40.23 0.74 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.804 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.667 ' O ' HG13 ' A' ' 56' ' ' VAL . 56.6 ttt85 -67.88 -49.71 60.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.21 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 55' ' ' ARG . 4.4 m -164.77 -176.68 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.556 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.0 t -96.23 136.96 36.0 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.488 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.5 tp -138.04 145.27 41.61 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.987 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.479 HG23 ' CD2' ' A' ' 50' ' ' HIS . 12.9 p -126.42 130.46 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.694 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.8 mt -134.3 162.26 32.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.475 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -91.89 165.03 13.44 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.623 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.698 ' HB3' ' HZ2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -57.0 -40.93 77.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.072 0.463 . . . . 0.0 110.635 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -62.22 -36.92 83.44 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.793 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.29 -42.85 99.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.278 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.7 mp -63.06 -41.96 99.59 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.884 -0.414 . . . . 0.0 109.884 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.31 -50.77 72.43 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.146 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.5 mt -69.2 -40.48 78.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.004 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.3 tp -62.58 134.02 55.76 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -85.13 112.47 20.72 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.003 0.43 . . . . 0.0 110.118 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.0 m -132.5 158.99 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.63 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -142.92 141.68 31.53 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.823 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.61 150.55 42.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.164 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.6 t -117.65 130.69 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.197 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 90.8 p -118.89 1.92 11.53 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.558 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 51.4 m -153.05 163.93 38.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.439 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.8 tp -61.24 -84.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.305 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -164.36 -72.25 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.49 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 45.0 p-80 -151.01 165.7 32.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.32 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -111.37 138.59 47.67 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.32 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -78.9 123.95 27.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.5 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.606 ' N ' ' ND1' ' A' ' 81' ' ' HIS . 0.6 OUTLIER -66.16 -44.48 84.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.453 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -146.83 147.38 30.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.605 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.602 179.927 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.9 mmm . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.664 ' H ' ' CD ' ' A' ' 2' ' ' GLN . 0.3 OUTLIER -63.73 -38.44 91.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.727 -179.82 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -97.66 133.55 42.06 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.851 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.456 ' OG1' ' CG2' ' A' ' 7' ' ' THR . 15.4 p -132.39 148.07 68.2 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.484 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 39' ' ' VAL . 44.9 Cg_endo -66.22 -31.29 44.78 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.392 2.062 . . . . 0.0 112.473 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -136.23 93.99 2.97 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.725 0.298 . . . . 0.0 111.318 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.456 ' CG2' ' OG1' ' A' ' 4' ' ' THR . 0.9 OUTLIER -141.77 149.16 40.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.368 178.825 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -102.78 102.05 12.16 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 25.3 m0 -97.46 142.74 28.94 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.894 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -100.68 123.66 45.19 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.5 mt -79.6 120.43 30.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.904 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.6 p -104.08 -15.66 15.5 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.348 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.47 164.66 10.41 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.88 169.51 17.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.9 t -84.03 166.42 17.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.447 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.9 ptt-85 -70.58 -37.03 73.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.556 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -81.09 -5.42 57.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.028 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.6 tp -41.15 141.75 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.386 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.8 m -80.02 150.88 72.52 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.806 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.06 -38.84 60.47 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.9 1.733 . . . . 0.0 112.544 179.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.63 -58.12 8.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.437 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -63.32 -48.65 77.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.346 0.594 . . . . 0.0 110.555 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -57.93 -40.76 81.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.04 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 28' ' ' SER . 12.1 tm0? -61.8 -39.44 91.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.207 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.51 -43.73 96.77 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.253 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.602 HD12 ' HD3' ' A' ' 33' ' ' PRO . 4.5 mm? -63.47 -39.21 93.86 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.283 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.5 tt -81.13 -23.18 38.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.958 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.469 ' N ' ' O ' ' A' ' 24' ' ' GLN . 40.3 t -61.22 -45.24 95.38 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.167 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.515 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -107.71 160.47 15.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.173 -179.554 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.04 33.92 2.4 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 36.5 tpp -112.8 74.01 0.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.464 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.2 mm? -81.86 153.58 70.06 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.075 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.602 ' HD3' HD12 ' A' ' 26' ' ' LEU . 66.4 Cg_exo -40.12 169.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 122.78 2.32 . . . . 0.0 112.439 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.15 12.11 7.13 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 90.2 p -126.63 -171.36 2.39 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 73.5 m -131.45 157.47 43.39 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.72 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -137.88 159.96 40.58 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.296 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -117.35 145.85 43.77 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.893 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 5' ' ' PRO . 57.5 t -86.06 127.66 40.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.213 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 40' ' ' VAL . 2.4 p -70.65 -41.37 77.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.209 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -176.41 171.31 2.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.818 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.56 130.65 37.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.36 109.61 43.82 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.716 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.511 ' C ' ' H ' ' A' ' 46' ' ' GLY . 33.9 Cg_exo -60.57 -21.86 70.26 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 121.793 1.662 . . . . 0.0 112.334 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.5 mt -52.99 -5.72 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.634 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 90.8 33.95 8.06 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.7 169.75 8.11 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -54.51 -171.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 121.807 1.672 . . . . 0.0 111.939 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 60' ' ' LEU . 9.5 mm -111.89 109.67 29.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.744 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.406 ' O ' HG12 ' A' ' 40' ' ' VAL . 2.7 m80 -85.71 125.73 33.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.161 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.6 pt -127.66 151.22 34.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.524 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.4 ' OE1' ' C ' ' A' ' 52' ' ' GLU . 1.9 pp20? -130.7 136.86 49.19 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.212 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 56' ' ' VAL . 2.9 p -128.87 143.68 50.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.09 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -49.28 -37.45 23.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.659 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -72.74 -37.82 67.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.91 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.779 HG22 ' H ' ' A' ' 57' ' ' SER . 3.5 p -169.53 -176.1 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.824 0.345 . . . . 0.0 110.207 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.779 ' H ' HG22 ' A' ' 56' ' ' VAL . 36.5 p -130.65 150.49 51.81 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 59' ' ' VAL . 5.8 tt -163.81 164.95 23.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.354 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.514 ' N ' HD23 ' A' ' 58' ' ' LEU . 3.6 p -126.47 137.79 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.828 0.347 . . . . 0.0 110.419 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 49' ' ' ILE . 11.9 mt -134.11 152.07 51.67 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.704 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -77.83 162.05 27.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.508 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -58.4 -39.49 79.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.862 0.363 . . . . 0.0 110.34 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.89 -39.68 92.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.4 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -59.87 -45.94 90.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.516 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 mp -62.02 -41.8 98.47 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.341 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.12 -51.76 68.0 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.18 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.23 -39.95 82.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.944 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.9 tp -60.02 128.92 39.24 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -75.59 110.28 9.85 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.423 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.6 m -133.24 161.4 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.64 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -143.28 138.35 29.51 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.395 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.81 134.13 44.78 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 80.9 t -89.71 133.8 30.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.383 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 37.8 p -148.8 161.92 40.83 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.853 0.359 . . . . 0.0 110.47 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.4 m -78.04 103.94 8.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.662 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.526 HD12 ' N ' ' A' ' 76' ' ' LEU . 10.7 mp -63.1 -41.52 99.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.331 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 57.41 96.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.399 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -149.9 159.64 44.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.362 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -110.91 149.01 31.25 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.486 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -79.47 150.49 31.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.619 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -143.91 140.23 29.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.491 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -80.77 150.9 29.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.589 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 . . . . . 0 C--O 1.219 -0.522 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.518 179.97 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ptm . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -62.9 -44.27 96.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.757 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -106.44 137.42 44.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.848 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 p -130.09 152.49 80.15 Favored Pre-proline 0 N--CA 1.466 0.343 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 39' ' ' VAL . 52.6 Cg_exo -50.45 -41.45 51.96 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.972 1.781 . . . . 0.0 112.586 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.446 ' OD1' ' ND2' ' A' ' 38' ' ' ASN . 67.0 t0 -134.37 100.59 4.72 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.003 0.43 . . . . 0.0 111.026 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 t -137.35 144.52 42.56 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.296 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.36 102.43 14.41 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.745 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 14.5 m0 -100.62 142.59 31.89 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.345 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -97.49 139.61 33.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.632 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.4 mt -98.84 114.88 37.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 m -97.26 -40.42 8.77 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.44 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.65 164.77 21.79 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.65 162.32 27.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.78 0.324 . . . . 0.0 110.172 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.487 ' O ' HG22 ' A' ' 18' ' ' ILE . 5.8 t -78.69 163.45 25.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.518 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 49.6 ptt85 -68.67 -37.62 79.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -70.08 -14.65 62.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.603 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 15' ' ' SER . 10.8 tp -41.94 145.53 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.404 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 t -84.98 149.84 54.13 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.515 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -48.94 -37.12 36.24 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.952 1.768 . . . . 0.0 112.394 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.38 -58.48 7.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.485 -178.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -63.45 -46.61 85.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.427 0.632 . . . . 0.0 110.668 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -57.49 -43.32 84.07 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.936 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -63.42 -37.79 88.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.216 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -59.06 -45.45 90.75 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.884 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.446 ' HA ' HD13 ' A' ' 26' ' ' LEU . 4.4 mm? -62.34 -43.52 98.63 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.184 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.3 tp -63.64 -42.42 98.15 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.536 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.6 m -72.32 -39.73 67.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.453 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.734 HD23 ' N ' ' A' ' 30' ' ' GLY . 1.7 tt -82.5 132.1 35.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.774 -178.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.734 ' N ' HD23 ' A' ' 29' ' ' LEU . . . -73.26 32.21 0.8 Allowed Glycine 0 N--CA 1.462 0.427 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.526 ' CB ' HD22 ' A' ' 29' ' ' LEU . 11.3 tpt -124.67 72.7 1.22 Allowed 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.0 mm? -81.62 152.01 69.08 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.106 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 32' ' ' LEU . 72.5 Cg_exo -40.77 169.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 122.676 2.251 . . . . 0.0 112.491 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.72 -17.92 15.35 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.5 m -103.36 -169.44 1.65 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.827 0.346 . . . . 0.0 110.269 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.6 m -132.17 155.58 47.94 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.579 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -132.07 155.25 48.41 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.027 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.446 ' ND2' ' OD1' ' A' ' 6' ' ' ASP . 3.2 t-20 -112.81 145.14 41.14 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.364 0.602 . . . . 0.0 110.858 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 5' ' ' PRO . 58.6 t -83.54 127.43 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.14 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 50' ' ' HIS . 2.3 p -70.42 -39.3 76.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.132 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -173.67 160.56 3.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.564 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 70.5 t -136.17 112.11 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.64 109.81 45.59 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 119.494 -0.289 . . . . 0.0 110.928 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.542 ' C ' ' H ' ' A' ' 46' ' ' GLY . 31.7 Cg_exo -57.81 -12.52 12.09 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 121.838 1.692 . . . . 0.0 112.156 178.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 82.0 mt -51.58 -5.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.819 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.542 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 89.11 31.69 11.64 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.34 162.39 22.8 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -52.96 -170.74 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.885 1.723 . . . . 0.0 111.876 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.6 mm -109.64 113.57 44.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.428 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.489 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -96.62 127.75 42.91 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.433 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.1 pt -127.33 149.61 32.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.654 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -135.69 131.55 35.82 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.503 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 55' ' ' ARG . 2.7 p -125.52 137.48 53.94 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.074 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -39.05 -24.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.755 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.539 ' O ' HG13 ' A' ' 56' ' ' VAL . 84.8 mtt85 -84.96 -49.86 7.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.208 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 55' ' ' ARG . 16.0 m -161.2 -174.87 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.474 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.8 p -131.05 151.76 51.07 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.637 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.2 tp -154.21 151.91 29.73 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.274 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.407 HG22 ' CG ' ' A' ' 50' ' ' HIS . 45.0 t -118.91 129.5 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.1 mt -137.79 152.26 48.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.467 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.8 tpp85 -81.22 162.79 23.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.462 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -57.7 -37.59 73.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.021 0.438 . . . . 0.0 110.502 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -61.57 -41.24 97.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.175 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.13 -46.02 91.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.371 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.6 mp -60.92 -40.96 95.16 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.182 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.56 -51.37 69.74 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.454 -0.499 . . . . 0.0 110.445 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.99 -42.61 80.5 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.382 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.3 mt -60.92 134.55 57.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.304 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -78.01 108.06 11.01 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.758 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.2 m -131.03 160.71 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.806 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -147.72 145.75 28.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.514 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.37 135.77 53.74 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.0 t -86.3 130.48 36.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.854 0.359 . . . . 0.0 110.438 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 37.2 t -153.83 -33.45 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.579 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.6 p -78.07 156.04 30.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.498 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.567 HD12 ' N ' ' A' ' 76' ' ' LEU . 10.4 mp -89.69 -2.79 58.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.317 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -58.9 148.24 31.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.465 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 40.1 p-80 -150.98 158.78 44.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.4 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -105.15 153.59 21.32 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.279 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -106.26 123.25 47.75 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.379 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -85.67 126.52 34.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.441 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.537 ' CG ' ' H ' ' A' ' 83' ' ' HIS . 14.2 t-160 -73.66 -123.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.524 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.537 ' H ' ' CG ' ' A' ' 82' ' ' HIS . 39.7 p-80 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.529 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 tpp . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -64.28 -32.6 74.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.817 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -66.08 130.97 45.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.737 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.67 154.59 59.62 Favored Pre-proline 0 N--CA 1.467 0.395 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.45 -32.9 59.38 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.477 2.118 . . . . 0.0 112.085 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 6' ' ' ASP . 47.8 p-10 -136.72 93.77 2.9 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.928 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.5 t -140.69 151.04 44.23 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.093 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -100.71 102.45 13.56 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 22.9 m0 -98.93 129.4 45.26 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.247 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -85.66 136.31 33.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.877 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.1 mt -91.2 119.07 37.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.1 m -102.16 -43.01 5.86 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.827 0.346 . . . . 0.0 110.33 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.06 -174.1 33.98 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.7 OUTLIER -95.0 157.1 16.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.901 0.381 . . . . 0.0 110.325 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.413 ' O ' HG22 ' A' ' 18' ' ' ILE . 6.8 t -85.23 171.89 11.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.599 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.409 ' N ' ' OG ' ' A' ' 15' ' ' SER . 89.6 mtm180 -68.48 -38.28 80.87 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.869 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -75.81 -6.01 48.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.434 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.413 HG22 ' O ' ' A' ' 15' ' ' SER . 9.3 tp -41.9 147.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.601 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.45 155.66 87.49 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.436 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.32 -30.1 63.44 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.535 2.156 . . . . 0.0 112.028 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.89 -53.46 31.99 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.004 0.43 . . . . 0.0 111.161 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -63.68 -46.33 86.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.342 0.591 . . . . 0.0 110.268 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -56.46 -44.51 80.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.96 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 28' ' ' SER . 39.5 mm-40 -64.07 -31.57 72.8 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -59.09 -48.91 79.87 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.469 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.453 HD22 ' N ' ' A' ' 26' ' ' LEU . 4.5 mm? -64.7 -40.7 95.81 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.104 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.2 tp -69.37 -34.33 74.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.219 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 24' ' ' GLN . 11.9 t -59.44 -44.67 92.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.4 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.548 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -116.36 167.9 10.62 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.269 -179.631 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.81 7.91 80.55 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 94.2 mtp -77.6 73.96 4.16 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.4 mp -93.77 169.21 10.41 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.576 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 32' ' ' LEU . 54.0 Cg_exo -48.6 -170.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.317 2.011 . . . . 0.0 112.333 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.83 5.34 20.44 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.0 t -145.43 -172.31 3.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.759 0.314 . . . . 0.0 110.366 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.5 t -130.11 155.75 45.67 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.496 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -131.84 164.57 25.76 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.27 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 38' ' ' ASN . 12.8 p-10 -116.64 149.68 39.35 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.518 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.5 t -88.31 125.21 41.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.501 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.2 p -67.51 -42.54 87.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.348 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.48 ' NH2' ' ND1' ' A' ' 50' ' ' HIS . 37.0 ptt-85 -170.1 160.19 7.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.409 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 86.4 t -129.24 127.58 65.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.407 ' HB1' ' OD1' ' A' ' 47' ' ' ASP . . . -93.39 110.93 49.8 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.507 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -76.28 -11.39 19.21 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.073 1.848 . . . . 0.0 112.415 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.522 ' N ' HD12 ' A' ' 45' ' ' LEU . 10.5 mp -59.29 -30.63 68.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.579 -178.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.39 28.23 1.36 Allowed Glycine 0 N--CA 1.468 0.78 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -97.9 178.72 1.25 Allowed Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 47' ' ' ASP . 19.2 Cg_exo -64.13 -179.14 0.73 Allowed 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.974 1.783 . . . . 0.0 111.888 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.0 mm -103.6 117.95 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.528 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.48 ' ND1' ' NH2' ' A' ' 41' ' ' ARG . 10.8 m170 -96.37 117.47 30.91 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.2 pt -118.66 147.38 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.431 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.413 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 84.2 tt0 -134.26 112.04 10.73 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.217 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 54' ' ' ARG . 1.2 p -86.46 172.56 10.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.766 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 53' ' ' THR . 95.5 mtt180 -34.02 -51.84 0.43 Allowed 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.479 0.487 . . . . 0.0 111.929 -178.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.6 tpt85 -142.03 31.68 1.58 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.619 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -141.96 138.08 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.541 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.3 t -116.9 131.91 56.83 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.35 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.1 tp -145.87 146.38 31.09 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.932 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.427 HG23 ' CD2' ' A' ' 50' ' ' HIS . 4.9 p -136.93 127.2 39.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.8 mt -138.17 165.38 26.8 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.587 0.232 . . . . 0.0 110.428 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -74.0 148.14 42.31 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 120.94 0.4 . . . . 0.0 111.275 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -43.94 -41.77 5.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.184 0.516 . . . . 0.0 110.807 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -57.98 -40.63 81.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.387 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -60.05 -42.66 94.97 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.477 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.554 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.0 mm? -62.05 -42.07 98.79 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.59 -48.48 81.51 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.669 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.37 -39.26 85.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.873 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 38.5 mt -62.78 138.99 58.66 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.341 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -83.14 102.15 11.66 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.488 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.1 m -127.07 152.35 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.306 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -144.04 123.46 13.12 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.708 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.11 145.73 53.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.111 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.7 128.21 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.762 0.315 . . . . 0.0 110.671 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.6 t -68.98 -41.77 77.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.184 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 95.8 p -157.66 162.64 38.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.397 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.7 tp -148.99 94.3 2.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.125 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -121.5 129.2 52.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.163 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -103.64 119.45 38.93 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.394 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -94.08 11.14 30.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.498 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -60.39 -42.65 96.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.578 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 86.6 t60 53.48 88.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.63 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.423 ' O ' ' OXT' ' A' ' 83' ' ' HIS . 34.3 p80 -76.1 148.68 37.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.665 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.423 ' OXT' ' O ' ' A' ' 82' ' ' HIS . 79.8 m80 . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.543 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 ptt? . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.4 tp60 -62.52 -52.23 64.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.819 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -104.87 135.01 47.03 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.48 157.26 78.76 Favored Pre-proline 0 N--CA 1.466 0.342 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 39' ' ' VAL . 52.2 Cg_exo -50.19 -35.22 42.22 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.03 1.82 . . . . 0.0 112.768 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -136.56 96.54 3.36 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.708 0.29 . . . . 0.0 110.328 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.86 130.99 42.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.982 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.3 102.32 15.04 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 20.1 m0 -105.5 143.67 33.33 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.185 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -95.57 147.75 23.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.817 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 46.9 mt -100.12 123.0 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.8 m -103.86 -47.88 4.08 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.795 0.331 . . . . 0.0 110.405 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 160.6 169.9 24.49 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.9 OUTLIER -83.4 151.22 25.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.916 0.389 . . . . 0.0 110.546 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.2 t -82.46 174.36 11.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.538 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -70.74 -40.09 72.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.0 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -70.77 -10.4 59.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.305 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.3 tp -41.38 149.51 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.776 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.66 154.25 87.38 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.368 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.52 -30.96 51.78 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.528 2.152 . . . . 0.0 112.179 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.43 -54.36 25.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.921 0.391 . . . . 0.0 111.286 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -63.76 -45.72 88.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.351 0.596 . . . . 0.0 110.194 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.404 ' NH1' HD11 ' A' ' 27' ' ' LEU . 68.2 ttp85 -57.89 -44.72 86.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.293 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 69.5 tp60 -61.78 -34.2 75.45 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -59.68 -48.41 81.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.067 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.417 ' HA ' HD13 ' A' ' 26' ' ' LEU . 4.5 mm? -61.88 -41.38 97.81 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.597 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.404 HD11 ' NH1' ' A' ' 23' ' ' ARG . 87.0 mt -61.8 -39.81 93.02 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.448 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.1 m -82.66 -12.98 57.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.849 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.446 ' HG ' ' H ' ' A' ' 31' ' ' MET . 12.4 tp -95.85 124.54 39.91 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.799 0.333 . . . . 0.0 110.15 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.87 13.1 32.44 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.464 ' CE ' HH21 ' A' ' 55' ' ' ARG . 68.6 mtp -118.49 75.66 1.03 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.26 0.552 . . . . 0.0 109.531 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.496 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.7 mp -78.7 166.69 40.8 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.839 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.496 ' O ' ' O ' ' A' ' 32' ' ' LEU . 80.1 Cg_exo -40.56 175.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.666 2.244 . . . . 0.0 112.747 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.71 12.49 6.59 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.6 t -140.8 -156.37 0.67 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.836 0.351 . . . . 0.0 110.266 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.0 t -147.7 153.79 39.75 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.839 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.45 ' CE1' HG21 ' A' ' 51' ' ' ILE . 45.3 p90 -129.76 149.97 51.27 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.492 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -108.06 144.13 35.82 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.316 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 5' ' ' PRO . 12.5 t -81.05 121.02 33.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.488 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 50' ' ' HIS . 2.0 p -68.34 -37.67 78.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.509 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -171.82 155.66 3.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.366 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.4 t -123.68 114.06 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.3 111.99 54.41 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.403 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.548 ' C ' ' H ' ' A' ' 46' ' ' GLY . 61.4 Cg_endo -75.0 -11.64 21.48 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.916 1.744 . . . . 0.0 112.269 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 45' ' ' LEU . 9.9 mp -60.14 5.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.954 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.548 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 88.63 29.51 18.56 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.41 160.01 29.81 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.43 172.44 2.63 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.969 2.446 . . . . 0.0 112.002 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.3 mm -91.48 113.26 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.893 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.429 ' O ' HG12 ' A' ' 40' ' ' VAL . 12.1 m-70 -94.53 125.09 38.96 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.162 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.45 HG21 ' CE1' ' A' ' 37' ' ' PHE . 36.3 pt -124.57 146.71 29.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.099 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -136.79 129.06 29.84 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.234 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -130.57 144.45 51.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.519 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -49.19 -33.19 11.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.937 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.464 HH21 ' CE ' ' A' ' 31' ' ' MET . 73.8 mtp85 -69.96 -43.92 70.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.714 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.835 HG22 ' H ' ' A' ' 57' ' ' SER . 9.8 p -170.05 -179.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.433 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.835 ' H ' HG22 ' A' ' 56' ' ' VAL . 20.7 t -128.49 150.94 49.94 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.247 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 52.7 tp -163.21 157.22 20.14 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.036 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.609 ' C ' HD12 ' A' ' 60' ' ' LEU . 3.5 p -130.98 131.79 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.609 HD12 ' C ' ' A' ' 59' ' ' VAL . 10.3 mp -126.33 150.6 48.42 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.645 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' A' ' 64' ' ' ASP . 88.6 mtm180 -79.03 143.65 35.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.286 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -40.47 -40.92 1.31 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.125 0.488 . . . . 0.0 111.124 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -61.19 -42.32 98.36 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.368 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 61' ' ' ARG . 98.1 m-20 -61.4 -38.51 87.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.229 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.498 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.1 mm? -62.58 -42.72 99.73 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.14 -51.25 70.83 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.154 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.426 ' N ' HD22 ' A' ' 67' ' ' LEU . 4.1 mm? -68.56 -39.76 80.91 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.178 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.16 134.11 56.12 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -83.14 114.55 21.41 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.077 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 m -132.09 161.85 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.022 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -146.13 144.77 30.19 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.506 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.66 147.45 52.68 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.1 t -103.93 130.9 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.6 m -157.22 1.81 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.533 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.1 m -68.37 141.98 55.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.495 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.4 mt -96.91 -0.91 46.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.613 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -135.17 148.12 49.61 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.392 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 27.8 p-80 -154.15 160.58 41.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.418 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -94.61 123.85 38.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.485 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.454 ' O ' ' CG ' ' A' ' 81' ' ' HIS . 10.5 p-80 -153.43 119.15 5.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.372 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.506 ' O ' ' N ' ' A' ' 83' ' ' HIS . 73.7 m80 -157.51 -35.43 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.534 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 75.9 m80 47.02 -90.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.616 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 81' ' ' HIS . 66.1 t-80 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.521 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -144.68 -50.64 0.27 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.447 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -70.69 136.39 48.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.652 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -143.3 153.3 59.29 Favored Pre-proline 0 N--CA 1.464 0.264 0 C-N-CA 121.136 -0.226 . . . . 0.0 110.404 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 39' ' ' VAL . 34.9 Cg_exo -50.96 -43.02 49.91 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.626 1.551 . . . . 0.0 112.407 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 6' ' ' ASP . 48.0 p-10 -135.29 98.45 3.97 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.946 0.403 . . . . 0.0 111.526 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.516 ' HG1' ' HD1' ' A' ' 9' ' ' TRP . 1.2 t -131.9 143.92 50.48 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.241 178.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -87.54 102.68 14.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.516 ' HD1' ' HG1' ' A' ' 7' ' ' THR . 11.5 m0 -103.17 136.09 43.61 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 -178.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.0 tttt -91.88 143.97 25.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.773 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 48.9 mt -101.43 119.13 49.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 6.6 p -108.63 -19.14 13.53 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.773 0.321 . . . . 0.0 110.588 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.04 -177.59 23.39 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.101 -0.799 . . . . 0.0 111.101 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -104.76 150.43 24.77 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.808 0.337 . . . . 0.0 110.41 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.471 ' O ' HG22 ' A' ' 18' ' ' ILE . 8.3 t -77.86 170.24 16.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.854 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -70.7 -39.48 73.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.106 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -66.83 -14.81 63.1 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.002 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.478 ' CG2' ' HE ' ' A' ' 23' ' ' ARG . 10.0 tp -41.23 149.34 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.759 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.35 154.5 88.04 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.981 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.25 -30.09 64.12 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.534 2.156 . . . . 0.0 112.362 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.3 -52.06 45.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.468 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -63.13 -46.7 86.04 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.59 0.71 . . . . 0.0 110.527 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.478 ' HE ' ' CG2' ' A' ' 18' ' ' ILE . 33.9 ttm180 -58.42 -48.51 80.46 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.407 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -59.84 -30.84 69.23 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -57.5 -44.23 84.84 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 29' ' ' LEU . 4.6 mm? -61.8 -42.62 99.24 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 120.071 -0.651 . . . . 0.0 109.647 178.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.45 HD22 ' N ' ' A' ' 27' ' ' LEU . 3.9 mm? -67.94 -33.59 74.96 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.788 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.7 t -60.1 -44.26 94.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.73 -178.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.524 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -118.19 170.3 8.98 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.033 0.444 . . . . 0.0 110.599 -179.602 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.64 4.18 81.93 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 58.6 mmm -73.34 73.76 1.34 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.1 mp -95.36 170.38 7.91 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.104 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 32' ' ' LEU . 52.9 Cg_exo -50.0 -165.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.402 2.068 . . . . 0.0 113.028 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.33 5.34 55.94 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 76.9 p -143.15 -172.93 3.78 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.733 0.301 . . . . 0.0 110.289 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.8 m -130.04 156.13 45.0 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.745 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.42 ' HB2' HG22 ' A' ' 53' ' ' THR . 42.5 p90 -128.5 153.56 47.03 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.989 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 39' ' ' VAL . 59.9 t-20 -108.74 147.07 32.55 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.662 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.525 ' N ' ' OD1' ' A' ' 38' ' ' ASN . 21.4 t -89.58 126.51 42.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.647 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 p -72.24 -41.76 66.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.716 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -173.32 154.98 2.78 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.419 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 42' ' ' VAL . 17.9 m -139.56 122.45 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.294 178.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -95.47 110.07 48.89 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.754 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.57 ' C ' ' H ' ' A' ' 46' ' ' GLY . 38.1 Cg_exo -61.56 -14.63 36.55 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 121.811 1.674 . . . . 0.0 111.869 178.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 78.3 mt -53.73 2.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.863 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.57 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 90.04 26.08 25.07 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.01 162.26 23.48 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.99 170.46 2.12 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.181 1.92 . . . . 0.0 111.39 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 60' ' ' LEU . 6.7 mm -96.85 115.97 37.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.606 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.456 ' CD2' HG23 ' A' ' 59' ' ' VAL . 13.6 m170 -93.77 120.47 34.07 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.401 ' O ' ' O ' ' A' ' 58' ' ' LEU . 47.0 pt -118.95 148.54 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.461 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.784 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -133.97 128.84 35.24 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.066 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.42 HG22 ' HB2' ' A' ' 37' ' ' PHE . 1.2 p -118.47 137.46 53.16 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -41.34 -35.86 0.72 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.256 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.54 ' O ' HG13 ' A' ' 56' ' ' VAL . 78.7 mmt-85 -70.02 -47.43 62.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.955 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 55' ' ' ARG . 16.3 m -160.6 -175.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.004 0.43 . . . . 0.0 111.049 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 t -116.6 142.39 46.95 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.551 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.401 ' O ' ' O ' ' A' ' 51' ' ' ILE . 63.6 tp -150.6 150.06 30.69 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.507 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.456 HG23 ' CD2' ' A' ' 50' ' ' HIS . 7.7 p -125.69 130.54 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 49' ' ' ILE . 94.3 mt -132.41 155.79 47.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.619 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -84.84 168.33 15.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.842 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -59.21 -43.42 92.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.532 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -59.22 -39.3 82.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.725 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -60.11 -45.7 92.07 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.453 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.54 -40.96 98.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.863 0.363 . . . . 0.0 110.15 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.99 -39.08 90.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.483 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.4 mt -82.08 -55.29 4.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.815 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 70.6 mt -46.74 132.88 11.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.398 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.407 ' O ' ' OG1' ' A' ' 12' ' ' THR . 96.8 mt-10 -76.27 108.87 9.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.5 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.36 161.58 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.634 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 31.0 tp10 -145.42 143.05 29.85 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.412 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.31 131.41 41.88 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 75' ' ' SER . 36.0 t -82.98 -80.65 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.409 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.6 t 41.49 16.8 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.261 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.554 ' N ' ' O ' ' A' ' 73' ' ' VAL . 37.3 t -156.03 146.18 21.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.001 0.429 . . . . 0.0 110.458 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.1 mt -103.04 16.29 27.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.527 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -62.12 -40.15 94.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.588 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.536 ' CG ' ' N ' ' A' ' 79' ' ' HIS . 51.4 t-80 44.51 -109.81 0.17 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.614 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.536 ' N ' ' CG ' ' A' ' 78' ' ' HIS . 74.5 m80 -146.73 -97.23 0.09 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.624 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.615 ' CD2' ' CD2' ' A' ' 81' ' ' HIS . 36.9 t60 -154.84 -67.23 0.13 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.494 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.615 ' CD2' ' CD2' ' A' ' 80' ' ' HIS . 60.2 m-70 -138.7 146.7 41.87 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.549 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.62 ' CG ' ' H ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -69.58 -75.51 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.67 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.62 ' H ' ' CG ' ' A' ' 82' ' ' HIS . 86.0 t60 . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.924 -1.036 . . . . 0.0 110.506 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 tpp . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.573 ' NE2' ' CZ ' ' A' ' 3' ' ' TYR . 0.7 OUTLIER -62.62 -51.71 66.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.68 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.573 ' CZ ' ' NE2' ' A' ' 2' ' ' GLN . 67.7 m-85 -89.8 134.83 33.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.699 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.9 151.5 78.32 Favored Pre-proline 0 N--CA 1.468 0.46 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 39' ' ' VAL . 43.3 Cg_endo -66.96 -33.68 31.83 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.659 2.24 . . . . 0.0 112.228 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -136.63 94.65 3.02 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.818 0.342 . . . . 0.0 110.995 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 t -140.4 148.19 40.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.246 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -96.02 102.07 13.82 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 19.2 m0 -99.34 137.46 37.82 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.25 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -93.41 130.29 39.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.863 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.6 mt -83.05 115.84 26.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.0 m -98.73 -43.72 6.68 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.849 0.357 . . . . 0.0 110.422 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.06 -179.79 31.7 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.8 p90 -95.89 147.67 23.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.855 0.359 . . . . 0.0 110.475 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.476 ' O ' HG22 ' A' ' 18' ' ' ILE . 5.7 m -78.47 172.93 12.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.517 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 85.6 mmt-85 -70.06 -40.35 75.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.607 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -65.72 -15.18 62.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.628 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.476 HG22 ' O ' ' A' ' 15' ' ' SER . 10.5 tp -41.58 148.43 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.636 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 92.6 p -83.05 144.83 48.08 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.713 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -50.17 -37.18 48.18 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.051 1.834 . . . . 0.0 112.692 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.24 -58.51 7.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.891 0.377 . . . . 0.0 111.414 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -64.33 -47.18 80.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.261 0.553 . . . . 0.0 110.681 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -57.56 -47.55 81.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.371 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 68.3 tp60 -60.18 -32.27 70.91 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.459 ' NZ ' HD11 ' A' ' 58' ' ' LEU . 31.1 ttmt -60.8 -44.36 96.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.895 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.53 HD13 HD11 ' A' ' 29' ' ' LEU . 4.6 mm? -62.25 -42.94 99.77 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.368 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.16 -39.9 96.0 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.743 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.1 t -60.71 -45.2 95.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.039 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.53 HD11 HD13 ' A' ' 26' ' ' LEU . 2.0 pp -92.74 133.94 35.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.502 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.7 -1.67 72.81 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 67.2 mtt -86.66 74.46 9.85 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -82.23 168.54 23.03 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.336 -179.096 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 32' ' ' LEU . 72.7 Cg_exo -43.4 177.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 122.451 2.101 . . . . 0.0 112.312 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.42 11.88 7.09 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 99.0 p -146.43 -161.94 1.42 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.845 0.355 . . . . 0.0 110.306 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.5 m -135.3 158.34 44.62 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.632 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -136.6 156.05 49.09 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.147 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -110.56 146.33 36.25 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.485 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.428 ' O ' ' O ' ' A' ' 5' ' ' PRO . 21.5 t -86.7 126.33 40.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.494 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.407 HG12 ' H ' ' A' ' 40' ' ' VAL . 2.2 p -68.02 -41.21 84.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.95 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -174.74 160.56 2.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.083 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.4 t -133.31 118.23 30.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.2 110.39 48.02 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.474 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -76.4 -11.55 18.99 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.292 1.995 . . . . 0.0 112.271 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.0 mt -56.98 -30.45 64.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.686 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.98 21.98 0.68 Allowed Glycine 0 N--CA 1.465 0.609 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.16 159.81 30.46 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -60.55 173.9 1.86 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.761 2.307 . . . . 0.0 111.819 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 60' ' ' LEU . 8.0 mm -93.07 114.1 29.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.325 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -93.63 125.47 38.27 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.296 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.4 pt -127.1 150.25 32.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.571 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -127.07 137.97 53.13 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.356 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 56' ' ' VAL . 0.8 OUTLIER -131.53 137.95 48.71 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.9 ptt-85 -42.73 -44.65 4.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.793 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 76.2 mmt-85 -65.12 -42.08 94.27 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.675 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.807 HG22 ' H ' ' A' ' 57' ' ' SER . 11.1 p -169.46 179.43 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.239 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.807 ' H ' HG22 ' A' ' 56' ' ' VAL . 8.1 p -123.16 150.6 43.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.165 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.528 HD23 ' N ' ' A' ' 59' ' ' VAL . 7.1 tt -159.68 162.82 35.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.395 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.528 ' N ' HD23 ' A' ' 58' ' ' LEU . 4.1 p -122.14 132.49 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.096 0.474 . . . . 0.0 110.661 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 49' ' ' ILE . 51.5 mt -124.79 157.58 35.44 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.36 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -91.01 170.95 9.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.011 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -61.08 -44.37 97.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.201 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -62.42 -37.35 85.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.564 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -59.96 -46.0 90.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.447 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.31 -42.16 98.99 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.083 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.47 -49.44 77.34 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.2 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.2 mt -69.71 -41.8 74.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.314 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.1 tp -63.12 134.19 55.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.27 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -83.24 115.01 21.77 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.227 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.1 m -134.04 155.34 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.554 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -141.15 142.45 34.06 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.675 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.74 145.73 46.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.255 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.9 t -104.1 128.93 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.231 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.0 t -148.12 -61.55 0.26 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.519 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.3 t -64.24 -31.9 73.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.571 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.1 tp 58.32 97.13 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.31 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -123.87 131.68 53.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.193 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -103.13 120.63 41.05 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.15 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -74.66 128.07 34.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.241 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -158.71 86.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.452 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 78.9 m80 50.07 86.64 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.635 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -82.01 130.51 35.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.5 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.473 -179.974 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.0 mtm . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.448 ' OE1' ' N ' ' A' ' 2' ' ' GLN . 1.5 mm100 -66.61 -31.43 72.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.469 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 5.0 m-85 -77.5 101.09 6.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.966 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.68 158.46 45.35 Favored Pre-proline 0 N--CA 1.469 0.503 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -51.14 -38.73 61.05 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.996 1.798 . . . . 0.0 112.735 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -136.79 94.62 3.0 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.76 129.22 43.85 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.16 102.13 14.85 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.423 ' CZ3' HD23 ' A' ' 65' ' ' LEU . 24.4 m0 -100.86 141.39 33.81 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.292 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -97.16 129.11 44.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.781 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.2 mt -80.62 122.56 36.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.061 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 6.2 p -109.12 -15.33 14.35 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.342 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.81 178.41 15.64 Favored Glycine 0 N--CA 1.466 0.686 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.5 p90 -99.36 153.36 19.04 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.464 ' O ' HG22 ' A' ' 18' ' ' ILE . 1.9 t -82.29 171.97 13.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.647 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.436 ' N ' ' OG ' ' A' ' 15' ' ' SER . 99.6 mtt180 -69.89 -40.67 75.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.835 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.425 ' HB3' HD22 ' A' ' 67' ' ' LEU . 31.5 tp10 -66.19 -14.94 62.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.297 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 15' ' ' SER . 10.5 tp -41.06 147.33 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.729 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.76 155.23 87.09 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.521 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.12 -31.57 64.79 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.577 2.185 . . . . 0.0 112.016 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.66 -54.39 32.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.892 0.377 . . . . 0.0 111.129 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -62.62 -45.5 92.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.466 0.65 . . . . 0.0 110.34 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -57.64 -42.7 83.95 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.811 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 28' ' ' SER . 58.3 tp60 -61.77 -37.3 83.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.063 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -60.54 -43.25 97.39 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 120.081 -0.647 . . . . 0.0 110.025 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.421 ' HA ' HD13 ' A' ' 26' ' ' LEU . 4.5 mm? -63.43 -40.12 96.33 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.401 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.4 tt -80.3 -26.45 38.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.437 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.46 ' N ' ' O ' ' A' ' 24' ' ' GLN . 15.0 t -60.59 -45.53 93.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.336 -178.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.512 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -107.16 163.55 12.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.247 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.63 34.24 4.11 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 94.7 mtp -108.71 73.92 0.89 Allowed 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 33' ' ' PRO . 3.3 mm? -81.59 154.55 71.18 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.142 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.471 ' O ' ' O ' ' A' ' 32' ' ' LEU . 77.3 Cg_exo -42.48 176.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 122.742 2.295 . . . . 0.0 112.537 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.24 12.05 7.11 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 95.7 p -136.94 -156.93 0.74 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.863 0.363 . . . . 0.0 110.268 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 97.3 p -146.61 161.36 40.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.459 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.429 ' HB2' HG22 ' A' ' 53' ' ' THR . 48.5 p90 -138.05 155.09 49.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.29 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 27.4 p30 -109.85 152.35 25.87 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.534 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.6 t -92.96 125.26 45.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.503 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.408 ' H ' HG12 ' A' ' 40' ' ' VAL . 1.7 p -67.14 -41.69 87.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.026 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.607 ' NH2' ' ND1' ' A' ' 50' ' ' HIS . 37.7 ptt-85 -172.12 157.2 4.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.252 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.6 t -126.33 120.21 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.22 110.56 49.08 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.355 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -76.53 -12.24 18.62 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.008 1.805 . . . . 0.0 112.213 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.1 tp -57.63 -31.29 66.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.873 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.87 25.97 0.8 Allowed Glycine 0 N--CA 1.464 0.532 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.2 159.69 30.7 Favored Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.432 ' HG2' ' HE2' ' A' ' 50' ' ' HIS . 17.5 Cg_endo -56.56 175.7 0.26 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.838 2.359 . . . . 0.0 111.764 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.454 ' N ' ' O ' ' A' ' 60' ' ' LEU . 7.2 mm -92.5 114.21 29.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.936 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.607 ' ND1' ' NH2' ' A' ' 41' ' ' ARG . 15.8 m170 -94.32 119.91 33.78 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.872 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 58' ' ' LEU . 48.2 pt -126.11 149.87 31.26 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.221 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 12.5 tm-20 -132.68 130.11 39.67 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.188 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.429 HG22 ' HB2' ' A' ' 37' ' ' PHE . 1.4 p -116.06 137.14 52.38 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.701 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.414 ' H ' ' HG3' ' A' ' 54' ' ' ARG . 79.5 mtp180 -39.08 -36.76 0.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.818 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.548 ' O ' HG13 ' A' ' 56' ' ' VAL . 32.9 mmt180 -71.11 -49.05 48.45 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.147 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 55' ' ' ARG . 15.2 m -160.81 -176.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.95 0.405 . . . . 0.0 110.501 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 m -109.06 148.18 31.2 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.741 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' A' ' 51' ' ' ILE . 63.0 tp -152.61 149.16 28.17 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.4 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 59' ' ' VAL . 13.4 p -128.84 129.76 68.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.624 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 49' ' ' ILE . 76.3 mt -133.59 163.8 28.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.325 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -93.66 164.23 13.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.492 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -55.91 -39.09 71.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.035 0.445 . . . . 0.0 110.288 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -62.0 -40.94 97.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.729 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -60.43 -43.86 96.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.151 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.423 HD23 ' CZ3' ' A' ' 9' ' ' TRP . 10.8 mp -62.64 -42.22 99.48 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.31 -50.32 74.04 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.243 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.425 HD22 ' HB3' ' A' ' 17' ' ' GLU . 98.3 mt -68.79 -41.1 79.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.2 tp -65.1 131.22 45.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.107 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.444 ' O ' ' OG1' ' A' ' 12' ' ' THR . 94.3 mt-10 -78.19 115.29 17.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.181 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.418 HG21 ' CE3' ' A' ' 9' ' ' TRP . 27.0 m -136.4 160.2 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.419 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -141.0 132.34 26.69 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.156 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.31 135.33 54.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.884 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 85.0 t -93.98 128.29 45.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.176 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.4 m -142.42 -19.97 0.69 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.492 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 70.7 m -70.82 145.36 50.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.428 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.3 tp -159.75 100.13 1.43 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.169 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -140.52 154.53 46.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.268 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -132.69 140.17 48.0 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.38 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.524 ' O ' ' CD2' ' A' ' 79' ' ' HIS . 36.5 p-80 -97.86 92.58 5.9 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.491 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -97.34 -13.24 22.02 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.615 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -92.3 123.82 35.91 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.431 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -79.73 130.69 35.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.439 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 85.3 t60 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.538 179.957 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 tpt . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.455 ' CD ' ' CE2' ' A' ' 3' ' ' TYR . 62.1 tt0 -74.1 -90.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.773 -179.692 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.455 ' CE2' ' CD ' ' A' ' 2' ' ' GLN . 94.3 m-85 -84.51 90.76 7.7 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.586 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.22 154.92 65.41 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.47 -179.312 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' A' ' 39' ' ' VAL . 51.8 Cg_exo -51.18 -36.51 56.11 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.075 1.85 . . . . 0.0 112.793 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -131.98 98.64 4.5 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.748 0.308 . . . . 0.0 110.371 -179.201 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.55 129.71 31.31 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -88.47 102.1 14.57 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 22.4 m0 -105.13 144.39 31.99 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.118 -179.092 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -100.46 132.05 46.05 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.185 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 34.2 mt -82.03 120.54 33.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.672 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.5 m -102.39 -40.49 6.7 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.374 179.696 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 161.14 175.34 32.06 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -96.47 143.55 27.39 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.619 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.536 ' O ' HG22 ' A' ' 18' ' ' ILE . 3.6 m -72.0 167.01 21.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.677 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -66.49 -39.02 88.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.333 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.98 -17.61 64.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.812 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 15' ' ' SER . 10.6 tp -41.88 146.36 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.398 -179.399 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.0 p -81.9 147.98 59.71 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.561 -179.324 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -49.85 -41.97 45.64 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.848 1.699 . . . . 0.0 112.644 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.95 -57.87 7.46 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.158 -178.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -63.23 -44.41 95.32 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.469 0.652 . . . . 0.0 110.734 -179.617 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -57.8 -46.09 85.14 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.989 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 28' ' ' SER . 78.0 mt-30 -64.59 -31.98 73.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.752 179.205 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.6 mmtt -59.77 -42.64 93.76 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 119.891 -0.723 . . . . 0.0 109.241 179.277 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.512 HD12 ' HD3' ' A' ' 33' ' ' PRO . 4.6 mm? -64.51 -41.29 96.51 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.794 178.43 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 45.0 mt -79.68 -16.12 56.3 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.895 0.379 . . . . 0.0 110.945 -179.465 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 24' ' ' GLN . 37.2 t -59.45 -41.56 89.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.035 -179.045 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.773 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -124.16 -171.16 2.27 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.948 -179.498 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.13 43.2 2.04 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -179.334 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.481 ' SD ' HD11 ' A' ' 29' ' ' LEU . 64.1 mtt -120.12 71.98 0.92 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.883 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.485 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.1 mm? -82.98 152.05 64.88 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.333 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.512 ' HD3' HD12 ' A' ' 26' ' ' LEU . 77.2 Cg_exo -41.88 171.6 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.586 2.191 . . . . 0.0 112.366 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.51 -12.94 18.47 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 179.311 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.2 m -96.11 -156.68 0.54 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.893 0.378 . . . . 0.0 110.347 179.719 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.7 p -150.37 160.57 43.64 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.447 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -146.21 165.96 27.63 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.507 -179.68 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -126.13 143.88 50.96 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.267 0.556 . . . . 0.0 110.57 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.443 ' O ' ' O ' ' A' ' 5' ' ' PRO . 61.5 t -78.54 128.97 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.219 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.9 p -76.1 -40.44 37.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.09 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -173.16 160.95 4.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.097 -179.055 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 55.2 t -126.25 131.19 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -92.82 111.29 50.54 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-O 119.451 -0.309 . . . . 0.0 110.321 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.29 -13.11 18.94 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.923 1.748 . . . . 0.0 112.056 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.1 tp -61.98 -32.08 72.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.646 -179.001 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 127.79 30.01 0.78 Allowed Glycine 0 N--CA 1.464 0.542 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.89 173.29 4.08 Favored Pre-proline 0 CA--C 1.534 0.327 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -179.35 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -61.46 -170.94 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.141 1.894 . . . . 0.0 111.503 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.4 mm -108.17 114.48 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -88.45 124.5 34.03 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.285 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.2 pt -129.21 144.25 38.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.397 179.691 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -124.17 114.34 19.51 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.125 179.626 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 56' ' ' VAL . 0.7 OUTLIER -105.83 137.82 43.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.895 -179.585 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -41.43 -42.42 2.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.474 -179.503 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -67.12 -44.6 79.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.718 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.683 HG22 ' N ' ' A' ' 57' ' ' SER . 14.8 p -170.28 172.85 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.499 -179.71 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.683 ' N ' HG22 ' A' ' 56' ' ' VAL . 94.2 p -111.52 153.8 25.68 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.561 179.409 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.2 tt -161.35 159.66 28.66 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.585 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 59' ' ' VAL . 11.9 p -114.96 130.45 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.824 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.628 HD23 HD12 ' A' ' 65' ' ' LEU . 1.3 tp -133.53 152.34 51.89 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.035 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -82.63 161.64 22.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.626 -179.617 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.1 -45.94 91.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.644 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.69 -40.4 87.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.853 -179.7 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.46 -40.32 96.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.262 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.628 HD12 HD23 ' A' ' 60' ' ' LEU . 2.3 mp -61.64 -44.47 96.92 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.62 -42.45 98.9 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.28 -179.809 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.425 ' O ' ' OG ' ' A' ' 15' ' ' SER . 94.2 mt -68.02 -41.13 82.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.669 179.698 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.1 tp -64.95 131.03 45.54 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.066 -179.625 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -74.76 114.47 13.24 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.154 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.9 m -132.57 158.19 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.647 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -143.55 135.69 26.81 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.694 -179.766 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.37 129.29 37.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.345 179.782 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 75' ' ' SER . 15.3 t -76.78 -76.9 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.854 -179.739 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.2 p 39.71 22.55 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.815 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 73' ' ' VAL . 48.0 p -154.98 156.09 35.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.544 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.2 mt -120.43 19.96 11.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.454 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -48.03 -75.22 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.403 -179.743 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 44.94 -162.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.535 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.2 t60 49.34 92.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.669 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -78.11 147.61 34.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.518 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -61.01 -41.89 97.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.643 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -83.49 128.17 34.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.513 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 78.9 m80 . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.565 179.982 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mtp . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -64.94 -41.46 95.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.769 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -70.53 136.2 49.16 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -179.34 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.18 155.71 72.4 Favored Pre-proline 0 N--CA 1.466 0.325 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.154 -179.44 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 39' ' ' VAL . 40.9 Cg_endo -66.43 -22.1 52.63 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.653 2.235 . . . . 0.0 112.192 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -137.11 93.4 2.82 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.709 0.29 . . . . 0.0 110.325 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.92 130.71 25.94 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.12 102.46 15.0 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 18.3 m0 -102.22 140.63 36.24 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.884 0.373 . . . . 0.0 110.17 -179.211 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -98.15 128.51 44.68 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.536 179.702 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.7 mt -81.85 124.49 39.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.232 -179.302 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -109.35 -44.06 3.99 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.49 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.32 -176.68 39.47 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -100.63 150.15 23.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.854 0.359 . . . . 0.0 110.479 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.414 ' O ' HG22 ' A' ' 18' ' ' ILE . 2.3 t -78.24 169.86 17.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.564 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -69.74 -39.24 76.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.925 0.393 . . . . 0.0 110.784 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -66.83 -14.94 63.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.451 -179.707 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.414 HG22 ' O ' ' A' ' 15' ' ' SER . 10.5 tp -40.63 146.86 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.545 -179.473 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.9 m -79.5 143.84 60.25 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.507 -179.391 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -47.99 -41.06 33.41 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.917 1.745 . . . . 0.0 112.663 179.209 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.13 -55.99 19.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.86 0.362 . . . . 0.0 111.492 -178.888 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -63.24 -47.26 83.2 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.476 0.655 . . . . 0.0 110.623 -179.592 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -56.78 -44.87 82.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.999 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -60.43 -35.81 76.69 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.024 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -56.73 -46.71 81.16 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 29' ' ' LEU . 4.5 mm? -63.05 -43.44 98.63 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.506 179.488 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.58 -31.3 68.26 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.721 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.0 t -58.94 -45.03 91.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.228 -179.163 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.471 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -119.22 174.84 6.1 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.39 -179.697 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -90.67 0.16 76.57 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 46.3 tpp -66.85 73.7 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.5 mp -99.59 169.47 8.05 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.369 -179.041 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 32' ' ' LEU . 61.7 Cg_exo -49.96 -166.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.242 1.961 . . . . 0.0 112.256 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.94 4.98 51.04 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.728 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.1 m -140.65 -169.92 2.9 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.925 0.393 . . . . 0.0 110.259 179.794 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.2 p -134.04 158.74 42.8 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.194 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -137.72 163.87 30.25 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.218 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.46 ' OD1' ' N ' ' A' ' 38' ' ' ASN . 12.1 p-10 -121.66 150.28 41.98 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.314 0.578 . . . . 0.0 110.387 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.438 ' O ' ' O ' ' A' ' 5' ' ' PRO . 14.8 t -85.41 128.73 38.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.504 -179.651 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 p -68.95 -40.93 81.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.248 179.682 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -174.85 167.27 3.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.994 -179.198 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.6 m -133.51 125.1 49.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.084 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.76 111.21 51.76 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.582 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -76.24 -11.91 19.21 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.051 1.834 . . . . 0.0 112.311 179.798 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.526 ' N ' HD12 ' A' ' 45' ' ' LEU . 10.6 mp -61.52 -32.23 72.27 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.809 -178.882 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.2 26.48 0.82 Allowed Glycine 0 N--CA 1.466 0.669 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.27 160.32 29.18 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -55.71 173.72 0.35 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.698 2.265 . . . . 0.0 111.855 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.4 mm -92.84 118.0 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.771 -179.376 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.435 ' CD2' HG23 ' A' ' 59' ' ' VAL . 12.7 m170 -97.02 123.7 40.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.03 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.8 pt -127.33 148.88 32.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.719 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 97.0 mt-10 -134.95 112.16 10.4 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.094 179.593 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.425 ' O ' ' C ' ' A' ' 54' ' ' ARG . 1.2 p -85.52 173.93 9.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.889 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 53' ' ' THR . 99.9 mtt180 -33.55 -52.95 0.41 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.708 -178.186 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 57.4 ttp85 -142.93 32.29 1.4 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.016 179.431 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -140.62 136.98 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.489 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.6 t -113.7 130.47 56.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.237 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.403 HD21 HD11 ' A' ' 60' ' ' LEU . 59.9 tp -145.62 148.09 32.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.111 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.435 HG23 ' CD2' ' A' ' 50' ' ' HIS . 3.8 p -136.4 123.6 32.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.32 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.403 HD11 HD21 ' A' ' 58' ' ' LEU . 94.4 mt -140.68 173.16 11.76 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.443 -179.513 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.9 mtm-85 -84.05 163.31 19.96 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.922 0.391 . . . . 0.0 110.91 -179.519 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -58.73 -34.37 71.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.517 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -60.6 -40.25 91.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.546 179.78 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -61.56 -43.84 98.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.512 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 mp -61.58 -42.12 98.4 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.897 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.79 -44.24 97.26 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.326 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.6 mt -68.75 -41.19 79.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.042 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 63.7 mt -64.06 137.64 58.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.875 0.369 . . . . 0.0 110.611 -179.477 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -79.39 108.58 13.02 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.215 -179.465 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.4 m -134.95 156.54 39.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.479 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -138.92 128.06 23.97 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.595 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.1 134.58 48.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.095 179.675 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.8 m -120.45 131.11 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 121.029 0.443 . . . . 0.0 110.348 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.8 t -83.81 -42.6 16.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.6 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.7 p -156.07 132.26 10.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.45 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.544 ' N ' HD12 ' A' ' 76' ' ' LEU . 10.6 mp -63.18 -41.99 99.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.327 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 76' ' ' LEU . 45.2 tp10 49.64 100.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.254 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -153.4 154.24 34.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.573 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -168.57 83.67 0.16 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.548 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 51.1 p-80 -153.46 166.66 32.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.547 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.484 ' CE1' ' H ' ' A' ' 83' ' ' HIS . 57.9 t-80 -145.48 138.44 26.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.419 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -59.65 -43.41 93.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.63 -179.892 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.484 ' H ' ' CE1' ' A' ' 81' ' ' HIS . 99.1 m-70 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.389 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -62.8 -43.63 98.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.644 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -75.34 90.51 2.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.152 -179.62 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.07 154.44 40.63 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.424 -179.101 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 39' ' ' VAL . 41.2 Cg_endo -67.33 -37.42 17.89 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.672 2.248 . . . . 0.0 112.243 179.733 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -136.56 95.95 3.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.626 -179.596 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -140.07 147.76 40.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.383 179.651 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -97.25 101.8 13.43 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.632 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 28.7 m0 -98.02 142.95 29.1 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.341 -179.34 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -99.78 131.37 45.8 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.881 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.0 mt -80.98 125.58 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.467 -179.386 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.4 m -104.93 -51.95 2.95 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.475 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 168.14 167.78 29.29 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.0 OUTLIER -87.7 148.26 24.85 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 179.616 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.528 ' O ' HG22 ' A' ' 18' ' ' ILE . 43.7 t -80.68 171.05 15.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.659 179.874 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -67.16 -38.85 86.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.343 179.673 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -65.4 -18.31 65.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.689 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.528 HG22 ' O ' ' A' ' 15' ' ' SER . 10.8 tp -41.91 147.27 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.822 -179.698 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.58 158.19 81.37 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.28 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.88 -32.39 45.62 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.663 2.242 . . . . 0.0 111.958 179.63 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.15 -57.42 11.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.018 0.437 . . . . 0.0 110.979 -179.465 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -61.27 -45.29 95.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.603 0.716 . . . . 0.0 110.322 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -56.51 -42.86 79.08 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.192 -179.65 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 28' ' ' SER . 62.8 mt-30 -62.15 -37.2 84.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.414 179.41 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -58.81 -43.34 90.58 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.811 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.6 mm? -64.68 -41.71 95.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.262 0.553 . . . . 0.0 110.575 179.638 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.4 tt -78.73 -26.21 44.67 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.19 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 24' ' ' GLN . 14.4 t -61.19 -45.18 95.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.273 -178.994 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.5 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -112.03 169.27 8.97 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.237 -179.742 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.05 40.76 2.95 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.571 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.549 ' SD ' ' CZ ' ' A' ' 55' ' ' ARG . 38.0 ttp -108.82 72.11 0.81 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.188 0.518 . . . . 0.0 109.793 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.506 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.2 mm? -82.74 151.88 65.31 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.566 -179.276 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 32' ' ' LEU . 73.9 Cg_exo -41.96 175.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 122.49 2.126 . . . . 0.0 112.009 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.5 -21.22 9.27 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.783 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.8 m -97.63 -174.43 2.9 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.514 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.8 m -133.6 151.68 51.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.332 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.424 ' HB2' HG22 ' A' ' 53' ' ' THR . 52.2 p90 -133.17 155.04 50.02 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.109 -179.925 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -109.05 145.0 36.33 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.318 0.58 . . . . 0.0 110.713 -179.669 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.446 ' O ' ' O ' ' A' ' 5' ' ' PRO . 48.8 t -89.45 125.05 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.18 -179.908 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.428 HG12 ' H ' ' A' ' 40' ' ' VAL . 2.2 p -69.11 -40.44 80.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.965 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.2 ptt-85 -176.82 166.84 2.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.006 -178.918 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 42' ' ' VAL . 27.9 m -132.67 122.31 46.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.031 179.299 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.89 111.98 56.47 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.543 ' C ' ' H ' ' A' ' 46' ' ' GLY . 59.2 Cg_endo -75.75 -11.98 20.12 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.642 2.228 . . . . 0.0 112.013 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.9 mt -61.83 4.91 0.1 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.955 -179.191 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.543 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 91.07 24.98 25.66 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.42 160.07 30.46 Favored Pre-proline 0 C--N 1.332 -0.176 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.62 168.01 4.55 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.809 2.339 . . . . 0.0 111.749 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.9 mm -90.12 118.23 34.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.097 0.475 . . . . 0.0 110.074 -179.362 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.414 ' O ' HG12 ' A' ' 40' ' ' VAL . 12.5 m170 -96.72 121.52 38.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.064 179.535 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.1 pt -123.84 147.73 28.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.141 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -129.85 135.27 48.19 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.471 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 56' ' ' VAL . 1.7 p -123.94 143.57 50.3 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.911 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -54.27 -18.32 3.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.771 -178.726 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.549 ' CZ ' ' SD ' ' A' ' 31' ' ' MET . 16.8 ptm180 -97.97 -31.31 12.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.891 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.716 HG22 ' H ' ' A' ' 57' ' ' SER . 4.2 p -170.22 179.37 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.969 0.414 . . . . 0.0 110.393 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.716 ' H ' HG22 ' A' ' 56' ' ' VAL . 54.3 m -124.25 155.91 37.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.478 178.711 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.4 tp -158.66 151.71 22.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.292 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.414 HG23 ' CD2' ' A' ' 50' ' ' HIS . 4.4 p -135.82 126.68 43.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.025 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.8 mt -131.56 161.8 31.78 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.505 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -78.23 150.86 33.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.569 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -44.71 -47.22 10.66 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.279 0.561 . . . . 0.0 110.857 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -52.96 -34.63 56.58 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.263 -179.764 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -63.6 -40.78 97.8 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.348 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.61 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.0 mm? -63.33 -43.21 98.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.076 -179.285 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.84 -47.25 85.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.207 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.8 mt -68.31 -41.81 80.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.567 179.77 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 49.7 tp -64.63 131.47 47.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.26 -179.661 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -81.55 114.32 20.18 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.441 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.4 m -130.98 156.42 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.335 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -137.39 125.55 23.04 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.444 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.03 138.98 52.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.281 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.0 t -97.99 129.21 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 120.886 0.374 . . . . 0.0 110.285 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.2 m -162.62 9.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.55 -179.85 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.1 m -73.73 151.89 40.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.394 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.438 ' C ' ' N ' ' A' ' 78' ' ' HIS . 0.3 OUTLIER -90.38 23.76 2.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.224 -179.618 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -47.15 -17.52 0.06 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.641 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.438 ' N ' ' C ' ' A' ' 76' ' ' LEU . 79.5 m80 -70.27 139.18 52.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.334 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -150.77 166.96 28.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.261 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -105.0 148.7 26.44 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.43 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -64.44 -39.34 93.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.422 -179.701 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -137.28 143.86 42.38 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.498 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.559 -179.886 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.3 mtt . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -65.0 -44.42 89.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.834 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -105.12 133.64 49.57 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.482 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 p -128.45 152.17 77.84 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.491 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.57 -40.82 54.66 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.944 1.763 . . . . 0.0 112.765 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -135.24 101.22 4.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.021 0.439 . . . . 0.0 111.036 -179.297 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -137.86 142.8 40.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.393 179.143 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.66 102.21 14.38 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.565 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 18.9 m0 -100.65 137.04 39.58 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.394 -179.254 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -91.57 143.89 26.11 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.768 179.515 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.5 mt -97.2 117.01 41.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.316 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.9 m -101.7 -47.04 4.75 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.597 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 162.16 176.63 34.44 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.4 p90 -92.11 148.4 22.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.219 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.442 ' OG ' ' N ' ' A' ' 16' ' ' ARG . 1.9 t -75.89 172.18 13.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.528 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.442 ' N ' ' OG ' ' A' ' 15' ' ' SER . 35.8 ptt-85 -71.54 -37.13 71.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.665 179.712 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -69.67 -13.84 62.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.327 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 15' ' ' SER . 10.6 tp -41.35 149.44 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.516 -179.566 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.4 p -79.21 140.65 57.05 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.522 -179.541 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -47.44 -40.95 29.46 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 121.941 1.761 . . . . 0.0 112.703 179.061 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.98 -56.71 16.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.903 0.383 . . . . 0.0 111.19 -178.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -61.7 -44.35 97.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.285 0.564 . . . . 0.0 110.484 -179.708 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -58.62 -43.19 89.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.935 -179.386 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -62.81 -37.07 85.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.977 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -58.4 -47.35 84.17 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -63.21 -38.98 93.31 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.098 179.627 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.6 tp -60.34 -44.26 95.67 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.108 -179.39 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.5 m -75.97 -33.15 59.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.805 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.453 ' HG ' ' H ' ' A' ' 31' ' ' MET . 8.4 tp -71.34 129.47 38.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.259 -179.327 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.63 2.49 87.26 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.453 ' H ' ' HG ' ' A' ' 29' ' ' LEU . 24.0 tpp -109.39 75.78 0.97 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.068 0.461 . . . . 0.0 109.854 179.484 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.2 mp -79.42 165.82 45.68 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.858 -179.213 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.479 ' O ' ' O ' ' A' ' 32' ' ' LEU . 71.4 Cg_exo -40.34 172.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.578 2.185 . . . . 0.0 112.393 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.42 8.64 9.09 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.551 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 t -137.2 -157.52 0.78 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.903 0.382 . . . . 0.0 110.207 179.563 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.9 m -145.33 157.96 43.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.445 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -139.35 153.75 47.74 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.378 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -107.06 147.95 29.35 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.342 0.591 . . . . 0.0 110.682 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.6 t -88.12 126.49 41.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.241 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 50' ' ' HIS . 2.4 p -64.66 -39.9 87.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.891 179.899 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -174.08 161.13 3.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.096 -179.474 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 55.8 t -126.39 125.23 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.773 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.02 111.69 54.13 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.43 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.67 -11.99 20.26 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.202 1.934 . . . . 0.0 112.0 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.8 tp -58.68 -31.55 68.32 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.832 -178.97 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.71 32.98 1.13 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -100.24 179.45 1.02 Allowed Pre-proline 0 N--CA 1.466 0.343 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.463 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 47' ' ' ASP . 24.0 Cg_exo -62.7 -178.19 0.37 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.36 2.04 . . . . 0.0 111.71 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.3 mm -107.87 119.9 58.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.449 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.416 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -102.31 123.09 45.49 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.816 179.644 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.8 pt -127.81 152.13 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.054 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -123.52 135.61 54.12 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.08 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 56' ' ' VAL . 1.4 p -131.45 140.88 49.7 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.859 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -38.85 -37.3 0.33 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.565 -179.469 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.3 ttp85 -75.34 -49.4 19.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.777 179.608 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.844 HG22 ' H ' ' A' ' 57' ' ' SER . 10.2 p -171.73 -179.59 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.621 -179.564 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.844 ' H ' HG22 ' A' ' 56' ' ' VAL . 1.7 t -107.72 164.08 12.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.13 178.724 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.417 HD21 HD11 ' A' ' 60' ' ' LEU . 58.8 tp -149.15 146.31 27.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.205 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.4 t -127.9 124.41 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.79 178.969 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.417 HD11 HD21 ' A' ' 58' ' ' LEU . 89.6 mt -144.55 167.32 22.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.71 179.813 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -81.94 147.91 29.0 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.036 0.446 . . . . 0.0 111.424 -179.668 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -42.2 -40.99 2.56 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.701 -179.684 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -55.44 -38.81 69.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.547 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -61.75 -41.01 97.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.431 179.869 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.637 HD22 ' N ' ' A' ' 65' ' ' LEU . 3.3 mm? -62.84 -42.14 99.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.972 -179.301 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.65 98.13 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.048 179.608 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.36 -41.96 79.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.035 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.0 mt -68.36 135.71 52.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.861 0.362 . . . . 0.0 110.222 -179.65 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -81.31 111.35 17.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.283 -179.693 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.4 m -130.97 156.36 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.632 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -144.07 146.82 33.08 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.907 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.65 143.0 56.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.105 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.9 t -98.7 130.28 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.343 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.1 p -149.49 -66.08 0.22 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.463 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 66.6 m -87.12 143.55 27.26 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.542 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.63 ' O ' HD23 ' A' ' 76' ' ' LEU . 2.9 tt -62.75 -46.18 89.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.875 0.369 . . . . 0.0 110.128 -179.7 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 51.71 95.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.286 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.425 ' NE2' HD13 ' A' ' 76' ' ' LEU . 76.0 m80 -80.31 155.32 27.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.331 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -133.1 140.69 47.79 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.512 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -142.09 150.97 41.89 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.508 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -78.71 141.28 38.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.498 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -65.8 -40.08 91.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.517 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.613 -179.971 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.9 mtm . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -64.18 -43.98 93.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.559 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -70.09 137.43 51.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.045 -179.467 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.01 156.91 70.23 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.092 -179.371 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -67.73 -50.25 0.93 Allowed 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.708 2.272 . . . . 0.0 112.196 -179.796 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -129.06 97.58 4.66 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.81 -179.599 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 t -139.49 151.87 46.52 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.273 179.485 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -101.61 102.73 13.48 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.126 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -99.53 133.8 43.33 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.889 0.376 . . . . 0.0 110.152 -179.104 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -92.18 133.49 35.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.98 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.3 mt -85.34 123.31 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.303 -179.242 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.8 m -106.33 -47.74 3.73 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.874 0.369 . . . . 0.0 110.563 179.64 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 164.79 170.73 30.14 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.8 p90 -89.91 146.04 24.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.874 0.369 . . . . 0.0 110.412 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.419 ' O ' HG22 ' A' ' 18' ' ' ILE . 3.8 m -74.63 170.1 16.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.537 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -69.13 -37.74 78.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.481 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -72.06 -10.01 59.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.543 -179.581 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.419 HG22 ' O ' ' A' ' 15' ' ' SER . 9.8 tp -41.5 146.99 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.517 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.04 153.92 95.01 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.325 -179.586 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.14 -33.16 62.17 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.382 2.055 . . . . 0.0 112.117 -179.912 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.29 -55.29 22.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.827 0.346 . . . . 0.0 111.278 -179.42 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.457 ' CD2' HD21 ' A' ' 60' ' ' LEU . 31.5 t80 -61.64 -42.3 98.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.569 0.7 . . . . 0.0 110.338 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 68.5 ttp85 -58.07 -44.11 87.35 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.838 179.633 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 28' ' ' SER . 73.2 mt-30 -62.41 -36.3 81.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.252 179.115 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.414 ' O ' ' CD1' ' A' ' 29' ' ' LEU . 26.7 mmtp -59.27 -45.65 90.67 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.954 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.6 mm? -63.62 -43.5 96.68 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.519 179.027 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 tt -70.71 -33.77 71.22 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.28 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 24' ' ' GLN . 74.8 m -58.86 -43.61 90.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.293 -178.729 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.452 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -119.72 176.92 5.16 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.475 -179.559 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -90.51 -2.96 72.33 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.595 ' CE ' ' HE ' ' A' ' 55' ' ' ARG . 35.4 tpp -61.89 73.85 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.783 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 30' ' ' GLY . 1.6 mp -101.12 169.9 7.21 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.34 -179.058 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.479 ' O ' ' O ' ' A' ' 32' ' ' LEU . 57.3 Cg_exo -50.19 -160.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.381 2.054 . . . . 0.0 112.584 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.22 10.66 59.35 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.1 t -142.41 -156.53 0.69 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.755 0.312 . . . . 0.0 110.376 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.3 p -151.86 164.02 37.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.591 -179.782 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -143.62 162.09 36.83 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.552 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 38' ' ' ASN . 7.9 p-10 -114.18 147.95 38.08 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.258 0.551 . . . . 0.0 110.84 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.8 t -88.7 123.11 40.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.234 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.404 HG22 ' HE ' ' A' ' 41' ' ' ARG . 2.3 p -66.47 -41.61 88.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.209 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.404 ' HE ' HG22 ' A' ' 40' ' ' VAL . 20.1 ptp180 -174.17 166.78 4.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.913 -179.453 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.6 m -128.72 130.12 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.994 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.0 110.95 49.21 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.545 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -76.65 -13.21 18.16 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.922 1.748 . . . . 0.0 112.392 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.3 mt -62.45 -30.99 71.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.768 -178.813 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.52 28.69 0.96 Allowed Glycine 0 N--CA 1.466 0.698 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.94 163.93 18.42 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.87 -173.8 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.913 1.742 . . . . 0.0 111.902 179.431 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.2 mm -103.07 115.08 44.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.775 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -92.02 119.1 31.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.174 -0.467 . . . . 0.0 109.779 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.6 pt -125.06 146.88 29.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.274 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.415 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 93.6 mt-10 -127.38 128.41 45.8 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.464 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 56' ' ' VAL . 0.8 OUTLIER -119.69 138.26 53.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.562 179.991 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.417 ' H ' ' HG2' ' A' ' 54' ' ' ARG . 35.6 mmm-85 -45.25 -38.29 5.38 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.382 -179.342 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.595 ' HE ' ' CE ' ' A' ' 31' ' ' MET . 74.6 mtp85 -69.95 -43.38 71.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.849 179.679 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.677 HG22 ' N ' ' A' ' 57' ' ' SER . 14.7 p -170.38 171.11 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-O 120.93 0.395 . . . . 0.0 110.648 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.677 ' N ' HG22 ' A' ' 56' ' ' VAL . 28.4 t -98.62 161.08 13.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.7 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 64.8 tp -163.56 149.25 11.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.11 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.681 ' O ' HD12 ' A' ' 60' ' ' LEU . 6.3 p -134.48 127.81 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.87 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.681 HD12 ' O ' ' A' ' 59' ' ' VAL . 2.4 mp -133.33 155.82 48.74 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.399 -179.669 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.445 ' O ' ' N ' ' A' ' 64' ' ' ASP . 95.3 mtm-85 -78.4 143.92 36.36 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.123 179.91 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -39.5 -43.4 1.26 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.479 -179.849 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.415 ' HG2' ' H ' ' A' ' 63' ' ' LYS . 13.3 ptpt -58.54 -41.83 86.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.353 179.821 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 61' ' ' ARG . 97.3 m-20 -62.75 -40.17 96.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.354 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.468 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.2 mm? -61.28 -42.38 98.55 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.3 -40.17 96.6 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.15 179.585 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.8 mt -67.32 -41.36 85.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.196 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.5 mt -71.05 141.38 50.91 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.618 -179.733 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -84.19 103.42 13.38 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.093 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.8 m -122.85 154.8 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.279 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.531 ' N ' ' OE1' ' A' ' 71' ' ' GLU . 56.6 mp0 -142.57 125.6 16.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.575 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.03 132.35 48.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.911 179.769 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.7 m -133.9 159.66 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.362 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 28.9 t -82.49 -68.85 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.628 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 45.0 t -73.64 137.59 44.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.467 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.2 -4.57 14.35 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.153 -179.861 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -58.42 146.65 34.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.62 -179.932 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -79.24 114.67 18.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.388 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -66.25 -42.83 88.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.65 -179.905 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -83.97 121.28 27.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.408 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -66.54 -40.4 89.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.575 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -71.36 144.04 50.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.553 -179.852 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 60.9 m170 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.576 -179.889 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 3' ' ' TYR . 80.1 mmm . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 51.84 -86.85 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.708 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.496 ' N ' ' O ' ' A' ' 1' ' ' MET . 65.9 m-85 -79.73 99.32 7.38 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.808 -179.626 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.31 156.99 35.97 Favored Pre-proline 0 N--CA 1.464 0.262 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.559 -179.448 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 39' ' ' VAL . 51.3 Cg_exo -50.95 -38.64 58.96 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.164 1.909 . . . . 0.0 112.616 179.358 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -136.8 95.82 3.2 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -179.546 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.75 129.21 47.93 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.84 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.21 101.55 13.13 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.235 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -102.29 148.06 25.91 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.333 -179.101 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -100.39 128.9 46.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.761 179.686 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.456 ' CD1' ' NH2' ' A' ' 55' ' ' ARG . 32.3 mt -83.85 122.53 37.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.24 -179.47 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.3 m -108.31 -46.17 3.77 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.87 0.367 . . . . 0.0 110.502 179.796 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.6 -179.44 39.95 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.87 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -90.57 160.09 16.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 0.0 110.435 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.8 t -82.25 169.21 16.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.614 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -69.74 -38.5 76.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.531 179.377 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -74.0 -6.59 48.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.881 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.0 tp -42.55 147.04 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.524 -179.532 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.9 p -82.73 149.19 59.67 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.754 -179.563 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.11 -38.81 50.99 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 122.303 2.002 . . . . 0.0 112.554 178.913 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.43 -57.11 13.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.859 0.361 . . . . 0.0 111.153 -179.081 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -63.58 -49.08 74.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.287 0.565 . . . . 0.0 110.578 -179.841 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -57.0 -43.86 82.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.237 -179.24 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -63.2 -33.11 74.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.755 179.293 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -59.76 -49.01 79.38 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.543 -0.463 . . . . 0.0 109.941 179.668 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.449 HD22 ' N ' ' A' ' 26' ' ' LEU . 4.5 mm? -63.87 -38.94 92.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.278 179.593 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.4 tp -60.55 -41.13 93.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.335 -179.353 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.3 m -83.65 -11.78 56.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.897 -179.398 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.452 ' HG ' ' H ' ' A' ' 31' ' ' MET . 9.5 tp -97.27 123.25 41.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.888 0.375 . . . . 0.0 110.261 -179.731 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.27 3.81 61.12 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.452 ' H ' ' HG ' ' A' ' 29' ' ' LEU . 66.7 mtt -108.48 75.83 1.0 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.21 0.529 . . . . 0.0 109.803 179.575 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.503 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.9 OUTLIER -78.51 167.9 31.58 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.093 -178.942 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.503 ' O ' ' O ' ' A' ' 32' ' ' LEU . 72.9 Cg_exo -42.2 177.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.509 2.139 . . . . 0.0 112.416 -179.551 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.74 11.06 7.33 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 179.784 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.9 m -143.5 -169.54 3.09 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.736 0.303 . . . . 0.0 110.37 179.587 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.45 ' O ' ' NH1' ' A' ' 54' ' ' ARG . 69.0 m -131.41 157.42 43.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.449 -179.74 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -133.52 157.72 44.95 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.212 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -112.93 147.16 37.66 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.447 -179.943 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 5' ' ' PRO . 14.5 t -85.27 127.03 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.171 179.867 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 p -68.26 -40.11 82.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.839 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -173.98 157.35 2.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.14 -179.072 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 73.8 t -131.82 105.93 10.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.968 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.467 ' HB3' ' OD1' ' A' ' 47' ' ' ASP . . . -93.72 111.4 52.47 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.525 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.89 -9.2 19.47 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.952 2.435 . . . . 0.0 112.275 -179.95 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 51.8 mt -50.73 -29.62 11.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.733 -178.149 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 132.29 20.55 1.01 Allowed Glycine 0 N--CA 1.467 0.723 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.362 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -97.4 160.89 27.75 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.647 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -60.17 175.31 1.08 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.749 2.3 . . . . 0.0 111.671 179.708 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.409 HG21 ' CD2' ' A' ' 65' ' ' LEU . 10.7 mm -94.55 115.73 34.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.185 -179.593 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -96.13 122.65 39.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.077 179.59 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.6 pt -128.37 147.26 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.361 179.71 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -122.87 121.03 35.23 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.019 179.635 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 55' ' ' ARG . 1.4 p -108.74 135.85 49.29 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.45 ' NH1' ' O ' ' A' ' 36' ' ' SER . 8.1 ptp85 -43.13 -18.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.62 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.613 ' O ' HG13 ' A' ' 56' ' ' VAL . 88.5 mtm180 -87.36 -51.38 5.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.967 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 55' ' ' ARG . 13.2 m -162.25 177.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.652 -179.547 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.3 p -97.63 143.14 28.61 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.337 179.539 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.1 tp -147.49 144.33 28.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.253 179.549 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 59' ' ' VAL . 4.8 p -136.9 124.14 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.864 179.2 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.7 mt -138.8 178.81 6.88 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.561 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -88.35 161.89 16.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.806 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -58.71 -32.52 69.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.503 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.87 -42.19 99.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.501 179.926 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -60.9 -44.57 96.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.504 -179.962 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.409 ' CD2' HG21 ' A' ' 49' ' ' ILE . 8.8 mp -62.81 -41.65 99.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.218 179.652 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.94 -51.36 69.45 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.304 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.98 -43.45 78.92 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.864 179.759 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.8 tp -53.0 132.67 38.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.36 -179.004 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -75.43 108.2 8.06 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.442 -179.557 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.8 m -134.22 160.36 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.733 179.812 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -145.19 136.93 25.47 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.598 179.836 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -76.31 129.5 36.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.145 179.467 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.1 t -83.93 130.01 36.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.254 -179.785 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.7 m -154.85 40.66 0.44 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.609 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 78.6 p -147.45 127.31 13.53 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.263 -179.919 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.565 HD12 ' N ' ' A' ' 76' ' ' LEU . 10.3 mp -96.25 69.87 2.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.174 -179.969 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.81 -40.79 98.47 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.273 179.838 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.471 ' CG ' ' N ' ' A' ' 79' ' ' HIS . 30.9 t-80 43.57 -101.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.743 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.53 ' CG ' ' N ' ' A' ' 80' ' ' HIS . 85.8 t60 54.52 165.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.521 -179.978 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.53 ' N ' ' CG ' ' A' ' 79' ' ' HIS . 6.7 p80 -151.91 144.38 24.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.401 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -96.45 131.8 42.66 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.432 179.801 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -147.74 149.39 32.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.349 -179.89 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 77.5 t60 . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.598 -179.945 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.1 ttm . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.604 ' H ' ' CD ' ' A' ' 2' ' ' GLN . 0.7 OUTLIER -88.48 -6.17 57.78 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.461 -179.984 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.422 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 41.5 m-85 -87.06 90.25 8.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.934 -179.894 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.44 156.33 41.56 Favored Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.99 -179.512 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 39' ' ' VAL . 40.5 Cg_endo -66.09 -20.1 56.97 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.522 2.148 . . . . 0.0 112.211 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -136.62 93.53 2.88 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.393 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.96 131.52 27.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.203 -179.544 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.02 102.41 14.48 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.056 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 24.4 m0 -101.37 135.71 42.4 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.362 -179.213 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -90.25 131.79 35.87 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.5 mt -84.73 117.78 30.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.765 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 11.0 p -102.43 -19.34 14.97 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.745 0.307 . . . . 0.0 110.187 179.735 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 137.63 179.04 16.52 Favored Glycine 0 N--CA 1.463 0.474 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 179.425 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -96.06 147.77 23.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.625 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.451 ' O ' HG22 ' A' ' 18' ' ' ILE . 10.1 t -76.92 170.46 16.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.578 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -69.01 -38.85 79.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.543 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.465 ' HB3' HD12 ' A' ' 67' ' ' LEU . 75.3 tt0 -69.62 -13.23 62.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.634 -179.431 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 15' ' ' SER . 10.2 tp -41.45 147.1 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.725 -179.911 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.02 154.48 90.76 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.114 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.11 -29.72 56.13 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.456 2.104 . . . . 0.0 112.276 -179.607 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.33 -55.6 17.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.629 -179.206 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -62.25 -44.12 97.27 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.449 0.642 . . . . 0.0 110.346 -179.569 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -59.1 -45.7 90.21 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.999 179.758 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -59.28 -37.98 79.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.959 179.584 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -60.36 -41.66 94.15 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.839 179.367 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.424 ' HA ' HD13 ' A' ' 26' ' ' LEU . 4.4 mm? -61.73 -43.91 97.93 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.269 179.39 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.27 -38.89 92.67 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.375 179.418 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.0 m -61.12 -42.39 98.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.367 -179.191 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.47 ' CD1' ' O ' ' A' ' 31' ' ' MET . 2.5 pp -96.81 131.15 43.84 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.957 0.408 . . . . 0.0 110.675 -179.351 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.01 -22.95 72.68 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.47 ' O ' ' CD1' ' A' ' 29' ' ' LEU . 63.6 ttp -69.89 73.99 0.44 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.306 0.574 . . . . 0.0 109.789 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -82.03 169.45 18.46 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.815 -179.178 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 32' ' ' LEU . 61.0 Cg_exo -44.11 176.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.551 2.167 . . . . 0.0 112.946 -178.961 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.83 11.34 9.31 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.769 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 m -138.35 -156.16 0.66 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.754 0.311 . . . . 0.0 110.483 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.4 p -144.68 162.28 37.09 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.414 -179.75 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.401 ' HB2' HG22 ' A' ' 53' ' ' THR . 41.9 p90 -139.37 163.47 32.42 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.284 -179.708 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -122.22 144.38 49.01 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.309 0.575 . . . . 0.0 110.731 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' PRO . 19.4 t -82.32 125.67 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.535 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 p -68.77 -39.75 80.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.728 179.386 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.456 ' NH2' ' HD1' ' A' ' 50' ' ' HIS . 38.3 ptt-85 -173.24 160.9 4.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.732 -179.44 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 62.4 t -129.55 118.71 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.007 179.087 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.61 111.15 51.27 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.463 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.91 -11.25 19.88 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.065 1.843 . . . . 0.0 112.357 179.843 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.514 HD22 ' N ' ' A' ' 45' ' ' LEU . 4.0 mm? -59.43 -31.59 69.42 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.842 -178.624 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.55 26.32 0.8 Allowed Glycine 0 N--CA 1.469 0.838 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.747 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -97.59 159.9 29.98 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.78 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.45 175.39 0.55 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.308 2.005 . . . . 0.0 111.628 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 60' ' ' LEU . 8.3 mm -94.27 115.33 32.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.794 -179.579 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.456 ' HD1' ' NH2' ' A' ' 41' ' ' ARG . 12.4 m170 -94.6 125.44 39.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.156 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.1 pt -127.15 148.58 31.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.474 179.737 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -130.91 130.33 43.36 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.488 179.784 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.401 HG22 ' HB2' ' A' ' 37' ' ' PHE . 0.7 OUTLIER -124.38 138.06 54.4 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.511 -179.697 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -42.95 -34.62 1.01 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.437 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -69.73 -46.49 65.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.647 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.648 HG22 ' N ' ' A' ' 57' ' ' SER . 14.8 p -170.86 167.57 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 120.922 0.391 . . . . 0.0 111.177 -179.918 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.648 ' N ' HG22 ' A' ' 56' ' ' VAL . 9.9 p -93.25 154.79 17.82 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.599 178.994 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 64.2 tp -163.3 148.43 11.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.331 179.712 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.45 HG23 ' CD2' ' A' ' 50' ' ' HIS . 4.9 p -128.58 131.4 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.954 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 49' ' ' ILE . 91.7 mt -135.05 161.15 36.13 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.519 -179.428 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -86.33 164.82 16.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.571 179.734 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -59.0 -39.16 80.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.988 0.423 . . . . 0.0 110.542 -179.604 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -61.78 -40.15 94.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.59 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -59.66 -44.88 93.4 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.804 -0.359 . . . . 0.0 110.375 -179.581 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.2 mp -62.62 -41.42 98.99 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.275 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.22 -52.32 65.78 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.403 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.465 HD12 ' HB3' ' A' ' 17' ' ' GLU . 4.0 mm? -69.14 -40.69 78.09 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.301 179.609 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.9 tp -59.87 135.63 57.76 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.331 -179.309 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.445 ' O ' ' OG1' ' A' ' 12' ' ' THR . 70.7 mm-40 -81.51 113.69 19.73 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.547 -179.545 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.0 m -133.93 160.43 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.692 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -143.75 139.53 29.48 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.442 179.761 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.5 136.22 51.16 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.002 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 51.7 t -89.74 131.76 36.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.154 -179.657 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.403 ' OG ' ' N ' ' A' ' 75' ' ' SER . 78.7 p -88.65 -85.15 0.2 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.863 0.363 . . . . 0.0 110.694 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.403 ' N ' ' OG ' ' A' ' 74' ' ' SER . 90.1 p -155.26 111.55 3.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.556 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.507 ' N ' HD22 ' A' ' 76' ' ' LEU . 4.0 mm? -63.4 -41.0 98.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.261 179.829 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.448 ' O ' ' O ' ' A' ' 78' ' ' HIS . 79.5 mm-40 56.26 -106.1 0.31 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.417 -179.777 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.448 ' O ' ' O ' ' A' ' 77' ' ' GLU . 56.7 t-80 44.29 98.48 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.869 179.997 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -144.44 -161.68 1.33 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.567 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 49.58 89.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.693 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 51.1 p-80 -152.22 160.8 43.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.372 179.83 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.424 ' O ' ' OXT' ' A' ' 83' ' ' HIS . 97.1 m-70 -112.89 139.87 48.17 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.525 179.957 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.424 ' OXT' ' O ' ' A' ' 82' ' ' HIS . 51.6 p-80 . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.629 179.954 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -64.69 -28.23 69.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.818 -179.958 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -68.79 136.65 53.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.864 -179.161 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.77 155.93 62.9 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.136 -179.2 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 39' ' ' VAL . 39.1 Cg_endo -65.63 -23.45 56.73 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.596 2.197 . . . . 0.0 112.348 179.91 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -137.36 93.86 2.86 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.66 131.46 27.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.36 -0.382 . . . . 0.0 109.995 -179.969 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.11 101.74 14.27 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.252 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 22.2 m0 -102.85 142.06 34.61 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.083 -179.001 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -94.25 143.41 26.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.899 179.605 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.6 mt -96.66 115.59 36.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 O-C-N 123.23 0.332 . . . . 0.0 110.112 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.5 m -98.81 -44.12 6.5 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.558 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.67 177.34 27.05 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.865 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.7 OUTLIER -86.38 154.09 21.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.875 0.369 . . . . 0.0 110.466 -179.933 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.507 ' O ' HG22 ' A' ' 18' ' ' ILE . 8.1 t -85.11 172.44 11.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.467 179.543 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.401 ' N ' ' OG ' ' A' ' 15' ' ' SER . 99.7 mtt180 -68.11 -39.09 82.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.777 179.712 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.431 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 3.0 tm-20 -69.27 -15.7 63.41 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.561 -179.844 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 15' ' ' SER . 10.6 tp -40.81 146.72 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.427 -179.567 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.4 m -80.61 143.7 55.34 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.741 -179.375 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -49.31 -39.14 43.5 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.801 1.667 . . . . 0.0 112.609 179.056 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.43 -57.83 9.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.866 0.365 . . . . 0.0 111.043 -178.976 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -63.69 -43.71 95.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.447 0.642 . . . . 0.0 110.551 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -57.85 -44.97 86.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.956 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -62.7 -35.72 80.62 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.541 179.178 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.2 mmtt -59.46 -44.15 93.05 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.714 179.667 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.517 HD13 HD11 ' A' ' 29' ' ' LEU . 4.6 mm? -63.32 -42.16 98.97 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.163 178.725 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.84 -39.49 94.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.745 179.901 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.7 m -61.43 -44.64 96.77 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.317 -179.461 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.517 HD11 HD13 ' A' ' 26' ' ' LEU . 2.1 pp -92.85 138.07 31.81 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.521 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.85 -2.19 90.04 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.216 -0.753 . . . . 0.0 111.216 -179.648 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 48.3 ttp -86.82 75.29 9.63 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.681 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -82.56 169.96 16.33 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.034 -179.262 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' A' ' 32' ' ' LEU . 73.7 Cg_exo -44.76 -179.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.531 2.154 . . . . 0.0 112.454 -179.652 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.96 11.67 7.5 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 179.609 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 86.7 p -144.33 -157.76 0.82 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.673 0.273 . . . . 0.0 110.306 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 82.8 p -140.83 164.62 29.75 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.628 -179.822 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.447 ' HB2' HG22 ' A' ' 53' ' ' THR . 41.9 p90 -143.14 162.12 36.41 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.373 -179.696 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.445 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 22.2 p-10 -119.38 148.19 43.49 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.429 0.633 . . . . 0.0 110.638 179.692 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 5' ' ' PRO . 5.9 t -84.43 127.09 40.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.448 -179.716 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.416 ' H ' HG12 ' A' ' 40' ' ' VAL . 1.8 p -68.67 -39.21 80.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.813 179.464 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.412 ' HE ' HG22 ' A' ' 40' ' ' VAL . 19.3 ptp180 -172.82 160.65 4.47 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.132 -179.377 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 67.4 t -125.67 126.36 70.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.129 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.8 111.56 53.3 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.582 -179.787 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -75.74 -11.77 20.15 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.181 1.921 . . . . 0.0 112.314 -179.946 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.9 mt -58.46 -29.91 66.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.805 -178.842 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.96 27.42 2.08 Favored Glycine 0 N--CA 1.467 0.72 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.924 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -97.51 178.31 1.39 Allowed Pre-proline 0 CA--C 1.531 0.237 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.817 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 47' ' ' ASP . 19.5 Cg_exo -64.28 -177.88 0.56 Allowed 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.047 1.832 . . . . 0.0 112.265 -179.888 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.8 mm -106.57 117.84 53.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.885 -179.186 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.412 ' CG ' HG22 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -96.62 125.05 40.82 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.261 179.788 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.7 pt -123.63 147.85 27.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.134 179.49 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.445 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 13.3 tm-20 -132.59 130.09 39.81 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.182 -179.603 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.522 ' O ' ' N ' ' A' ' 55' ' ' ARG . 1.0 OUTLIER -122.44 136.78 54.97 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.883 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.8 ptt85 -40.4 -22.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.865 -179.632 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.527 ' O ' HG13 ' A' ' 56' ' ' VAL . 94.1 mtm-85 -86.07 -49.88 7.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.101 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 55' ' ' ARG . 16.6 m -160.43 -175.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.456 -179.224 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.3 p -128.5 150.88 49.97 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.707 179.601 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.0 tp -154.28 150.5 28.07 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.16 -179.831 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.412 HG22 ' CG ' ' A' ' 50' ' ' HIS . 56.0 t -117.45 130.4 72.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.954 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 98.1 mt -135.92 139.74 43.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.979 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.564 ' O ' ' N ' ' A' ' 64' ' ' ASP . 81.8 mtp180 -78.34 142.18 37.88 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.576 179.635 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 61' ' ' ARG . 16.8 ptpt -35.22 -35.18 0.04 OUTLIER 'General case' 0 C--O 1.235 0.301 0 O-C-N 123.313 0.383 . . . . 0.0 111.385 179.799 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 61' ' ' ARG . 54.9 mtpt -62.82 -44.78 95.24 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.159 179.149 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.564 ' N ' ' O ' ' A' ' 61' ' ' ARG . 10.6 m-20 -64.13 -36.27 83.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.233 179.024 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.542 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.0 mm? -62.22 -42.86 99.69 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.725 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.16 -44.1 93.11 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.994 0.426 . . . . 0.0 110.088 179.433 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.409 HD22 ' HB3' ' A' ' 17' ' ' GLU . 97.9 mt -68.23 -38.97 82.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.658 179.559 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.5 tp -69.78 125.09 25.7 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.849 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -76.03 115.48 15.79 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.091 -179.674 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.9 m -131.87 158.73 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.731 -179.998 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -143.32 144.58 32.15 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.429 179.645 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.27 140.77 54.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.924 179.274 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.4 t -95.24 128.96 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.385 -179.927 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.2 t -160.21 -28.14 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.474 179.926 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.5 t -74.21 149.85 40.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.568 179.614 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.36 64.65 3.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.978 -179.881 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.1 -32.75 72.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.458 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -64.26 140.55 58.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.686 -179.651 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -65.67 -40.3 92.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.604 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -58.1 -42.99 86.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.516 -179.768 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -78.82 145.76 34.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.446 179.817 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.2 p-80 -152.09 163.6 39.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.665 -179.796 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 84.2 t60 . . . . . 0 C--O 1.219 -0.53 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.563 179.919 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 3' ' ' TYR . 26.1 ttt . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 55.14 -83.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.795 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.496 ' N ' ' O ' ' A' ' 1' ' ' MET . 71.0 m-85 -81.1 137.83 35.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.909 -179.581 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.81 159.34 47.38 Favored Pre-proline 0 N--CA 1.465 0.314 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.203 -179.525 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 39' ' ' VAL . 43.8 Cg_endo -66.82 -32.63 36.19 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.688 2.259 . . . . 0.0 112.119 -179.826 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -136.62 95.5 3.16 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.906 -179.758 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 t -140.11 148.79 42.22 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.382 179.313 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -101.04 102.09 13.0 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.156 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 19.8 m0 -98.48 136.41 38.64 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.178 -179.008 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -95.45 129.5 42.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.969 179.805 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.6 mt -81.86 123.67 38.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.21 -179.296 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 11.7 p -108.14 -17.94 13.9 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.498 179.845 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 136.2 -179.04 18.28 Favored Glycine 0 N--CA 1.464 0.539 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.852 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -98.68 150.87 21.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.879 0.371 . . . . 0.0 110.472 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.412 ' O ' HG22 ' A' ' 18' ' ' ILE . 5.6 t -77.13 171.64 14.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.491 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.402 ' N ' ' OG ' ' A' ' 15' ' ' SER . 9.1 mpt_? -71.78 -40.64 69.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.503 -179.802 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -66.37 -13.1 60.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.248 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 15' ' ' SER . 10.1 tp -40.61 148.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.618 -179.828 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 72.0 p -81.16 142.78 51.61 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.687 -179.46 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -49.04 -38.15 39.12 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.916 1.744 . . . . 0.0 112.638 178.938 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.97 -57.4 12.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.877 0.37 . . . . 0.0 111.451 -178.909 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -63.02 -48.48 78.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.271 0.558 . . . . 0.0 110.579 -179.623 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.5 ttp85 -58.43 -46.37 86.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.168 0.509 . . . . 0.0 110.243 -179.677 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -60.46 -31.04 70.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.576 179.382 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -61.18 -44.95 96.48 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.867 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.6 mm? -61.77 -43.1 99.52 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.308 179.621 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.75 -38.71 92.13 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.692 179.554 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.0 t -60.46 -43.92 96.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.023 -179.212 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.475 ' CD1' ' O ' ' A' ' 31' ' ' MET . 2.3 pp -97.5 131.53 44.03 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.475 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.5 -21.53 74.51 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.475 ' O ' ' CD1' ' A' ' 29' ' ' LEU . 26.0 mmt -69.48 76.29 0.4 Allowed 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -82.2 169.69 17.48 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.324 -178.984 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 32' ' ' LEU . 71.3 Cg_exo -46.5 -178.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.435 2.09 . . . . 0.0 112.275 -179.475 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.89 8.91 9.34 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 179.665 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 m -138.03 -158.25 0.84 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.784 0.326 . . . . 0.0 110.256 179.657 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.7 t -141.6 153.06 44.55 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.46 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -128.37 157.41 41.09 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.339 -179.819 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 39' ' ' VAL . 50.0 t-20 -110.05 146.94 34.51 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.543 -179.803 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.529 ' N ' ' OD1' ' A' ' 38' ' ' ASN . 54.3 t -88.22 126.52 41.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.041 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 p -70.27 -40.64 78.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.075 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -173.73 159.25 3.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.152 -179.279 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.4 t -131.31 120.93 47.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.772 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.49 110.75 50.69 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.444 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -76.7 -11.69 18.42 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.2 1.933 . . . . 0.0 112.299 179.805 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.8 mt -59.39 -30.91 68.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.956 -178.551 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.24 22.77 0.7 Allowed Glycine 0 N--CA 1.465 0.568 0 N-CA-C 111.006 -0.837 . . . . 0.0 111.006 179.755 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.6 159.8 30.19 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.11 171.7 2.12 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.795 2.33 . . . . 0.0 111.939 -179.814 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.4 mm -92.56 114.27 29.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.799 -179.255 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -92.0 122.21 34.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.893 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.422 ' O ' ' O ' ' A' ' 58' ' ' LEU . 45.6 pt -127.54 149.17 32.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.326 -179.966 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -126.85 129.87 49.1 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.375 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.95 138.87 54.56 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.847 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -41.16 -37.03 0.83 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.346 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.404 HH11 ' HB3' ' A' ' 31' ' ' MET . 57.9 ttp180 -65.47 -49.02 70.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.555 179.836 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.63 HG22 ' H ' ' A' ' 57' ' ' SER . 7.1 p -171.13 173.1 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.803 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.63 ' H ' HG22 ' A' ' 56' ' ' VAL . 40.0 t -92.11 136.71 32.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.151 178.812 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 51' ' ' ILE . 64.1 tp -143.03 148.72 37.21 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.791 0.329 . . . . 0.0 110.154 -179.877 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 p -130.13 130.54 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.099 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.4 mt -134.59 155.69 50.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.323 -179.506 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -77.63 170.15 17.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.683 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.15 -47.07 87.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.132 0.492 . . . . 0.0 110.578 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -58.41 -38.23 76.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.733 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -58.07 -46.56 85.24 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.37 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.0 mp -62.75 -41.49 99.24 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.175 179.172 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.68 -53.11 59.14 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.365 -179.711 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.2 mm? -68.57 -41.11 80.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.146 179.482 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.2 tp -58.15 133.13 55.33 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.185 -179.038 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.429 ' O ' ' OG1' ' A' ' 12' ' ' THR . 47.6 mm-40 -77.85 110.42 12.72 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.312 -179.46 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.36 156.9 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.472 179.608 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -141.79 137.05 31.27 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.493 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.45 117.48 27.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.203 179.768 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.454 HG23 ' H ' ' A' ' 73' ' ' VAL . 0.6 OUTLIER -65.06 -149.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.343 -179.671 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.419 ' H ' HG12 ' A' ' 73' ' ' VAL . 4.8 p 48.75 52.1 14.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.403 179.876 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.7 p -153.1 162.81 40.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.653 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.1 tp 59.82 42.04 17.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.378 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -65.9 -32.88 74.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.609 -179.808 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 44.0 p-80 -145.31 168.4 20.57 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.63 -179.616 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -60.18 133.31 55.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.577 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -85.0 130.73 34.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.582 -179.833 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 43.0 p-80 -150.75 148.57 28.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.478 179.992 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -154.07 143.7 21.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.57 -179.924 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.461 179.975 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.9 tpp . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -72.16 -12.66 61.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.868 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -79.4 91.78 5.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.977 -179.641 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.66 159.13 32.4 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.12 -179.257 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 39' ' ' VAL . 42.6 Cg_endo -67.5 -20.19 47.97 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.697 2.264 . . . . 0.0 112.078 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -136.47 93.81 2.93 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.823 0.344 . . . . 0.0 110.121 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.51 131.64 28.05 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.838 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.88 102.12 14.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.228 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 21.1 m0 -100.04 140.37 34.35 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.118 -179.353 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -101.39 125.23 48.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.733 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.2 mt -81.14 123.6 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.393 -179.169 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.9 p -105.29 -16.16 14.84 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.436 179.933 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.39 163.08 9.64 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.516 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.84 159.54 33.59 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.56 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 p -77.35 167.41 21.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.643 -179.733 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.25 -40.44 74.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.863 0.363 . . . . 0.0 110.7 179.508 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -80.47 -2.39 45.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.145 -179.725 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.6 tp -40.42 146.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.561 -179.406 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.2 p -76.23 137.95 68.3 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.461 -179.258 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -46.92 -41.97 25.42 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.883 1.722 . . . . 0.0 112.666 179.195 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.83 -54.28 44.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.912 0.387 . . . . 0.0 111.228 -179.181 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -63.07 -49.24 75.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.355 0.598 . . . . 0.0 110.557 -179.859 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.1 ttt-85 -57.2 -42.67 81.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.088 -179.247 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.524 ' NE2' ' OG ' ' A' ' 28' ' ' SER . 12.4 tm0? -62.52 -34.99 78.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.02 179.332 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -59.22 -46.47 88.36 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.942 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.492 HD22 ' N ' ' A' ' 26' ' ' LEU . 4.6 mm? -65.19 -37.79 88.46 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.821 179.557 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 tt -75.66 -23.83 56.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.082 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.524 ' OG ' ' NE2' ' A' ' 24' ' ' GLN . 49.1 m -58.11 -44.09 87.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.903 0.382 . . . . 0.0 111.317 -179.2 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.588 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -116.9 156.65 27.0 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.162 -179.675 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -63.16 -26.24 69.04 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.769 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 86.9 mtp -61.55 73.96 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.006 0.432 . . . . 0.0 110.109 -179.884 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -85.38 169.2 16.72 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.585 -178.357 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 32' ' ' LEU . 55.7 Cg_exo -47.69 -177.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.075 1.85 . . . . 0.0 112.009 -179.764 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.63 -4.63 39.95 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.537 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.8 m -101.18 -169.6 1.72 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.713 0.292 . . . . 0.0 110.25 179.544 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.1 t -133.05 151.26 52.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.383 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -138.11 163.53 31.42 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.228 -179.654 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -122.57 146.67 47.21 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.446 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 5' ' ' PRO . 62.1 t -85.48 126.75 40.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.295 -179.83 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 40' ' ' VAL . 2.2 p -70.04 -41.1 79.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.16 179.736 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.3 ptt-85 -174.25 169.42 3.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.966 -179.209 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.6 m -136.12 116.62 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.123 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.31 111.3 51.39 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.311 -179.745 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.497 ' C ' ' H ' ' A' ' 46' ' ' GLY . 60.3 Cg_endo -75.45 -11.76 20.68 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.287 1.991 . . . . 0.0 112.054 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.524 HD22 ' N ' ' A' ' 45' ' ' LEU . 4.2 mm? -53.0 -6.69 0.06 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.58 -178.978 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.497 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 104.37 23.69 7.88 Favored Glycine 0 N--CA 1.462 0.418 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.613 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.73 165.01 16.31 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 -179.491 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -58.06 -170.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.025 1.817 . . . . 0.0 111.704 179.257 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.8 mm -106.36 112.9 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -88.19 120.49 29.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.958 -179.806 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 58' ' ' LEU . 48.6 pt -126.33 147.99 31.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.144 179.901 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -127.97 129.43 46.76 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.306 179.649 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 p -114.19 136.7 52.67 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.807 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -39.04 -35.39 0.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.808 -179.433 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.556 ' O ' HG13 ' A' ' 56' ' ' VAL . 18.9 mmm180 -73.3 -49.29 28.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.109 -179.537 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 55' ' ' ARG . 15.6 m -160.94 -176.84 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.517 -179.472 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 p -106.58 148.21 28.55 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.699 179.721 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' A' ' 51' ' ' ILE . 61.0 tp -154.6 150.31 27.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.473 179.896 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 59' ' ' VAL . 12.1 p -127.57 131.33 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.82 179.194 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.6 mt -136.69 159.71 41.02 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.308 -179.445 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.405 ' HG2' ' N ' ' A' ' 62' ' ' LYS . 69.1 ttt180 -85.06 166.63 16.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.339 -179.583 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.405 ' N ' ' HG2' ' A' ' 61' ' ' ARG . 88.2 tttt -58.49 -44.43 89.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.856 0.36 . . . . 0.0 110.588 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -57.38 -39.92 77.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.723 -179.719 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -60.27 -45.15 94.3 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.394 179.992 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.5 -41.04 98.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.786 0.326 . . . . 0.0 110.127 179.47 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.06 -40.79 98.73 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.565 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.9 mt -75.8 -48.82 20.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.355 -179.641 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.2 mt -55.74 133.09 50.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.351 -179.151 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -74.27 109.38 7.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.192 -179.401 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.48 159.74 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.436 179.994 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -139.82 126.34 20.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.513 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.92 124.13 22.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.91 179.771 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.3 m -130.95 159.31 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.42 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.5 t -156.6 175.75 13.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.56 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.432 ' O ' ' OE1' ' A' ' 77' ' ' GLU . 2.0 t 68.27 33.52 4.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.547 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.8 tp -91.97 54.7 2.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.552 -179.817 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.432 ' OE1' ' O ' ' A' ' 75' ' ' SER . 57.8 mp0 -68.66 -35.55 77.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.447 179.955 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -139.58 146.53 39.95 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.425 -179.821 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -75.75 -152.91 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.175 -179.938 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -146.8 147.92 31.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.272 -179.955 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -81.29 154.83 26.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.555 -179.881 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -64.56 -42.08 95.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.506 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.524 ' CG ' ' O ' ' A' ' 83' ' ' HIS . 57.0 p-80 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.597 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 . . . . . 0 N--CA 1.465 0.286 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.9 158.87 74.41 Favored Pre-proline 0 N--CA 1.468 0.441 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 39' ' ' VAL . 44.1 Cg_endo -66.97 -19.41 52.05 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.549 2.166 . . . . 0.0 112.369 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -136.98 92.63 2.75 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.83 131.81 26.14 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.63 102.22 14.39 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.447 ' CZ3' HD12 ' A' ' 65' ' ' LEU . 22.4 m0 -101.44 132.04 47.24 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.191 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -86.84 136.63 32.9 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.8 mt -92.4 117.93 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 12.5 p -104.21 -32.24 9.22 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.73 0.3 . . . . 0.0 110.25 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.72 174.48 21.79 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -90.15 153.49 20.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.801 0.334 . . . . 0.0 110.334 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.464 ' O ' HG22 ' A' ' 18' ' ' ILE . 1.5 t -80.73 168.32 18.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.659 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -68.36 -40.57 81.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.877 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -63.63 -17.4 62.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.419 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 15' ' ' SER . 10.8 tp -41.89 147.42 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.587 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.98 155.15 84.78 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.343 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.98 -31.03 66.86 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.562 2.175 . . . . 0.0 112.213 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.24 -56.82 12.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.142 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -61.44 -44.2 97.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.65 0.738 . . . . 0.0 110.543 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -58.0 -47.62 82.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.589 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 45.4 tp60 -57.98 -37.27 73.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.532 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -57.91 -40.82 81.33 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.388 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.506 HD13 HD11 ' A' ' 29' ' ' LEU . 4.4 mm? -61.38 -42.86 99.39 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.81 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.92 -39.95 96.11 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.199 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.5 m -60.47 -44.11 96.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.795 0.331 . . . . 0.0 111.205 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.506 HD11 HD13 ' A' ' 26' ' ' LEU . 2.2 pp -93.5 132.65 37.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.555 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.94 -2.02 69.86 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 71.8 mtm -86.95 75.0 9.62 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -82.6 168.62 22.08 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.127 -179.199 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.451 ' O ' ' O ' ' A' ' 32' ' ' LEU . 77.5 Cg_exo -43.47 177.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.603 2.202 . . . . 0.0 112.412 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.95 11.96 7.34 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.487 ' OG ' ' N ' ' A' ' 36' ' ' SER . 34.9 t -144.2 -172.0 3.69 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.848 0.356 . . . . 0.0 110.344 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.487 ' N ' ' OG ' ' A' ' 35' ' ' SER . 67.7 m -128.28 155.7 44.18 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.517 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -135.53 159.14 42.55 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.349 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -111.97 150.64 30.28 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.572 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' PRO . 13.1 t -86.1 126.82 40.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.526 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 p -67.86 -41.46 84.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.825 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -173.78 161.51 3.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.994 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.471 ' O ' HG23 ' A' ' 42' ' ' VAL . 33.2 m -129.86 121.99 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.33 110.57 49.37 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.507 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -76.65 -11.74 18.5 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.042 1.828 . . . . 0.0 112.327 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.0 mt -59.67 -31.04 69.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.996 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 132.12 24.83 0.77 Allowed Glycine 0 N--CA 1.468 0.772 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.71 160.36 28.8 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.93 175.42 0.46 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.86 2.374 . . . . 0.0 112.02 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.6 mm -92.05 114.81 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.885 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -92.74 122.16 34.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.872 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.5 pt -127.5 150.69 33.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.801 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -128.83 137.64 51.61 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.128 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 55' ' ' ARG . 0.7 OUTLIER -129.49 138.27 51.29 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.753 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -43.78 -21.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.59 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 53' ' ' THR . 85.0 mtt85 -82.81 -48.81 10.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.533 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.635 HG22 ' N ' ' A' ' 57' ' ' SER . 14.9 p -169.66 168.55 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.665 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.635 ' N ' HG22 ' A' ' 56' ' ' VAL . 5.3 p -99.6 146.15 26.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.551 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.7 tp -155.96 147.86 23.18 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.335 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.669 ' O ' HD12 ' A' ' 60' ' ' LEU . 3.3 p -126.68 131.43 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.615 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.669 HD12 ' O ' ' A' ' 59' ' ' VAL . 2.6 mp -132.95 155.05 49.82 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.056 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -72.91 162.09 29.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.941 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -54.55 -45.9 73.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.869 0.366 . . . . 0.0 110.807 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -59.98 -40.67 89.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.526 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -61.12 -40.76 95.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.495 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.447 HD12 ' CZ3' ' A' ' 9' ' ' TRP . 2.2 mm? -63.06 -42.12 99.63 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.24 93.52 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.214 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.27 -42.13 84.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.221 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.5 mt -66.81 135.74 54.39 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.626 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.453 ' O ' ' OG1' ' A' ' 12' ' ' THR . 94.6 mt-10 -79.97 113.25 17.99 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.142 0.496 . . . . 0.0 110.175 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.9 m -132.16 155.94 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.747 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -142.54 137.9 30.48 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.754 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.9 148.03 51.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.145 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 38.7 t . . . . . 0 N--CA 1.466 0.372 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.347 -179.555 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 . . . . . 0 N--CA 1.456 -0.147 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.91 155.99 74.46 Favored Pre-proline 0 N--CA 1.467 0.38 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 39' ' ' VAL . 43.3 Cg_endo -66.79 -22.19 49.95 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.51 2.14 . . . . 0.0 112.288 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 6' ' ' ASP . 39.1 p-10 -137.42 93.61 2.83 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.735 0.302 . . . . 0.0 110.304 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.51 129.81 25.4 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.6 102.44 15.18 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 18.1 m0 -101.57 137.52 39.78 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.933 0.397 . . . . 0.0 110.322 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -95.24 129.57 42.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.038 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.2 mt -82.42 122.62 37.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.123 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 8.9 p -110.75 -19.33 12.89 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.559 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.72 -179.95 22.41 Favored Glycine 0 N--CA 1.464 0.559 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -100.12 157.42 16.58 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.848 0.356 . . . . 0.0 110.321 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 67' ' ' LEU . 15.5 m -74.8 165.76 24.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.765 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -70.54 -38.99 74.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.56 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -74.15 -6.34 47.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.383 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.6 tp -41.41 146.58 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.449 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.42 155.2 93.04 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.248 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.82 -31.27 68.23 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.415 2.077 . . . . 0.0 112.13 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.46 -53.47 42.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.224 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -63.06 -46.4 87.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.745 0.783 . . . . 0.0 110.652 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 67.0 ttp85 -57.99 -44.18 86.99 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.729 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -61.09 -36.12 78.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.08 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -59.22 -43.0 92.32 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.437 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.6 mm? -62.43 -43.66 98.28 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.032 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 49.1 mt -70.35 -32.56 70.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.81 0.338 . . . . 0.0 111.091 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.5 m -58.91 -44.03 91.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.334 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.495 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -118.73 173.21 7.0 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.295 -179.691 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -88.92 -3.14 77.11 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 33.2 ttm -64.6 74.18 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.2 mp -99.8 169.96 7.38 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.289 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 32' ' ' LEU . 62.9 Cg_exo -49.67 -164.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.331 2.021 . . . . 0.0 112.564 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.77 5.1 56.74 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.9 m -138.63 -156.28 0.67 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.813 0.34 . . . . 0.0 110.2 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.5 p -146.38 164.23 33.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.505 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -139.21 151.54 46.64 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.232 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -108.84 146.98 32.81 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.431 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' PRO . 10.0 t -87.03 127.15 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.597 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 50' ' ' HIS . 2.2 p -69.93 -39.05 77.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.885 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -173.44 166.93 4.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.284 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.518 ' O ' HG23 ' A' ' 42' ' ' VAL . 36.0 m -139.29 117.02 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.62 110.91 50.04 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.492 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.19 -11.68 19.34 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.135 1.89 . . . . 0.0 112.312 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.2 mt -58.58 -30.54 67.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.744 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.48 25.37 0.78 Allowed Glycine 0 N--CA 1.467 0.712 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.68 160.25 29.08 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -60.2 172.06 2.73 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.754 2.302 . . . . 0.0 111.88 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.2 mm -96.87 119.06 44.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.163 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.47 ' CD2' HG23 ' A' ' 59' ' ' VAL . 11.8 m170 -101.97 131.02 48.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.117 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.7 pt -127.26 149.84 32.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.5 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -138.91 144.42 39.09 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.034 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 56' ' ' VAL . 1.0 OUTLIER -132.5 173.15 11.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.515 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 53' ' ' THR . 99.8 mtt180 -33.6 -52.25 0.4 Allowed 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.35 0.406 . . . . 0.0 111.788 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -142.93 32.44 1.39 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.008 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 53' ' ' THR . 2.3 t -141.54 139.13 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.82 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.0 m -137.53 143.22 41.53 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.45 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.6 tp -161.57 152.49 18.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.203 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.47 HG23 ' CD2' ' A' ' 50' ' ' HIS . 4.2 p -122.32 128.87 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.7 mt -136.66 161.52 35.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.366 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -85.47 162.55 18.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.801 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -58.09 -37.55 74.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.605 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -61.8 -41.1 97.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.535 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -59.84 -45.86 91.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.347 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.2 mp -62.02 -41.08 97.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.264 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.03 -47.27 83.57 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.276 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.476 ' O ' ' OG ' ' A' ' 15' ' ' SER . 11.1 mp -75.98 -52.52 10.07 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.336 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.6 tp -43.03 128.66 4.42 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.479 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.45 ' O ' ' OG1' ' A' ' 12' ' ' THR . 78.8 mm-40 -70.28 109.52 4.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.237 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.0 m -137.88 159.36 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.544 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -141.31 124.66 16.58 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.518 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.9 132.4 49.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.873 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.418 179.881 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 . . . . . 0 CA--C 1.519 -0.236 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.431 ' OG1' HG21 ' A' ' 7' ' ' THR . 13.0 p -138.46 148.94 61.11 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.773 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 39' ' ' VAL . 42.8 Cg_endo -66.56 -52.46 0.76 Allowed 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.438 2.092 . . . . 0.0 112.34 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -117.14 94.47 4.58 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.873 0.368 . . . . 0.0 110.917 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.431 HG21 ' OG1' ' A' ' 4' ' ' THR . 1.5 t -141.39 150.3 42.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.13 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -99.6 102.21 13.66 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 18.4 m0 -97.8 137.62 36.39 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.285 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -93.55 140.91 29.06 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.4 mt -93.79 119.46 41.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 123.357 0.411 . . . . 0.0 110.248 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.5 m -102.21 -46.99 4.66 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.494 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.57 177.07 32.33 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.2 p90 -95.84 146.48 24.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.809 0.338 . . . . 0.0 110.322 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.47 ' O ' HG22 ' A' ' 18' ' ' ILE . 40.0 t -77.55 172.2 13.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.485 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -69.68 -39.61 76.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.882 0.372 . . . . 0.0 110.806 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -67.44 -14.36 62.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.386 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 15' ' ' SER . 10.4 tp -41.5 147.41 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.751 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.41 154.72 87.9 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.354 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.91 -31.3 67.33 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.67 2.247 . . . . 0.0 111.989 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.99 -54.78 25.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.984 0.421 . . . . 0.0 111.116 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -62.58 -44.98 94.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.594 0.711 . . . . 0.0 110.308 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -57.82 -39.93 78.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.821 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 28' ' ' SER . 15.9 mm-40 -63.77 -36.25 83.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.948 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -60.31 -44.81 95.09 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.55 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.407 ' N ' HD22 ' A' ' 26' ' ' LEU . 4.5 mm? -64.2 -41.56 97.02 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.175 178.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 tt -75.16 -28.1 59.96 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.107 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.527 ' N ' ' O ' ' A' ' 24' ' ' GLN . 14.5 t -61.2 -44.67 96.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.171 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.522 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -115.45 169.21 9.34 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.257 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.53 5.86 84.23 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.2 tpt -76.89 73.82 3.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.898 0.38 . . . . 0.0 110.05 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.8 mp -95.8 166.73 13.93 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.424 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 32' ' ' LEU . 77.9 Cg_exo -45.11 178.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.265 1.977 . . . . 0.0 112.162 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.43 3.4 14.61 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 m -141.31 -157.05 0.73 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.818 0.342 . . . . 0.0 110.26 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 89.3 p -143.78 163.29 33.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.397 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -140.93 159.79 41.46 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.332 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -113.26 144.76 42.17 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.567 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 5' ' ' PRO . 99.2 t -85.98 129.13 38.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.287 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.401 HG22 ' HE ' ' A' ' 41' ' ' ARG . 2.4 p -67.29 -41.84 87.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.187 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.401 ' HE ' HG22 ' A' ' 40' ' ' VAL . 20.1 ptp180 -174.9 161.13 2.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.94 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.2 t -131.88 122.47 49.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.1 110.82 50.38 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.406 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.61 -11.22 20.41 Favored 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 122.287 1.992 . . . . 0.0 112.226 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.533 ' N ' HD22 ' A' ' 45' ' ' LEU . 4.1 mm? -60.65 -31.8 71.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.986 -178.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 132.72 24.69 0.73 Allowed Glycine 0 N--CA 1.465 0.611 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.23 160.17 29.56 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.57 170.09 2.04 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.682 2.254 . . . . 0.0 111.78 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.5 mm -95.46 114.42 32.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.872 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.578 ' CD2' HG23 ' A' ' 59' ' ' VAL . 12.3 m170 -97.13 125.85 41.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.709 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.445 HG22 HG22 ' A' ' 39' ' ' VAL . 44.8 pt -125.99 150.05 31.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.699 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -134.98 111.97 10.23 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.987 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 54' ' ' ARG . 1.3 p -83.5 173.89 11.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.511 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 53' ' ' THR . 91.2 mtm180 -33.68 -53.14 0.43 Allowed 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.409 0.443 . . . . 0.0 111.779 -178.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -142.53 31.67 1.49 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.323 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 t -140.57 136.95 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.499 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.1 p -112.0 138.81 48.12 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.181 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.8 tp -155.22 149.88 26.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.079 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.578 HG23 ' CD2' ' A' ' 50' ' ' HIS . 9.1 p -124.24 128.44 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.79 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.6 mt -133.62 161.16 35.38 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.417 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -94.74 160.47 14.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.418 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -53.32 -37.31 62.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.916 0.389 . . . . 0.0 110.642 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.43 -42.18 99.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.39 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -60.83 -42.1 97.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.342 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.2 -41.81 98.71 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.074 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.72 -51.7 68.83 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.35 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.1 mm? -69.17 -40.18 78.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.019 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.7 tp -60.16 136.08 57.92 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -86.86 109.9 19.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.038 0.447 . . . . 0.0 110.37 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 m -132.6 157.11 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.628 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -142.4 143.93 32.89 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.854 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.17 147.09 53.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.041 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.465 0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.198 -179.7 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 . . . . . 0 CA--C 1.523 -0.072 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.32 151.66 56.84 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.321 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 39' ' ' VAL . 42.5 Cg_endo -66.11 -27.49 49.4 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.513 2.142 . . . . 0.0 111.876 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -135.69 94.52 3.09 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.907 0.384 . . . . 0.0 110.703 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.4 ' HG1' ' HE1' ' A' ' 9' ' ' TRP . 1.8 t -140.44 152.24 45.53 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.137 179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.74 102.79 14.64 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.4 ' HE1' ' HG1' ' A' ' 7' ' ' THR . 12.9 m0 -99.69 134.32 42.74 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.217 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -97.79 130.44 44.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.816 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.9 mt -84.03 118.33 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.265 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.5 m -99.12 -35.63 9.95 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.032 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 144.75 176.89 19.15 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -89.03 146.29 24.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.818 0.342 . . . . 0.0 110.33 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.5 m -74.99 171.19 14.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.429 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.1 ttm-85 -69.31 -41.32 76.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.549 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -72.44 -4.72 31.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.664 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.1 tp -41.84 147.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.665 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 m -68.12 152.11 96.71 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.058 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.97 -31.22 56.4 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.427 2.085 . . . . 0.0 112.075 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.74 -53.93 23.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.492 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.404 ' CE1' ' CD2' ' A' ' 26' ' ' LEU . 33.4 t80 -61.65 -44.25 97.32 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.295 0.569 . . . . 0.0 110.335 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -59.7 -42.78 93.76 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.825 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.4 HE22 ' HB3' ' A' ' 28' ' ' SER . 19.6 tm0? -61.8 -37.21 83.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.641 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -59.9 -45.67 91.79 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.746 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.414 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.6 mm? -62.86 -41.33 99.33 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.497 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.2 mt -62.18 -38.75 90.26 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.392 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.4 ' HB3' HE22 ' A' ' 24' ' ' GLN . 3.3 p -80.13 -10.24 59.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.835 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.1 tp -100.16 126.87 46.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.482 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.28 1.9 73.71 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 77.3 mtm -108.81 74.82 0.93 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.259 0.552 . . . . 0.0 109.701 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.3 mp -78.87 165.94 45.79 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.831 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 32' ' ' LEU . 68.1 Cg_exo -42.65 179.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.788 2.325 . . . . 0.0 113.043 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.0 11.86 7.36 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.2 p -143.07 -160.38 1.1 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.72 0.295 . . . . 0.0 110.396 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 97.6 p -139.98 165.15 28.1 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.542 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -143.63 169.12 18.33 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.438 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 16.4 p-10 -124.88 151.64 45.06 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.306 0.574 . . . . 0.0 110.279 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' PRO . 16.6 t -87.06 124.94 40.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.425 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.458 ' H ' HG12 ' A' ' 40' ' ' VAL . 2.0 p -71.63 -39.81 70.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.913 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -172.99 166.76 5.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.672 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.645 ' O ' HG23 ' A' ' 42' ' ' VAL . 33.3 m -149.31 104.65 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.894 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.83 111.29 53.84 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.405 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -75.87 -9.96 19.69 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.455 2.103 . . . . 0.0 112.348 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.518 ' N ' HD12 ' A' ' 45' ' ' LEU . 10.6 mp -52.12 -30.15 25.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.768 -178.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 147.36 16.15 0.13 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -97.96 153.05 38.33 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.26 -175.03 0.47 Allowed 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.216 1.944 . . . . 0.0 111.778 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.43 HG21 ' CD2' ' A' ' 65' ' ' LEU . 12.8 mm -91.49 114.55 28.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.716 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.462 ' CD2' HG23 ' A' ' 59' ' ' VAL . 12.0 m170 -95.71 120.49 36.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.233 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.4 pt -125.18 144.42 35.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.229 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.435 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 13.1 tm-20 -123.62 124.66 43.28 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.187 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.49 141.25 48.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.336 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.415 ' H ' ' HG2' ' A' ' 54' ' ' ARG . 21.5 mmt85 -50.11 -38.94 41.19 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.978 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -67.77 -41.06 83.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.756 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.746 HG22 ' H ' ' A' ' 57' ' ' SER . 13.1 p -170.7 177.18 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.578 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.746 ' H ' HG22 ' A' ' 56' ' ' VAL . 47.8 t -111.48 145.11 39.6 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.273 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.416 HD21 HD11 ' A' ' 60' ' ' LEU . 62.3 tp -147.76 149.21 31.95 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.552 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 59' ' ' VAL . 7.7 p -137.19 122.98 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.416 HD11 HD21 ' A' ' 58' ' ' LEU . 96.7 mt -140.98 175.95 9.2 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.442 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -86.64 162.69 17.82 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.07 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -58.37 -32.91 69.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.611 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.06 -41.6 98.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.209 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -60.08 -44.62 94.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.496 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.43 ' CD2' HG21 ' A' ' 49' ' ' ILE . 7.8 mp -62.01 -40.91 97.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.976 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.85 -48.86 78.57 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.455 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.14 -40.24 86.68 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.888 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 77.1 mt -66.62 140.64 57.94 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.511 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -84.29 108.66 17.27 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.443 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.1 m -132.38 158.91 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.296 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -143.09 129.57 20.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.48 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.61 129.21 36.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.683 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.7 m . . . . . 0 N--CA 1.464 0.246 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.19 179.776 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 . . . . . 0 CA--C 1.517 -0.293 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.06 153.15 76.63 Favored Pre-proline 0 N--CA 1.465 0.297 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.396 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 39' ' ' VAL . 40.1 Cg_endo -66.52 -33.96 35.04 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.518 2.145 . . . . 0.0 112.22 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -136.7 95.2 3.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.702 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -140.03 148.17 41.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.277 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -103.2 102.0 11.97 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 27.4 m0 -96.37 147.33 23.92 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.396 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -105.1 125.7 51.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.743 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.2 mt -82.86 120.33 34.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.194 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.2 p -104.55 -10.48 17.58 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.495 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 142.09 167.46 11.33 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.15 161.86 25.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.399 . . . . 0.0 110.074 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.6 p -72.64 163.29 28.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.555 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 85.4 mtm-85 -69.89 -39.78 76.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.588 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -79.78 -3.38 47.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.183 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.1 tp -41.25 144.81 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.683 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 57.3 m -80.17 148.72 68.08 Favored Pre-proline 0 C--N 1.327 -0.383 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.934 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -50.09 -40.18 50.69 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.299 1.999 . . . . 0.0 112.35 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.38 -56.53 17.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.002 0.43 . . . . 0.0 111.201 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -63.36 -51.22 66.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.405 0.622 . . . . 0.0 110.517 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 68.6 ttt-85 -55.51 -44.12 76.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.482 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 28' ' ' SER . 68.9 tp60 -62.82 -32.6 73.83 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.818 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -59.4 -47.03 87.02 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.456 -0.497 . . . . 0.0 109.837 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.532 HD22 ' N ' ' A' ' 26' ' ' LEU . 4.4 mm? -65.54 -37.85 87.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.151 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.5 tp -74.62 -28.44 60.88 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.871 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 24' ' ' GLN . 68.7 m -57.61 -44.41 85.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.05 -178.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.607 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -114.54 153.13 30.61 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.114 -179.743 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -61.79 -24.59 64.67 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 67.6 mtt -61.13 73.67 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 120.976 0.417 . . . . 0.0 109.994 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 30' ' ' GLY . 0.5 OUTLIER -86.66 168.57 17.9 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.826 -179.167 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.457 ' HD3' HD12 ' A' ' 26' ' ' LEU . 67.6 Cg_exo -46.52 -178.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.29 1.993 . . . . 0.0 111.97 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.77 -11.78 45.87 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.2 m -100.73 -171.82 2.08 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.984 0.421 . . . . 0.0 110.238 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.3 m -130.19 157.59 42.04 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.427 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -138.65 158.38 44.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.215 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -112.38 145.03 40.83 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.562 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 5' ' ' PRO . 51.7 t -89.81 124.56 42.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.135 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.42 HG12 ' H ' ' A' ' 40' ' ' VAL . 2.0 p -68.61 -41.22 82.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.069 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -173.68 164.22 4.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.119 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 42' ' ' VAL . 27.6 m -135.99 124.15 36.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.045 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.98 110.76 51.65 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.736 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.32 -12.02 19.06 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.781 2.321 . . . . 0.0 112.184 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.53 ' N ' HD12 ' A' ' 45' ' ' LEU . 10.9 mp -60.6 -32.34 71.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.626 -178.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 135.33 22.03 0.65 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.97 160.03 30.08 Favored Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.46 169.08 3.35 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.77 2.313 . . . . 0.0 111.808 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.511 ' N ' ' O ' ' A' ' 60' ' ' LEU . 8.3 mm -93.48 114.41 30.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.976 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -91.3 122.88 34.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.856 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' A' ' 58' ' ' LEU . 44.9 pt -125.65 147.43 30.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.266 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -127.65 129.66 47.6 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.27 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.76 137.56 54.72 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.795 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.618 ' HE ' ' NH1' ' A' ' 55' ' ' ARG . 35.1 ptt180 -44.99 -31.46 1.3 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.245 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.618 ' NH1' ' HE ' ' A' ' 54' ' ' ARG . 86.5 mmt-85 -71.88 -46.37 58.07 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.599 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.625 HG22 ' N ' ' A' ' 57' ' ' SER . 13.9 p -170.97 168.46 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.794 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.625 ' N ' HG22 ' A' ' 56' ' ' VAL . 97.5 p -89.18 153.52 20.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.609 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 51' ' ' ILE . 61.1 tp -162.62 149.16 12.9 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.332 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 p -130.29 131.39 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 49' ' ' ILE . 89.7 mt -134.91 161.39 35.36 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.47 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -88.14 161.85 17.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.749 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.405 ' CG ' ' N ' ' A' ' 63' ' ' LYS . 20.4 ptmt -55.32 -41.0 71.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.965 0.412 . . . . 0.0 110.777 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.405 ' N ' ' CG ' ' A' ' 62' ' ' LYS . 21.0 ptmt -60.36 -40.21 89.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.67 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.92 -44.4 97.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.549 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.42 -41.86 97.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.703 0.287 . . . . 0.0 110.232 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.65 -50.51 73.57 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.395 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.27 -40.45 81.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.752 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.7 tp -61.76 129.71 42.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.338 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -74.53 107.58 6.75 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.64 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.2 m -132.68 161.89 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.607 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -143.0 140.74 31.14 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.37 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.03 112.59 20.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.301 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 63.0 t . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.518 -179.627 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 . . . . . 0 N--CA 1.455 -0.22 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.83 156.63 68.68 Favored Pre-proline 0 N--CA 1.467 0.411 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 39' ' ' VAL . 45.3 Cg_endo -67.09 -21.72 48.56 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.45 2.1 . . . . 0.0 112.289 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -137.01 93.06 2.79 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.41 HG21 ' HE1' ' A' ' 9' ' ' TRP . 0.2 OUTLIER -140.3 131.83 27.04 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.55 103.05 15.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.41 ' HE1' HG21 ' A' ' 7' ' ' THR . 10.4 m0 -101.63 136.32 41.67 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.287 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -101.13 130.98 47.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.828 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.3 mt -83.97 124.29 39.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.723 -178.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.1 m -109.91 -41.34 4.52 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.812 0.339 . . . . 0.0 110.489 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 160.53 -174.31 37.21 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -103.74 147.1 27.66 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.815 0.34 . . . . 0.0 110.982 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.41 ' O ' HG22 ' A' ' 18' ' ' ILE . 3.5 m -78.84 173.16 12.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.604 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.415 ' N ' ' CD ' ' A' ' 16' ' ' ARG . 3.0 mpt_? -69.79 -40.37 76.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.61 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -68.66 -11.98 60.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.724 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 15' ' ' SER . 10.0 tp -41.16 148.35 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.625 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.9 p -76.35 141.16 69.67 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.57 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -49.49 -40.0 45.17 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 121.605 1.537 . . . . 0.0 112.952 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.62 -54.99 37.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 111.689 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -63.55 -45.79 88.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.451 0.643 . . . . 0.0 110.382 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -58.3 -44.55 88.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.945 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.482 ' O ' ' N ' ' A' ' 28' ' ' SER . 62.3 tp60 -61.57 -33.96 74.78 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -59.64 -47.29 86.18 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.904 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.6 mm? -62.68 -42.19 99.5 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.102 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.5 tt -72.99 -30.7 63.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.88 0.372 . . . . 0.0 110.871 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 24' ' ' GLN . 74.6 m -60.18 -43.28 95.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.395 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.505 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -118.66 171.96 7.83 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.398 -179.574 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.77 6.79 73.88 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 97.1 mtp -77.94 74.9 4.48 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.9 OUTLIER -92.96 169.89 9.72 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.131 -179.173 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 32' ' ' LEU . 51.4 Cg_exo -49.38 -169.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.123 1.882 . . . . 0.0 112.595 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.91 0.87 19.54 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.1 m -139.8 -173.25 3.58 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.728 0.299 . . . . 0.0 110.266 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 73.0 m -128.82 155.93 44.42 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.817 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -130.14 157.12 43.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.42 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -113.58 152.41 30.34 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.297 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 5' ' ' PRO . 20.8 t -87.95 123.0 40.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.479 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.403 ' H ' HG12 ' A' ' 40' ' ' VAL . 1.6 p -66.67 -42.01 89.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.689 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.548 ' NH2' ' CE1' ' A' ' 50' ' ' HIS . 50.7 ptt85 -172.94 162.94 4.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.489 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.8 t -128.06 127.95 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.418 ' HB1' ' OD1' ' A' ' 47' ' ' ASP . . . -93.39 110.77 48.78 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.366 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.05 -12.62 19.48 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.813 1.675 . . . . 0.0 112.516 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.2 tp -57.85 -30.52 65.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.959 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.81 30.51 1.24 Allowed Glycine 0 N--CA 1.467 0.753 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -98.74 -179.16 0.8 Allowed Pre-proline 0 N--CA 1.467 0.378 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.425 ' CD ' ' CB ' ' A' ' 47' ' ' ASP . 15.5 Cg_exo -65.53 -173.12 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.762 1.641 . . . . 0.0 111.594 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.402 HG21 ' CD2' ' A' ' 65' ' ' LEU . 10.8 mm -105.62 114.26 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.801 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.548 ' CE1' ' NH2' ' A' ' 41' ' ' ARG . 15.2 m170 -89.63 116.95 28.15 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.404 ' O ' ' O ' ' A' ' 58' ' ' LEU . 44.8 pt -124.41 148.25 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.147 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -125.81 123.96 39.88 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.865 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 p -107.44 137.03 46.23 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.765 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -38.46 -35.7 0.2 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.869 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.576 ' O ' HG13 ' A' ' 56' ' ' VAL . 3.6 mpt_? -72.51 -49.35 33.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.079 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 55' ' ' ARG . 15.7 m -162.55 -176.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 120.977 0.417 . . . . 0.0 110.991 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.2 m -99.78 145.84 27.25 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.792 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.404 ' O ' ' O ' ' A' ' 51' ' ' ILE . 60.3 tp -153.78 144.8 22.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.374 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.0 p -130.72 128.72 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.6 mt -136.95 166.19 24.22 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.85 0.357 . . . . 0.0 110.514 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -82.33 160.71 22.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.867 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -57.34 -34.59 68.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.746 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.7 -40.61 97.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.109 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -61.05 -45.9 92.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.812 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.402 ' CD2' HG21 ' A' ' 49' ' ' ILE . 10.4 mp -62.0 -42.3 99.0 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.141 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.01 -49.68 76.72 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.083 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.8 mt -68.81 -41.41 78.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.487 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.2 tp -60.48 132.11 52.86 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.715 -0.394 . . . . 0.0 109.94 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -74.73 110.87 9.38 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.446 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.3 m -137.23 162.25 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.813 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -138.84 127.42 23.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.329 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.78 125.21 28.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.856 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.464 0.259 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.082 -179.949 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.985 0.421 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.73 156.45 36.53 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.982 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 39' ' ' VAL . 37.1 Cg_endo -65.13 -31.52 54.32 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.697 2.264 . . . . 0.0 111.925 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -136.78 94.66 3.01 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.696 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.5 t -140.53 151.15 44.53 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.922 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -104.92 102.49 12.01 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.406 ' O ' ' OG ' ' A' ' 36' ' ' SER . 26.1 m0 -96.63 132.61 42.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.213 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.5 tttt -87.43 127.22 35.22 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.76 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.6 mt -81.53 122.51 36.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.213 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.9 m -104.25 -49.09 3.67 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.515 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.3 169.87 30.47 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -88.41 152.82 21.65 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.713 0.292 . . . . 0.0 110.241 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.517 ' O ' HG22 ' A' ' 18' ' ' ILE . 38.3 t -82.81 168.77 16.82 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.094 0.474 . . . . 0.0 110.782 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -66.62 -40.03 88.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.362 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.47 ' OE1' ' N ' ' A' ' 17' ' ' GLU . 52.5 mp0 -65.13 -15.47 62.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.657 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.517 HG22 ' O ' ' A' ' 15' ' ' SER . 10.6 tp -42.34 146.75 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.598 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.7 p -79.85 141.41 55.25 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.551 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -47.15 -41.42 27.11 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.927 1.751 . . . . 0.0 112.616 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.33 -57.47 9.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.821 0.343 . . . . 0.0 111.296 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -61.95 -46.25 90.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.47 0.652 . . . . 0.0 110.444 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -57.37 -43.63 83.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.114 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.53 ' NE2' ' OG ' ' A' ' 28' ' ' SER . 3.1 tm0? -60.29 -37.94 82.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.111 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -60.7 -41.96 96.25 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.178 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.447 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.4 mm? -62.59 -42.25 99.45 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.201 -0.6 . . . . 0.0 110.276 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mp -73.9 -29.77 62.24 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.474 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.53 ' OG ' ' NE2' ' A' ' 24' ' ' GLN . 49.9 m -58.7 -44.83 90.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.388 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.514 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -115.9 170.97 8.07 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.28 -179.688 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -87.11 -3.22 82.78 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 22.3 mmt -67.26 73.45 0.13 Allowed 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 120.868 0.366 . . . . 0.0 110.118 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.2 mp -99.07 169.85 7.65 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.425 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 32' ' ' LEU . 72.2 Cg_exo -48.63 -168.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.332 2.022 . . . . 0.0 112.462 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.95 7.06 56.73 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.6 m -139.54 -156.65 0.7 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.826 0.346 . . . . 0.0 110.387 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 9' ' ' TRP . 33.4 t -148.8 153.56 38.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.441 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.407 ' HB2' HG22 ' A' ' 53' ' ' THR . 45.0 p90 -128.94 155.54 45.15 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.291 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -106.42 143.81 34.01 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.523 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 5' ' ' PRO . 14.5 t -88.12 122.82 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.281 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.43 HG12 ' H ' ' A' ' 40' ' ' VAL . 2.2 p -68.31 -39.99 81.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.878 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.542 ' NH2' ' ND1' ' A' ' 50' ' ' HIS . 38.1 ptt-85 -174.69 159.87 2.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.136 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 42' ' ' VAL . 36.0 m -133.89 123.84 45.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.68 110.4 49.05 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.686 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -76.42 -11.67 18.93 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.481 2.121 . . . . 0.0 112.176 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.632 ' O ' HD23 ' A' ' 45' ' ' LEU . 1.1 tt -60.59 -33.15 72.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.645 -177.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.13 20.9 0.49 Allowed Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.03 160.22 29.59 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.33 168.03 5.45 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.878 2.386 . . . . 0.0 111.819 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.405 ' N ' ' O ' ' A' ' 60' ' ' LEU . 5.5 mm -89.63 119.77 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.884 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.542 ' ND1' ' NH2' ' A' ' 41' ' ' ARG . 12.4 m170 -95.47 122.64 38.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.887 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.7 pt -125.87 148.91 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.278 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -130.71 132.36 45.32 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.422 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 55' ' ' ARG . 1.4 p -122.63 137.1 55.0 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.0 ptt-85 -41.17 -21.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.871 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.566 ' O ' HG13 ' A' ' 56' ' ' VAL . 33.7 mmt180 -85.3 -50.57 7.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.924 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 55' ' ' ARG . 14.8 m -161.01 -176.0 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.515 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.7 p -113.29 145.27 41.32 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.396 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.9 tp -149.75 148.28 29.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.309 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.8 p -136.54 126.69 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.743 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 49' ' ' ILE . 23.3 mt -132.23 165.57 23.84 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.378 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -81.06 148.49 29.65 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.215 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -41.78 -40.81 2.16 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.961 0.41 . . . . 0.0 111.122 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -58.03 -40.58 81.23 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.563 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -62.08 -41.39 98.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.842 0.353 . . . . 0.0 110.53 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.556 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.0 mm? -62.14 -42.08 98.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.913 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.18 -41.54 97.07 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.371 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.8 mt -68.33 -43.29 77.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.987 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.5 mt -65.33 133.42 51.36 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.284 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.3 112.2 16.3 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.009 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.406 HG21 ' CE3' ' A' ' 9' ' ' TRP . 26.9 m -129.53 160.39 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.591 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -144.72 128.31 17.09 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.507 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.74 132.61 47.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.951 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.8 t . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.225 -179.618 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 . . . . . 0 CA--C 1.518 -0.261 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.24 156.58 77.97 Favored Pre-proline 0 N--CA 1.466 0.351 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.302 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 39' ' ' VAL . 52.4 Cg_exo -51.06 -35.35 50.63 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.907 1.738 . . . . 0.0 112.885 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -135.74 95.93 3.33 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.5 130.82 42.87 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.89 102.39 15.09 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.431 ' CE3' HG21 ' A' ' 70' ' ' VAL . 22.1 m0 -103.2 144.32 31.48 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.057 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -96.89 140.73 31.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.505 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.9 mt -96.94 122.03 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 O-C-N 123.263 0.352 . . . . 0.0 110.295 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.2 p -109.78 -44.7 3.78 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.761 0.315 . . . . 0.0 110.441 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 167.62 -179.33 41.11 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -97.66 152.18 19.35 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.779 0.323 . . . . 0.0 110.649 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.464 ' O ' HG22 ' A' ' 18' ' ' ILE . 2.6 m -80.05 169.87 17.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.718 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -68.8 -39.61 80.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.574 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -65.64 -14.66 61.63 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.694 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 15' ' ' SER . 10.5 tp -42.29 147.08 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.465 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.9 m -82.0 150.17 64.57 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.904 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -51.25 -39.31 62.39 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.074 1.849 . . . . 0.0 112.652 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.56 -56.77 15.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 0.0 111.374 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.576 ' CZ ' HD21 ' A' ' 68' ' ' LEU . 35.6 t80 -64.11 -47.02 81.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.513 0.673 . . . . 0.0 110.477 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -56.88 -43.79 81.63 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.029 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -63.51 -33.58 75.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.023 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -59.61 -47.37 85.83 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 29' ' ' LEU . 4.5 mm? -63.06 -42.19 99.64 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.121 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.3 tp -68.8 -34.33 75.35 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.9 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.2 t -59.69 -44.61 93.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.62 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.547 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -116.26 168.42 10.14 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.834 0.35 . . . . 0.0 110.219 -179.447 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.02 -1.08 80.11 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.6 mtt -67.78 73.6 0.17 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 120.863 0.363 . . . . 0.0 110.021 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.3 mp -95.78 167.75 12.04 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.261 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 32' ' ' LEU . 75.8 Cg_exo -46.03 -179.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.236 1.957 . . . . 0.0 112.322 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.46 7.16 11.2 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' A' ' 36' ' ' SER . 28.9 t -145.77 -175.59 4.8 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.817 0.341 . . . . 0.0 110.446 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.492 ' N ' ' OG ' ' A' ' 35' ' ' SER . 46.9 m -127.18 156.03 42.46 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.509 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -132.53 150.93 52.08 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.286 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -106.74 146.33 30.96 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.36 0.6 . . . . 0.0 110.401 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' PRO . 6.7 t -83.49 127.3 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.363 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.425 HG12 ' H ' ' A' ' 40' ' ' VAL . 2.2 p -71.13 -38.39 70.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.112 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -172.83 154.13 2.84 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.994 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 73.5 t -126.32 118.91 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.71 111.27 51.91 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.221 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -76.27 -11.2 19.27 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.148 1.899 . . . . 0.0 112.262 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 45' ' ' LEU . 10.7 mp -59.89 -31.71 70.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.646 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.7 27.93 0.71 Allowed Glycine 0 N--CA 1.466 0.697 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.84 160.21 29.06 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.23 172.06 1.01 Allowed 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.835 2.356 . . . . 0.0 111.859 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.412 ' N ' ' O ' ' A' ' 60' ' ' LEU . 7.3 mm -90.42 116.93 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.995 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.407 ' CD2' HG23 ' A' ' 59' ' ' VAL . 12.1 m170 -96.72 121.89 39.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.706 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.5 pt -129.2 147.25 33.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.632 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.414 ' OE1' ' OG ' ' A' ' 57' ' ' SER . 57.0 mm-40 -122.49 114.51 20.79 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.099 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.02 137.5 44.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.685 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -42.89 -40.28 2.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.439 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -66.23 -47.03 75.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.562 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.657 HG22 ' N ' ' A' ' 57' ' ' SER . 11.2 p -170.52 173.39 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 120.981 0.42 . . . . 0.0 110.59 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.657 ' N ' HG22 ' A' ' 56' ' ' VAL . 4.4 m -95.19 152.8 18.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.38 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.3 tp -155.66 145.33 21.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.019 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.407 HG23 ' CD2' ' A' ' 50' ' ' HIS . 4.8 p -137.99 126.08 30.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 49' ' ' ILE . 19.0 mt -132.37 -178.63 5.0 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.499 ' CD ' ' N ' ' A' ' 61' ' ' ARG . 9.8 mpt_? -94.85 150.97 19.62 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.348 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -42.07 -43.34 3.21 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.828 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.47 -40.02 85.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.466 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -59.42 -43.08 93.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.51 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.532 HD22 ' N ' ' A' ' 65' ' ' LEU . 3.8 mm? -62.81 -41.87 99.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.812 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.3 -46.03 89.68 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.229 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.9 mp -67.3 -40.25 86.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.675 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.576 HD21 ' CZ ' ' A' ' 22' ' ' TYR . 21.5 mt -63.47 128.02 33.93 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.204 -0.599 . . . . 0.0 110.173 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -77.5 104.87 8.28 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.649 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.431 HG21 ' CE3' ' A' ' 9' ' ' TRP . 31.0 m -125.05 160.3 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.424 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -142.86 134.67 26.81 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.36 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.16 132.78 47.8 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.601 -0.44 . . . . 0.0 109.857 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.553 -179.701 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 . . . . . 0 CA--C 1.518 -0.288 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 p -130.77 150.52 76.7 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 121.044 -0.263 . . . . 0.0 110.454 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 39' ' ' VAL . 42.6 Cg_exo -50.75 -49.39 16.96 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.794 1.662 . . . . 0.0 113.147 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -134.18 103.35 5.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.065 0.459 . . . . 0.0 111.165 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.72 144.42 41.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.529 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.46 101.89 14.63 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.574 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 23.8 m0 -100.36 141.23 33.48 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.015 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -95.25 130.37 42.03 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.3 mt -83.52 121.26 36.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.243 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.6 m -103.06 -49.64 3.71 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.812 0.339 . . . . 0.0 110.648 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.16 169.89 27.25 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -85.34 158.33 20.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.901 0.381 . . . . 0.0 110.396 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.413 ' O ' HG22 ' A' ' 18' ' ' ILE . 47.2 t -79.87 169.44 17.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.72 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -69.67 -39.61 76.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.841 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -74.6 -7.62 53.74 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.458 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.413 HG22 ' O ' ' A' ' 15' ' ' SER . 10.4 tp -42.46 148.6 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.648 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.1 m -75.16 154.14 86.37 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.355 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.98 -25.79 51.68 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.516 2.144 . . . . 0.0 112.137 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.0 -55.93 9.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.18 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -63.45 -45.65 89.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.189 0.518 . . . . 0.0 110.596 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -58.11 -45.54 87.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.136 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 17.1 tm0? -62.24 -33.73 75.16 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -59.21 -46.79 87.5 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.695 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.6 mm? -62.03 -39.54 92.67 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.229 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.9 tp -59.95 -42.38 93.91 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.227 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.0 t -82.92 -9.43 59.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.296 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.7 tp -94.91 124.67 39.09 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.937 0.398 . . . . 0.0 110.367 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.6 -19.45 74.76 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 45.1 ttp -89.51 73.13 7.84 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.632 0.73 . . . . 0.0 109.306 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' A' ' 33' ' ' PRO . 9.5 mt -80.51 156.91 73.08 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.983 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 32' ' ' LEU . 75.6 Cg_exo -37.91 162.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.476 2.117 . . . . 0.0 112.444 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.16 3.75 17.02 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 96.4 p -129.3 -156.66 0.77 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.767 0.318 . . . . 0.0 110.346 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.5 t -145.3 151.99 39.21 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.702 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -132.62 159.43 39.57 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.356 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -111.38 146.37 37.26 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.733 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 5' ' ' PRO . 51.2 t -90.45 125.66 43.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.146 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -66.83 -42.22 88.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 50.1 ptt85 -174.28 156.75 2.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.076 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.57 ' O ' HG23 ' A' ' 42' ' ' VAL . 32.9 m -128.92 117.23 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.09 110.31 47.32 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 120.951 -0.299 . . . . 0.0 110.413 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.67 -11.58 18.49 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.181 1.921 . . . . 0.0 112.187 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tp -57.15 -31.08 65.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.973 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.62 22.98 0.66 Allowed Glycine 0 N--CA 1.465 0.604 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.35 159.82 30.3 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -59.84 173.46 1.69 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.763 2.309 . . . . 0.0 111.761 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 60' ' ' LEU . 8.2 mm -92.96 114.63 30.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.093 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.499 ' CD2' HG23 ' A' ' 59' ' ' VAL . 12.4 m170 -96.0 121.93 38.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.093 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.7 pt -126.26 149.37 31.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.286 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -129.32 135.15 48.37 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.553 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -126.69 145.59 50.52 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.797 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -50.09 -38.6 39.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.169 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.0 tpm_? -67.74 -43.7 79.31 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.772 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.723 HG22 ' H ' ' A' ' 57' ' ' SER . 11.8 p -170.74 176.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.584 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.723 ' H ' HG22 ' A' ' 56' ' ' VAL . 47.4 t -105.87 149.2 26.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.43 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.4 tp -152.77 149.4 28.3 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.205 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.499 HG23 ' CD2' ' A' ' 50' ' ' HIS . 10.2 p -128.93 128.22 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.64 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.424 HD13 ' OD1' ' A' ' 64' ' ' ASP . 58.7 mt -132.34 162.59 30.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.269 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -85.58 171.9 11.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.717 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -61.9 -40.07 94.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.625 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.48 -39.26 87.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.467 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.424 ' OD1' HD13 ' A' ' 60' ' ' LEU . 6.5 t70 -57.17 -47.13 81.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.345 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.62 -40.88 98.35 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.661 -0.416 . . . . 0.0 109.924 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.07 -54.11 48.94 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.499 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 67' ' ' LEU . 11.1 mp -69.53 -41.57 75.8 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.153 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 38.7 tp -59.0 130.32 46.44 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -83.84 114.03 21.36 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 110.23 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.26 158.43 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.912 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -144.11 141.81 30.23 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.759 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.1 145.4 51.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.098 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.149 -179.741 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 . . . . . 0 CA--C 1.52 -0.197 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.15 155.29 77.58 Favored Pre-proline 0 N--CA 1.466 0.357 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.19 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 39' ' ' VAL . 50.1 Cg_endo -67.68 -23.12 42.84 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.638 2.225 . . . . 0.0 112.307 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -137.86 94.4 2.89 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.689 0.281 . . . . 0.0 110.582 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.12 130.7 27.26 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.9 101.94 14.03 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.443 ' CE3' HG21 ' A' ' 70' ' ' VAL . 23.0 m0 -101.76 145.86 28.56 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.23 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -102.8 128.51 49.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.88 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.0 mt -81.03 123.74 37.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.337 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 7.8 p -111.47 -15.17 13.59 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.55 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.34 178.28 16.84 Favored Glycine 0 N--CA 1.465 0.598 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.421 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.5 p90 -98.58 152.17 19.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.85 0.357 . . . . 0.0 110.119 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.478 ' O ' HG22 ' A' ' 18' ' ' ILE . 5.1 t -80.21 168.71 18.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.463 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 16' ' ' ARG . 37.1 mtp-105 -68.56 -39.52 81.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.943 0.401 . . . . 0.0 110.662 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -64.24 -17.08 63.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.616 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.478 HG22 ' O ' ' A' ' 15' ' ' SER . 10.7 tp -41.92 147.89 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.476 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.5 t -80.96 146.33 59.03 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.699 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -49.67 -41.05 46.61 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.874 1.716 . . . . 0.0 112.755 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.52 -56.27 20.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.244 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -61.94 -46.75 87.97 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.48 0.657 . . . . 0.0 110.396 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -57.34 -44.08 83.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.848 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 28' ' ' SER . 5.9 tm0? -60.12 -38.39 82.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.361 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -57.87 -43.92 86.29 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.538 HD12 ' HD3' ' A' ' 33' ' ' PRO . 4.6 mm? -63.51 -40.84 98.1 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.269 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.4 mt -80.74 -18.14 48.74 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.885 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 24' ' ' GLN . 38.8 t -61.04 -43.97 98.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.077 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.596 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -115.82 154.53 29.5 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.398 -179.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.65 5.97 42.51 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.512 ' N ' ' SD ' ' A' ' 31' ' ' MET . 0.0 OUTLIER -89.27 74.73 7.86 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -82.42 171.24 12.33 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.355 -178.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.538 ' HD3' HD12 ' A' ' 26' ' ' LEU . 63.3 Cg_exo -48.47 -171.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.321 2.014 . . . . 0.0 112.206 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.01 11.25 8.46 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 81.8 p -139.24 -156.83 0.71 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.921 0.391 . . . . 0.0 110.413 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.8 p -141.15 163.0 34.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.468 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -139.51 160.93 38.72 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.194 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.413 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 24.2 p30 -119.22 151.19 38.8 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.24 0.543 . . . . 0.0 110.429 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' PRO . 61.0 t -88.15 127.53 41.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.279 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -69.06 -41.3 81.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.069 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -173.56 162.07 4.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.964 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 68.0 t -130.14 124.2 57.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.39 110.56 49.39 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.28 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.72 -11.31 20.22 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.29 1.994 . . . . 0.0 112.331 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.529 HD22 ' N ' ' A' ' 45' ' ' LEU . 4.1 mm? -60.65 -31.43 70.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.708 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.5 24.76 0.82 Allowed Glycine 0 N--CA 1.465 0.606 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.1 160.05 29.92 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.05 173.15 0.62 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.805 2.336 . . . . 0.0 111.665 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.437 ' N ' ' O ' ' A' ' 60' ' ' LEU . 8.5 mm -93.48 114.26 29.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -92.17 122.33 34.55 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.891 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 58' ' ' LEU . 44.4 pt -126.84 151.91 34.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.574 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.413 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 95.1 mt-10 -130.95 134.46 46.76 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.248 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.22 141.85 51.63 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.996 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.406 ' H ' ' HG3' ' A' ' 54' ' ' ARG . 84.0 mtm180 -40.89 -36.53 0.66 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.36 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -65.54 -50.39 65.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.87 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.685 HG22 ' H ' ' A' ' 57' ' ' SER . 8.5 p -172.39 174.56 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-O 120.905 0.383 . . . . 0.0 110.808 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.685 ' H ' HG22 ' A' ' 56' ' ' VAL . 89.8 p -89.07 150.09 22.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.233 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 51' ' ' ILE . 63.9 tp -159.96 145.42 15.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.783 0.325 . . . . 0.0 110.342 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.8 p -126.5 129.96 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 49' ' ' ILE . 67.2 mt -132.93 161.41 34.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.55 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -85.25 165.29 17.46 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.706 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -59.11 -35.85 74.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.485 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.82 -40.41 95.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.595 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -60.64 -46.4 90.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.723 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.406 ' N ' HD12 ' A' ' 65' ' ' LEU . 9.6 mp -62.71 -40.26 96.6 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.67 -38.62 91.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.517 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.1 mt -82.32 -54.97 4.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.031 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 66.2 mt -45.81 137.61 5.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.657 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.43 ' O ' ' OG1' ' A' ' 12' ' ' THR . 97.2 mt-10 -80.02 111.56 16.49 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.295 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.443 HG21 ' CE3' ' A' ' 9' ' ' TRP . 25.7 m -135.97 159.04 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.395 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -141.54 131.58 24.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.718 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.22 142.36 54.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.115 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t . . . . . 0 C--N 1.332 -0.187 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.258 -179.964 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 . . . . . 0 CA--C 1.52 -0.185 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.22 156.51 73.71 Favored Pre-proline 0 N--CA 1.466 0.33 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.174 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 39' ' ' VAL . 41.4 Cg_endo -66.69 -27.75 44.7 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.683 2.255 . . . . 0.0 112.322 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -136.39 94.91 3.08 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.582 0.229 . . . . 0.0 110.408 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.21 128.77 24.46 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.13 101.52 14.18 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 25.2 m0 -99.57 140.59 33.54 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.213 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -98.26 120.44 38.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.882 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.7 mt -74.65 128.52 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.327 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.2 m -110.13 -47.41 3.32 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.567 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 170.62 166.3 29.31 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -87.42 157.25 19.27 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.84 0.352 . . . . 0.0 110.106 179.673 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 67' ' ' LEU . 13.0 m -73.77 163.85 27.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.519 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -69.82 -40.76 75.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.376 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -68.95 -12.19 61.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.355 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.456 HG22 ' O ' ' A' ' 15' ' ' SER . 10.3 tp -41.37 146.95 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.614 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.26 156.97 83.46 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.352 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.61 -30.57 70.49 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.777 2.318 . . . . 0.0 111.756 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.78 -56.8 12.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.881 0.372 . . . . 0.0 111.24 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -61.93 -45.46 93.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.364 0.602 . . . . 0.0 110.442 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -57.26 -43.16 82.75 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.946 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.513 ' O ' ' N ' ' A' ' 28' ' ' SER . 63.5 tp60 -61.51 -38.22 86.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.145 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -59.75 -41.47 91.08 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.456 -0.498 . . . . 0.0 109.819 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.608 HD12 ' HD3' ' A' ' 33' ' ' PRO . 4.4 mm? -64.04 -39.03 93.18 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.425 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.8 tt -82.34 -24.47 34.54 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.071 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 24' ' ' GLN . 96.5 p -60.84 -45.78 93.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.772 0.32 . . . . 0.0 111.484 -178.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.5 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -103.43 161.69 13.64 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.978 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.98 31.28 3.42 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 65.6 mtt -111.65 73.08 0.8 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.473 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.2 mm? -82.84 153.06 67.09 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.648 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.608 ' HD3' HD12 ' A' ' 26' ' ' LEU . 77.8 Cg_exo -39.62 167.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.459 2.106 . . . . 0.0 111.918 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.39 -16.19 12.84 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.811 -0.915 . . . . 0.0 110.811 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.8 m -100.18 -170.76 1.92 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.731 0.301 . . . . 0.0 110.302 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 73.4 m -132.39 156.34 46.84 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.481 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -139.17 157.06 46.61 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.241 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -112.2 146.45 38.08 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.468 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 5' ' ' PRO . 17.5 t -86.3 129.7 37.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.434 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -70.31 -40.24 77.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.146 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -173.77 161.45 3.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.114 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 69.5 t -134.47 110.61 13.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.69 111.55 53.08 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.47 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.518 ' C ' ' H ' ' A' ' 46' ' ' GLY . 60.4 Cg_endo -75.82 -12.13 19.97 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.353 2.035 . . . . 0.0 112.135 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.584 ' N ' HD12 ' A' ' 45' ' ' LEU . 10.2 mp -55.09 -3.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.812 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 103.37 26.62 6.83 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.27 159.58 30.92 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-O 121.028 0.442 . . . . 0.0 109.997 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.95 177.54 0.5 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.758 2.305 . . . . 0.0 111.521 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.473 HG21 ' CD2' ' A' ' 65' ' ' LEU . 10.2 mm -95.92 115.42 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.269 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.455 ' CD2' HG23 ' A' ' 59' ' ' VAL . 11.9 m170 -98.71 122.39 41.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.838 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 35.7 pt -126.77 148.0 31.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.748 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -134.36 111.96 10.61 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.875 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 54' ' ' ARG . 1.3 p -83.65 175.26 9.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.683 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 53' ' ' THR . 99.8 mtt180 -33.53 -53.3 0.41 Allowed 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.548 0.53 . . . . 0.0 111.548 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -143.04 31.41 1.4 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.351 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 t -138.48 134.01 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 120.369 -0.533 . . . . 0.0 110.454 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.7 m -111.12 136.94 49.42 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.195 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.2 tp -156.42 147.27 21.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.245 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.455 HG23 ' CD2' ' A' ' 50' ' ' HIS . 5.9 p -127.5 126.03 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.846 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.0 mt -132.18 167.72 19.28 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.289 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -85.72 166.32 16.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.517 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -60.53 -35.79 76.84 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.999 0.428 . . . . 0.0 110.549 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.27 -41.13 98.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.274 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -57.5 -47.13 82.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.535 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.473 ' CD2' HG21 ' A' ' 49' ' ' ILE . 11.0 mp -61.79 -41.09 97.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.095 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.09 -52.01 67.01 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.598 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.465 ' O ' ' OG ' ' A' ' 15' ' ' SER . 10.8 mp -68.8 -42.34 77.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.038 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 tp -56.43 132.22 50.61 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.286 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -78.91 110.03 13.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.224 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.71 159.05 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.418 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -142.86 133.09 24.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.608 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.23 145.45 54.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.173 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.9 t . . . . . 0 C--N 1.332 -0.17 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.191 -179.959 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.5 OUTLIER . . . . . 0 CA--C 1.519 -0.226 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.68 164.55 39.02 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 39' ' ' VAL . 31.3 Cg_exo -55.64 -36.14 94.22 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.878 1.719 . . . . 0.0 112.687 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 6' ' ' ASP . 47.0 p-10 -136.74 94.38 2.98 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.796 0.331 . . . . 0.0 110.533 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.29 130.52 33.1 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.95 102.6 15.37 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -105.96 141.33 37.54 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.912 0.387 . . . . 0.0 110.464 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -94.52 147.86 22.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.838 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.3 mt -101.63 115.83 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.0 m -97.73 -43.58 7.11 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.852 0.358 . . . . 0.0 110.42 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.65 179.52 34.52 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.9 OUTLIER -95.84 149.0 22.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.938 0.399 . . . . 0.0 110.506 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.425 ' O ' HG22 ' A' ' 18' ' ' ILE . 4.3 m -78.28 172.16 13.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.545 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -69.49 -40.54 76.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.618 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -66.8 -13.79 61.91 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.968 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.425 HG22 ' O ' ' A' ' 15' ' ' SER . 10.4 tp -41.53 148.49 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.715 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.05 155.21 86.52 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.302 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.99 -31.02 66.8 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.645 2.23 . . . . 0.0 112.216 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.44 -55.34 18.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.902 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -62.82 -43.51 98.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.435 0.636 . . . . 0.0 110.513 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -58.51 -43.32 89.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.6 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.535 ' O ' ' N ' ' A' ' 28' ' ' SER . 18.8 mm-40 -63.36 -35.18 79.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.043 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -59.74 -41.95 92.08 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.368 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.534 HD12 ' HD3' ' A' ' 33' ' ' PRO . 4.6 mm? -70.06 -39.0 75.94 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.748 178.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp -81.91 -15.48 53.76 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.432 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 24' ' ' GLN . 2.8 m -57.14 -29.73 63.83 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.596 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.886 HD13 ' N ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -134.69 -176.92 4.39 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.696 0.284 . . . . 0.0 110.723 179.513 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.39 -9.2 56.97 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 79.2 mtp -76.08 75.13 2.94 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.5 OUTLIER -83.04 171.82 10.83 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.034 -179.275 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.534 ' HD3' HD12 ' A' ' 26' ' ' LEU . 77.7 Cg_exo -48.74 -168.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.523 2.149 . . . . 0.0 112.589 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.03 11.99 7.27 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.6 p -136.12 -158.11 0.84 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.761 0.315 . . . . 0.0 110.214 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 82.5 p -138.68 161.56 36.84 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.761 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -141.21 159.4 42.29 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.183 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 47.6 p-10 -117.38 151.16 37.59 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.196 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 5' ' ' PRO . 61.1 t -87.88 126.34 41.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.283 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.413 HG12 ' H ' ' A' ' 40' ' ' VAL . 1.8 p -68.72 -43.31 83.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.941 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -173.23 147.26 1.53 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.391 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 42' ' ' VAL . 20.9 m -115.99 125.64 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.36 110.39 48.35 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.805 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.1 -12.19 17.6 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.854 1.703 . . . . 0.0 112.315 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.8 mt -60.6 -31.02 70.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.011 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.34 26.34 0.89 Allowed Glycine 0 N--CA 1.469 0.869 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.02 160.27 28.8 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -54.81 175.24 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.603 2.202 . . . . 0.0 111.645 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.4 mm -94.64 113.68 29.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.018 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 16.2 m170 -93.95 119.65 33.14 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.1 pt -127.17 150.43 33.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.368 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.429 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 8.6 tm-20 -126.25 132.31 51.74 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.214 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.08 138.4 54.46 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.924 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -40.59 -38.58 0.89 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.332 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -67.13 -48.66 67.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.744 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.637 HG22 ' N ' ' A' ' 57' ' ' SER . 8.5 p -171.5 172.07 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.933 0.397 . . . . 0.0 110.87 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.637 ' N ' HG22 ' A' ' 56' ' ' VAL . 10.7 p -86.26 151.26 23.76 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.461 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.1 tp -155.66 146.45 22.2 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.884 0.373 . . . . 0.0 110.299 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.6 p -125.65 130.9 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.64 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.4 mt -134.71 163.2 30.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.576 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 83.6 mtt85 -92.08 174.8 7.13 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.972 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -62.05 -44.67 96.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.092 0.472 . . . . 0.0 110.623 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -61.63 -38.02 86.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.627 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -59.47 -48.36 81.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.259 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.433 ' CD2' ' CE1' ' A' ' 3' ' ' TYR . 10.5 mp -62.92 -41.77 99.57 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.113 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.36 -50.94 71.85 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.269 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.0 mt -68.83 -41.92 77.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.239 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.2 tp -62.19 136.21 57.83 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -84.9 116.37 23.3 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.871 0.367 . . . . 0.0 110.427 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.0 m -133.28 161.45 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.527 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -145.59 145.98 31.2 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.463 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.96 135.92 45.07 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.8 t . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.787 0.327 . . . . 0.0 110.289 -179.742 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 . . . . . 0 CA--C 1.52 -0.196 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.07 152.34 38.55 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.314 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -49.9 -44.05 38.58 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.852 1.701 . . . . 0.0 112.816 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -135.47 100.64 4.56 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.935 0.398 . . . . 0.0 110.835 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.35 143.45 42.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.389 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -96.48 102.45 14.24 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.576 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 26.5 m0 -98.51 145.77 26.45 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.377 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -100.34 132.58 45.64 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.788 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 36.1 mt -82.37 124.56 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.21 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.5 m -108.03 -49.55 3.19 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.81 0.338 . . . . 0.0 110.804 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.11 -178.88 40.54 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 2.3 p90 -102.52 144.29 31.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.909 0.385 . . . . 0.0 110.464 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.41 ' O ' HG22 ' A' ' 18' ' ' ILE . 19.7 m -75.31 171.36 14.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.453 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -68.78 -38.48 80.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.785 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -71.7 -10.27 59.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.482 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 15' ' ' SER . 10.0 tp -41.56 147.51 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.518 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.2 t -78.64 140.72 59.54 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.356 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -48.25 -40.24 35.09 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.902 1.735 . . . . 0.0 112.89 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.53 -58.14 8.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.897 0.379 . . . . 0.0 111.364 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -62.07 -47.2 85.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.55 0.691 . . . . 0.0 110.471 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -56.51 -43.16 79.5 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.878 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -59.73 -37.53 79.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.182 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -59.47 -43.03 93.32 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.633 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.5 mm? -62.4 -42.62 99.57 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.967 178.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 48.7 mt -70.85 -32.55 69.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.917 0.389 . . . . 0.0 110.928 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 64.7 m -58.0 -44.12 87.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.399 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.564 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -117.94 166.24 12.74 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.161 -179.777 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.4 8.49 79.73 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 16.1 mmt -78.4 73.37 4.96 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.5 mp -91.4 167.84 14.79 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.089 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 32' ' ' LEU . 71.6 Cg_exo -44.33 176.69 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 122.292 1.994 . . . . 0.0 112.363 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.34 1.58 15.91 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.434 ' OG ' ' N ' ' A' ' 36' ' ' SER . 32.7 t -134.48 -155.85 0.69 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.903 0.382 . . . . 0.0 110.321 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.434 ' N ' ' OG ' ' A' ' 35' ' ' SER . 27.3 p -150.71 161.94 41.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.554 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -138.38 156.49 47.55 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.293 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -108.95 145.72 35.0 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.496 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.7 t -89.85 126.72 42.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.434 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -67.52 -42.31 86.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.114 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -173.87 156.93 2.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.059 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.539 ' O ' HG23 ' A' ' 42' ' ' VAL . 30.8 m -126.05 122.11 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.75 110.27 48.43 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.511 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -76.86 -11.88 18.08 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.199 1.933 . . . . 0.0 112.283 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.1 mt -59.69 -31.47 69.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.026 -178.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.83 25.01 0.78 Allowed Glycine 0 N--CA 1.466 0.673 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.52 160.13 29.47 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.4 169.58 2.19 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.898 2.399 . . . . 0.0 111.638 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.1 mm -92.77 113.65 28.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.99 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.479 ' CD2' HG23 ' A' ' 59' ' ' VAL . 13.2 m170 -95.6 121.25 37.09 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.909 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 48.0 pt -127.93 149.87 33.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.428 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -118.97 125.51 49.6 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.173 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.0 p -111.77 136.94 50.36 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -39.29 -40.23 0.74 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.804 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.667 ' O ' HG13 ' A' ' 56' ' ' VAL . 56.6 ttt85 -67.88 -49.71 60.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.21 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 55' ' ' ARG . 4.4 m -164.77 -176.68 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.556 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.0 t -96.23 136.96 36.0 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.488 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.5 tp -138.04 145.27 41.61 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.987 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.479 HG23 ' CD2' ' A' ' 50' ' ' HIS . 12.9 p -126.42 130.46 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.694 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.8 mt -134.3 162.26 32.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.475 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -91.89 165.03 13.44 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.623 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.698 ' HB3' ' HZ2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -57.0 -40.93 77.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.072 0.463 . . . . 0.0 110.635 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -62.22 -36.92 83.44 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.793 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.29 -42.85 99.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.278 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.7 mp -63.06 -41.96 99.59 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.884 -0.414 . . . . 0.0 109.884 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.31 -50.77 72.43 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.146 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.5 mt -69.2 -40.48 78.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.004 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.3 tp -62.58 134.02 55.76 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -85.13 112.47 20.72 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.003 0.43 . . . . 0.0 110.118 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.0 m -132.5 158.99 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.63 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -142.92 141.68 31.53 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.823 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.61 150.55 42.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.164 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.6 t . . . . . 0 N--CA 1.466 0.375 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.197 -179.933 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 . . . . . 0 CA--C 1.518 -0.26 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.456 ' OG1' ' CG2' ' A' ' 7' ' ' THR . 15.4 p -132.39 148.07 68.2 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.484 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 39' ' ' VAL . 44.9 Cg_endo -66.22 -31.29 44.78 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.392 2.062 . . . . 0.0 112.473 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -136.23 93.99 2.97 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.725 0.298 . . . . 0.0 111.318 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.456 ' CG2' ' OG1' ' A' ' 4' ' ' THR . 0.9 OUTLIER -141.77 149.16 40.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.368 178.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -102.78 102.05 12.16 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 25.3 m0 -97.46 142.74 28.94 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.894 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -100.68 123.66 45.19 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.5 mt -79.6 120.43 30.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.904 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.6 p -104.08 -15.66 15.5 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.348 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.47 164.66 10.41 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.88 169.51 17.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.9 t -84.03 166.42 17.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.447 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.9 ptt-85 -70.58 -37.03 73.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.556 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -81.09 -5.42 57.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.028 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.6 tp -41.15 141.75 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.386 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.8 m -80.02 150.88 72.52 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.806 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.06 -38.84 60.47 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.9 1.733 . . . . 0.0 112.544 179.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.63 -58.12 8.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.437 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -63.32 -48.65 77.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.346 0.594 . . . . 0.0 110.555 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -57.93 -40.76 81.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.04 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 28' ' ' SER . 12.1 tm0? -61.8 -39.44 91.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.207 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.51 -43.73 96.77 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.253 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.602 HD12 ' HD3' ' A' ' 33' ' ' PRO . 4.5 mm? -63.47 -39.21 93.86 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.283 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.5 tt -81.13 -23.18 38.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.958 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.469 ' N ' ' O ' ' A' ' 24' ' ' GLN . 40.3 t -61.22 -45.24 95.38 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.167 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.515 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -107.71 160.47 15.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.173 -179.554 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.04 33.92 2.4 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 36.5 tpp -112.8 74.01 0.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.464 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.2 mm? -81.86 153.58 70.06 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.075 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.602 ' HD3' HD12 ' A' ' 26' ' ' LEU . 66.4 Cg_exo -40.12 169.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 122.78 2.32 . . . . 0.0 112.439 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.15 12.11 7.13 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 90.2 p -126.63 -171.36 2.39 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 73.5 m -131.45 157.47 43.39 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.72 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -137.88 159.96 40.58 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.296 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -117.35 145.85 43.77 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.893 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 5' ' ' PRO . 57.5 t -86.06 127.66 40.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.213 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.417 ' H ' HG12 ' A' ' 40' ' ' VAL . 2.4 p -70.65 -41.37 77.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.209 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -176.41 171.31 2.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.818 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.56 130.65 37.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.36 109.61 43.82 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.716 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.511 ' C ' ' H ' ' A' ' 46' ' ' GLY . 33.9 Cg_exo -60.57 -21.86 70.26 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 121.793 1.662 . . . . 0.0 112.334 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.5 mt -52.99 -5.72 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.634 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 90.8 33.95 8.06 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.7 169.75 8.11 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -54.51 -171.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 121.807 1.672 . . . . 0.0 111.939 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 60' ' ' LEU . 9.5 mm -111.89 109.67 29.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.744 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.406 ' O ' HG12 ' A' ' 40' ' ' VAL . 12.0 m170 -85.71 125.73 33.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.161 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.6 pt -127.66 151.22 34.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.524 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.4 ' OE1' ' C ' ' A' ' 52' ' ' GLU . 1.9 pp20? -130.7 136.86 49.19 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.212 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 56' ' ' VAL . 2.9 p -128.87 143.68 50.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.09 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -49.28 -37.45 23.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.659 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -72.74 -37.82 67.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.91 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.779 HG22 ' H ' ' A' ' 57' ' ' SER . 3.5 p -169.53 -176.1 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.824 0.345 . . . . 0.0 110.207 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.779 ' H ' HG22 ' A' ' 56' ' ' VAL . 36.5 p -130.65 150.49 51.81 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 59' ' ' VAL . 5.8 tt -163.81 164.95 23.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.354 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.514 ' N ' HD23 ' A' ' 58' ' ' LEU . 3.6 p -126.47 137.79 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.828 0.347 . . . . 0.0 110.419 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 49' ' ' ILE . 11.9 mt -134.11 152.07 51.67 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.704 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -77.83 162.05 27.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.508 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -58.4 -39.49 79.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.862 0.363 . . . . 0.0 110.34 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.89 -39.68 92.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.4 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -59.87 -45.94 90.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.516 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 mp -62.02 -41.8 98.47 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.341 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.12 -51.76 68.0 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.18 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.23 -39.95 82.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.944 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.9 tp -60.02 128.92 39.24 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -75.59 110.28 9.85 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.423 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.6 m -133.24 161.4 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.64 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -143.28 138.35 29.51 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.395 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.81 134.13 44.78 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 80.9 t . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.383 -179.868 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 . . . . . 0 CA--C 1.518 -0.274 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 p -130.09 152.49 80.15 Favored Pre-proline 0 N--CA 1.466 0.343 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 39' ' ' VAL . 52.6 Cg_exo -50.45 -41.45 51.96 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.972 1.781 . . . . 0.0 112.586 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -134.37 100.59 4.72 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.003 0.43 . . . . 0.0 111.026 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 t -137.35 144.52 42.56 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.296 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.36 102.43 14.41 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.745 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 14.5 m0 -100.62 142.59 31.89 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.345 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -97.49 139.61 33.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.632 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.4 mt -98.84 114.88 37.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 m -97.26 -40.42 8.77 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.44 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.65 164.77 21.79 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.65 162.32 27.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.78 0.324 . . . . 0.0 110.172 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.487 ' O ' HG22 ' A' ' 18' ' ' ILE . 5.8 t -78.69 163.45 25.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.518 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 49.6 ptt85 -68.67 -37.62 79.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -70.08 -14.65 62.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.603 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 15' ' ' SER . 10.8 tp -41.94 145.53 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.404 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 t -84.98 149.84 54.13 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.515 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -48.94 -37.12 36.24 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.952 1.768 . . . . 0.0 112.394 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.38 -58.48 7.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.485 -178.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -63.45 -46.61 85.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.427 0.632 . . . . 0.0 110.668 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -57.49 -43.32 84.07 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.936 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -63.42 -37.79 88.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.216 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -59.06 -45.45 90.75 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.884 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.446 ' HA ' HD13 ' A' ' 26' ' ' LEU . 4.4 mm? -62.34 -43.52 98.63 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.184 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.3 tp -63.64 -42.42 98.15 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.536 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.6 m -72.32 -39.73 67.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.453 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.734 HD23 ' N ' ' A' ' 30' ' ' GLY . 1.7 tt -82.5 132.1 35.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.774 -178.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.734 ' N ' HD23 ' A' ' 29' ' ' LEU . . . -73.26 32.21 0.8 Allowed Glycine 0 N--CA 1.462 0.427 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.526 ' CB ' HD22 ' A' ' 29' ' ' LEU . 11.3 tpt -124.67 72.7 1.22 Allowed 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.0 mm? -81.62 152.01 69.08 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.106 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 32' ' ' LEU . 72.5 Cg_exo -40.77 169.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 122.676 2.251 . . . . 0.0 112.491 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.72 -17.92 15.35 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.5 m -103.36 -169.44 1.65 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.827 0.346 . . . . 0.0 110.269 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.6 m -132.17 155.58 47.94 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.579 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -132.07 155.25 48.41 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.027 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -112.81 145.14 41.14 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.364 0.602 . . . . 0.0 110.858 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 5' ' ' PRO . 58.6 t -83.54 127.43 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.14 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 50' ' ' HIS . 2.3 p -70.42 -39.3 76.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.132 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -173.67 160.56 3.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.564 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 70.5 t -136.17 112.11 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.64 109.81 45.59 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 119.494 -0.289 . . . . 0.0 110.928 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.542 ' C ' ' H ' ' A' ' 46' ' ' GLY . 31.7 Cg_exo -57.81 -12.52 12.09 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 121.838 1.692 . . . . 0.0 112.156 178.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 82.0 mt -51.58 -5.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.819 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.542 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 89.11 31.69 11.64 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.34 162.39 22.8 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -52.96 -170.74 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.885 1.723 . . . . 0.0 111.876 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.6 mm -109.64 113.57 44.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.428 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.489 ' O ' HG12 ' A' ' 40' ' ' VAL . 16.6 m170 -96.62 127.75 42.91 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.433 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.1 pt -127.33 149.61 32.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.654 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -135.69 131.55 35.82 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.503 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 55' ' ' ARG . 2.7 p -125.52 137.48 53.94 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.074 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -39.05 -24.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.755 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.539 ' O ' HG13 ' A' ' 56' ' ' VAL . 84.8 mtt85 -84.96 -49.86 7.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.208 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 55' ' ' ARG . 16.0 m -161.2 -174.87 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.474 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.8 p -131.05 151.76 51.07 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.637 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.2 tp -154.21 151.91 29.73 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.274 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.455 HG22 ' CD2' ' A' ' 50' ' ' HIS . 45.0 t -118.91 129.5 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.1 mt -137.79 152.26 48.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.467 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.8 tpp85 -81.22 162.79 23.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.462 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -57.7 -37.59 73.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.021 0.438 . . . . 0.0 110.502 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -61.57 -41.24 97.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.175 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.13 -46.02 91.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.371 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.6 mp -60.92 -40.96 95.16 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.182 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.56 -51.37 69.74 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.454 -0.499 . . . . 0.0 110.445 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.99 -42.61 80.5 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.382 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.3 mt -60.92 134.55 57.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.304 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -78.01 108.06 11.01 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.758 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.2 m -131.03 160.71 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.806 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -147.72 145.75 28.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.514 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.37 135.77 53.74 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 C--N 1.331 -0.226 0 CA-C-O 120.854 0.359 . . . . 0.0 110.438 -179.499 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.67 154.59 59.62 Favored Pre-proline 0 N--CA 1.467 0.395 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.45 -32.9 59.38 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.477 2.118 . . . . 0.0 112.085 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 6' ' ' ASP . 47.8 p-10 -136.72 93.77 2.9 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.928 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.5 t -140.69 151.04 44.23 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.093 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -100.71 102.45 13.56 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 22.9 m0 -98.93 129.4 45.26 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.247 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -85.66 136.31 33.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.877 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.1 mt -91.2 119.07 37.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.1 m -102.16 -43.01 5.86 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.827 0.346 . . . . 0.0 110.33 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.06 -174.1 33.98 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.7 OUTLIER -95.0 157.1 16.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.901 0.381 . . . . 0.0 110.325 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.413 ' O ' HG22 ' A' ' 18' ' ' ILE . 6.8 t -85.23 171.89 11.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.599 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.409 ' N ' ' OG ' ' A' ' 15' ' ' SER . 89.6 mtm180 -68.48 -38.28 80.87 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.869 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -75.81 -6.01 48.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.434 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.413 HG22 ' O ' ' A' ' 15' ' ' SER . 9.3 tp -41.9 147.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.601 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.45 155.66 87.49 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.436 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.32 -30.1 63.44 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.535 2.156 . . . . 0.0 112.028 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.89 -53.46 31.99 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.004 0.43 . . . . 0.0 111.161 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -63.68 -46.33 86.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.342 0.591 . . . . 0.0 110.268 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -56.46 -44.51 80.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.96 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 28' ' ' SER . 39.5 mm-40 -64.07 -31.57 72.8 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -59.09 -48.91 79.87 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.469 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.453 HD22 ' N ' ' A' ' 26' ' ' LEU . 4.5 mm? -64.7 -40.7 95.81 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.104 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.2 tp -69.37 -34.33 74.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.219 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 24' ' ' GLN . 11.9 t -59.44 -44.67 92.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.4 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.548 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -116.36 167.9 10.62 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.269 -179.631 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.81 7.91 80.55 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 94.2 mtp -77.6 73.96 4.16 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.4 mp -93.77 169.21 10.41 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.576 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 32' ' ' LEU . 54.0 Cg_exo -48.6 -170.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.317 2.011 . . . . 0.0 112.333 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.83 5.34 20.44 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.0 t -145.43 -172.31 3.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.759 0.314 . . . . 0.0 110.366 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.5 t -130.11 155.75 45.67 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.496 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -131.84 164.57 25.76 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.27 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 38' ' ' ASN . 12.8 p-10 -116.64 149.68 39.35 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.518 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.5 t -88.31 125.21 41.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.501 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.2 p -67.51 -42.54 87.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.348 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.48 ' NH2' ' ND1' ' A' ' 50' ' ' HIS . 37.0 ptt-85 -170.1 160.19 7.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.409 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 86.4 t -129.24 127.58 65.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.407 ' HB1' ' OD1' ' A' ' 47' ' ' ASP . . . -93.39 110.93 49.8 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.507 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -76.28 -11.39 19.21 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.073 1.848 . . . . 0.0 112.415 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.522 ' N ' HD12 ' A' ' 45' ' ' LEU . 10.5 mp -59.29 -30.63 68.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.579 -178.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.39 28.23 1.36 Allowed Glycine 0 N--CA 1.468 0.78 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -97.9 178.72 1.25 Allowed Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 47' ' ' ASP . 19.2 Cg_exo -64.13 -179.14 0.73 Allowed 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.974 1.783 . . . . 0.0 111.888 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.0 mm -103.6 117.95 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.528 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.48 ' ND1' ' NH2' ' A' ' 41' ' ' ARG . 10.8 m170 -96.37 117.47 30.91 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.2 pt -118.66 147.38 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.431 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.413 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 84.2 tt0 -134.26 112.04 10.73 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.217 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 54' ' ' ARG . 1.2 p -86.46 172.56 10.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.766 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 53' ' ' THR . 95.5 mtt180 -34.02 -51.84 0.43 Allowed 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.479 0.487 . . . . 0.0 111.929 -178.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.6 tpt85 -142.03 31.68 1.58 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.619 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -141.96 138.08 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.541 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.3 t -116.9 131.91 56.83 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.35 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.1 tp -145.87 146.38 31.09 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.932 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.427 HG23 ' CD2' ' A' ' 50' ' ' HIS . 4.9 p -136.93 127.2 39.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.8 mt -138.17 165.38 26.8 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.587 0.232 . . . . 0.0 110.428 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -74.0 148.14 42.31 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 120.94 0.4 . . . . 0.0 111.275 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -43.94 -41.77 5.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.184 0.516 . . . . 0.0 110.807 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -57.98 -40.63 81.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.387 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -60.05 -42.66 94.97 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.477 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.554 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.0 mm? -62.05 -42.07 98.79 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.59 -48.48 81.51 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.669 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.37 -39.26 85.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.873 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 38.5 mt -62.78 138.99 58.66 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.341 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -83.14 102.15 11.66 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.488 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.1 m -127.07 152.35 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.306 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -144.04 123.46 13.12 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.708 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.11 145.73 53.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.111 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.466 0.349 0 CA-C-O 120.762 0.315 . . . . 0.0 110.671 -179.905 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 . . . . . 0 CA--C 1.519 -0.217 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.48 157.26 78.76 Favored Pre-proline 0 N--CA 1.466 0.342 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 39' ' ' VAL . 52.2 Cg_exo -50.19 -35.22 42.22 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.03 1.82 . . . . 0.0 112.768 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -136.56 96.54 3.36 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.708 0.29 . . . . 0.0 110.328 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.86 130.99 42.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.982 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.3 102.32 15.04 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 20.1 m0 -105.5 143.67 33.33 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.185 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -95.57 147.75 23.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.817 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 46.9 mt -100.12 123.0 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.8 m -103.86 -47.88 4.08 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.795 0.331 . . . . 0.0 110.405 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 160.6 169.9 24.49 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.9 OUTLIER -83.4 151.22 25.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.916 0.389 . . . . 0.0 110.546 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.2 t -82.46 174.36 11.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.538 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -70.74 -40.09 72.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.0 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -70.77 -10.4 59.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.305 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.3 tp -41.38 149.51 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.776 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.66 154.25 87.38 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.368 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.52 -30.96 51.78 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.528 2.152 . . . . 0.0 112.179 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.43 -54.36 25.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.921 0.391 . . . . 0.0 111.286 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -63.76 -45.72 88.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.351 0.596 . . . . 0.0 110.194 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.404 ' NH1' HD11 ' A' ' 27' ' ' LEU . 68.2 ttp85 -57.89 -44.72 86.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.293 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 69.5 tp60 -61.78 -34.2 75.45 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -59.68 -48.41 81.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.067 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.417 ' HA ' HD13 ' A' ' 26' ' ' LEU . 4.5 mm? -61.88 -41.38 97.81 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.597 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.404 HD11 ' NH1' ' A' ' 23' ' ' ARG . 87.0 mt -61.8 -39.81 93.02 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.448 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.1 m -82.66 -12.98 57.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.849 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.446 ' HG ' ' H ' ' A' ' 31' ' ' MET . 12.4 tp -95.85 124.54 39.91 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.799 0.333 . . . . 0.0 110.15 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.87 13.1 32.44 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.464 ' CE ' HH21 ' A' ' 55' ' ' ARG . 68.6 mtp -118.49 75.66 1.03 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.26 0.552 . . . . 0.0 109.531 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.496 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.7 mp -78.7 166.69 40.8 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.839 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.496 ' O ' ' O ' ' A' ' 32' ' ' LEU . 80.1 Cg_exo -40.56 175.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.666 2.244 . . . . 0.0 112.747 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.71 12.49 6.59 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.6 t -140.8 -156.37 0.67 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.836 0.351 . . . . 0.0 110.266 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.0 t -147.7 153.79 39.75 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.839 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.45 ' CE1' HG21 ' A' ' 51' ' ' ILE . 45.3 p90 -129.76 149.97 51.27 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.492 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -108.06 144.13 35.82 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.316 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 5' ' ' PRO . 12.5 t -81.05 121.02 33.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.488 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 50' ' ' HIS . 2.0 p -68.34 -37.67 78.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.509 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -171.82 155.66 3.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.366 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.4 t -123.68 114.06 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.3 111.99 54.41 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.403 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.548 ' C ' ' H ' ' A' ' 46' ' ' GLY . 61.4 Cg_endo -75.0 -11.64 21.48 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.916 1.744 . . . . 0.0 112.269 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 45' ' ' LEU . 9.9 mp -60.14 5.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.954 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.548 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 88.63 29.51 18.56 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.41 160.01 29.81 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.43 172.44 2.63 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.969 2.446 . . . . 0.0 112.002 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.3 mm -91.48 113.26 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.893 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.429 ' O ' HG12 ' A' ' 40' ' ' VAL . 12.1 m-70 -94.53 125.09 38.96 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.162 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.45 HG21 ' CE1' ' A' ' 37' ' ' PHE . 36.3 pt -124.57 146.71 29.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.099 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -136.79 129.06 29.84 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.234 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -130.57 144.45 51.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.519 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -49.19 -33.19 11.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.937 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.464 HH21 ' CE ' ' A' ' 31' ' ' MET . 73.8 mtp85 -69.96 -43.92 70.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.714 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.835 HG22 ' H ' ' A' ' 57' ' ' SER . 9.8 p -170.05 -179.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.433 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.835 ' H ' HG22 ' A' ' 56' ' ' VAL . 20.7 t -128.49 150.94 49.94 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.247 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 52.7 tp -163.21 157.22 20.14 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.036 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.609 ' C ' HD12 ' A' ' 60' ' ' LEU . 3.5 p -130.98 131.79 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.609 HD12 ' C ' ' A' ' 59' ' ' VAL . 10.3 mp -126.33 150.6 48.42 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.645 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' A' ' 64' ' ' ASP . 88.6 mtm180 -79.03 143.65 35.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.286 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -40.47 -40.92 1.31 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.125 0.488 . . . . 0.0 111.124 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -61.19 -42.32 98.36 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.368 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 61' ' ' ARG . 98.1 m-20 -61.4 -38.51 87.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.229 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.498 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.1 mm? -62.58 -42.72 99.73 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.14 -51.25 70.83 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.154 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.426 ' N ' HD22 ' A' ' 67' ' ' LEU . 4.1 mm? -68.56 -39.76 80.91 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.178 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.16 134.11 56.12 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -83.14 114.55 21.41 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.077 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 m -132.09 161.85 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.022 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -146.13 144.77 30.19 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.506 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.66 147.45 52.68 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.1 t . . . . . 0 N--CA 1.464 0.253 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.512 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 . . . . . 0 C--O 1.232 0.16 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -143.3 153.3 59.29 Favored Pre-proline 0 N--CA 1.464 0.264 0 C-N-CA 121.136 -0.226 . . . . 0.0 110.404 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 39' ' ' VAL . 34.9 Cg_exo -50.96 -43.02 49.91 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.626 1.551 . . . . 0.0 112.407 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 6' ' ' ASP . 48.0 p-10 -135.29 98.45 3.97 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.946 0.403 . . . . 0.0 111.526 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.516 ' HG1' ' HD1' ' A' ' 9' ' ' TRP . 1.2 t -131.9 143.92 50.48 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.241 178.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -87.54 102.68 14.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.516 ' HD1' ' HG1' ' A' ' 7' ' ' THR . 11.5 m0 -103.17 136.09 43.61 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 -178.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.0 tttt -91.88 143.97 25.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.773 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 48.9 mt -101.43 119.13 49.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 6.6 p -108.63 -19.14 13.53 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.773 0.321 . . . . 0.0 110.588 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.04 -177.59 23.39 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.101 -0.799 . . . . 0.0 111.101 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -104.76 150.43 24.77 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.808 0.337 . . . . 0.0 110.41 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.471 ' O ' HG22 ' A' ' 18' ' ' ILE . 8.3 t -77.86 170.24 16.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.854 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -70.7 -39.48 73.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.106 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -66.83 -14.81 63.1 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.002 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.478 ' CG2' ' HE ' ' A' ' 23' ' ' ARG . 10.0 tp -41.23 149.34 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.759 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.35 154.5 88.04 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.981 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.25 -30.09 64.12 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.534 2.156 . . . . 0.0 112.362 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.3 -52.06 45.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.468 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -63.13 -46.7 86.04 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.59 0.71 . . . . 0.0 110.527 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.478 ' HE ' ' CG2' ' A' ' 18' ' ' ILE . 33.9 ttm180 -58.42 -48.51 80.46 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.407 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -59.84 -30.84 69.23 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -57.5 -44.23 84.84 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 29' ' ' LEU . 4.6 mm? -61.8 -42.62 99.24 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 120.071 -0.651 . . . . 0.0 109.647 178.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.45 HD22 ' N ' ' A' ' 27' ' ' LEU . 3.9 mm? -67.94 -33.59 74.96 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.788 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.7 t -60.1 -44.26 94.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.73 -178.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.524 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -118.19 170.3 8.98 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.033 0.444 . . . . 0.0 110.599 -179.602 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.64 4.18 81.93 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 58.6 mmm -73.34 73.76 1.34 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.1 mp -95.36 170.38 7.91 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.104 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 32' ' ' LEU . 52.9 Cg_exo -50.0 -165.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.402 2.068 . . . . 0.0 113.028 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.33 5.34 55.94 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 76.9 p -143.15 -172.93 3.78 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.733 0.301 . . . . 0.0 110.289 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.8 m -130.04 156.13 45.0 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.745 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.42 ' HB2' HG22 ' A' ' 53' ' ' THR . 42.5 p90 -128.5 153.56 47.03 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.989 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 39' ' ' VAL . 59.9 t-20 -108.74 147.07 32.55 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.662 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.525 ' N ' ' OD1' ' A' ' 38' ' ' ASN . 21.4 t -89.58 126.51 42.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.647 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 p -72.24 -41.76 66.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.716 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -173.32 154.98 2.78 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.419 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 42' ' ' VAL . 17.9 m -139.56 122.45 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.294 178.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -95.47 110.07 48.89 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.754 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.57 ' C ' ' H ' ' A' ' 46' ' ' GLY . 38.1 Cg_exo -61.56 -14.63 36.55 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 121.811 1.674 . . . . 0.0 111.869 178.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 78.3 mt -53.73 2.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.863 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.57 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 90.04 26.08 25.07 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.01 162.26 23.48 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.99 170.46 2.12 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.181 1.92 . . . . 0.0 111.39 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 60' ' ' LEU . 6.7 mm -96.85 115.97 37.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.606 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.456 ' CD2' HG23 ' A' ' 59' ' ' VAL . 13.6 m170 -93.77 120.47 34.07 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.401 ' O ' ' O ' ' A' ' 58' ' ' LEU . 47.0 pt -118.95 148.54 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.461 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.784 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -133.97 128.84 35.24 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.066 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.42 HG22 ' HB2' ' A' ' 37' ' ' PHE . 1.2 p -118.47 137.46 53.16 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -41.34 -35.86 0.72 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.256 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.54 ' O ' HG13 ' A' ' 56' ' ' VAL . 78.7 mmt-85 -70.02 -47.43 62.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.955 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 55' ' ' ARG . 16.3 m -160.6 -175.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.004 0.43 . . . . 0.0 111.049 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 t -116.6 142.39 46.95 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.551 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.401 ' O ' ' O ' ' A' ' 51' ' ' ILE . 63.6 tp -150.6 150.06 30.69 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.507 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.456 HG23 ' CD2' ' A' ' 50' ' ' HIS . 7.7 p -125.69 130.54 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 49' ' ' ILE . 94.3 mt -132.41 155.79 47.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.619 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -84.84 168.33 15.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.842 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -59.21 -43.42 92.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.532 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -59.22 -39.3 82.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.725 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -60.11 -45.7 92.07 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.453 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.54 -40.96 98.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.863 0.363 . . . . 0.0 110.15 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.99 -39.08 90.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.483 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.4 mt -82.08 -55.29 4.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.815 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 70.6 mt -46.74 132.88 11.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.398 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.407 ' O ' ' OG1' ' A' ' 12' ' ' THR . 96.8 mt-10 -76.27 108.87 9.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.5 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.36 161.58 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.634 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 31.0 tp10 -145.42 143.05 29.85 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.412 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.31 131.41 41.88 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 36.0 t . . . . . 0 C--N 1.327 -0.371 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.409 -179.506 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 . . . . . 0 CA--C 1.521 -0.135 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.9 151.5 78.32 Favored Pre-proline 0 N--CA 1.468 0.46 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 39' ' ' VAL . 43.3 Cg_endo -66.96 -33.68 31.83 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.659 2.24 . . . . 0.0 112.228 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -136.63 94.65 3.02 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.818 0.342 . . . . 0.0 110.995 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 t -140.4 148.19 40.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.246 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -96.02 102.07 13.82 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 19.2 m0 -99.34 137.46 37.82 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.25 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -93.41 130.29 39.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.863 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.6 mt -83.05 115.84 26.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.0 m -98.73 -43.72 6.68 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.849 0.357 . . . . 0.0 110.422 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.06 -179.79 31.7 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.8 p90 -95.89 147.67 23.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.855 0.359 . . . . 0.0 110.475 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.476 ' O ' HG22 ' A' ' 18' ' ' ILE . 5.7 m -78.47 172.93 12.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.517 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 85.6 mmt-85 -70.06 -40.35 75.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.607 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -65.72 -15.18 62.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.628 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.476 HG22 ' O ' ' A' ' 15' ' ' SER . 10.5 tp -41.58 148.43 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.636 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 92.6 p -83.05 144.83 48.08 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.713 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -50.17 -37.18 48.18 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.051 1.834 . . . . 0.0 112.692 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.24 -58.51 7.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.891 0.377 . . . . 0.0 111.414 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -64.33 -47.18 80.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.261 0.553 . . . . 0.0 110.681 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -57.56 -47.55 81.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.371 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 68.3 tp60 -60.18 -32.27 70.91 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.459 ' NZ ' HD11 ' A' ' 58' ' ' LEU . 31.1 ttmt -60.8 -44.36 96.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.895 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.53 HD13 HD11 ' A' ' 29' ' ' LEU . 4.6 mm? -62.25 -42.94 99.77 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.368 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.16 -39.9 96.0 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.743 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.1 t -60.71 -45.2 95.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.039 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.53 HD11 HD13 ' A' ' 26' ' ' LEU . 2.0 pp -92.74 133.94 35.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.502 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.7 -1.67 72.81 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 67.2 mtt -86.66 74.46 9.85 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -82.23 168.54 23.03 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.336 -179.096 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 32' ' ' LEU . 72.7 Cg_exo -43.4 177.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 122.451 2.101 . . . . 0.0 112.312 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.42 11.88 7.09 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 99.0 p -146.43 -161.94 1.42 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.845 0.355 . . . . 0.0 110.306 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.5 m -135.3 158.34 44.62 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.632 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -136.6 156.05 49.09 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.147 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -110.56 146.33 36.25 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.485 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.428 ' O ' ' O ' ' A' ' 5' ' ' PRO . 21.5 t -86.7 126.33 40.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.494 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.407 HG12 ' H ' ' A' ' 40' ' ' VAL . 2.2 p -68.02 -41.21 84.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.95 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -174.74 160.56 2.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.083 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.4 t -133.31 118.23 30.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.2 110.39 48.02 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.474 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -76.4 -11.55 18.99 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.292 1.995 . . . . 0.0 112.271 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.0 mt -56.98 -30.45 64.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.686 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.98 21.98 0.68 Allowed Glycine 0 N--CA 1.465 0.609 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.16 159.81 30.46 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -60.55 173.9 1.86 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.761 2.307 . . . . 0.0 111.819 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 60' ' ' LEU . 8.0 mm -93.07 114.1 29.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.325 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -93.63 125.47 38.27 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.296 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.4 pt -127.1 150.25 32.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.571 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -127.07 137.97 53.13 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.356 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 56' ' ' VAL . 0.8 OUTLIER -131.53 137.95 48.71 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.9 ptt-85 -42.73 -44.65 4.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.793 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 76.2 mmt-85 -65.12 -42.08 94.27 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.675 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.807 HG22 ' H ' ' A' ' 57' ' ' SER . 11.1 p -169.46 179.43 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.239 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.807 ' H ' HG22 ' A' ' 56' ' ' VAL . 8.1 p -123.16 150.6 43.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.165 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.528 HD23 ' N ' ' A' ' 59' ' ' VAL . 7.1 tt -159.68 162.82 35.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.395 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.528 ' N ' HD23 ' A' ' 58' ' ' LEU . 4.1 p -122.14 132.49 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.096 0.474 . . . . 0.0 110.661 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 49' ' ' ILE . 51.5 mt -124.79 157.58 35.44 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.36 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -91.01 170.95 9.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.011 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -61.08 -44.37 97.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.201 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -62.42 -37.35 85.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.564 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -59.96 -46.0 90.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.447 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.31 -42.16 98.99 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.083 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.47 -49.44 77.34 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.2 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.2 mt -69.71 -41.8 74.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.314 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.1 tp -63.12 134.19 55.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.27 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -83.24 115.01 21.77 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.227 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.1 m -134.04 155.34 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.554 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -141.15 142.45 34.06 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.675 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.74 145.73 46.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.255 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.465 0.298 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.231 -179.77 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 5.0 m-85 . . . . . 0 CA--C 1.519 -0.249 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.68 158.46 45.35 Favored Pre-proline 0 N--CA 1.469 0.503 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -51.14 -38.73 61.05 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.996 1.798 . . . . 0.0 112.735 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -136.79 94.62 3.0 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.76 129.22 43.85 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.16 102.13 14.85 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.423 ' CZ3' HD23 ' A' ' 65' ' ' LEU . 24.4 m0 -100.86 141.39 33.81 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.292 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -97.16 129.11 44.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.781 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.2 mt -80.62 122.56 36.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.061 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 6.2 p -109.12 -15.33 14.35 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.342 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.81 178.41 15.64 Favored Glycine 0 N--CA 1.466 0.686 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.5 p90 -99.36 153.36 19.04 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.464 ' O ' HG22 ' A' ' 18' ' ' ILE . 1.9 t -82.29 171.97 13.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.647 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.436 ' N ' ' OG ' ' A' ' 15' ' ' SER . 99.6 mtt180 -69.89 -40.67 75.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.835 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.425 ' HB3' HD22 ' A' ' 67' ' ' LEU . 31.5 tp10 -66.19 -14.94 62.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.297 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 15' ' ' SER . 10.5 tp -41.06 147.33 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.729 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.76 155.23 87.09 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.521 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.12 -31.57 64.79 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.577 2.185 . . . . 0.0 112.016 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.66 -54.39 32.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.892 0.377 . . . . 0.0 111.129 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -62.62 -45.5 92.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.466 0.65 . . . . 0.0 110.34 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -57.64 -42.7 83.95 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.811 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 28' ' ' SER . 58.3 tp60 -61.77 -37.3 83.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.063 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -60.54 -43.25 97.39 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 120.081 -0.647 . . . . 0.0 110.025 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.421 ' HA ' HD13 ' A' ' 26' ' ' LEU . 4.5 mm? -63.43 -40.12 96.33 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.401 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.4 tt -80.3 -26.45 38.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.437 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.46 ' N ' ' O ' ' A' ' 24' ' ' GLN . 15.0 t -60.59 -45.53 93.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.336 -178.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.512 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -107.16 163.55 12.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.247 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.63 34.24 4.11 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 94.7 mtp -108.71 73.92 0.89 Allowed 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 33' ' ' PRO . 3.3 mm? -81.59 154.55 71.18 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.142 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.471 ' O ' ' O ' ' A' ' 32' ' ' LEU . 77.3 Cg_exo -42.48 176.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 122.742 2.295 . . . . 0.0 112.537 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.24 12.05 7.11 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 95.7 p -136.94 -156.93 0.74 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.863 0.363 . . . . 0.0 110.268 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 97.3 p -146.61 161.36 40.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.459 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.429 ' HB2' HG22 ' A' ' 53' ' ' THR . 48.5 p90 -138.05 155.09 49.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.29 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 27.4 p30 -109.85 152.35 25.87 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.534 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.6 t -92.96 125.26 45.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.503 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.408 ' H ' HG12 ' A' ' 40' ' ' VAL . 1.7 p -67.14 -41.69 87.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.026 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.607 ' NH2' ' ND1' ' A' ' 50' ' ' HIS . 37.7 ptt-85 -172.12 157.2 4.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.252 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.6 t -126.33 120.21 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.22 110.56 49.08 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.355 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -76.53 -12.24 18.62 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.008 1.805 . . . . 0.0 112.213 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.1 tp -57.63 -31.29 66.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.873 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.87 25.97 0.8 Allowed Glycine 0 N--CA 1.464 0.532 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.2 159.69 30.7 Favored Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.432 ' HG2' ' HE2' ' A' ' 50' ' ' HIS . 17.5 Cg_endo -56.56 175.7 0.26 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.838 2.359 . . . . 0.0 111.764 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.454 ' N ' ' O ' ' A' ' 60' ' ' LEU . 7.2 mm -92.5 114.21 29.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.936 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.607 ' ND1' ' NH2' ' A' ' 41' ' ' ARG . 15.8 m170 -94.32 119.91 33.78 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.872 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 58' ' ' LEU . 48.2 pt -126.11 149.87 31.26 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.221 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 12.5 tm-20 -132.68 130.11 39.67 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.188 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.429 HG22 ' HB2' ' A' ' 37' ' ' PHE . 1.4 p -116.06 137.14 52.38 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.701 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.414 ' H ' ' HG3' ' A' ' 54' ' ' ARG . 79.5 mtp180 -39.08 -36.76 0.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.818 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.548 ' O ' HG13 ' A' ' 56' ' ' VAL . 32.9 mmt180 -71.11 -49.05 48.45 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.147 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 55' ' ' ARG . 15.2 m -160.81 -176.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.95 0.405 . . . . 0.0 110.501 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 m -109.06 148.18 31.2 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.741 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' A' ' 51' ' ' ILE . 63.0 tp -152.61 149.16 28.17 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.4 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 59' ' ' VAL . 13.4 p -128.84 129.76 68.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.624 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 49' ' ' ILE . 76.3 mt -133.59 163.8 28.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.325 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -93.66 164.23 13.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.492 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -55.91 -39.09 71.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.035 0.445 . . . . 0.0 110.288 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -62.0 -40.94 97.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.729 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -60.43 -43.86 96.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.151 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.423 HD23 ' CZ3' ' A' ' 9' ' ' TRP . 10.8 mp -62.64 -42.22 99.48 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.31 -50.32 74.04 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.243 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.425 HD22 ' HB3' ' A' ' 17' ' ' GLU . 98.3 mt -68.79 -41.1 79.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.2 tp -65.1 131.22 45.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.107 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.444 ' O ' ' OG1' ' A' ' 12' ' ' THR . 94.3 mt-10 -78.19 115.29 17.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.181 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.418 HG21 ' CE3' ' A' ' 9' ' ' TRP . 27.0 m -136.4 160.2 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.419 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -141.0 132.34 26.69 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.156 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.31 135.33 54.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.884 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 85.0 t . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.176 -179.906 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 . . . . . 0 CA--C 1.516 -0.336 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.22 154.92 65.41 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.47 -179.312 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' A' ' 39' ' ' VAL . 51.8 Cg_exo -51.18 -36.51 56.11 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.075 1.85 . . . . 0.0 112.793 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -131.98 98.64 4.5 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.748 0.308 . . . . 0.0 110.371 -179.201 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.55 129.71 31.31 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -88.47 102.1 14.57 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 22.4 m0 -105.13 144.39 31.99 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.118 -179.092 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -100.46 132.05 46.05 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.185 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 34.2 mt -82.03 120.54 33.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.672 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.5 m -102.39 -40.49 6.7 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.374 179.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 161.14 175.34 32.06 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -96.47 143.55 27.39 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.536 ' O ' HG22 ' A' ' 18' ' ' ILE . 3.6 m -72.0 167.01 21.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.677 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -66.49 -39.02 88.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.333 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.98 -17.61 64.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.812 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 15' ' ' SER . 10.6 tp -41.88 146.36 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.398 -179.399 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.0 p -81.9 147.98 59.71 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.561 -179.324 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -49.85 -41.97 45.64 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.848 1.699 . . . . 0.0 112.644 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.95 -57.87 7.46 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.158 -178.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -63.23 -44.41 95.32 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.469 0.652 . . . . 0.0 110.734 -179.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -57.8 -46.09 85.14 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.989 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 28' ' ' SER . 78.0 mt-30 -64.59 -31.98 73.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.752 179.205 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.6 mmtt -59.77 -42.64 93.76 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 119.891 -0.723 . . . . 0.0 109.241 179.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.512 HD12 ' HD3' ' A' ' 33' ' ' PRO . 4.6 mm? -64.51 -41.29 96.51 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.794 178.43 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 45.0 mt -79.68 -16.12 56.3 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.895 0.379 . . . . 0.0 110.945 -179.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 24' ' ' GLN . 37.2 t -59.45 -41.56 89.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.035 -179.045 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.773 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -124.16 -171.16 2.27 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.948 -179.498 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.13 43.2 2.04 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -179.334 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.481 ' SD ' HD11 ' A' ' 29' ' ' LEU . 64.1 mtt -120.12 71.98 0.92 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.485 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.1 mm? -82.98 152.05 64.88 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.333 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.512 ' HD3' HD12 ' A' ' 26' ' ' LEU . 77.2 Cg_exo -41.88 171.6 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.586 2.191 . . . . 0.0 112.366 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.51 -12.94 18.47 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 179.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.2 m -96.11 -156.68 0.54 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.893 0.378 . . . . 0.0 110.347 179.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.7 p -150.37 160.57 43.64 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.447 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -146.21 165.96 27.63 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.507 -179.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -126.13 143.88 50.96 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.267 0.556 . . . . 0.0 110.57 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.443 ' O ' ' O ' ' A' ' 5' ' ' PRO . 61.5 t -78.54 128.97 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.219 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.9 p -76.1 -40.44 37.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.09 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -173.16 160.95 4.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.097 -179.055 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 55.2 t -126.25 131.19 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -92.82 111.29 50.54 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-O 119.451 -0.309 . . . . 0.0 110.321 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.29 -13.11 18.94 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.923 1.748 . . . . 0.0 112.056 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.1 tp -61.98 -32.08 72.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.646 -179.001 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 127.79 30.01 0.78 Allowed Glycine 0 N--CA 1.464 0.542 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.89 173.29 4.08 Favored Pre-proline 0 CA--C 1.534 0.327 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -179.35 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -61.46 -170.94 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.141 1.894 . . . . 0.0 111.503 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.4 mm -108.17 114.48 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -88.45 124.5 34.03 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.285 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.2 pt -129.21 144.25 38.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.397 179.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -124.17 114.34 19.51 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.125 179.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 56' ' ' VAL . 0.7 OUTLIER -105.83 137.82 43.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.895 -179.585 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -41.43 -42.42 2.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.474 -179.503 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -67.12 -44.6 79.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.718 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.683 HG22 ' N ' ' A' ' 57' ' ' SER . 14.8 p -170.28 172.85 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.499 -179.71 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.683 ' N ' HG22 ' A' ' 56' ' ' VAL . 94.2 p -111.52 153.8 25.68 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.561 179.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.2 tt -161.35 159.66 28.66 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.585 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 59' ' ' VAL . 11.9 p -114.96 130.45 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.824 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.628 HD23 HD12 ' A' ' 65' ' ' LEU . 1.3 tp -133.53 152.34 51.89 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.035 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -82.63 161.64 22.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.626 -179.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.1 -45.94 91.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.644 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.69 -40.4 87.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.853 -179.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.46 -40.32 96.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.262 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.628 HD12 HD23 ' A' ' 60' ' ' LEU . 2.3 mp -61.64 -44.47 96.92 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.62 -42.45 98.9 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.28 -179.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.425 ' O ' ' OG ' ' A' ' 15' ' ' SER . 94.2 mt -68.02 -41.13 82.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.669 179.698 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.1 tp -64.95 131.03 45.54 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.066 -179.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -74.76 114.47 13.24 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.154 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.9 m -132.57 158.19 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.647 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -143.55 135.69 26.81 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.694 -179.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.37 129.29 37.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.345 179.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.3 t . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.854 -179.739 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 . . . . . 0 N--CA 1.456 -0.142 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.18 155.71 72.4 Favored Pre-proline 0 N--CA 1.466 0.325 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.154 -179.44 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 39' ' ' VAL . 40.9 Cg_endo -66.43 -22.1 52.63 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.653 2.235 . . . . 0.0 112.192 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -137.11 93.4 2.82 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.709 0.29 . . . . 0.0 110.325 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.92 130.71 25.94 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.12 102.46 15.0 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 18.3 m0 -102.22 140.63 36.24 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.884 0.373 . . . . 0.0 110.17 -179.211 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -98.15 128.51 44.68 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.536 179.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.7 mt -81.85 124.49 39.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.232 -179.302 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -109.35 -44.06 3.99 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.49 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.32 -176.68 39.47 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -100.63 150.15 23.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.854 0.359 . . . . 0.0 110.479 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.414 ' O ' HG22 ' A' ' 18' ' ' ILE . 2.3 t -78.24 169.86 17.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.564 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -69.74 -39.24 76.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.925 0.393 . . . . 0.0 110.784 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -66.83 -14.94 63.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.451 -179.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.414 HG22 ' O ' ' A' ' 15' ' ' SER . 10.5 tp -40.63 146.86 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.545 -179.473 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.9 m -79.5 143.84 60.25 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.507 -179.391 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -47.99 -41.06 33.41 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.917 1.745 . . . . 0.0 112.663 179.209 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.13 -55.99 19.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.86 0.362 . . . . 0.0 111.492 -178.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -63.24 -47.26 83.2 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.476 0.655 . . . . 0.0 110.623 -179.592 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -56.78 -44.87 82.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.999 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -60.43 -35.81 76.69 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.024 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -56.73 -46.71 81.16 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 29' ' ' LEU . 4.5 mm? -63.05 -43.44 98.63 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.506 179.488 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.58 -31.3 68.26 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.721 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.0 t -58.94 -45.03 91.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.228 -179.163 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.471 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -119.22 174.84 6.1 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.39 -179.697 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -90.67 0.16 76.57 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 46.3 tpp -66.85 73.7 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.5 mp -99.59 169.47 8.05 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.369 -179.041 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 32' ' ' LEU . 61.7 Cg_exo -49.96 -166.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.242 1.961 . . . . 0.0 112.256 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.94 4.98 51.04 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.1 m -140.65 -169.92 2.9 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.925 0.393 . . . . 0.0 110.259 179.794 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.2 p -134.04 158.74 42.8 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.194 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -137.72 163.87 30.25 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.218 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.46 ' OD1' ' N ' ' A' ' 38' ' ' ASN . 12.1 p-10 -121.66 150.28 41.98 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.314 0.578 . . . . 0.0 110.387 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.438 ' O ' ' O ' ' A' ' 5' ' ' PRO . 14.8 t -85.41 128.73 38.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.504 -179.651 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 p -68.95 -40.93 81.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.248 179.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -174.85 167.27 3.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.994 -179.198 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.6 m -133.51 125.1 49.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.084 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.76 111.21 51.76 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.582 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -76.24 -11.91 19.21 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.051 1.834 . . . . 0.0 112.311 179.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.526 ' N ' HD12 ' A' ' 45' ' ' LEU . 10.6 mp -61.52 -32.23 72.27 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.809 -178.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.2 26.48 0.82 Allowed Glycine 0 N--CA 1.466 0.669 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.27 160.32 29.18 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -55.71 173.72 0.35 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.698 2.265 . . . . 0.0 111.855 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.4 mm -92.84 118.0 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.771 -179.376 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.435 ' CD2' HG23 ' A' ' 59' ' ' VAL . 12.7 m170 -97.02 123.7 40.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.03 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.8 pt -127.33 148.88 32.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.719 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 97.0 mt-10 -134.95 112.16 10.4 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.094 179.593 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.425 ' O ' ' C ' ' A' ' 54' ' ' ARG . 1.2 p -85.52 173.93 9.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.889 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 53' ' ' THR . 99.9 mtt180 -33.55 -52.95 0.41 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.708 -178.186 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 57.4 ttp85 -142.93 32.29 1.4 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.016 179.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -140.62 136.98 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.489 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.6 t -113.7 130.47 56.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.237 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.403 HD21 HD11 ' A' ' 60' ' ' LEU . 59.9 tp -145.62 148.09 32.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.111 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.435 HG23 ' CD2' ' A' ' 50' ' ' HIS . 3.8 p -136.4 123.6 32.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.32 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.403 HD11 HD21 ' A' ' 58' ' ' LEU . 94.4 mt -140.68 173.16 11.76 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.443 -179.513 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.9 mtm-85 -84.05 163.31 19.96 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.922 0.391 . . . . 0.0 110.91 -179.519 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -58.73 -34.37 71.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.517 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -60.6 -40.25 91.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.546 179.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -61.56 -43.84 98.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.512 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 mp -61.58 -42.12 98.4 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.79 -44.24 97.26 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.326 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.6 mt -68.75 -41.19 79.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.042 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 63.7 mt -64.06 137.64 58.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.875 0.369 . . . . 0.0 110.611 -179.477 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -79.39 108.58 13.02 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.215 -179.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.4 m -134.95 156.54 39.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.479 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -138.92 128.06 23.97 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.595 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.1 134.58 48.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.095 179.675 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.8 m . . . . . 0 N--CA 1.466 0.333 0 CA-C-O 121.029 0.443 . . . . 0.0 110.348 179.975 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 . . . . . 0 CA--C 1.516 -0.351 0 CA-C-O 120.917 0.389 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.07 154.44 40.63 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.424 -179.101 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 39' ' ' VAL . 41.2 Cg_endo -67.33 -37.42 17.89 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.672 2.248 . . . . 0.0 112.243 179.733 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -136.56 95.95 3.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.626 -179.596 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -140.07 147.76 40.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.383 179.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -97.25 101.8 13.43 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.632 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 28.7 m0 -98.02 142.95 29.1 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.341 -179.34 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -99.78 131.37 45.8 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.881 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.0 mt -80.98 125.58 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.467 -179.386 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.4 m -104.93 -51.95 2.95 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.475 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 168.14 167.78 29.29 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.0 OUTLIER -87.7 148.26 24.85 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 179.616 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.528 ' O ' HG22 ' A' ' 18' ' ' ILE . 43.7 t -80.68 171.05 15.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.659 179.874 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -67.16 -38.85 86.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.343 179.673 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -65.4 -18.31 65.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.689 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.528 HG22 ' O ' ' A' ' 15' ' ' SER . 10.8 tp -41.91 147.27 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.822 -179.698 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.58 158.19 81.37 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.28 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.88 -32.39 45.62 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.663 2.242 . . . . 0.0 111.958 179.63 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.15 -57.42 11.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.018 0.437 . . . . 0.0 110.979 -179.465 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -61.27 -45.29 95.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.603 0.716 . . . . 0.0 110.322 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -56.51 -42.86 79.08 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.192 -179.65 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 28' ' ' SER . 62.8 mt-30 -62.15 -37.2 84.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.414 179.41 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -58.81 -43.34 90.58 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.811 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.6 mm? -64.68 -41.71 95.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.262 0.553 . . . . 0.0 110.575 179.638 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.4 tt -78.73 -26.21 44.67 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.19 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 24' ' ' GLN . 14.4 t -61.19 -45.18 95.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.273 -178.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.5 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -112.03 169.27 8.97 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.237 -179.742 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.05 40.76 2.95 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.571 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.549 ' SD ' ' CZ ' ' A' ' 55' ' ' ARG . 38.0 ttp -108.82 72.11 0.81 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.188 0.518 . . . . 0.0 109.793 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.506 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.2 mm? -82.74 151.88 65.31 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.566 -179.276 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 32' ' ' LEU . 73.9 Cg_exo -41.96 175.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 122.49 2.126 . . . . 0.0 112.009 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.5 -21.22 9.27 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.783 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.8 m -97.63 -174.43 2.9 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.8 m -133.6 151.68 51.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.332 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.424 ' HB2' HG22 ' A' ' 53' ' ' THR . 52.2 p90 -133.17 155.04 50.02 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.109 -179.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -109.05 145.0 36.33 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.318 0.58 . . . . 0.0 110.713 -179.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.446 ' O ' ' O ' ' A' ' 5' ' ' PRO . 48.8 t -89.45 125.05 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.18 -179.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.428 HG12 ' H ' ' A' ' 40' ' ' VAL . 2.2 p -69.11 -40.44 80.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.965 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.2 ptt-85 -176.82 166.84 2.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.006 -178.918 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 42' ' ' VAL . 27.9 m -132.67 122.31 46.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.031 179.299 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.89 111.98 56.47 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.543 ' C ' ' H ' ' A' ' 46' ' ' GLY . 59.2 Cg_endo -75.75 -11.98 20.12 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.642 2.228 . . . . 0.0 112.013 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.9 mt -61.83 4.91 0.1 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.955 -179.191 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.543 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 91.07 24.98 25.66 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.42 160.07 30.46 Favored Pre-proline 0 C--N 1.332 -0.176 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.62 168.01 4.55 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.809 2.339 . . . . 0.0 111.749 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.9 mm -90.12 118.23 34.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.097 0.475 . . . . 0.0 110.074 -179.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.414 ' O ' HG12 ' A' ' 40' ' ' VAL . 12.5 m170 -96.72 121.52 38.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.064 179.535 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.1 pt -123.84 147.73 28.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.141 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -129.85 135.27 48.19 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.471 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 56' ' ' VAL . 1.7 p -123.94 143.57 50.3 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.911 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -54.27 -18.32 3.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.771 -178.726 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.549 ' CZ ' ' SD ' ' A' ' 31' ' ' MET . 16.8 ptm180 -97.97 -31.31 12.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.891 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.716 HG22 ' H ' ' A' ' 57' ' ' SER . 4.2 p -170.22 179.37 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.969 0.414 . . . . 0.0 110.393 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.716 ' H ' HG22 ' A' ' 56' ' ' VAL . 54.3 m -124.25 155.91 37.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.478 178.711 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.4 tp -158.66 151.71 22.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.292 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.414 HG23 ' CD2' ' A' ' 50' ' ' HIS . 4.4 p -135.82 126.68 43.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.025 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.8 mt -131.56 161.8 31.78 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.505 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -78.23 150.86 33.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.569 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -44.71 -47.22 10.66 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.279 0.561 . . . . 0.0 110.857 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -52.96 -34.63 56.58 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.263 -179.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -63.6 -40.78 97.8 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.348 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.61 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.0 mm? -63.33 -43.21 98.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.076 -179.285 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.84 -47.25 85.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.207 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.8 mt -68.31 -41.81 80.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.567 179.77 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 49.7 tp -64.63 131.47 47.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.26 -179.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -81.55 114.32 20.18 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.441 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.4 m -130.98 156.42 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.335 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -137.39 125.55 23.04 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.444 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.03 138.98 52.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.281 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.463 0.21 0 CA-C-O 120.886 0.374 . . . . 0.0 110.285 -179.875 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 . . . . . 0 CA--C 1.519 -0.232 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 p -128.45 152.17 77.84 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.491 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.57 -40.82 54.66 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.944 1.763 . . . . 0.0 112.765 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -135.24 101.22 4.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.021 0.439 . . . . 0.0 111.036 -179.297 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -137.86 142.8 40.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.393 179.143 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.66 102.21 14.38 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.565 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 18.9 m0 -100.65 137.04 39.58 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.394 -179.254 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -91.57 143.89 26.11 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.768 179.515 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.5 mt -97.2 117.01 41.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.316 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.9 m -101.7 -47.04 4.75 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.597 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 162.16 176.63 34.44 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.4 p90 -92.11 148.4 22.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.219 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.442 ' OG ' ' N ' ' A' ' 16' ' ' ARG . 1.9 t -75.89 172.18 13.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.528 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.442 ' N ' ' OG ' ' A' ' 15' ' ' SER . 35.8 ptt-85 -71.54 -37.13 71.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.665 179.712 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -69.67 -13.84 62.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.327 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 15' ' ' SER . 10.6 tp -41.35 149.44 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.516 -179.566 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.4 p -79.21 140.65 57.05 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.522 -179.541 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -47.44 -40.95 29.46 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 121.941 1.761 . . . . 0.0 112.703 179.061 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.98 -56.71 16.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.903 0.383 . . . . 0.0 111.19 -178.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -61.7 -44.35 97.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.285 0.564 . . . . 0.0 110.484 -179.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -58.62 -43.19 89.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.935 -179.386 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -62.81 -37.07 85.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.977 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -58.4 -47.35 84.17 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -63.21 -38.98 93.31 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.098 179.627 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.6 tp -60.34 -44.26 95.67 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.108 -179.39 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.5 m -75.97 -33.15 59.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.805 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.453 ' HG ' ' H ' ' A' ' 31' ' ' MET . 8.4 tp -71.34 129.47 38.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.259 -179.327 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.63 2.49 87.26 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.453 ' H ' ' HG ' ' A' ' 29' ' ' LEU . 24.0 tpp -109.39 75.78 0.97 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.068 0.461 . . . . 0.0 109.854 179.484 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.2 mp -79.42 165.82 45.68 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.858 -179.213 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.479 ' O ' ' O ' ' A' ' 32' ' ' LEU . 71.4 Cg_exo -40.34 172.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.578 2.185 . . . . 0.0 112.393 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.42 8.64 9.09 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.551 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 t -137.2 -157.52 0.78 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.903 0.382 . . . . 0.0 110.207 179.563 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.9 m -145.33 157.96 43.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.445 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -139.35 153.75 47.74 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.378 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -107.06 147.95 29.35 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.342 0.591 . . . . 0.0 110.682 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.6 t -88.12 126.49 41.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.241 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 50' ' ' HIS . 2.4 p -64.66 -39.9 87.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.891 179.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -174.08 161.13 3.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.096 -179.474 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 55.8 t -126.39 125.23 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.773 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.02 111.69 54.13 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.43 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.67 -11.99 20.26 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.202 1.934 . . . . 0.0 112.0 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.8 tp -58.68 -31.55 68.32 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.832 -178.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.71 32.98 1.13 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -100.24 179.45 1.02 Allowed Pre-proline 0 N--CA 1.466 0.343 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.463 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 47' ' ' ASP . 24.0 Cg_exo -62.7 -178.19 0.37 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.36 2.04 . . . . 0.0 111.71 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.3 mm -107.87 119.9 58.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.449 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.548 ' CD2' HG22 ' A' ' 59' ' ' VAL . 16.4 m170 -102.31 123.09 45.49 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.816 179.644 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.8 pt -127.81 152.13 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.054 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -123.52 135.61 54.12 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.08 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 56' ' ' VAL . 1.4 p -131.45 140.88 49.7 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -38.85 -37.3 0.33 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.565 -179.469 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.3 ttp85 -75.34 -49.4 19.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.777 179.608 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.844 HG22 ' H ' ' A' ' 57' ' ' SER . 10.2 p -171.73 -179.59 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.621 -179.564 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.844 ' H ' HG22 ' A' ' 56' ' ' VAL . 1.7 t -107.72 164.08 12.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.13 178.724 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.417 HD21 HD11 ' A' ' 60' ' ' LEU . 58.8 tp -149.15 146.31 27.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.205 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.548 HG22 ' CD2' ' A' ' 50' ' ' HIS . 57.4 t -127.9 124.41 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.79 178.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.417 HD11 HD21 ' A' ' 58' ' ' LEU . 89.6 mt -144.55 167.32 22.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.71 179.813 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -81.94 147.91 29.0 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.036 0.446 . . . . 0.0 111.424 -179.668 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -42.2 -40.99 2.56 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.701 -179.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -55.44 -38.81 69.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.547 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -61.75 -41.01 97.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.431 179.869 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.637 HD22 ' N ' ' A' ' 65' ' ' LEU . 3.3 mm? -62.84 -42.14 99.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.972 -179.301 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.65 98.13 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.048 179.608 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.36 -41.96 79.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.035 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.0 mt -68.36 135.71 52.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.861 0.362 . . . . 0.0 110.222 -179.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -81.31 111.35 17.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.283 -179.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.4 m -130.97 156.36 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.632 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -144.07 146.82 33.08 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.907 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.65 143.0 56.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.105 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.9 t . . . . . 0 N--CA 1.463 0.218 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.343 -179.775 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 . . . . . 0 N--CA 1.456 -0.139 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.01 156.91 70.23 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.092 -179.371 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -67.73 -50.25 0.93 Allowed 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.708 2.272 . . . . 0.0 112.196 -179.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -129.06 97.58 4.66 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.81 -179.599 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 t -139.49 151.87 46.52 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.273 179.485 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -101.61 102.73 13.48 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.126 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -99.53 133.8 43.33 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.889 0.376 . . . . 0.0 110.152 -179.104 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -92.18 133.49 35.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.98 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.3 mt -85.34 123.31 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.303 -179.242 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.8 m -106.33 -47.74 3.73 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.874 0.369 . . . . 0.0 110.563 179.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 164.79 170.73 30.14 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.8 p90 -89.91 146.04 24.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.874 0.369 . . . . 0.0 110.412 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.419 ' O ' HG22 ' A' ' 18' ' ' ILE . 3.8 m -74.63 170.1 16.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.537 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -69.13 -37.74 78.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.481 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -72.06 -10.01 59.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.543 -179.581 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.419 HG22 ' O ' ' A' ' 15' ' ' SER . 9.8 tp -41.5 146.99 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.517 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.04 153.92 95.01 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.325 -179.586 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.14 -33.16 62.17 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.382 2.055 . . . . 0.0 112.117 -179.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.29 -55.29 22.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.827 0.346 . . . . 0.0 111.278 -179.42 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.457 ' CD2' HD21 ' A' ' 60' ' ' LEU . 31.5 t80 -61.64 -42.3 98.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.569 0.7 . . . . 0.0 110.338 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 68.5 ttp85 -58.07 -44.11 87.35 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.838 179.633 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 28' ' ' SER . 73.2 mt-30 -62.41 -36.3 81.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.252 179.115 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.414 ' O ' ' CD1' ' A' ' 29' ' ' LEU . 26.7 mmtp -59.27 -45.65 90.67 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.954 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.6 mm? -63.62 -43.5 96.68 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.519 179.027 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 tt -70.71 -33.77 71.22 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.28 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 24' ' ' GLN . 74.8 m -58.86 -43.61 90.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.293 -178.729 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.452 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -119.72 176.92 5.16 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.475 -179.559 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -90.51 -2.96 72.33 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.595 ' CE ' ' HE ' ' A' ' 55' ' ' ARG . 35.4 tpp -61.89 73.85 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.783 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 30' ' ' GLY . 1.6 mp -101.12 169.9 7.21 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.34 -179.058 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.479 ' O ' ' O ' ' A' ' 32' ' ' LEU . 57.3 Cg_exo -50.19 -160.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.381 2.054 . . . . 0.0 112.584 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.22 10.66 59.35 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.1 t -142.41 -156.53 0.69 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.755 0.312 . . . . 0.0 110.376 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.3 p -151.86 164.02 37.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.591 -179.782 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -143.62 162.09 36.83 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.552 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 38' ' ' ASN . 7.9 p-10 -114.18 147.95 38.08 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.258 0.551 . . . . 0.0 110.84 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.8 t -88.7 123.11 40.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.234 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.404 HG22 ' HE ' ' A' ' 41' ' ' ARG . 2.3 p -66.47 -41.61 88.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.209 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.404 ' HE ' HG22 ' A' ' 40' ' ' VAL . 20.1 ptp180 -174.17 166.78 4.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.913 -179.453 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.6 m -128.72 130.12 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.0 110.95 49.21 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.545 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -76.65 -13.21 18.16 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.922 1.748 . . . . 0.0 112.392 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.3 mt -62.45 -30.99 71.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.768 -178.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.52 28.69 0.96 Allowed Glycine 0 N--CA 1.466 0.698 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.94 163.93 18.42 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.87 -173.8 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.913 1.742 . . . . 0.0 111.902 179.431 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.2 mm -103.07 115.08 44.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.775 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -92.02 119.1 31.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.174 -0.467 . . . . 0.0 109.779 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.6 pt -125.06 146.88 29.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.274 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.415 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 93.6 mt-10 -127.38 128.41 45.8 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.464 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 56' ' ' VAL . 0.8 OUTLIER -119.69 138.26 53.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.562 179.991 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.417 ' H ' ' HG2' ' A' ' 54' ' ' ARG . 35.6 mmm-85 -45.25 -38.29 5.38 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.382 -179.342 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.595 ' HE ' ' CE ' ' A' ' 31' ' ' MET . 74.6 mtp85 -69.95 -43.38 71.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.849 179.679 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.677 HG22 ' N ' ' A' ' 57' ' ' SER . 14.7 p -170.38 171.11 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-O 120.93 0.395 . . . . 0.0 110.648 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.677 ' N ' HG22 ' A' ' 56' ' ' VAL . 28.4 t -98.62 161.08 13.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.7 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 64.8 tp -163.56 149.25 11.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.11 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.681 ' O ' HD12 ' A' ' 60' ' ' LEU . 6.3 p -134.48 127.81 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.681 HD12 ' O ' ' A' ' 59' ' ' VAL . 2.4 mp -133.33 155.82 48.74 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.399 -179.669 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.445 ' O ' ' N ' ' A' ' 64' ' ' ASP . 95.3 mtm-85 -78.4 143.92 36.36 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.123 179.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -39.5 -43.4 1.26 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.479 -179.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.415 ' HG2' ' H ' ' A' ' 63' ' ' LYS . 13.3 ptpt -58.54 -41.83 86.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.353 179.821 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 61' ' ' ARG . 97.3 m-20 -62.75 -40.17 96.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.354 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.468 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.2 mm? -61.28 -42.38 98.55 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.3 -40.17 96.6 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.15 179.585 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.8 mt -67.32 -41.36 85.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.196 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.5 mt -71.05 141.38 50.91 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.618 -179.733 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -84.19 103.42 13.38 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.093 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.8 m -122.85 154.8 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.279 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.531 ' N ' ' OE1' ' A' ' 71' ' ' GLU . 56.6 mp0 -142.57 125.6 16.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.575 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.03 132.35 48.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.911 179.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.464 0.248 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.362 179.928 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 . . . . . 0 CA--C 1.516 -0.335 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.31 156.99 35.97 Favored Pre-proline 0 N--CA 1.464 0.262 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.559 -179.448 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 39' ' ' VAL . 51.3 Cg_exo -50.95 -38.64 58.96 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.164 1.909 . . . . 0.0 112.616 179.358 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -136.8 95.82 3.2 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -179.546 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.75 129.21 47.93 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.84 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.21 101.55 13.13 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.235 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -102.29 148.06 25.91 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.333 -179.101 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -100.39 128.9 46.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.761 179.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.456 ' CD1' ' NH2' ' A' ' 55' ' ' ARG . 32.3 mt -83.85 122.53 37.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.24 -179.47 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.3 m -108.31 -46.17 3.77 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.87 0.367 . . . . 0.0 110.502 179.796 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.6 -179.44 39.95 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.87 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -90.57 160.09 16.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 0.0 110.435 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.8 t -82.25 169.21 16.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.614 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -69.74 -38.5 76.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.531 179.377 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -74.0 -6.59 48.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.881 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.0 tp -42.55 147.04 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.524 -179.532 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.9 p -82.73 149.19 59.67 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.754 -179.563 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.11 -38.81 50.99 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 122.303 2.002 . . . . 0.0 112.554 178.913 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.43 -57.11 13.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.859 0.361 . . . . 0.0 111.153 -179.081 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -63.58 -49.08 74.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.287 0.565 . . . . 0.0 110.578 -179.841 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -57.0 -43.86 82.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.237 -179.24 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -63.2 -33.11 74.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.755 179.293 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -59.76 -49.01 79.38 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.543 -0.463 . . . . 0.0 109.941 179.668 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.449 HD22 ' N ' ' A' ' 26' ' ' LEU . 4.5 mm? -63.87 -38.94 92.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.278 179.593 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.4 tp -60.55 -41.13 93.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.335 -179.353 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.3 m -83.65 -11.78 56.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.897 -179.398 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.452 ' HG ' ' H ' ' A' ' 31' ' ' MET . 9.5 tp -97.27 123.25 41.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.888 0.375 . . . . 0.0 110.261 -179.731 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.27 3.81 61.12 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.452 ' H ' ' HG ' ' A' ' 29' ' ' LEU . 66.7 mtt -108.48 75.83 1.0 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.21 0.529 . . . . 0.0 109.803 179.575 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.503 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.9 OUTLIER -78.51 167.9 31.58 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.093 -178.942 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.503 ' O ' ' O ' ' A' ' 32' ' ' LEU . 72.9 Cg_exo -42.2 177.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.509 2.139 . . . . 0.0 112.416 -179.551 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.74 11.06 7.33 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 179.784 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.9 m -143.5 -169.54 3.09 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.736 0.303 . . . . 0.0 110.37 179.587 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.45 ' O ' ' NH1' ' A' ' 54' ' ' ARG . 69.0 m -131.41 157.42 43.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.449 -179.74 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -133.52 157.72 44.95 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.212 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -112.93 147.16 37.66 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.447 -179.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 5' ' ' PRO . 14.5 t -85.27 127.03 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.171 179.867 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 p -68.26 -40.11 82.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.839 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -173.98 157.35 2.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.14 -179.072 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 73.8 t -131.82 105.93 10.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.467 ' HB3' ' OD1' ' A' ' 47' ' ' ASP . . . -93.72 111.4 52.47 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.525 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.89 -9.2 19.47 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.952 2.435 . . . . 0.0 112.275 -179.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 51.8 mt -50.73 -29.62 11.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.733 -178.149 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 132.29 20.55 1.01 Allowed Glycine 0 N--CA 1.467 0.723 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.362 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -97.4 160.89 27.75 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.647 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -60.17 175.31 1.08 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.749 2.3 . . . . 0.0 111.671 179.708 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.409 HG21 ' CD2' ' A' ' 65' ' ' LEU . 10.7 mm -94.55 115.73 34.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.185 -179.593 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -96.13 122.65 39.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.077 179.59 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.6 pt -128.37 147.26 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.361 179.71 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -122.87 121.03 35.23 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.019 179.635 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 55' ' ' ARG . 1.4 p -108.74 135.85 49.29 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.45 ' NH1' ' O ' ' A' ' 36' ' ' SER . 8.1 ptp85 -43.13 -18.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.62 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.613 ' O ' HG13 ' A' ' 56' ' ' VAL . 88.5 mtm180 -87.36 -51.38 5.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.967 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 55' ' ' ARG . 13.2 m -162.25 177.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.652 -179.547 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.3 p -97.63 143.14 28.61 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.337 179.539 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.1 tp -147.49 144.33 28.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.253 179.549 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 59' ' ' VAL . 4.8 p -136.9 124.14 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.864 179.2 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.7 mt -138.8 178.81 6.88 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.561 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -88.35 161.89 16.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.806 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -58.71 -32.52 69.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.503 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.87 -42.19 99.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.501 179.926 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -60.9 -44.57 96.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.504 -179.962 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.409 ' CD2' HG21 ' A' ' 49' ' ' ILE . 8.8 mp -62.81 -41.65 99.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.218 179.652 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.94 -51.36 69.45 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.304 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.98 -43.45 78.92 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.864 179.759 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.8 tp -53.0 132.67 38.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.36 -179.004 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -75.43 108.2 8.06 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.442 -179.557 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.8 m -134.22 160.36 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.733 179.812 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -145.19 136.93 25.47 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.598 179.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -76.31 129.5 36.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.145 179.467 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.1 t . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.254 -179.785 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.422 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 41.5 m-85 . . . . . 0 C--O 1.231 0.128 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.44 156.33 41.56 Favored Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.99 -179.512 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 39' ' ' VAL . 40.5 Cg_endo -66.09 -20.1 56.97 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.522 2.148 . . . . 0.0 112.211 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -136.62 93.53 2.88 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.393 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.96 131.52 27.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.203 -179.544 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.02 102.41 14.48 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.056 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 24.4 m0 -101.37 135.71 42.4 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.362 -179.213 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -90.25 131.79 35.87 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.5 mt -84.73 117.78 30.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.765 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 11.0 p -102.43 -19.34 14.97 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.745 0.307 . . . . 0.0 110.187 179.735 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 137.63 179.04 16.52 Favored Glycine 0 N--CA 1.463 0.474 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 179.425 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -96.06 147.77 23.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.625 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.451 ' O ' HG22 ' A' ' 18' ' ' ILE . 10.1 t -76.92 170.46 16.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.578 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -69.01 -38.85 79.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.543 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.465 ' HB3' HD12 ' A' ' 67' ' ' LEU . 75.3 tt0 -69.62 -13.23 62.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.634 -179.431 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 15' ' ' SER . 10.2 tp -41.45 147.1 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.725 -179.911 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.02 154.48 90.76 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.114 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.11 -29.72 56.13 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.456 2.104 . . . . 0.0 112.276 -179.607 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.33 -55.6 17.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.629 -179.206 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -62.25 -44.12 97.27 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.449 0.642 . . . . 0.0 110.346 -179.569 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -59.1 -45.7 90.21 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.999 179.758 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -59.28 -37.98 79.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.959 179.584 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -60.36 -41.66 94.15 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.839 179.367 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.4 mm? -61.73 -43.91 97.93 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.269 179.39 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.27 -38.89 92.67 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.375 179.418 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.0 m -61.12 -42.39 98.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.367 -179.191 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.47 ' CD1' ' O ' ' A' ' 31' ' ' MET . 2.5 pp -96.81 131.15 43.84 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.957 0.408 . . . . 0.0 110.675 -179.351 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.01 -22.95 72.68 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.47 ' O ' ' CD1' ' A' ' 29' ' ' LEU . 63.6 ttp -69.89 73.99 0.44 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.306 0.574 . . . . 0.0 109.789 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -82.03 169.45 18.46 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.815 -179.178 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 32' ' ' LEU . 61.0 Cg_exo -44.11 176.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.551 2.167 . . . . 0.0 112.946 -178.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.83 11.34 9.31 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.769 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 m -138.35 -156.16 0.66 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.754 0.311 . . . . 0.0 110.483 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.4 p -144.68 162.28 37.09 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.414 -179.75 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.401 ' HB2' HG22 ' A' ' 53' ' ' THR . 41.9 p90 -139.37 163.47 32.42 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.284 -179.708 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -122.22 144.38 49.01 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.309 0.575 . . . . 0.0 110.731 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' PRO . 19.4 t -82.32 125.67 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.535 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 p -68.77 -39.75 80.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.728 179.386 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.456 ' NH2' ' HD1' ' A' ' 50' ' ' HIS . 38.3 ptt-85 -173.24 160.9 4.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.732 -179.44 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 62.4 t -129.55 118.71 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.007 179.087 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.61 111.15 51.27 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.463 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.91 -11.25 19.88 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.065 1.843 . . . . 0.0 112.357 179.843 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.514 ' N ' HD22 ' A' ' 45' ' ' LEU . 4.0 mm? -59.43 -31.59 69.42 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.842 -178.624 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.55 26.32 0.8 Allowed Glycine 0 N--CA 1.469 0.838 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.747 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -97.59 159.9 29.98 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.78 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.45 175.39 0.55 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.308 2.005 . . . . 0.0 111.628 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 60' ' ' LEU . 8.3 mm -94.27 115.33 32.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.794 -179.579 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.456 ' HD1' ' NH2' ' A' ' 41' ' ' ARG . 12.4 m170 -94.6 125.44 39.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.156 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.1 pt -127.15 148.58 31.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.474 179.737 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -130.91 130.33 43.36 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.488 179.784 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.401 HG22 ' HB2' ' A' ' 37' ' ' PHE . 0.7 OUTLIER -124.38 138.06 54.4 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.511 -179.697 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -42.95 -34.62 1.01 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.437 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -69.73 -46.49 65.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.647 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.648 HG22 ' N ' ' A' ' 57' ' ' SER . 14.8 p -170.86 167.57 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 120.922 0.391 . . . . 0.0 111.177 -179.918 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.648 ' N ' HG22 ' A' ' 56' ' ' VAL . 9.9 p -93.25 154.79 17.82 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.599 178.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 64.2 tp -163.3 148.43 11.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.331 179.712 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.45 HG23 ' CD2' ' A' ' 50' ' ' HIS . 4.9 p -128.58 131.4 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.954 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 49' ' ' ILE . 91.7 mt -135.05 161.15 36.13 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.519 -179.428 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -86.33 164.82 16.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.571 179.734 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -59.0 -39.16 80.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.988 0.423 . . . . 0.0 110.542 -179.604 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -61.78 -40.15 94.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.59 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -59.66 -44.88 93.4 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.804 -0.359 . . . . 0.0 110.375 -179.581 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.2 mp -62.62 -41.42 98.99 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.275 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.22 -52.32 65.78 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.403 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.465 HD12 ' HB3' ' A' ' 17' ' ' GLU . 4.0 mm? -69.14 -40.69 78.09 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.301 179.609 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.9 tp -59.87 135.63 57.76 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.331 -179.309 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.445 ' O ' ' OG1' ' A' ' 12' ' ' THR . 70.7 mm-40 -81.51 113.69 19.73 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.547 -179.545 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.0 m -133.93 160.43 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.692 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -143.75 139.53 29.48 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.442 179.761 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.5 136.22 51.16 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.002 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 51.7 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.154 -179.657 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.77 155.93 62.9 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.136 -179.2 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 39' ' ' VAL . 39.1 Cg_endo -65.63 -23.45 56.73 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.596 2.197 . . . . 0.0 112.348 179.91 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -137.36 93.86 2.86 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.66 131.46 27.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.36 -0.382 . . . . 0.0 109.995 -179.969 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.11 101.74 14.27 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.252 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 22.2 m0 -102.85 142.06 34.61 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.083 -179.001 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -94.25 143.41 26.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.899 179.605 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.6 mt -96.66 115.59 36.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 O-C-N 123.23 0.332 . . . . 0.0 110.112 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.5 m -98.81 -44.12 6.5 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.558 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.67 177.34 27.05 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.865 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.7 OUTLIER -86.38 154.09 21.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.875 0.369 . . . . 0.0 110.466 -179.933 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.507 ' O ' HG22 ' A' ' 18' ' ' ILE . 8.1 t -85.11 172.44 11.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.467 179.543 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.401 ' N ' ' OG ' ' A' ' 15' ' ' SER . 99.7 mtt180 -68.11 -39.09 82.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.777 179.712 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.431 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 3.0 tm-20 -69.27 -15.7 63.41 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.561 -179.844 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 15' ' ' SER . 10.6 tp -40.81 146.72 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.427 -179.567 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.4 m -80.61 143.7 55.34 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.741 -179.375 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -49.31 -39.14 43.5 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.801 1.667 . . . . 0.0 112.609 179.056 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.43 -57.83 9.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.866 0.365 . . . . 0.0 111.043 -178.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -63.69 -43.71 95.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.447 0.642 . . . . 0.0 110.551 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -57.85 -44.97 86.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.956 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -62.7 -35.72 80.62 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.541 179.178 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.2 mmtt -59.46 -44.15 93.05 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.714 179.667 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.517 HD13 HD11 ' A' ' 29' ' ' LEU . 4.6 mm? -63.32 -42.16 98.97 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.163 178.725 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.84 -39.49 94.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.745 179.901 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.7 m -61.43 -44.64 96.77 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.317 -179.461 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.517 HD11 HD13 ' A' ' 26' ' ' LEU . 2.1 pp -92.85 138.07 31.81 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.521 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.85 -2.19 90.04 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.216 -0.753 . . . . 0.0 111.216 -179.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 48.3 ttp -86.82 75.29 9.63 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.681 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -82.56 169.96 16.33 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.034 -179.262 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' A' ' 32' ' ' LEU . 73.7 Cg_exo -44.76 -179.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.531 2.154 . . . . 0.0 112.454 -179.652 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.96 11.67 7.5 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 179.609 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 86.7 p -144.33 -157.76 0.82 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.673 0.273 . . . . 0.0 110.306 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 82.8 p -140.83 164.62 29.75 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.628 -179.822 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.447 ' HB2' HG22 ' A' ' 53' ' ' THR . 41.9 p90 -143.14 162.12 36.41 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.373 -179.696 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.445 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 22.2 p-10 -119.38 148.19 43.49 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.429 0.633 . . . . 0.0 110.638 179.692 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 5' ' ' PRO . 5.9 t -84.43 127.09 40.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.448 -179.716 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.416 ' H ' HG12 ' A' ' 40' ' ' VAL . 1.8 p -68.67 -39.21 80.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.813 179.464 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.412 ' HE ' HG22 ' A' ' 40' ' ' VAL . 19.3 ptp180 -172.82 160.65 4.47 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.132 -179.377 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 67.4 t -125.67 126.36 70.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.129 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.8 111.56 53.3 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.582 -179.787 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -75.74 -11.77 20.15 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.181 1.921 . . . . 0.0 112.314 -179.946 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.9 mt -58.46 -29.91 66.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.805 -178.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.96 27.42 2.08 Favored Glycine 0 N--CA 1.467 0.72 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -97.51 178.31 1.39 Allowed Pre-proline 0 CA--C 1.531 0.237 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.817 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 47' ' ' ASP . 19.5 Cg_exo -64.28 -177.88 0.56 Allowed 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.047 1.832 . . . . 0.0 112.265 -179.888 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.8 mm -106.57 117.84 53.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.885 -179.186 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.461 ' CD2' HG13 ' A' ' 59' ' ' VAL . 17.5 m170 -96.62 125.05 40.82 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.261 179.788 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.7 pt -123.63 147.85 27.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.134 179.49 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.445 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 13.3 tm-20 -132.59 130.09 39.81 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.182 -179.603 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.522 ' O ' ' N ' ' A' ' 55' ' ' ARG . 1.0 OUTLIER -122.44 136.78 54.97 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.883 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.8 ptt85 -40.4 -22.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.865 -179.632 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.527 ' O ' HG13 ' A' ' 56' ' ' VAL . 94.1 mtm-85 -86.07 -49.88 7.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.101 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 55' ' ' ARG . 16.6 m -160.43 -175.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.456 -179.224 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.3 p -128.5 150.88 49.97 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.707 179.601 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.0 tp -154.28 150.5 28.07 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.16 -179.831 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.461 HG13 ' CD2' ' A' ' 50' ' ' HIS . 56.0 t -117.45 130.4 72.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.954 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 98.1 mt -135.92 139.74 43.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.979 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.564 ' O ' ' N ' ' A' ' 64' ' ' ASP . 81.8 mtp180 -78.34 142.18 37.88 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.576 179.635 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 61' ' ' ARG . 16.8 ptpt -35.22 -35.18 0.04 OUTLIER 'General case' 0 C--O 1.235 0.301 0 O-C-N 123.313 0.383 . . . . 0.0 111.385 179.799 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 61' ' ' ARG . 54.9 mtpt -62.82 -44.78 95.24 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.159 179.149 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.564 ' N ' ' O ' ' A' ' 61' ' ' ARG . 10.6 m-20 -64.13 -36.27 83.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.233 179.024 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.542 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.0 mm? -62.22 -42.86 99.69 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.725 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.16 -44.1 93.11 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.994 0.426 . . . . 0.0 110.088 179.433 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.409 HD22 ' HB3' ' A' ' 17' ' ' GLU . 97.9 mt -68.23 -38.97 82.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.658 179.559 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.5 tp -69.78 125.09 25.7 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.849 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -76.03 115.48 15.79 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.091 -179.674 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.9 m -131.87 158.73 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.731 -179.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -143.32 144.58 32.15 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.429 179.645 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.27 140.77 54.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.924 179.274 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.4 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.385 -179.927 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 C--O 1.231 0.112 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.81 159.34 47.38 Favored Pre-proline 0 N--CA 1.465 0.314 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.203 -179.525 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 39' ' ' VAL . 43.8 Cg_endo -66.82 -32.63 36.19 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.688 2.259 . . . . 0.0 112.119 -179.826 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -136.62 95.5 3.16 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.906 -179.758 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 t -140.11 148.79 42.22 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.382 179.313 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -101.04 102.09 13.0 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.156 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 19.8 m0 -98.48 136.41 38.64 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.178 -179.008 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -95.45 129.5 42.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.969 179.805 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.6 mt -81.86 123.67 38.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.21 -179.296 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 11.7 p -108.14 -17.94 13.9 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.498 179.845 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 136.2 -179.04 18.28 Favored Glycine 0 N--CA 1.464 0.539 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.852 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -98.68 150.87 21.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.879 0.371 . . . . 0.0 110.472 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.412 ' O ' HG22 ' A' ' 18' ' ' ILE . 5.6 t -77.13 171.64 14.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.491 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.402 ' N ' ' OG ' ' A' ' 15' ' ' SER . 9.1 mpt_? -71.78 -40.64 69.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.503 -179.802 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -66.37 -13.1 60.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.248 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 15' ' ' SER . 10.1 tp -40.61 148.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.618 -179.828 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 72.0 p -81.16 142.78 51.61 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.687 -179.46 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -49.04 -38.15 39.12 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.916 1.744 . . . . 0.0 112.638 178.938 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.97 -57.4 12.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.877 0.37 . . . . 0.0 111.451 -178.909 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -63.02 -48.48 78.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.271 0.558 . . . . 0.0 110.579 -179.623 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.5 ttp85 -58.43 -46.37 86.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.168 0.509 . . . . 0.0 110.243 -179.677 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -60.46 -31.04 70.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.576 179.382 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -61.18 -44.95 96.48 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.867 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.6 mm? -61.77 -43.1 99.52 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.308 179.621 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.75 -38.71 92.13 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.692 179.554 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.0 t -60.46 -43.92 96.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.023 -179.212 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.475 ' CD1' ' O ' ' A' ' 31' ' ' MET . 2.3 pp -97.5 131.53 44.03 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.475 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.5 -21.53 74.51 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.475 ' O ' ' CD1' ' A' ' 29' ' ' LEU . 26.0 mmt -69.48 76.29 0.4 Allowed 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -82.2 169.69 17.48 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.324 -178.984 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 32' ' ' LEU . 71.3 Cg_exo -46.5 -178.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.435 2.09 . . . . 0.0 112.275 -179.475 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.89 8.91 9.34 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 179.665 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 m -138.03 -158.25 0.84 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.784 0.326 . . . . 0.0 110.256 179.657 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.7 t -141.6 153.06 44.55 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.46 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -128.37 157.41 41.09 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.339 -179.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 39' ' ' VAL . 50.0 t-20 -110.05 146.94 34.51 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.543 -179.803 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.529 ' N ' ' OD1' ' A' ' 38' ' ' ASN . 54.3 t -88.22 126.52 41.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.041 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 p -70.27 -40.64 78.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.075 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -173.73 159.25 3.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.152 -179.279 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.4 t -131.31 120.93 47.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.772 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.49 110.75 50.69 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.444 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -76.7 -11.69 18.42 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.2 1.933 . . . . 0.0 112.299 179.805 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.8 mt -59.39 -30.91 68.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.956 -178.551 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.24 22.77 0.7 Allowed Glycine 0 N--CA 1.465 0.568 0 N-CA-C 111.006 -0.837 . . . . 0.0 111.006 179.755 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.6 159.8 30.19 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.11 171.7 2.12 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.795 2.33 . . . . 0.0 111.939 -179.814 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.4 mm -92.56 114.27 29.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.799 -179.255 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -92.0 122.21 34.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.893 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.422 ' O ' ' O ' ' A' ' 58' ' ' LEU . 45.6 pt -127.54 149.17 32.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.326 -179.966 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -126.85 129.87 49.1 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.375 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.95 138.87 54.56 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.847 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -41.16 -37.03 0.83 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.346 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.404 HH11 ' HB3' ' A' ' 31' ' ' MET . 57.9 ttp180 -65.47 -49.02 70.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.555 179.836 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.63 HG22 ' H ' ' A' ' 57' ' ' SER . 7.1 p -171.13 173.1 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.803 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.63 ' H ' HG22 ' A' ' 56' ' ' VAL . 40.0 t -92.11 136.71 32.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.151 178.812 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 51' ' ' ILE . 64.1 tp -143.03 148.72 37.21 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.791 0.329 . . . . 0.0 110.154 -179.877 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 p -130.13 130.54 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.099 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.4 mt -134.59 155.69 50.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.323 -179.506 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -77.63 170.15 17.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.683 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.15 -47.07 87.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.132 0.492 . . . . 0.0 110.578 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -58.41 -38.23 76.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.733 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -58.07 -46.56 85.24 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.37 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.0 mp -62.75 -41.49 99.24 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.175 179.172 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.68 -53.11 59.14 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.365 -179.711 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.2 mm? -68.57 -41.11 80.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.146 179.482 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.2 tp -58.15 133.13 55.33 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.185 -179.038 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.429 ' O ' ' OG1' ' A' ' 12' ' ' THR . 47.6 mm-40 -77.85 110.42 12.72 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.312 -179.46 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.36 156.9 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.472 179.608 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -141.79 137.05 31.27 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.493 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.45 117.48 27.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.203 179.768 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.454 HG23 ' H ' ' A' ' 73' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.343 -179.671 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 . . . . . 0 CA--C 1.522 -0.13 0 CA-C-O 120.907 0.384 . . . . 0.0 109.977 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.66 159.13 32.4 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.12 -179.257 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 39' ' ' VAL . 42.6 Cg_endo -67.5 -20.19 47.97 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.697 2.264 . . . . 0.0 112.078 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -136.47 93.81 2.93 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.823 0.344 . . . . 0.0 110.121 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.51 131.64 28.05 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.838 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.88 102.12 14.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.228 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 21.1 m0 -100.04 140.37 34.35 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.118 -179.353 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -101.39 125.23 48.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.733 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.2 mt -81.14 123.6 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.393 -179.169 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.9 p -105.29 -16.16 14.84 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.436 179.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.39 163.08 9.64 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.516 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.84 159.54 33.59 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.56 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 p -77.35 167.41 21.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.643 -179.733 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.25 -40.44 74.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.863 0.363 . . . . 0.0 110.7 179.508 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -80.47 -2.39 45.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.145 -179.725 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.6 tp -40.42 146.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.561 -179.406 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.2 p -76.23 137.95 68.3 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.461 -179.258 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -46.92 -41.97 25.42 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.883 1.722 . . . . 0.0 112.666 179.195 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.83 -54.28 44.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.912 0.387 . . . . 0.0 111.228 -179.181 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -63.07 -49.24 75.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.355 0.598 . . . . 0.0 110.557 -179.859 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.1 ttt-85 -57.2 -42.67 81.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.088 -179.247 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.524 ' NE2' ' OG ' ' A' ' 28' ' ' SER . 12.4 tm0? -62.52 -34.99 78.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.02 179.332 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -59.22 -46.47 88.36 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.942 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.492 HD22 ' N ' ' A' ' 26' ' ' LEU . 4.6 mm? -65.19 -37.79 88.46 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.821 179.557 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 tt -75.66 -23.83 56.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.082 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.524 ' OG ' ' NE2' ' A' ' 24' ' ' GLN . 49.1 m -58.11 -44.09 87.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.903 0.382 . . . . 0.0 111.317 -179.2 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.588 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -116.9 156.65 27.0 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.162 -179.675 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -63.16 -26.24 69.04 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.769 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 86.9 mtp -61.55 73.96 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.006 0.432 . . . . 0.0 110.109 -179.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -85.38 169.2 16.72 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.585 -178.357 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 32' ' ' LEU . 55.7 Cg_exo -47.69 -177.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.075 1.85 . . . . 0.0 112.009 -179.764 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.63 -4.63 39.95 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.537 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.8 m -101.18 -169.6 1.72 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.713 0.292 . . . . 0.0 110.25 179.544 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.1 t -133.05 151.26 52.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.383 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -138.11 163.53 31.42 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.228 -179.654 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -122.57 146.67 47.21 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.446 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 5' ' ' PRO . 62.1 t -85.48 126.75 40.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.295 -179.83 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 40' ' ' VAL . 2.2 p -70.04 -41.1 79.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.16 179.736 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.3 ptt-85 -174.25 169.42 3.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.966 -179.209 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.6 m -136.12 116.62 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.123 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.31 111.3 51.39 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.311 -179.745 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.497 ' C ' ' H ' ' A' ' 46' ' ' GLY . 60.3 Cg_endo -75.45 -11.76 20.68 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.287 1.991 . . . . 0.0 112.054 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.524 HD22 ' N ' ' A' ' 45' ' ' LEU . 4.2 mm? -53.0 -6.69 0.06 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.58 -178.978 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.497 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 104.37 23.69 7.88 Favored Glycine 0 N--CA 1.462 0.418 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.613 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.73 165.01 16.31 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 -179.491 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -58.06 -170.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.025 1.817 . . . . 0.0 111.704 179.257 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.8 mm -106.36 112.9 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -88.19 120.49 29.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.958 -179.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 58' ' ' LEU . 48.6 pt -126.33 147.99 31.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.144 179.901 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -127.97 129.43 46.76 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.306 179.649 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 p -114.19 136.7 52.67 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.807 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -39.04 -35.39 0.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.808 -179.433 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.556 ' O ' HG13 ' A' ' 56' ' ' VAL . 18.9 mmm180 -73.3 -49.29 28.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.109 -179.537 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 55' ' ' ARG . 15.6 m -160.94 -176.84 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.517 -179.472 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 p -106.58 148.21 28.55 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.699 179.721 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' A' ' 51' ' ' ILE . 61.0 tp -154.6 150.31 27.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.473 179.896 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 59' ' ' VAL . 12.1 p -127.57 131.33 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.82 179.194 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.6 mt -136.69 159.71 41.02 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.308 -179.445 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.405 ' HG2' ' N ' ' A' ' 62' ' ' LYS . 69.1 ttt180 -85.06 166.63 16.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.339 -179.583 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.405 ' N ' ' HG2' ' A' ' 61' ' ' ARG . 88.2 tttt -58.49 -44.43 89.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.856 0.36 . . . . 0.0 110.588 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -57.38 -39.92 77.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.723 -179.719 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -60.27 -45.15 94.3 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.394 179.992 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.5 -41.04 98.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.786 0.326 . . . . 0.0 110.127 179.47 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.06 -40.79 98.73 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.565 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.9 mt -75.8 -48.82 20.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.355 -179.641 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.2 mt -55.74 133.09 50.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.351 -179.151 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -74.27 109.38 7.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.192 -179.401 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.48 159.74 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.436 179.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -139.82 126.34 20.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.513 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.92 124.13 22.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.91 179.771 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.464 0.233 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.42 179.846 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.44 ' SD ' ' N ' ' A' ' 1' ' ' MET . 2.6 mpt? . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -62.82 -44.22 96.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.547 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -105.75 137.11 44.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.922 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.9 158.87 74.41 Favored Pre-proline 0 N--CA 1.468 0.441 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 39' ' ' VAL . 44.1 Cg_endo -66.97 -19.41 52.05 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.549 2.166 . . . . 0.0 112.369 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -136.98 92.63 2.75 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.83 131.81 26.14 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.63 102.22 14.39 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.447 ' CZ3' HD12 ' A' ' 65' ' ' LEU . 22.4 m0 -101.44 132.04 47.24 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.191 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -86.84 136.63 32.9 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.8 mt -92.4 117.93 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 12.5 p -104.21 -32.24 9.22 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.73 0.3 . . . . 0.0 110.25 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.72 174.48 21.79 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -90.15 153.49 20.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.801 0.334 . . . . 0.0 110.334 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.464 ' O ' HG22 ' A' ' 18' ' ' ILE . 1.5 t -80.73 168.32 18.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.659 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -68.36 -40.57 81.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.877 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -63.63 -17.4 62.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.419 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 15' ' ' SER . 10.8 tp -41.89 147.42 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.587 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.98 155.15 84.78 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.343 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.98 -31.03 66.86 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.562 2.175 . . . . 0.0 112.213 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.24 -56.82 12.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.142 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -61.44 -44.2 97.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.65 0.738 . . . . 0.0 110.543 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -58.0 -47.62 82.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.589 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 45.4 tp60 -57.98 -37.27 73.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.532 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -57.91 -40.82 81.33 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.388 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.506 HD13 HD11 ' A' ' 29' ' ' LEU . 4.4 mm? -61.38 -42.86 99.39 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.81 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.92 -39.95 96.11 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.199 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.5 m -60.47 -44.11 96.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.795 0.331 . . . . 0.0 111.205 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.506 HD11 HD13 ' A' ' 26' ' ' LEU . 2.2 pp -93.5 132.65 37.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.555 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.94 -2.02 69.86 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 71.8 mtm -86.95 75.0 9.62 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -82.6 168.62 22.08 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.127 -179.199 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.451 ' O ' ' O ' ' A' ' 32' ' ' LEU . 77.5 Cg_exo -43.47 177.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.603 2.202 . . . . 0.0 112.412 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.95 11.96 7.34 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.487 ' OG ' ' N ' ' A' ' 36' ' ' SER . 34.9 t -144.2 -172.0 3.69 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.848 0.356 . . . . 0.0 110.344 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.487 ' N ' ' OG ' ' A' ' 35' ' ' SER . 67.7 m -128.28 155.7 44.18 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.517 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -135.53 159.14 42.55 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.349 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -111.97 150.64 30.28 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.572 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' PRO . 13.1 t -86.1 126.82 40.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.526 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 p -67.86 -41.46 84.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.825 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -173.78 161.51 3.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.994 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.471 ' O ' HG23 ' A' ' 42' ' ' VAL . 33.2 m -129.86 121.99 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.33 110.57 49.37 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.507 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -76.65 -11.74 18.5 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.042 1.828 . . . . 0.0 112.327 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.0 mt -59.67 -31.04 69.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.996 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 132.12 24.83 0.77 Allowed Glycine 0 N--CA 1.468 0.772 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.71 160.36 28.8 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.93 175.42 0.46 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.86 2.374 . . . . 0.0 112.02 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.6 mm -92.05 114.81 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.885 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -92.74 122.16 34.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.872 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.5 pt -127.5 150.69 33.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.801 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -128.83 137.64 51.61 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.128 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 55' ' ' ARG . 0.7 OUTLIER -129.49 138.27 51.29 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.753 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -43.78 -21.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.59 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 53' ' ' THR . 85.0 mtt85 -82.81 -48.81 10.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.533 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.635 HG22 ' N ' ' A' ' 57' ' ' SER . 14.9 p -169.66 168.55 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.665 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.635 ' N ' HG22 ' A' ' 56' ' ' VAL . 5.3 p -99.6 146.15 26.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.551 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.7 tp -155.96 147.86 23.18 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.335 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.669 ' O ' HD12 ' A' ' 60' ' ' LEU . 3.3 p -126.68 131.43 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.615 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.669 HD12 ' O ' ' A' ' 59' ' ' VAL . 2.6 mp -132.95 155.05 49.82 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.056 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -72.91 162.09 29.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.941 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -54.55 -45.9 73.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.869 0.366 . . . . 0.0 110.807 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -59.98 -40.67 89.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.526 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -61.12 -40.76 95.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.495 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.447 HD12 ' CZ3' ' A' ' 9' ' ' TRP . 2.2 mm? -63.06 -42.12 99.63 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.24 93.52 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.214 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.27 -42.13 84.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.221 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.5 mt -66.81 135.74 54.39 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.626 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.453 ' O ' ' OG1' ' A' ' 12' ' ' THR . 94.6 mt-10 -79.97 113.25 17.99 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.142 0.496 . . . . 0.0 110.175 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.9 m -132.16 155.94 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.747 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -142.54 137.9 30.48 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.754 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.9 148.03 51.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.145 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 38.7 t -113.28 132.43 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.347 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 65.4 p -150.21 11.88 0.73 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.549 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.3 t -61.86 -42.48 99.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.427 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.0 mt 49.18 87.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.226 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -136.64 140.49 42.81 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.109 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -140.05 144.57 36.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.185 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -114.85 143.33 45.28 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.289 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -91.83 125.04 36.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.454 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -59.86 -45.69 91.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.651 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -150.23 152.82 35.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.511 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 78.9 m80 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.624 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.6 mtp . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -66.51 -24.49 66.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -71.73 138.2 48.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.566 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.91 155.99 74.46 Favored Pre-proline 0 N--CA 1.467 0.38 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 39' ' ' VAL . 43.3 Cg_endo -66.79 -22.19 49.95 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.51 2.14 . . . . 0.0 112.288 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 6' ' ' ASP . 39.1 p-10 -137.42 93.61 2.83 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.735 0.302 . . . . 0.0 110.304 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.51 129.81 25.4 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.6 102.44 15.18 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 18.1 m0 -101.57 137.52 39.78 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.933 0.397 . . . . 0.0 110.322 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -95.24 129.57 42.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.038 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.2 mt -82.42 122.62 37.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.123 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 8.9 p -110.75 -19.33 12.89 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.559 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.72 -179.95 22.41 Favored Glycine 0 N--CA 1.464 0.559 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -100.12 157.42 16.58 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.848 0.356 . . . . 0.0 110.321 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 67' ' ' LEU . 15.5 m -74.8 165.76 24.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.765 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -70.54 -38.99 74.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.56 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -74.15 -6.34 47.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.383 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.6 tp -41.41 146.58 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.449 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.42 155.2 93.04 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.248 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.82 -31.27 68.23 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.415 2.077 . . . . 0.0 112.13 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.46 -53.47 42.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.224 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -63.06 -46.4 87.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.745 0.783 . . . . 0.0 110.652 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 67.0 ttp85 -57.99 -44.18 86.99 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.729 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -61.09 -36.12 78.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.08 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -59.22 -43.0 92.32 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.437 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.6 mm? -62.43 -43.66 98.28 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.032 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 49.1 mt -70.35 -32.56 70.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.81 0.338 . . . . 0.0 111.091 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.5 m -58.91 -44.03 91.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.334 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.495 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -118.73 173.21 7.0 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.295 -179.691 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -88.92 -3.14 77.11 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 33.2 ttm -64.6 74.18 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.2 mp -99.8 169.96 7.38 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.289 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 32' ' ' LEU . 62.9 Cg_exo -49.67 -164.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.331 2.021 . . . . 0.0 112.564 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.77 5.1 56.74 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.9 m -138.63 -156.28 0.67 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.813 0.34 . . . . 0.0 110.2 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.5 p -146.38 164.23 33.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.505 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -139.21 151.54 46.64 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.232 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -108.84 146.98 32.81 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.431 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' PRO . 10.0 t -87.03 127.15 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.597 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 50' ' ' HIS . 2.2 p -69.93 -39.05 77.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.885 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -173.44 166.93 4.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.284 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.518 ' O ' HG23 ' A' ' 42' ' ' VAL . 36.0 m -139.29 117.02 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.62 110.91 50.04 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.492 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.19 -11.68 19.34 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.135 1.89 . . . . 0.0 112.312 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.2 mt -58.58 -30.54 67.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.744 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.48 25.37 0.78 Allowed Glycine 0 N--CA 1.467 0.712 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.68 160.25 29.08 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -60.2 172.06 2.73 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.754 2.302 . . . . 0.0 111.88 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.2 mm -96.87 119.06 44.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.163 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.47 ' CD2' HG23 ' A' ' 59' ' ' VAL . 11.8 m170 -101.97 131.02 48.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.117 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.7 pt -127.26 149.84 32.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.5 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -138.91 144.42 39.09 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.034 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 56' ' ' VAL . 1.0 OUTLIER -132.5 173.15 11.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.515 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 53' ' ' THR . 99.8 mtt180 -33.6 -52.25 0.4 Allowed 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.35 0.406 . . . . 0.0 111.788 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -142.93 32.44 1.39 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.008 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 53' ' ' THR . 2.3 t -141.54 139.13 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.82 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.0 m -137.53 143.22 41.53 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.45 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.6 tp -161.57 152.49 18.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.203 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.47 HG23 ' CD2' ' A' ' 50' ' ' HIS . 4.2 p -122.32 128.87 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.7 mt -136.66 161.52 35.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.366 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -85.47 162.55 18.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.801 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -58.09 -37.55 74.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.605 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -61.8 -41.1 97.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.535 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -59.84 -45.86 91.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.347 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.2 mp -62.02 -41.08 97.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.264 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.03 -47.27 83.57 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.276 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.476 ' O ' ' OG ' ' A' ' 15' ' ' SER . 11.1 mp -75.98 -52.52 10.07 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.336 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.6 tp -43.03 128.66 4.42 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.479 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.45 ' O ' ' OG1' ' A' ' 12' ' ' THR . 78.8 mm-40 -70.28 109.52 4.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.237 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.0 m -137.88 159.36 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.544 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -141.31 124.66 16.58 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.518 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.9 132.4 49.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.873 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.9 m -134.89 160.26 41.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.418 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.0 m -139.38 36.91 2.07 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.575 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 63.2 m -130.96 120.53 23.66 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.968 0.414 . . . . 0.0 110.375 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 77.8 mt -93.95 -2.73 52.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.511 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -133.04 149.75 52.16 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.306 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -143.8 65.15 1.31 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.343 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 61.1 m170 44.97 79.02 0.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.672 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.468 ' CD2' ' N ' ' A' ' 81' ' ' HIS . 35.0 p-80 -60.37 -44.15 95.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.611 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.468 ' N ' ' CD2' ' A' ' 80' ' ' HIS . 85.9 t60 44.59 96.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.728 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -70.71 135.92 48.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.532 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.625 179.952 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.6 mtp . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -64.54 -46.13 84.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.961 0.41 . . . . 0.0 110.966 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -78.21 140.41 38.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.637 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.431 ' OG1' HG21 ' A' ' 7' ' ' THR . 13.0 p -138.46 148.94 61.11 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.773 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 39' ' ' VAL . 42.8 Cg_endo -66.56 -52.46 0.76 Allowed 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.438 2.092 . . . . 0.0 112.34 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -117.14 94.47 4.58 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.873 0.368 . . . . 0.0 110.917 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.431 HG21 ' OG1' ' A' ' 4' ' ' THR . 1.5 t -141.39 150.3 42.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.13 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -99.6 102.21 13.66 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 18.4 m0 -97.8 137.62 36.39 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.285 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -93.55 140.91 29.06 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.4 mt -93.79 119.46 41.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 123.357 0.411 . . . . 0.0 110.248 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.5 m -102.21 -46.99 4.66 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.494 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.57 177.07 32.33 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.2 p90 -95.84 146.48 24.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.809 0.338 . . . . 0.0 110.322 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.47 ' O ' HG22 ' A' ' 18' ' ' ILE . 40.0 t -77.55 172.2 13.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.485 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -69.68 -39.61 76.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.882 0.372 . . . . 0.0 110.806 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -67.44 -14.36 62.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.386 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 15' ' ' SER . 10.4 tp -41.5 147.41 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.751 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.41 154.72 87.9 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.354 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.91 -31.3 67.33 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.67 2.247 . . . . 0.0 111.989 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.99 -54.78 25.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.984 0.421 . . . . 0.0 111.116 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -62.58 -44.98 94.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.594 0.711 . . . . 0.0 110.308 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -57.82 -39.93 78.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.821 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 28' ' ' SER . 15.9 mm-40 -63.77 -36.25 83.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.948 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -60.31 -44.81 95.09 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.55 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.407 ' N ' HD22 ' A' ' 26' ' ' LEU . 4.5 mm? -64.2 -41.56 97.02 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.175 178.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 tt -75.16 -28.1 59.96 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.107 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.527 ' N ' ' O ' ' A' ' 24' ' ' GLN . 14.5 t -61.2 -44.67 96.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.171 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.522 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -115.45 169.21 9.34 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.257 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.53 5.86 84.23 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.2 tpt -76.89 73.82 3.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.898 0.38 . . . . 0.0 110.05 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.8 mp -95.8 166.73 13.93 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.424 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 32' ' ' LEU . 77.9 Cg_exo -45.11 178.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.265 1.977 . . . . 0.0 112.162 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.43 3.4 14.61 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 m -141.31 -157.05 0.73 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.818 0.342 . . . . 0.0 110.26 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 89.3 p -143.78 163.29 33.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.397 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -140.93 159.79 41.46 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.332 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -113.26 144.76 42.17 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.567 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 5' ' ' PRO . 99.2 t -85.98 129.13 38.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.287 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.401 HG22 ' HE ' ' A' ' 41' ' ' ARG . 2.4 p -67.29 -41.84 87.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.187 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.401 ' HE ' HG22 ' A' ' 40' ' ' VAL . 20.1 ptp180 -174.9 161.13 2.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.94 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.2 t -131.88 122.47 49.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.1 110.82 50.38 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.406 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.61 -11.22 20.41 Favored 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 122.287 1.992 . . . . 0.0 112.226 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.533 HD22 ' N ' ' A' ' 45' ' ' LEU . 4.1 mm? -60.65 -31.8 71.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.986 -178.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 132.72 24.69 0.73 Allowed Glycine 0 N--CA 1.465 0.611 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.23 160.17 29.56 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.57 170.09 2.04 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.682 2.254 . . . . 0.0 111.78 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.5 mm -95.46 114.42 32.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.872 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.578 ' CD2' HG23 ' A' ' 59' ' ' VAL . 12.3 m170 -97.13 125.85 41.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.709 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.445 HG22 HG22 ' A' ' 39' ' ' VAL . 44.8 pt -125.99 150.05 31.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.699 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -134.98 111.97 10.23 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.987 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 54' ' ' ARG . 1.3 p -83.5 173.89 11.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.511 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 53' ' ' THR . 91.2 mtm180 -33.68 -53.14 0.43 Allowed 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.409 0.443 . . . . 0.0 111.779 -178.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -142.53 31.67 1.49 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.323 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 t -140.57 136.95 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.499 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.1 p -112.0 138.81 48.12 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.181 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.8 tp -155.22 149.88 26.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.079 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.578 HG23 ' CD2' ' A' ' 50' ' ' HIS . 9.1 p -124.24 128.44 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.79 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.6 mt -133.62 161.16 35.38 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.417 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -94.74 160.47 14.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.418 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -53.32 -37.31 62.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.916 0.389 . . . . 0.0 110.642 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.43 -42.18 99.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.39 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -60.83 -42.1 97.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.342 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.2 -41.81 98.71 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.074 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.72 -51.7 68.83 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.35 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.1 mm? -69.17 -40.18 78.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.019 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.7 tp -60.16 136.08 57.92 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -86.86 109.9 19.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.038 0.447 . . . . 0.0 110.37 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 m -132.6 157.11 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.628 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -142.4 143.93 32.89 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.854 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.17 147.09 53.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.041 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.8 t -108.44 130.42 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.198 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.1 p -155.51 156.96 36.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.264 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.9 m 38.6 80.79 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.812 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 56.5 tp -62.67 -43.09 99.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.273 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.525 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 96.5 mt-10 42.63 76.05 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.57 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.525 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 38.7 p-80 41.27 -164.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.547 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -101.97 122.73 44.62 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.869 0.366 . . . . 0.0 110.27 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -85.07 136.71 33.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.282 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.493 ' CG ' ' O ' ' A' ' 81' ' ' HIS . 42.5 p-80 -87.61 86.64 7.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.498 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -65.68 -43.64 88.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.448 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.512 ' ND1' ' OXT' ' A' ' 83' ' ' HIS . 60.1 t-80 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.536 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -150.35 -7.94 0.29 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.858 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -85.66 90.89 8.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.806 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.32 151.66 56.84 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.321 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 39' ' ' VAL . 42.5 Cg_endo -66.11 -27.49 49.4 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.513 2.142 . . . . 0.0 111.876 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -135.69 94.52 3.09 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.907 0.384 . . . . 0.0 110.703 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.4 ' HG1' ' HE1' ' A' ' 9' ' ' TRP . 1.8 t -140.44 152.24 45.53 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.137 179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.74 102.79 14.64 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.4 ' HE1' ' HG1' ' A' ' 7' ' ' THR . 12.9 m0 -99.69 134.32 42.74 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.217 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -97.79 130.44 44.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.816 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.9 mt -84.03 118.33 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.265 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.5 m -99.12 -35.63 9.95 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.032 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 144.75 176.89 19.15 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -89.03 146.29 24.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.818 0.342 . . . . 0.0 110.33 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.5 m -74.99 171.19 14.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.429 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.1 ttm-85 -69.31 -41.32 76.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.549 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -72.44 -4.72 31.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.664 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.1 tp -41.84 147.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.665 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 m -68.12 152.11 96.71 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.058 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.97 -31.22 56.4 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.427 2.085 . . . . 0.0 112.075 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.74 -53.93 23.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.492 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.404 ' CE1' ' CD2' ' A' ' 26' ' ' LEU . 33.4 t80 -61.65 -44.25 97.32 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.295 0.569 . . . . 0.0 110.335 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -59.7 -42.78 93.76 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.825 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.4 HE22 ' HB3' ' A' ' 28' ' ' SER . 19.6 tm0? -61.8 -37.21 83.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.641 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -59.9 -45.67 91.79 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.746 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.414 ' HA ' HD13 ' A' ' 26' ' ' LEU . 4.6 mm? -62.86 -41.33 99.33 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.497 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.2 mt -62.18 -38.75 90.26 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.392 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.4 ' HB3' HE22 ' A' ' 24' ' ' GLN . 3.3 p -80.13 -10.24 59.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.835 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.1 tp -100.16 126.87 46.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.482 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.28 1.9 73.71 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 77.3 mtm -108.81 74.82 0.93 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.259 0.552 . . . . 0.0 109.701 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.3 mp -78.87 165.94 45.79 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.831 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 32' ' ' LEU . 68.1 Cg_exo -42.65 179.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.788 2.325 . . . . 0.0 113.043 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.0 11.86 7.36 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.2 p -143.07 -160.38 1.1 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.72 0.295 . . . . 0.0 110.396 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 97.6 p -139.98 165.15 28.1 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.542 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -143.63 169.12 18.33 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.438 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 16.4 p-10 -124.88 151.64 45.06 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.306 0.574 . . . . 0.0 110.279 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' PRO . 16.6 t -87.06 124.94 40.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.425 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.458 ' H ' HG12 ' A' ' 40' ' ' VAL . 2.0 p -71.63 -39.81 70.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.913 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -172.99 166.76 5.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.672 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 42' ' ' VAL . 33.3 m -149.31 104.65 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.894 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.83 111.29 53.84 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.405 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -75.87 -9.96 19.69 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.455 2.103 . . . . 0.0 112.348 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.518 ' N ' HD12 ' A' ' 45' ' ' LEU . 10.6 mp -52.12 -30.15 25.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.768 -178.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 147.36 16.15 0.13 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -97.96 153.05 38.33 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.26 -175.03 0.47 Allowed 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.216 1.944 . . . . 0.0 111.778 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.43 HG21 ' CD2' ' A' ' 65' ' ' LEU . 12.8 mm -91.49 114.55 28.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.716 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.462 ' CD2' HG23 ' A' ' 59' ' ' VAL . 12.0 m170 -95.71 120.49 36.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.233 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.4 pt -125.18 144.42 35.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.229 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.435 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 13.1 tm-20 -123.62 124.66 43.28 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.187 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.49 141.25 48.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.336 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.415 ' H ' ' HG2' ' A' ' 54' ' ' ARG . 21.5 mmt85 -50.11 -38.94 41.19 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.978 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -67.77 -41.06 83.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.756 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.746 HG22 ' H ' ' A' ' 57' ' ' SER . 13.1 p -170.7 177.18 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.578 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.746 ' H ' HG22 ' A' ' 56' ' ' VAL . 47.8 t -111.48 145.11 39.6 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.273 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.416 HD21 HD11 ' A' ' 60' ' ' LEU . 62.3 tp -147.76 149.21 31.95 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.552 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 59' ' ' VAL . 7.7 p -137.19 122.98 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.416 HD11 HD21 ' A' ' 58' ' ' LEU . 96.7 mt -140.98 175.95 9.2 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.442 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -86.64 162.69 17.82 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.07 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -58.37 -32.91 69.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.611 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.06 -41.6 98.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.209 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -60.08 -44.62 94.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.496 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.43 ' CD2' HG21 ' A' ' 49' ' ' ILE . 7.8 mp -62.01 -40.91 97.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.976 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.85 -48.86 78.57 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.455 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.14 -40.24 86.68 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.888 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 77.1 mt -66.62 140.64 57.94 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.511 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -84.29 108.66 17.27 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.443 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.1 m -132.38 158.91 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.296 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -143.09 129.57 20.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.48 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.61 129.21 36.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.683 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.7 m -128.45 155.87 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.19 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.1 t -106.31 -32.91 7.96 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.666 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.4 p -72.92 143.42 47.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.555 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 77' ' ' GLU . 45.9 tp -64.25 -51.36 63.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.14 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 76' ' ' LEU . 96.7 mt-10 35.59 52.87 0.78 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.408 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.494 ' O ' ' N ' ' A' ' 80' ' ' HIS . 18.5 t-80 -63.96 -44.12 93.73 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.841 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 74.1 m80 43.12 -92.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.756 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 78' ' ' HIS . 86.6 t60 47.51 71.66 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.596 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -84.75 -11.07 56.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.477 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.551 ' CG ' ' N ' ' A' ' 83' ' ' HIS . 85.9 t60 48.39 -108.45 0.26 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.592 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.551 ' N ' ' CG ' ' A' ' 82' ' ' HIS . 54.4 t-80 . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.561 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mtp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -64.76 -40.16 94.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.475 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -75.81 137.8 40.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.929 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.06 153.15 76.63 Favored Pre-proline 0 N--CA 1.465 0.297 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.396 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 39' ' ' VAL . 40.1 Cg_endo -66.52 -33.96 35.04 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.518 2.145 . . . . 0.0 112.22 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -136.7 95.2 3.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.702 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -140.03 148.17 41.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.277 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -103.2 102.0 11.97 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 27.4 m0 -96.37 147.33 23.92 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.396 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -105.1 125.7 51.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.743 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.2 mt -82.86 120.33 34.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.194 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.2 p -104.55 -10.48 17.58 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.495 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 142.09 167.46 11.33 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.15 161.86 25.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.399 . . . . 0.0 110.074 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.6 p -72.64 163.29 28.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.555 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 85.4 mtm-85 -69.89 -39.78 76.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.588 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -79.78 -3.38 47.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.183 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.1 tp -41.25 144.81 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.683 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 57.3 m -80.17 148.72 68.08 Favored Pre-proline 0 C--N 1.327 -0.383 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.934 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -50.09 -40.18 50.69 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.299 1.999 . . . . 0.0 112.35 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.38 -56.53 17.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.002 0.43 . . . . 0.0 111.201 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -63.36 -51.22 66.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.405 0.622 . . . . 0.0 110.517 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 68.6 ttt-85 -55.51 -44.12 76.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.482 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 28' ' ' SER . 68.9 tp60 -62.82 -32.6 73.83 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.818 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -59.4 -47.03 87.02 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.456 -0.497 . . . . 0.0 109.837 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.532 HD22 ' N ' ' A' ' 26' ' ' LEU . 4.4 mm? -65.54 -37.85 87.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.151 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.5 tp -74.62 -28.44 60.88 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.871 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 24' ' ' GLN . 68.7 m -57.61 -44.41 85.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.05 -178.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.607 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -114.54 153.13 30.61 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.114 -179.743 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -61.79 -24.59 64.67 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 67.6 mtt -61.13 73.67 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 120.976 0.417 . . . . 0.0 109.994 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 30' ' ' GLY . 0.5 OUTLIER -86.66 168.57 17.9 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.826 -179.167 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.457 ' HD3' HD12 ' A' ' 26' ' ' LEU . 67.6 Cg_exo -46.52 -178.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.29 1.993 . . . . 0.0 111.97 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.77 -11.78 45.87 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.2 m -100.73 -171.82 2.08 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.984 0.421 . . . . 0.0 110.238 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.3 m -130.19 157.59 42.04 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.427 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -138.65 158.38 44.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.215 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -112.38 145.03 40.83 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.562 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 5' ' ' PRO . 51.7 t -89.81 124.56 42.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.135 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.42 HG12 ' H ' ' A' ' 40' ' ' VAL . 2.0 p -68.61 -41.22 82.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.069 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -173.68 164.22 4.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.119 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 42' ' ' VAL . 27.6 m -135.99 124.15 36.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.045 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.98 110.76 51.65 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.736 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.32 -12.02 19.06 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.781 2.321 . . . . 0.0 112.184 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.53 ' N ' HD12 ' A' ' 45' ' ' LEU . 10.9 mp -60.6 -32.34 71.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.626 -178.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 135.33 22.03 0.65 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.97 160.03 30.08 Favored Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.46 169.08 3.35 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.77 2.313 . . . . 0.0 111.808 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.511 ' N ' ' O ' ' A' ' 60' ' ' LEU . 8.3 mm -93.48 114.41 30.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.976 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -91.3 122.88 34.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.856 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' A' ' 58' ' ' LEU . 44.9 pt -125.65 147.43 30.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.266 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -127.65 129.66 47.6 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.27 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.76 137.56 54.72 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.795 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.618 ' HE ' ' NH1' ' A' ' 55' ' ' ARG . 35.1 ptt180 -44.99 -31.46 1.3 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.245 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.618 ' NH1' ' HE ' ' A' ' 54' ' ' ARG . 86.5 mmt-85 -71.88 -46.37 58.07 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.599 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.625 HG22 ' N ' ' A' ' 57' ' ' SER . 13.9 p -170.97 168.46 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.794 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.625 ' N ' HG22 ' A' ' 56' ' ' VAL . 97.5 p -89.18 153.52 20.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.609 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 51' ' ' ILE . 61.1 tp -162.62 149.16 12.9 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.332 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 p -130.29 131.39 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 49' ' ' ILE . 89.7 mt -134.91 161.39 35.36 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.47 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -88.14 161.85 17.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.749 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.405 ' CG ' ' N ' ' A' ' 63' ' ' LYS . 20.4 ptmt -55.32 -41.0 71.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.965 0.412 . . . . 0.0 110.777 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.405 ' N ' ' CG ' ' A' ' 62' ' ' LYS . 21.0 ptmt -60.36 -40.21 89.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.67 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.92 -44.4 97.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.549 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.42 -41.86 97.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.703 0.287 . . . . 0.0 110.232 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.65 -50.51 73.57 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.395 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.27 -40.45 81.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.752 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.7 tp -61.76 129.71 42.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.338 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -74.53 107.58 6.75 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.64 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.2 m -132.68 161.89 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.607 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -143.0 140.74 31.14 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.37 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.03 112.59 20.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.301 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.42 HG12 ' H ' ' A' ' 75' ' ' SER . 63.0 t -63.48 -46.0 96.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.518 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.2 m 46.69 28.64 0.82 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.7 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.42 ' H ' HG12 ' A' ' 73' ' ' VAL . 8.8 p -149.52 127.9 12.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.4 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 56.9 tp -63.02 -48.33 79.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.744 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -174.32 153.52 1.98 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.442 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -151.49 64.01 0.88 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.622 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.507 ' CG ' ' O ' ' A' ' 79' ' ' HIS . 21.6 t-160 -101.25 53.19 0.83 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.457 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -157.51 81.26 0.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.542 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.558 ' CG ' ' N ' ' A' ' 82' ' ' HIS . 52.5 t-80 44.22 -114.21 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.586 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.558 ' N ' ' CG ' ' A' ' 81' ' ' HIS . 71.8 m80 43.31 -168.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.648 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 79.4 m80 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.56 -179.97 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -65.05 -39.09 92.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.648 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -69.54 136.91 51.98 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.83 156.63 68.68 Favored Pre-proline 0 N--CA 1.467 0.411 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 39' ' ' VAL . 45.3 Cg_endo -67.09 -21.72 48.56 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.45 2.1 . . . . 0.0 112.289 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -137.01 93.06 2.79 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.41 HG21 ' HE1' ' A' ' 9' ' ' TRP . 0.2 OUTLIER -140.3 131.83 27.04 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.55 103.05 15.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.41 ' HE1' HG21 ' A' ' 7' ' ' THR . 10.4 m0 -101.63 136.32 41.67 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.287 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -101.13 130.98 47.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.828 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.3 mt -83.97 124.29 39.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.723 -178.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.1 m -109.91 -41.34 4.52 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.812 0.339 . . . . 0.0 110.489 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 160.53 -174.31 37.21 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -103.74 147.1 27.66 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.815 0.34 . . . . 0.0 110.982 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.41 ' O ' HG22 ' A' ' 18' ' ' ILE . 3.5 m -78.84 173.16 12.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.604 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.415 ' N ' ' CD ' ' A' ' 16' ' ' ARG . 3.0 mpt_? -69.79 -40.37 76.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.61 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -68.66 -11.98 60.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.724 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 15' ' ' SER . 10.0 tp -41.16 148.35 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.625 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.9 p -76.35 141.16 69.67 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.57 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -49.49 -40.0 45.17 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 121.605 1.537 . . . . 0.0 112.952 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.62 -54.99 37.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 111.689 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -63.55 -45.79 88.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.451 0.643 . . . . 0.0 110.382 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -58.3 -44.55 88.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.945 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.482 ' O ' ' N ' ' A' ' 28' ' ' SER . 62.3 tp60 -61.57 -33.96 74.78 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -59.64 -47.29 86.18 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.904 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.6 mm? -62.68 -42.19 99.5 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.102 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.5 tt -72.99 -30.7 63.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.88 0.372 . . . . 0.0 110.871 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 24' ' ' GLN . 74.6 m -60.18 -43.28 95.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.395 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.505 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -118.66 171.96 7.83 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.398 -179.574 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.77 6.79 73.88 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 97.1 mtp -77.94 74.9 4.48 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.9 OUTLIER -92.96 169.89 9.72 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.131 -179.173 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 32' ' ' LEU . 51.4 Cg_exo -49.38 -169.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.123 1.882 . . . . 0.0 112.595 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.91 0.87 19.54 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.1 m -139.8 -173.25 3.58 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.728 0.299 . . . . 0.0 110.266 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 73.0 m -128.82 155.93 44.42 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.817 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -130.14 157.12 43.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.42 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -113.58 152.41 30.34 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.297 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 5' ' ' PRO . 20.8 t -87.95 123.0 40.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.479 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.403 HG12 ' H ' ' A' ' 40' ' ' VAL . 1.6 p -66.67 -42.01 89.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.689 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.548 ' NH2' ' CE1' ' A' ' 50' ' ' HIS . 50.7 ptt85 -172.94 162.94 4.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.489 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.8 t -128.06 127.95 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.418 ' HB1' ' OD1' ' A' ' 47' ' ' ASP . . . -93.39 110.77 48.78 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.366 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.05 -12.62 19.48 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.813 1.675 . . . . 0.0 112.516 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.2 tp -57.85 -30.52 65.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.959 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.81 30.51 1.24 Allowed Glycine 0 N--CA 1.467 0.753 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -98.74 -179.16 0.8 Allowed Pre-proline 0 N--CA 1.467 0.378 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.425 ' CD ' ' CB ' ' A' ' 47' ' ' ASP . 15.5 Cg_exo -65.53 -173.12 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.762 1.641 . . . . 0.0 111.594 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.402 HG21 ' CD2' ' A' ' 65' ' ' LEU . 10.8 mm -105.62 114.26 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.801 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.548 ' CE1' ' NH2' ' A' ' 41' ' ' ARG . 15.2 m170 -89.63 116.95 28.15 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.404 ' O ' ' O ' ' A' ' 58' ' ' LEU . 44.8 pt -124.41 148.25 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.147 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -125.81 123.96 39.88 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.865 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 p -107.44 137.03 46.23 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.765 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -38.46 -35.7 0.2 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.869 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.576 ' O ' HG13 ' A' ' 56' ' ' VAL . 3.6 mpt_? -72.51 -49.35 33.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.079 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 55' ' ' ARG . 15.7 m -162.55 -176.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 120.977 0.417 . . . . 0.0 110.991 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.2 m -99.78 145.84 27.25 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.792 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.404 ' O ' ' O ' ' A' ' 51' ' ' ILE . 60.3 tp -153.78 144.8 22.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.374 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.0 p -130.72 128.72 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.6 mt -136.95 166.19 24.22 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.85 0.357 . . . . 0.0 110.514 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -82.33 160.71 22.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.867 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -57.34 -34.59 68.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.746 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.7 -40.61 97.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.109 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -61.05 -45.9 92.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.812 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.402 ' CD2' HG21 ' A' ' 49' ' ' ILE . 10.4 mp -62.0 -42.3 99.0 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.141 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.01 -49.68 76.72 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.083 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.8 mt -68.81 -41.41 78.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.487 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.2 tp -60.48 132.11 52.86 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.715 -0.394 . . . . 0.0 109.94 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -74.73 110.87 9.38 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.446 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.3 m -137.23 162.25 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.813 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -138.84 127.42 23.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.329 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.78 125.21 28.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.856 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.3 m -123.24 131.22 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.082 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.5 m -88.13 -8.55 55.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.517 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.0 p -74.38 156.63 36.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.48 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.1 tp -164.02 55.32 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.277 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -151.64 136.98 17.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.594 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.464 ' O ' ' N ' ' A' ' 80' ' ' HIS . 44.9 p-80 -156.42 154.48 30.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.328 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 78.7 m80 39.85 25.91 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.832 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.464 ' N ' ' O ' ' A' ' 78' ' ' HIS . 85.8 t60 -59.2 -44.73 92.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.459 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -88.5 135.72 33.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.472 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -65.78 -39.64 91.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.548 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.475 179.986 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.43 ' O ' ' N ' ' A' ' 3' ' ' TYR . 66.5 mtm . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 48.93 -92.86 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.732 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.43 ' N ' ' O ' ' A' ' 1' ' ' MET . 76.1 m-85 -72.13 89.8 1.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.985 0.421 . . . . 0.0 110.17 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.73 156.45 36.53 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.982 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 39' ' ' VAL . 37.1 Cg_endo -65.13 -31.52 54.32 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.697 2.264 . . . . 0.0 111.925 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -136.78 94.66 3.01 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.696 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.5 t -140.53 151.15 44.53 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.922 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -104.92 102.49 12.01 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.406 ' O ' ' OG ' ' A' ' 36' ' ' SER . 26.1 m0 -96.63 132.61 42.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.213 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.5 tttt -87.43 127.22 35.22 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.76 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.6 mt -81.53 122.51 36.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.213 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.9 m -104.25 -49.09 3.67 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.515 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.3 169.87 30.47 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -88.41 152.82 21.65 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.713 0.292 . . . . 0.0 110.241 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.517 ' O ' HG22 ' A' ' 18' ' ' ILE . 38.3 t -82.81 168.77 16.82 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.094 0.474 . . . . 0.0 110.782 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -66.62 -40.03 88.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.362 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.47 ' OE1' ' N ' ' A' ' 17' ' ' GLU . 52.5 mp0 -65.13 -15.47 62.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.657 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.517 HG22 ' O ' ' A' ' 15' ' ' SER . 10.6 tp -42.34 146.75 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.598 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.7 p -79.85 141.41 55.25 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.551 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -47.15 -41.42 27.11 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.927 1.751 . . . . 0.0 112.616 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.33 -57.47 9.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.821 0.343 . . . . 0.0 111.296 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -61.95 -46.25 90.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.47 0.652 . . . . 0.0 110.444 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -57.37 -43.63 83.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.114 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.53 ' NE2' ' OG ' ' A' ' 28' ' ' SER . 3.1 tm0? -60.29 -37.94 82.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.111 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -60.7 -41.96 96.25 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.178 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.447 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.4 mm? -62.59 -42.25 99.45 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.201 -0.6 . . . . 0.0 110.276 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mp -73.9 -29.77 62.24 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.474 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.53 ' OG ' ' NE2' ' A' ' 24' ' ' GLN . 49.9 m -58.7 -44.83 90.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.388 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.514 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -115.9 170.97 8.07 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.28 -179.688 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -87.11 -3.22 82.78 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 22.3 mmt -67.26 73.45 0.13 Allowed 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 120.868 0.366 . . . . 0.0 110.118 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.2 mp -99.07 169.85 7.65 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.425 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 32' ' ' LEU . 72.2 Cg_exo -48.63 -168.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.332 2.022 . . . . 0.0 112.462 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.95 7.06 56.73 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.6 m -139.54 -156.65 0.7 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.826 0.346 . . . . 0.0 110.387 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 9' ' ' TRP . 33.4 t -148.8 153.56 38.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.441 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.407 ' HB2' HG22 ' A' ' 53' ' ' THR . 45.0 p90 -128.94 155.54 45.15 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.291 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -106.42 143.81 34.01 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.523 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 5' ' ' PRO . 14.5 t -88.12 122.82 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.281 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.43 HG12 ' H ' ' A' ' 40' ' ' VAL . 2.2 p -68.31 -39.99 81.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.878 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.542 ' NH2' ' ND1' ' A' ' 50' ' ' HIS . 38.1 ptt-85 -174.69 159.87 2.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.136 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 42' ' ' VAL . 36.0 m -133.89 123.84 45.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.68 110.4 49.05 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.686 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -76.42 -11.67 18.93 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.481 2.121 . . . . 0.0 112.176 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.632 ' O ' HD23 ' A' ' 45' ' ' LEU . 1.1 tt -60.59 -33.15 72.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.645 -177.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.13 20.9 0.49 Allowed Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.03 160.22 29.59 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.33 168.03 5.45 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.878 2.386 . . . . 0.0 111.819 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.405 ' N ' ' O ' ' A' ' 60' ' ' LEU . 5.5 mm -89.63 119.77 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.884 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.542 ' ND1' ' NH2' ' A' ' 41' ' ' ARG . 12.4 m170 -95.47 122.64 38.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.887 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.7 pt -125.87 148.91 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.278 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -130.71 132.36 45.32 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.422 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 55' ' ' ARG . 1.4 p -122.63 137.1 55.0 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.0 ptt-85 -41.17 -21.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.871 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.566 ' O ' HG13 ' A' ' 56' ' ' VAL . 33.7 mmt180 -85.3 -50.57 7.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.924 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 55' ' ' ARG . 14.8 m -161.01 -176.0 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.515 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.7 p -113.29 145.27 41.32 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.396 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.9 tp -149.75 148.28 29.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.309 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.8 p -136.54 126.69 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.743 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 49' ' ' ILE . 23.3 mt -132.23 165.57 23.84 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.378 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -81.06 148.49 29.65 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.215 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -41.78 -40.81 2.16 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.961 0.41 . . . . 0.0 111.122 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -58.03 -40.58 81.23 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.563 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -62.08 -41.39 98.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.842 0.353 . . . . 0.0 110.53 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.556 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.0 mm? -62.14 -42.08 98.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.913 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.18 -41.54 97.07 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.371 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.8 mt -68.33 -43.29 77.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.987 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.5 mt -65.33 133.42 51.36 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.284 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.3 112.2 16.3 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.009 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.406 HG21 ' CE3' ' A' ' 9' ' ' TRP . 26.9 m -129.53 160.39 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.591 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -144.72 128.31 17.09 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.507 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.74 132.61 47.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.951 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.8 t -88.47 131.86 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.225 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 55.6 m -90.12 40.12 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.791 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.7 m -133.15 142.67 48.77 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.822 0.344 . . . . 0.0 110.386 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 77' ' ' GLU . 55.8 tp -63.5 -44.12 95.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.564 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' A' ' 76' ' ' LEU . 97.8 mt-10 45.45 96.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.664 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -77.06 128.71 34.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.535 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.431 ' ND1' ' N ' ' A' ' 80' ' ' HIS . 52.1 t-80 -63.64 -90.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.691 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.431 ' N ' ' ND1' ' A' ' 79' ' ' HIS . 50.8 t-80 -161.09 -67.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.505 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -76.86 140.21 40.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.495 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -85.01 128.37 34.6 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.588 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.446 ' OXT' ' CG ' ' A' ' 83' ' ' HIS . 52.5 p-80 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.926 -1.035 . . . . 0.0 110.52 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mmt . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.439 ' NE2' ' CZ2' ' A' ' 9' ' ' TRP . 56.0 tp60 -63.5 -53.15 56.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.764 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -102.81 133.1 48.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.902 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.24 156.58 77.97 Favored Pre-proline 0 N--CA 1.466 0.351 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.302 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 39' ' ' VAL . 52.4 Cg_exo -51.06 -35.35 50.63 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.907 1.738 . . . . 0.0 112.885 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -135.74 95.93 3.33 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.5 130.82 42.87 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.89 102.39 15.09 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.439 ' CZ2' ' NE2' ' A' ' 2' ' ' GLN . 22.1 m0 -103.2 144.32 31.48 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.057 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -96.89 140.73 31.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.505 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.9 mt -96.94 122.03 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 O-C-N 123.263 0.352 . . . . 0.0 110.295 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.2 p -109.78 -44.7 3.78 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.761 0.315 . . . . 0.0 110.441 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 167.62 -179.33 41.11 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -97.66 152.18 19.35 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.779 0.323 . . . . 0.0 110.649 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.464 ' O ' HG22 ' A' ' 18' ' ' ILE . 2.6 m -80.05 169.87 17.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.718 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -68.8 -39.61 80.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.574 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -65.64 -14.66 61.63 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.694 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 15' ' ' SER . 10.5 tp -42.29 147.08 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.465 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.9 m -82.0 150.17 64.57 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.904 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -51.25 -39.31 62.39 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.074 1.849 . . . . 0.0 112.652 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.56 -56.77 15.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 0.0 111.374 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.576 ' CZ ' HD21 ' A' ' 68' ' ' LEU . 35.6 t80 -64.11 -47.02 81.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.513 0.673 . . . . 0.0 110.477 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -56.88 -43.79 81.63 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.029 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -63.51 -33.58 75.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.023 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -59.61 -47.37 85.83 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 29' ' ' LEU . 4.5 mm? -63.06 -42.19 99.64 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.121 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.3 tp -68.8 -34.33 75.35 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.9 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.2 t -59.69 -44.61 93.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.62 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.547 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -116.26 168.42 10.14 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.834 0.35 . . . . 0.0 110.219 -179.447 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.02 -1.08 80.11 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.6 mtt -67.78 73.6 0.17 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 120.863 0.363 . . . . 0.0 110.021 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.3 mp -95.78 167.75 12.04 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.261 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 32' ' ' LEU . 75.8 Cg_exo -46.03 -179.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.236 1.957 . . . . 0.0 112.322 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.46 7.16 11.2 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' A' ' 36' ' ' SER . 28.9 t -145.77 -175.59 4.8 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.817 0.341 . . . . 0.0 110.446 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.492 ' N ' ' OG ' ' A' ' 35' ' ' SER . 46.9 m -127.18 156.03 42.46 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.509 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -132.53 150.93 52.08 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.286 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -106.74 146.33 30.96 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.36 0.6 . . . . 0.0 110.401 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' PRO . 6.7 t -83.49 127.3 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.363 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.425 HG12 ' H ' ' A' ' 40' ' ' VAL . 2.2 p -71.13 -38.39 70.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.112 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -172.83 154.13 2.84 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.994 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 73.5 t -126.32 118.91 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.71 111.27 51.91 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.221 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -76.27 -11.2 19.27 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.148 1.899 . . . . 0.0 112.262 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 45' ' ' LEU . 10.7 mp -59.89 -31.71 70.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.646 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.7 27.93 0.71 Allowed Glycine 0 N--CA 1.466 0.697 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.84 160.21 29.06 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.23 172.06 1.01 Allowed 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.835 2.356 . . . . 0.0 111.859 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.412 ' N ' ' O ' ' A' ' 60' ' ' LEU . 7.3 mm -90.42 116.93 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.995 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.407 ' CD2' HG23 ' A' ' 59' ' ' VAL . 12.1 m170 -96.72 121.89 39.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.706 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.5 pt -129.2 147.25 33.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.632 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.414 ' OE1' ' OG ' ' A' ' 57' ' ' SER . 57.0 mm-40 -122.49 114.51 20.79 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.099 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.02 137.5 44.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.685 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -42.89 -40.28 2.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.439 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -66.23 -47.03 75.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.562 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.657 HG22 ' N ' ' A' ' 57' ' ' SER . 11.2 p -170.52 173.39 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 120.981 0.42 . . . . 0.0 110.59 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.657 ' N ' HG22 ' A' ' 56' ' ' VAL . 4.4 m -95.19 152.8 18.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.38 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.3 tp -155.66 145.33 21.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.019 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.407 HG23 ' CD2' ' A' ' 50' ' ' HIS . 4.8 p -137.99 126.08 30.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 49' ' ' ILE . 19.0 mt -132.37 -178.63 5.0 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.499 ' CD ' ' N ' ' A' ' 61' ' ' ARG . 9.8 mpt_? -94.85 150.97 19.62 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.348 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -42.07 -43.34 3.21 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.828 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.47 -40.02 85.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.466 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -59.42 -43.08 93.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.51 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.532 HD22 ' N ' ' A' ' 65' ' ' LEU . 3.8 mm? -62.81 -41.87 99.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.812 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.3 -46.03 89.68 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.229 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.9 mp -67.3 -40.25 86.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.675 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.576 HD21 ' CZ ' ' A' ' 22' ' ' TYR . 21.5 mt -63.47 128.02 33.93 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.204 -0.599 . . . . 0.0 110.173 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -77.5 104.87 8.28 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.649 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.431 HG21 ' CE3' ' A' ' 9' ' ' TRP . 31.0 m -125.05 160.3 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.424 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -142.86 134.67 26.81 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.36 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.16 132.78 47.8 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.601 -0.44 . . . . 0.0 109.857 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.0 m -82.11 37.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.553 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 90.7 p -85.39 -7.07 59.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.81 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.5 m -149.53 155.48 40.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.383 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.9 tp -141.1 86.65 2.05 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.516 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -92.36 -9.43 41.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.438 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.542 ' O ' ' N ' ' A' ' 80' ' ' HIS . 96.6 m-70 -59.47 -44.24 93.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.653 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.549 ' CE1' ' NE2' ' A' ' 80' ' ' HIS . 11.1 t-160 54.45 -81.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.789 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.549 ' NE2' ' CE1' ' A' ' 79' ' ' HIS . 54.8 m170 -110.8 145.79 37.53 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.901 0.381 . . . . 0.0 110.413 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -60.94 -43.01 99.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.777 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -131.55 143.2 50.19 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.551 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.573 -179.939 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.4 ptt? . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -66.96 -60.12 2.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.02 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -84.77 136.23 33.78 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 p -130.77 150.52 76.7 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 121.044 -0.263 . . . . 0.0 110.454 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 39' ' ' VAL . 42.6 Cg_exo -50.75 -49.39 16.96 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.794 1.662 . . . . 0.0 113.147 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -134.18 103.35 5.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.065 0.459 . . . . 0.0 111.165 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.72 144.42 41.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.529 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.46 101.89 14.63 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.574 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 23.8 m0 -100.36 141.23 33.48 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.015 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -95.25 130.37 42.03 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.3 mt -83.52 121.26 36.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.243 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.6 m -103.06 -49.64 3.71 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.812 0.339 . . . . 0.0 110.648 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.16 169.89 27.25 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -85.34 158.33 20.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.901 0.381 . . . . 0.0 110.396 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.413 ' O ' HG22 ' A' ' 18' ' ' ILE . 47.2 t -79.87 169.44 17.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.72 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -69.67 -39.61 76.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.841 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -74.6 -7.62 53.74 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.458 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.413 HG22 ' O ' ' A' ' 15' ' ' SER . 10.4 tp -42.46 148.6 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.648 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.1 m -75.16 154.14 86.37 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.355 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.98 -25.79 51.68 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.516 2.144 . . . . 0.0 112.137 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.0 -55.93 9.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.18 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -63.45 -45.65 89.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.189 0.518 . . . . 0.0 110.596 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -58.11 -45.54 87.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.136 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 17.1 tm0? -62.24 -33.73 75.16 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -59.21 -46.79 87.5 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.695 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.6 mm? -62.03 -39.54 92.67 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.229 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.9 tp -59.95 -42.38 93.91 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.227 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.0 t -82.92 -9.43 59.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.296 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.7 tp -94.91 124.67 39.09 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.937 0.398 . . . . 0.0 110.367 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.6 -19.45 74.76 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 45.1 ttp -89.51 73.13 7.84 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.632 0.73 . . . . 0.0 109.306 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' A' ' 33' ' ' PRO . 9.5 mt -80.51 156.91 73.08 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.983 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 32' ' ' LEU . 75.6 Cg_exo -37.91 162.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.476 2.117 . . . . 0.0 112.444 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.16 3.75 17.02 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 96.4 p -129.3 -156.66 0.77 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.767 0.318 . . . . 0.0 110.346 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.5 t -145.3 151.99 39.21 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.702 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -132.62 159.43 39.57 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.356 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -111.38 146.37 37.26 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.733 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 5' ' ' PRO . 51.2 t -90.45 125.66 43.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.146 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -66.83 -42.22 88.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 50.1 ptt85 -174.28 156.75 2.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.076 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.57 ' O ' HG23 ' A' ' 42' ' ' VAL . 32.9 m -128.92 117.23 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.09 110.31 47.32 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 120.951 -0.299 . . . . 0.0 110.413 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.67 -11.58 18.49 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.181 1.921 . . . . 0.0 112.187 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tp -57.15 -31.08 65.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.973 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.62 22.98 0.66 Allowed Glycine 0 N--CA 1.465 0.604 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.35 159.82 30.3 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -59.84 173.46 1.69 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.763 2.309 . . . . 0.0 111.761 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 60' ' ' LEU . 8.2 mm -92.96 114.63 30.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.093 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.499 ' CD2' HG23 ' A' ' 59' ' ' VAL . 12.4 m170 -96.0 121.93 38.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.093 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.7 pt -126.26 149.37 31.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.286 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -129.32 135.15 48.37 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.553 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -126.69 145.59 50.52 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.797 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -50.09 -38.6 39.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.169 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.0 tpm_? -67.74 -43.7 79.31 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.772 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.723 HG22 ' H ' ' A' ' 57' ' ' SER . 11.8 p -170.74 176.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.584 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.723 ' H ' HG22 ' A' ' 56' ' ' VAL . 47.4 t -105.87 149.2 26.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.43 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.4 tp -152.77 149.4 28.3 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.205 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.499 HG23 ' CD2' ' A' ' 50' ' ' HIS . 10.2 p -128.93 128.22 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.64 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.424 HD13 ' OD1' ' A' ' 64' ' ' ASP . 58.7 mt -132.34 162.59 30.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.269 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -85.58 171.9 11.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.717 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -61.9 -40.07 94.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.625 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.48 -39.26 87.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.467 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.424 ' OD1' HD13 ' A' ' 60' ' ' LEU . 6.5 t70 -57.17 -47.13 81.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.345 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.62 -40.88 98.35 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.661 -0.416 . . . . 0.0 109.924 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.07 -54.11 48.94 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.499 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 67' ' ' LEU . 11.1 mp -69.53 -41.57 75.8 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.153 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 38.7 tp -59.0 130.32 46.44 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -83.84 114.03 21.36 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 110.23 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.26 158.43 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.912 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -144.11 141.81 30.23 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.759 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.1 145.4 51.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.098 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.3 t -104.0 128.09 57.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.149 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.5 t -169.03 73.24 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.396 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.9 m -156.25 168.38 27.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.448 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 77' ' ' GLU . 56.9 tp -62.16 -43.87 97.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.519 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 76' ' ' LEU . 82.6 tt0 58.18 152.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.293 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.608 ' ND1' ' N ' ' A' ' 79' ' ' HIS . 58.6 t-80 -59.92 -111.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.655 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.608 ' N ' ' ND1' ' A' ' 78' ' ' HIS . 52.5 t-80 -160.65 138.03 9.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.36 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -145.5 137.91 25.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.429 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -152.27 162.88 40.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.399 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 42.61 91.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.801 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.64 -179.925 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -65.41 -40.24 93.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.628 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -72.71 137.24 45.82 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.15 155.29 77.58 Favored Pre-proline 0 N--CA 1.466 0.357 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.19 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 39' ' ' VAL . 50.1 Cg_endo -67.68 -23.12 42.84 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.638 2.225 . . . . 0.0 112.307 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -137.86 94.4 2.89 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.689 0.281 . . . . 0.0 110.582 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.12 130.7 27.26 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.9 101.94 14.03 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.443 ' CE3' HG21 ' A' ' 70' ' ' VAL . 23.0 m0 -101.76 145.86 28.56 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.23 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -102.8 128.51 49.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.88 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.0 mt -81.03 123.74 37.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.337 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 7.8 p -111.47 -15.17 13.59 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.55 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.34 178.28 16.84 Favored Glycine 0 N--CA 1.465 0.598 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.421 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.5 p90 -98.58 152.17 19.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.85 0.357 . . . . 0.0 110.119 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.478 ' O ' HG22 ' A' ' 18' ' ' ILE . 5.1 t -80.21 168.71 18.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.463 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 16' ' ' ARG . 37.1 mtp-105 -68.56 -39.52 81.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.943 0.401 . . . . 0.0 110.662 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -64.24 -17.08 63.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.616 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.478 HG22 ' O ' ' A' ' 15' ' ' SER . 10.7 tp -41.92 147.89 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.476 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.5 t -80.96 146.33 59.03 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.699 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -49.67 -41.05 46.61 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.874 1.716 . . . . 0.0 112.755 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.52 -56.27 20.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.244 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -61.94 -46.75 87.97 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.48 0.657 . . . . 0.0 110.396 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -57.34 -44.08 83.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.848 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 28' ' ' SER . 5.9 tm0? -60.12 -38.39 82.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.361 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -57.87 -43.92 86.29 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.538 HD12 ' HD3' ' A' ' 33' ' ' PRO . 4.6 mm? -63.51 -40.84 98.1 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.269 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.4 mt -80.74 -18.14 48.74 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.885 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 24' ' ' GLN . 38.8 t -61.04 -43.97 98.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.077 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.596 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -115.82 154.53 29.5 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.398 -179.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.65 5.97 42.51 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.512 ' N ' ' SD ' ' A' ' 31' ' ' MET . 0.0 OUTLIER -89.27 74.73 7.86 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -82.42 171.24 12.33 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.355 -178.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.538 ' HD3' HD12 ' A' ' 26' ' ' LEU . 63.3 Cg_exo -48.47 -171.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.321 2.014 . . . . 0.0 112.206 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.01 11.25 8.46 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 81.8 p -139.24 -156.83 0.71 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.921 0.391 . . . . 0.0 110.413 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.8 p -141.15 163.0 34.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.468 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -139.51 160.93 38.72 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.194 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.413 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 24.2 p30 -119.22 151.19 38.8 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.24 0.543 . . . . 0.0 110.429 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' PRO . 61.0 t -88.15 127.53 41.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.279 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -69.06 -41.3 81.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.069 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -173.56 162.07 4.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.964 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 68.0 t -130.14 124.2 57.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.39 110.56 49.39 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.28 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.72 -11.31 20.22 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.29 1.994 . . . . 0.0 112.331 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.529 HD22 ' N ' ' A' ' 45' ' ' LEU . 4.1 mm? -60.65 -31.43 70.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.708 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.5 24.76 0.82 Allowed Glycine 0 N--CA 1.465 0.606 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.1 160.05 29.92 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.05 173.15 0.62 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.805 2.336 . . . . 0.0 111.665 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.437 ' N ' ' O ' ' A' ' 60' ' ' LEU . 8.5 mm -93.48 114.26 29.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -92.17 122.33 34.55 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.891 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 58' ' ' LEU . 44.4 pt -126.84 151.91 34.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.574 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.413 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 95.1 mt-10 -130.95 134.46 46.76 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.248 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.22 141.85 51.63 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.996 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.406 ' H ' ' HG3' ' A' ' 54' ' ' ARG . 84.0 mtm180 -40.89 -36.53 0.66 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.36 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -65.54 -50.39 65.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.87 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.685 HG22 ' H ' ' A' ' 57' ' ' SER . 8.5 p -172.39 174.56 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-O 120.905 0.383 . . . . 0.0 110.808 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.685 ' H ' HG22 ' A' ' 56' ' ' VAL . 89.8 p -89.07 150.09 22.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.233 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 51' ' ' ILE . 63.9 tp -159.96 145.42 15.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.783 0.325 . . . . 0.0 110.342 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.8 p -126.5 129.96 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 49' ' ' ILE . 67.2 mt -132.93 161.41 34.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.55 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -85.25 165.29 17.46 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.706 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -59.11 -35.85 74.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.485 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.82 -40.41 95.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.595 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -60.64 -46.4 90.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.723 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.406 ' N ' HD12 ' A' ' 65' ' ' LEU . 9.6 mp -62.71 -40.26 96.6 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.67 -38.62 91.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.517 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.1 mt -82.32 -54.97 4.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.031 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 66.2 mt -45.81 137.61 5.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.657 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.43 ' O ' ' OG1' ' A' ' 12' ' ' THR . 97.2 mt-10 -80.02 111.56 16.49 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.295 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.443 HG21 ' CE3' ' A' ' 9' ' ' TRP . 25.7 m -135.97 159.04 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.395 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -141.54 131.58 24.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.718 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.22 142.36 54.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.115 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t -105.15 123.49 59.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.258 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 74.3 p -124.56 -2.11 7.96 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.606 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.5 t -105.88 115.54 30.41 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.402 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.9 tp -64.43 -41.7 96.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.132 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -41.34 158.81 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.737 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.428 ' O ' ' O ' ' A' ' 79' ' ' HIS . 28.6 p-80 -150.27 165.71 32.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.579 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.428 ' O ' ' O ' ' A' ' 78' ' ' HIS . 57.1 m170 55.06 163.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.403 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.531 ' CE1' ' ND1' ' A' ' 81' ' ' HIS . 51.8 t-80 -133.08 -99.71 0.27 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.491 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.531 ' ND1' ' CE1' ' A' ' 80' ' ' HIS . 80.4 m80 -141.35 151.91 43.95 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.585 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -60.29 -45.26 93.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.73 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.573 179.904 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mmm . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -147.21 -30.16 0.34 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.465 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -79.22 137.12 37.28 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.22 156.51 73.71 Favored Pre-proline 0 N--CA 1.466 0.33 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.174 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 39' ' ' VAL . 41.4 Cg_endo -66.69 -27.75 44.7 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.683 2.255 . . . . 0.0 112.322 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -136.39 94.91 3.08 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.582 0.229 . . . . 0.0 110.408 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.21 128.77 24.46 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.13 101.52 14.18 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 25.2 m0 -99.57 140.59 33.54 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.213 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -98.26 120.44 38.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.882 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.7 mt -74.65 128.52 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.327 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.2 m -110.13 -47.41 3.32 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.567 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 170.62 166.3 29.31 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -87.42 157.25 19.27 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.84 0.352 . . . . 0.0 110.106 179.673 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 67' ' ' LEU . 13.0 m -73.77 163.85 27.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.519 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -69.82 -40.76 75.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.376 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -68.95 -12.19 61.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.355 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.456 HG22 ' O ' ' A' ' 15' ' ' SER . 10.3 tp -41.37 146.95 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.614 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.26 156.97 83.46 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.352 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.61 -30.57 70.49 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.777 2.318 . . . . 0.0 111.756 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.78 -56.8 12.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.881 0.372 . . . . 0.0 111.24 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -61.93 -45.46 93.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.364 0.602 . . . . 0.0 110.442 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -57.26 -43.16 82.75 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.946 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.513 ' O ' ' N ' ' A' ' 28' ' ' SER . 63.5 tp60 -61.51 -38.22 86.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.145 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -59.75 -41.47 91.08 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.456 -0.498 . . . . 0.0 109.819 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.608 HD12 ' HD3' ' A' ' 33' ' ' PRO . 4.4 mm? -64.04 -39.03 93.18 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.425 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.8 tt -82.34 -24.47 34.54 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.071 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 24' ' ' GLN . 96.5 p -60.84 -45.78 93.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.772 0.32 . . . . 0.0 111.484 -178.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.5 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -103.43 161.69 13.64 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.978 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.98 31.28 3.42 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 65.6 mtt -111.65 73.08 0.8 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.473 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.2 mm? -82.84 153.06 67.09 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.648 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.608 ' HD3' HD12 ' A' ' 26' ' ' LEU . 77.8 Cg_exo -39.62 167.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.459 2.106 . . . . 0.0 111.918 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.39 -16.19 12.84 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.811 -0.915 . . . . 0.0 110.811 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.8 m -100.18 -170.76 1.92 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.731 0.301 . . . . 0.0 110.302 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 73.4 m -132.39 156.34 46.84 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.481 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -139.17 157.06 46.61 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.241 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -112.2 146.45 38.08 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.468 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 5' ' ' PRO . 17.5 t -86.3 129.7 37.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.434 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -70.31 -40.24 77.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.146 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -173.77 161.45 3.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.114 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 69.5 t -134.47 110.61 13.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.69 111.55 53.08 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.47 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.518 ' C ' ' H ' ' A' ' 46' ' ' GLY . 60.4 Cg_endo -75.82 -12.13 19.97 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.353 2.035 . . . . 0.0 112.135 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.584 ' N ' HD12 ' A' ' 45' ' ' LEU . 10.2 mp -55.09 -3.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.812 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 103.37 26.62 6.83 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.27 159.58 30.92 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-O 121.028 0.442 . . . . 0.0 109.997 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.95 177.54 0.5 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.758 2.305 . . . . 0.0 111.521 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.473 HG21 ' CD2' ' A' ' 65' ' ' LEU . 10.2 mm -95.92 115.42 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.269 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.455 ' CD2' HG23 ' A' ' 59' ' ' VAL . 11.9 m170 -98.71 122.39 41.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.838 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 35.7 pt -126.77 148.0 31.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.748 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -134.36 111.96 10.61 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.875 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 54' ' ' ARG . 1.3 p -83.65 175.26 9.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.683 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 53' ' ' THR . 99.8 mtt180 -33.53 -53.3 0.41 Allowed 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.548 0.53 . . . . 0.0 111.548 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -143.04 31.41 1.4 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.351 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 t -138.48 134.01 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 120.369 -0.533 . . . . 0.0 110.454 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.7 m -111.12 136.94 49.42 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.195 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.2 tp -156.42 147.27 21.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.245 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.455 HG23 ' CD2' ' A' ' 50' ' ' HIS . 5.9 p -127.5 126.03 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.846 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.0 mt -132.18 167.72 19.28 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.289 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -85.72 166.32 16.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.517 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -60.53 -35.79 76.84 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.999 0.428 . . . . 0.0 110.549 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.27 -41.13 98.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.274 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -57.5 -47.13 82.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.535 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.473 ' CD2' HG21 ' A' ' 49' ' ' ILE . 11.0 mp -61.79 -41.09 97.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.095 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.09 -52.01 67.01 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.598 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.465 ' O ' ' OG ' ' A' ' 15' ' ' SER . 10.8 mp -68.8 -42.34 77.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.038 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 tp -56.43 132.22 50.61 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.286 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -78.91 110.03 13.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.224 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.71 159.05 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.418 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -142.86 133.09 24.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.608 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.23 145.45 54.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.173 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 75' ' ' SER . 62.9 t -109.58 129.41 64.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.191 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 97.6 p -104.64 -1.82 25.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.701 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.4 ' H ' HG12 ' A' ' 73' ' ' VAL . 37.9 t -142.05 135.59 29.34 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.344 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.6 tp -62.94 -43.33 99.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.499 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 47.79 -172.26 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.396 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -153.26 -54.68 0.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.501 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -82.83 136.6 34.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.486 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -78.82 140.61 38.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.468 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -148.01 156.67 42.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.605 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -75.47 139.29 42.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.441 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.484 179.957 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.584 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.499 ' NE2' ' CD2' ' A' ' 3' ' ' TYR . 3.1 pt20 -74.47 -101.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.936 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.5 OUTLIER -83.03 150.47 26.32 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.68 164.55 39.02 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 39' ' ' VAL . 31.3 Cg_exo -55.64 -36.14 94.22 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.878 1.719 . . . . 0.0 112.687 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 6' ' ' ASP . 47.0 p-10 -136.74 94.38 2.98 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.796 0.331 . . . . 0.0 110.533 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.29 130.52 33.1 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.95 102.6 15.37 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -105.96 141.33 37.54 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.912 0.387 . . . . 0.0 110.464 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -94.52 147.86 22.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.838 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.3 mt -101.63 115.83 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.0 m -97.73 -43.58 7.11 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.852 0.358 . . . . 0.0 110.42 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.65 179.52 34.52 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.9 OUTLIER -95.84 149.0 22.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.938 0.399 . . . . 0.0 110.506 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.425 ' O ' HG22 ' A' ' 18' ' ' ILE . 4.3 m -78.28 172.16 13.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.545 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -69.49 -40.54 76.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.618 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -66.8 -13.79 61.91 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.968 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.425 HG22 ' O ' ' A' ' 15' ' ' SER . 10.4 tp -41.53 148.49 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.715 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.05 155.21 86.52 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.302 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.99 -31.02 66.8 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.645 2.23 . . . . 0.0 112.216 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.44 -55.34 18.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.902 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -62.82 -43.51 98.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.435 0.636 . . . . 0.0 110.513 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -58.51 -43.32 89.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.6 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.535 ' O ' ' N ' ' A' ' 28' ' ' SER . 18.8 mm-40 -63.36 -35.18 79.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.043 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -59.74 -41.95 92.08 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.368 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.534 HD12 ' HD3' ' A' ' 33' ' ' PRO . 4.6 mm? -70.06 -39.0 75.94 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.748 178.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp -81.91 -15.48 53.76 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.432 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 24' ' ' GLN . 2.8 m -57.14 -29.73 63.83 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.596 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.886 HD13 ' N ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -134.69 -176.92 4.39 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.696 0.284 . . . . 0.0 110.723 179.513 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.39 -9.2 56.97 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 79.2 mtp -76.08 75.13 2.94 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.5 OUTLIER -83.04 171.82 10.83 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.034 -179.275 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.534 ' HD3' HD12 ' A' ' 26' ' ' LEU . 77.7 Cg_exo -48.74 -168.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.523 2.149 . . . . 0.0 112.589 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.03 11.99 7.27 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.6 p -136.12 -158.11 0.84 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.761 0.315 . . . . 0.0 110.214 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 82.5 p -138.68 161.56 36.84 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.761 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -141.21 159.4 42.29 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.183 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 47.6 p-10 -117.38 151.16 37.59 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.196 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 5' ' ' PRO . 61.1 t -87.88 126.34 41.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.283 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.413 HG12 ' H ' ' A' ' 40' ' ' VAL . 1.8 p -68.72 -43.31 83.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.941 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -173.23 147.26 1.53 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.391 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 42' ' ' VAL . 20.9 m -115.99 125.64 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.36 110.39 48.35 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.805 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.1 -12.19 17.6 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.854 1.703 . . . . 0.0 112.315 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.8 mt -60.6 -31.02 70.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.011 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.34 26.34 0.89 Allowed Glycine 0 N--CA 1.469 0.869 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.02 160.27 28.8 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -54.81 175.24 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.603 2.202 . . . . 0.0 111.645 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.4 mm -94.64 113.68 29.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.018 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 16.2 m170 -93.95 119.65 33.14 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.1 pt -127.17 150.43 33.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.368 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.429 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 8.6 tm-20 -126.25 132.31 51.74 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.214 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.08 138.4 54.46 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.924 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -40.59 -38.58 0.89 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.332 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -67.13 -48.66 67.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.744 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.637 HG22 ' N ' ' A' ' 57' ' ' SER . 8.5 p -171.5 172.07 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.933 0.397 . . . . 0.0 110.87 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.637 ' N ' HG22 ' A' ' 56' ' ' VAL . 10.7 p -86.26 151.26 23.76 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.461 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.1 tp -155.66 146.45 22.2 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.884 0.373 . . . . 0.0 110.299 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.6 p -125.65 130.9 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.64 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.4 mt -134.71 163.2 30.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.576 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 83.6 mtt85 -92.08 174.8 7.13 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.972 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -62.05 -44.67 96.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.092 0.472 . . . . 0.0 110.623 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -61.63 -38.02 86.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.627 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -59.47 -48.36 81.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.259 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.433 ' CD2' ' CE1' ' A' ' 3' ' ' TYR . 10.5 mp -62.92 -41.77 99.57 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.113 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.36 -50.94 71.85 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.269 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.0 mt -68.83 -41.92 77.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.239 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.2 tp -62.19 136.21 57.83 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -84.9 116.37 23.3 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.871 0.367 . . . . 0.0 110.427 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.0 m -133.28 161.45 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.527 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -145.59 145.98 31.2 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.463 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.96 135.92 45.07 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.2 131.63 35.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.787 0.327 . . . . 0.0 110.289 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.0 p -147.79 -44.21 0.16 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.557 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.0 p -76.21 144.83 40.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.075 0.464 . . . . 0.0 110.455 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 77' ' ' GLU . 90.3 mt -63.91 -41.78 97.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.562 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 76' ' ' LEU . 80.2 mm-40 56.27 156.75 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.597 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -79.74 156.45 27.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.434 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -53.38 -77.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.544 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -143.1 141.09 31.14 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.462 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.46 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 48.6 p-80 -76.73 122.04 24.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.509 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -84.1 -16.38 43.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.606 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.471 ' O ' ' CD2' ' A' ' 83' ' ' HIS . 85.0 t60 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.556 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mtp . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.479 ' O ' HG23 ' A' ' 4' ' ' THR . 1.4 mp0 -72.65 -70.39 0.35 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.549 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -73.18 90.14 1.56 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.05 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 2' ' ' GLN . 0.8 OUTLIER -103.07 152.34 38.55 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.314 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -49.9 -44.05 38.58 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.852 1.701 . . . . 0.0 112.816 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -135.47 100.64 4.56 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.935 0.398 . . . . 0.0 110.835 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.35 143.45 42.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.389 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -96.48 102.45 14.24 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.576 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 26.5 m0 -98.51 145.77 26.45 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.377 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -100.34 132.58 45.64 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.788 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 36.1 mt -82.37 124.56 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.21 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.5 m -108.03 -49.55 3.19 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.81 0.338 . . . . 0.0 110.804 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.11 -178.88 40.54 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 2.3 p90 -102.52 144.29 31.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.909 0.385 . . . . 0.0 110.464 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.41 ' O ' HG22 ' A' ' 18' ' ' ILE . 19.7 m -75.31 171.36 14.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.453 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -68.78 -38.48 80.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.785 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -71.7 -10.27 59.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.482 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 15' ' ' SER . 10.0 tp -41.56 147.51 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.518 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.2 t -78.64 140.72 59.54 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.356 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -48.25 -40.24 35.09 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.902 1.735 . . . . 0.0 112.89 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.53 -58.14 8.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.897 0.379 . . . . 0.0 111.364 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -62.07 -47.2 85.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.55 0.691 . . . . 0.0 110.471 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -56.51 -43.16 79.5 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.878 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -59.73 -37.53 79.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.182 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -59.47 -43.03 93.32 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.633 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.5 mm? -62.4 -42.62 99.57 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.967 178.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 48.7 mt -70.85 -32.55 69.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.917 0.389 . . . . 0.0 110.928 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 64.7 m -58.0 -44.12 87.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.399 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.564 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -117.94 166.24 12.74 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.161 -179.777 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.4 8.49 79.73 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 16.1 mmt -78.4 73.37 4.96 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.5 mp -91.4 167.84 14.79 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.089 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 32' ' ' LEU . 71.6 Cg_exo -44.33 176.69 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 122.292 1.994 . . . . 0.0 112.363 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.34 1.58 15.91 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.434 ' OG ' ' N ' ' A' ' 36' ' ' SER . 32.7 t -134.48 -155.85 0.69 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.903 0.382 . . . . 0.0 110.321 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.434 ' N ' ' OG ' ' A' ' 35' ' ' SER . 27.3 p -150.71 161.94 41.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.554 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -138.38 156.49 47.55 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.293 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -108.95 145.72 35.0 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.496 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.7 t -89.85 126.72 42.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.434 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -67.52 -42.31 86.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.114 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -173.87 156.93 2.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.059 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.539 ' O ' HG23 ' A' ' 42' ' ' VAL . 30.8 m -126.05 122.11 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.75 110.27 48.43 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.511 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -76.86 -11.88 18.08 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.199 1.933 . . . . 0.0 112.283 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.1 mt -59.69 -31.47 69.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.026 -178.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.83 25.01 0.78 Allowed Glycine 0 N--CA 1.466 0.673 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.52 160.13 29.47 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.4 169.58 2.19 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.898 2.399 . . . . 0.0 111.638 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.1 mm -92.77 113.65 28.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.99 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.479 ' CD2' HG23 ' A' ' 59' ' ' VAL . 13.2 m170 -95.6 121.25 37.09 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.909 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 48.0 pt -127.93 149.87 33.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.428 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -118.97 125.51 49.6 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.173 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.0 p -111.77 136.94 50.36 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -39.29 -40.23 0.74 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.804 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.667 ' O ' HG13 ' A' ' 56' ' ' VAL . 56.6 ttt85 -67.88 -49.71 60.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.21 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 55' ' ' ARG . 4.4 m -164.77 -176.68 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.556 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.0 t -96.23 136.96 36.0 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.488 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.5 tp -138.04 145.27 41.61 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.987 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.479 HG23 ' CD2' ' A' ' 50' ' ' HIS . 12.9 p -126.42 130.46 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.694 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.8 mt -134.3 162.26 32.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.475 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -91.89 165.03 13.44 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.623 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.698 ' HB3' ' HZ2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -57.0 -40.93 77.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.072 0.463 . . . . 0.0 110.635 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -62.22 -36.92 83.44 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.793 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.29 -42.85 99.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.278 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.7 mp -63.06 -41.96 99.59 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.884 -0.414 . . . . 0.0 109.884 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.31 -50.77 72.43 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.146 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.5 mt -69.2 -40.48 78.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.004 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.3 tp -62.58 134.02 55.76 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -85.13 112.47 20.72 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.003 0.43 . . . . 0.0 110.118 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.0 m -132.5 158.99 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.63 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -142.92 141.68 31.53 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.823 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.61 150.55 42.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.164 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.6 t -117.65 130.69 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.197 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 90.8 p -118.89 1.92 11.53 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.558 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 51.4 m -153.05 163.93 38.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.439 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.8 tp -61.24 -84.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.305 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -164.36 -72.25 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.49 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 45.0 p-80 -151.01 165.7 32.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.32 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -111.37 138.59 47.67 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.32 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -78.9 123.95 27.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.5 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.606 ' N ' ' ND1' ' A' ' 81' ' ' HIS . 0.6 OUTLIER -66.16 -44.48 84.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.453 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -146.83 147.38 30.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.605 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.602 179.927 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.9 mmm . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.728 ' H ' ' NE2' ' A' ' 2' ' ' GLN . 1.4 pm0 -63.73 -38.44 91.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.727 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -97.66 133.55 42.06 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.851 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.456 ' OG1' ' CG2' ' A' ' 7' ' ' THR . 15.4 p -132.39 148.07 68.2 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.484 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 39' ' ' VAL . 44.9 Cg_endo -66.22 -31.29 44.78 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.392 2.062 . . . . 0.0 112.473 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -136.23 93.99 2.97 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.725 0.298 . . . . 0.0 111.318 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.456 ' CG2' ' OG1' ' A' ' 4' ' ' THR . 0.9 OUTLIER -141.77 149.16 40.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.368 178.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -102.78 102.05 12.16 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 25.3 m0 -97.46 142.74 28.94 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.894 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -100.68 123.66 45.19 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.5 mt -79.6 120.43 30.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.904 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.6 p -104.08 -15.66 15.5 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.348 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.47 164.66 10.41 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.88 169.51 17.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.9 t -84.03 166.42 17.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.447 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.9 ptt-85 -70.58 -37.03 73.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.556 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -81.09 -5.42 57.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.028 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.6 tp -41.15 141.75 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.386 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.8 m -80.02 150.88 72.52 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.806 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.06 -38.84 60.47 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.9 1.733 . . . . 0.0 112.544 179.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.63 -58.12 8.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.437 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -63.32 -48.65 77.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.346 0.594 . . . . 0.0 110.555 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -57.93 -40.76 81.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.04 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 28' ' ' SER . 12.1 tm0? -61.8 -39.44 91.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.207 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.51 -43.73 96.77 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.253 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.602 HD12 ' HD3' ' A' ' 33' ' ' PRO . 4.5 mm? -63.47 -39.21 93.86 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.283 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.5 tt -81.13 -23.18 38.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.958 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.469 ' N ' ' O ' ' A' ' 24' ' ' GLN . 40.3 t -61.22 -45.24 95.38 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.167 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.515 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -107.71 160.47 15.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.173 -179.554 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.04 33.92 2.4 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 36.5 tpp -112.8 74.01 0.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.464 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.2 mm? -81.86 153.58 70.06 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.075 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.602 ' HD3' HD12 ' A' ' 26' ' ' LEU . 66.4 Cg_exo -40.12 169.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 122.78 2.32 . . . . 0.0 112.439 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.15 12.11 7.13 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 90.2 p -126.63 -171.36 2.39 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 73.5 m -131.45 157.47 43.39 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.72 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -137.88 159.96 40.58 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.296 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -117.35 145.85 43.77 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.893 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 5' ' ' PRO . 57.5 t -86.06 127.66 40.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.213 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 40' ' ' VAL . 2.4 p -70.65 -41.37 77.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.209 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -176.41 171.31 2.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.818 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.56 130.65 37.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.36 109.61 43.82 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.716 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.511 ' C ' ' H ' ' A' ' 46' ' ' GLY . 33.9 Cg_exo -60.57 -21.86 70.26 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 121.793 1.662 . . . . 0.0 112.334 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.5 mt -52.99 -5.72 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.634 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 90.8 33.95 8.06 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.7 169.75 8.11 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -54.51 -171.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 121.807 1.672 . . . . 0.0 111.939 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 60' ' ' LEU . 9.5 mm -111.89 109.67 29.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.744 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.406 ' O ' HG12 ' A' ' 40' ' ' VAL . 12.0 m170 -85.71 125.73 33.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.161 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.6 pt -127.66 151.22 34.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.524 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.4 ' OE1' ' C ' ' A' ' 52' ' ' GLU . 1.9 pp20? -130.7 136.86 49.19 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.212 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 56' ' ' VAL . 2.9 p -128.87 143.68 50.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.09 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -49.28 -37.45 23.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.659 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -72.74 -37.82 67.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.91 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.779 HG22 ' H ' ' A' ' 57' ' ' SER . 3.5 p -169.53 -176.1 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.824 0.345 . . . . 0.0 110.207 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.779 ' H ' HG22 ' A' ' 56' ' ' VAL . 36.5 p -130.65 150.49 51.81 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 59' ' ' VAL . 5.8 tt -163.81 164.95 23.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.354 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.514 ' N ' HD23 ' A' ' 58' ' ' LEU . 3.6 p -126.47 137.79 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.828 0.347 . . . . 0.0 110.419 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 49' ' ' ILE . 11.9 mt -134.11 152.07 51.67 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.704 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -77.83 162.05 27.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.508 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -58.4 -39.49 79.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.862 0.363 . . . . 0.0 110.34 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.89 -39.68 92.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.4 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -59.87 -45.94 90.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.516 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 mp -62.02 -41.8 98.47 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.341 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.12 -51.76 68.0 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.18 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.23 -39.95 82.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.944 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.9 tp -60.02 128.92 39.24 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -75.59 110.28 9.85 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.423 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.6 m -133.24 161.4 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.64 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -143.28 138.35 29.51 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.395 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.81 134.13 44.78 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 80.9 t -89.71 133.8 30.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.383 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 37.8 p -148.8 161.92 40.83 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.853 0.359 . . . . 0.0 110.47 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.4 m -78.04 103.94 8.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.662 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.526 HD12 ' N ' ' A' ' 76' ' ' LEU . 10.7 mp -63.1 -41.52 99.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.331 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 57.41 96.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.399 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -149.9 159.64 44.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.362 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -110.91 149.01 31.25 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.486 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -79.47 150.49 31.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.619 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -143.91 140.23 29.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.491 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -80.77 150.9 29.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.589 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 . . . . . 0 C--O 1.219 -0.522 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.518 179.97 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ptm . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -62.9 -44.27 96.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.757 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -106.44 137.42 44.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.848 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 p -130.09 152.49 80.15 Favored Pre-proline 0 N--CA 1.466 0.343 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 39' ' ' VAL . 52.6 Cg_exo -50.45 -41.45 51.96 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.972 1.781 . . . . 0.0 112.586 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -134.37 100.59 4.72 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.003 0.43 . . . . 0.0 111.026 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 t -137.35 144.52 42.56 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.296 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.36 102.43 14.41 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.745 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 14.5 m0 -100.62 142.59 31.89 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.345 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -97.49 139.61 33.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.632 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.4 mt -98.84 114.88 37.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 m -97.26 -40.42 8.77 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.44 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.65 164.77 21.79 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.65 162.32 27.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.78 0.324 . . . . 0.0 110.172 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.487 ' O ' HG22 ' A' ' 18' ' ' ILE . 5.8 t -78.69 163.45 25.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.518 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 49.6 ptt85 -68.67 -37.62 79.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -70.08 -14.65 62.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.603 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 15' ' ' SER . 10.8 tp -41.94 145.53 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.404 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 t -84.98 149.84 54.13 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.515 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -48.94 -37.12 36.24 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.952 1.768 . . . . 0.0 112.394 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.38 -58.48 7.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.485 -178.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -63.45 -46.61 85.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.427 0.632 . . . . 0.0 110.668 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -57.49 -43.32 84.07 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.936 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -63.42 -37.79 88.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.216 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -59.06 -45.45 90.75 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.884 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.446 ' HA ' HD13 ' A' ' 26' ' ' LEU . 4.4 mm? -62.34 -43.52 98.63 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.184 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.3 tp -63.64 -42.42 98.15 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.536 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.6 m -72.32 -39.73 67.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.453 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.734 HD23 ' N ' ' A' ' 30' ' ' GLY . 1.7 tt -82.5 132.1 35.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.774 -178.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.734 ' N ' HD23 ' A' ' 29' ' ' LEU . . . -73.26 32.21 0.8 Allowed Glycine 0 N--CA 1.462 0.427 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.526 ' CB ' HD22 ' A' ' 29' ' ' LEU . 11.3 tpt -124.67 72.7 1.22 Allowed 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.0 mm? -81.62 152.01 69.08 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.106 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 32' ' ' LEU . 72.5 Cg_exo -40.77 169.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 122.676 2.251 . . . . 0.0 112.491 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.72 -17.92 15.35 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.5 m -103.36 -169.44 1.65 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.827 0.346 . . . . 0.0 110.269 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.6 m -132.17 155.58 47.94 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.579 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -132.07 155.25 48.41 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.027 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -112.81 145.14 41.14 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.364 0.602 . . . . 0.0 110.858 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 5' ' ' PRO . 58.6 t -83.54 127.43 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.14 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 50' ' ' HIS . 2.3 p -70.42 -39.3 76.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.132 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -173.67 160.56 3.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.564 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 70.5 t -136.17 112.11 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.64 109.81 45.59 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 119.494 -0.289 . . . . 0.0 110.928 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.542 ' C ' ' H ' ' A' ' 46' ' ' GLY . 31.7 Cg_exo -57.81 -12.52 12.09 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 121.838 1.692 . . . . 0.0 112.156 178.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 82.0 mt -51.58 -5.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.819 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.542 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 89.11 31.69 11.64 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.34 162.39 22.8 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -52.96 -170.74 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.885 1.723 . . . . 0.0 111.876 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.6 mm -109.64 113.57 44.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.428 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.489 ' O ' HG12 ' A' ' 40' ' ' VAL . 16.6 m170 -96.62 127.75 42.91 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.433 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.1 pt -127.33 149.61 32.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.654 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -135.69 131.55 35.82 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.503 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 55' ' ' ARG . 2.7 p -125.52 137.48 53.94 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.074 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -39.05 -24.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.755 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.539 ' O ' HG13 ' A' ' 56' ' ' VAL . 84.8 mtt85 -84.96 -49.86 7.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.208 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 55' ' ' ARG . 16.0 m -161.2 -174.87 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.474 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.8 p -131.05 151.76 51.07 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.637 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.2 tp -154.21 151.91 29.73 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.274 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.455 HG22 ' CD2' ' A' ' 50' ' ' HIS . 45.0 t -118.91 129.5 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.1 mt -137.79 152.26 48.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.467 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.8 tpp85 -81.22 162.79 23.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.462 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -57.7 -37.59 73.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.021 0.438 . . . . 0.0 110.502 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -61.57 -41.24 97.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.175 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.13 -46.02 91.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.371 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.6 mp -60.92 -40.96 95.16 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.182 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.56 -51.37 69.74 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.454 -0.499 . . . . 0.0 110.445 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.99 -42.61 80.5 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.382 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.3 mt -60.92 134.55 57.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.304 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -78.01 108.06 11.01 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.758 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.2 m -131.03 160.71 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.806 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -147.72 145.75 28.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.514 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.37 135.77 53.74 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.0 t -86.3 130.48 36.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.854 0.359 . . . . 0.0 110.438 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 37.2 t -153.83 -33.45 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.579 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.6 p -78.07 156.04 30.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.498 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.567 HD12 ' N ' ' A' ' 76' ' ' LEU . 10.4 mp -89.69 -2.79 58.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.317 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -58.9 148.24 31.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.465 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 40.1 p-80 -150.98 158.78 44.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.4 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -105.15 153.59 21.32 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.279 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -106.26 123.25 47.75 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.379 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -85.67 126.52 34.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.441 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.537 ' CG ' ' H ' ' A' ' 83' ' ' HIS . 5.2 t60 -73.66 -123.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.524 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.537 ' H ' ' CG ' ' A' ' 82' ' ' HIS . 39.7 p-80 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.529 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 tpp . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -64.28 -32.6 74.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.817 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -66.08 130.97 45.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.737 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.67 154.59 59.62 Favored Pre-proline 0 N--CA 1.467 0.395 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.45 -32.9 59.38 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.477 2.118 . . . . 0.0 112.085 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 6' ' ' ASP . 47.8 p-10 -136.72 93.77 2.9 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.928 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.5 t -140.69 151.04 44.23 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.093 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -100.71 102.45 13.56 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 22.9 m0 -98.93 129.4 45.26 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.247 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -85.66 136.31 33.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.877 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.1 mt -91.2 119.07 37.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.1 m -102.16 -43.01 5.86 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.827 0.346 . . . . 0.0 110.33 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.06 -174.1 33.98 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.7 OUTLIER -95.0 157.1 16.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.901 0.381 . . . . 0.0 110.325 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.413 ' O ' HG22 ' A' ' 18' ' ' ILE . 6.8 t -85.23 171.89 11.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.599 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.409 ' N ' ' OG ' ' A' ' 15' ' ' SER . 89.6 mtm180 -68.48 -38.28 80.87 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.869 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -75.81 -6.01 48.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.434 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.413 HG22 ' O ' ' A' ' 15' ' ' SER . 9.3 tp -41.9 147.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.601 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.45 155.66 87.49 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.436 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.32 -30.1 63.44 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.535 2.156 . . . . 0.0 112.028 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.89 -53.46 31.99 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.004 0.43 . . . . 0.0 111.161 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -63.68 -46.33 86.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.342 0.591 . . . . 0.0 110.268 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -56.46 -44.51 80.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.96 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 28' ' ' SER . 39.5 mm-40 -64.07 -31.57 72.8 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -59.09 -48.91 79.87 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.469 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.453 HD22 ' N ' ' A' ' 26' ' ' LEU . 4.5 mm? -64.7 -40.7 95.81 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.104 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.2 tp -69.37 -34.33 74.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.219 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 24' ' ' GLN . 11.9 t -59.44 -44.67 92.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.4 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.548 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -116.36 167.9 10.62 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.269 -179.631 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.81 7.91 80.55 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 94.2 mtp -77.6 73.96 4.16 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.4 mp -93.77 169.21 10.41 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.576 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 32' ' ' LEU . 54.0 Cg_exo -48.6 -170.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.317 2.011 . . . . 0.0 112.333 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.83 5.34 20.44 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.0 t -145.43 -172.31 3.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.759 0.314 . . . . 0.0 110.366 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.5 t -130.11 155.75 45.67 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.496 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -131.84 164.57 25.76 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.27 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 38' ' ' ASN . 12.8 p-10 -116.64 149.68 39.35 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.518 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.5 t -88.31 125.21 41.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.501 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.2 p -67.51 -42.54 87.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.348 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.48 ' NH2' ' ND1' ' A' ' 50' ' ' HIS . 37.0 ptt-85 -170.1 160.19 7.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.409 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 86.4 t -129.24 127.58 65.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.407 ' HB1' ' OD1' ' A' ' 47' ' ' ASP . . . -93.39 110.93 49.8 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.507 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -76.28 -11.39 19.21 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.073 1.848 . . . . 0.0 112.415 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.522 ' N ' HD12 ' A' ' 45' ' ' LEU . 10.5 mp -59.29 -30.63 68.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.579 -178.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.39 28.23 1.36 Allowed Glycine 0 N--CA 1.468 0.78 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -97.9 178.72 1.25 Allowed Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 47' ' ' ASP . 19.2 Cg_exo -64.13 -179.14 0.73 Allowed 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.974 1.783 . . . . 0.0 111.888 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.0 mm -103.6 117.95 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.528 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.48 ' ND1' ' NH2' ' A' ' 41' ' ' ARG . 10.8 m170 -96.37 117.47 30.91 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.2 pt -118.66 147.38 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.431 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.413 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 84.2 tt0 -134.26 112.04 10.73 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.217 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 54' ' ' ARG . 1.2 p -86.46 172.56 10.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.766 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 53' ' ' THR . 95.5 mtt180 -34.02 -51.84 0.43 Allowed 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.479 0.487 . . . . 0.0 111.929 -178.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.6 tpt85 -142.03 31.68 1.58 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.619 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -141.96 138.08 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.541 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.3 t -116.9 131.91 56.83 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.35 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.1 tp -145.87 146.38 31.09 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.932 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.427 HG23 ' CD2' ' A' ' 50' ' ' HIS . 4.9 p -136.93 127.2 39.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.8 mt -138.17 165.38 26.8 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.587 0.232 . . . . 0.0 110.428 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -74.0 148.14 42.31 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 120.94 0.4 . . . . 0.0 111.275 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -43.94 -41.77 5.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.184 0.516 . . . . 0.0 110.807 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -57.98 -40.63 81.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.387 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -60.05 -42.66 94.97 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.477 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.554 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.0 mm? -62.05 -42.07 98.79 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.59 -48.48 81.51 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.669 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.37 -39.26 85.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.873 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 38.5 mt -62.78 138.99 58.66 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.341 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -83.14 102.15 11.66 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.488 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.1 m -127.07 152.35 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.306 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -144.04 123.46 13.12 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.708 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.11 145.73 53.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.111 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.7 128.21 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.762 0.315 . . . . 0.0 110.671 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.6 t -68.98 -41.77 77.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.184 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 95.8 p -157.66 162.64 38.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.397 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.7 tp -148.99 94.3 2.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.125 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -121.5 129.2 52.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.163 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -103.64 119.45 38.93 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.394 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -94.08 11.14 30.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.498 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -60.39 -42.65 96.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.578 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 86.6 t60 53.48 88.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.63 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.423 ' O ' ' OXT' ' A' ' 83' ' ' HIS . 34.3 p80 -76.1 148.68 37.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.665 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.423 ' OXT' ' O ' ' A' ' 82' ' ' HIS . 79.8 m80 . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.543 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 ptt? . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.4 tp60 -62.52 -52.23 64.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.819 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -104.87 135.01 47.03 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.48 157.26 78.76 Favored Pre-proline 0 N--CA 1.466 0.342 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 39' ' ' VAL . 52.2 Cg_exo -50.19 -35.22 42.22 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.03 1.82 . . . . 0.0 112.768 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -136.56 96.54 3.36 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.708 0.29 . . . . 0.0 110.328 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.86 130.99 42.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.982 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.3 102.32 15.04 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 20.1 m0 -105.5 143.67 33.33 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.185 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -95.57 147.75 23.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.817 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 46.9 mt -100.12 123.0 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.8 m -103.86 -47.88 4.08 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.795 0.331 . . . . 0.0 110.405 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 160.6 169.9 24.49 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.9 OUTLIER -83.4 151.22 25.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.916 0.389 . . . . 0.0 110.546 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.2 t -82.46 174.36 11.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.538 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -70.74 -40.09 72.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.0 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -70.77 -10.4 59.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.305 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.3 tp -41.38 149.51 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.776 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.66 154.25 87.38 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.368 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.52 -30.96 51.78 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.528 2.152 . . . . 0.0 112.179 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.43 -54.36 25.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.921 0.391 . . . . 0.0 111.286 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -63.76 -45.72 88.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.351 0.596 . . . . 0.0 110.194 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.404 ' NH1' HD11 ' A' ' 27' ' ' LEU . 68.2 ttp85 -57.89 -44.72 86.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.293 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 69.5 tp60 -61.78 -34.2 75.45 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -59.68 -48.41 81.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.067 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.417 ' HA ' HD13 ' A' ' 26' ' ' LEU . 4.5 mm? -61.88 -41.38 97.81 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.597 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.404 HD11 ' NH1' ' A' ' 23' ' ' ARG . 87.0 mt -61.8 -39.81 93.02 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.448 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.1 m -82.66 -12.98 57.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.849 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.446 ' HG ' ' H ' ' A' ' 31' ' ' MET . 12.4 tp -95.85 124.54 39.91 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.799 0.333 . . . . 0.0 110.15 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.87 13.1 32.44 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.464 ' CE ' HH21 ' A' ' 55' ' ' ARG . 68.6 mtp -118.49 75.66 1.03 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.26 0.552 . . . . 0.0 109.531 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.496 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.7 mp -78.7 166.69 40.8 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.839 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.496 ' O ' ' O ' ' A' ' 32' ' ' LEU . 80.1 Cg_exo -40.56 175.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.666 2.244 . . . . 0.0 112.747 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.71 12.49 6.59 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.6 t -140.8 -156.37 0.67 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.836 0.351 . . . . 0.0 110.266 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.0 t -147.7 153.79 39.75 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.839 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.45 ' CE1' HG21 ' A' ' 51' ' ' ILE . 45.3 p90 -129.76 149.97 51.27 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.492 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -108.06 144.13 35.82 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.316 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 5' ' ' PRO . 12.5 t -81.05 121.02 33.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.488 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 50' ' ' HIS . 2.0 p -68.34 -37.67 78.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.509 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -171.82 155.66 3.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.366 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.4 t -123.68 114.06 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.3 111.99 54.41 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.403 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.548 ' C ' ' H ' ' A' ' 46' ' ' GLY . 61.4 Cg_endo -75.0 -11.64 21.48 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.916 1.744 . . . . 0.0 112.269 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 45' ' ' LEU . 9.9 mp -60.14 5.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.954 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.548 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 88.63 29.51 18.56 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.41 160.01 29.81 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.43 172.44 2.63 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.969 2.446 . . . . 0.0 112.002 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.3 mm -91.48 113.26 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.893 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.429 ' O ' HG12 ' A' ' 40' ' ' VAL . 12.1 m-70 -94.53 125.09 38.96 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.162 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.45 HG21 ' CE1' ' A' ' 37' ' ' PHE . 36.3 pt -124.57 146.71 29.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.099 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -136.79 129.06 29.84 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.234 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -130.57 144.45 51.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.519 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -49.19 -33.19 11.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.937 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.464 HH21 ' CE ' ' A' ' 31' ' ' MET . 73.8 mtp85 -69.96 -43.92 70.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.714 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.835 HG22 ' H ' ' A' ' 57' ' ' SER . 9.8 p -170.05 -179.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.433 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.835 ' H ' HG22 ' A' ' 56' ' ' VAL . 20.7 t -128.49 150.94 49.94 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.247 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 52.7 tp -163.21 157.22 20.14 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.036 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.609 ' C ' HD12 ' A' ' 60' ' ' LEU . 3.5 p -130.98 131.79 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.609 HD12 ' C ' ' A' ' 59' ' ' VAL . 10.3 mp -126.33 150.6 48.42 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.645 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' A' ' 64' ' ' ASP . 88.6 mtm180 -79.03 143.65 35.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.286 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -40.47 -40.92 1.31 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.125 0.488 . . . . 0.0 111.124 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -61.19 -42.32 98.36 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.368 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 61' ' ' ARG . 98.1 m-20 -61.4 -38.51 87.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.229 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.498 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.1 mm? -62.58 -42.72 99.73 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.14 -51.25 70.83 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.154 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.426 ' N ' HD22 ' A' ' 67' ' ' LEU . 4.1 mm? -68.56 -39.76 80.91 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.178 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.16 134.11 56.12 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -83.14 114.55 21.41 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.077 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 m -132.09 161.85 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.022 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -146.13 144.77 30.19 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.506 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.66 147.45 52.68 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.1 t -103.93 130.9 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.6 m -157.22 1.81 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.533 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.1 m -68.37 141.98 55.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.495 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.4 mt -96.91 -0.91 46.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.613 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -135.17 148.12 49.61 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.392 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 27.8 p-80 -154.15 160.58 41.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.418 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -94.61 123.85 38.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.485 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.495 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 2.6 p80 -153.43 119.15 5.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.372 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.506 ' O ' ' N ' ' A' ' 83' ' ' HIS . 90.6 m-70 -157.51 -35.43 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.534 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 75.9 m80 47.02 -90.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.616 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 81' ' ' HIS . 66.1 t-80 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.521 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -144.68 -50.64 0.27 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.447 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -70.69 136.39 48.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.652 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -143.3 153.3 59.29 Favored Pre-proline 0 N--CA 1.464 0.264 0 C-N-CA 121.136 -0.226 . . . . 0.0 110.404 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 39' ' ' VAL . 34.9 Cg_exo -50.96 -43.02 49.91 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.626 1.551 . . . . 0.0 112.407 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 6' ' ' ASP . 48.0 p-10 -135.29 98.45 3.97 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.946 0.403 . . . . 0.0 111.526 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.516 ' HG1' ' HD1' ' A' ' 9' ' ' TRP . 1.2 t -131.9 143.92 50.48 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.241 178.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -87.54 102.68 14.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.516 ' HD1' ' HG1' ' A' ' 7' ' ' THR . 11.5 m0 -103.17 136.09 43.61 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 -178.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.0 tttt -91.88 143.97 25.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.773 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 48.9 mt -101.43 119.13 49.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 6.6 p -108.63 -19.14 13.53 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.773 0.321 . . . . 0.0 110.588 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.04 -177.59 23.39 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.101 -0.799 . . . . 0.0 111.101 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -104.76 150.43 24.77 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.808 0.337 . . . . 0.0 110.41 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.471 ' O ' HG22 ' A' ' 18' ' ' ILE . 8.3 t -77.86 170.24 16.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.854 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -70.7 -39.48 73.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.106 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -66.83 -14.81 63.1 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.002 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.478 ' CG2' ' HE ' ' A' ' 23' ' ' ARG . 10.0 tp -41.23 149.34 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.759 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.35 154.5 88.04 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.981 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.25 -30.09 64.12 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.534 2.156 . . . . 0.0 112.362 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.3 -52.06 45.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.468 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -63.13 -46.7 86.04 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.59 0.71 . . . . 0.0 110.527 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.478 ' HE ' ' CG2' ' A' ' 18' ' ' ILE . 33.9 ttm180 -58.42 -48.51 80.46 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.407 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -59.84 -30.84 69.23 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -57.5 -44.23 84.84 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 29' ' ' LEU . 4.6 mm? -61.8 -42.62 99.24 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 120.071 -0.651 . . . . 0.0 109.647 178.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.45 HD22 ' N ' ' A' ' 27' ' ' LEU . 3.9 mm? -67.94 -33.59 74.96 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.788 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.7 t -60.1 -44.26 94.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.73 -178.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.524 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -118.19 170.3 8.98 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.033 0.444 . . . . 0.0 110.599 -179.602 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.64 4.18 81.93 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 58.6 mmm -73.34 73.76 1.34 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.1 mp -95.36 170.38 7.91 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.104 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 32' ' ' LEU . 52.9 Cg_exo -50.0 -165.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.402 2.068 . . . . 0.0 113.028 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.33 5.34 55.94 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 76.9 p -143.15 -172.93 3.78 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.733 0.301 . . . . 0.0 110.289 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.8 m -130.04 156.13 45.0 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.745 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.42 ' HB2' HG22 ' A' ' 53' ' ' THR . 42.5 p90 -128.5 153.56 47.03 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.989 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 39' ' ' VAL . 59.9 t-20 -108.74 147.07 32.55 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.662 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.525 ' N ' ' OD1' ' A' ' 38' ' ' ASN . 21.4 t -89.58 126.51 42.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.647 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 p -72.24 -41.76 66.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.716 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -173.32 154.98 2.78 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.419 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 42' ' ' VAL . 17.9 m -139.56 122.45 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.294 178.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -95.47 110.07 48.89 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.754 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.57 ' C ' ' H ' ' A' ' 46' ' ' GLY . 38.1 Cg_exo -61.56 -14.63 36.55 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 121.811 1.674 . . . . 0.0 111.869 178.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 78.3 mt -53.73 2.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.863 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.57 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 90.04 26.08 25.07 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.01 162.26 23.48 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.99 170.46 2.12 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.181 1.92 . . . . 0.0 111.39 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 60' ' ' LEU . 6.7 mm -96.85 115.97 37.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.606 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.456 ' CD2' HG23 ' A' ' 59' ' ' VAL . 13.6 m170 -93.77 120.47 34.07 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.401 ' O ' ' O ' ' A' ' 58' ' ' LEU . 47.0 pt -118.95 148.54 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.461 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.784 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -133.97 128.84 35.24 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.066 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.42 HG22 ' HB2' ' A' ' 37' ' ' PHE . 1.2 p -118.47 137.46 53.16 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -41.34 -35.86 0.72 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.256 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.54 ' O ' HG13 ' A' ' 56' ' ' VAL . 78.7 mmt-85 -70.02 -47.43 62.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.955 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 55' ' ' ARG . 16.3 m -160.6 -175.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.004 0.43 . . . . 0.0 111.049 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 t -116.6 142.39 46.95 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.551 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.401 ' O ' ' O ' ' A' ' 51' ' ' ILE . 63.6 tp -150.6 150.06 30.69 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.507 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.456 HG23 ' CD2' ' A' ' 50' ' ' HIS . 7.7 p -125.69 130.54 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 49' ' ' ILE . 94.3 mt -132.41 155.79 47.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.619 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -84.84 168.33 15.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.842 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -59.21 -43.42 92.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.532 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -59.22 -39.3 82.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.725 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -60.11 -45.7 92.07 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.453 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.54 -40.96 98.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.863 0.363 . . . . 0.0 110.15 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.99 -39.08 90.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.483 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.4 mt -82.08 -55.29 4.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.815 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 70.6 mt -46.74 132.88 11.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.398 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.407 ' O ' ' OG1' ' A' ' 12' ' ' THR . 96.8 mt-10 -76.27 108.87 9.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.5 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.36 161.58 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.634 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 31.0 tp10 -145.42 143.05 29.85 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.412 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.31 131.41 41.88 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 75' ' ' SER . 36.0 t -82.98 -80.65 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.409 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.6 t 41.49 16.8 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.261 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.554 ' N ' ' O ' ' A' ' 73' ' ' VAL . 37.3 t -156.03 146.18 21.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.001 0.429 . . . . 0.0 110.458 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.1 mt -103.04 16.29 27.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.527 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -62.12 -40.15 94.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.588 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.536 ' CG ' ' N ' ' A' ' 79' ' ' HIS . 51.4 t-80 44.51 -109.81 0.17 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.614 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.536 ' N ' ' CG ' ' A' ' 78' ' ' HIS . 74.5 m80 -146.73 -97.23 0.09 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.624 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.615 ' CD2' ' CD2' ' A' ' 81' ' ' HIS . 36.9 t60 -154.84 -67.23 0.13 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.494 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.615 ' CD2' ' CD2' ' A' ' 80' ' ' HIS . 60.2 m-70 -138.7 146.7 41.87 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.549 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.62 ' CG ' ' H ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -69.58 -75.51 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.67 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.62 ' H ' ' CG ' ' A' ' 82' ' ' HIS . 86.0 t60 . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.924 -1.036 . . . . 0.0 110.506 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 tpp . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.573 ' NE2' ' CZ ' ' A' ' 3' ' ' TYR . 0.7 OUTLIER -62.62 -51.71 66.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.68 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.573 ' CZ ' ' NE2' ' A' ' 2' ' ' GLN . 67.7 m-85 -89.8 134.83 33.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.699 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.9 151.5 78.32 Favored Pre-proline 0 N--CA 1.468 0.46 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 39' ' ' VAL . 43.3 Cg_endo -66.96 -33.68 31.83 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.659 2.24 . . . . 0.0 112.228 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -136.63 94.65 3.02 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.818 0.342 . . . . 0.0 110.995 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 t -140.4 148.19 40.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.246 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -96.02 102.07 13.82 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 19.2 m0 -99.34 137.46 37.82 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.25 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -93.41 130.29 39.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.863 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.6 mt -83.05 115.84 26.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.0 m -98.73 -43.72 6.68 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.849 0.357 . . . . 0.0 110.422 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.06 -179.79 31.7 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.8 p90 -95.89 147.67 23.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.855 0.359 . . . . 0.0 110.475 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.476 ' O ' HG22 ' A' ' 18' ' ' ILE . 5.7 m -78.47 172.93 12.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.517 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 85.6 mmt-85 -70.06 -40.35 75.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.607 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -65.72 -15.18 62.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.628 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.476 HG22 ' O ' ' A' ' 15' ' ' SER . 10.5 tp -41.58 148.43 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.636 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 92.6 p -83.05 144.83 48.08 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.713 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -50.17 -37.18 48.18 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.051 1.834 . . . . 0.0 112.692 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.24 -58.51 7.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.891 0.377 . . . . 0.0 111.414 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -64.33 -47.18 80.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.261 0.553 . . . . 0.0 110.681 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -57.56 -47.55 81.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.371 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 68.3 tp60 -60.18 -32.27 70.91 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.459 ' NZ ' HD11 ' A' ' 58' ' ' LEU . 31.1 ttmt -60.8 -44.36 96.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.895 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.53 HD13 HD11 ' A' ' 29' ' ' LEU . 4.6 mm? -62.25 -42.94 99.77 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.368 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.16 -39.9 96.0 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.743 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.1 t -60.71 -45.2 95.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.039 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.53 HD11 HD13 ' A' ' 26' ' ' LEU . 2.0 pp -92.74 133.94 35.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.502 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.7 -1.67 72.81 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 67.2 mtt -86.66 74.46 9.85 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -82.23 168.54 23.03 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.336 -179.096 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 32' ' ' LEU . 72.7 Cg_exo -43.4 177.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 122.451 2.101 . . . . 0.0 112.312 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.42 11.88 7.09 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 99.0 p -146.43 -161.94 1.42 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.845 0.355 . . . . 0.0 110.306 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.5 m -135.3 158.34 44.62 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.632 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -136.6 156.05 49.09 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.147 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -110.56 146.33 36.25 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.485 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.428 ' O ' ' O ' ' A' ' 5' ' ' PRO . 21.5 t -86.7 126.33 40.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.494 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.407 HG12 ' H ' ' A' ' 40' ' ' VAL . 2.2 p -68.02 -41.21 84.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.95 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -174.74 160.56 2.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.083 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.4 t -133.31 118.23 30.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.2 110.39 48.02 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.474 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -76.4 -11.55 18.99 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.292 1.995 . . . . 0.0 112.271 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.0 mt -56.98 -30.45 64.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.686 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.98 21.98 0.68 Allowed Glycine 0 N--CA 1.465 0.609 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.16 159.81 30.46 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -60.55 173.9 1.86 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.761 2.307 . . . . 0.0 111.819 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 60' ' ' LEU . 8.0 mm -93.07 114.1 29.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.325 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -93.63 125.47 38.27 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.296 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.4 pt -127.1 150.25 32.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.571 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -127.07 137.97 53.13 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.356 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 56' ' ' VAL . 0.8 OUTLIER -131.53 137.95 48.71 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.9 ptt-85 -42.73 -44.65 4.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.793 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 76.2 mmt-85 -65.12 -42.08 94.27 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.675 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.807 HG22 ' H ' ' A' ' 57' ' ' SER . 11.1 p -169.46 179.43 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.239 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.807 ' H ' HG22 ' A' ' 56' ' ' VAL . 8.1 p -123.16 150.6 43.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.165 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.528 HD23 ' N ' ' A' ' 59' ' ' VAL . 7.1 tt -159.68 162.82 35.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.395 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.528 ' N ' HD23 ' A' ' 58' ' ' LEU . 4.1 p -122.14 132.49 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.096 0.474 . . . . 0.0 110.661 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 49' ' ' ILE . 51.5 mt -124.79 157.58 35.44 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.36 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -91.01 170.95 9.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.011 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -61.08 -44.37 97.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.201 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -62.42 -37.35 85.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.564 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -59.96 -46.0 90.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.447 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.31 -42.16 98.99 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.083 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.47 -49.44 77.34 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.2 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.2 mt -69.71 -41.8 74.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.314 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.1 tp -63.12 134.19 55.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.27 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -83.24 115.01 21.77 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.227 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.1 m -134.04 155.34 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.554 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -141.15 142.45 34.06 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.675 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.74 145.73 46.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.255 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.9 t -104.1 128.93 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.231 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.0 t -148.12 -61.55 0.26 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.519 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.3 t -64.24 -31.9 73.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.571 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.1 tp 58.32 97.13 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.31 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -123.87 131.68 53.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.193 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -103.13 120.63 41.05 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.15 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -74.66 128.07 34.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.241 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -158.71 86.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.452 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 78.9 m80 50.07 86.64 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.635 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -82.01 130.51 35.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.5 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.473 -179.974 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.0 mtm . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.591 ' N ' ' NE2' ' A' ' 2' ' ' GLN . 3.7 mm-40 -66.61 -31.43 72.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.469 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 5.0 m-85 -77.5 101.09 6.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.966 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.68 158.46 45.35 Favored Pre-proline 0 N--CA 1.469 0.503 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -51.14 -38.73 61.05 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.996 1.798 . . . . 0.0 112.735 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -136.79 94.62 3.0 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.76 129.22 43.85 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.16 102.13 14.85 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.423 ' CZ3' HD23 ' A' ' 65' ' ' LEU . 24.4 m0 -100.86 141.39 33.81 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.292 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -97.16 129.11 44.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.781 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.2 mt -80.62 122.56 36.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.061 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 6.2 p -109.12 -15.33 14.35 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.342 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.81 178.41 15.64 Favored Glycine 0 N--CA 1.466 0.686 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.5 p90 -99.36 153.36 19.04 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.464 ' O ' HG22 ' A' ' 18' ' ' ILE . 1.9 t -82.29 171.97 13.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.647 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.436 ' N ' ' OG ' ' A' ' 15' ' ' SER . 99.6 mtt180 -69.89 -40.67 75.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.835 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.425 ' HB3' HD22 ' A' ' 67' ' ' LEU . 31.5 tp10 -66.19 -14.94 62.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.297 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 15' ' ' SER . 10.5 tp -41.06 147.33 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.729 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.76 155.23 87.09 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.521 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.12 -31.57 64.79 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.577 2.185 . . . . 0.0 112.016 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.66 -54.39 32.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.892 0.377 . . . . 0.0 111.129 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -62.62 -45.5 92.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.466 0.65 . . . . 0.0 110.34 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -57.64 -42.7 83.95 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.811 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 28' ' ' SER . 58.3 tp60 -61.77 -37.3 83.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.063 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -60.54 -43.25 97.39 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 120.081 -0.647 . . . . 0.0 110.025 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.421 ' HA ' HD13 ' A' ' 26' ' ' LEU . 4.5 mm? -63.43 -40.12 96.33 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.401 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.4 tt -80.3 -26.45 38.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.437 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.46 ' N ' ' O ' ' A' ' 24' ' ' GLN . 15.0 t -60.59 -45.53 93.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.336 -178.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.512 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -107.16 163.55 12.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.247 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.63 34.24 4.11 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 94.7 mtp -108.71 73.92 0.89 Allowed 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 33' ' ' PRO . 3.3 mm? -81.59 154.55 71.18 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.142 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.471 ' O ' ' O ' ' A' ' 32' ' ' LEU . 77.3 Cg_exo -42.48 176.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 122.742 2.295 . . . . 0.0 112.537 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.24 12.05 7.11 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 95.7 p -136.94 -156.93 0.74 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.863 0.363 . . . . 0.0 110.268 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 97.3 p -146.61 161.36 40.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.459 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.429 ' HB2' HG22 ' A' ' 53' ' ' THR . 48.5 p90 -138.05 155.09 49.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.29 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 27.4 p30 -109.85 152.35 25.87 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.534 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.6 t -92.96 125.26 45.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.503 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.408 ' H ' HG12 ' A' ' 40' ' ' VAL . 1.7 p -67.14 -41.69 87.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.026 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.607 ' NH2' ' ND1' ' A' ' 50' ' ' HIS . 37.7 ptt-85 -172.12 157.2 4.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.252 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.6 t -126.33 120.21 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.22 110.56 49.08 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.355 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -76.53 -12.24 18.62 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.008 1.805 . . . . 0.0 112.213 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.1 tp -57.63 -31.29 66.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.873 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.87 25.97 0.8 Allowed Glycine 0 N--CA 1.464 0.532 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.2 159.69 30.7 Favored Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.432 ' HG2' ' HE2' ' A' ' 50' ' ' HIS . 17.5 Cg_endo -56.56 175.7 0.26 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.838 2.359 . . . . 0.0 111.764 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.454 ' N ' ' O ' ' A' ' 60' ' ' LEU . 7.2 mm -92.5 114.21 29.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.936 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.607 ' ND1' ' NH2' ' A' ' 41' ' ' ARG . 15.8 m170 -94.32 119.91 33.78 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.872 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 58' ' ' LEU . 48.2 pt -126.11 149.87 31.26 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.221 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 12.5 tm-20 -132.68 130.11 39.67 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.188 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.429 HG22 ' HB2' ' A' ' 37' ' ' PHE . 1.4 p -116.06 137.14 52.38 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.701 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.414 ' H ' ' HG3' ' A' ' 54' ' ' ARG . 79.5 mtp180 -39.08 -36.76 0.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.818 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.548 ' O ' HG13 ' A' ' 56' ' ' VAL . 32.9 mmt180 -71.11 -49.05 48.45 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.147 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 55' ' ' ARG . 15.2 m -160.81 -176.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.95 0.405 . . . . 0.0 110.501 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 m -109.06 148.18 31.2 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.741 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' A' ' 51' ' ' ILE . 63.0 tp -152.61 149.16 28.17 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.4 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 59' ' ' VAL . 13.4 p -128.84 129.76 68.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.624 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 49' ' ' ILE . 76.3 mt -133.59 163.8 28.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.325 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -93.66 164.23 13.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.492 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -55.91 -39.09 71.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.035 0.445 . . . . 0.0 110.288 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -62.0 -40.94 97.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.729 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -60.43 -43.86 96.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.151 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.423 HD23 ' CZ3' ' A' ' 9' ' ' TRP . 10.8 mp -62.64 -42.22 99.48 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.31 -50.32 74.04 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.243 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.425 HD22 ' HB3' ' A' ' 17' ' ' GLU . 98.3 mt -68.79 -41.1 79.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.2 tp -65.1 131.22 45.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.107 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.444 ' O ' ' OG1' ' A' ' 12' ' ' THR . 94.3 mt-10 -78.19 115.29 17.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.181 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.418 HG21 ' CE3' ' A' ' 9' ' ' TRP . 27.0 m -136.4 160.2 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.419 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -141.0 132.34 26.69 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.156 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.31 135.33 54.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.884 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 85.0 t -93.98 128.29 45.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.176 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.4 m -142.42 -19.97 0.69 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.492 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 70.7 m -70.82 145.36 50.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.428 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.3 tp -159.75 100.13 1.43 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.169 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -140.52 154.53 46.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.268 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -132.69 140.17 48.0 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.38 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.528 ' CD2' ' H ' ' A' ' 79' ' ' HIS . 9.4 p80 -97.86 92.58 5.9 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.491 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -97.34 -13.24 22.02 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.615 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -92.3 123.82 35.91 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.431 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -79.73 130.69 35.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.439 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 85.3 t60 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.538 179.957 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 tpt . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.455 ' CD ' ' CE2' ' A' ' 3' ' ' TYR . 10.3 tt0 -74.1 -90.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.773 -179.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.455 ' CE2' ' CD ' ' A' ' 2' ' ' GLN . 94.3 m-85 -84.51 90.76 7.7 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.586 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.22 154.92 65.41 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.47 -179.312 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' A' ' 39' ' ' VAL . 51.8 Cg_exo -51.18 -36.51 56.11 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.075 1.85 . . . . 0.0 112.793 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -131.98 98.64 4.5 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.748 0.308 . . . . 0.0 110.371 -179.201 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.55 129.71 31.31 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -88.47 102.1 14.57 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 22.4 m0 -105.13 144.39 31.99 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.118 -179.092 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -100.46 132.05 46.05 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.185 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 34.2 mt -82.03 120.54 33.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.672 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.5 m -102.39 -40.49 6.7 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.374 179.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 161.14 175.34 32.06 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -96.47 143.55 27.39 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.536 ' O ' HG22 ' A' ' 18' ' ' ILE . 3.6 m -72.0 167.01 21.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.677 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -66.49 -39.02 88.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.333 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.98 -17.61 64.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.812 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 15' ' ' SER . 10.6 tp -41.88 146.36 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.398 -179.399 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.0 p -81.9 147.98 59.71 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.561 -179.324 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -49.85 -41.97 45.64 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.848 1.699 . . . . 0.0 112.644 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.95 -57.87 7.46 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.158 -178.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -63.23 -44.41 95.32 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.469 0.652 . . . . 0.0 110.734 -179.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -57.8 -46.09 85.14 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.989 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 28' ' ' SER . 78.0 mt-30 -64.59 -31.98 73.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.752 179.205 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.6 mmtt -59.77 -42.64 93.76 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 119.891 -0.723 . . . . 0.0 109.241 179.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.512 HD12 ' HD3' ' A' ' 33' ' ' PRO . 4.6 mm? -64.51 -41.29 96.51 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.794 178.43 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 45.0 mt -79.68 -16.12 56.3 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.895 0.379 . . . . 0.0 110.945 -179.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 24' ' ' GLN . 37.2 t -59.45 -41.56 89.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.035 -179.045 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.773 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -124.16 -171.16 2.27 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.948 -179.498 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.13 43.2 2.04 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -179.334 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.481 ' SD ' HD11 ' A' ' 29' ' ' LEU . 64.1 mtt -120.12 71.98 0.92 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.485 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.1 mm? -82.98 152.05 64.88 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.333 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.512 ' HD3' HD12 ' A' ' 26' ' ' LEU . 77.2 Cg_exo -41.88 171.6 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.586 2.191 . . . . 0.0 112.366 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.51 -12.94 18.47 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 179.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.2 m -96.11 -156.68 0.54 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.893 0.378 . . . . 0.0 110.347 179.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.7 p -150.37 160.57 43.64 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.447 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -146.21 165.96 27.63 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.507 -179.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -126.13 143.88 50.96 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.267 0.556 . . . . 0.0 110.57 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.443 ' O ' ' O ' ' A' ' 5' ' ' PRO . 61.5 t -78.54 128.97 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.219 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.9 p -76.1 -40.44 37.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.09 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -173.16 160.95 4.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.097 -179.055 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 55.2 t -126.25 131.19 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -92.82 111.29 50.54 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-O 119.451 -0.309 . . . . 0.0 110.321 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.29 -13.11 18.94 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.923 1.748 . . . . 0.0 112.056 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.1 tp -61.98 -32.08 72.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.646 -179.001 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 127.79 30.01 0.78 Allowed Glycine 0 N--CA 1.464 0.542 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.89 173.29 4.08 Favored Pre-proline 0 CA--C 1.534 0.327 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -179.35 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -61.46 -170.94 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.141 1.894 . . . . 0.0 111.503 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.4 mm -108.17 114.48 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -88.45 124.5 34.03 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.285 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.2 pt -129.21 144.25 38.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.397 179.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -124.17 114.34 19.51 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.125 179.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 56' ' ' VAL . 0.7 OUTLIER -105.83 137.82 43.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.895 -179.585 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -41.43 -42.42 2.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.474 -179.503 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -67.12 -44.6 79.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.718 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.683 HG22 ' N ' ' A' ' 57' ' ' SER . 14.8 p -170.28 172.85 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.499 -179.71 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.683 ' N ' HG22 ' A' ' 56' ' ' VAL . 94.2 p -111.52 153.8 25.68 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.561 179.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.2 tt -161.35 159.66 28.66 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.585 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 59' ' ' VAL . 11.9 p -114.96 130.45 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.824 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.628 HD23 HD12 ' A' ' 65' ' ' LEU . 1.3 tp -133.53 152.34 51.89 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.035 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -82.63 161.64 22.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.626 -179.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.1 -45.94 91.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.644 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.69 -40.4 87.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.853 -179.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.46 -40.32 96.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.262 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.628 HD12 HD23 ' A' ' 60' ' ' LEU . 2.3 mp -61.64 -44.47 96.92 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.62 -42.45 98.9 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.28 -179.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.425 ' O ' ' OG ' ' A' ' 15' ' ' SER . 94.2 mt -68.02 -41.13 82.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.669 179.698 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.1 tp -64.95 131.03 45.54 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.066 -179.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -74.76 114.47 13.24 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.154 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.9 m -132.57 158.19 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.647 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -143.55 135.69 26.81 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.694 -179.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.37 129.29 37.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.345 179.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 75' ' ' SER . 15.3 t -76.78 -76.9 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.854 -179.739 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.2 p 39.71 22.55 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 73' ' ' VAL . 48.0 p -154.98 156.09 35.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.544 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.2 mt -120.43 19.96 11.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.454 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -48.03 -75.22 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.403 -179.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 44.94 -162.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.535 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.2 t60 49.34 92.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.669 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -78.11 147.61 34.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.518 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -61.01 -41.89 97.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.643 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -83.49 128.17 34.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.513 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 78.9 m80 . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.565 179.982 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mtp . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -64.94 -41.46 95.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.769 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -70.53 136.2 49.16 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -179.34 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.18 155.71 72.4 Favored Pre-proline 0 N--CA 1.466 0.325 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.154 -179.44 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 39' ' ' VAL . 40.9 Cg_endo -66.43 -22.1 52.63 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.653 2.235 . . . . 0.0 112.192 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -137.11 93.4 2.82 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.709 0.29 . . . . 0.0 110.325 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.92 130.71 25.94 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.12 102.46 15.0 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 18.3 m0 -102.22 140.63 36.24 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.884 0.373 . . . . 0.0 110.17 -179.211 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -98.15 128.51 44.68 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.536 179.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.7 mt -81.85 124.49 39.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.232 -179.302 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -109.35 -44.06 3.99 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.49 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.32 -176.68 39.47 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -100.63 150.15 23.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.854 0.359 . . . . 0.0 110.479 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.414 ' O ' HG22 ' A' ' 18' ' ' ILE . 2.3 t -78.24 169.86 17.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.564 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -69.74 -39.24 76.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.925 0.393 . . . . 0.0 110.784 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -66.83 -14.94 63.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.451 -179.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.414 HG22 ' O ' ' A' ' 15' ' ' SER . 10.5 tp -40.63 146.86 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.545 -179.473 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.9 m -79.5 143.84 60.25 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.507 -179.391 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -47.99 -41.06 33.41 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.917 1.745 . . . . 0.0 112.663 179.209 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.13 -55.99 19.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.86 0.362 . . . . 0.0 111.492 -178.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -63.24 -47.26 83.2 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.476 0.655 . . . . 0.0 110.623 -179.592 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -56.78 -44.87 82.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.999 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -60.43 -35.81 76.69 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.024 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -56.73 -46.71 81.16 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 29' ' ' LEU . 4.5 mm? -63.05 -43.44 98.63 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.506 179.488 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.58 -31.3 68.26 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.721 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.0 t -58.94 -45.03 91.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.228 -179.163 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.471 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -119.22 174.84 6.1 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.39 -179.697 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -90.67 0.16 76.57 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 46.3 tpp -66.85 73.7 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.5 mp -99.59 169.47 8.05 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.369 -179.041 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 32' ' ' LEU . 61.7 Cg_exo -49.96 -166.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.242 1.961 . . . . 0.0 112.256 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.94 4.98 51.04 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.1 m -140.65 -169.92 2.9 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.925 0.393 . . . . 0.0 110.259 179.794 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.2 p -134.04 158.74 42.8 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.194 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -137.72 163.87 30.25 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.218 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.46 ' OD1' ' N ' ' A' ' 38' ' ' ASN . 12.1 p-10 -121.66 150.28 41.98 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.314 0.578 . . . . 0.0 110.387 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.438 ' O ' ' O ' ' A' ' 5' ' ' PRO . 14.8 t -85.41 128.73 38.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.504 -179.651 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 p -68.95 -40.93 81.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.248 179.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -174.85 167.27 3.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.994 -179.198 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.6 m -133.51 125.1 49.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.084 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.76 111.21 51.76 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.582 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -76.24 -11.91 19.21 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.051 1.834 . . . . 0.0 112.311 179.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.526 ' N ' HD12 ' A' ' 45' ' ' LEU . 10.6 mp -61.52 -32.23 72.27 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.809 -178.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.2 26.48 0.82 Allowed Glycine 0 N--CA 1.466 0.669 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.27 160.32 29.18 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -55.71 173.72 0.35 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.698 2.265 . . . . 0.0 111.855 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.4 mm -92.84 118.0 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.771 -179.376 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.435 ' CD2' HG23 ' A' ' 59' ' ' VAL . 12.7 m170 -97.02 123.7 40.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.03 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.8 pt -127.33 148.88 32.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.719 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 97.0 mt-10 -134.95 112.16 10.4 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.094 179.593 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.425 ' O ' ' C ' ' A' ' 54' ' ' ARG . 1.2 p -85.52 173.93 9.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.889 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 53' ' ' THR . 99.9 mtt180 -33.55 -52.95 0.41 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.708 -178.186 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 57.4 ttp85 -142.93 32.29 1.4 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.016 179.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -140.62 136.98 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.489 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.6 t -113.7 130.47 56.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.237 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.403 HD21 HD11 ' A' ' 60' ' ' LEU . 59.9 tp -145.62 148.09 32.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.111 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.435 HG23 ' CD2' ' A' ' 50' ' ' HIS . 3.8 p -136.4 123.6 32.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.32 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.403 HD11 HD21 ' A' ' 58' ' ' LEU . 94.4 mt -140.68 173.16 11.76 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.443 -179.513 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.9 mtm-85 -84.05 163.31 19.96 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.922 0.391 . . . . 0.0 110.91 -179.519 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -58.73 -34.37 71.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.517 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -60.6 -40.25 91.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.546 179.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -61.56 -43.84 98.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.512 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 mp -61.58 -42.12 98.4 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.79 -44.24 97.26 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.326 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.6 mt -68.75 -41.19 79.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.042 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 63.7 mt -64.06 137.64 58.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.875 0.369 . . . . 0.0 110.611 -179.477 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -79.39 108.58 13.02 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.215 -179.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.4 m -134.95 156.54 39.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.479 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -138.92 128.06 23.97 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.595 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.1 134.58 48.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.095 179.675 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.8 m -120.45 131.11 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 121.029 0.443 . . . . 0.0 110.348 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.8 t -83.81 -42.6 16.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.6 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.7 p -156.07 132.26 10.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.45 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.544 ' N ' HD12 ' A' ' 76' ' ' LEU . 10.6 mp -63.18 -41.99 99.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.327 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 76' ' ' LEU . 45.2 tp10 49.64 100.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.254 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -153.4 154.24 34.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.573 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -168.57 83.67 0.16 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.548 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 51.1 p-80 -153.46 166.66 32.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.547 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.484 ' CE1' ' H ' ' A' ' 83' ' ' HIS . 57.9 t-80 -145.48 138.44 26.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.419 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -59.65 -43.41 93.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.63 -179.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.484 ' H ' ' CE1' ' A' ' 81' ' ' HIS . 99.1 m-70 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.389 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -62.8 -43.63 98.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.644 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -75.34 90.51 2.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.152 -179.62 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.07 154.44 40.63 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.424 -179.101 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 39' ' ' VAL . 41.2 Cg_endo -67.33 -37.42 17.89 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.672 2.248 . . . . 0.0 112.243 179.733 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -136.56 95.95 3.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.626 -179.596 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -140.07 147.76 40.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.383 179.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -97.25 101.8 13.43 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.632 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 28.7 m0 -98.02 142.95 29.1 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.341 -179.34 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -99.78 131.37 45.8 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.881 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.0 mt -80.98 125.58 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.467 -179.386 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.4 m -104.93 -51.95 2.95 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.475 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 168.14 167.78 29.29 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.0 OUTLIER -87.7 148.26 24.85 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 179.616 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.528 ' O ' HG22 ' A' ' 18' ' ' ILE . 43.7 t -80.68 171.05 15.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.659 179.874 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -67.16 -38.85 86.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.343 179.673 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -65.4 -18.31 65.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.689 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.528 HG22 ' O ' ' A' ' 15' ' ' SER . 10.8 tp -41.91 147.27 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.822 -179.698 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.58 158.19 81.37 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.28 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.88 -32.39 45.62 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.663 2.242 . . . . 0.0 111.958 179.63 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.15 -57.42 11.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.018 0.437 . . . . 0.0 110.979 -179.465 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -61.27 -45.29 95.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.603 0.716 . . . . 0.0 110.322 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -56.51 -42.86 79.08 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.192 -179.65 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 28' ' ' SER . 62.8 mt-30 -62.15 -37.2 84.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.414 179.41 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -58.81 -43.34 90.58 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.811 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.6 mm? -64.68 -41.71 95.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.262 0.553 . . . . 0.0 110.575 179.638 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.4 tt -78.73 -26.21 44.67 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.19 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 24' ' ' GLN . 14.4 t -61.19 -45.18 95.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.273 -178.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.5 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -112.03 169.27 8.97 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.237 -179.742 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.05 40.76 2.95 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.571 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.549 ' SD ' ' CZ ' ' A' ' 55' ' ' ARG . 38.0 ttp -108.82 72.11 0.81 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.188 0.518 . . . . 0.0 109.793 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.506 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.2 mm? -82.74 151.88 65.31 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.566 -179.276 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 32' ' ' LEU . 73.9 Cg_exo -41.96 175.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 122.49 2.126 . . . . 0.0 112.009 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.5 -21.22 9.27 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.783 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.8 m -97.63 -174.43 2.9 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.8 m -133.6 151.68 51.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.332 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.424 ' HB2' HG22 ' A' ' 53' ' ' THR . 52.2 p90 -133.17 155.04 50.02 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.109 -179.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -109.05 145.0 36.33 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.318 0.58 . . . . 0.0 110.713 -179.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.446 ' O ' ' O ' ' A' ' 5' ' ' PRO . 48.8 t -89.45 125.05 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.18 -179.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.428 HG12 ' H ' ' A' ' 40' ' ' VAL . 2.2 p -69.11 -40.44 80.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.965 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.2 ptt-85 -176.82 166.84 2.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.006 -178.918 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 42' ' ' VAL . 27.9 m -132.67 122.31 46.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.031 179.299 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.89 111.98 56.47 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.543 ' C ' ' H ' ' A' ' 46' ' ' GLY . 59.2 Cg_endo -75.75 -11.98 20.12 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.642 2.228 . . . . 0.0 112.013 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.9 mt -61.83 4.91 0.1 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.955 -179.191 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.543 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 91.07 24.98 25.66 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.42 160.07 30.46 Favored Pre-proline 0 C--N 1.332 -0.176 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.62 168.01 4.55 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.809 2.339 . . . . 0.0 111.749 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.9 mm -90.12 118.23 34.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.097 0.475 . . . . 0.0 110.074 -179.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.414 ' O ' HG12 ' A' ' 40' ' ' VAL . 12.5 m170 -96.72 121.52 38.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.064 179.535 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.1 pt -123.84 147.73 28.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.141 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -129.85 135.27 48.19 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.471 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 56' ' ' VAL . 1.7 p -123.94 143.57 50.3 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.911 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -54.27 -18.32 3.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.771 -178.726 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.549 ' CZ ' ' SD ' ' A' ' 31' ' ' MET . 16.8 ptm180 -97.97 -31.31 12.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.891 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.716 HG22 ' H ' ' A' ' 57' ' ' SER . 4.2 p -170.22 179.37 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.969 0.414 . . . . 0.0 110.393 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.716 ' H ' HG22 ' A' ' 56' ' ' VAL . 54.3 m -124.25 155.91 37.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.478 178.711 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.4 tp -158.66 151.71 22.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.292 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.414 HG23 ' CD2' ' A' ' 50' ' ' HIS . 4.4 p -135.82 126.68 43.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.025 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.8 mt -131.56 161.8 31.78 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.505 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -78.23 150.86 33.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.569 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -44.71 -47.22 10.66 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.279 0.561 . . . . 0.0 110.857 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -52.96 -34.63 56.58 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.263 -179.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -63.6 -40.78 97.8 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.348 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.61 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.0 mm? -63.33 -43.21 98.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.076 -179.285 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.84 -47.25 85.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.207 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.8 mt -68.31 -41.81 80.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.567 179.77 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 49.7 tp -64.63 131.47 47.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.26 -179.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -81.55 114.32 20.18 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.441 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.4 m -130.98 156.42 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.335 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -137.39 125.55 23.04 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.444 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.03 138.98 52.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.281 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.0 t -97.99 129.21 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 120.886 0.374 . . . . 0.0 110.285 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.2 m -162.62 9.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.55 -179.85 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.1 m -73.73 151.89 40.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.394 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.438 ' C ' ' N ' ' A' ' 78' ' ' HIS . 0.3 OUTLIER -90.38 23.76 2.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.224 -179.618 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -47.15 -17.52 0.06 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.641 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.438 ' N ' ' C ' ' A' ' 76' ' ' LEU . 79.5 m80 -70.27 139.18 52.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.334 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -150.77 166.96 28.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.261 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -105.0 148.7 26.44 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.43 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -64.44 -39.34 93.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.422 -179.701 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -137.28 143.86 42.38 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.498 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.559 -179.886 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.3 mtt . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -65.0 -44.42 89.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.834 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -105.12 133.64 49.57 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.482 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 p -128.45 152.17 77.84 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.491 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.57 -40.82 54.66 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.944 1.763 . . . . 0.0 112.765 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -135.24 101.22 4.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.021 0.439 . . . . 0.0 111.036 -179.297 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -137.86 142.8 40.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.393 179.143 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.66 102.21 14.38 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.565 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 18.9 m0 -100.65 137.04 39.58 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.394 -179.254 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -91.57 143.89 26.11 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.768 179.515 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.5 mt -97.2 117.01 41.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.316 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.9 m -101.7 -47.04 4.75 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.597 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 162.16 176.63 34.44 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.4 p90 -92.11 148.4 22.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.219 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.442 ' OG ' ' N ' ' A' ' 16' ' ' ARG . 1.9 t -75.89 172.18 13.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.528 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.442 ' N ' ' OG ' ' A' ' 15' ' ' SER . 35.8 ptt-85 -71.54 -37.13 71.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.665 179.712 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -69.67 -13.84 62.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.327 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 15' ' ' SER . 10.6 tp -41.35 149.44 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.516 -179.566 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.4 p -79.21 140.65 57.05 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.522 -179.541 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -47.44 -40.95 29.46 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 121.941 1.761 . . . . 0.0 112.703 179.061 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.98 -56.71 16.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.903 0.383 . . . . 0.0 111.19 -178.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -61.7 -44.35 97.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.285 0.564 . . . . 0.0 110.484 -179.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -58.62 -43.19 89.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.935 -179.386 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -62.81 -37.07 85.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.977 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -58.4 -47.35 84.17 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -63.21 -38.98 93.31 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.098 179.627 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.6 tp -60.34 -44.26 95.67 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.108 -179.39 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.5 m -75.97 -33.15 59.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.805 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.453 ' HG ' ' H ' ' A' ' 31' ' ' MET . 8.4 tp -71.34 129.47 38.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.259 -179.327 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.63 2.49 87.26 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.453 ' H ' ' HG ' ' A' ' 29' ' ' LEU . 24.0 tpp -109.39 75.78 0.97 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.068 0.461 . . . . 0.0 109.854 179.484 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 33' ' ' PRO . 1.2 mp -79.42 165.82 45.68 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.858 -179.213 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.479 ' O ' ' O ' ' A' ' 32' ' ' LEU . 71.4 Cg_exo -40.34 172.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.578 2.185 . . . . 0.0 112.393 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.42 8.64 9.09 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.551 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 t -137.2 -157.52 0.78 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.903 0.382 . . . . 0.0 110.207 179.563 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.9 m -145.33 157.96 43.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.445 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -139.35 153.75 47.74 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.378 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -107.06 147.95 29.35 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.342 0.591 . . . . 0.0 110.682 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.6 t -88.12 126.49 41.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.241 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 50' ' ' HIS . 2.4 p -64.66 -39.9 87.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.891 179.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -174.08 161.13 3.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.096 -179.474 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 55.8 t -126.39 125.23 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.773 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.02 111.69 54.13 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.43 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.67 -11.99 20.26 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.202 1.934 . . . . 0.0 112.0 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.8 tp -58.68 -31.55 68.32 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.832 -178.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.71 32.98 1.13 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -100.24 179.45 1.02 Allowed Pre-proline 0 N--CA 1.466 0.343 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.463 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 47' ' ' ASP . 24.0 Cg_exo -62.7 -178.19 0.37 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.36 2.04 . . . . 0.0 111.71 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.3 mm -107.87 119.9 58.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.449 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.548 ' CD2' HG22 ' A' ' 59' ' ' VAL . 16.4 m170 -102.31 123.09 45.49 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.816 179.644 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.8 pt -127.81 152.13 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.054 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -123.52 135.61 54.12 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.08 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 56' ' ' VAL . 1.4 p -131.45 140.88 49.7 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -38.85 -37.3 0.33 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.565 -179.469 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.3 ttp85 -75.34 -49.4 19.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.777 179.608 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.844 HG22 ' H ' ' A' ' 57' ' ' SER . 10.2 p -171.73 -179.59 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.621 -179.564 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.844 ' H ' HG22 ' A' ' 56' ' ' VAL . 1.7 t -107.72 164.08 12.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.13 178.724 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.417 HD21 HD11 ' A' ' 60' ' ' LEU . 58.8 tp -149.15 146.31 27.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.205 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.548 HG22 ' CD2' ' A' ' 50' ' ' HIS . 57.4 t -127.9 124.41 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.79 178.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.417 HD11 HD21 ' A' ' 58' ' ' LEU . 89.6 mt -144.55 167.32 22.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.71 179.813 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -81.94 147.91 29.0 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.036 0.446 . . . . 0.0 111.424 -179.668 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -42.2 -40.99 2.56 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.701 -179.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -55.44 -38.81 69.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.547 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -61.75 -41.01 97.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.431 179.869 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.637 HD22 ' N ' ' A' ' 65' ' ' LEU . 3.3 mm? -62.84 -42.14 99.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.972 -179.301 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.65 98.13 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.048 179.608 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.36 -41.96 79.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.035 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.0 mt -68.36 135.71 52.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.861 0.362 . . . . 0.0 110.222 -179.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -81.31 111.35 17.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.283 -179.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.4 m -130.97 156.36 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.632 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -144.07 146.82 33.08 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.907 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.65 143.0 56.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.105 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.9 t -98.7 130.28 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.343 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.1 p -149.49 -66.08 0.22 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.463 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 66.6 m -87.12 143.55 27.26 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.542 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.63 ' O ' HD23 ' A' ' 76' ' ' LEU . 2.9 tt -62.75 -46.18 89.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.875 0.369 . . . . 0.0 110.128 -179.7 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 51.71 95.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.286 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.425 ' NE2' HD13 ' A' ' 76' ' ' LEU . 76.0 m80 -80.31 155.32 27.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.331 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -133.1 140.69 47.79 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.512 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -142.09 150.97 41.89 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.508 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -78.71 141.28 38.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.498 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -65.8 -40.08 91.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.517 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.613 -179.971 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.9 mtm . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -64.18 -43.98 93.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.559 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -70.09 137.43 51.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.045 -179.467 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.01 156.91 70.23 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.092 -179.371 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -67.73 -50.25 0.93 Allowed 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.708 2.272 . . . . 0.0 112.196 -179.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -129.06 97.58 4.66 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.81 -179.599 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 t -139.49 151.87 46.52 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.273 179.485 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -101.61 102.73 13.48 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.126 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -99.53 133.8 43.33 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.889 0.376 . . . . 0.0 110.152 -179.104 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -92.18 133.49 35.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.98 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.3 mt -85.34 123.31 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.303 -179.242 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.8 m -106.33 -47.74 3.73 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.874 0.369 . . . . 0.0 110.563 179.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 164.79 170.73 30.14 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 1.8 p90 -89.91 146.04 24.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.874 0.369 . . . . 0.0 110.412 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.419 ' O ' HG22 ' A' ' 18' ' ' ILE . 3.8 m -74.63 170.1 16.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.537 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -69.13 -37.74 78.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.481 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -72.06 -10.01 59.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.543 -179.581 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.419 HG22 ' O ' ' A' ' 15' ' ' SER . 9.8 tp -41.5 146.99 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.517 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.04 153.92 95.01 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.325 -179.586 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.14 -33.16 62.17 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.382 2.055 . . . . 0.0 112.117 -179.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.29 -55.29 22.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.827 0.346 . . . . 0.0 111.278 -179.42 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.457 ' CD2' HD21 ' A' ' 60' ' ' LEU . 31.5 t80 -61.64 -42.3 98.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.569 0.7 . . . . 0.0 110.338 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 68.5 ttp85 -58.07 -44.11 87.35 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.838 179.633 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 28' ' ' SER . 73.2 mt-30 -62.41 -36.3 81.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.252 179.115 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.414 ' O ' ' CD1' ' A' ' 29' ' ' LEU . 26.7 mmtp -59.27 -45.65 90.67 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.954 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.6 mm? -63.62 -43.5 96.68 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.519 179.027 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 tt -70.71 -33.77 71.22 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.28 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 24' ' ' GLN . 74.8 m -58.86 -43.61 90.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.293 -178.729 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.452 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -119.72 176.92 5.16 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.475 -179.559 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -90.51 -2.96 72.33 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.595 ' CE ' ' HE ' ' A' ' 55' ' ' ARG . 35.4 tpp -61.89 73.85 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.783 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 30' ' ' GLY . 1.6 mp -101.12 169.9 7.21 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.34 -179.058 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.479 ' O ' ' O ' ' A' ' 32' ' ' LEU . 57.3 Cg_exo -50.19 -160.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.381 2.054 . . . . 0.0 112.584 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.22 10.66 59.35 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.1 t -142.41 -156.53 0.69 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.755 0.312 . . . . 0.0 110.376 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.3 p -151.86 164.02 37.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.591 -179.782 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -143.62 162.09 36.83 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.552 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 38' ' ' ASN . 7.9 p-10 -114.18 147.95 38.08 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.258 0.551 . . . . 0.0 110.84 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.8 t -88.7 123.11 40.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.234 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.404 HG22 ' HE ' ' A' ' 41' ' ' ARG . 2.3 p -66.47 -41.61 88.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.209 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.404 ' HE ' HG22 ' A' ' 40' ' ' VAL . 20.1 ptp180 -174.17 166.78 4.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.913 -179.453 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.6 m -128.72 130.12 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.0 110.95 49.21 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.545 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -76.65 -13.21 18.16 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.922 1.748 . . . . 0.0 112.392 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.3 mt -62.45 -30.99 71.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.768 -178.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.52 28.69 0.96 Allowed Glycine 0 N--CA 1.466 0.698 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.94 163.93 18.42 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.87 -173.8 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.913 1.742 . . . . 0.0 111.902 179.431 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.2 mm -103.07 115.08 44.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.775 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -92.02 119.1 31.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.174 -0.467 . . . . 0.0 109.779 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.6 pt -125.06 146.88 29.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.274 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.415 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 93.6 mt-10 -127.38 128.41 45.8 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.464 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 56' ' ' VAL . 0.8 OUTLIER -119.69 138.26 53.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.562 179.991 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.417 ' H ' ' HG2' ' A' ' 54' ' ' ARG . 35.6 mmm-85 -45.25 -38.29 5.38 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.382 -179.342 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.595 ' HE ' ' CE ' ' A' ' 31' ' ' MET . 74.6 mtp85 -69.95 -43.38 71.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.849 179.679 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.677 HG22 ' N ' ' A' ' 57' ' ' SER . 14.7 p -170.38 171.11 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-O 120.93 0.395 . . . . 0.0 110.648 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.677 ' N ' HG22 ' A' ' 56' ' ' VAL . 28.4 t -98.62 161.08 13.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.7 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 64.8 tp -163.56 149.25 11.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.11 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.681 ' O ' HD12 ' A' ' 60' ' ' LEU . 6.3 p -134.48 127.81 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.681 HD12 ' O ' ' A' ' 59' ' ' VAL . 2.4 mp -133.33 155.82 48.74 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.399 -179.669 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.445 ' O ' ' N ' ' A' ' 64' ' ' ASP . 95.3 mtm-85 -78.4 143.92 36.36 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.123 179.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -39.5 -43.4 1.26 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.479 -179.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.415 ' HG2' ' H ' ' A' ' 63' ' ' LYS . 13.3 ptpt -58.54 -41.83 86.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.353 179.821 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 61' ' ' ARG . 97.3 m-20 -62.75 -40.17 96.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.354 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.468 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.2 mm? -61.28 -42.38 98.55 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.3 -40.17 96.6 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.15 179.585 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.8 mt -67.32 -41.36 85.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.196 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.5 mt -71.05 141.38 50.91 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.618 -179.733 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -84.19 103.42 13.38 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.093 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.8 m -122.85 154.8 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.279 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.531 ' N ' ' OE1' ' A' ' 71' ' ' GLU . 56.6 mp0 -142.57 125.6 16.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.575 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.03 132.35 48.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.911 179.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.7 m -133.9 159.66 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.362 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 28.9 t -82.49 -68.85 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.628 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 45.0 t -73.64 137.59 44.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.467 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.2 -4.57 14.35 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.153 -179.861 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -58.42 146.65 34.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.62 -179.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -79.24 114.67 18.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.388 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -66.25 -42.83 88.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.65 -179.905 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -83.97 121.28 27.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.408 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -66.54 -40.4 89.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.575 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -71.36 144.04 50.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.553 -179.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 60.9 m170 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.576 -179.889 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 3' ' ' TYR . 80.1 mmm . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 51.84 -86.85 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.708 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.496 ' N ' ' O ' ' A' ' 1' ' ' MET . 65.9 m-85 -79.73 99.32 7.38 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.808 -179.626 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.31 156.99 35.97 Favored Pre-proline 0 N--CA 1.464 0.262 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.559 -179.448 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 39' ' ' VAL . 51.3 Cg_exo -50.95 -38.64 58.96 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.164 1.909 . . . . 0.0 112.616 179.358 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -136.8 95.82 3.2 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -179.546 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.75 129.21 47.93 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.84 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.21 101.55 13.13 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.235 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -102.29 148.06 25.91 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.333 -179.101 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -100.39 128.9 46.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.761 179.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.456 ' CD1' ' NH2' ' A' ' 55' ' ' ARG . 32.3 mt -83.85 122.53 37.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.24 -179.47 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.3 m -108.31 -46.17 3.77 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.87 0.367 . . . . 0.0 110.502 179.796 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.6 -179.44 39.95 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.87 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -90.57 160.09 16.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 0.0 110.435 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.8 t -82.25 169.21 16.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.614 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -69.74 -38.5 76.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.531 179.377 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -74.0 -6.59 48.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.881 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.0 tp -42.55 147.04 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.524 -179.532 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.9 p -82.73 149.19 59.67 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.754 -179.563 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.11 -38.81 50.99 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 122.303 2.002 . . . . 0.0 112.554 178.913 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.43 -57.11 13.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.859 0.361 . . . . 0.0 111.153 -179.081 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -63.58 -49.08 74.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.287 0.565 . . . . 0.0 110.578 -179.841 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -57.0 -43.86 82.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.237 -179.24 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -63.2 -33.11 74.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.755 179.293 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -59.76 -49.01 79.38 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.543 -0.463 . . . . 0.0 109.941 179.668 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.449 HD22 ' N ' ' A' ' 26' ' ' LEU . 4.5 mm? -63.87 -38.94 92.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.278 179.593 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.4 tp -60.55 -41.13 93.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.335 -179.353 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.3 m -83.65 -11.78 56.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.897 -179.398 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.452 ' HG ' ' H ' ' A' ' 31' ' ' MET . 9.5 tp -97.27 123.25 41.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.888 0.375 . . . . 0.0 110.261 -179.731 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.27 3.81 61.12 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.452 ' H ' ' HG ' ' A' ' 29' ' ' LEU . 66.7 mtt -108.48 75.83 1.0 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.21 0.529 . . . . 0.0 109.803 179.575 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.503 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.9 OUTLIER -78.51 167.9 31.58 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.093 -178.942 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.503 ' O ' ' O ' ' A' ' 32' ' ' LEU . 72.9 Cg_exo -42.2 177.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.509 2.139 . . . . 0.0 112.416 -179.551 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.74 11.06 7.33 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 179.784 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.9 m -143.5 -169.54 3.09 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.736 0.303 . . . . 0.0 110.37 179.587 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.45 ' O ' ' NH1' ' A' ' 54' ' ' ARG . 69.0 m -131.41 157.42 43.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.449 -179.74 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -133.52 157.72 44.95 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.212 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -112.93 147.16 37.66 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.447 -179.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 5' ' ' PRO . 14.5 t -85.27 127.03 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.171 179.867 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 p -68.26 -40.11 82.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.839 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -173.98 157.35 2.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.14 -179.072 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 73.8 t -131.82 105.93 10.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.467 ' HB3' ' OD1' ' A' ' 47' ' ' ASP . . . -93.72 111.4 52.47 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.525 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.89 -9.2 19.47 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.952 2.435 . . . . 0.0 112.275 -179.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 51.8 mt -50.73 -29.62 11.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.733 -178.149 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 132.29 20.55 1.01 Allowed Glycine 0 N--CA 1.467 0.723 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.362 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -97.4 160.89 27.75 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.647 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -60.17 175.31 1.08 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.749 2.3 . . . . 0.0 111.671 179.708 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.409 HG21 ' CD2' ' A' ' 65' ' ' LEU . 10.7 mm -94.55 115.73 34.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.185 -179.593 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -96.13 122.65 39.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.077 179.59 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.6 pt -128.37 147.26 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.361 179.71 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -122.87 121.03 35.23 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.019 179.635 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 55' ' ' ARG . 1.4 p -108.74 135.85 49.29 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.45 ' NH1' ' O ' ' A' ' 36' ' ' SER . 8.1 ptp85 -43.13 -18.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.62 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.613 ' O ' HG13 ' A' ' 56' ' ' VAL . 88.5 mtm180 -87.36 -51.38 5.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.967 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 55' ' ' ARG . 13.2 m -162.25 177.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.652 -179.547 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.3 p -97.63 143.14 28.61 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.337 179.539 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.1 tp -147.49 144.33 28.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.253 179.549 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 59' ' ' VAL . 4.8 p -136.9 124.14 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.864 179.2 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.7 mt -138.8 178.81 6.88 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.561 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -88.35 161.89 16.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.806 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -58.71 -32.52 69.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.503 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.87 -42.19 99.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.501 179.926 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -60.9 -44.57 96.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.504 -179.962 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.409 ' CD2' HG21 ' A' ' 49' ' ' ILE . 8.8 mp -62.81 -41.65 99.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.218 179.652 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.94 -51.36 69.45 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.304 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.98 -43.45 78.92 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.864 179.759 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.8 tp -53.0 132.67 38.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.36 -179.004 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -75.43 108.2 8.06 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.442 -179.557 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.8 m -134.22 160.36 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.733 179.812 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -145.19 136.93 25.47 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.598 179.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -76.31 129.5 36.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.145 179.467 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.1 t -83.93 130.01 36.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.254 -179.785 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.7 m -154.85 40.66 0.44 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.609 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 78.6 p -147.45 127.31 13.53 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.263 -179.919 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.565 HD12 ' N ' ' A' ' 76' ' ' LEU . 10.3 mp -96.25 69.87 2.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.174 -179.969 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.81 -40.79 98.47 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.273 179.838 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.471 ' CG ' ' N ' ' A' ' 79' ' ' HIS . 30.9 t-80 43.57 -101.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.743 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.53 ' CG ' ' N ' ' A' ' 80' ' ' HIS . 85.8 t60 54.52 165.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.521 -179.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.53 ' N ' ' CG ' ' A' ' 79' ' ' HIS . 6.7 p80 -151.91 144.38 24.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.401 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -96.45 131.8 42.66 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.432 179.801 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -147.74 149.39 32.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.349 -179.89 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 77.5 t60 . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.598 -179.945 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.1 ttm . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.627 ' N ' ' NE2' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -88.48 -6.17 57.78 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.461 -179.984 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.422 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 41.5 m-85 -87.06 90.25 8.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.934 -179.894 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.44 156.33 41.56 Favored Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.99 -179.512 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 39' ' ' VAL . 40.5 Cg_endo -66.09 -20.1 56.97 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.522 2.148 . . . . 0.0 112.211 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -136.62 93.53 2.88 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.393 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.96 131.52 27.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.203 -179.544 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.02 102.41 14.48 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.056 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 24.4 m0 -101.37 135.71 42.4 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.362 -179.213 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -90.25 131.79 35.87 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.5 mt -84.73 117.78 30.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.765 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 11.0 p -102.43 -19.34 14.97 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.745 0.307 . . . . 0.0 110.187 179.735 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 137.63 179.04 16.52 Favored Glycine 0 N--CA 1.463 0.474 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 179.425 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -96.06 147.77 23.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.625 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.451 ' O ' HG22 ' A' ' 18' ' ' ILE . 10.1 t -76.92 170.46 16.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.578 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -69.01 -38.85 79.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.543 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.465 ' HB3' HD12 ' A' ' 67' ' ' LEU . 75.3 tt0 -69.62 -13.23 62.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.634 -179.431 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 15' ' ' SER . 10.2 tp -41.45 147.1 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.725 -179.911 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.02 154.48 90.76 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.114 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.11 -29.72 56.13 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.456 2.104 . . . . 0.0 112.276 -179.607 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.33 -55.6 17.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.629 -179.206 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -62.25 -44.12 97.27 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.449 0.642 . . . . 0.0 110.346 -179.569 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -59.1 -45.7 90.21 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.999 179.758 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -59.28 -37.98 79.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.959 179.584 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -60.36 -41.66 94.15 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.839 179.367 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.424 ' HA ' HD13 ' A' ' 26' ' ' LEU . 4.4 mm? -61.73 -43.91 97.93 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.269 179.39 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.27 -38.89 92.67 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.375 179.418 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.0 m -61.12 -42.39 98.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.367 -179.191 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.47 ' CD1' ' O ' ' A' ' 31' ' ' MET . 2.5 pp -96.81 131.15 43.84 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.957 0.408 . . . . 0.0 110.675 -179.351 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.01 -22.95 72.68 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.47 ' O ' ' CD1' ' A' ' 29' ' ' LEU . 63.6 ttp -69.89 73.99 0.44 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.306 0.574 . . . . 0.0 109.789 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -82.03 169.45 18.46 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.815 -179.178 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 32' ' ' LEU . 61.0 Cg_exo -44.11 176.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.551 2.167 . . . . 0.0 112.946 -178.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.83 11.34 9.31 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.769 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 m -138.35 -156.16 0.66 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.754 0.311 . . . . 0.0 110.483 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.4 p -144.68 162.28 37.09 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.414 -179.75 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.401 ' HB2' HG22 ' A' ' 53' ' ' THR . 41.9 p90 -139.37 163.47 32.42 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.284 -179.708 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -122.22 144.38 49.01 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.309 0.575 . . . . 0.0 110.731 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' PRO . 19.4 t -82.32 125.67 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.535 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 p -68.77 -39.75 80.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.728 179.386 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.456 ' NH2' ' HD1' ' A' ' 50' ' ' HIS . 38.3 ptt-85 -173.24 160.9 4.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.732 -179.44 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 62.4 t -129.55 118.71 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.007 179.087 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.61 111.15 51.27 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.463 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.91 -11.25 19.88 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.065 1.843 . . . . 0.0 112.357 179.843 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.514 HD22 ' N ' ' A' ' 45' ' ' LEU . 4.0 mm? -59.43 -31.59 69.42 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.842 -178.624 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.55 26.32 0.8 Allowed Glycine 0 N--CA 1.469 0.838 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.747 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -97.59 159.9 29.98 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.78 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.45 175.39 0.55 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.308 2.005 . . . . 0.0 111.628 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 60' ' ' LEU . 8.3 mm -94.27 115.33 32.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.794 -179.579 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.456 ' HD1' ' NH2' ' A' ' 41' ' ' ARG . 12.4 m170 -94.6 125.44 39.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.156 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.1 pt -127.15 148.58 31.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.474 179.737 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -130.91 130.33 43.36 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.488 179.784 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.401 HG22 ' HB2' ' A' ' 37' ' ' PHE . 0.7 OUTLIER -124.38 138.06 54.4 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.511 -179.697 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -42.95 -34.62 1.01 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.437 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -69.73 -46.49 65.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.647 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.648 HG22 ' N ' ' A' ' 57' ' ' SER . 14.8 p -170.86 167.57 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 120.922 0.391 . . . . 0.0 111.177 -179.918 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.648 ' N ' HG22 ' A' ' 56' ' ' VAL . 9.9 p -93.25 154.79 17.82 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.599 178.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 64.2 tp -163.3 148.43 11.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.331 179.712 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.45 HG23 ' CD2' ' A' ' 50' ' ' HIS . 4.9 p -128.58 131.4 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.954 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 49' ' ' ILE . 91.7 mt -135.05 161.15 36.13 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.519 -179.428 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -86.33 164.82 16.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.571 179.734 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -59.0 -39.16 80.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.988 0.423 . . . . 0.0 110.542 -179.604 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -61.78 -40.15 94.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.59 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -59.66 -44.88 93.4 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.804 -0.359 . . . . 0.0 110.375 -179.581 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.2 mp -62.62 -41.42 98.99 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.275 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.22 -52.32 65.78 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.403 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.465 HD12 ' HB3' ' A' ' 17' ' ' GLU . 4.0 mm? -69.14 -40.69 78.09 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.301 179.609 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.9 tp -59.87 135.63 57.76 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.331 -179.309 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.445 ' O ' ' OG1' ' A' ' 12' ' ' THR . 70.7 mm-40 -81.51 113.69 19.73 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.547 -179.545 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.0 m -133.93 160.43 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.692 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -143.75 139.53 29.48 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.442 179.761 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.5 136.22 51.16 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.002 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 51.7 t -89.74 131.76 36.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.154 -179.657 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.403 ' OG ' ' N ' ' A' ' 75' ' ' SER . 78.7 p -88.65 -85.15 0.2 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.863 0.363 . . . . 0.0 110.694 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.403 ' N ' ' OG ' ' A' ' 74' ' ' SER . 90.1 p -155.26 111.55 3.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.556 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.507 ' N ' HD22 ' A' ' 76' ' ' LEU . 4.0 mm? -63.4 -41.0 98.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.261 179.829 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.448 ' O ' ' O ' ' A' ' 78' ' ' HIS . 79.5 mm-40 56.26 -106.1 0.31 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.417 -179.777 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.448 ' O ' ' O ' ' A' ' 77' ' ' GLU . 56.7 t-80 44.29 98.48 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.869 179.997 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -144.44 -161.68 1.33 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.567 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 49.58 89.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.693 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 51.1 p-80 -152.22 160.8 43.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.372 179.83 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.424 ' O ' ' OXT' ' A' ' 83' ' ' HIS . 97.1 m-70 -112.89 139.87 48.17 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.525 179.957 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.424 ' OXT' ' O ' ' A' ' 82' ' ' HIS . 51.6 p-80 . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.629 179.954 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -64.69 -28.23 69.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.818 -179.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -68.79 136.65 53.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.864 -179.161 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.77 155.93 62.9 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.136 -179.2 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 39' ' ' VAL . 39.1 Cg_endo -65.63 -23.45 56.73 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.596 2.197 . . . . 0.0 112.348 179.91 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -137.36 93.86 2.86 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.66 131.46 27.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.36 -0.382 . . . . 0.0 109.995 -179.969 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.11 101.74 14.27 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.252 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 22.2 m0 -102.85 142.06 34.61 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.083 -179.001 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -94.25 143.41 26.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.899 179.605 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.6 mt -96.66 115.59 36.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 O-C-N 123.23 0.332 . . . . 0.0 110.112 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.5 m -98.81 -44.12 6.5 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.558 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.67 177.34 27.05 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.865 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 14' ' ' PHE . 0.7 OUTLIER -86.38 154.09 21.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.875 0.369 . . . . 0.0 110.466 -179.933 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.507 ' O ' HG22 ' A' ' 18' ' ' ILE . 8.1 t -85.11 172.44 11.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.467 179.543 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.401 ' N ' ' OG ' ' A' ' 15' ' ' SER . 99.7 mtt180 -68.11 -39.09 82.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.777 179.712 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.431 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 3.0 tm-20 -69.27 -15.7 63.41 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.561 -179.844 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 15' ' ' SER . 10.6 tp -40.81 146.72 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.427 -179.567 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.4 m -80.61 143.7 55.34 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.741 -179.375 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -49.31 -39.14 43.5 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.801 1.667 . . . . 0.0 112.609 179.056 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.43 -57.83 9.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.866 0.365 . . . . 0.0 111.043 -178.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -63.69 -43.71 95.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.447 0.642 . . . . 0.0 110.551 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -57.85 -44.97 86.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.956 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -62.7 -35.72 80.62 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.541 179.178 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.2 mmtt -59.46 -44.15 93.05 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.714 179.667 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.517 HD13 HD11 ' A' ' 29' ' ' LEU . 4.6 mm? -63.32 -42.16 98.97 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.163 178.725 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.84 -39.49 94.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.745 179.901 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.7 m -61.43 -44.64 96.77 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.317 -179.461 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.517 HD11 HD13 ' A' ' 26' ' ' LEU . 2.1 pp -92.85 138.07 31.81 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.521 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.85 -2.19 90.04 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.216 -0.753 . . . . 0.0 111.216 -179.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 48.3 ttp -86.82 75.29 9.63 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.681 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -82.56 169.96 16.33 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.034 -179.262 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' A' ' 32' ' ' LEU . 73.7 Cg_exo -44.76 -179.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.531 2.154 . . . . 0.0 112.454 -179.652 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.96 11.67 7.5 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 179.609 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 86.7 p -144.33 -157.76 0.82 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.673 0.273 . . . . 0.0 110.306 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 82.8 p -140.83 164.62 29.75 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.628 -179.822 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.447 ' HB2' HG22 ' A' ' 53' ' ' THR . 41.9 p90 -143.14 162.12 36.41 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.373 -179.696 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.445 ' OD1' ' O ' ' A' ' 52' ' ' GLU . 22.2 p-10 -119.38 148.19 43.49 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.429 0.633 . . . . 0.0 110.638 179.692 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 5' ' ' PRO . 5.9 t -84.43 127.09 40.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.448 -179.716 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.416 ' H ' HG12 ' A' ' 40' ' ' VAL . 1.8 p -68.67 -39.21 80.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.813 179.464 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.412 ' HE ' HG22 ' A' ' 40' ' ' VAL . 19.3 ptp180 -172.82 160.65 4.47 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.132 -179.377 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 67.4 t -125.67 126.36 70.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.129 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.8 111.56 53.3 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.582 -179.787 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -75.74 -11.77 20.15 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.181 1.921 . . . . 0.0 112.314 -179.946 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.9 mt -58.46 -29.91 66.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.805 -178.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.96 27.42 2.08 Favored Glycine 0 N--CA 1.467 0.72 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -97.51 178.31 1.39 Allowed Pre-proline 0 CA--C 1.531 0.237 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.817 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 47' ' ' ASP . 19.5 Cg_exo -64.28 -177.88 0.56 Allowed 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.047 1.832 . . . . 0.0 112.265 -179.888 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.8 mm -106.57 117.84 53.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.885 -179.186 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.461 ' CD2' HG13 ' A' ' 59' ' ' VAL . 17.5 m170 -96.62 125.05 40.82 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.261 179.788 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.7 pt -123.63 147.85 27.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.134 179.49 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.445 ' O ' ' OD1' ' A' ' 38' ' ' ASN . 13.3 tm-20 -132.59 130.09 39.81 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.182 -179.603 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.522 ' O ' ' N ' ' A' ' 55' ' ' ARG . 1.0 OUTLIER -122.44 136.78 54.97 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.883 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.8 ptt85 -40.4 -22.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.865 -179.632 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.527 ' O ' HG13 ' A' ' 56' ' ' VAL . 94.1 mtm-85 -86.07 -49.88 7.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.101 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 55' ' ' ARG . 16.6 m -160.43 -175.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.456 -179.224 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.3 p -128.5 150.88 49.97 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.707 179.601 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.0 tp -154.28 150.5 28.07 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.16 -179.831 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.461 HG13 ' CD2' ' A' ' 50' ' ' HIS . 56.0 t -117.45 130.4 72.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.954 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 98.1 mt -135.92 139.74 43.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.979 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.564 ' O ' ' N ' ' A' ' 64' ' ' ASP . 81.8 mtp180 -78.34 142.18 37.88 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.576 179.635 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 61' ' ' ARG . 16.8 ptpt -35.22 -35.18 0.04 OUTLIER 'General case' 0 C--O 1.235 0.301 0 O-C-N 123.313 0.383 . . . . 0.0 111.385 179.799 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 61' ' ' ARG . 54.9 mtpt -62.82 -44.78 95.24 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.159 179.149 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.564 ' N ' ' O ' ' A' ' 61' ' ' ARG . 10.6 m-20 -64.13 -36.27 83.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.233 179.024 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.542 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.0 mm? -62.22 -42.86 99.69 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.725 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.16 -44.1 93.11 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.994 0.426 . . . . 0.0 110.088 179.433 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.409 HD22 ' HB3' ' A' ' 17' ' ' GLU . 97.9 mt -68.23 -38.97 82.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.658 179.559 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.5 tp -69.78 125.09 25.7 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.849 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -76.03 115.48 15.79 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.091 -179.674 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.9 m -131.87 158.73 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.731 -179.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -143.32 144.58 32.15 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.429 179.645 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.27 140.77 54.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.924 179.274 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.4 t -95.24 128.96 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.385 -179.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.2 t -160.21 -28.14 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.474 179.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.5 t -74.21 149.85 40.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.568 179.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.36 64.65 3.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.978 -179.881 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.1 -32.75 72.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.458 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -64.26 140.55 58.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.686 -179.651 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -65.67 -40.3 92.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.604 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -58.1 -42.99 86.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.516 -179.768 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -78.82 145.76 34.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.446 179.817 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.2 p-80 -152.09 163.6 39.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.665 -179.796 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 84.2 t60 . . . . . 0 C--O 1.219 -0.53 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.563 179.919 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 3' ' ' TYR . 26.1 ttt . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 55.14 -83.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.795 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.496 ' N ' ' O ' ' A' ' 1' ' ' MET . 71.0 m-85 -81.1 137.83 35.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.909 -179.581 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.81 159.34 47.38 Favored Pre-proline 0 N--CA 1.465 0.314 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.203 -179.525 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 39' ' ' VAL . 43.8 Cg_endo -66.82 -32.63 36.19 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.688 2.259 . . . . 0.0 112.119 -179.826 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -136.62 95.5 3.16 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.906 -179.758 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 t -140.11 148.79 42.22 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.382 179.313 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -101.04 102.09 13.0 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.156 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 19.8 m0 -98.48 136.41 38.64 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.178 -179.008 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -95.45 129.5 42.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.969 179.805 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.6 mt -81.86 123.67 38.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.21 -179.296 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 11.7 p -108.14 -17.94 13.9 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.498 179.845 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 136.2 -179.04 18.28 Favored Glycine 0 N--CA 1.464 0.539 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.852 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -98.68 150.87 21.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.879 0.371 . . . . 0.0 110.472 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.412 ' O ' HG22 ' A' ' 18' ' ' ILE . 5.6 t -77.13 171.64 14.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.491 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.402 ' N ' ' OG ' ' A' ' 15' ' ' SER . 9.1 mpt_? -71.78 -40.64 69.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.503 -179.802 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -66.37 -13.1 60.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.248 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 15' ' ' SER . 10.1 tp -40.61 148.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.618 -179.828 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 72.0 p -81.16 142.78 51.61 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.687 -179.46 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -49.04 -38.15 39.12 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.916 1.744 . . . . 0.0 112.638 178.938 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.97 -57.4 12.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.877 0.37 . . . . 0.0 111.451 -178.909 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -63.02 -48.48 78.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.271 0.558 . . . . 0.0 110.579 -179.623 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.5 ttp85 -58.43 -46.37 86.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.168 0.509 . . . . 0.0 110.243 -179.677 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -60.46 -31.04 70.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.576 179.382 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -61.18 -44.95 96.48 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.867 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.6 mm? -61.77 -43.1 99.52 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.308 179.621 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.75 -38.71 92.13 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.692 179.554 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.0 t -60.46 -43.92 96.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.023 -179.212 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.475 ' CD1' ' O ' ' A' ' 31' ' ' MET . 2.3 pp -97.5 131.53 44.03 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.475 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.5 -21.53 74.51 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.475 ' O ' ' CD1' ' A' ' 29' ' ' LEU . 26.0 mmt -69.48 76.29 0.4 Allowed 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -82.2 169.69 17.48 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.324 -178.984 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 32' ' ' LEU . 71.3 Cg_exo -46.5 -178.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.435 2.09 . . . . 0.0 112.275 -179.475 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.89 8.91 9.34 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 179.665 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 m -138.03 -158.25 0.84 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.784 0.326 . . . . 0.0 110.256 179.657 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.7 t -141.6 153.06 44.55 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.46 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -128.37 157.41 41.09 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.339 -179.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 39' ' ' VAL . 50.0 t-20 -110.05 146.94 34.51 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.543 -179.803 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.529 ' N ' ' OD1' ' A' ' 38' ' ' ASN . 54.3 t -88.22 126.52 41.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.041 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 p -70.27 -40.64 78.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.075 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -173.73 159.25 3.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.152 -179.279 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.4 t -131.31 120.93 47.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.772 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.49 110.75 50.69 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.444 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -76.7 -11.69 18.42 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.2 1.933 . . . . 0.0 112.299 179.805 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.8 mt -59.39 -30.91 68.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.956 -178.551 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.24 22.77 0.7 Allowed Glycine 0 N--CA 1.465 0.568 0 N-CA-C 111.006 -0.837 . . . . 0.0 111.006 179.755 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.6 159.8 30.19 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.11 171.7 2.12 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.795 2.33 . . . . 0.0 111.939 -179.814 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.4 mm -92.56 114.27 29.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.799 -179.255 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -92.0 122.21 34.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.893 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.422 ' O ' ' O ' ' A' ' 58' ' ' LEU . 45.6 pt -127.54 149.17 32.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.326 -179.966 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -126.85 129.87 49.1 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.375 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.95 138.87 54.56 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.847 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -41.16 -37.03 0.83 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.346 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.404 HH11 ' HB3' ' A' ' 31' ' ' MET . 57.9 ttp180 -65.47 -49.02 70.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.555 179.836 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.63 HG22 ' H ' ' A' ' 57' ' ' SER . 7.1 p -171.13 173.1 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.803 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.63 ' H ' HG22 ' A' ' 56' ' ' VAL . 40.0 t -92.11 136.71 32.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.151 178.812 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 51' ' ' ILE . 64.1 tp -143.03 148.72 37.21 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.791 0.329 . . . . 0.0 110.154 -179.877 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 p -130.13 130.54 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.099 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.4 mt -134.59 155.69 50.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.323 -179.506 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -77.63 170.15 17.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.683 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.15 -47.07 87.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.132 0.492 . . . . 0.0 110.578 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -58.41 -38.23 76.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.733 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -58.07 -46.56 85.24 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.37 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.0 mp -62.75 -41.49 99.24 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.175 179.172 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.68 -53.11 59.14 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.365 -179.711 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.2 mm? -68.57 -41.11 80.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.146 179.482 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.2 tp -58.15 133.13 55.33 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.185 -179.038 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.429 ' O ' ' OG1' ' A' ' 12' ' ' THR . 47.6 mm-40 -77.85 110.42 12.72 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.312 -179.46 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.36 156.9 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.472 179.608 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -141.79 137.05 31.27 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.493 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.45 117.48 27.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.203 179.768 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.454 HG23 ' H ' ' A' ' 73' ' ' VAL . 0.6 OUTLIER -65.06 -149.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.343 -179.671 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.419 ' H ' HG12 ' A' ' 73' ' ' VAL . 4.8 p 48.75 52.1 14.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.403 179.876 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.7 p -153.1 162.81 40.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.653 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.1 tp 59.82 42.04 17.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.378 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -65.9 -32.88 74.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.609 -179.808 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 44.0 p-80 -145.31 168.4 20.57 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.63 -179.616 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -60.18 133.31 55.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.577 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -85.0 130.73 34.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.582 -179.833 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 43.0 p-80 -150.75 148.57 28.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.478 179.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -154.07 143.7 21.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.57 -179.924 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.461 179.975 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.9 tpp . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -72.16 -12.66 61.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.868 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -79.4 91.78 5.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.977 -179.641 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.66 159.13 32.4 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.12 -179.257 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 39' ' ' VAL . 42.6 Cg_endo -67.5 -20.19 47.97 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.697 2.264 . . . . 0.0 112.078 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -136.47 93.81 2.93 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.823 0.344 . . . . 0.0 110.121 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.51 131.64 28.05 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.838 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.88 102.12 14.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.228 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 21.1 m0 -100.04 140.37 34.35 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.118 -179.353 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -101.39 125.23 48.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.733 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.2 mt -81.14 123.6 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.393 -179.169 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.9 p -105.29 -16.16 14.84 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.436 179.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.39 163.08 9.64 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.516 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.84 159.54 33.59 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.56 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 p -77.35 167.41 21.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.643 -179.733 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.25 -40.44 74.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.863 0.363 . . . . 0.0 110.7 179.508 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -80.47 -2.39 45.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.145 -179.725 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.6 tp -40.42 146.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.561 -179.406 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.2 p -76.23 137.95 68.3 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.461 -179.258 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -46.92 -41.97 25.42 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.883 1.722 . . . . 0.0 112.666 179.195 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.83 -54.28 44.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.912 0.387 . . . . 0.0 111.228 -179.181 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -63.07 -49.24 75.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.355 0.598 . . . . 0.0 110.557 -179.859 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.1 ttt-85 -57.2 -42.67 81.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.088 -179.247 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.524 ' NE2' ' OG ' ' A' ' 28' ' ' SER . 12.4 tm0? -62.52 -34.99 78.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.02 179.332 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -59.22 -46.47 88.36 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.942 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.492 HD22 ' N ' ' A' ' 26' ' ' LEU . 4.6 mm? -65.19 -37.79 88.46 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.821 179.557 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 tt -75.66 -23.83 56.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.082 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.524 ' OG ' ' NE2' ' A' ' 24' ' ' GLN . 49.1 m -58.11 -44.09 87.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.903 0.382 . . . . 0.0 111.317 -179.2 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.588 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -116.9 156.65 27.0 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.162 -179.675 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -63.16 -26.24 69.04 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.769 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 86.9 mtp -61.55 73.96 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.006 0.432 . . . . 0.0 110.109 -179.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -85.38 169.2 16.72 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.585 -178.357 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 32' ' ' LEU . 55.7 Cg_exo -47.69 -177.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.075 1.85 . . . . 0.0 112.009 -179.764 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.63 -4.63 39.95 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.537 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.8 m -101.18 -169.6 1.72 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.713 0.292 . . . . 0.0 110.25 179.544 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.1 t -133.05 151.26 52.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.383 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -138.11 163.53 31.42 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.228 -179.654 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -122.57 146.67 47.21 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.446 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 5' ' ' PRO . 62.1 t -85.48 126.75 40.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.295 -179.83 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 40' ' ' VAL . 2.2 p -70.04 -41.1 79.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.16 179.736 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.3 ptt-85 -174.25 169.42 3.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.966 -179.209 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.6 m -136.12 116.62 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.123 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.31 111.3 51.39 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.311 -179.745 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.497 ' C ' ' H ' ' A' ' 46' ' ' GLY . 60.3 Cg_endo -75.45 -11.76 20.68 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.287 1.991 . . . . 0.0 112.054 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.524 HD22 ' N ' ' A' ' 45' ' ' LEU . 4.2 mm? -53.0 -6.69 0.06 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.58 -178.978 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.497 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 104.37 23.69 7.88 Favored Glycine 0 N--CA 1.462 0.418 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.613 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.73 165.01 16.31 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 -179.491 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -58.06 -170.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.025 1.817 . . . . 0.0 111.704 179.257 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.8 mm -106.36 112.9 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -88.19 120.49 29.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.958 -179.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 58' ' ' LEU . 48.6 pt -126.33 147.99 31.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.144 179.901 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -127.97 129.43 46.76 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.306 179.649 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 p -114.19 136.7 52.67 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.807 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -39.04 -35.39 0.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.808 -179.433 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.556 ' O ' HG13 ' A' ' 56' ' ' VAL . 18.9 mmm180 -73.3 -49.29 28.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.109 -179.537 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 55' ' ' ARG . 15.6 m -160.94 -176.84 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.517 -179.472 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 p -106.58 148.21 28.55 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.699 179.721 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' A' ' 51' ' ' ILE . 61.0 tp -154.6 150.31 27.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.473 179.896 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 59' ' ' VAL . 12.1 p -127.57 131.33 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.82 179.194 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.6 mt -136.69 159.71 41.02 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.308 -179.445 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.405 ' HG2' ' N ' ' A' ' 62' ' ' LYS . 69.1 ttt180 -85.06 166.63 16.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.339 -179.583 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.405 ' N ' ' HG2' ' A' ' 61' ' ' ARG . 88.2 tttt -58.49 -44.43 89.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.856 0.36 . . . . 0.0 110.588 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -57.38 -39.92 77.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.723 -179.719 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -60.27 -45.15 94.3 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.394 179.992 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.5 -41.04 98.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.786 0.326 . . . . 0.0 110.127 179.47 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.06 -40.79 98.73 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.565 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.9 mt -75.8 -48.82 20.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.355 -179.641 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.2 mt -55.74 133.09 50.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.351 -179.151 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -74.27 109.38 7.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.192 -179.401 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.48 159.74 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.436 179.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -139.82 126.34 20.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.513 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.92 124.13 22.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.91 179.771 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.3 m -130.95 159.31 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.42 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.5 t -156.6 175.75 13.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.56 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.432 ' O ' ' OE1' ' A' ' 77' ' ' GLU . 2.0 t 68.27 33.52 4.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.547 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.8 tp -91.97 54.7 2.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.552 -179.817 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.432 ' OE1' ' O ' ' A' ' 75' ' ' SER . 57.8 mp0 -68.66 -35.55 77.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.447 179.955 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -139.58 146.53 39.95 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.425 -179.821 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -75.75 -152.91 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.175 -179.938 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -146.8 147.92 31.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.272 -179.955 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -81.29 154.83 26.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.555 -179.881 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -64.56 -42.08 95.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.506 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.524 ' CG ' ' O ' ' A' ' 83' ' ' HIS . 57.0 p-80 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.597 -179.944 . . . . . . . . 1 1 . 1 stop_ save_